model,disease_category,disease,incident_rate,protein,beta,odds_ratio,ci_lower,ci_upper,pvalue
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,CDH3;Cadherin-3,1.75652825497849,5.79229308200717,4.88206128215052,6.87223228240373,3.45959009497994e-90
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388387222060394,CDH3;Cadherin-3,2.14761482872305,8.56440643991882,5.32533255148,13.773610748072,8.07576286562148e-19
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,CDH3;Cadherin-3,0.349788468091022,1.41876740227211,1.29479477049052,1.5546100336715,6.48871000348662e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55549082435187,CDH3;Cadherin-3,0.313998940988379,1.368888286878,1.27632685190236,1.46816243751263,1.4926456824234e-18
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34566462763375,CDH3;Cadherin-3,0.397327066354613,1.48784247369505,1.2845998200926,1.7232411151758,1.14583869458342e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.174774249927177,CDH3;Cadherin-3,0.504809945067073,1.65667063211289,1.34771028401355,2.0364596277561,1.63828704829277e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40984561607923,CDH3;Cadherin-3,0.205853260785064,1.22857291094316,1.14165370003996,1.3221096707789,3.82735363934313e-08
primary,Circulatory system disorders,I85 (oesophageal varices),0.0504903388678512,CDH3;Cadherin-3,0.967724382554184,2.63194833195495,1.80381145915885,3.84028607142273,5.16457896654295e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0194193611030197,CDH3;Cadherin-3,1.40197975073859,4.06323620422283,2.2245234362286,7.42176422258675,5.08645296084558e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,COL1A1;Collagen alpha-1(I) chain,0.498488670973827,1.64623139237427,1.40456139083283,1.92948333545719,7.55866689928589e-10
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,COL1A1;Collagen alpha-1(I) chain,1.21157641503715,3.35877530521874,2.1919061123393,5.14683155790248,2.64000924286372e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,CHRDL2;Chordin-like protein 2,0.512062002473694,1.66872857223158,1.41406949703407,1.9692490741245,1.35377668625123e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,CHRDL2;Chordin-like protein 2,0.2569098452126,1.29292855780555,1.21399571480606,1.37699353894029,1.31126464610122e-15
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,CHRDL2;Chordin-like protein 2,0.258209665392369,1.29461022513178,1.17378546791967,1.42787219711129,2.39951712148615e-07
primary,Circulatory system disorders,I85 (oesophageal varices),0.0521612917857304,CSF1R;Macrophage colony-stimulating factor 1 receptor,1.47292658208992,4.36198217825875,2.95356323795424,6.44201156045866,1.32250103190427e-13
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311795944641132,CST6;Cystatin-M,1.4581327881283,4.29792689124629,3.64478212854622,5.06811516052565,2.44133520000059e-67
primary,Circulatory system disorders,I15 (secondary hypertension),0.0402317347924042,CST6;Cystatin-M,1.91516488947993,6.78805798407648,4.2929958612256,10.7332344788307,2.55790117418769e-16
primary,Circulatory system disorders,I50 (heart failure),0.911248793047956,CST6;Cystatin-M,0.357817543333766,1.43020464630058,1.30032166828721,1.57306102035052,1.75505070581352e-13
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57104924364338,CST6;Cystatin-M,0.205978963672367,1.2287273558122,1.14226104395755,1.32173895179897,3.15483032614619e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29120443740095,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,1.85370701561481,6.38343922513415,5.37409380789443,7.58235672796087,6.59094355859009e-99
primary,Circulatory system disorders,I15 (secondary hypertension),0.0396196513470681,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,1.76870300185826,5.86324381133538,3.91017836994965,8.79183114902384,1.15886533322324e-17
primary,Circulatory system disorders,I20 (angina pectoris),4.61568938193343,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.184074810932928,1.20210575038515,1.15344399592646,1.25282045787438,2.52826091423736e-18
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6485736925515,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.242251642480559,1.27411477388081,1.20763794038263,1.34425095696065,7.94979680244722e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70047543581616,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.267161499933927,1.30625138880958,1.24779835959899,1.36744264619431,2.70994254934026e-30
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01624405705229,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.270855767646895,1.31108595573417,1.20244774072888,1.42953936799068,8.38591719990516e-10
primary,Circulatory system disorders,I50 (heart failure),0.903328050713153,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.493888569942197,1.63867595286379,1.49842705237383,1.79205178806671,2.79838358932664e-27
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70958795562599,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.183150231662535,1.20099482197735,1.1232900696885,1.28407488086883,8.0200437069801e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56695721077654,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.188149252807529,1.20701365208261,1.12586205862205,1.29401461320838,1.16859814134684e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.166402535657686,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.56988754379156,1.7680682100063,1.43975045907423,2.17125486957301,5.40331832216385e-08
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170364500792393,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.464978663389553,1.5919802210629,1.29990614728256,1.94968000540165,6.91434440310564e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40649762282091,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.283158031961124,1.32731490342099,1.23297498689898,1.42887314954737,5.1767678303781e-14
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243660855784469,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.508517598360738,1.66282439339571,1.40010723193748,1.97483799826219,6.80443944244531e-09
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174811591950897,KLK4;Kallikrein-4,0.560594305042868,1.75171324302013,1.43499468476328,2.13833494880037,3.60186095071875e-08
primary,Circulatory system disorders,I11 (hypertensive heart disease),0.0330199673685028,KLK4;Kallikrein-4,1.10907993181562,3.03156786175398,1.98191412180524,4.63713518124008,3.14541073916468e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,KLK4;Kallikrein-4,1.05575598407006,2.87414714225816,2.48462167817583,3.32474028859622,8.12995810544472e-46
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,KLK4;Kallikrein-4,0.947895831183299,2.58027460981782,1.73384166132355,3.83992218585182,2.96609149801764e-06
primary,Circulatory system disorders,I20 (angina pectoris),4.60142957035195,KLK4;Kallikrein-4,0.220398544781745,1.24657344694129,1.1963846837009,1.29886764666036,7.62608693406144e-26
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,KLK4;Kallikrein-4,0.390493981348807,1.47771057508167,1.40180115442301,1.55773059311469,1.00347136918784e-47
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,KLK4;Kallikrein-4,0.357129008047144,1.42922023887303,1.3659466237773,1.49542482528022,6.66056093781443e-54
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,KLK4;Kallikrein-4,0.233828273626399,1.26342750975294,1.15911718610607,1.37712484253896,1.04613195585102e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359334939010177,KLK4;Kallikrein-4,0.481009389467141,1.61770647423217,1.40559631850409,1.86182490827651,1.97629814609671e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547742988112811,KLK4;Kallikrein-4,0.321152356522027,1.37871562120975,1.2289288816127,1.54675896433757,4.42466292894663e-08
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376816098205267,KLK4;Kallikrein-4,0.453785732967666,1.57426064917758,1.37383950002122,1.8039200296037,6.52170927283341e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382643151270297,KLK4;Kallikrein-4,0.431460675642796,1.53950459889422,1.34495930168624,1.76219042988511,3.86063423037005e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,KLK4;Kallikrein-4,0.451459655022473,1.57060305177902,1.48226728580112,1.66420319053614,9.51189591766375e-53
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.26447051511149,KLK4;Kallikrein-4,0.188608879761813,1.20756855560583,1.11806462058616,1.30423750974561,1.58459795816248e-06
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,KLK4;Kallikrein-4,0.636108370724927,1.88911482107579,1.73197396397075,2.06051296465592,9.80342059762363e-47
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71121125009711,KLK4;Kallikrein-4,0.221745765029131,1.24825398770395,1.16830942998302,1.33366895604143,5.15625614551706e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,KLK4;Kallikrein-4,0.232906842022651,1.26226388389956,1.17824263181806,1.35227674637666,3.42488440216343e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.174811591950897,KLK4;Kallikrein-4,0.910431859465997,2.4853956432871,2.05325521610722,3.00848694074275,9.43395132451627e-21
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.16704218786419,KLK4;Kallikrein-4,0.783963239719593,2.19013511816976,1.80138189439305,2.66278452712919,3.74465632248937e-15
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,KLK4;Kallikrein-4,0.445005227435483,1.5604983532158,1.45223025536476,1.67683816074855,7.33782335928539e-34
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149561028669101,KLK4;Kallikrein-4,0.684972447065559,1.98371717755482,1.60701387575313,2.44872424557122,1.83076647138152e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242793877709579,KLK4;Kallikrein-4,0.463068818349574,1.58894268706686,1.34166705070973,1.8817924025545,8.07459821012339e-08
primary,Circulatory system disorders,I87 (other disorders of veins),0.120425763343951,KLK4;Kallikrein-4,0.558362284812811,1.74780774382246,1.37139847421238,2.2275304857111,6.41332999229519e-06
primary,Circulatory system disorders,I89 (other non-infective disorders of lymphatic vessels and lymph nodes),0.17869629399425,KLK4;Kallikrein-4,0.492538104363346,1.63646447099573,1.33855290219871,2.00067995850774,1.55534715595622e-06
primary,Circulatory system disorders,I95 (hypotension),0.518607722787662,KLK4;Kallikrein-4,0.34504418551156,1.41205231054295,1.25445458272608,1.58944911610648,1.10019545027144e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.310485306332318,ACAN;Aggrecan core protein,0.486511763016086,1.62663223345691,1.38974289639544,1.90390066377295,1.37505061319024e-09
primary,Circulatory system disorders,I15 (secondary hypertension),0.0375746549064588,ACAN;Aggrecan core protein,1.11663328913464,3.05455307553547,1.96813322911129,4.74068236502275,6.38741719849666e-07
primary,Circulatory system disorders,I20 (angina pectoris),4.6058616461654,ACAN;Aggrecan core protein,-0.296978203439133,0.743060208342489,0.711606104274763,0.775904633061992,2.78560892897927e-41
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67373333860696,ACAN;Aggrecan core protein,-0.373719918721207,0.688169628269098,0.650225869101173,0.728327585499895,3.70780605906833e-38
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72384606257168,ACAN;Aggrecan core protein,-0.331453858644383,0.717879279375675,0.684098557174956,0.753328090451065,2.10399259430504e-41
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,NPTXR;Neuronal pentraxin receptor,0.71922862191456,2.05284907694875,1.77302179468902,2.37684011857762,6.6200668006056e-22
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,NPTXR;Neuronal pentraxin receptor,0.266730886131203,1.3056890200223,1.19413168939718,1.42766818110943,4.81413047333898e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,CCN5;CCN family member 5,1.12757929009735,3.08817187648585,2.64944164333255,3.59955297098842,3.7180892418865e-47
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,CCN5;CCN family member 5,1.41781418973502,4.12808735582646,2.73494455622195,6.23087776260986,1.48168934899427e-11
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,CCN5;CCN family member 5,0.222905362592314,1.24970229955348,1.1794262102094,1.32416578840653,4.40320355192797e-14
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71117465042497,CCN5;CCN family member 5,0.21945790717851,1.24540142439256,1.18581263532603,1.30798463574523,1.74191409043778e-18
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354471035212095,CCN5;CCN family member 5,0.465220890822778,1.59236588905339,1.37349482883961,1.84611479517766,6.97508936154943e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552269789667463,CCN5;CCN family member 5,0.367592597626051,1.44425352678599,1.28013846632965,1.6294083058173,2.33178491893429e-09
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.381888684344522,CCN5;CCN family member 5,0.359810745304126,1.4330581759053,1.2383180951479,1.65842342413945,1.37652783422318e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301594140456699,CCN5;CCN family member 5,0.393920357796296,1.48278245190998,1.25845644345685,1.74709566717521,2.51692389930751e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38580549136344,CCN5;CCN family member 5,0.383827363933834,1.46789200870484,1.26876475989283,1.69827143480997,2.46546571742075e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,CCN5;CCN family member 5,0.337961242671745,1.40208616123865,1.31667623622356,1.49303644240994,5.70207862056229e-26
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,CCN5;CCN family member 5,0.51397424931193,1.67192264612324,1.51918297836055,1.84001886174131,7.35383624334946e-26
primary,Circulatory system disorders,I63 (cerebral infarction),0.36426305275939,CCN5;CCN family member 5,0.346767003602354,1.41448711657041,1.2174453935691,1.64341974885472,5.88067508676789e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,CCN5;CCN family member 5,0.240612560049214,1.27202810531748,1.18225354293875,1.36861970969066,1.16842352945789e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174297912341858,CCN5;CCN family member 5,0.517508053045605,1.67784134421195,1.35107954597571,2.08363125970792,2.83088516127089e-06
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17038110532294,CCN5;CCN family member 5,0.539039083048853,1.71435871409623,1.37507893610008,2.1373506083463,1.661480323149e-06
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0117504210567545,CCN5;CCN family member 5,1.50761874702386,4.51596432706669,2.37260528433694,8.59558643739522,4.41217438860446e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.199723111141372,SRPX;Sushi repeat-containing protein SRPX,0.589628154341396,1.80331773483997,1.46967500300907,2.21270338417009,1.61665115523515e-08
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.56235673271146,SRPX;Sushi repeat-containing protein SRPX,0.198488025168303,1.21955742333192,1.14952458048319,1.2938568988049,4.76317248464328e-11
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00088513651528,SRPX;Sushi repeat-containing protein SRPX,0.308082707291458,1.36081353348449,1.23719972572366,1.49677811465031,2.28841928132595e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.397176641474319,SRPX;Sushi repeat-containing protein SRPX,0.517245888467952,1.67740153129878,1.44584134417924,1.94604747507808,8.83430666468518e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.553777717255622,SRPX;Sushi repeat-containing protein SRPX,0.386334681678594,1.47157709830035,1.29670150868965,1.6700367368512,2.16032113558066e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.308662989945757,SRPX;Sushi repeat-containing protein SRPX,0.403916778524496,1.49767930269027,1.26694114689187,1.77044000758012,2.22677968785173e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383559156623771,SRPX;Sushi repeat-containing protein SRPX,0.399253965729311,1.49071216033804,1.28272156524644,1.73242799153593,1.91451430723151e-07
primary,Circulatory system disorders,I45 (other conduction disorders),0.256462631351989,SRPX;Sushi repeat-containing protein SRPX,0.417703548432481,1.51847045472483,1.26487340338008,1.82291169670472,7.45536074930546e-06
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.705839631420076,SRPX;Sushi repeat-containing protein SRPX,0.359822758730047,1.43307539194695,1.28027206460021,1.60411613733462,3.97799717795028e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15383218719502,SRPX;Sushi repeat-containing protein SRPX,0.540233172898018,1.71640703513086,1.60918256467251,1.83077618097749,1.51004395984876e-60
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.23465195978302,SRPX;Sushi repeat-containing protein SRPX,0.240341161751229,1.27168292589738,1.16744383273921,1.38522935208325,3.63156711994516e-08
primary,Circulatory system disorders,I50 (heart failure),0.916910646603572,SRPX;Sushi repeat-containing protein SRPX,0.605005680605811,1.83126261153725,1.66350672555217,2.01593579448926,5.38243142931704e-35
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66133315176686,SRPX;Sushi repeat-containing protein SRPX,0.267946564380437,1.30727728297697,1.21409480832366,1.4076115661406,1.23102836854227e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55693243457933,SRPX;Sushi repeat-containing protein SRPX,0.185611652586467,1.20395461691795,1.11574510186572,1.29913787403074,1.74315882989684e-06
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.52831302058509,SRPX;Sushi repeat-containing protein SRPX,0.211492533969932,1.23552074115926,1.16261079775855,1.31300303143386,9.42673541756651e-12
primary,Circulatory system disorders,I85 (oesophageal varices),0.0522003585937677,SRPX;Sushi repeat-containing protein SRPX,0.942046290353814,2.56522524697974,1.74214993241733,3.77716087765857,1.82489161283238e-06
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0181566464673974,SRPX;Sushi repeat-containing protein SRPX,1.37389472910824,3.9507077066621,2.17067216398306,7.1904415795517,6.9070423868163e-06
primary,Circulatory system disorders,I00 (rheumatic fever without mention of heart involvement),0.367104343096884,ANGPT2;Angiopoietin-2,0.342357722372163,1.40826397495013,1.22077019731169,1.62455425886842,2.64722242754263e-06
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.116541061300598,ANGPT2;Angiopoietin-2,1.0879105878102,2.96806607585054,2.31073423100838,3.81238833631269,1.63316917895202e-17
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174811591950897,ANGPT2;Angiopoietin-2,0.786972909431764,2.19673663070354,1.79135288526445,2.69385885068778,4.0026649187115e-14
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0271929143034729,ANGPT2;Angiopoietin-2,1.66260144892557,5.27301048472359,3.17133168535886,8.76749653792791,1.46507780698082e-10
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0961075285525,ANGPT2;Angiopoietin-2,0.210686682603826,1.23452549614578,1.21046499979382,1.25906424464448,9.90577960081755e-98
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,ANGPT2;Angiopoietin-2,0.893919354016873,2.44469251435161,2.09768807402903,2.84909923630719,2.48941182576026e-30
primary,Circulatory system disorders,I20 (angina pectoris),4.60142957035195,ANGPT2;Angiopoietin-2,0.425849022205114,1.53088962734444,1.46836978244068,1.59607142501618,3.88720639386115e-89
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,ANGPT2;Angiopoietin-2,0.55979611586063,1.75031560232421,1.65783771432572,1.84795211332588,7.58172805752882e-91
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.110714008235568,ANGPT2;Angiopoietin-2,0.943665164531328,2.56938138711787,1.99725680834151,3.30539402088693,2.09369589304495e-13
primary,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.159272783777484,ANGPT2;Angiopoietin-2,0.514638467892936,1.67303353710718,1.35166657369031,2.07080745412193,2.25750781989146e-06
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,ANGPT2;Angiopoietin-2,0.514154832428567,1.67222459438801,1.59630107709129,1.75175919768939,2.69232260549595e-104
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,ANGPT2;Angiopoietin-2,0.343771335584157,1.41025612324293,1.293229205449,1.53787304274007,7.38200692938165e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359334939010177,ANGPT2;Angiopoietin-2,0.727393449231838,2.06967884776126,1.79381190383004,2.38797084784884,2.14350584194339e-23
primary,Circulatory system disorders,I31 (other diseases of pericardium),0.194235102167663,ANGPT2;Angiopoietin-2,0.491808026180674,1.63527016001198,1.34758696761266,1.98436803003741,6.30203375190645e-07
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547742988112811,ANGPT2;Angiopoietin-2,0.817270038113545,2.26430991248676,2.01638215423203,2.54272205743585,2.12953214420125e-43
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376816098205267,ANGPT2;Angiopoietin-2,0.676277122534371,1.96654288913389,1.71147380156607,2.25962613699626,1.41249559272632e-21
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0582705306502991,ANGPT2;Angiopoietin-2,1.52185885608871,4.5807322079919,3.22024486362767,6.51599752501319,2.57966172401953e-17
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304949110403232,ANGPT2;Angiopoietin-2,0.904525927147258,2.47076032497229,2.11839280444793,2.88173967105599,1.02454469509724e-30
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382643151270297,ANGPT2;Angiopoietin-2,0.673700912260278,1.96148318137239,1.70902355866508,2.2512365328726,9.36320737164732e-22
primary,Circulatory system disorders,I45 (other conduction disorders),0.260275036904669,ANGPT2;Angiopoietin-2,0.391060433298295,1.47854786423736,1.24992146284137,1.74899291822009,5.04665485871218e-06
primary,Circulatory system disorders,I46 (cardiac arrest),0.0815787429104187,ANGPT2;Angiopoietin-2,0.986994625764408,2.68315844742148,2.00078452182499,3.5982581709511,4.33772878167528e-11
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.708958122911972,ANGPT2;Angiopoietin-2,0.315231950364757,1.37057717996747,1.23652985736118,1.51915604387941,1.93744924657251e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,ANGPT2;Angiopoietin-2,0.970104513989204,2.63822017586076,2.48078806958817,2.80564300580267,1.1091033305578e-209
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.26447051511149,ANGPT2;Angiopoietin-2,0.411775366709226,1.50949531534114,1.39742988016083,1.63054772148897,1.2875290900217e-25
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,ANGPT2;Angiopoietin-2,1.04900063557338,2.85479670972672,2.60423156661051,3.1294698821556,6.00142394478663e-111
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71121125009711,ANGPT2;Angiopoietin-2,0.487081568836282,1.62755936208741,1.52273481306869,1.73959999757285,1.23149859045712e-46
primary,Circulatory system disorders,I63 (cerebral infarction),0.367104343096884,ANGPT2;Angiopoietin-2,0.522973437293181,1.68703649649618,1.46494843953405,1.94279338692314,3.82344837683699e-13
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,ANGPT2;Angiopoietin-2,0.417440570314613,1.51807118272481,1.41629764419773,1.62715805202439,4.3889850819765e-32
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132079869474011,ANGPT2;Angiopoietin-2,0.599595447866901,1.82138180742914,1.44250525834594,2.29977095004685,4.67763824815469e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,ANGPT2;Angiopoietin-2,0.409915154326972,1.50668994356722,1.30106376948548,1.74481423531172,4.36568138178246e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.174811591950897,ANGPT2;Angiopoietin-2,0.81813262410392,2.2662639171225,1.85198869321359,2.77320923225478,1.97061596909454e-15
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,ANGPT2;Angiopoietin-2,0.480185223841088,1.6163737654249,1.50209828204263,1.73934301156448,1.03400037130575e-37
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149561028669101,ANGPT2;Angiopoietin-2,0.879345955043564,2.40932338517242,1.93638668209826,2.99776859033578,3.09521668530789e-15
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242793877709579,ANGPT2;Angiopoietin-2,0.492027128248466,1.63562849033946,1.37513111058825,1.94547308093824,2.71405536714243e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55613394452645,ANGPT2;Angiopoietin-2,0.250062302289533,1.28410541690309,1.21537855096234,1.35671862928158,5.10047460499361e-19
primary,Circulatory system disorders,I85 (oesophageal varices),0.0563281796286224,ANGPT2;Angiopoietin-2,1.03626978203293,2.81868307736696,1.97017589083834,4.03262182203141,1.41966285015807e-08
primary,Circulatory system disorders,I95 (hypotension),0.518607722787662,ANGPT2;Angiopoietin-2,0.465531912879969,1.59286122699453,1.41302715097959,1.795582545391,2.60858850527578e-14
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.021365861238443,ANGPT2;Angiopoietin-2,1.68942489385307,5.41636482453147,3.05588046433192,9.600181765891,7.24175040609702e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311917606669936,SOST;Sclerostin,0.511014940781174,1.66698222489463,1.42116187576954,1.95532246220013,3.43265385043099e-10
primary,Circulatory system disorders,I08 (multiple valve diseases),0.17222361979217,GDF15;Growth/differentiation factor 15,0.549548856477681,1.73247124835423,1.44691612724197,2.07438190083295,2.23046285751677e-09
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0956711883429,GDF15;Growth/differentiation factor 15,0.289819019933281,1.33618564317473,1.31019149839325,1.36269551070647,7.9765377739528e-184
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,GDF15;Growth/differentiation factor 15,1.09543712674831,2.9904896207277,2.66200973386437,3.35950243078102,5.00828252076523e-76
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,GDF15;Growth/differentiation factor 15,1.15602576106868,3.17728087758263,2.37702203706934,4.24695842849595,5.80002555439824e-15
primary,Circulatory system disorders,I20 (angina pectoris),4.59779011939547,GDF15;Growth/differentiation factor 15,0.414221089879604,1.51319164126194,1.45488080393006,1.5738395454801,8.02036443178831e-95
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66849855835284,GDF15;Growth/differentiation factor 15,0.540558822477253,1.71696607337999,1.63318470287688,1.80504537664662,1.51980660812335e-99
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.108365423689455,GDF15;Growth/differentiation factor 15,0.622067654135587,1.8627756384786,1.48642972982476,2.33440774877291,6.58209584381469e-08
primary,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.158677941830988,GDF15;Growth/differentiation factor 15,0.495449916597332,1.64123649250647,1.35190280727501,1.99249325457389,5.52519428546936e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71538595506705,GDF15;Growth/differentiation factor 15,0.497376827220406,1.64440205743973,1.57490719479459,1.71696347279988,7.46758650615433e-113
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00818545968225,GDF15;Growth/differentiation factor 15,0.374132279667982,1.453729436586,1.34166837516214,1.57515024869037,6.1809416757038e-20
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354122723842328,GDF15;Growth/differentiation factor 15,0.578618841008776,1.78357333045236,1.57500734763914,2.01975808549038,7.55777972557851e-20
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545697312150473,GDF15;Growth/differentiation factor 15,0.471163897856341,1.60185750717221,1.44175772235392,1.7797355502245,1.79036127998482e-18
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.373473692358302,GDF15;Growth/differentiation factor 15,0.388484931295448,1.47474476080419,1.29420717545923,1.68046673728856,5.51828456411384e-09
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0580529055479226,GDF15;Growth/differentiation factor 15,0.67629889744602,1.96658571089777,1.47202078526921,2.62731300876296,4.73757452043344e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30768039940399,GDF15;Growth/differentiation factor 15,0.50284906940311,1.65342528988334,1.43937697194675,1.89930452029419,1.16987620565507e-12
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387019370319484,GDF15;Growth/differentiation factor 15,0.474563804293347,1.60731294155013,1.41827224080936,1.82155076982981,1.05660881653402e-13
primary,Circulatory system disorders,I46 (cardiac arrest),0.0812740677670917,GDF15;Growth/differentiation factor 15,0.66040754044234,1.93558100122172,1.50390623727664,2.49116182872864,2.90583387346757e-07
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.706310350833059,GDF15;Growth/differentiation factor 15,0.236319039487363,1.26657833421609,1.14703884938993,1.39857571307096,2.98038736990402e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1711786674923,GDF15;Growth/differentiation factor 15,0.385113900605126,1.46978172093492,1.39018081836456,1.55394052245362,7.28272900641347e-42
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,GDF15;Growth/differentiation factor 15,0.7357607688523,2.08706916590645,1.93122435907758,2.25549024524418,4.51704396817787e-77
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70869051996052,GDF15;Growth/differentiation factor 15,0.322538257876942,1.38062770973422,1.29635265519854,1.47038143150485,1.04862148540432e-23
primary,Circulatory system disorders,I63 (cerebral infarction),0.35992801439712,GDF15;Growth/differentiation factor 15,0.490929624775344,1.63383436709891,1.43647369421593,1.8583109108521,7.77286326431344e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56549335294231,GDF15;Growth/differentiation factor 15,0.537429247184899,1.71160109820463,1.60778578162843,1.82211980778192,1.36876459924707e-63
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.133521682760222,GDF15;Growth/differentiation factor 15,0.498568579497089,1.64636294554982,1.33400988908843,2.03185221537725,3.40350707598446e-06
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35218762699073,GDF15;Growth/differentiation factor 15,0.559637369621604,1.75003776835836,1.54241735581532,1.98560537401488,3.76871696451655e-18
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127716392205429,GDF15;Growth/differentiation factor 15,0.694736221587478,2.00318060844445,1.6469259583566,2.43649845318609,3.56542309785198e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.176093813495365,GDF15;Growth/differentiation factor 15,0.787324690141444,2.19750953621313,1.8648214729667,2.58954984793543,5.44684124148541e-21
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170288522940573,GDF15;Growth/differentiation factor 15,0.600604948914749,1.82322142266279,1.51943855328654,2.18773990489213,1.05701145572201e-10
primary,Circulatory system disorders,I72 (other aneurysm),0.106430326837858,GDF15;Growth/differentiation factor 15,0.540712928714012,1.71723068894913,1.36374752949272,2.16233663144792,4.2614875994465e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40488031425972,GDF15;Growth/differentiation factor 15,0.51807743445915,1.6787969479139,1.57184602246435,1.79302498593748,1.10208785288314e-53
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149002457573001,GDF15;Growth/differentiation factor 15,0.715174471277468,2.04454336523495,1.70540712616524,2.4511200335639,1.08851899425296e-14
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249627493856067,GDF15;Growth/differentiation factor 15,0.739623790968261,2.09514715292753,1.8221159927533,2.40909009628273,2.98408249995856e-25
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0116105811095845,GDF15;Growth/differentiation factor 15,1.12990511505581,3.09536278286537,1.94349063304889,4.92992896112767,1.95296903286747e-06
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56400332836658,GDF15;Growth/differentiation factor 15,0.23384150685511,1.26344422908877,1.19845381887039,1.33195897487506,3.99974234392201e-18
primary,Circulatory system disorders,I85 (oesophageal varices),0.0503125181415329,GDF15;Growth/differentiation factor 15,0.75353159444493,2.12448961944685,1.58089235614263,2.85500535542485,5.81568138014744e-07
primary,Circulatory system disorders,I95 (hypotension),0.512800665673317,GDF15;Growth/differentiation factor 15,0.450160712259741,1.56856425274008,1.40654761461773,1.74924317485173,5.8302373201875e-16
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0174158716643768,GDF15;Growth/differentiation factor 15,1.0871696404596,2.9658677096926,1.97686934866706,4.44964725530715,1.49828672889693e-07
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.1230012300123,COL5A1;Collagen alpha-1(V) chain,0.628473977454043,1.87474748831414,1.4238289885685,2.46846929874198,7.5628385005869e-06
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.401494580983545,COL5A1;Collagen alpha-1(V) chain,0.421266095431799,1.52388972455694,1.31144751832096,1.77074557705778,3.8085267670628e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15832347002715,COL5A1;Collagen alpha-1(V) chain,0.410765970926653,1.50797240587452,1.4129255830012,1.6094129827056,3.97977462263195e-35
primary,Circulatory system disorders,I50 (heart failure),0.907424168581308,COL5A1;Collagen alpha-1(V) chain,0.531200774832573,1.70097356907881,1.54137674941114,1.87709532001831,4.22773792239748e-26
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65935621620367,COL5A1;Collagen alpha-1(V) chain,0.194870048840189,1.21515306567872,1.12811831947326,1.30890257479184,2.75949512997439e-07
primary,Circulatory system disorders,I85 (oesophageal varices),0.0533778922694887,COL5A1;Collagen alpha-1(V) chain,1.17959129056046,3.25304438120701,2.16208310928004,4.89449165977081,1.51939369219538e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.018566223398083,COL5A1;Collagen alpha-1(V) chain,1.54918014334344,4.70760903540928,2.39952810634156,9.23580881244845,6.61962136042886e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202373914229842,VGF;Neurosecretory protein VGF,1.50247894621704,4.49281271827102,3.67236172267431,5.49656260624521,2.64915177797656e-48
primary,Circulatory system disorders,I50 (heart failure),0.916367274546364,VGF;Neurosecretory protein VGF,0.250040770014305,1.28407776748951,1.16327476327848,1.41742584384264,7.04395082214921e-07
primary,Circulatory system disorders,I85 (oesophageal varices),0.0510063954172715,DPP10;Inactive dipeptidyl peptidase 10,1.01904283202631,2.77054162070589,1.91669966615221,4.00474889604014,5.92804331999476e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0196178443912582,DPP10;Inactive dipeptidyl peptidase 10,1.76282258877927,5.82886669063814,3.2664622034581,10.4013715086805,2.42964978069916e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202811385411567,PRRT3;Proline-rich transmembrane protein 3,1.75873111741198,5.80506677101567,4.71875037359414,7.14146703002704,3.73639250357724e-62
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5572184535049,PRRT3;Proline-rich transmembrane protein 3,0.202244806460904,1.22414765068663,1.13404663165735,1.32140727625244,2.16220767327346e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40569270578362,PRRT3;Proline-rich transmembrane protein 3,0.203311391750598,1.22545400510862,1.1304987201308,1.3283849790321,7.78270387417713e-07
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.125409322092942,C7;Complement component C7,0.786692133210351,2.19611992587501,1.67921416658612,2.87214271103394,9.16695309476312e-09
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174179614017975,C7;Complement component C7,0.628393468831342,1.8745965610515,1.49924651253161,2.34391892015958,3.54076341515492e-08
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.917508534801,C7;Complement component C7,0.213582056368205,1.23810508850698,1.21175323627941,1.26503001130291,2.49820830193483e-84
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202048352260851,C7;Complement component C7,0.844028198344687,2.32571658078982,1.90259094963076,2.84294299581864,1.75265932972499e-16
primary,Circulatory system disorders,I20 (angina pectoris),4.42880698576371,C7;Complement component C7,0.249309026741913,1.28313849591666,1.22554245669808,1.34344133955114,1.94591262288722e-26
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.5801806823196,C7;Complement component C7,0.346580808002894,1.41422376981157,1.33317213597044,1.5002030249036,1.18176696342898e-30
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54629694140597,C7;Complement component C7,0.302909904655324,1.35379248854676,1.2865787251801,1.42451764993167,2.07548639736046e-31
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.397129519960983,C7;Complement component C7,0.701412737717693,2.01659962237296,1.73877463539451,2.33881605710913,1.78849201981873e-20
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555052370003948,C7;Complement component C7,0.475591235595623,1.60896519382134,1.41860482986343,1.82486971736714,1.33337302679641e-13
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0534150816321791,C7;Complement component C7,0.919290641370057,2.5075110343184,1.67947873233419,3.74378756109035,6.94490776734809e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.308878515525209,C7;Complement component C7,0.428911257078197,1.53558475607264,1.29981916411926,1.81411430772404,4.57534057818104e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.380872755985972,C7;Complement component C7,0.430904711412546,1.53864892728837,1.32401744962999,1.78807350470136,1.89183499789577e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15750481896932,C7;Complement component C7,0.502797216327825,1.65333955692009,1.55033356656113,1.76318938674603,5.65790276520492e-53
primary,Circulatory system disorders,I50 (heart failure),0.905733992893471,C7;Complement component C7,0.737647185349658,2.09100996343624,1.89935405400629,2.3020050727073,4.06843373210502e-51
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65818992545112,C7;Complement component C7,0.307905691967503,1.36057266995491,1.26378615294974,1.46477154058663,2.88591806706039e-16
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5652941313082,C7;Complement component C7,0.293771724854174,1.3414776427079,1.24369577699709,1.44694731554866,2.79060625689857e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41433846582596,C7;Complement component C7,0.30667550089265,1.35889993470259,1.2541716844815,1.47237340420273,6.64703368196569e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.0534150816321791,C7;Complement component C7,1.6505423157573,5.20980442022952,3.52748540497131,7.69445057342876,1.07861959794093e-16
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.018579158828584,C7;Complement component C7,1.82132614032092,6.1800486296925,3.2524487268307,11.7428449371992,2.68166658575261e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.309968022286308,CLC;Galectin-10,0.461695824618059,1.58676257569989,1.35726737887686,1.85506224552839,6.9375988591481e-09
primary,Circulatory system disorders,I50 (heart failure),0.91224766052616,CLC;Galectin-10,0.216020647707793,1.24112800518449,1.13222151555795,1.3605100274871,4.02355047863261e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.297310513447432,KLK6;Kallikrein-6,1.57217013368387,4.8170905895262,4.07478575201459,5.69462130278372,1.03964301770217e-75
primary,Circulatory system disorders,I15 (secondary hypertension),0.0391198044009779,KLK6;Kallikrein-6,2.06633555207017,7.89583615921815,5.01700448607299,12.4265841950673,4.24603004020219e-19
primary,Circulatory system disorders,I50 (heart failure),0.903667481662591,KLK6;Kallikrein-6,0.26903726072755,1.30870390339758,1.19294421618879,1.4356965594249,1.24367377723075e-08
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,PLA2G15;Phospholipase A2 group XV,0.265366384642449,1.30390862036586,1.19108215886629,1.42742268248119,9.09510677328493e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56024214020699,PLA2G15;Phospholipase A2 group XV,0.256237772428729,1.29205990764112,1.20520890516941,1.38516965629201,5.3018533652894e-13
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34954110525288,PLA2G15;Phospholipase A2 group XV,0.332445754174247,1.39437425815029,1.20484134496797,1.61372248712452,8.1998269624011e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40597539543057,PLA2G15;Phospholipase A2 group XV,0.256497373878803,1.29239537180834,1.20053814344725,1.39128090697354,9.18667049985577e-12
primary,Circulatory system disorders,I85 (oesophageal varices),0.0566295645381761,PLA2G15;Phospholipase A2 group XV,0.95636194305581,2.60221223549138,1.81896269762827,3.72273083300188,1.65472582555112e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214801796524116,PLA2G15;Phospholipase A2 group XV,1.63648328926495,5.13707211258111,2.93407929827692,8.99413656112028,1.02421017353362e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303395619851316,GFAP;Glial fibrillary acidic protein,0.479730533499072,1.61563898294658,1.37606814510045,1.89691864644255,4.67702494553598e-09
primary,Circulatory system disorders,I85 (oesophageal varices),0.0570720091315214,CDHR2;Cadherin-related family member 2,0.94528402341731,2.57354422161957,1.85937179363661,3.56202556331014,1.19884826581152e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216480034636805,CDHR2;Cadherin-related family member 2,1.41315290242106,4.10888993171807,2.65938044694065,6.34846228579153,1.93619052134202e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306225288782076,SPP1;Osteopontin,1.21268302257197,3.36249420858299,2.88729895786196,3.91589768422403,7.29852583736125e-55
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387626947825412,SPP1;Osteopontin,1.78722280154729,5.9728416447114,3.95436436631433,9.02163635114121,1.99886839507209e-17
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0097681990852,SPP1;Osteopontin,0.344600176032609,1.41142548510081,1.29442836791535,1.53899740562726,5.93407327224419e-15
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17458717730056,SPP1;Osteopontin,0.190657790828925,1.2100452926242,1.13943183207018,1.28503484718496,5.13975431450311e-10
primary,Circulatory system disorders,I50 (heart failure),0.914799596867974,SPP1;Osteopontin,0.43932779552743,1.55166383249812,1.41634780639731,1.69990777562397,3.84559778495969e-21
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56601286921466,SPP1;Osteopontin,0.244611327992989,1.2771248340549,1.19059755809486,1.36994052328621,8.27161727972183e-12
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352740522521125,SPP1;Osteopontin,0.385531930903753,1.47039626266623,1.27103993202564,1.70102064835772,2.1449079282876e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176370261260562,SPP1;Osteopontin,0.539452407861856,1.71506744754963,1.39784262454745,2.10428291281838,2.34542859832277e-07
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170555857043181,SPP1;Osteopontin,0.502287817668586,1.65249756244016,1.34142343830315,2.03570931884489,2.35403894850342e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40320955112799,SPP1;Osteopontin,0.206030538799794,1.22879072921639,1.14166116913593,1.3225698631328,4.00575900269736e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56609039460423,SPP1;Osteopontin,0.203617250347359,1.22582887807716,1.16064889810521,1.29466924991789,2.79090271383544e-13
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,PODXL2;Podocalyxin-like protein 2,1.23013954049253,3.42170696965411,2.92312543399378,4.00532883400188,6.61015186502703e-53
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,PODXL2;Podocalyxin-like protein 2,1.54688043341581,4.69679533912332,3.0777039978766,7.16764395563392,7.35910497277686e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214801796524116,PODXL2;Podocalyxin-like protein 2,1.37524114818551,3.95603059750383,2.23685402099867,6.99651293355265,2.27416850990503e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,SEZ6L;Seizure 6-like protein,1.3291782559763,3.7779376140119,3.24329766873274,4.40071004057508,2.35432674137916e-65
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,SEZ6L;Seizure 6-like protein,1.63173366693911,5.11273081193764,3.48477331714287,7.50120997160539,7.24108846717004e-17
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,SEZ6L;Seizure 6-like protein,0.228344082298429,1.25651759652229,1.14450442165908,1.37949355239839,1.64196300011979e-06
primary,Circulatory system disorders,I85 (oesophageal varices),0.0566295645381761,SEZ6L;Seizure 6-like protein,0.953980946796694,2.59602374819941,1.80893261334714,3.72558891994615,2.26796359073819e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214801796524116,SEZ6L;Seizure 6-like protein,1.28611474230665,3.61869962723295,2.0836694162476,6.28457992905521,4.95496320314206e-06
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.113906400361358,TFPI;Tissue factor pathway inhibitor,-0.764665078471083,0.465489807427664,0.358254006062064,0.604824390383806,1.04282913307058e-08
primary,Circulatory system disorders,I20 (angina pectoris),4.60338969736247,TFPI;Tissue factor pathway inhibitor,-0.363225864938767,0.69542934265321,0.666520627036267,0.725591903694768,4.23628205470728e-63
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67483650503741,TFPI;Tissue factor pathway inhibitor,-0.405152288088533,0.66687524596861,0.63104436673006,0.704740612756205,7.05146467656888e-47
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71177752901667,TFPI;Tissue factor pathway inhibitor,-0.419565611697361,0.657332295266979,0.626955886465007,0.689180460266835,1.15876262485372e-67
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.349574814902099,TFPI;Tissue factor pathway inhibitor,-0.414541868129408,0.66064287294129,0.569238931990111,0.766723744706386,4.86667302282845e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545965160352717,TFPI;Tissue factor pathway inhibitor,-0.384395655156621,0.680861987324195,0.604343762416352,0.767068470980069,2.62221337090678e-10
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.375105559810679,TFPI;Tissue factor pathway inhibitor,-0.474955274722783,0.62191287106857,0.538757631529257,0.717902813001264,8.84208624081116e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388852883992222,TFPI;Tissue factor pathway inhibitor,-0.383122307701932,0.681729513416602,0.592066489601421,0.784971177436692,1.00928547472283e-07
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.714860857440248,TFPI;Tissue factor pathway inhibitor,-0.315318937727689,0.729556154177385,0.657312972987607,0.809739353962412,3.09068794920584e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17207722068383,TFPI;Tissue factor pathway inhibitor,-0.614702085960744,0.540801983816297,0.508641589948476,0.574995815283742,5.66924890124696e-86
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25297040397494,TFPI;Tissue factor pathway inhibitor,-0.229379978445281,0.795026383214379,0.734708070116138,0.860296729702483,1.21288302356028e-08
primary,Circulatory system disorders,I50 (heart failure),0.921070720163396,TFPI;Tissue factor pathway inhibitor,-0.405832598348934,0.666421718183665,0.6077444758306,0.73076420128689,6.13165911463756e-18
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70466819851136,TFPI;Tissue factor pathway inhibitor,-0.284210994623833,0.752607831746091,0.703199452041417,0.805487755659104,2.33625933980813e-16
primary,Circulatory system disorders,I63 (cerebral infarction),0.367249945992655,TFPI;Tissue factor pathway inhibitor,-0.395929012391629,0.673054472768909,0.582136063977784,0.778172580854778,8.92915467792704e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57308666705944,TFPI;Tissue factor pathway inhibitor,-0.290245057404668,0.748080222516636,0.697029927670186,0.802869427990095,8.39429029729581e-16
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174811591950897,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.487403369753773,1.62808319646407,1.3420502907553,1.97507866349546,7.63565122652113e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.54696673941321,4.69720071822271,4.12669791340937,5.34657371347143,3.00097202170819e-121
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.5519679328234,4.72075116859278,3.46251376915389,6.43621746555995,9.8869328727751e-23
primary,Circulatory system disorders,I20 (angina pectoris),4.60142957035195,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.260827664807114,1.29800395439575,1.24650979850019,1.35162536841201,1.46645604403535e-36
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.38605204410154,1.47116123408704,1.39708235520163,1.54916807060249,1.45029085636981e-48
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.385848909610564,1.47086242084927,1.40692338854347,1.53770722605323,6.2546107097127e-65
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.436272854991202,1.54693082496687,1.4243369690049,1.68007643507598,3.92009680895172e-25
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359334939010177,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.603910971522037,1.82925900860289,1.60397448594669,2.08618562818338,2.13444379378088e-19
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547742988112811,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.364235726775788,1.43941348246841,1.2865770116516,1.61040587135323,2.02039054383938e-10
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376816098205267,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.329425901692964,1.39016980519603,1.21438668734232,1.59139762270302,1.78743763471563e-06
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0582705306502991,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.765355230033469,2.14975789760396,1.58031637728518,2.92438848621552,1.09016175463466e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304949110403232,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.508966772679397,1.66357145917849,1.44011784732053,1.92169689789094,4.65027055267204e-12
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382643151270297,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.406253513734586,1.50118307474974,1.31584532662516,1.71262577623385,1.51769147507949e-09
primary,Circulatory system disorders,I45 (other conduction disorders),0.260275036904669,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.371188306101508,1.4494559890966,1.2347276777342,1.70152714822374,5.69542329191421e-06
primary,Circulatory system disorders,I46 (cardiac arrest),0.0815787429104187,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.701166366825916,2.01610285212301,1.55188585208445,2.61918149771067,1.50969105464741e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.384083823083733,1.46826851131824,1.38709355258853,1.55419395995722,5.41608591355739e-40
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.26447051511149,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.207642354333859,1.23077291022779,1.14074941129685,1.32790071294317,8.41831435960822e-08
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.716543787017691,2.0473449083073,1.88779477285979,2.22037969054338,3.98550408177529e-67
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71121125009711,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.206582078991496,1.22946864362207,1.15147535074863,1.31274468417161,6.49225302679937e-10
primary,Circulatory system disorders,I61 (intracerebral haemorrhage),0.0893481469971253,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.601278358204796,1.82444961039673,1.40618537327808,2.36712487850527,6.01938184219525e-06
primary,Circulatory system disorders,I63 (cerebral infarction),0.367104343096884,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.566841311446956,1.76269045853633,1.54804683289361,2.0070953840636,1.16732745775801e-17
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.471937477125282,1.60309715035087,1.50111833082017,1.71200392447339,5.56204355193923e-45
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132079869474011,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.618871210861059,1.8568308879076,1.50409183190201,2.29229417589999,8.54550066595305e-09
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.547187356751398,1.72838484489482,1.50913800052929,1.97948376557634,2.65340740657272e-15
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126252816408981,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.635082532248527,1.88717788806606,1.51849257848925,2.34537885245955,1.02519391630147e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.174811591950897,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.8436481468645,2.32483285670176,1.95691955703851,2.76191619229328,8.14669890722893e-22
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.16704218786419,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.60629998695003,1.83363436090733,1.52024190725704,2.21163155248525,2.29632547790513e-10
primary,Circulatory system disorders,I72 (other aneurysm),0.106829306192215,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.568159420401022,1.76501540854507,1.38797136711586,2.24448390378177,3.5905102792062e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.446108088698872,1.56222031576951,1.45653628053452,1.67557262226751,9.30931712981575e-36
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149561028669101,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.681086204113977,1.97602293119473,1.62498884056905,2.40288827044502,8.78155919397171e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242793877709579,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.594240904424884,1.81165520341801,1.54641516618777,2.12238902452216,1.87494001540555e-13
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0116541061300598,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.49908774562615,4.47760249416335,2.64682781644051,7.57469903074388,2.28691105230722e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55613394452645,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.257567595849458,1.29377926213285,1.22561235190568,1.36573752420359,1.09276665006704e-20
primary,Circulatory system disorders,I85 (oesophageal varices),0.0563281796286224,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.982084404011479,2.67001583741715,2.00012599653517,3.56426774333617,2.67781513345103e-11
primary,Circulatory system disorders,I95 (hypotension),0.518607722787662,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.426169108216881,1.53137972213177,1.36590943454756,1.71689556718904,2.78003056333767e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.021365861238443,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.45320666788149,4.27680684921076,2.86201004080993,6.39098974659075,1.33380644927261e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302321045445679,CRLF1;Cytokine receptor-like factor 1,0.468733864943319,1.59796966641148,1.36126023360831,1.87584048349271,1.00242543403322e-08
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64287107470255,CRLF1;Cytokine receptor-like factor 1,0.193150735338939,1.21306563159782,1.14713894886287,1.28278115569392,1.24666958221236e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1650087770626,CRLF1;Cytokine receptor-like factor 1,0.276368352099292,1.31833338547049,1.24042989234584,1.40112950032127,5.95132034031393e-19
primary,Circulatory system disorders,I50 (heart failure),0.905012677979325,CRLF1;Cytokine receptor-like factor 1,0.298030438953113,1.34720279469815,1.2266174580728,1.47964253899832,4.68304087417724e-10
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70470060464209,CRLF1;Cytokine receptor-like factor 1,0.217556019674352,1.24303506197669,1.16174040165364,1.33001844741221,2.89517764761743e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.175541252194265,CRLF1;Cytokine receptor-like factor 1,0.501551520206276,1.65128128050606,1.33749325140308,2.03868682289746,3.09659865855142e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40433001755412,CRLF1;Cytokine receptor-like factor 1,0.262180876307,1.29976161725031,1.20696724023622,1.3996902362872,3.98949797401719e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202373914229842,VWC2L;von Willebrand factor C domain-containing protein 2-like,0.928390597347126,2.53043341247702,2.10072275021844,3.04804299106785,1.41165203723139e-22
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,ITGA11;Integrin alpha-11,-0.474922077793485,0.621933517008869,0.530701465572826,0.72884912643216,4.41611716756335e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.58272844979793,ITGA11;Integrin alpha-11,-0.332981440465237,0.716783497200483,0.687106873462271,0.747741874957631,9.59641897701465e-54
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64840899281986,ITGA11;Integrin alpha-11,-0.329162931003238,0.71952577413987,0.680782530559941,0.760473890576714,2.14103705894317e-31
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68619296111743,ITGA11;Integrin alpha-11,-0.357181819030171,0.699645277343626,0.667379921097589,0.733470544490146,9.73438532665727e-50
primary,Circulatory system disorders,I50 (heart failure),0.904382626437007,ITGA11;Integrin alpha-11,-0.326898549399403,0.72115690111632,0.657242651660314,0.791286558646049,5.05798341867341e-12
primary,Circulatory system disorders,I63 (cerebral infarction),0.364891905677404,ITGA11;Integrin alpha-11,-0.372752051060432,0.68883600782902,0.596093915942854,0.796007194489316,4.3663561641152e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56942755130066,ITGA11;Integrin alpha-11,-0.327504058757367,0.720720366040508,0.671751315848899,0.773259141843504,7.33189225285953e-20
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.13143955742143,ITGA11;Integrin alpha-11,-0.57909454416186,0.560405559395876,0.44037513304155,0.713151963946551,2.49055147164561e-06
primary,Circulatory system disorders,I70 (atherosclerosis),0.176560599521324,ITGA11;Integrin alpha-11,-0.472601494956863,0.623378441138606,0.506259807921422,0.767591412148432,8.54485242666789e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39875230509671,ITGA11;Integrin alpha-11,-0.300573762733859,0.740393288710849,0.687524952067668,0.797327021105864,1.83472158412353e-15
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24914662376898,ITGA11;Integrin alpha-11,-0.503980620679261,0.604121090198796,0.507402020129252,0.719276386660844,1.49974669506727e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,PTPRR;Receptor-type tyrosine-protein phosphatase R,1.39970454533608,4.05400201608013,3.34156280355493,4.91833711127541,9.86741105025277e-46
primary,Circulatory system disorders,I50 (heart failure),0.910021613013309,PTPRR;Receptor-type tyrosine-protein phosphatase R,0.315251864055,1.37060447348864,1.24460598309271,1.50935850242265,1.48038525911904e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.308419450452615,CHI3L1;Chitinase-3-like protein 1,0.678509030584598,1.97093693376701,1.68970727163015,2.29897359270947,5.72025141206491e-18
primary,Circulatory system disorders,I20 (angina pectoris),4.56821276936633,CHI3L1;Chitinase-3-like protein 1,0.193406767876541,1.21337625563299,1.16344807773386,1.26544704994625,1.8558453745113e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65360890811503,CHI3L1;Chitinase-3-like protein 1,0.233259396114142,1.26270897865175,1.1959153312682,1.33323315044129,4.02538132842108e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68901706320596,CHI3L1;Chitinase-3-like protein 1,0.245622161580099,1.27841644742521,1.22032674577396,1.33927132114993,4.0926219292626e-25
primary,Circulatory system disorders,I26 (pulmonary embolism),0.997356404710406,CHI3L1;Chitinase-3-like protein 1,0.250908192616424,1.28519208879178,1.17663150549876,1.40376889227764,2.51370949080443e-08
primary,Circulatory system disorders,I50 (heart failure),0.923255627653608,CHI3L1;Chitinase-3-like protein 1,0.34251785235075,1.40848949828633,1.28653713916047,1.54200186407166,1.23736899758305e-13
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56813266041816,CHI3L1;Chitinase-3-like protein 1,0.258389960834317,1.29484365849732,1.20695951346702,1.38912704298971,5.78771731284583e-13
primary,Circulatory system disorders,I70 (atherosclerosis),0.166226067451734,CHI3L1;Chitinase-3-like protein 1,0.51959853820541,1.68135251538947,1.36326395966797,2.07366024822882,1.19752120801141e-06
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170231514860209,CHI3L1;Chitinase-3-like protein 1,0.47550842692302,1.60883196306578,1.30789279869203,1.97901562572299,6.78465967876411e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39189297444524,CHI3L1;Chitinase-3-like protein 1,0.262133066681613,1.29969947761975,1.20590523908412,1.40078894873034,6.92483600596083e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248337739325482,CHI3L1;Chitinase-3-like protein 1,0.454122462844404,1.5747908390323,1.32428572099934,1.87268211638544,2.78453659530822e-07
primary,Circulatory system disorders,I20 (angina pectoris),4.58852481252543,FLT3LG;Fms-related tyrosine kinase 3 ligand,0.194133280425019,1.21425810900872,1.16514353421652,1.26544302224951,3.10145959502993e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65274090724126,FLT3LG;Fms-related tyrosine kinase 3 ligand,0.243364394339237,1.27553333657137,1.20908072167116,1.34563827174097,4.88081750186207e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,FLT3LG;Fms-related tyrosine kinase 3 ligand,0.239131304009642,1.27014530080601,1.2134134998949,1.3295295340783,1.09898729137872e-24
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,FLT3LG;Fms-related tyrosine kinase 3 ligand,0.197086498092596,1.2178493777983599,1.13152647563546,1.31075775860297,1.48676263586403e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,COL9A1;Collagen alpha-1(IX) chain,0.430112706739373,1.53743079259544,1.31017997220639,1.80409828585619,1.36059811585767e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,TIMP4;Metalloproteinase inhibitor 4,0.843579963831057,2.32467434794921,1.9902486805794,2.71529426284551,1.8397114813764e-26
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,TIMP4;Metalloproteinase inhibitor 4,1.05829532673538,2.88145486119732,1.88664556115658,4.40081713707146,9.68837569743518e-07
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,TIMP4;Metalloproteinase inhibitor 4,0.193704479470094,1.21373754558907,1.1486550274535,1.28250762357998,5.63152074478564e-12
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,TIMP4;Metalloproteinase inhibitor 4,0.244424935355792,1.27688680957275,1.16748736853594,1.39653752871475,8.87226065182863e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354471035212095,TIMP4;Metalloproteinase inhibitor 4,0.368388317839848,1.44540320586188,1.24501348612003,1.67804642343799,1.31173124703643e-06
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552269789667463,TIMP4;Metalloproteinase inhibitor 4,0.305905401989537,1.3578538501994,1.20496508161416,1.53014150089017,5.18962168559196e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301594140456699,TIMP4;Metalloproteinase inhibitor 4,0.384565196606986,1.46897546704585,1.25252989892025,1.72282428119503,2.26099985323562e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38580549136344,TIMP4;Metalloproteinase inhibitor 4,0.331270974842138,1.39273713790638,1.20899145373946,1.60440897187821,4.45269839755092e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,TIMP4;Metalloproteinase inhibitor 4,0.331936117704761,1.39366381522541,1.31150692342981,1.48096727144162,9.382171572862e-27
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,TIMP4;Metalloproteinase inhibitor 4,0.544597718084888,1.72391474314217,1.57335984199682,1.88887625214278,1.60826818940288e-31
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,TIMP4;Metalloproteinase inhibitor 4,0.230513457547097,1.25924641353955,1.17226438051025,1.35268251460649,2.75227718192694e-10
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.119462614077004,TIMP4;Metalloproteinase inhibitor 4,0.692319453803299,1.99834523142929,1.55809727560827,2.56298738627676,4.9616785802055e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,TIMP4;Metalloproteinase inhibitor 4,0.272087043025083,1.31270125782693,1.21714360990947,1.41576111337311,1.71581136597088e-12
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150797070228349,TIMP4;Metalloproteinase inhibitor 4,0.514243488098989,1.67237285315242,1.33858811452451,2.0893887594054,5.97489158571019e-06
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.115645458465639,ESM1;Endothelial cell-specific molecule 1,0.664400833512491,1.94332579674798,1.51089555106765,2.49952099576808,2.29550467363993e-07
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0274412952291348,ESM1;Endothelial cell-specific molecule 1,1.28069728476981,3.59914848222969,2.18163434346179,5.93769062902688,5.33117132951093e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303814340036849,ESM1;Endothelial cell-specific molecule 1,0.421399464000096,1.5240929771012,1.30540752776435,1.77941321269025,9.68428014134104e-08
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392018503273354,ESM1;Endothelial cell-specific molecule 1,0.993608554554557,2.70096348203562,1.793844093377,4.06679920413617,1.94961827879705e-06
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358696930495119,ESM1;Endothelial cell-specific molecule 1,0.397284609304959,1.48777930563424,1.2885549640477,1.71780585542143,6.08475904718857e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546865812066329,ESM1;Endothelial cell-specific molecule 1,0.376247468136473,1.45680760262959,1.29682071074969,1.63653184552587,2.31207478571857e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16786232310165,ESM1;Endothelial cell-specific molecule 1,0.474960128307222,1.60795008451587,1.51556940002347,1.70596178192471,8.98474490812552e-56
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.2564193029911,ESM1;Endothelial cell-specific molecule 1,0.2843015481619,1.3288335776654,1.22993728422479,1.43568188376693,5.80556930348332e-13
primary,Circulatory system disorders,I50 (heart failure),0.905562742561448,ESM1;Endothelial cell-specific molecule 1,0.404063239706886,1.49789867063583,1.3686330719958,1.63937323553107,1.70920413443148e-18
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70332039672272,ESM1;Endothelial cell-specific molecule 1,0.212130856721286,1.2363096539218,1.15648065023453,1.32164905661871,4.70009357096482e-10
primary,Circulatory system disorders,I85 (oesophageal varices),0.0529224979419028,ESM1;Endothelial cell-specific molecule 1,1.33630611013775,3.80496240231148,2.66783023379793,5.4267841707429,1.61973967195759e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215610176800345,ESM1;Endothelial cell-specific molecule 1,1.31483637102112,3.72414155791227,2.13394591299689,6.49933546061224,3.69638797158725e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.195783818239766,GSN;Gelsolin,0.636466884207987,1.88979221563048,1.52820691524274,2.33693132954466,4.25641675954335e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55598051268041,GSN;Gelsolin,-0.228598769747079,0.795647707400576,0.756223639030698,0.83712706350098,1.18166120643948e-18
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311917606669936,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.797259798295297,2.21945084528524,1.90736431817914,2.5826015552917,6.24230023098227e-25
primary,Circulatory system disorders,I50 (heart failure),0.9122118685630209,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.224400490079128,1.2515721613044,1.14328729561376,1.37011307740566,1.17242043795043e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57920549288867,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.23334916015979,1.26282232960549,1.17821504454342,1.35350523958742,4.25159916978956e-11
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357037763609612,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.441888031376894,1.55564154764009,1.34663778946081,1.79708355408103,1.93792614373625e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.176557135850907,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.465973622811258,1.59356496503025,1.3008388081365,1.95216292894101,6.80290470899151e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40264835703776,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.270362992869878,1.31044004480206,1.2172089000652,1.41081215469985,6.97150278435533e-13
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249141736145169,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.437403782650033,1.54868128145638,1.3042862169715,1.83887070209359,5.98828198686603e-07
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.8275501387057,OCLN;Occludin,0.192101714167824,1.21179376729125,1.18631288875577,1.23782195099141,3.10707256469023e-70
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202373914229842,OCLN;Occludin,1.3613925619186,3.90162277177395,3.20760495910146,4.74580269307518,2.92915994699334e-42
primary,Circulatory system disorders,I15 (secondary hypertension),0.0204647778434671,OCLN;Occludin,1.42421139176588,4.15458021437713,2.29043500580967,7.53592078094891,2.7624723358256e-06
primary,Circulatory system disorders,I20 (angina pectoris),4.45222611305652,OCLN;Occludin,0.31290394025976,1.36739017357374,1.30634933099329,1.43128322756085,4.074372441597e-41
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.57174041566237,OCLN;Occludin,0.429862532253192,1.53704621474466,1.44771645753874,1.63188796670681,5.70796661317706e-45
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.118240938651143,OCLN;Occludin,0.677313277262345,1.96858158786749,1.50959480374502,2.56712162659608,5.71629806872754e-07
primary,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.159170494338078,OCLN;Occludin,0.532297403234797,1.70283992817025,1.35219793652951,2.14440781385379,6.04296529283351e-06
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55859748055846,OCLN;Occludin,0.387777116558896,1.47370128406752,1.40021016951979,1.55104963664639,6.2254554601008e-50
primary,Circulatory system disorders,I26 (pulmonary embolism),0.998226385920232,OCLN;Occludin,0.357394777843493,1.4296001329248,1.30310178101986,1.56837828773365,4.00841952991063e-14
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.395652371640365,OCLN;Occludin,0.550219074117861,1.73363277033876,1.5001881533249,2.00340375687632,8.89122957149071e-14
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554822865978443,OCLN;Occludin,0.40383537721986,1.49755739460291,1.32306005524321,1.69506904939216,1.67135188118761e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.306971667652007,OCLN;Occludin,0.572487915304898,1.7726718271766,1.5026974905884,2.09114970015369,1.11334243716958e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382009186411387,OCLN;Occludin,0.345624109006079,1.41287143034378,1.21557713475444,1.64218758448835,6.67152931641256e-06
primary,Circulatory system disorders,I46 (cardiac arrest),0.0864068397835281,OCLN;Occludin,0.81790133656852,2.26573981913754,1.66963276205203,3.07467429048056,1.51439154939982e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14425394515439,OCLN;Occludin,0.401333860077758,1.49381591075307,1.40044965892304,1.5934067754603,3.61495045550853e-34
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.241529855837,OCLN;Occludin,0.207616412700959,1.2307409823829,1.13136299527964,1.33884824944485,1.34375294688427e-06
primary,Circulatory system disorders,I50 (heart failure),0.916367274546364,OCLN;Occludin,0.751179627768046,2.11949876212226,1.92413549321368,2.33469785183101,2.41968306931087e-52
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65992086952567,OCLN;Occludin,0.319859563014749,1.37693437824402,1.28051252616287,1.48061673997955,5.85890148036045e-18
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55759698030833,OCLN;Occludin,0.403400459373437,1.49690622177955,1.38892029343675,1.61328785200328,4.57752058392064e-26
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343353494929282,OCLN;Occludin,0.409363287942475,1.50585868142942,1.28674772565026,1.76228045578274,3.35278365551126e-07
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.131884123880121,OCLN;Occludin,0.692873470802261,1.99945265539482,1.56039112894367,2.56205694009027,4.32042317173103e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.165992086952567,OCLN;Occludin,0.878541615535813,2.40738625034825,1.93166240279484,3.00026989704854,5.23418380733863e-15
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39842648597025,OCLN;Occludin,0.382143385488882,1.46542219034676,1.35490196576976,1.58495762070923,1.27623606939154e-21
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.14097958069944,OCLN;Occludin,0.676861436195889,1.96769230278631,1.54494338813126,2.50611965991051,4.1400912088377e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.234208013097457,OCLN;Occludin,0.615947922333335,1.8514107616314,1.53449632592389,2.23377648442449,1.27466503879823e-10
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5353585883851,OCLN;Occludin,0.228791039538137,1.25707933168532,1.18501934209981,1.33352122620233,3.04803320281867e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.0522988767110828,OCLN;Occludin,1.08411467531546,2.95682091307754,2.02122621516458,4.32548808560789,2.32873990278205e-08
primary,Circulatory system disorders,I95 (hypotension),0.502523989267361,OCLN;Occludin,0.30306106525382,1.35399714409711,1.18812744190465,1.54302324949604,5.48625225928291e-06
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0181909136386375,OCLN;Occludin,1.76372691038791,5.83414024487555,3.10800638555093,10.9514551048269,4.03603494786722e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,OMG;Oligodendrocyte-myelin glycoprotein,-0.440532475591836,0.643693578694363,0.549289776055916,0.754322110685303,5.20465350406078e-08
primary,Circulatory system disorders,I60 (subarachnoid haemorrhage),0.184992029598724,OMG;Oligodendrocyte-myelin glycoprotein,-0.480168235918479,0.618679298970202,0.504186108070975,0.759172196232703,4.24864253352551e-06
primary,Circulatory system disorders,I63 (cerebral infarction),0.369984059197449,OMG;Oligodendrocyte-myelin glycoprotein,-0.402589444359695,0.668586534957115,0.579360345918756,0.771554280293538,3.61664561302475e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,OMG;Oligodendrocyte-myelin glycoprotein,-0.339882565322248,0.711853914189266,0.663516663207853,0.763712538426243,2.70880860820144e-21
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346368055418888,OMG;Oligodendrocyte-myelin glycoprotein,-0.490386790843666,0.612389481725295,0.527545174262422,0.710879173242565,1.15744142116319e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.173184027709444,OMG;Oligodendrocyte-myelin glycoprotein,-0.64097660472079,0.526777719145016,0.42731951526732,0.64938472377989,1.92661573538247e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246000039360006,OMG;Oligodendrocyte-myelin glycoprotein,-0.449723094387825,0.637804738883311,0.535109238830703,0.760209047840248,5.14826276776509e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302321045445679,OMD;Osteomodulin,0.389428565968897,1.47613703789213,1.25369836197272,1.73804211661271,2.96640323949431e-06
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390091671542812,OMD;Osteomodulin,1.00352962264156,2.72789328998456,1.76614080384995,4.21336837092575,6.05823196125562e-06
primary,Circulatory system disorders,I85 (oesophageal varices),0.0526623756582797,OMD;Osteomodulin,1.01950714219703,2.77182831004712,1.89253817984147,4.05964448285119,1.63626210442747e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,PAEP;Glycodelin,0.536419374475971,1.70987347145536,1.42865545287309,2.04644673599024,4.88264658590729e-09
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64571157794977,PAEP;Glycodelin,0.235822902356268,1.2659500935347,1.19395330135506,1.34228837719333,2.93172745570841e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69807297425367,PAEP;Glycodelin,0.220270400804598,1.24641371629647,1.18650792651417,1.30934409914658,1.86982618770691e-18
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1659295529932,PAEP;Glycodelin,0.187164062086547,1.20582509900434,1.13242372363659,1.28398420047182,5.1900299503178e-09
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,PAEP;Glycodelin,0.273344117055116,1.31435245811039,1.19095880927627,1.45053075781069,5.50059560997083e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,SUSD2;Sushi domain-containing protein 2,0.189468938838777,1.20860758265141,1.12354373554346,1.3001116401899,3.61233731600463e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.310225742883343,TFRC;Transferrin receptor protein 1,0.574941245965648,1.77702611639331,1.51676833439982,2.0819407596569,1.1120829099151e-12
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66716094667629,TFRC;Transferrin receptor protein 1,0.184750322706946,1.20291806130505,1.13834335309813,1.27115589358492,5.28525803424833e-11
primary,Circulatory system disorders,I26 (pulmonary embolism),1.006770335395,TFRC;Transferrin receptor protein 1,0.259261473682405,1.29597262326416,1.18792461855917,1.41384816343592,5.31100548417922e-09
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.374612217821395,TFRC;Transferrin receptor protein 1,0.421202887572059,1.52379340579306,1.32037518469792,1.7585504260061,8.33880540241125e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16572688427994,TFRC;Transferrin receptor protein 1,0.278498557624694,1.32114469980812,1.24345647322617,1.40368670348593,2.12065842072812e-19
primary,Circulatory system disorders,I50 (heart failure),0.915068386240805,TFRC;Transferrin receptor protein 1,0.308879064389775,1.36189765861944,1.24117415682168,1.49436339965592,6.93173941208485e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,MOG;Myelin-oligodendrocyte glycoprotein,1.57755918418744,4.84312020846326,4.15390009206711,5.64669655835484,3.19213203397934e-90
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,MOG;Myelin-oligodendrocyte glycoprotein,1.62058311146644,5.05603769070872,3.43973516738768,7.43182712792436,1.63716772941824e-16
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,MOG;Myelin-oligodendrocyte glycoprotein,0.375335818415973,1.4554801095821,1.33099266154154,1.59161084099111,1.90851070974426e-16
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172493991782308,IGFBP2;Insulin-like growth factor-binding protein 2,0.556841379501262,1.74515151419021,1.43613324058758,2.12066242978565,2.14217739852257e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306225288782076,IGFBP2;Insulin-like growth factor-binding protein 2,1.24339791717169,3.46737532468951,3.0380442573932,3.9573787027651,6.68817373668883e-76
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387626947825412,IGFBP2;Insulin-like growth factor-binding protein 2,1.32052822907744,3.74539928362931,2.67650895829199,5.24116153258194,1.33327335456993e-14
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67074967051709,IGFBP2;Insulin-like growth factor-binding protein 2,0.21730315032091,1.24272077624256,1.17751925321261,1.31153263396031,2.72757673072813e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.7173424296457,IGFBP2;Insulin-like growth factor-binding protein 2,0.202007833259289,1.22385759486768,1.16889025382541,1.28140978814168,6.93769259701554e-18
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0097681990852,IGFBP2;Insulin-like growth factor-binding protein 2,0.29230817122252,1.33951575424682,1.23128051012522,1.45726537626503,1.04706791470148e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354678657260252,IGFBP2;Insulin-like growth factor-binding protein 2,0.403781263155967,1.497476357879,1.30269770452403,1.72137820970975,1.35131373020972e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544615861694705,IGFBP2;Insulin-like growth factor-binding protein 2,0.288326169549863,1.33419240609754,1.18987197700473,1.4960175639814,7.96219552484262e-07
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.374060004651523,IGFBP2;Insulin-like growth factor-binding protein 2,0.323868296352742,1.38246521941733,1.20479189929728,1.58634041614436,3.94140392908626e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387626947825412,IGFBP2;Insulin-like growth factor-binding protein 2,0.310638390591935,1.36429578978385,1.19111507761468,1.56265589866377,7.28934949185803e-06
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.705481045042251,IGFBP2;Insulin-like growth factor-binding protein 2,0.239672694701599,1.27083313182516,1.14849986412582,1.40619681324368,3.46626508210576e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17458717730056,IGFBP2;Insulin-like growth factor-binding protein 2,0.334022820718611,1.39657501405626,1.31759399469365,1.48029042158752,2.4321252301039e-29
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25978758043259,IGFBP2;Insulin-like growth factor-binding protein 2,0.197550922691741,1.21841510836689,1.12867319522124,1.3152924890767,4.17492918062962e-07
primary,Circulatory system disorders,I50 (heart failure),0.914799596867974,IGFBP2;Insulin-like growth factor-binding protein 2,0.580821966219695,1.78750709752177,1.64083888071075,1.9472854167782,2.41839723675907e-40
primary,Circulatory system disorders,I63 (cerebral infarction),0.358554926738506,IGFBP2;Insulin-like growth factor-binding protein 2,0.428267977981457,1.53459726414829,1.33622313153996,1.76242178985283,1.3274456645079e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56601286921466,IGFBP2;Insulin-like growth factor-binding protein 2,0.348056797263061,1.41631269014004,1.32344984467912,1.51569146674997,8.3492375580437e-24
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352740522521125,IGFBP2;Insulin-like growth factor-binding protein 2,0.359311041718994,1.43234225048724,1.24421905289811,1.6489092638086,5.68637124098329e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176370261260562,IGFBP2;Insulin-like growth factor-binding protein 2,0.657672394092142,1.93029413737982,1.59973807295794,2.32915345317337,6.76309503773818e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40320955112799,IGFBP2;Insulin-like growth factor-binding protein 2,0.317884285290254,1.37421723487843,1.27943226944199,1.47602421303674,2.83681555572955e-18
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.250019381347391,IGFBP2;Insulin-like growth factor-binding protein 2,0.556075155658867,1.74381484964897,1.48385644563502,2.0493156455946,1.46402096891663e-11
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0116288084347623,IGFBP2;Insulin-like growth factor-binding protein 2,1.39576257351585,4.03805271088264,2.18511186139024,7.46225856167031,8.39895931361989e-06
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56609039460423,IGFBP2;Insulin-like growth factor-binding protein 2,0.256471604515702,1.29236206803184,1.22498657851066,1.36344327700159,6.08748269180969e-21
primary,Circulatory system disorders,I85 (oesophageal varices),0.0503915032173036,IGFBP2;Insulin-like growth factor-binding protein 2,0.801647010408005,2.22920943777234,1.58381813973471,3.13759174287878,4.29186883948129e-06
primary,Circulatory system disorders,I95 (hypotension),0.513605705868671,IGFBP2;Insulin-like growth factor-binding protein 2,0.300189429879707,1.35011453538802,1.20022435728755,1.51872376826735,5.74419971702393e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307662350306688,C1QA;Complement C1q subcomponent subunit A,0.963472191906276,2.62078054647569,2.24468978876797,3.0598841350614,3.4918568492558e-34
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389446013046441,C1QA;Complement C1q subcomponent subunit A,1.6495720195013,5.20475181816293,3.446493233174,7.86000135671897,4.39046825961407e-15
primary,Circulatory system disorders,I20 (angina pectoris),4.59156849381754,C1QA;Complement C1q subcomponent subunit A,0.209711919966521,1.23332271312654,1.18268285971098,1.28613085259859,1.08703569389635e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65212734884626,C1QA;Complement C1q subcomponent subunit A,0.269935851312945,1.30988042092887,1.23979921254141,1.3839230576826,6.4731362709943e-22
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70363158407165,C1QA;Complement C1q subcomponent subunit A,0.255762825789167,1.29144639383457,1.23246821999163,1.35324689196419,7.84694163131967e-27
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00282348359458,C1QA;Complement C1q subcomponent subunit A,0.219239185688318,1.24512905812439,1.14134287881652,1.35835286675054,7.92598493813289e-07
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.37970986272028,C1QA;Complement C1q subcomponent subunit A,0.335398031514503,1.39849692030308,1.21444156156517,1.61044689015466,3.18631654197308e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16337260247298,C1QA;Complement C1q subcomponent subunit A,0.312324070093182,1.36659749465365,1.28678339566378,1.45136214741896,2.64032145727052e-24
primary,Circulatory system disorders,I50 (heart failure),0.905461980332976,C1QA;Complement C1q subcomponent subunit A,0.489833128013541,1.63204385483091,1.48845046538729,1.78948994678052,1.91996778765485e-25
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.69798461688248,C1QA;Complement C1q subcomponent subunit A,0.185959095366366,1.20437299493392,1.12599857314806,1.28820261900578,6.07610044200931e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55778405218576,C1QA;Complement C1q subcomponent subunit A,0.222877971884315,1.2496680697915,1.16475035465531,1.34077682690945,5.3816589871684e-10
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.167461785609969,C1QA;Complement C1q subcomponent subunit A,0.485866309195354,1.62558265623015,1.31434453981493,2.0105222734127,7.43899537276485e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40979456722811,C1QA;Complement C1q subcomponent subunit A,0.216578366948037,1.24182039921538,1.15375968272906,1.33660235055169,7.87102759616477e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24729821828449,C1QA;Complement C1q subcomponent subunit A,0.517034752199764,1.67704740838462,1.40929484656814,1.9956703998588,5.68414719992663e-09
primary,Circulatory system disorders,I85 (oesophageal varices),0.0525752117612695,C1QA;Complement C1q subcomponent subunit A,1.05556629596641,2.87360200244203,1.97564803399504,4.17968602015657,3.35442152474435e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214195307175542,C1QA;Complement C1q subcomponent subunit A,1.54007995081775,4.66496322370353,2.63218201914332,8.26762044578863,1.33016979772031e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,APLP1;Amyloid-like protein 1,0.40637665140597,1.50136793831949,1.28323137590783,1.75658554531448,3.90980107845449e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35650623885918,APLP1;Amyloid-like protein 1,-0.367092305644601,0.692745697754913,0.598551105161707,0.801763788621341,8.52691566096897e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204228457378913,CHAD;Chondroadherin,0.52054348460536,1.68294205429219,1.35447917177623,2.09105759403521,2.6162033935684e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311364815775817,DPP4;Dipeptidyl peptidase 4,-0.573323698611871,0.563648922798086,0.480388755612439,0.661339601436784,2.06094597024875e-12
primary,Circulatory system disorders,I20 (angina pectoris),4.59462696099956,DPP4;Dipeptidyl peptidase 4,-0.260749454182239,0.77047393445651,0.738086347500117,0.804282704438997,1.17886410984282e-32
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67454393038202,DPP4;Dipeptidyl peptidase 4,-0.292363956618065,0.746496794076657,0.705375249533879,0.790015617835995,4.83259806875376e-24
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70244700810346,DPP4;Dipeptidyl peptidase 4,-0.291500915298449,0.747141329745357,0.711985075404175,0.784033522467831,2.05201992325956e-32
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.349287453594666,DPP4;Dipeptidyl peptidase 4,-0.409894840825132,0.663720042718625,0.572151911592969,0.76994288785983,6.24754610174351e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17356592551195,DPP4;Dipeptidyl peptidase 4,-0.294831720687668,0.744656887271844,0.700148977187381,0.791994129576494,6.83891070802191e-21
primary,Circulatory system disorders,I50 (heart failure),0.930102590714941,DPP4;Dipeptidyl peptidase 4,-0.430098028782779,0.650445329234051,0.592172948792086,0.714451964051026,2.67452261381695e-19
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57678336194163,DPP4;Dipeptidyl peptidase 4,-0.243349506119516,0.783997453973708,0.729986812255489,0.842004262978568,2.35708517086672e-11
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.169653906031695,DPP4;Dipeptidyl peptidase 4,-0.568112941467424,0.566593625852881,0.455024011959463,0.705519551538994,3.82203894939401e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40313759929743,DPP4;Dipeptidyl peptidase 4,-0.226523942374363,0.79730025282333,0.739984001531951,0.859055995583844,2.66123339337133e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304315388542034,MMP10;Stromelysin-2,0.967923930673188,2.63247358469877,2.23699293167198,3.09787173487275,2.20123093492553e-31
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392665017473593,MMP10;Stromelysin-2,1.4060280398079,4.07971869937642,2.59666342318648,6.40980441185437,1.06392154308781e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.58043742882946,MMP10;Stromelysin-2,0.196295723531957,1.21688671416683,1.16636015420829,1.26960207768834,1.16625736867652e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65245219303412,MMP10;Stromelysin-2,0.247950677915839,1.28139672947805,1.21156893551039,1.35524899177556,4.21738677851091e-18
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68712451407704,MMP10;Stromelysin-2,0.253972542654871,1.28913640751859,1.22919594414149,1.35199980532855,1.39290587284551e-25
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00522244473239,MMP10;Stromelysin-2,0.204698128170195,1.22715456565015,1.12456285667516,1.33910551914218,4.31792907977375e-06
primary,Circulatory system disorders,I50 (heart failure),0.905092865276632,MMP10;Stromelysin-2,0.295438409337946,1.34371532691911,1.22297470263598,1.47637631089641,7.74187308765237e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55888011937016,MMP10;Stromelysin-2,0.315152241515709,1.37046793719179,1.2763689030715,1.47150432947011,3.83595976940746e-18
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40377743746809,MMP10;Stromelysin-2,0.216274350362047,1.24144292259968,1.1528921460219,1.3367950639535,1.01506848774499e-08
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153412952713855,NCAN;Neurocan core protein,-0.529252696272275,0.58904500076431,0.467446631463778,0.742275138102716,7.24624303633036e-06
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24662588600835,NCAN;Neurocan core protein,-0.445280937657678,0.640644269647696,0.533963083275924,0.768639430491011,1.65655960370751e-06
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174297912341858,OGN;Mimecan,0.580282181698247,1.78654248922229,1.45014805397537,2.20097117466516,4.98670742444836e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,OGN;Mimecan,1.8164431569947,6.14994511257905,5.2235011786836,7.24070381032566,2.09509290005252e-105
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,OGN;Mimecan,1.81435769745699,6.13713301508654,4.05969380368593,9.27764591769664,7.62230344515846e-18
primary,Circulatory system disorders,I20 (angina pectoris),4.61595707179507,OGN;Mimecan,0.252925693938708,1.28778758285629,1.23474812335088,1.34310538902319,4.58129760879926e-32
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,OGN;Mimecan,0.362791792501048,1.4373365638334,1.361688546267,1.51718717425954,1.665827233944e-39
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71117465042497,OGN;Mimecan,0.367630872593771,1.44430880660101,1.37880171886812,1.51292814643261,2.40289030173491e-54
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,OGN;Mimecan,0.348749120466427,1.41729357578441,1.29653531415059,1.54929916527245,1.6470046363296e-14
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354471035212095,OGN;Mimecan,0.490523274437403,1.63317059282328,1.40852485016684,1.89364510320624,8.20118434004004e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552269789667463,OGN;Mimecan,0.428638698565339,1.53516627640784,1.36394149519093,1.72788606001757,1.21218053701572e-12
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.381888684344522,OGN;Mimecan,0.371250666559739,1.44954638065467,1.25869352285682,1.66933782649492,2.54844159073152e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301594140456699,OGN;Mimecan,0.416237011082657,1.51624519320177,1.29485917226376,1.77548225718494,2.35668586687034e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38580549136344,OGN;Mimecan,0.446230853064406,1.56241211252806,1.35944063965929,1.79568826924743,3.27985498865226e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,OGN;Mimecan,0.35442667899093,1.4253632292955,1.34221659437512,1.51366057009118,6.75373646332149e-31
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,OGN;Mimecan,0.733995135775043,2.0833874188163,1.90448923914188,2.27909039740113,8.76776262350953e-58
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7038110532294,OGN;Mimecan,0.273798127034879,1.31494932272429,1.2281282137905,1.40790814991245,3.95877249681987e-15
primary,Circulatory system disorders,I61 (intracerebral haemorrhage),0.090086561435118,OGN;Mimecan,0.710553393630274,2.0351171679601,1.53170999914797,2.70397261206743,9.54379354228381e-07
primary,Circulatory system disorders,I63 (cerebral infarction),0.36426305275939,OGN;Mimecan,0.469943780763515,1.59990424529386,1.38622187269038,1.84652518080778,1.32031392044887e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,OGN;Mimecan,0.463533204501263,1.58968074140441,1.48141447784406,1.70585943190579,5.82637612946367e-38
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348595824683717,OGN;Mimecan,0.554718316816603,1.74145037839322,1.5028041627723,2.01799375828944,1.62184912933692e-13
primary,Circulatory system disorders,I70 (atherosclerosis),0.174297912341858,OGN;Mimecan,0.723153308874411,2.06092169784458,1.68658052165229,2.51834892560336,1.53980783850953e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17038110532294,OGN;Mimecan,0.773561317008581,2.16747157848716,1.77614569850254,2.6450155792458,2.64855294739267e-14
primary,Circulatory system disorders,I72 (other aneurysm),0.10575378951079,OGN;Mimecan,0.832550237235349,2.29917471099163,1.77159094711627,2.98387410494965,3.85354865463418e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,OGN;Mimecan,0.321229468798275,1.37882194120884,1.27875549407566,1.48671888751738,6.45944739007986e-17
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150797070228349,OGN;Mimecan,0.737867239275834,2.09147014901934,1.68343992177549,2.59839827228615,2.67152697091244e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246758842191845,OGN;Mimecan,0.519283723809358,1.68082328472187,1.41331045651035,1.99897121078333,4.32483939634825e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56746700090086,OGN;Mimecan,0.194458359709042,1.21465290333167,1.14772733245926,1.28548099696355,1.7570608481961e-11
primary,Circulatory system disorders,I95 (hypotension),0.513101719478281,OGN;Mimecan,0.486114256083001,1.62598576436302,1.43765567400879,1.83898672937384,9.96153757060539e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303320874346881,SCG3;Secretogranin-3,1.18753616794956,3.27899236022434,2.80074668768853,3.8389015849495,2.5042978413222e-49
primary,Circulatory system disorders,I15 (secondary hypertension),0.0391381773350815,SCG3;Secretogranin-3,1.40496621008196,4.0753890318796,2.67496236200686,6.20898297376565,6.13811457753318e-11
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64769769671826,SCG3;Secretogranin-3,0.216808496000136,1.24210621105227,1.1751071845982,1.31292520355252,1.80871678386365e-14
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69464394043169,SCG3;Secretogranin-3,0.208038557185634,1.2312606425788,1.17449077299169,1.29077452528807,5.71961476623887e-18
primary,Circulatory system disorders,I50 (heart failure),0.906048805307136,SCG3;Secretogranin-3,0.287965732292506,1.33371160010131,1.21505519649474,1.4639554131996,1.38368956871075e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56552709340326,SCG3;Secretogranin-3,0.182407167181694,1.20010273686289,1.11781821423844,1.28844436481743,4.8195870396544e-07
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,BCAN;Brevican core protein,-0.23252356334672,0.792531074442263,0.721951306902026,0.870010896790088,1.02899915441614e-06
primary,Circulatory system disorders,I63 (cerebral infarction),0.365266150687095,BCAN;Brevican core protein,-0.383063329974055,0.681769721460008,0.588748508430167,0.789488120044705,3.08609771838179e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56373400726583,BCAN;Brevican core protein,-0.283159760170384,0.753399415025669,0.701458495744177,0.809186405189721,7.89872014926835e-15
primary,Circulatory system disorders,I70 (atherosclerosis),0.165850576528194,BCAN;Brevican core protein,-0.608809271329595,0.543998237876203,0.437745385085459,0.67604158237931,3.99634793020881e-08
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152029695150845,BCAN;Brevican core protein,-0.577174352888023,0.561482679067778,0.447432788483816,0.704603701399351,6.28517399901927e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242852629916284,BCAN;Brevican core protein,-0.415774672591843,0.659828931277996,0.551380567817553,0.789607476147987,5.66686211344401e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.201695145719077,TF;Serotransferrin,-0.473805930291981,0.622628074091951,0.505408725242649,0.767034084069943,8.50058223051355e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,SYT1;Synaptotagmin-1,1.10060305407643,3.00597824489215,2.4630680210656,3.66855691011556,2.50107717357875e-27
primary,Circulatory system disorders,I50 (heart failure),0.910021613013309,SYT1;Synaptotagmin-1,0.240773843605089,1.27223327907861,1.15390721719994,1.40269294815813,1.33729828743202e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40825844613809,SYT1;Synaptotagmin-1,0.216867875184493,1.24217996849577,1.14756765535251,1.34459268430511,8.08334685760577e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311821590684823,PTGDS;Prostaglandin-H2 D-isomerase,1.83745287760774,6.28052061554002,5.31222073264676,7.42532006620332,1.3138293589705e-102
primary,Circulatory system disorders,I15 (secondary hypertension),0.0394710874284586,PTGDS;Prostaglandin-H2 D-isomerase,1.99537080762486,7.35492978635328,4.77054016025386,11.3393851314539,1.6573772655904599e-19
primary,Circulatory system disorders,I20 (angina pectoris),4.58259325044405,PTGDS;Prostaglandin-H2 D-isomerase,0.212398765457397,1.23664091645071,1.18356590911886,1.29209598253685,2.31196349031093e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66429840142095,PTGDS;Prostaglandin-H2 D-isomerase,0.260561436495048,1.29765843498948,1.22494078493782,1.37469291136782,8.3260321366203e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68659956581803,PTGDS;Prostaglandin-H2 D-isomerase,0.294323670122417,1.34221826931912,1.27776618313334,1.40992139741582,9.78330826550387e-32
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00848628379711,PTGDS;Prostaglandin-H2 D-isomerase,0.298720660486331,1.34813298405809,1.23170869660267,1.47556199588291,9.02578438311808e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.349319123741859,PTGDS;Prostaglandin-H2 D-isomerase,0.420276864184005,1.52238299060025,1.30770277470432,1.77230637947754,5.99044192598447e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546674560884152,PTGDS;Prostaglandin-H2 D-isomerase,0.307903407198293,1.36056956136392,1.20335278319884,1.53832654659189,8.89372738738935e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.3098480363134,PTGDS;Prostaglandin-H2 D-isomerase,0.403658022495775,1.4972918192756,1.27147249471152,1.76321768767659,1.30236883963267e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388790211170317,PTGDS;Prostaglandin-H2 D-isomerase,0.385288696288026,1.47003865488937,1.26968045679884,1.7020137903968,2.55264994958033e-07
primary,Circulatory system disorders,I50 (heart failure),0.91572922834024,PTGDS;Prostaglandin-H2 D-isomerase,0.579504792802595,1.78515419062343,1.62090065365077,1.96605231611375,5.75697014383746e-32
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70515097690941,PTGDS;Prostaglandin-H2 D-isomerase,0.237194539849343,1.26768770956457,1.18196072211422,1.35963243017627,3.14872475393531e-11
primary,Circulatory system disorders,I61 (intracerebral haemorrhage),0.086836392342609,PTGDS;Prostaglandin-H2 D-isomerase,0.692615465306228,1.99893685216357,1.4764124098515,2.70639051275619,7.45741434905019e-06
primary,Circulatory system disorders,I63 (cerebral infarction),0.365107558713242,PTGDS;Prostaglandin-H2 D-isomerase,0.452797924852713,1.57270634953455,1.35260478926207,1.82862376468126,3.94693589444593e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56897572528123,PTGDS;Prostaglandin-H2 D-isomerase,0.445405742928557,1.56112348216174,1.45086503318986,1.6797610189823,9.48113033721528e-33
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.134201697256759,PTGDS;Prostaglandin-H2 D-isomerase,0.635769115721955,1.88847403812211,1.47260498042338,2.42178604586539,5.45253231775543e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349319123741859,PTGDS;Prostaglandin-H2 D-isomerase,0.3765317913968,1.45722186580637,1.25057248640486,1.69801877881451,1.39545655132578e-06
primary,Circulatory system disorders,I70 (atherosclerosis),0.169725675942372,PTGDS;Prostaglandin-H2 D-isomerase,0.801609661649928,2.22912618112312,1.79072789636848,2.77485124425964,7.25709476620394e-13
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.4031971580817,PTGDS;Prostaglandin-H2 D-isomerase,0.313415623182439,1.36809002280938,1.26713733122528,1.47708560421049,1.11420762259468e-15
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146043023485297,PTGDS;Prostaglandin-H2 D-isomerase,0.628105948837501,1.87405765453672,1.47856566385414,2.37533724635049,2.06228790004656e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248667850799289,PTGDS;Prostaglandin-H2 D-isomerase,0.618211713829979,1.85560671716266,1.54874426416086,2.22326976019171,2.04262918361682e-11
primary,Circulatory system disorders,I95 (hypotension),0.519044799684231,PTGDS;Prostaglandin-H2 D-isomerase,0.369804978482279,1.44745230279085,1.2768666719678,1.64082767202758,7.46417500059012e-09
primary,Circulatory system disorders,I85 (oesophageal varices),0.0522003585937677,PTPRZ1;Receptor-type tyrosine-protein phosphatase zeta,1.09231146045309,2.98115694113318,1.99003643606067,4.46589647637768,1.17619513934725e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17165277096616,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,-0.262831688013344,0.768871296676549,0.723388966972894,0.817213280604581,2.95879011227257e-17
primary,Circulatory system disorders,I50 (heart failure),0.9122118685630209,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,-0.320626541149069,0.725694217318131,0.661616953723666,0.795977331120403,1.06113575193041e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296124882334483,STC2;Stanniocalcin-2,0.897987720305346,2.4546586782189,2.08985403674223,2.88314356917863,7.4973255505348e-28
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65335738939441,STC2;Stanniocalcin-2,0.235771603739274,1.26588515371139,1.19631097520495,1.33950557639277,2.96755871342798e-16
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70842485095701,STC2;Stanniocalcin-2,0.216508658260198,1.24173383656193,1.18372866117724,1.302581386624,7.29483150161398e-19
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15131785378098,STC2;Stanniocalcin-2,0.345510334580223,1.41271069085217,1.32825197264068,1.50253983216777,4.51212939008589e-28
primary,Circulatory system disorders,I50 (heart failure),0.902102290555381,STC2;Stanniocalcin-2,0.417614980513994,1.51833597291285,1.38093552760384,1.66940749988624,6.17941068894601e-18
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70614998431126,STC2;Stanniocalcin-2,0.216550042011272,1.24178522522925,1.16009846990005,1.32922384229204,4.44675752868314e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56299027298399,STC2;Stanniocalcin-2,0.188237086546077,1.2071196732602,1.12385763956074,1.29655025181066,2.44146724405827e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.174537182303106,STC2;Stanniocalcin-2,0.691572187404441,1.99685249299063,1.6153093555271,2.46851778894188,1.63424686986485e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41002510197678,STC2;Stanniocalcin-2,0.304107585310932,1.35541487097609,1.25851739452746,1.45977280922124,9.29837061220707e-16
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,RTBDN;Retbindin,1.33440301271871,3.7977280741831,3.24891564595015,4.43924684330192,5.07723548322238e-63
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,RTBDN;Retbindin,1.21665770767678,3.37588566000011,2.23112172732316,5.10801533140359,8.52247774667354e-09
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999744159959065,RTBDN;Retbindin,0.216600585538799,1.24184799102115,1.13811099845919,1.35504044411409,1.13453272287432e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307008049121287,RTBDN;Retbindin,0.403560426329667,1.49714569646512,1.28220248419556,1.74812111509073,3.33227572666473e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383760061401609,RTBDN;Retbindin,0.321582630157809,1.37930897383564,1.20035862700994,1.58493736996133,5.74142285513944e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,RTBDN;Retbindin,0.194663197730287,1.2149017359132,1.14478889511581,1.28930865264516,1.37649614150343e-10
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,RTBDN;Retbindin,0.474983783649483,1.60798812157535,1.46931873738502,1.75974465807815,5.56420615801511e-25
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.1248042841907,BGLAP;Osteocalcin,1.16477928376225,3.20521536204911,2.46306396603418,4.1709860802588,4.39679987515605e-18
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172456829063514,BGLAP;Osteocalcin,0.825612216965134,2.28327819916895,1.82580317476299,2.85537861192346,4.58215878704772e-13
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204225192312056,BGLAP;Osteocalcin,0.575130060066118,1.77736167565915,1.44493473271911,2.18626797084267,5.21433027471892e-08
primary,Circulatory system disorders,I26 (pulmonary embolism),1.005241779936,BGLAP;Osteocalcin,0.505112517543329,1.65717197089022,1.50900045732636,1.81989271624867,4.12230790716385e-26
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40164287821371,BGLAP;Osteocalcin,0.70622222438203,2.02632179194611,1.74912035191789,2.34745425036849,5.00248721872925e-21
primary,Circulatory system disorders,I33 (acute and subacute endocarditis),0.047652544872813,BGLAP;Osteocalcin,1.07199289924339,2.92119535085425,1.92649388612562,4.42948837746586,4.48542804095737e-07
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.553677188046018,BGLAP;Osteocalcin,0.48736344524292,1.62801819733636,1.43521123602706,1.84672693769823,3.50981182201972e-14
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.340375320520093,BGLAP;Osteocalcin,0.568372637832729,1.76539178072054,1.50268723710424,2.07402316495446,4.70710702700055e-12
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301799450861149,BGLAP;Osteocalcin,0.501719754736841,1.65155910640642,1.39109939510672,1.9607854705053,1.00640682249792e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383489527785972,BGLAP;Osteocalcin,0.530239325869679,1.69933895572948,1.45923391321015,1.97895132529302,8.94944071892092e-12
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14890285688352,BGLAP;Osteocalcin,0.677924286125362,1.96978477620719,1.84338050001063,2.10485684564594,2.79323559773157e-89
primary,Circulatory system disorders,I50 (heart failure),0.909936690190383,BGLAP;Osteocalcin,0.642956261048163,1.90209566715714,1.72084920890714,2.10243169958839,2.57620277014281e-36
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66556990174499,BGLAP;Osteocalcin,0.224977604640617,1.25229467028862,1.16344632592755,1.34792805330578,2.07440053244641e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55891896798202,BGLAP;Osteocalcin,0.202328695231109,1.22425034723508,1.13410548937705,1.32156040751418,2.16242624267586e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54373822868683,BGLAP;Osteocalcin,0.278607928710798,1.32128920274091,1.245196803512,1.40203151209173,3.37775703693722e-20
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.205722835234711,SLITRK1;SLIT and NTRK-like protein 1,1.01173536412709,2.7503697690913,2.25527882360435,3.35414574355902,1.65760594149783e-23
primary,Circulatory system disorders,I15 (secondary hypertension),0.0187020759304282,SLITRK1;SLIT and NTRK-like protein 1,1.44341057897517,4.23511540901185,2.36766850424419,7.57547033949131,1.14445265478251e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1.82356534111583,6.19390250451183,5.23037668637307,7.33492643758344,3.52901319961537e-99
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1.99839075671411,7.3771748724704,4.79193345690825,11.3571504254823,1.10566408999936e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.240426411918588,1.27179134170081,1.19069463812084,1.3584114390385,8.56638141617163e-13
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.112176017948162,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.754721343034616,2.12701873218121,1.5646534258772,2.89150850420012,1.45416559215915e-06
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.21679680194714,1.24209168588134,1.17452530180112,1.3135449306794,3.03370168501125e-14
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352272056363529,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.560662058770225,1.75183193214237,1.47903819308082,2.07493973639798,8.47831480456591e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541200086592013,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.456221250396429,1.57809946127538,1.37288918365891,1.81398319640078,1.37263735315744e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307008049121287,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.591562825977082,1.80680993955714,1.50329231664444,2.1716083568959,2.89011923160061e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.343299976449907,1.40959154277795,1.31192783713781,1.51452561735864,7.1883304360625e-21
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.668479593003975,1.95126834214152,1.75118907919415,2.17420733619227,9.2645844722896e-34
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71019227363076,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.24218465746145,1.27402943013674,1.17592900776089,1.38031375885966,3.14066735098018e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.325464361615472,1.38467348593092,1.27347533220082,1.50558131293096,2.53856830518708e-14
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346368055418888,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.505417876210693,1.65767807998331,1.3941291943114,1.97104875794126,1.05820586025795e-08
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.122613019686201,SERPIND1;Heparin cofactor 2,-1.22564528252859,0.293568204757537,0.226751327447737,0.380074030060209,1.38216371232387e-20
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0317885606593855,SERPIND1;Heparin cofactor 2,-1.52568758024624,0.217471476355559,0.133322915404831,0.354731539470617,9.87306029928042e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554029200063577,SERPIND1;Heparin cofactor 2,-0.482142039079008,0.617459352178024,0.543857666898255,0.70102174667592,9.68320907359916e-14
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.340591721350559,SERPIND1;Heparin cofactor 2,-0.744990461769509,0.474738828086682,0.404557972573466,0.557094335477936,6.99764778472685e-20
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14345723303285,SERPIND1;Heparin cofactor 2,-0.287301122209967,0.750285767109428,0.703094760101605,0.800644186632303,4.39475211582836e-18
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65527576576372,SERPIND1;Heparin cofactor 2,-0.234438009001227,0.79101526819804,0.734543306981192,0.851828814687489,5.51866291866174e-10
primary,Circulatory system disorders,I85 (oesophageal varices),0.0522240639404191,SERPIND1;Heparin cofactor 2,-1.36830818921769,0.254537224307481,0.172468578385562,0.375657984571063,5.57660709519859e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305298404569627,LY6D;Lymphocyte antigen 6D,1.79331919286864,6.00936564385295,5.07365092460431,7.11765077616894,8.76807242447982e-96
primary,Circulatory system disorders,I15 (secondary hypertension),0.0393933425251132,LY6D;Lymphocyte antigen 6D,1.96699305851449,7.1491470688089,4.68168053748249,10.9170848805806,8.48476811754944e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.63935394918258,LY6D;Lymphocyte antigen 6D,0.18264150916427,1.20038400427264,1.1364291677204,1.26793802785263,6.22541572721299e-11
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00649990151664,LY6D;Lymphocyte antigen 6D,0.253843562428187,1.28897014513503,1.18106991006771,1.40672793446595,1.26289832709862e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356509749852274,LY6D;Lymphocyte antigen 6D,0.440801444558565,1.55395212605821,1.34211455663343,1.79922585456345,3.74480878477899e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16860350600748,LY6D;Lymphocyte antigen 6D,0.2128746625821,1.23722957036538,1.16515003684986,1.31376815120314,3.62949751140241e-12
primary,Circulatory system disorders,I50 (heart failure),0.906046878077604,LY6D;Lymphocyte antigen 6D,0.561415856160162,1.75315295631016,1.59858194067224,1.92266984257721,9.12874044613809e-33
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56588536537325,LY6D;Lymphocyte antigen 6D,0.305824621114229,1.35774416600709,1.26548184167955,1.45673304792713,1.62743584334785e-17
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354540082726019,LY6D;Lymphocyte antigen 6D,0.376159923226443,1.45668007212149,1.25796712828079,1.68678241649748,4.98468700741179e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.173330707110498,LY6D;Lymphocyte antigen 6D,0.562094013538915,1.75434227314998,1.42415914816802,2.16107646067512,1.26710595538377e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40437266102028,LY6D;Lymphocyte antigen 6D,0.246809680143407,1.27993549245674,1.18841107657421,1.37850857934861,7.02883352002248e-11
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.57041559976364,LY6D;Lymphocyte antigen 6D,0.186397665742005,1.2049013130946,1.14021708788338,1.27325505793996,3.57101027318857e-11
primary,Circulatory system disorders,I95 (hypotension),0.523931455584006,LY6D;Lymphocyte antigen 6D,0.3069188268376,1.3592306305451,1.20441811110696,1.53394231618954,6.53548434654438e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.173936835522201,CST3;Cystatin-C,0.530845929317088,1.70037009331253,1.38570847336801,2.08648392486506,3.68829656924719e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.310741088180112,CST3;Cystatin-C,1.69994227307227,5.47363140668227,4.70937090291782,6.36191996634956,9.36250642844828e-109
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390869293308317,CST3;Cystatin-C,1.8529966891331,6.37890650925281,4.4120253141752,9.22262347930222,6.76659063123482e-23
primary,Circulatory system disorders,I20 (angina pectoris),4.57903377110694,CST3;Cystatin-C,0.209263918435952,1.23277030641215,1.18152606547997,1.28623707319917,4.44355499741793e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66963727329581,CST3;Cystatin-C,0.340553239610127,1.40572507826951,1.32991059230564,1.4858615361879,2.21065310615711e-33
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69957786116322,CST3;Cystatin-C,0.299657235603819,1.34939620332355,1.28703908165844,1.41477453132014,2.20891158328193e-35
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00648843026891,CST3;Cystatin-C,0.352934283058124,1.42323760953699,1.30484204915156,1.55237585615643,1.65839719511778e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351782363977485,CST3;Cystatin-C,0.601664564948088,1.82515436122006,1.58295982819436,2.1044049147352,1.20072176470221e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545262664165103,CST3;Cystatin-C,0.479152005346752,1.61470456063183,1.43685004924779,1.81457405349302,8.45766061392298e-16
primary,Circulatory system disorders,I42 (cardiomyopathy),0.306832395247029,CST3;Cystatin-C,0.605347341769535,1.83188838974817,1.57013337660834,2.13728026070183,1.41553242379748e-14
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383051907442151,CST3;Cystatin-C,0.49627549125866,1.64259201523355,1.42805217121779,1.88936271579502,3.66553028351003e-12
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16737023139462,CST3;Cystatin-C,0.30998114381468,1.36339940537794,1.28321537223474,1.44859388283954,1.20061486464907e-23
primary,Circulatory system disorders,I50 (heart failure),0.918542839274546,CST3;Cystatin-C,0.766396703327769,2.1519979793337,1.9668473102253,2.35457794765259,1.38651596005064e-62
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70419011882426,CST3;Cystatin-C,0.298683466634443,1.34808284273204,1.26009079737388,1.44221936598214,4.21756412345181e-18
primary,Circulatory system disorders,I63 (cerebral infarction),0.365462789243277,CST3;Cystatin-C,0.423086789166646,1.52666678835522,1.32217043628434,1.76279201130589,8.11278399847546e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56543151969981,CST3;Cystatin-C,0.432691344962127,1.54140038627546,1.43698707652995,1.65340049998745,1.18588471781314e-33
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349828017510944,CST3;Cystatin-C,0.460312024198759,1.58456833153045,1.36981961875483,1.83298352783965,5.82880458371409e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.171982489055659,CST3;Cystatin-C,0.899659839398162,2.45876659336564,2.01628154402614,2.99835763441005,6.25620841690115e-19
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171982489055659,CST3;Cystatin-C,0.581077899615384,1.78796463883061,1.45100012741133,2.20318212887547,4.93008620991084e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39931207004377,CST3;Cystatin-C,0.360708228025528,1.43434489817607,1.33228847430223,1.54421908363445,9.86581025811132e-22
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146575984990619,CST3;Cystatin-C,0.794521128634475,2.21338081828488,1.78239143326705,2.74858516222314,6.45086776645338e-13
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24624765478424,CST3;Cystatin-C,0.67048120017974,1.95517792627753,1.64879440211545,2.31849448208839,1.25523469666466e-14
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55433083176985,CST3;Cystatin-C,0.235345905441784,1.26534638324161,1.19723907332841,1.33732811202983,7.61773422993956e-17
primary,Circulatory system disorders,I95 (hypotension),0.517901813633521,CST3;Cystatin-C,0.39206387446483,1.48003224465068,1.31231073975527,1.66918960490579,1.66990956897816e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.199723111141372,IGSF9;Protein turtle homolog A,-0.53442935912273,0.586003592356493,0.479200725241595,0.71661037257735,1.93047700151352e-07
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.8756598240469,RNASE4;Ribonuclease 4,0.183959219673462,1.20196680549801,1.17642498288532,1.22806317660455,3.07525240517293e-63
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.197067448680351,RNASE4;Ribonuclease 4,1.27521867347158,3.57948406273227,2.9636679608224,4.32325966495885,5.2318379395551e-40
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.55953079178885,RNASE4;Ribonuclease 4,0.24422438786816,1.27663075880712,1.20253360385182,1.35529359771079,1.19105572684568e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.50263929618768,RNASE4;Ribonuclease 4,0.235566453174563,1.26562548329392,1.2020892880046,1.33251987181576,3.12672248910442e-19
primary,Circulatory system disorders,I26 (pulmonary embolism),0.99941348973607,RNASE4;Ribonuclease 4,0.320591043314838,1.37794194707967,1.25336629213137,1.51489953211755,3.33275233027105e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.387096774193548,RNASE4;Ribonuclease 4,0.624038634633473,1.86645075353428,1.60992888627551,2.16384614566914,1.31063640774212e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.551319648093841,RNASE4;Ribonuclease 4,0.393153566596477,1.48164590317808,1.30583648481726,1.68112516990335,1.05662721263375e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.300293255131964,RNASE4;Ribonuclease 4,0.556247492592332,1.74411539924984,1.47538800316228,2.06178884427721,7.24209771709466e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.3683284457478,RNASE4;Ribonuclease 4,0.469237693736306,1.59877497239087,1.37251426856485,1.86233503788355,1.66973211185431e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.11847507331378,RNASE4;Ribonuclease 4,0.267748419047686,1.30701827774592,1.22425767707764,1.39537354786264,1.0367173744515e-15
primary,Circulatory system disorders,I50 (heart failure),0.893841642228739,RNASE4;Ribonuclease 4,0.699762678529121,2.01327485742023,1.82698323577638,2.21856203830902,2.65602737897394e-45
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.63519061583577,RNASE4;Ribonuclease 4,0.278553056964837,1.32121670328454,1.22655982828656,1.42317850037255,2.07235414157345e-13
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55777126099706,RNASE4;Ribonuclease 4,0.275261780483943,1.31687536201903,1.22043198820641,1.42094007355651,1.3084169650012e-12
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.12199413489736,RNASE4;Ribonuclease 4,0.648798299114624,1.91324030445174,1.47820964805594,2.47629858687005,8.24816581092987e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40527859237536,RNASE4;Ribonuclease 4,0.296119203659888,1.34463043214787,1.24094964098025,1.45697370735363,4.72848124609209e-13
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.52434017595307,RNASE4;Ribonuclease 4,0.187753960333253,1.20653662295882,1.13564556416066,1.28185295525438,1.22296927407032e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,MIA;Melanoma-derived growth regulatory protein,1.36904221812198,3.93158329235391,3.33722187933939,4.63180086418954,3.07839307933272e-60
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,MIA;Melanoma-derived growth regulatory protein,1.68896308954599,5.41386410139358,3.49445917402132,8.38754240606256,3.98450446283413e-14
primary,Circulatory system disorders,I42 (cardiomyopathy),0.302675258738527,MIA;Melanoma-derived growth regulatory protein,0.409320728623871,1.50579459447378,1.28497152586717,1.7645662297585,4.21787453707768e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386643233743409,MIA;Melanoma-derived growth regulatory protein,0.350294261180956,1.41948518653026,1.23305948745673,1.63409650164956,1.08087893197069e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16754540128881,MIA;Melanoma-derived growth regulatory protein,0.199863259588987,1.22123575446334,1.14982262999786,1.29708420157152,7.97581721070767e-11
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,MIA;Melanoma-derived growth regulatory protein,0.373599203056916,1.45295469394148,1.32405225953252,1.59440635930181,3.22591812544227e-15
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56024214020699,MIA;Melanoma-derived growth regulatory protein,0.217161283143955,1.24254448745938,1.15799918470175,1.33326242687584,1.54060817509473e-09
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34954110525288,MIA;Melanoma-derived growth regulatory protein,0.370982483180036,1.44915768852998,1.25066810769099,1.67914892313256,7.96943562627243e-07
primary,Circulatory system disorders,I20 (angina pectoris),4.59249676584734,MEGF10;Multiple epidermal growth factor-like domains protein 10,-0.245231186082993,0.782523608760525,0.750565101343492,0.815842885808996,9.6583679765946e-31
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65004508212787,MEGF10;Multiple epidermal growth factor-like domains protein 10,-0.227617788093197,0.796428606165547,0.754368071007294,0.840834267908275,1.99494582540612e-16
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69673448586773,MEGF10;Multiple epidermal growth factor-like domains protein 10,-0.2254352112401,0.798168771137609,0.762090833720457,0.83595466449739,1.26589007801285e-21
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,SCARA5;Scavenger receptor class A member 5,1.51009882492087,4.5271781702324,3.85712713334994,5.31362889437052,3.10343252591328e-76
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388387222060394,SCARA5;Scavenger receptor class A member 5,1.65894159166113,5.25374729076763,3.41551032333813,8.08132840549335,4.32743228628628e-14
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16720069909699,SCARA5;Scavenger receptor class A member 5,0.196657196411269,1.21732666522159,1.14717130567687,1.29177238179362,8.38672983362472e-11
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,SCARA5;Scavenger receptor class A member 5,0.520746444332952,1.68328365841785,1.53723239254549,1.84321114259419,2.44586902339037e-29
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55549082435187,SCARA5;Scavenger receptor class A member 5,0.207025785669546,1.2300142881138,1.14709811812386,1.31892392207791,6.09887836198527e-09
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34566462763375,SCARA5;Scavenger receptor class A member 5,0.367915047017098,1.44471930054641,1.24764372495107,1.67292458225858,8.79374601476517e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.174774249927177,SCARA5;Scavenger receptor class A member 5,0.523090364991603,1.68723376932398,1.3747723278359,2.07071217154075,5.55751153683912e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.198729058347775,BCHE;Cholinesterase,-0.629004709960954,0.533122148202176,0.432183503394009,0.657635524428124,4.26968868126767e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13980358174465,BCHE;Cholinesterase,-0.238394765245031,0.787891597473801,0.737566080098143,0.841650919314532,1.45246538821006e-12
primary,Circulatory system disorders,I50 (heart failure),0.903523974581167,BCHE;Cholinesterase,-0.35364979266113,0.702120812165746,0.634923883183581,0.776429502705837,5.57754260831768e-12
primary,Circulatory system disorders,I85 (oesophageal varices),0.0531484690930098,BCHE;Cholinesterase,-1.2193615627599,0.295418713038003,0.200284504962061,0.435741227358358,7.78893457661654e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,ERBB2;Receptor tyrosine-protein kinase erbB-2,-0.526550405035588,0.590638924561091,0.502343430315986,0.694453869909763,1.84634265653355e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30079466699185,EPHA2;Ephrin type-A receptor 2,1.85192839864112,6.37209562273014,5.3833967891595,7.54237597848626,8.62070336911952e-103
primary,Circulatory system disorders,I15 (secondary hypertension),0.038615531573278,EPHA2;Ephrin type-A receptor 2,1.84217458459315,6.31024551450881,4.1853372221552,9.51397613616283,1.44668924405813e-18
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65430969656321,EPHA2;Ephrin type-A receptor 2,0.202714004650387,1.22472215331525,1.15897716377034,1.29419664140885,5.98621155078676e-13
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70099384183891,EPHA2;Ephrin type-A receptor 2,0.200928556760544,1.22253742666913,1.16634127921867,1.2814411924167,5.81699143898257e-17
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00400382090522,EPHA2;Ephrin type-A receptor 2,0.375722147120452,1.45604251195633,1.33249657577397,1.59104333562183,9.96729081340476e-17
primary,Circulatory system disorders,I50 (heart failure),0.910513586569924,EPHA2;Ephrin type-A receptor 2,0.530082067063851,1.69907174072611,1.54903905932191,1.86363588623632,2.6470468469993e-29
primary,Circulatory system disorders,I63 (cerebral infarction),0.369896144544031,EPHA2;Ephrin type-A receptor 2,0.418310908040052,1.51939299247205,1.31486796081667,1.75573147598738,1.42015524776402e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57510720891002,EPHA2;Ephrin type-A receptor 2,0.437748664101798,1.5492154850182,1.44308415632452,1.66315222054207,1.1945291576509e-33
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345507387760908,EPHA2;Ephrin type-A receptor 2,0.640634132346918,1.89768388056652,1.63514928017261,2.20237023874778,3.37963136137519e-17
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.128040973111395,EPHA2;Ephrin type-A receptor 2,0.79054750793072,2.2046031335846,1.73119924649575,2.80746135168963,1.45775493009299e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174786090279048,EPHA2;Ephrin type-A receptor 2,0.762429665018288,2.14347783195702,1.74433643702246,2.63395129435802,4.10359057607384e-13
primary,Circulatory system disorders,I72 (other aneurysm),0.109749405524053,EPHA2;Ephrin type-A receptor 2,0.656978272238603,1.92895474294056,1.4842080588194,2.50697089144806,8.97430441620792e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40438591142816,EPHA2;Ephrin type-A receptor 2,0.429123023846822,1.53590997632859,1.42459301385431,1.65592518876899,5.17241238889538e-29
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150397333495925,EPHA2;Ephrin type-A receptor 2,0.565955818854635,1.76113030004908,1.40656942798446,2.20506707457403,8.04167719389832e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.241855171432636,EPHA2;Ephrin type-A receptor 2,0.673481168539685,1.96105220511414,1.64360874274255,2.33980609324698,7.71645587794866e-14
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5648842550251,EPHA2;Ephrin type-A receptor 2,0.282248252131993,1.32610788823724,1.25371086995679,1.40268555803911,6.59990881495803e-23
primary,Circulatory system disorders,I82 (other venous embolism and thrombosis),0.103652216328272,EPHA2;Ephrin type-A receptor 2,0.691841552168577,1.99739044714111,1.52282309340203,2.61985033955438,5.77633976655234e-07
primary,Circulatory system disorders,I85 (oesophageal varices),0.0569070991606202,EPHA2;Ephrin type-A receptor 2,1.28714797044168,3.62244050175562,2.57002080438432,5.10582450008729,1.98233047416806e-13
primary,Circulatory system disorders,I95 (hypotension),0.516228685242769,EPHA2;Ephrin type-A receptor 2,0.417247927771332,1.51777876579817,1.34195505517303,1.71663899847284,3.09022991357174e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0223563603845294,EPHA2;Ephrin type-A receptor 2,1.74346888618958,5.7171411768137,3.42198190195179,9.55168793177305,2.77857075103139e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306237159359615,IGFBP1;Insulin-like growth factor-binding protein 1,0.642564260567068,1.90135019086361,1.6331010473024,2.21366127605431,1.22153527629323e-16
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17273326355777,IGFBP1;Insulin-like growth factor-binding protein 1,0.242253564660709,1.27411722296129,1.20113473970583,1.35153421525728,8.32054477985528e-16
primary,Circulatory system disorders,I50 (heart failure),0.914835058340117,IGFBP1;Insulin-like growth factor-binding protein 1,0.298646781736572,1.34803338935773,1.23257592352868,1.47430595076119,6.27166937278386e-11
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0307218448902,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.187044395827464,1.20568081105901,1.18219762281793,1.22963046964254,1.57452754889262e-77
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,1.39569816207943,4.03779262248358,3.51088392786291,4.64377905882723,3.18919529751049e-85
primary,Circulatory system disorders,I15 (secondary hypertension),0.039488232506713,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,1.4459500462108,4.24588401330387,2.9728250077651,6.06410771146669,1.85110323270636e-15
primary,Circulatory system disorders,I20 (angina pectoris),4.61025114515874,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.363215634425689,1.43794589645021,1.38002631835036,1.4982963539345,3.5994948223908e-67
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64571157794977,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.498352676923027,1.64600752992099,1.56060454850542,1.73608412916092,4.54114626973134e-75
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.110567051018796,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.62980043334685,1.87723590819229,1.47170495040152,2.39451165401398,3.93924146136232e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69807297425367,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.468401309627027,1.59743834145601,1.52619892887267,1.67200304395352,4.60486834963344e-90
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01287316379718,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.377302274319772,1.45834506301553,1.34006774922824,1.58706179150016,2.27058991638109e-18
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361317327436424,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.564929304854254,1.75932340270096,1.53407182392271,2.01764923064465,6.38026996451682e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554809666719317,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.371900026523922,1.45048796372058,1.2944214687812,1.62537116668751,1.52198584466108e-10
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.36724056231243,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.373496629090973,1.4528056662595,1.2636751300328,1.67024281300916,1.53228504156456e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30405939030169,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.505392164588757,1.65763545893915,1.42620729126881,1.92661707141316,4.47993665680292e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383035855315116,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.488995170267781,1.63067684387003,1.42554851785746,1.86532196963065,1.0109628504028e-12
primary,Circulatory system disorders,I46 (cardiac arrest),0.0809508766387616,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.726890324062369,2.06863780215032,1.56458137555129,2.73508455575056,3.37146736526848e-07
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.706839361870162,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.262863206034476,1.30064878587674,1.17423722201384,1.44066908499235,4.68145702992096e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1659295529932,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.363877388287879,1.43889777762159,1.35703840173579,1.5256950811385,4.16788436367249e-34
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.80901838898924,2.24570249808861,2.06177086488186,2.44604276635289,7.3278377687995e-77
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.711814879166,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.301003880813642,1.35121458533983,1.26506665240916,1.44322898098542,3.39282968880124e-19
primary,Circulatory system disorders,I63 (cerebral infarction),0.365266150687095,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.439440380689009,1.55183853665578,1.35102146649962,1.78250524034188,5.12865797219717e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56373400726583,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.460338158439191,1.58460974356134,1.48064586053604,1.69587347408008,2.45022171583782e-40
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.130311167272152,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.601886340638869,1.82555918097723,1.45770714702269,2.28623858369434,1.58415839889743e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357368504185752,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.601109172579959,1.82414096585925,1.59081509067465,2.09168889761712,7.41635157081267e-18
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.124387932396145,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.63587143181966,1.88866726930147,1.50101312004793,2.37643762502008,5.79634671608895e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.165850576528194,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.934429153232725,2.5457598041173,2.10727971191416,3.07547827828344,3.37133782979436e-22
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.169799399778865,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.714175122676414,2.04250117428341,1.68184637358669,2.48049471846369,5.81552965925938e-13
primary,Circulatory system disorders,I72 (other aneurysm),0.106618227768125,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.679328964352877,1.97255363421722,1.54227471862866,2.52287597849189,6.27128022431412e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.502410199806343,1.65269981100004,1.53914993971041,1.77462675650268,1.58843037753494e-43
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152029695150845,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.917556790113233,2.50316715007286,2.05532650672334,3.04858900068051,7.29580569885178e-20
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242852629916284,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.791289910806656,2.20624044498842,1.87918652049366,2.59021488714383,4.20978447969313e-22
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55686305480966,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.234147745404924,1.2638312036675,1.19665699704235,1.33477622686486,4.36326738575113e-17
primary,Circulatory system disorders,I85 (oesophageal varices),0.0513347022587269,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.93661183815516,2.55132246421663,1.82527428402841,3.56617434068616,4.21221375503244e-08
primary,Circulatory system disorders,I95 (hypotension),0.519270257463275,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.401841045848383,1.49457374509209,1.32929650306104,1.6804006287347,1.80989702420551e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197441162533565,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,1.48856347598427,4.43072610073703,2.71948895237129,7.21875842247295,2.27168344644177e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,GGT5;Glutathione hydrolase 5 proenzyme,1.0371669493409,2.82121304240676,2.40841292722457,3.30476677843536,8.63391361151048e-38
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361317327436424,GGT5;Glutathione hydrolase 5 proenzyme,0.471143216814608,1.60182437943282,1.38692660940768,1.85001955052339,1.45227914467338e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554809666719317,GGT5;Glutathione hydrolase 5 proenzyme,0.404918393023178,1.49918015150471,1.33486145013513,1.68372614733773,8.12973019945128e-12
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30405939030169,GGT5;Glutathione hydrolase 5 proenzyme,0.515246736561745,1.67405150055591,1.43325210921691,1.95530737997288,7.8920199984265e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1659295529932,GGT5;Glutathione hydrolase 5 proenzyme,0.395980526247197,1.48584038238134,1.40020629835325,1.57671169206392,4.61307320936444e-39
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,GGT5;Glutathione hydrolase 5 proenzyme,0.633626207238024,1.88443154397858,1.72143338855428,2.06286358075338,6.97796418039772e-43
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.711814879166,GGT5;Glutathione hydrolase 5 proenzyme,0.277761081635709,1.32017074649177,1.23492583103104,1.41129997939839,3.46846545800297e-16
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56373400726583,GGT5;Glutathione hydrolase 5 proenzyme,0.23776496931737,1.26841104227589,1.18303412433888,1.35994942078827,2.26819542282242e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,GGT5;Glutathione hydrolase 5 proenzyme,0.233551149570458,1.26307743210676,1.17320995410358,1.35982872794188,5.57641764523159e-10
primary,Circulatory system disorders,I85 (oesophageal varices),0.0513347022587269,GGT5;Glutathione hydrolase 5 proenzyme,1.15011108428367,3.15854375477316,2.17436208911511,4.58819563712895,1.56727583996074e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,DPT;Dermatopontin,1.26498118278149,3.54302606558606,3.03567797774679,4.13516644171185,6.44576089036976e-58
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,DPT;Dermatopontin,1.62964662127489,5.10207143643514,3.39544956672078,7.66647609719245,4.37358043018755e-15
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00818545968225,DPT;Dermatopontin,0.237712165224944,1.26834406675029,1.16284817363163,1.38341075657076,8.08898426842117e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354122723842328,DPT;Dermatopontin,0.386101665816053,1.47123423744106,1.27165091009145,1.70214180970713,2.09384349200874e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387019370319484,DPT;Dermatopontin,0.378104912499091,1.45951605632083,1.26829020231119,1.67957389781652,1.31339486809456e-07
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,DPT;Dermatopontin,0.418124662881664,1.51911003923366,1.38541082957142,1.66571190439907,5.82410758213412e-19
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56549335294231,DPT;Dermatopontin,0.198321032831686,1.21935378359177,1.13662867294089,1.30809972065246,3.15204158329069e-08
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35218762699073,DPT;Dermatopontin,0.406649011671928,1.50177690698135,1.29718988453537,1.73863048519708,5.25978452372247e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40488031425972,DPT;Dermatopontin,0.185087199250174,1.20332336444806,1.11788683450825,1.29528953622891,8.40532464094715e-07
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.55981805101069,GHR;Growth hormone receptor,-0.286713778374531,0.75072657226898,0.705869547393229,0.798434198489037,7.44986946534946e-20
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53454477941005,GHR;Growth hormone receptor,-0.250384188172229,0.778501634490378,0.738629002091979,0.820526669258404,1.01840617159201e-20
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15832347002715,GHR;Growth hormone receptor,-0.224482070353433,0.798929901102264,0.747694750172036,0.85367589745469,3.17293683692851e-11
primary,Circulatory system disorders,I50 (heart failure),0.907424168581308,GHR;Growth hormone receptor,-0.344631207225098,0.708481588184974,0.639892661252599,0.784422437060829,3.27432313362917e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54099654204089,GHR;Growth hormone receptor,-0.254485146247374,0.775315569350914,0.717211543839903,0.838126822191965,1.52448916074469e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41799531202859,GHR;Growth hormone receptor,-0.245669453300551,0.782180729457707,0.721478577874739,0.847990102959386,2.51555322140871e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.018566223398083,GHR;Growth hormone receptor,-1.79340687782429,0.166392324606074,0.0823763523245132,0.336096524142576,5.74306634355322e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15222025672427,LCAT;Phosphatidylcholine-sterol acyltransferase,-0.325805712659766,0.721945438665826,0.676527675908849,0.770412260976912,8.55401456210449e-23
primary,Circulatory system disorders,I50 (heart failure),0.895813489363632,LCAT;Phosphatidylcholine-sterol acyltransferase,-0.291711768251224,0.746983809397238,0.675968670551059,0.825459574992925,1.04441829534332e-08
primary,Circulatory system disorders,I85 (oesophageal varices),0.0521612917857304,LCAT;Phosphatidylcholine-sterol acyltransferase,-1.01809333474184,0.361283129882991,0.244994043462308,0.532770095523286,2.78886157314461e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,"KRT18;Keratin, type I cytoskeletal 18",0.522934463383085,1.6869707473687,1.43128917129177,1.9883265796731,4.49065654943109e-10
primary,Circulatory system disorders,I20 (angina pectoris),4.61102473776395,"KRT18;Keratin, type I cytoskeletal 18",0.195635019459683,1.21608297770449,1.16417935833176,1.27030066121581,1.48642582073972e-18
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,"KRT18;Keratin, type I cytoskeletal 18",0.191733863704558,1.21134809036883,1.14345140053228,1.28327639929178,7.27809861328637e-11
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,"KRT18;Keratin, type I cytoskeletal 18",0.192993604170348,1.21287503615219,1.15497978056807,1.27367238636648,1.04476465163324e-14
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,"KRT18;Keratin, type I cytoskeletal 18",0.259822834817772,1.29670033616312,1.17765405634236,1.42778072452607,1.23540836348514e-07
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71019227363076,"KRT18;Keratin, type I cytoskeletal 18",0.183876602353003,1.20186750632323,1.12100295932278,1.28856528945139,2.28996824143048e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,"KRT18;Keratin, type I cytoskeletal 18",0.196284921141643,1.21687356895257,1.13108235781108,1.30917193835561,1.42422138610368e-07
primary,Circulatory system disorders,I85 (oesophageal varices),0.0570720091315214,"KRT18;Keratin, type I cytoskeletal 18",0.925632002274055,2.52346259059066,1.76046422201036,3.61715016215366,4.68711602505633e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216480034636805,"KRT18;Keratin, type I cytoskeletal 18",1.62319084778379,5.06923971002784,2.99523508269838,8.57935705486356,1.48165891077762e-09
primary,Circulatory system disorders,I08 (multiple valve diseases),0.173184027709444,TAFA5;Chemokine-like protein TAFA-5,0.560122606395542,1.75088715710001,1.41864750270828,2.160935560839,1.81536559283802e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,TAFA5;Chemokine-like protein TAFA-5,1.89590954158026,6.65860192656925,5.59401572897752,7.92578744225586,6.00315583627323e-101
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,TAFA5;Chemokine-like protein TAFA-5,1.88815006773201,6.60713461691035,4.3250450585998,10.0933579314218,2.4648880207601e-18
primary,Circulatory system disorders,I20 (angina pectoris),4.61102473776395,TAFA5;Chemokine-like protein TAFA-5,0.236912350708246,1.26733003232732,1.21542024460246,1.32145685245196,1.21791269097695e-28
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,TAFA5;Chemokine-like protein TAFA-5,0.334005096508298,1.39655026108636,1.32212534106145,1.47516469972095,6.21115841451827e-33
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,TAFA5;Chemokine-like protein TAFA-5,0.295909925488724,1.34434905979371,1.28308024208375,1.40854354645285,1.72121046593431e-35
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999744159959065,TAFA5;Chemokine-like protein TAFA-5,0.290628200526559,1.33726729623352,1.22464426718316,1.46024757515011,9.5064950005883e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352272056363529,TAFA5;Chemokine-like protein TAFA-5,0.41625321767722,1.516269766572,1.3079658243897,1.75774776538452,3.37759066238364e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383760061401609,TAFA5;Chemokine-like protein TAFA-5,0.45281508453693,1.57273333691042,1.3661536798295,1.81055044212749,2.92754869915755e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,TAFA5;Chemokine-like protein TAFA-5,0.237228963520703,1.26773134878078,1.19392695231093,1.34609807540636,9.06167862478655e-15
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,TAFA5;Chemokine-like protein TAFA-5,0.657574878985835,1.93010591371928,1.76015900828138,2.11646153594472,1.97970552427752e-44
primary,Circulatory system disorders,I63 (cerebral infarction),0.369984059197449,TAFA5;Chemokine-like protein TAFA-5,0.380737719081326,1.4633637426852,1.26778779211313,1.68911032013989,1.97664177404784e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,TAFA5;Chemokine-like protein TAFA-5,0.370480778415013,1.44843082156393,1.34979694067979,1.55427218837805,7.3593299382377e-25
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.129888020782083,TAFA5;Chemokine-like protein TAFA-5,0.618825411225485,1.85674584767703,1.46031426829373,2.36079672555282,4.41828367908516e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346368055418888,TAFA5;Chemokine-like protein TAFA-5,0.524688313066098,1.6899320365482,1.45624163696535,1.9611239066775,4.8559758389696e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.173184027709444,TAFA5;Chemokine-like protein TAFA-5,0.650538433740144,1.91657249854477,1.55601373702246,2.36067976443909,9.48361002521492e-10
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.165312026449924,TAFA5;Chemokine-like protein TAFA-5,0.689580676115068,1.99287969595575,1.61131590682464,2.4647987807551,2.02585509587241e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,TAFA5;Chemokine-like protein TAFA-5,0.252668097198577,1.28745589569556,1.19538033464563,1.38662368396134,2.49268323438243e-11
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151536024245763,TAFA5;Chemokine-like protein TAFA-5,0.613112894564314,1.84616939393237,1.47674334509669,2.3080120471912,7.36255961326321e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246000039360006,TAFA5;Chemokine-like protein TAFA-5,0.551810249867811,1.73639348056735,1.45646889356888,2.07011789449811,7.64145711509861e-10
primary,Circulatory system disorders,I95 (hypotension),0.511680081868813,TAFA5;Chemokine-like protein TAFA-5,0.318480212081789,1.37503641180658,1.21631471988752,1.55447032160292,3.59643397984614e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.310231795832357,AOC3;Membrane primary amine oxidase,0.431828672724727,1.5400712363483,1.31668143678785,1.80136162534016,6.6375556359003e-08
primary,Circulatory system disorders,I20 (angina pectoris),4.58713806290486,AOC3;Membrane primary amine oxidase,0.202009219293717,1.22385929117762,1.17308954485961,1.27682628420411,9.19120588250972e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6711152735503,AOC3;Membrane primary amine oxidase,0.288467619850043,1.3343811413619,1.26281031225817,1.41000830697862,1.11352013247867e-24
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70717240302817,AOC3;Membrane primary amine oxidase,0.261171221680573,1.2984499691874,1.23869488248793,1.36108766276362,1.69049493902482e-27
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351205806602669,AOC3;Membrane primary amine oxidase,0.370958917384691,1.44912353837886,1.24956609607117,1.6805505815869,9.2376739641151e-07
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546320143604152,AOC3;Membrane primary amine oxidase,0.372711440410551,1.4516653874211,1.28910130371854,1.6347298625466,7.71164360477109e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.306329509092328,AOC3;Membrane primary amine oxidase,0.411492355954164,1.50906817237806,1.28867477380859,1.76715397489633,3.24829012754313e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16772028408647,AOC3;Membrane primary amine oxidase,0.419953587414213,1.52189091908659,1.43248155960209,1.61688082759097,4.30634880549746e-42
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25263404354952,AOC3;Membrane primary amine oxidase,0.223226927364216,1.25010422440735,1.15510040078985,1.3529218506136,3.1050533149846e-08
primary,Circulatory system disorders,I50 (heart failure),0.917037383906969,AOC3;Membrane primary amine oxidase,0.49146306489698,1.63470615240438,1.49171469197984,1.79140436108599,6.7620053694487e-26
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70725044876297,AOC3;Membrane primary amine oxidase,0.22090513518575,1.24720510907087,1.16537806599529,1.33477763953279,1.76713746124911e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56481698275189,AOC3;Membrane primary amine oxidase,0.195998030380654,1.21652450924174,1.13321063398001,1.30596363748204,6.13279082150599e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40092093967064,AOC3;Membrane primary amine oxidase,0.210039199358258,1.23372642029283,1.14491310574247,1.32942917020894,3.58433984196947e-08
primary,Circulatory system disorders,I85 (oesophageal varices),0.0507297276203855,AOC3;Membrane primary amine oxidase,1.24770005258537,3.48232457666238,2.39965386180054,5.05347235710398,5.12863839652341e-11
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172207980274358,SPON1;Spondin-1,0.516980169630394,1.67695587332625,1.36211541768831,2.06456880567144,1.10010137823349e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303320874346881,SPON1;Spondin-1,1.23534383513438,3.43956095931617,2.95102273687835,4.0089760898849,2.8651877531802e-56
primary,Circulatory system disorders,I15 (secondary hypertension),0.0391381773350815,SPON1;Spondin-1,1.79349052842099,6.01039535004491,3.92552315969656,9.20255741571878,1.56071888161646e-16
primary,Circulatory system disorders,I20 (angina pectoris),4.5889512925383,SPON1;Spondin-1,0.196543359239277,1.21718809608394,1.16748281795803,1.26900956353235,2.48093299836782e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64769769671826,SPON1;Spondin-1,0.295590075071898,1.34391913794558,1.27323187219776,1.41853081812882,7.99474851122795e-27
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69464394043169,SPON1;Spondin-1,0.258647693685418,1.29517742525464,1.23671612522787,1.35640227265587,5.00973958018624e-28
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00389424864484,SPON1;Spondin-1,0.37181444750244,1.45036383769134,1.32914630881264,1.58263634916302,6.84280770383283e-17
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358114322615995,SPON1;Spondin-1,0.595330891415127,1.81363096059974,1.56975180354551,2.09539957451659,6.48880098981429e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545977573824386,SPON1;Spondin-1,0.414459486249352,1.51355242365885,1.3460798372333,1.70186111982192,4.28687713544437e-12
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.37964032015029,SPON1;Spondin-1,0.446548718010577,1.56290882751007,1.35931919322287,1.79699074013471,3.58589045992909e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.303320874346881,SPON1;Spondin-1,0.381308801125404,1.46419968211489,1.25259489174104,1.71155153453121,1.68529771253214e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383554137883798,SPON1;Spondin-1,0.41951527364651,1.5212239995145,1.32426800663365,1.7474729020914,3.0282534936977e-09
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.712314827498483,SPON1;Spondin-1,0.265299843155471,1.30382185923402,1.17553654892141,1.44610683706619,5.15914907033122e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16825502436351,SPON1;Spondin-1,0.474880601135764,1.60782221387846,1.51506572497093,1.70625751004343,2.68991804783262e-55
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25633549245611,SPON1;Spondin-1,0.26298078259835,1.30080172068239,1.20314417343001,1.40638599587474,3.98822603025701e-11
primary,Circulatory system disorders,I50 (heart failure),0.906048805307136,SPON1;Spondin-1,0.681664268092952,1.97716552908841,1.80718167642906,2.16313809530202,5.80929732738918e-50
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70446762294279,SPON1;Spondin-1,0.264451898160813,1.30271675861304,1.21802461504332,1.39329774801875,1.25257567696171e-14
primary,Circulatory system disorders,I63 (cerebral infarction),0.363985049216257,SPON1;Spondin-1,0.397279486232211,1.48777168365215,1.28999437149817,1.71587150423492,4.79337826536058e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56552709340326,SPON1;Spondin-1,0.296789735052346,1.34553235141267,1.25471874287173,1.44291883657882,8.47334276492059e-17
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356157413749241,SPON1;Spondin-1,0.476949440214336,1.61115198249601,1.39433304955594,1.86168628185893,9.94780653914672e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.176121798007866,SPON1;Spondin-1,0.656273777850889,1.92759628371964,1.57669594637405,2.35659097212409,1.54154650409004e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40310365746267,SPON1;Spondin-1,0.353469011339522,1.42399885845048,1.32228703303417,1.53353447338531,8.88431339513952e-21
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152638891606817,SPON1;Spondin-1,0.7743108806012,2.16909684531476,1.74887218328113,2.69029444766355,1.82073152309984e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246570517211013,SPON1;Spondin-1,0.526837333637935,1.69356764035424,1.42608997232584,2.01121346346561,1.89168057623814e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56159370658108,SPON1;Spondin-1,0.240604946214027,1.272018420342,1.20342974226638,1.34451626452424,1.77396301303499e-17
primary,Circulatory system disorders,I85 (oesophageal varices),0.05283653940236,SPON1;Spondin-1,1.40827352563372,4.08888994298436,2.85131352732097,5.86362068065782,1.90883262555826e-14
primary,Circulatory system disorders,I95 (hypotension),0.520537758556584,SPON1;Spondin-1,0.314866039871261,1.37007576313761,1.21400726063825,1.54620788326277,3.34712921765746e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215259975342948,SPON1;Spondin-1,1.66991994035913,5.31174252395892,3.04776592855419,9.2574722935557,3.81917144404629e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,ITGAM;Integrin alpha-M,-0.252826042685142,0.776602965840619,0.7233637312333,0.833760583384749,3.00224836122739e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307333203656876,AMBP;Protein AMBP,1.65247925955895,5.21990529786727,4.48456068068833,6.07582620880505,5.9138917025934e-101
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389029371717564,AMBP;Protein AMBP,1.66503112614534,5.28583777495508,3.59501684872997,7.77189152618648,2.5449254465016e-17
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66290604940673,AMBP;Protein AMBP,0.200886349382397,1.2224858276586,1.15806153684697,1.29049411561937,3.52635892118252e-13
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69577903131686,AMBP;Protein AMBP,0.228537675662558,1.25676087353853,1.19997973513353,1.31622880538193,3.37653137246389e-22
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00369577903131,AMBP;Protein AMBP,0.282975705526146,1.32707292088714,1.21712681136407,1.4469507375145,1.42589839709193e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.379303637424625,AMBP;Protein AMBP,0.3984458785955,1.48950802161109,1.29549519075316,1.71257613480907,2.19338186799202e-08
primary,Circulatory system disorders,I50 (heart failure),0.912273876677689,AMBP;Protein AMBP,0.378799843507242,1.4605306717883,1.33411007150812,1.59893091941283,2.39419835512244e-16
primary,Circulatory system disorders,I63 (cerebral infarction),0.367632756273098,AMBP;Protein AMBP,0.390910223748034,1.47832578890696,1.28329235938008,1.70300019490736,6.11707627984001e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56778836802178,AMBP;Protein AMBP,0.361725608785708,1.43580491564985,1.33957448625856,1.53894820851818,1.62037002443314e-24
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.342345847111456,AMBP;Protein AMBP,0.511855443560454,1.66838391706823,1.4422405453855,1.92998657792409,5.67773163331333e-12
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126434545808208,AMBP;Protein AMBP,0.683434338308075,1.98066835010682,1.56465395489373,2.50729376987472,1.33580125771714e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.175063217272904,AMBP;Protein AMBP,0.718718725789936,2.05180260397891,1.68033733923253,2.50538616705227,1.75048228609419e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41023147247617,AMBP;Protein AMBP,0.285114117876681,1.32991378639961,1.23609439177719,1.43085406019264,2.19751652140572e-14
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149776308111262,AMBP;Protein AMBP,0.537600990799438,1.71189508000791,1.37507515328083,2.13121788868274,1.51471790886629e-06
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243143357323477,AMBP;Protein AMBP,0.488453007078061,1.62979299052898,1.37144666630767,1.93680531458707,2.90507156141902e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,IL12A_IL12B;Interleukin-12,0.978751788218358,2.66113251104813,2.27036588991532,3.11915637598901,1.35922033342053e-33
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,IL12A_IL12B;Interleukin-12,0.188469409275526,1.20740014717644,1.14255669645239,1.27592365431681,2.20453157925393e-11
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,IL12A_IL12B;Interleukin-12,0.21740506300323,1.24284743170403,1.18569973456344,1.30274950180538,1.4008332449141e-19
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,IL12A_IL12B;Interleukin-12,0.279101494696863,1.32194150711353,1.20498546680866,1.4502493153364,3.52065877934957e-09
primary,Circulatory system disorders,I63 (cerebral infarction),0.369984059197449,IL12A_IL12B;Interleukin-12,0.359638207559904,1.43281094060961,1.23973636518841,1.65595464421067,1.11610862127357e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,IL12A_IL12B;Interleukin-12,0.250398456103177,1.28453714639579,1.19625434428883,1.37933516258333,5.47977179767689e-12
primary,Circulatory system disorders,I85 (oesophageal varices),0.0509294626941685,CDHR5;Cadherin-related family member 5,-0.935704756061714,0.392309285735133,0.269460934980558,0.571164705878847,1.0482237061651e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.310231795832357,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.772248731320655,2.1646284526456,1.85125148525674,2.53105338486902,3.72376657847201e-22
primary,Circulatory system disorders,I20 (angina pectoris),4.58713806290486,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.28789375997885,1.33361561324594,1.27680356862841,1.39295553959321,2.02542213557675e-38
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6711152735503,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.378920350148532,1.46070668603929,1.38072756283674,1.54531862770684,1.01506821723249e-39
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70717240302817,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.361270747219658,1.43515197168819,1.367551387294,1.50609417750362,9.25111637528644e-49
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00678997892765,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.257135689758597,1.29322059164458,1.18129622482835,1.41574946529316,2.58618449916688e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16772028408647,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.310210731326258,1.36371246079014,1.28159147127942,1.45109554596031,1.25016986269754e-22
primary,Circulatory system disorders,I50 (heart failure),0.917037383906969,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.468110399252299,1.59697369765761,1.45425996218238,1.75369263909529,1.11758532945383e-22
primary,Circulatory system disorders,I63 (cerebral infarction),0.364863810192773,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.501929720742625,1.65190591408294,1.42545355678229,1.91433325624581,2.51796587099961e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56481698275189,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.388781710168017,1.47518249884412,1.37196260511472,1.58616816288081,8.22662657574274e-26
primary,Circulatory system disorders,I70 (atherosclerosis),0.171700616561304,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.584922960535363,1.7948527058219,1.45180534628797,2.21895879074495,6.49009227642483e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40092093967064,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.26874361187752,1.30831966042034,1.21144838350978,1.41293707362363,7.53535980913098e-12
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55599781471942,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.222695908999652,1.24944057232789,1.1797209674806,1.32328049327878,2.9219469667257e-14
primary,Circulatory system disorders,I95 (hypotension),0.517052993053929,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.331276799102912,1.39274524959429,1.22823898665911,1.5792849366748,2.39683403133857e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0175602903301334,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,1.57948130760279,4.8524382355495,2.62174152332945,8.98111298169489,4.94464958695676e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,OPTC;Opticin,0.93289537445004,2.54185816463474,2.19599033138543,2.94220008019984,7.36109991090341e-36
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,OPTC;Opticin,1.30283230964235,3.6797039833647,2.53350150425384,5.34446945559557,7.82926441585957e-12
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15344733490995,BPIFB2;BPI fold-containing family B member 2,-0.266245182438457,0.766251233121951,0.717396540105325,0.818432929959083,2.36046690517394e-15
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.114170714244247,NOTCH3;Neurogenic locus notch homolog protein 3,0.743468352533941,2.10321757883023,1.62836090224666,2.71655023023296,1.23789567178321e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,NOTCH3;Neurogenic locus notch homolog protein 3,0.779525138476438,2.18043661416954,1.87076018909455,2.5413753489763,1.97811261790282e-23
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00818545968225,NOTCH3;Neurogenic locus notch homolog protein 3,0.271831121466109,1.31236535225913,1.20232087815041,1.4324818350154,1.1756770711458e-09
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354122723842328,NOTCH3;Neurogenic locus notch homolog protein 3,0.491151416073422,1.63419677753229,1.41225249981237,1.89102098105808,4.25318313928165e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545697312150473,NOTCH3;Neurogenic locus notch homolog protein 3,0.405300722514488,1.49975344187534,1.33287945193811,1.6875197401733,1.64694851924858e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387019370319484,NOTCH3;Neurogenic locus notch homolog protein 3,0.389340547143916,1.47600711576243,1.2833597496853,1.6975731133188,4.86545396899403e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1711786674923,NOTCH3;Neurogenic locus notch homolog protein 3,0.597005584122796,1.81667077981494,1.71073020549541,1.92917194752967,1.81941757475844e-84
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25974805038992,NOTCH3;Neurogenic locus notch homolog protein 3,0.232425774452251,1.26165679571666,1.16633841246811,1.36476502288014,6.67265585279328e-09
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,NOTCH3;Neurogenic locus notch homolog protein 3,0.438352867409304,1.55015180897482,1.41487438567666,1.69836322941043,5.00871318342117e-21
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70869051996052,NOTCH3;Neurogenic locus notch homolog protein 3,0.229521050363234,1.2579973482457,1.17574776069988,1.34600071638766,2.87207058729351e-11
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56400332836658,NOTCH3;Neurogenic locus notch homolog protein 3,0.224185216456109,1.25130275982932,1.18376020378479,1.32269913429285,2.40271964792278e-15
primary,Circulatory system disorders,I85 (oesophageal varices),0.0503125181415329,NOTCH3;Neurogenic locus notch homolog protein 3,1.40861462161931,4.09028488482043,2.83686022597943,5.89751665795036,4.52361873913597e-14
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,EGLN1;Egl nine homolog 1,0.483840098794434,1.62229221842994,1.38991970126334,1.89351373290571,8.55960898268075e-10
primary,Circulatory system disorders,I50 (heart failure),0.904382626437007,EGLN1;Egl nine homolog 1,0.358441517514726,1.43109733555192,1.30598552180153,1.56819470785454,1.59923860717029e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39875230509671,EGLN1;Egl nine homolog 1,0.223785645991997,1.25080287608087,1.16242059619234,1.34590512241174,2.15946593983153e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302321045445679,AGRN;Agrin,1.60618486479486,4.98376118893716,4.26766451014137,5.82001596642223,1.43444904425217e-91
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390091671542812,AGRN;Agrin,1.74549639513771,5.72874449064381,3.83272777069889,8.56270400678557,1.71068153228074e-17
primary,Circulatory system disorders,I20 (angina pectoris),4.58162668227033,AGRN;Agrin,0.21336024238431,1.23783048994085,1.18747927021571,1.29031669036955,7.50323109244133e-24
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64287107470255,AGRN;Agrin,0.313420302233068,1.36809642418684,1.29597179016603,1.444235005789,8.0995526858828e-30
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.690267212795,AGRN;Agrin,0.286044208569616,1.33115130224652,1.27108219086597,1.39405917430516,6.37178519553338e-34
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00643651258045,AGRN;Agrin,0.307144917369496,1.3595379744638,1.24682209037941,1.48244366078457,3.50859162403183e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358884337819387,AGRN;Agrin,0.503633547811383,1.65472287522024,1.43388695852612,1.90957019135708,5.53884526720101e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546128340159937,AGRN;Agrin,0.385850610222738,1.47086492221794,1.30876995082112,1.65303582807188,9.36698568699386e-11
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304271503803393,AGRN;Agrin,0.4831529090364,1.62117777879251,1.38824009531916,1.89320089465243,1.02889446819951e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388141213185098,AGRN;Agrin,0.414558687891665,1.51370257799266,1.31874579513928,1.73748079657734,3.79119080243542e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1650087770626,AGRN;Agrin,0.288471724616534,1.33438661869613,1.2574024222021,1.41608415628542,1.82370723494189e-21
primary,Circulatory system disorders,I50 (heart failure),0.905012677979325,AGRN;Agrin,0.682939761349322,1.97968899938005,1.80882951565923,2.1666876288438,9.39734095559685e-50
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70470060464209,AGRN;Agrin,0.257628341478698,1.29385785595531,1.21027359284133,1.38321463949908,3.99782306923622e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56036668617125,AGRN;Agrin,0.337583869359429,1.40155715116325,1.30726888334836,1.50264606845492,2.08828272118641e-21
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354983421103959,AGRN;Agrin,0.586896148620727,1.798397784199,1.55832305744384,2.07545834271173,9.90949935084825e-16
primary,Circulatory system disorders,I70 (atherosclerosis),0.175541252194265,AGRN;Agrin,0.730175530628953,2.07544487984784,1.6984099299287,2.53617891263003,9.44594332495886e-13
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171640335478837,AGRN;Agrin,0.519195383307128,1.68067480650716,1.36946667475993,2.06260426579787,6.71598920576243e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40433001755412,AGRN;Agrin,0.381722219523513,1.4648051343459,1.36111887816835,1.57638992157211,2.17881996148785e-24
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152135751901696,AGRN;Agrin,0.556605198684087,1.74473939154914,1.40297672012787,2.16975485106113,5.61405202341977e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245757753071971,AGRN;Agrin,0.551241888285125,1.73540686162528,1.46167794372853,2.06039708562193,3.09316705355283e-10
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56095182367856,AGRN;Agrin,0.188395151471013,1.20731049162119,1.14280265051385,1.27545961021635,1.76290574733096e-11
primary,Circulatory system disorders,I95 (hypotension),0.51882192315194,AGRN;Agrin,0.413660826399376,1.51234409269418,1.34168097804661,1.70471572015351,1.27766446685364e-11
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0419192519513,VWC2;Brorin,0.185998502664744,1.20442045695506,1.18043560740505,1.22889264609761,2.08568176775677e-73
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.289234914220056,VWC2;Brorin,1.71372039015693,5.54956968299525,4.69381130269699,6.56134677777184,1.80165809921883e-89
primary,Circulatory system disorders,I15 (secondary hypertension),0.0396212211260351,VWC2;Brorin,1.71080826097041,5.53343212787597,3.68494618447808,8.30917727992459,1.61469300591599e-16
primary,Circulatory system disorders,I20 (angina pectoris),4.61389120012678,VWC2;Brorin,0.333107668085429,1.39529751939517,1.33739194302196,1.45571025591139,1.56052844039452e-53
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64273544910654,VWC2;Brorin,0.446783206482691,1.56327535458459,1.47966406066685,1.65161126718872,3.88192830110497e-57
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70062205317167,VWC2;Brorin,0.443698284367649,1.55846020287405,1.48679468979707,1.63358009051924,3.40173901458641e-76
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.556678156820793,VWC2;Brorin,0.337647559696847,1.40164641965386,1.2447765983364,1.57828536329661,2.46668447550048e-08
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.368477356472126,VWC2;Brorin,0.380373291632832,1.46283054993118,1.2657889639032,1.69054501092616,2.56409793421954e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.303102341614168,VWC2;Brorin,0.405437327609482,1.49995832983078,1.27958063464909,1.75829090430534,5.71101127356819e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382344783866238,VWC2;Brorin,0.397850054695129,1.48862080147175,1.29230903702932,1.71475384530961,3.50983880455527e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16331867348151,VWC2;Brorin,0.196046683468049,1.21658369835487,1.14496304750467,1.29268442184966,2.40594524010492e-10
primary,Circulatory system disorders,I50 (heart failure),0.9033638416736,VWC2;Brorin,0.642966943283936,1.90211598590004,1.73573750732088,2.08444261217871,4.0040233912107e-43
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71163675264471,VWC2;Brorin,0.268477650039502,1.30797174358709,1.22155222928262,1.400505063158,1.38092633667761e-14
primary,Circulatory system disorders,I63 (cerebral infarction),0.364515234359522,VWC2;Brorin,0.470781336748861,1.60124481599362,1.38534302082532,1.8507942958553,1.87970027479043e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56503823447838,VWC2;Brorin,0.449135321748993,1.56695668617243,1.45958717357198,1.68222446784841,2.56039780619833e-35
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.130750029715915,VWC2;Brorin,0.659117797946169,1.93308620931506,1.52622758590421,2.44840437111495,4.58890505416958e-08
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.358572051190617,VWC2;Brorin,0.509224220737386,1.66399979755505,1.43717767623375,1.926620049874,9.71209447105533e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.166409128729347,VWC2;Brorin,0.854291748478238,2.34970960570088,1.90938669721272,2.89157520536967,7.09164958406749e-16
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17037125084195,VWC2;Brorin,0.636436856637916,1.88973547061427,1.5384671757562,2.32120659132193,1.31457959597517e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40655334997424,VWC2;Brorin,0.276698276454146,1.31876840752041,1.22277319996872,1.42229982855236,7.19268758624479e-13
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152541701335235,VWC2;Brorin,0.737299842763065,2.09028379274926,1.67800774988529,2.60385348907292,4.77649159902296e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243670509925115,VWC2;Brorin,0.562284238236014,1.75467602412033,1.47155699062712,2.09226551824584,3.77651567037813e-10
primary,Circulatory system disorders,I95 (hypotension),0.521019057807361,VWC2;Brorin,0.470461719247265,1.60073311190524,1.41578677716369,1.80983926173057,5.898813856286e-14
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204228457378913,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,1.47909824764497,4.38898611734667,3.53251909753763,5.45310544865542,1.12259532860279e-40
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.401494580983545,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,0.401499385934355,1.49406319637682,1.28473277442082,1.73750127591633,1.856182168605e-07
primary,Circulatory system disorders,I50 (heart failure),0.907424168581308,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,0.396032578345639,1.48591772550411,1.341299824163,1.64612821622124,3.43803727179339e-14
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,NPY;Pro-neuropeptide Y,0.626406218531113,1.87087496756639,1.59884513061945,2.18918835679254,5.55084921867943e-15
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.8421112501421,PALM2;Paralemmin-2,0.220295190464177,1.24644461485117,1.22027286575993,1.27317768139011,4.96840516605163e-92
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,PALM2;Paralemmin-2,1.07030934297486,2.91628149164958,2.45395524099825,3.46571021200788,5.50643736726636e-34
primary,Circulatory system disorders,I20 (angina pectoris),4.43408030940734,PALM2;Paralemmin-2,0.195911667599142,1.21641945133796,1.16297651968359,1.27231827689515,1.27018051531787e-17
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.55488567853486,PALM2;Paralemmin-2,0.244776877913282,1.27733627947129,1.20517864827559,1.35381420272263,1.57846833489708e-16
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54453418268683,PALM2;Paralemmin-2,0.215452749959517,1.24042337148391,1.18005263417445,1.30388263706552,2.5928136640232e-17
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00102377431464,PALM2;Paralemmin-2,0.260742111762631,1.29789291095582,1.18348669998721,1.42335863033153,3.05680100675991e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.398134455693322,PALM2;Paralemmin-2,0.43578063169221,1.54616957694027,1.34138144155571,1.78222263003953,1.83840992473424e-09
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555113183938118,PALM2;Paralemmin-2,0.387229614348376,1.47289465019391,1.30485436335334,1.66257531223228,3.72323915093938e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307132294391991,PALM2;Paralemmin-2,0.494094008733265,1.63901263505311,1.3989147807739,1.92031884628283,9.72959174738846e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382209077465589,PALM2;Paralemmin-2,0.395225043163619,1.48471827902597,1.28455259983469,1.71607481730022,8.83950381631423e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14992606074394,PALM2;Paralemmin-2,0.310279189555648,1.36380582132621,1.28077044450373,1.45222457799919,3.63092506871877e-22
primary,Circulatory system disorders,I50 (heart failure),0.910021613013309,PALM2;Paralemmin-2,0.554340433072725,1.74079243692497,1.58750986613093,1.90887525999493,4.5342377851222e-32
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65623933568422,PALM2;Paralemmin-2,0.262768264901472,1.30052530666909,1.210378973948,1.39738553766333,7.52945523121569e-13
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55841201228529,PALM2;Paralemmin-2,0.29723466644491,1.34613115419873,1.25059373040519,1.44896703081766,2.5005801889547e-15
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345808212945057,PALM2;Paralemmin-2,0.416896332312882,1.51724521547961,1.30324500039491,1.76638547870754,7.68850564626472e-08
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127403025821863,PALM2;Paralemmin-2,0.687933704900567,1.98960018183653,1.56878962026317,2.52328854833951,1.3944459060295e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.166078944374928,PALM2;Paralemmin-2,0.616316335728689,1.85209297181625,1.5028235739036,2.28253564544577,7.44721924379911e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40825844613809,PALM2;Paralemmin-2,0.274013331526994,1.31523233617724,1.21661369934227,1.42184499406954,5.56117204542816e-12
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.52758503014446,PALM2;Paralemmin-2,0.19990637012839,1.22128840373031,1.15119071398045,1.29565444454364,3.39054215613297e-11
primary,Circulatory system disorders,I85 (oesophageal varices),0.0523262427482652,PALM2;Paralemmin-2,0.993055504261042,2.69947012637756,1.91673062108891,3.80185868740648,1.31681654123872e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0182004322602661,PALM2;Paralemmin-2,1.41747420432634,4.12668410491568,2.46001804112388,6.92251902916274,7.85109815927853e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304303439610491,IL1RN;Interleukin-1 receptor antagonist protein,0.455880843887901,1.57756235736967,1.35852230777267,1.83191912061427,2.26832047561955e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.58418407413224,IL1RN;Interleukin-1 receptor antagonist protein,0.285906488487526,1.33096798860318,1.27714128398737,1.38706328649533,5.71037625731112e-42
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64056855662007,IL1RN;Interleukin-1 receptor antagonist protein,0.363073927015075,1.43774214329763,1.36296234191538,1.5166247863526,1.70770489287664e-40
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68894298727815,IL1RN;Interleukin-1 receptor antagonist protein,0.324370587342308,1.38315979366502,1.32130675699016,1.44790829585208,6.65456180104605e-44
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00321972671587,IL1RN;Interleukin-1 receptor antagonist protein,0.23546311612787,1.26549470405155,1.1611128646402,1.37926027241009,8.27529099338667e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.357311135542641,IL1RN;Interleukin-1 receptor antagonist protein,0.358013279738532,1.43048461681545,1.24214498642823,1.64738115220325,6.68050589056263e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17135228522066,IL1RN;Interleukin-1 receptor antagonist protein,0.190539804085785,1.20990253174319,1.14026218430472,1.28379609222169,2.98385490562381e-10
primary,Circulatory system disorders,I50 (heart failure),0.903094078844039,IL1RN;Interleukin-1 receptor antagonist protein,0.446469430135126,1.56278491270215,1.43126126063007,1.70639473766956,2.42959546045084e-23
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56667190199466,IL1RN;Interleukin-1 receptor antagonist protein,0.298289347995041,1.34755164284102,1.2581504721007,1.4433054474729,1.64287692522704e-17
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355347887545154,IL1RN;Interleukin-1 receptor antagonist protein,0.382404779839382,1.46580529349673,1.27338310890363,1.68730458525789,1.00459470967363e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.172765823778859,IL1RN;Interleukin-1 receptor antagonist protein,0.549501718311926,1.73238958476211,1.42708542651871,2.10300912448767,2.77042419138699e-08
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170802575781372,IL1RN;Interleukin-1 receptor antagonist protein,0.563027408864189,1.75598053247953,1.44702822569317,2.13089667201896,1.18093128587546e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40175907020574,IL1RN;Interleukin-1 receptor antagonist protein,0.312050433945069,1.36622359533771,1.27081614204821,1.46879383311036,2.9467392408445e-17
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24540599968588,IL1RN;Interleukin-1 receptor antagonist protein,0.512990226080702,1.67027824459598,1.41725712892046,1.96847089878156,9.31138063695378e-10
primary,Circulatory system disorders,I08 (multiple valve diseases),0.173614497785927,COL18A1;Collagen alpha-1(XVIII) chain,0.697827772911657,2.00938312686894,1.63725857812952,2.46608605658268,2.41961665411592e-11
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.1255486413202,COL18A1;Collagen alpha-1(XVIII) chain,0.207732098823907,1.2308833702715,1.2069275877872,1.25531464069744,2.50596507723878e-95
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306263776993152,COL18A1;Collagen alpha-1(XVIII) chain,1.72621734069226,5.61935754026577,4.78047735173087,6.6054447792559,3.07586117325178e-97
primary,Circulatory system disorders,I15 (secondary hypertension),0.039014493884478,COL18A1;Collagen alpha-1(XVIII) chain,1.64275915042266,5.16941304135674,3.46880743727445,7.70375170007885,6.99583221227432e-16
primary,Circulatory system disorders,I20 (angina pectoris),4.60956245245108,COL18A1;Collagen alpha-1(XVIII) chain,0.232235808729131,1.26141714693438,1.20995569494072,1.31506734108807,8.46934166303348e-28
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66468993230985,COL18A1;Collagen alpha-1(XVIII) chain,0.334402608808101,1.39710551734572,1.32309551868574,1.4752554135598,2.14247467952977e-33
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71808126719076,COL18A1;Collagen alpha-1(XVIII) chain,0.329122857047953,1.38974858550832,1.32672835464176,1.45576230745734,6.30745175959759e-44
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00852466691375,COL18A1;Collagen alpha-1(XVIII) chain,0.308129782129972,1.36087759506966,1.24779713549439,1.48420586654801,3.36321178392904e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351130444960302,COL18A1;Collagen alpha-1(XVIII) chain,0.704628658885472,2.02309528695984,1.75083580416614,2.33769182146034,1.234913607109e-21
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544252189688469,COL18A1;Collagen alpha-1(XVIII) chain,0.523042976445034,1.68715381566239,1.50066195452036,1.89682159205132,2.10155077614068e-18
primary,Circulatory system disorders,I42 (cardiomyopathy),0.308214501687376,COL18A1;Collagen alpha-1(XVIII) chain,0.629904962238365,1.87743214383685,1.60850210876373,2.19132535512863,1.39806467803642e-15
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388194214150556,COL18A1;Collagen alpha-1(XVIII) chain,0.562763934700237,1.75551793792035,1.52879092676157,2.01586964993858,1.50958396264932e-15
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1789594834481,COL18A1;Collagen alpha-1(XVIII) chain,0.378816531397889,1.46055504516781,1.37594806852682,1.55036450049245,1.5430367471349e-35
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25821742777441,COL18A1;Collagen alpha-1(XVIII) chain,0.19533231907978,1.21571492463286,1.12469278903174,1.31410354221927,8.67824993376327e-07
primary,Circulatory system disorders,I50 (heart failure),0.912939156896787,COL18A1;Collagen alpha-1(XVIII) chain,0.829545786572709,2.29227732063059,2.09272393151466,2.51085928513956,2.82563461736181e-71
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71078555683436,COL18A1;Collagen alpha-1(XVIII) chain,0.327148906775663,1.38700799669245,1.29723557622939,1.48299292598849,9.46888556962767e-22
primary,Circulatory system disorders,I63 (cerebral infarction),0.356982619042974,COL18A1;Collagen alpha-1(XVIII) chain,0.510350022590881,1.66587418650866,1.44199250267763,1.92451541885465,4.18762266908468e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56838265415601,COL18A1;Collagen alpha-1(XVIII) chain,0.412112973384391,1.51000501707024,1.40810143641843,1.61928330772596,6.54728910570431e-31
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351130444960302,COL18A1;Collagen alpha-1(XVIII) chain,0.492022778643803,1.63562137601762,1.41365409576319,1.89244122285905,3.78799418524916e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.169713048397479,COL18A1;Collagen alpha-1(XVIII) chain,0.882877157813433,2.41784623368056,1.96944941684694,2.96833234695745,3.28538342126397e-17
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.169713048397479,COL18A1;Collagen alpha-1(XVIII) chain,0.580916123783729,1.78767541275972,1.45137395144706,2.2019021205385,4.67450817960507e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40452177984121,COL18A1;Collagen alpha-1(XVIII) chain,0.319993023102443,1.37711815629014,1.27924984853817,1.48247382522739,1.77538043740871e-17
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.15020580145524,COL18A1;Collagen alpha-1(XVIII) chain,0.717254683438944,2.04880087593546,1.64536215310356,2.55116177390869,1.45008131947679e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.247742036166435,COL18A1;Collagen alpha-1(XVIII) chain,0.509389733389296,1.66427523336775,1.40017380320737,1.97819159739777,7.56315069971144e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56130152351598,COL18A1;Collagen alpha-1(XVIII) chain,0.202672188903141,1.22467094171397,1.15913095149845,1.29391671712304,5.11715328109131e-13
primary,Circulatory system disorders,I95 (hypotension),0.51499131927511,COL18A1;Collagen alpha-1(XVIII) chain,0.410289938464351,1.50725473288844,1.33581990000778,1.70069096126011,2.73920980071079e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.290726420505112,LAYN;Layilin,1.98040940513561,7.24570880840527,6.08709281437783,8.62485553238076,6.1654128933054e-110
primary,Circulatory system disorders,I15 (secondary hypertension),0.0395546150347091,LAYN;Layilin,1.95603092312689,7.07120513625493,4.66612421050975,10.7159475022924,2.90661375556871e-20
primary,Circulatory system disorders,I20 (angina pectoris),4.61206811304709,LAYN;Layilin,0.207261806819759,1.23030463176314,1.18009405427118,1.28265156616914,1.85959203616824e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6442260150703,LAYN;Layilin,0.342354910748923,1.40826001544798,1.33419409103743,1.48643760636616,2.04410278610547e-35
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70033423649704,LAYN;Layilin,0.301994122132884,1.35255327655769,1.29150577496758,1.41648640012691,1.33908009135651e-37
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01457587564029,LAYN;Layilin,0.40056690551602,1.4926706610593,1.36846402666958,1.62815072882086,1.61357227561765e-19
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361924727567589,LAYN;Layilin,0.403594104360616,1.49719611823327,1.29522643657569,1.73065971567033,4.79307346102055e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555742341237663,LAYN;Layilin,0.304965557574564,1.35657827835537,1.2070065843411,1.52468482705936,3.11244211636122e-07
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0593319225520637,LAYN;Layilin,0.957398704427988,2.6049115076281,1.84835636146729,3.67113404321379,4.52264747346965e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.302592805015525,LAYN;Layilin,0.462215419065938,1.58758726295723,1.35879709172297,1.85490043572884,5.83008457099914e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.381702035084943,LAYN;Layilin,0.366201072161004,1.44224520886231,1.2548028563755,1.65768768529472,2.53160638344418e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16165971164685,LAYN;Layilin,0.285915098715099,1.33097944858979,1.25392145440328,1.41277293433934,5.65642414382826e-21
primary,Circulatory system disorders,I50 (heart failure),0.903822953543104,LAYN;Layilin,0.695173494746226,2.00405673709646,1.83252931886236,2.1916393719665,2.31749435287905e-52
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71073710025117,LAYN;Layilin,0.239568282338952,1.27070044806236,1.18804913344284,1.35910172673307,2.92060155014089e-12
primary,Circulatory system disorders,I63 (cerebral infarction),0.365880189071059,LAYN;Layilin,0.378254480601236,1.45973436969337,1.26599907910009,1.68311688787228,1.92460395794673e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56438502462274,LAYN;Layilin,0.425107067127943,1.52975419728398,1.42675598142654,1.64018790499001,6.23459869100567e-33
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357969266064118,LAYN;Layilin,0.516426275053686,1.67602727375951,1.45133734454957,1.9355027505735,2.03746635545835e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.166129383145778,LAYN;Layilin,0.64922337350078,1.91405374677422,1.55865070040194,2.35049568488674,5.83144049047316e-10
primary,Circulatory system disorders,I72 (other aneurysm),0.106797460593714,LAYN;Layilin,0.659367928127514,1.93356979299607,1.49093115705367,2.50762225116763,6.65541388007147e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40616656448391,LAYN;Layilin,0.412476838011153,1.51055455445473,1.4026935935195,1.62670954834743,1.00232152182405e-27
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.15228526788363,LAYN;Layilin,0.599836454936018,1.82182082622148,1.46689772154183,2.2626193183842,5.77562854278983e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243260882463461,LAYN;Layilin,0.561226084879489,1.7528202897947,1.47481475155531,2.08323042950032,1.89570815398681e-10
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0118663845104127,LAYN;Layilin,1.80281959694452,6.06672910226924,2.92221311566491,12.5949752956145,1.31688531128224e-06
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55720586199394,LAYN;Layilin,0.243454278583956,1.27564799207473,1.20662310285763,1.34862145091573,9.68526380776664e-18
primary,Circulatory system disorders,I85 (oesophageal varices),0.0514209995451219,LAYN;Layilin,1.09501336375891,2.98922263037701,2.06810335184242,4.32060222038597,5.67748139293258e-09
primary,Circulatory system disorders,I95 (hypotension),0.520143187706425,LAYN;Layilin,0.423529447148325,1.52734272918872,1.35367895981152,1.72328586146485,6.10368367864247e-12
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197773075173545,LAYN;Layilin,1.57904362465816,4.85031487080811,2.75424333987426,8.54156711768844,4.5277678845029e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,RGMB;RGM domain family member B,1.92334404653522,6.84380625256059,5.70480419204619,8.21021764215676,2.90183330145954e-95
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388387222060394,RGMB;RGM domain family member B,2.29477466719955,9.92219996326288,6.10002338805548,16.139290925302,2.34567772128112e-20
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.65964728955174,5.25745615766435,4.498299731588,6.14473176512962,1.27411486601599e-96
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.7517913096759,5.76492018963236,3.82470410213676,8.68937933636844,5.86382301065516e-17
primary,Circulatory system disorders,I20 (angina pectoris),4.61595707179507,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.213741126275895,1.23830204943398,1.1879403586927,1.2907987799319,6.1364898529963e-24
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.306869018288357,1.35916293092533,1.28737416818312,1.43495490157976,1.50463295506483e-28
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71117465042497,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.307501725339887,1.36002315500213,1.29853724452665,1.42442043148034,8.54245029974688e-39
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.340694414440141,1.40592354527742,1.28923677502371,1.5331714495416,1.29004035634779e-14
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38580549136344,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.342727695584482,1.40878509129034,1.22607870059008,1.61871781353575,1.32567634612625e-06
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.579656369545806,1.78542479899022,1.63087993389325,1.9546145897077,4.04756504244874e-36
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7038110532294,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.232577798200226,1.26184861209135,1.1802260476717,1.34911606380661,9.31649548541314e-12
primary,Circulatory system disorders,I63 (cerebral infarction),0.36426305275939,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.461538792973323,1.58651342332573,1.37636943077099,1.82874218659651,1.93515190874974e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.506236155774843,1.65903507920674,1.54760255269424,1.77849111792097,3.34952380409269e-46
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348595824683717,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.574286742797162,1.77586342770287,1.53699340115704,2.0518571592295,6.61009507534574e-15
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.119462614077004,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.680159922191476,1.9741934243255,1.5458829424028,2.52117386753241,5.01256013739663e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.174297912341858,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.74111269213414,2.09826894340825,1.71539688507042,2.56659703488434,5.60165049864748e-13
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17038110532294,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.527073674750309,1.69396794731688,1.37743262994432,2.08324337913568,5.91044865634898e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.502395223927269,1.65267506055286,1.53648379862589,1.77765288395236,1.4129406524227e-41
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150797070228349,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.699217161765291,2.01217688174461,1.61943002267452,2.50017336145262,2.7681330614831e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246758842191845,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.673812754861082,1.96170257102116,1.65427250022988,2.32626545905602,9.33893813768356e-15
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56746700090086,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.260402854655267,1.29745266624348,1.22830403321143,1.37049409236332,1.17586901069283e-20
primary,Circulatory system disorders,I85 (oesophageal varices),0.0489600877364772,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.26335302134218,3.537262140741,2.46980666419278,5.0660740509456,5.45528510965235e-12
primary,Circulatory system disorders,I95 (hypotension),0.513101719478281,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.402586437219276,1.49568820276681,1.32620194470262,1.68683450422586,5.35035336163267e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195840350945908,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.78649194982912,5.96847797792394,3.46199398625011,10.2896566298048,1.28565881214151e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",1.03174682310482,2.80596307728022,2.42316236765295,3.24923698723746,3.05165903281983e-43
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.996120163830455,2.70775577319111,1.82245146201669,4.02312022024248,8.18189581623002e-07
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999744159959065,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.234132321206669,1.26381171023478,1.15924539115485,1.37781012640939,1.07533713963445e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352272056363529,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.355015610002027,1.42620291713814,1.23532831097199,1.64657018121191,1.27977548173325e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.182655103312943,1.20040032258217,1.13102988877498,1.27402551316843,1.80903406502236e-09
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.459221973867591,1.58284201335369,1.44726934651557,1.73111442266743,9.03461045436104e-24
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.246681999045418,1.27977207932031,1.19397180950234,1.37173806112767,3.23712334588962e-12
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346368055418888,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.379838273645722,1.46204811860095,1.26544502643444,1.6891960191487,2.53508804006918e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.173184027709444,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.523148179794626,1.68733131923189,1.37869030767938,2.06506636407206,3.86190663135857e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.272975723507322,1.31386834832223,1.22172910884008,1.4129564600142,1.8605331550654e-13
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,CCL15;C-C motif chemokine 15,1.31215323695865,3.71416258029889,3.17355571917523,4.34686039685407,4.39162117230963e-60
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,CCL15;C-C motif chemokine 15,1.44777018464422,4.25361914735226,2.76415784946204,6.54567388553555,4.60477533653586e-11
primary,Circulatory system disorders,I20 (angina pectoris),4.59779011939547,CCL15;C-C motif chemokine 15,0.22913579394935,1.25751279004421,1.20614461417924,1.31106867164585,4.87579049807319e-27
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66849855835284,CCL15;C-C motif chemokine 15,0.337891851810236,1.40198887264752,1.32725889937892,1.48092644166654,1.18920218618932e-33
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71538595506705,CCL15;C-C motif chemokine 15,0.279549724202813,1.32253417311743,1.26237666658739,1.38555843541672,5.61194257290471e-32
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354122723842328,CCL15;C-C motif chemokine 15,0.410205433094295,1.50712736715109,1.30537938480399,1.74005574720857,2.21323542627659e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30768039940399,CCL15;C-C motif chemokine 15,0.400825494345974,1.49305669892944,1.27812817314213,1.74412735206188,4.3168847268287e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1711786674923,CCL15;C-C motif chemokine 15,0.184147612223578,1.20219326842095,1.13236875894274,1.27632332066989,1.62070514153961e-09
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,CCL15;C-C motif chemokine 15,0.566634455978618,1.76232587408544,1.60858222853557,1.93076389343086,4.68152770921899e-34
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56549335294231,CCL15;C-C motif chemokine 15,0.276108545562923,1.31799091832936,1.22925523812818,1.41313212009883,8.21842750065103e-15
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35218762699073,CCL15;C-C motif chemokine 15,0.415475175014391,1.51509050282349,1.31122496159382,1.75065248068167,1.75174852616377e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40488031425972,CCL15;C-C motif chemokine 15,0.248766237254575,1.28244221081549,1.19225186074019,1.37945519586798,2.29058716877249e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249627493856067,CCL15;C-C motif chemokine 15,0.454542199819648,1.57545197571777,1.32615176989914,1.87161755096989,2.31938750098417e-07
primary,Circulatory system disorders,I95 (hypotension),0.512800665673317,CCL15;C-C motif chemokine 15,0.321753510615878,1.37954469092405,1.223545263659,1.55543371445484,1.47887139355728e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.299853092109235,NEFL;Neurofilament light polypeptide,1.21483367947533,3.36973356185737,2.96323827865473,3.83199162878761,1.37070058909101e-76
primary,Circulatory system disorders,I15 (secondary hypertension),0.0402487371958704,NEFL;Neurofilament light polypeptide,1.28855286032849,3.62753320829042,2.65735750096139,4.95191075061937,4.86278545140225e-16
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.63427984946972,NEFL;Neurofilament light polypeptide,0.218279730491775,1.2439349855004,1.17934179194004,1.31206598352325,1.0306786247327e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70690869573967,NEFL;Neurofilament light polypeptide,0.220148797001463,1.24626215686358,1.19091397126799,1.30418267070674,2.13462092522583e-21
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00621842989676,NEFL;Neurofilament light polypeptide,0.225323972136413,1.25272849958541,1.14923953331616,1.36553664243099,3.02498287607557e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.362238634762834,NEFL;Neurofilament light polypeptide,0.386899127447128,1.47240795823219,1.28060409479008,1.69293945278291,5.53261196004443e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.390412750799943,NEFL;Neurofilament light polypeptide,0.337023161940954,1.40077150794975,1.22542222853785,1.60121203270894,7.84557367124625e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16538206113783,NEFL;Neurofilament light polypeptide,0.25016065112493,1.28423171338582,1.21125471197966,1.36160551315451,5.25953061859512e-17
primary,Circulatory system disorders,I50 (heart failure),0.901571713187498,NEFL;Neurofilament light polypeptide,0.440200877673694,1.55301915405471,1.4241321128093,1.69357075173528,2.31786996887256e-23
primary,Circulatory system disorders,I63 (cerebral infarction),0.370288382202008,NEFL;Neurofilament light polypeptide,0.507975282876725,1.66192286245917,1.45511649548039,1.89812129086794,6.78067378000332e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55963856633998,NEFL;Neurofilament light polypeptide,0.313420204444987,1.36809629040332,1.27786050210074,1.46470405551964,2.19909848631257e-19
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.350164013604073,NEFL;Neurofilament light polypeptide,0.510565411744854,1.66623303638512,1.45208278226001,1.91196574014886,3.48410000078134e-13
primary,Circulatory system disorders,I70 (atherosclerosis),0.17709444366183,NEFL;Neurofilament light polypeptide,0.564634014097418,1.75880396745785,1.45869704930269,2.12065376935137,3.31632491816718e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40468092813588,NEFL;Neurofilament light polypeptide,0.338826266687151,1.40329952415816,1.30559600021558,1.50831463498461,3.50895614218789e-20
primary,Circulatory system disorders,I95 (hypotension),0.525246020406109,NEFL;Neurofilament light polypeptide,0.360109890192061,1.43348693205964,1.27590229693155,1.61053459134576,1.35560435473115e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302321045445679,IL10RB;Interleukin-10 receptor subunit beta,1.55035542671905,4.71314506261058,4.03323978531523,5.50766568902977,9.89905602124466e-85
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390091671542812,IL10RB;Interleukin-10 receptor subunit beta,1.58323803409358,4.87070180294819,3.28729517533227,7.21679520332238,2.96360990483022e-15
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00643651258045,IL10RB;Interleukin-10 receptor subunit beta,0.261926165393835,1.29943059594105,1.19118445816882,1.41751335159579,3.58580002622433e-09
primary,Circulatory system disorders,I50 (heart failure),0.905012677979325,IL10RB;Interleukin-10 receptor subunit beta,0.313595138772019,1.36833563834167,1.24855921137366,1.49960242341728,1.9511406158573e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56036668617125,IL10RB;Interleukin-10 receptor subunit beta,0.298316227363806,1.34758786466537,1.25639837699075,1.44539589213967,7.13887444758653e-17
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354983421103959,IL10RB;Interleukin-10 receptor subunit beta,0.426512226072847,1.53190525601357,1.32478552784601,1.77140651379065,8.67554438630661e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.175541252194265,IL10RB;Interleukin-10 receptor subunit beta,0.555330390611214,1.74251660080456,1.41914842533867,2.13956768007185,1.14333122804729e-07
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171640335478837,IL10RB;Interleukin-10 receptor subunit beta,0.515543438530909,1.674548268625,1.36011015399573,2.06168000122422,1.18316636771117e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40433001755412,IL10RB;Interleukin-10 receptor subunit beta,0.308628401734197,1.36155632451735,1.26466340533797,1.46587275081133,2.52690035106197e-16
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245757753071971,IL10RB;Interleukin-10 receptor subunit beta,0.435435160735107,1.54563551251386,1.2983108370276,1.8400748645166,9.86195165103162e-07
primary,Circulatory system disorders,I85 (oesophageal varices),0.0526623756582797,IL10RB;Interleukin-10 receptor subunit beta,1.01822083481643,2.76826517896635,1.93546082788509,3.95941472473582,2.45468598158179e-08
primary,Circulatory system disorders,I95 (hypotension),0.51882192315194,IL10RB;Interleukin-10 receptor subunit beta,0.374756800594021,1.4546376045954,1.28944158835396,1.64099760688204,1.10736015495954e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214550419348546,IL10RB;Interleukin-10 receptor subunit beta,1.63933148281048,5.1517243445061,3.11697937354281,8.51473832231705,1.61063485425267e-10
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54892806961881,LGALS3BP;Galectin-3-binding protein,0.190098786576145,1.2093690611853,1.15005051227711,1.27174720635211,1.2789557587091e-13
primary,Circulatory system disorders,I50 (heart failure),0.899696324162625,LGALS3BP;Galectin-3-binding protein,0.263750070893506,1.30180279722929,1.18079536293686,1.4352110247613,1.16696816187572e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40280106966414,LGALS3BP;Galectin-3-binding protein,0.226390264448745,1.25406498677033,1.15802882058876,1.35806550155091,2.55671226157212e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303814340036849,MEPE;Matrix extracellular phosphoglycoprotein,1.42490842233377,4.15747709327261,3.52441920931727,4.9042451407007,4.05524297776312e-64
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392018503273354,MEPE;Matrix extracellular phosphoglycoprotein,1.84446436615999,6.32471115362668,4.01219201873352,9.97010387091012,1.97303984005348e-15
primary,Circulatory system disorders,I08 (multiple valve diseases),0.176555773770556,IGFBP4;Insulin-like growth factor-binding protein 4,0.59001880320522,1.80402233648115,1.47261069194979,2.21001830851428,1.21838272788736e-08
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0624491658235,IGFBP4;Insulin-like growth factor-binding protein 4,0.209878284365622,1.23352791118696,1.2092771605555,1.25826498449562,2.4144197318649e-95
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.297565910849253,IGFBP4;Insulin-like growth factor-binding protein 4,1.84566732717321,6.33232411269275,5.39910280307099,7.42685037324761,5.72744158431197e-114
primary,Circulatory system disorders,I15 (secondary hypertension),0.0376916820409053,IGFBP4;Insulin-like growth factor-binding protein 4,1.9385635044221,6.94876193196292,4.71575684599543,10.239139540899,1.11143892814308e-22
primary,Circulatory system disorders,I20 (angina pectoris),4.6182229363804,IGFBP4;Insulin-like growth factor-binding protein 4,0.254143338715651,1.28935660574276,1.23639112355685,1.34459106434701,1.59812854419237e-32
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65428792477533,IGFBP4;Insulin-like growth factor-binding protein 4,0.384085365387791,1.46827077583647,1.38987572663209,1.55108764752612,7.77857386249855e-43
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71759011287666,IGFBP4;Insulin-like growth factor-binding protein 4,0.370980711125141,1.44915512054528,1.38298698735323,1.51848902600429,1.40200296371815e-54
primary,Circulatory system disorders,I26 (pulmonary embolism),0.99982146045349,IGFBP4;Insulin-like growth factor-binding protein 4,0.381986131915754,1.46519176558922,1.34281155393742,1.59872537859508,9.18318206374495e-18
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359062865758098,IGFBP4;Insulin-like growth factor-binding protein 4,0.668445832234296,1.95120246693244,1.69390816978366,2.24757819513291,1.95209690302091e-20
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.55347259417961,IGFBP4;Insulin-like growth factor-binding protein 4,0.461895747131415,1.5870798369749,1.41291785001323,1.78270973709384,6.79329125657961e-15
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.384851911365034,IGFBP4;Insulin-like growth factor-binding protein 4,0.35569245147931,1.42716855718323,1.24064725158442,1.641731836355,6.44117977298727e-07
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0575294094308556,IGFBP4;Insulin-like growth factor-binding protein 4,0.983027311311987,2.67253460213693,1.91390929715111,3.73185981710359,7.89706648465476e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301533456327243,IGFBP4;Insulin-like growth factor-binding protein 4,0.47611460492399,1.60980749725286,1.3763961601251,1.88280108103177,2.56636950972804e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386835684104029,IGFBP4;Insulin-like growth factor-binding protein 4,0.549388533486113,1.73219351564495,1.50913031965994,1.988227482116,5.67478817434158e-15
primary,Circulatory system disorders,I46 (cardiac arrest),0.0833184550377908,IGFBP4;Insulin-like growth factor-binding protein 4,0.787077189638618,2.19696571879827,1.64636326060087,2.93170923154176,8.94438247374711e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14247455811462,IGFBP4;Insulin-like growth factor-binding protein 4,0.359183181715566,1.43215912290978,1.34822865525995,1.52131446348635,2.11288584422399e-31
primary,Circulatory system disorders,I50 (heart failure),0.898649050764744,IGFBP4;Insulin-like growth factor-binding protein 4,0.824033324566683,2.27967599307298,2.08311828178262,2.49478038709641,9.51044481865138e-72
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70802832827471,IGFBP4;Insulin-like growth factor-binding protein 4,0.299880479287895,1.34969748113119,1.26184943235737,1.44366137817937,2.47799778245843e-18
primary,Circulatory system disorders,I63 (cerebral infarction),0.368981729453073,IGFBP4;Insulin-like growth factor-binding protein 4,0.383490314604324,1.46739734005606,1.27224424929718,1.69248550723897,1.38750763017773e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56321291832807,IGFBP4;Insulin-like growth factor-binding protein 4,0.470102270554288,1.60015783387802,1.49204061558167,1.71610951242302,1.29547899577959e-39
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132912773512666,IGFBP4;Insulin-like growth factor-binding protein 4,0.684280279676461,1.98234458830089,1.57246820908597,2.49905851454385,7.03772411999548e-09
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351127774802118,IGFBP4;Insulin-like growth factor-binding protein 4,0.604705672904273,1.83071330105306,1.58542719511149,2.11394834211666,1.73589977115934e-16
primary,Circulatory system disorders,I70 (atherosclerosis),0.174572001031561,IGFBP4;Insulin-like growth factor-binding protein 4,0.897106088638995,2.45249552708948,2.01535297869939,2.98445700280034,3.34689843083448e-19
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170604455553571,IGFBP4;Insulin-like growth factor-binding protein 4,0.822782035909626,2.27682524428784,1.86252939640763,2.78327590588635,9.816691325283e-16
primary,Circulatory system disorders,I72 (other aneurysm),0.107123727905731,IGFBP4;Insulin-like growth factor-binding protein 4,0.643838074077591,1.90377369964638,1.47094111761755,2.46396966952392,9.96628070840387e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41244619016445,IGFBP4;Insulin-like growth factor-binding protein 4,0.472029163257802,1.60324413886694,1.48982246805311,1.72530071463493,1.88039275656854e-36
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150766728163621,IGFBP4;Insulin-like growth factor-binding protein 4,0.886853627989816,2.42747986835619,1.96693637612784,2.99585618670342,1.42846763220428e-16
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245987819635382,IGFBP4;Insulin-like growth factor-binding protein 4,0.768226562747885,2.15593943816625,1.82142836335144,2.55188452895733,4.24895813565863e-19
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55311551508659,IGFBP4;Insulin-like growth factor-binding protein 4,0.24976032474168,1.28371770444128,1.21452203418053,1.35685569987036,1.00479897726666e-18
primary,Circulatory system disorders,I95 (hypotension),0.5177646848777,IGFBP4;Insulin-like growth factor-binding protein 4,0.489596658148207,1.63165797126705,1.44721093838397,1.83961277833636,1.25058821811115e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,1.23676658262573,3.44445806889151,2.96196082316122,4.00555311048625,4.70120364129173e-58
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,1.34613791626765,3.84255656139013,2.62919577429145,5.6158773233467,3.57618023057542e-12
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999744159959065,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.237357187142715,1.26789391230808,1.15942846978631,1.38650638203163,1.97194760369414e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307008049121287,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.43926749447348,1.55157026835468,1.32269947329759,1.82004328741468,6.86543258386543e-08
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.511151992174679,1.66721070278775,1.51921656039771,1.82962166155059,4.40025068942485e-27
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.274622352162407,1.31603358377372,1.22499465576185,1.41383832612982,5.98306195499896e-14
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346368055418888,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.481603445579882,1.6186677681548,1.39230895314885,1.88182754821597,3.70196968904215e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.173184027709444,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.615368817512367,1.8503389111206,1.50120675547907,2.28066791833372,8.01845058721673e-09
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.165312026449924,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.541393405658085,1.71839962251168,1.38679234596232,2.12930023103006,7.45135255901819e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.270360838257976,1.31043722131538,1.21510263515959,1.41325157342222,2.29112580953465e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246000039360006,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.477824462827464,1.61256239389482,1.34979286377874,1.92648631059146,1.40121902838099e-07
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.56538095453927,"ATRN;Attractin, Isoform 2",-0.248263848692259,0.78015407348794,0.735175667852523,0.827884279899645,2.52244819884715e-16
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14159452476997,"ATRN;Attractin, Isoform 2",-0.252274382840784,0.777031504704856,0.728499202205066,0.828797008255246,1.76696566489045e-14
primary,Circulatory system disorders,I50 (heart failure),0.899696324162625,"ATRN;Attractin, Isoform 2",-0.241773954429322,0.785233656081859,0.711443820223553,0.866676857843724,1.57219957386666e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,VMO1;Vitelline membrane outer layer protein 1 homolog,0.866154421818456,2.377749428004,2.02467568978318,2.79239404656398,4.51681329755778e-26
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352272056363529,VMO1;Vitelline membrane outer layer protein 1 homolog,0.438977918472977,1.55112103588848,1.33815451841838,1.79798105141062,5.68649614444624e-09
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,VMO1;Vitelline membrane outer layer protein 1 homolog,0.380080621500015,1.46240248576369,1.33329473057634,1.60401221224611,7.64386366775234e-16
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,VMO1;Vitelline membrane outer layer protein 1 homolog,0.183142849927542,1.20098595658457,1.11528908719829,1.29326762403523,1.24205769612188e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298902686112058,"NOS3;Nitric oxide synthase, endothelial",0.464510514519176,1.5912351117454,1.35198283548662,1.87282642530003,2.30308830357003e-08
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.63194848442295,"NOS3;Nitric oxide synthase, endothelial",0.262344373234524,1.29997414165432,1.22690149925881,1.37739889468779,6.22902740248267e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70318361451583,"NOS3;Nitric oxide synthase, endothelial",0.23506618267695,1.2649924865516,1.20492165018301,1.32805812791973,2.80381870884328e-21
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16453690144235,"NOS3;Nitric oxide synthase, endothelial",0.212061947212951,1.23622446336666,1.16160104340329,1.31564183116491,2.46411368753822e-11
primary,Circulatory system disorders,I50 (heart failure),0.900720174928283,"NOS3;Nitric oxide synthase, endothelial",0.385950582710336,1.47101197559366,1.33656871691627,1.61897866151801,2.96358954901453e-15
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56071335433007,"NOS3;Nitric oxide synthase, endothelial",0.245529798535554,1.2782983744428,1.18941267459984,1.37382656919546,2.4348910274394e-11
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353066260105518,"NOS3;Nitric oxide synthase, endothelial",0.368326294569692,1.44531356000845,1.24699088535833,1.67517767072053,1.0022410457744e-06
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.122369556059299,"NOS3;Nitric oxide synthase, endothelial",0.662074822036992,1.93881085158685,1.51796403940174,2.4763350255072,1.13983622044539e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40624686553391,"NOS3;Nitric oxide synthase, endothelial",0.293337431863014,1.34089517485988,1.24498142817519,1.44419814566865,9.43577580655035e-15
primary,Circulatory system disorders,I85 (oesophageal varices),0.0441332825131898,"NOS3;Nitric oxide synthase, endothelial",1.00840865875879,2.74123530148111,1.85650259848023,4.04759518475098,3.94645636834141e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,CLMP;CXADR-like membrane protein,1.69869159633092,5.46678994231315,4.74274372067727,6.30137195545293,1.93423704729064e-121
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,CLMP;CXADR-like membrane protein,1.66635873841734,5.29285997840322,3.78737626744189,7.39677411822201,1.69759564718005e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,CLMP;CXADR-like membrane protein,0.198782019479079,1.219916018986,1.15447645104298,1.28906491945694,1.59022138044184e-12
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,CLMP;CXADR-like membrane protein,0.194233548167194,1.21437986603177,1.15814117396978,1.27334947773977,9.86504080538651e-16
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,CLMP;CXADR-like membrane protein,0.313187795245345,1.36777836918477,1.24912940014604,1.49769724977335,1.33571645002916e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382643151270297,CLMP;CXADR-like membrane protein,0.358478488715635,1.43115024591711,1.24306616332645,1.64769268669306,6.14382269803112e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,CLMP;CXADR-like membrane protein,0.18519412189207,1.20345203383996,1.13171873628294,1.27973210243948,3.50137077654802e-09
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,CLMP;CXADR-like membrane protein,0.536831764089462,1.71057875093034,1.56556087220463,1.86902963345902,1.55529800988598e-32
primary,Circulatory system disorders,I63 (cerebral infarction),0.367104343096884,CLMP;CXADR-like membrane protein,0.433195567219187,1.54217779063308,1.33688942540873,1.77898956541959,2.78774812688333e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,CLMP;CXADR-like membrane protein,0.446511682286446,1.56285094512175,1.45637392686361,1.67711260934755,2.53194336870039e-35
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132079869474011,CLMP;CXADR-like membrane protein,0.561735196371487,1.7537128979469,1.39924610045429,2.19797570093408,1.08326328190937e-06
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,CLMP;CXADR-like membrane protein,0.554258428179425,1.74064968928001,1.50308384299452,2.01576336204529,1.33047601913291e-13
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126252816408981,CLMP;CXADR-like membrane protein,0.724918349122969,2.06456251974379,1.63846800354552,2.60146575258552,7.91913015185814e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174811591950897,CLMP;CXADR-like membrane protein,0.719868710858109,2.05416350357578,1.69840169205755,2.4844462409307,1.18179995219145e-13
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.16704218786419,CLMP;CXADR-like membrane protein,0.539411679929912,1.71499759782177,1.40485369709621,2.09361072018664,1.15830194380868e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,CLMP;CXADR-like membrane protein,0.371745903250937,1.45026442699473,1.34331040341206,1.56573410200946,1.89277989165018e-21
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242793877709579,CLMP;CXADR-like membrane protein,0.523647423890457,1.68817391974489,1.42052339317605,2.00625431231715,2.75557799919244e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55613394452645,CLMP;CXADR-like membrane protein,0.189235343557316,1.2083252905953,1.13969460847431,1.28108880838416,2.25646297713461e-10
primary,Circulatory system disorders,I85 (oesophageal varices),0.0563281796286224,CLMP;CXADR-like membrane protein,0.89886094731096,2.45680308860856,1.75222581922068,3.44469380030085,1.86178137508169e-07
primary,Circulatory system disorders,I95 (hypotension),0.518607722787662,CLMP;CXADR-like membrane protein,0.379801105401091,1.4619937778487,1.29084705674261,1.65583195569427,2.24553362312375e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,SERPINB8;Serpin B8,0.856247858731791,2.35431039511211,2.01812938977925,2.7464926008234,1.25754054780493e-27
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387544325382215,SERPINB8;Serpin B8,1.04564303849001,2.84522752634146,1.86615014841583,4.33797874384504,1.17889389778855e-06
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,SERPINB8;Serpin B8,0.188228509456402,1.20710931973092,1.1525252961908,1.26427846277832,1.55249182030012e-15
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00180208111302,SERPINB8;Serpin B8,0.233899153857134,1.26351706496016,1.1585787033097,1.37796022737593,1.24152588908617e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354603057724727,SERPINB8;Serpin B8,0.392465518708158,1.48062681047566,1.2811050182723,1.71122251543109,1.07014824205175e-07
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,SERPINB8;Serpin B8,0.394786770699034,1.48406771046017,1.3542435563667,1.62633741831452,2.85278782400842e-17
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,SERPINB8;Serpin B8,0.225314455760277,1.25271657820654,1.1681665696417,1.34338617975931,2.62215069093656e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174394946421997,SERPINB8;Serpin B8,0.553610547186537,1.73952232067083,1.41607578355295,2.13684743377216,1.33185073354911e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,SERPINB8;Serpin B8,0.260441066198068,1.2975022448588,1.20582204588893,1.39615300711519,3.26399797759021e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354603057724727,IL18R1;Interleukin-18 receptor 1,0.401208533149889,1.49362870712525,1.29185258239412,1.72692050559994,6.01922631012326e-08
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,IL18R1;Interleukin-18 receptor 1,0.290690536279672,1.33735065839573,1.22013224969867,1.46583026877062,5.26485133200377e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,IL18R1;Interleukin-18 receptor 1,0.214772318028931,1.23957963489971,1.15199885872301,1.33381874437044,9.20075090016778e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303309003385319,SCGB1A1;Uteroglobin,1.45538278207512,4.28612380299977,3.63401315075052,5.05525337761838,6.30306145867534e-67
primary,Circulatory system disorders,I15 (secondary hypertension),0.0391366455981057,SCGB1A1;Uteroglobin,1.76604380079845,5.84767297934035,3.77410034287886,9.06051142435268,2.68292995285261e-15
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15838600473553,SCGB1A1;Uteroglobin,0.188838286535747,1.20784561179055,1.13683707405632,1.28328944860696,1.00445680152534e-09
primary,Circulatory system disorders,I50 (heart failure),0.904056513316243,SCGB1A1;Uteroglobin,0.361949046891011,1.43612576502344,1.30823597198561,1.57651773619541,2.82708964686569e-14
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306748466257668,FAS;Tumor necrosis factor receptor superfamily member 6,1.16253523076565,3.19803075324761,2.7846309363563,3.67280294317927,6.99566388904781e-61
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388289197794517,FAS;Tumor necrosis factor receptor superfamily member 6,1.41064035592736,4.09857911335664,2.83358584308438,5.92830133925225,6.84978150296729e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40560689601615,FAS;Tumor necrosis factor receptor superfamily member 6,0.231567063261704,1.26057386193777,1.17170400598478,1.35618420120119,5.36216218237835e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248505086588491,FAS;Tumor necrosis factor receptor superfamily member 6,0.45634143292442,1.57828913265542,1.33295730687387,1.8687744711796,1.19526523309286e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.297292443983319,"CA5A;Carbonic anhydrase 5A, mitochondrial",0.653295896450562,1.92186466886919,1.63412675644168,2.26026762666224,2.90782504794706e-15
primary,Circulatory system disorders,I50 (heart failure),0.911829844968974,"CA5A;Carbonic anhydrase 5A, mitochondrial",0.264312423413848,1.30253507519318,1.1829173095075,1.43424870738841,7.5374853977958e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.310231795832357,IL18BP;Interleukin-18-binding protein,1.43112482119207,4.18340212581363,3.58517973087732,4.88144379360848,7.90036091114265e-74
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390228674002965,IL18BP;Interleukin-18-binding protein,1.56660069623891,4.79033667610056,3.17176159070208,7.23488345960916,9.5518398248715e-14
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00678997892765,IL18BP;Interleukin-18-binding protein,0.327919090819315,1.38807665960065,1.27316622375345,1.51335841069345,1.02439379818578e-13
primary,Circulatory system disorders,I50 (heart failure),0.917037383906969,IL18BP;Interleukin-18-binding protein,0.346004703310176,1.41340926350421,1.29064555045722,1.54785002392935,8.42056529723198e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56481698275189,IL18BP;Interleukin-18-binding protein,0.375641386718177,1.45592492612553,1.35789663098248,1.56103000931666,4.45337121105382e-26
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349254663232654,IL18BP;Interleukin-18-binding protein,0.425372442417821,1.53016021011803,1.32286874099526,1.76993392924751,1.0207098819137e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.171700616561304,IL18BP;Interleukin-18-binding protein,0.592453912558435,1.80842068119788,1.47094155162379,2.22332787905406,1.88984521330272e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40092093967064,IL18BP;Interleukin-18-binding protein,0.371111741001423,1.44934501560213,1.3467666218815,1.55973643846036,3.80727947097157e-23
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146335752751112,IL18BP;Interleukin-18-binding protein,0.549162432678315,1.73180190956469,1.38465719309273,2.16597860389771,1.49940175437027e-06
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.247795207991883,IL18BP;Interleukin-18-binding protein,0.481670813071372,1.61877681741505,1.36252933036635,1.9232161291499,4.29533691872388e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55599781471942,IL18BP;Interleukin-18-binding protein,0.257617150716488,1.29384337678073,1.22478647590405,1.36679389964991,3.40495069445233e-20
primary,Circulatory system disorders,I85 (oesophageal varices),0.0507297276203855,IL18BP;Interleukin-18-binding protein,1.30459827861779,3.68620796766507,2.57173474965118,5.28364333946977,1.22666477855749e-12
primary,Circulatory system disorders,I95 (hypotension),0.517052993053929,IL18BP;Interleukin-18-binding protein,0.315007386072105,1.37026943182844,1.21494061300031,1.54545686901238,2.87174023490756e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0175602903301334,IL18BP;Interleukin-18-binding protein,1.58552619792757,4.88185952714212,2.73421616008616,8.71641122989972,8.28398072092337e-08
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.116541061300598,SLITRK2;SLIT and NTRK-like protein 2,0.647111529735085,1.91001582952779,1.47486237171305,2.47355993278845,9.31644627809957e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,SLITRK2;SLIT and NTRK-like protein 2,0.570651056523563,1.76941866807605,1.51475706321687,2.06689409078384,6.13470422564955e-13
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,SLITRK2;SLIT and NTRK-like protein 2,0.242983902193697,1.27504809847593,1.20083280454299,1.35385013407075,1.99772181433336e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302321045445679,CSF1;Macrophage colony-stimulating factor 1,1.45997895916554,4.30586892831676,3.69414364864455,5.01889178961585,7.97465034184871e-78
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390091671542812,CSF1;Macrophage colony-stimulating factor 1,1.41785760880217,4.12826659741982,2.76737276236849,6.15839880016241,3.70282287880558e-12
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64287107470255,CSF1;Macrophage colony-stimulating factor 1,0.194699119788231,1.21494537846761,1.15062429126428,1.28286208092993,2.29160933596809e-12
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.690267212795,CSF1;Macrophage colony-stimulating factor 1,0.190886635746504,1.21032223702691,1.1555446650079,1.26769649136133,6.58408420055108e-16
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00643651258045,CSF1;Macrophage colony-stimulating factor 1,0.316743040874086,1.37264981170911,1.25879874661694,1.49679804706576,7.50647076821664e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358884337819387,CSF1;Macrophage colony-stimulating factor 1,0.373468382655083,1.45276463025695,1.25777790792278,1.67797912304815,3.79564741380526e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1650087770626,CSF1;Macrophage colony-stimulating factor 1,0.226730197643675,1.25449135755262,1.18184707062957,1.33160085199169,9.36004714653991e-14
primary,Circulatory system disorders,I50 (heart failure),0.905012677979325,CSF1;Macrophage colony-stimulating factor 1,0.454600666840094,1.57554409039345,1.43843349873573,1.72572397886695,1.28962280532199e-22
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70470060464209,CSF1;Macrophage colony-stimulating factor 1,0.205507066632036,1.2281476597988,1.14864859939847,1.31314892566722,1.75671707100208e-09
primary,Circulatory system disorders,I63 (cerebral infarction),0.362785254534815,CSF1;Macrophage colony-stimulating factor 1,0.35726049101457,1.4294081693457,1.23862374074377,1.64957900238963,1.01993069050187e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56036668617125,CSF1;Macrophage colony-stimulating factor 1,0.359782461981848,1.43301764483225,1.33643769786566,1.53657710619817,5.18388944388143e-24
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354983421103959,CSF1;Macrophage colony-stimulating factor 1,0.557842501827,1.74689949916026,1.51295965261871,2.01701205639186,2.85757734052167e-14
primary,Circulatory system disorders,I70 (atherosclerosis),0.175541252194265,CSF1;Macrophage colony-stimulating factor 1,0.626413797728059,1.87088914734997,1.527188038041,2.2919418660205,1.46245961513908e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40433001755412,CSF1;Macrophage colony-stimulating factor 1,0.343765671205256,1.41024813504052,1.31033656764002,1.51777783777125,4.76516236793463e-20
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152135751901696,CSF1;Macrophage colony-stimulating factor 1,0.567297366430347,1.76349452563959,1.41752884659254,2.19389746419371,3.5533514616003e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245757753071971,CSF1;Macrophage colony-stimulating factor 1,0.558682700873572,1.7483678592249,1.47143551952292,2.07742040382561,2.15500916952717e-10
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56095182367856,CSF1;Macrophage colony-stimulating factor 1,0.291511001842836,1.33844835880794,1.26694930331985,1.4139823941664,2.2966391963477e-25
primary,Circulatory system disorders,I85 (oesophageal varices),0.0526623756582797,CSF1;Macrophage colony-stimulating factor 1,0.949256449608731,2.58378776848684,1.79680620123323,3.7154586999979,3.02470809710864e-07
primary,Circulatory system disorders,I95 (hypotension),0.51882192315194,CSF1;Macrophage colony-stimulating factor 1,0.412128620662136,1.510028644723,1.33949307814103,1.70227569301698,1.57902295545363e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214550419348546,CSF1;Macrophage colony-stimulating factor 1,1.56514260996323,4.7833570416284,2.84188390145919,8.05117498851652,3.82421761726364e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,CD83;CD83 antigen,1.3365409914471,3.80585622182919,3.26600724268705,4.43493859778433,9.75542268013152e-66
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392356887825165,CD83;CD83 antigen,1.24298190475018,3.46593315348577,2.3132667369431,5.19295610514254,1.68684763362862e-09
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64840899281986,CD83;CD83 antigen,0.29136333280421,1.33825072601802,1.26842825913239,1.41191667151342,1.61453830238257e-26
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68619296111743,CD83;CD83 antigen,0.240344739243489,1.27168747534134,1.21459903553734,1.33145917922173,1.11181729855062e-24
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0103189861498,CD83;CD83 antigen,0.375398478971242,1.45557131363137,1.33443201027698,1.587707603497,2.50635737498197e-17
primary,Circulatory system disorders,I50 (heart failure),0.904382626437007,CD83;CD83 antigen,0.411570782139919,1.50918652747988,1.37941523413457,1.65116631915098,2.91726629358865e-19
primary,Circulatory system disorders,I63 (cerebral infarction),0.364891905677404,CD83;CD83 antigen,0.353229704994246,1.42365812725918,1.23510042020109,1.64100216481274,1.10017332793621e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56942755130066,CD83;CD83 antigen,0.36172559662756,1.43580489819312,1.33952595056505,1.53900393255221,1.71199088715104e-24
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353121199042649,CD83;CD83 antigen,0.388231607937276,1.47437122082414,1.2750064448239,1.70490941878705,1.62681318673228e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176560599521324,CD83;CD83 antigen,0.792919110603348,2.20983778106675,1.81454498536353,2.69124384240695,3.13481174290153e-15
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39875230509671,CD83;CD83 antigen,0.451113313306772,1.57005918061146,1.45799935965584,1.69073176493315,7.2851931300539e-33
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149095617373563,CD83;CD83 antigen,0.708396199735676,2.03073175742163,1.63396581221806,2.52384195542175,1.69243634244827e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24914662376898,CD83;CD83 antigen,0.647440308201972,1.91064390484712,1.61298774095928,2.26322868948674,6.73037781477235e-14
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5522815553027,CD83;CD83 antigen,0.225217290605354,1.25259486371944,1.18480669738515,1.32426149858797,2.1254766669518e-15
primary,Circulatory system disorders,I85 (oesophageal varices),0.0510063954172715,CD83;CD83 antigen,1.10591785704337,3.02199695743024,2.08499021474937,4.38009998613612,5.21825980099556e-09
primary,Circulatory system disorders,I95 (hypotension),0.519872876368344,CD83;CD83 antigen,0.361089337948151,1.43489164542802,1.27184819544621,1.61883630569353,4.42532848671659e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0196178443912582,CD83;CD83 antigen,1.51346440584135,4.54244042347343,2.53863826718402,8.12788701231286,3.42847211822967e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303814340036849,CRHBP;Corticotropin-releasing factor-binding protein,0.923498511565807,2.51808454564545,2.15173589740597,2.94680670925395,1.14229871414585e-30
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392018503273354,CRHBP;Corticotropin-releasing factor-binding protein,1.12230670323817,3.07193207254184,2.00629004613826,4.70359042874945,2.42589457627038e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.175642872649049,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.59180099197284,1.80724031149348,1.475500104394,2.2135664604568,1.06927549128681e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.313788952260661,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,1.71231892978283,5.54179762837662,4.76685025075423,6.44272828772447,5.7959801760252e-110
primary,Circulatory system disorders,I15 (secondary hypertension),0.0394703084604606,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,1.84727677302973,6.34252385125987,4.42881932754362,9.08314515194099,6.69114636591009e-24
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67213988277318,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.237660723168184,1.26827882220099,1.20073523818927,1.33962185807857,1.71683200003326e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69836790274516,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.232273317177615,1.26146446162179,1.20379618324186,1.3218953591042,2.27019694417959e-22
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00846638116476,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.358720109995853,1.43149608405095,1.31220257199386,1.56163467622193,6.4686268773685e-16
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351285745298099,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.606770629530207,1.83449755042498,1.58923664239476,2.1176086510591,1.16654365731271e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546663772177379,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.492139621848257,1.63581249842593,1.45545345522372,1.8385215414499,1.4963969405592e-16
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307868405991592,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.541500102326115,1.71858297980738,1.47226214224187,2.00611519765505,6.86160155120119e-12
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386809022912514,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.47955543335939,1.61535610910133,1.40578825012513,1.85616529301532,1.34203066638698e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17086696532533,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.386456780440323,1.47175678701151,1.38587419336529,1.56296152311965,2.175554121251e-36
primary,Circulatory system disorders,I50 (heart failure),0.919658187128732,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.713948680450723,2.0420387181333,1.86664738510202,2.23390992837546,9.68778753889868e-55
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70314381006887,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.301006598273938,1.35121825721681,1.26307026690116,1.44551797827959,2.22589057872776e-18
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56499773045726,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.371358047648248,1.44970204288031,1.35131718950259,1.55524996607564,3.90319915668122e-25
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351285745298099,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.408222851906831,1.50414232480802,1.29961400234171,1.74085853892179,4.39197829399761e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.16972232637998,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.725167146627024,2.06507624164938,1.68459763710376,2.53148870086066,2.96301790042873e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.16972232637998,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.537213235684493,1.71123141261291,1.38896895414308,2.10826378716277,4.50443294079056e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40119595034635,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.343727572044741,1.41019440679397,1.30947864845959,1.51865650294668,9.7352438670343e-20
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146040141303704,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.666847955997588,1.94808717646466,1.56236100787537,2.42904400966001,3.15344883958679e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248662943300901,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.494585597363889,1.63981855310379,1.38007703429259,1.94844549998744,1.89540479410954e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55570247281482,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.245794888327841,1.27863728321201,1.20970583742698,1.35149657994311,3.5280497404649e-18
primary,Circulatory system disorders,I85 (oesophageal varices),0.0513114009985988,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.967999437676677,2.63267236239537,1.85781910940694,3.73069893221894,5.25299754665699e-08
primary,Circulatory system disorders,I95 (hypotension),0.517061040832034,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.445847811489028,1.56181375833567,1.38471120096227,1.76156747633117,3.85676963692165e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0177616388072072,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,1.31893491128881,3.73943642395184,2.19856553547754,6.3602310429834,1.13244380949139e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302321045445679,BTN2A1;Butyrophilin subfamily 2 member A1,1.91506352171633,6.78736992869329,5.71352729623832,8.06303849799764,2.66479097870977e-105
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390091671542812,BTN2A1;Butyrophilin subfamily 2 member A1,2.02333460822036,7.56350425220278,4.87067381168255,11.7451093595873,2.04605541851748e-19
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00643651258045,BTN2A1;Butyrophilin subfamily 2 member A1,0.321191244177152,1.37876923726984,1.26380329846172,1.50419342310273,4.8139799780799e-13
primary,Circulatory system disorders,I50 (heart failure),0.905012677979325,BTN2A1;Butyrophilin subfamily 2 member A1,0.38819837086612,1.47432221785732,1.34572377495646,1.61520963106866,7.64322131977827e-17
primary,Circulatory system disorders,I63 (cerebral infarction),0.362785254534815,BTN2A1;Butyrophilin subfamily 2 member A1,0.371247281466303,1.44954147381303,1.25552952426998,1.67353331298662,4.10762359279869e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56036668617125,BTN2A1;Butyrophilin subfamily 2 member A1,0.380995795900503,1.46374145168209,1.36471307238412,1.56995567839723,1.56884705955023e-26
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354983421103959,BTN2A1;Butyrophilin subfamily 2 member A1,0.51056718316881,1.66623598799285,1.4401451257017,1.92782124393871,6.77276900162945e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.175541252194265,BTN2A1;Butyrophilin subfamily 2 member A1,0.528120849540186,1.69574275695193,1.38090114362798,2.08236738091197,4.66009880006127e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40433001755412,BTN2A1;Butyrophilin subfamily 2 member A1,0.368687049221164,1.44583505765875,1.34271850630587,1.55687063531013,1.57138055555586e-22
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245757753071971,BTN2A1;Butyrophilin subfamily 2 member A1,0.483875675071584,1.62234993457418,1.3628364446069,1.93128039731284,5.30307198534714e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56095182367856,BTN2A1;Butyrophilin subfamily 2 member A1,0.23561556383882,1.26568764052839,1.19781073533794,1.33741095827995,5.38167901788456e-17
primary,Circulatory system disorders,I85 (oesophageal varices),0.0526623756582797,BTN2A1;Butyrophilin subfamily 2 member A1,1.11564396382445,3.05153262321785,2.10383285176038,4.42613648834845,4.10604722380122e-09
primary,Circulatory system disorders,I95 (hypotension),0.51882192315194,BTN2A1;Butyrophilin subfamily 2 member A1,0.444511736175857,1.55972845090349,1.38211578818543,1.76016572660076,5.74491095510279e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214550419348546,BTN2A1;Butyrophilin subfamily 2 member A1,1.44370784547505,4.23637455408761,2.40255050329741,7.46992387377065,6.07095340385775e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302908726178535,CD28;T-cell-specific surface glycoprotein CD28,0.731772266047583,2.07876146334542,1.7767705559664,2.43208061219792,6.43293664447454e-20
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00100300902708,CD28;T-cell-specific surface glycoprotein CD28,0.230530104068733,1.2592673757867,1.1520515531986,1.37646125237881,3.82312692301588e-07
primary,Circulatory system disorders,I63 (cerebral infarction),0.365095285857572,CD28;T-cell-specific surface glycoprotein CD28,0.413426416492171,1.51198962580265,1.30752700710407,1.74842478672632,2.44460008600397e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56469408224674,CD28;T-cell-specific surface glycoprotein CD28,0.245139043529593,1.27779897053252,1.19002359594962,1.37204860025573,1.46507797814546e-11
primary,Circulatory system disorders,I85 (oesophageal varices),0.0501504513540621,CD28;T-cell-specific surface glycoprotein CD28,1.18043621705208,3.25579412608567,2.21443981202326,4.78685188637792,1.94214179219187e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303814340036849,TREM2;Triggering receptor expressed on myeloid cells 2,0.804405882594292,2.23536803317011,1.93035172803637,2.58858019041007,6.13001757116499e-27
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65004508212787,TREM2;Triggering receptor expressed on myeloid cells 2,0.210912469262037,1.23480426700221,1.17125510001189,1.30180144171103,5.12663782848687e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69673448586773,TREM2;Triggering receptor expressed on myeloid cells 2,0.200919119051329,1.22252588877084,1.16844892508344,1.2791055874421,3.19871618183592e-18
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00356736837978,TREM2;Triggering receptor expressed on myeloid cells 2,0.345654634113958,1.41291455905486,1.29678607334777,1.53944246643201,2.80952410549678e-15
primary,Circulatory system disorders,I50 (heart failure),0.905562742561448,TREM2;Triggering receptor expressed on myeloid cells 2,0.281197842200984,1.32471566267364,1.21217976055482,1.4476991317935,5.36400725322341e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56807401309341,TREM2;Triggering receptor expressed on myeloid cells 2,0.288235969885322,1.3340720678174,1.24573435884534,1.42867399417338,1.63938062792367e-16
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356736837978752,TREM2;Triggering receptor expressed on myeloid cells 2,0.455272031600914,1.57660221032733,1.36926666939141,1.81533267782954,2.47338803042684e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.176408326473009,TREM2;Triggering receptor expressed on myeloid cells 2,0.706065942857,2.02600514003033,1.67137624362161,2.45587840744646,6.3874437178951e-13
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172488141440276,TREM2;Triggering receptor expressed on myeloid cells 2,0.501832574867409,1.65174544603168,1.35763525519786,2.0095699548468,5.27646203873057e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39950605668587,TREM2;Triggering receptor expressed on myeloid cells 2,0.322847983499805,1.38105539174017,1.28382047830198,1.48565475258448,4.42933695127801e-18
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152887216276608,TREM2;Triggering receptor expressed on myeloid cells 2,0.625477096659877,1.86913750399837,1.51592443410161,2.3046498428688,4.82894521993504e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246971657062213,TREM2;Triggering receptor expressed on myeloid cells 2,0.617292218475189,1.85390127959703,1.57124791275415,2.18740144479625,2.59614328745616e-13
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174297912341858,RELT;Tumor necrosis factor receptor superfamily member 19L,0.555372650943569,1.74259024169128,1.40106874283831,2.16736028546752,6.03718733367232e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,RELT;Tumor necrosis factor receptor superfamily member 19L,1.91125879412156,6.76159489960506,5.70999033481798,8.00687267499947,8.3117469021379e-109
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,RELT;Tumor necrosis factor receptor superfamily member 19L,2.14704509429654,8.55952839245506,5.46592935316156,13.4040382828707,6.44576842529814e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,RELT;Tumor necrosis factor receptor superfamily member 19L,0.271087498611575,1.31138981015235,1.23577283052814,1.39163379521496,3.68019217464722e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71117465042497,RELT;Tumor necrosis factor receptor superfamily member 19L,0.240903791912676,1.27239861438237,1.2098201948449,1.33821392697924,7.79778768112113e-21
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,RELT;Tumor necrosis factor receptor superfamily member 19L,0.372972215861361,1.45204399548063,1.32313244474229,1.59351527746869,3.75452948095418e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354471035212095,RELT;Tumor necrosis factor receptor superfamily member 19L,0.636934077550592,1.89067532024677,1.62508139035136,2.19967639024981,1.62703167150933e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552269789667463,RELT;Tumor necrosis factor receptor superfamily member 19L,0.465220032060496,1.59236452159022,1.40618651262372,1.80319235525035,2.24522408834666e-13
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301594140456699,RELT;Tumor necrosis factor receptor superfamily member 19L,0.5610150085172,1.75245034990834,1.48124651286416,2.07330933927775,6.15378441306486e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38580549136344,RELT;Tumor necrosis factor receptor superfamily member 19L,0.443637605760914,1.55836564054927,1.34066459309901,1.81141762238304,7.5338558389863e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,RELT;Tumor necrosis factor receptor superfamily member 19L,0.316272873468533,1.37200458820183,1.28576833617196,1.46402469021069,1.31018985009116e-21
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,RELT;Tumor necrosis factor receptor superfamily member 19L,0.712384510580583,2.03884711944871,1.84830764675353,2.24902904220827,5.89496507427697e-46
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7038110532294,RELT;Tumor necrosis factor receptor superfamily member 19L,0.293580775758285,1.3412215132195,1.24780698265412,1.44162933252428,1.58175212942901e-15
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,RELT;Tumor necrosis factor receptor superfamily member 19L,0.413004584123337,1.51135195414187,1.40178218358564,1.6294862040875,5.57229704619733e-27
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348595824683717,RELT;Tumor necrosis factor receptor superfamily member 19L,0.529036329808732,1.69729588680785,1.45306029753465,1.98258347039184,2.49034721913794e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.174297912341858,RELT;Tumor necrosis factor receptor superfamily member 19L,0.767153372971119,2.15362694709472,1.72978832583558,2.68131594945991,6.84344812838243e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17038110532294,RELT;Tumor necrosis factor receptor superfamily member 19L,0.660125004005898,1.93503420631157,1.54332683450728,2.42615970634067,1.06399064617673e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,RELT;Tumor necrosis factor receptor superfamily member 19L,0.387512352172472,1.47331115210007,1.36218705521466,1.59350049803577,3.49005596262068e-22
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150797070228349,RELT;Tumor necrosis factor receptor superfamily member 19L,0.707279980965826,2.02846628113626,1.60381323819345,2.56555773186009,3.60164414272373e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246758842191845,RELT;Tumor necrosis factor receptor superfamily member 19L,0.546678460978493,1.72750550091949,1.43434179880338,2.08058864225861,8.33958399374774e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56746700090086,RELT;Tumor necrosis factor receptor superfamily member 19L,0.203132262594351,1.22523451022622,1.15499069113986,1.29975039328478,1.54691276791474e-11
primary,Circulatory system disorders,I85 (oesophageal varices),0.0489600877364772,RELT;Tumor necrosis factor receptor superfamily member 19L,1.00853589621295,2.74158411147251,1.86428383703467,4.03172697792301,2.96752241285248e-07
primary,Circulatory system disorders,I95 (hypotension),0.513101719478281,RELT;Tumor necrosis factor receptor superfamily member 19L,0.318413847221435,1.37494516073509,1.20739370679223,1.5657479282805,1.56721564832938e-06
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195840350945908,RELT;Tumor necrosis factor receptor superfamily member 19L,1.46373983799689,4.32209326938691,2.49860019650364,7.47638227813305,1.64904548538106e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,ISM1;Isthmin-1,0.660675098147989,1.93609895012103,1.65591763568353,2.26368695150254,1.19449609388801e-16
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204225192312056,COL15A1;Collagen alpha-1(XV) chain,1.56272004080698,4.77178305344992,3.90764543262979,5.8270162689423,4.75701121753496e-53
primary,Circulatory system disorders,I15 (secondary hypertension),0.0181533504277383,COL15A1;Collagen alpha-1(XV) chain,1.53678058672426,4.64959717458048,2.54276060442786,8.50207992377289,6.01628264924666e-07
primary,Circulatory system disorders,I26 (pulmonary embolism),1.005241779936,COL15A1;Collagen alpha-1(XV) chain,0.247153083105377,1.28037510157319,1.16374889420894,1.40868911574169,3.9360751029847e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40164287821371,COL15A1;Collagen alpha-1(XV) chain,0.409034907795567,1.50536426851652,1.29569326828572,1.7489645399829,9.04090329240637e-08
primary,Circulatory system disorders,I46 (cardiac arrest),0.0884975833352243,COL15A1;Collagen alpha-1(XV) chain,0.820849228778069,2.27242883029719,1.66053925598492,3.10979265931473,2.92111981669535e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14890285688352,COL15A1;Collagen alpha-1(XV) chain,0.225993976055575,1.25356811383079,1.17313104141956,1.3395204461658,2.40475475970794e-11
primary,Circulatory system disorders,I50 (heart failure),0.909936690190383,COL15A1;Collagen alpha-1(XV) chain,0.537225661169724,1.71125267562566,1.54658368595212,1.89345442243766,2.30571600036487e-25
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55891896798202,COL15A1;Collagen alpha-1(XV) chain,0.302015952879619,1.35258280412802,1.25199780801932,1.46124875802864,1.85734801787535e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40915382695318,COL15A1;Collagen alpha-1(XV) chain,0.272016699373977,1.31260892087534,1.21064696014191,1.42315822521833,4.30270979211896e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0181533504277383,COL15A1;Collagen alpha-1(XV) chain,1.49257499535035,4.44853574227375,2.41442583117306,8.19634630924745,1.6930253408076e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202881371386887,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,1.16846565725551,3.21705278818166,2.621251454768,3.94827769122341,5.0164297842998e-29
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.205146907980214,HIP1R;Huntingtin-interacting protein 1-related protein,0.932903090965558,2.54187777899839,2.0804371517644,3.10566586348748,7.01330445697464e-20
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.398896765517084,HIP1R;Huntingtin-interacting protein 1-related protein,0.383143922125848,1.46688913267922,1.26537448872455,1.70049558193741,3.74125475387678e-07
primary,Circulatory system disorders,I50 (heart failure),0.911764035467621,HIP1R;Huntingtin-interacting protein 1-related protein,0.43724286026279,1.54843208401875,1.40190271974353,1.71027695791708,6.66908521253144e-18
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55911650064963,HIP1R;Huntingtin-interacting protein 1-related protein,0.270048736689618,1.31002829561987,1.2141275909683,1.41350394150586,3.35036493918523e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40867543479747,HIP1R;Huntingtin-interacting protein 1-related protein,0.272657435209551,1.31345022594741,1.21305667701158,1.4221524259619,1.807215176847e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204228457378913,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,0.633253507977608,1.88372934859781,1.53507229400811,2.31157599066797,1.32782736194467e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,LPL;Lipoprotein lipase,0.622879468114564,1.86428847977138,1.56508985849893,2.22068497660683,2.9799820059031e-12
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,ELOA;Elongin-A,0.227428159430389,1.2553672502162,1.14461232528046,1.37683903808151,1.39217641256213e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,CD74;HLA class II histocompatibility antigen gamma chain,1.37745690949319,3.96480593547064,3.42160070937271,4.59424913692665,5.49143628087689e-75
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388387222060394,CD74;HLA class II histocompatibility antigen gamma chain,1.45200417754113,4.27166712114303,2.92269216368556,6.24326441921424,6.42899833790462e-14
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65462666278279,CD74;HLA class II histocompatibility antigen gamma chain,0.245675330723035,1.27848442153908,1.21093435067765,1.34980266700951,7.28573345342651e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70715603456646,CD74;HLA class II histocompatibility antigen gamma chain,0.219800717432533,1.24582843395866,1.18961421349641,1.30469901019266,1.05439844878265e-20
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00786484124672,CD74;HLA class II histocompatibility antigen gamma chain,0.289374768374923,1.3355921724554,1.22616428250854,1.45478585257331,3.25064685895203e-11
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,CD74;HLA class II histocompatibility antigen gamma chain,0.476170470974087,1.60989743335131,1.47161104880844,1.76117850434032,2.7143289335456e-25
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70307796873482,CD74;HLA class II histocompatibility antigen gamma chain,0.191991319183484,1.21165999872111,1.13375066655213,1.29492312182323,1.49625372574481e-08
primary,Circulatory system disorders,I63 (cerebral infarction),0.363142052626468,CD74;HLA class II histocompatibility antigen gamma chain,0.383007286483196,1.46668871703215,1.27313540072789,1.68966772225445,1.13143398835114e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55549082435187,CD74;HLA class II histocompatibility antigen gamma chain,0.324857271389201,1.38383311930603,1.29125043255782,1.48305398689771,3.75509251642703e-20
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34566462763375,CD74;HLA class II histocompatibility antigen gamma chain,0.495310366486247,1.64100747375179,1.4216946426174,1.89415184399337,1.31535352894573e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.174774249927177,CD74;HLA class II histocompatibility antigen gamma chain,0.623536551723489,1.86551387572345,1.52781595103647,2.27785422593331,9.36883715894047e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40984561607923,CD74;HLA class II histocompatibility antigen gamma chain,0.378249498355,1.45972709695542,1.35813617136969,1.56891719880855,8.9319325136923e-25
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153412952713855,CD74;HLA class II histocompatibility antigen gamma chain,0.538379378800583,1.71322811734023,1.3827151055454,2.12274428063575,8.51138824655281e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24662588600835,CD74;HLA class II histocompatibility antigen gamma chain,0.466713354684178,1.59474421193594,1.34494394296421,1.89094059630325,7.89864231665536e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55752985726769,CD74;HLA class II histocompatibility antigen gamma chain,0.207292605311471,1.23034252387365,1.16529642195107,1.29901945765635,7.43845999279599e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.0504903388678512,CD74;HLA class II histocompatibility antigen gamma chain,1.11423585659782,3.04723876189684,2.15190943456866,4.31508125892288,3.43783317493074e-10
primary,Circulatory system disorders,I95 (hypotension),0.514613069230022,CD74;HLA class II histocompatibility antigen gamma chain,0.31170510624758,1.36575188194182,1.21232624048427,1.53859426674005,2.94703312513027e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0194193611030197,CD74;HLA class II histocompatibility antigen gamma chain,1.56118149927366,4.76444711180672,2.80636843676939,8.0887298986782,7.42305947700219e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302908726178535,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.737443888695431,2.09058491131402,1.78706529531306,2.4456550540579,3.14726662475975e-20
primary,Circulatory system disorders,I15 (secondary hypertension),0.0401203610832497,LTBP3;Latent-transforming growth factor beta-binding protein 3,1.05519123021604,2.87252441484647,1.89063082760954,4.36436156302489,7.63883086650672e-07
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00100300902708,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.238112321781791,1.26885170450545,1.1616785964032,1.38591229365096,1.23315588109574e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17452357071213,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.185447098702263,1.20375651780876,1.13190043180149,1.28017422156192,3.51872084994421e-09
primary,Circulatory system disorders,I50 (heart failure),0.910732196589769,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.396791284598794,1.48704552835556,1.35353227474563,1.63372861117615,1.37493250541002e-16
primary,Circulatory system disorders,I70 (atherosclerosis),0.170511534603811,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.532381383902973,1.70298293981023,1.37534751539294,2.10866770821636,1.04301495760605e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40822467402206,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.245305761898854,1.27801202085234,1.18624352954311,1.37687977617223,1.10137535224846e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306659161927682,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.57533674194335,4.83236860535267,4.11678348763261,5.67233773846744,1.04324670926704e-82
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388176154338838,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.46433689964244,4.32467459603541,2.85693377817599,6.54646268123681,4.43269945467497e-12
primary,Circulatory system disorders,I20 (angina pectoris),4.59406478660015,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.20519223567306,1.22776106175301,1.17789832621499,1.27973458422399,3.01293124072999e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65318401490596,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.311202223396272,1.36506524140559,1.29302866822586,1.44111508049582,2.30290975717377e-29
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70708227393591,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.317845164814934,1.37416347589855,1.31211682183662,1.4391441577972,1.96694964343092e-41
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0014944781942,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.341738405971231,1.40739208398966,1.29063017480872,1.53471731619038,1.04500783036845e-14
primary,Circulatory system disorders,I50 (heart failure),0.904450439609494,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.499131713132692,1.64729032899677,1.50371431477853,1.80457511199921,7.55928254820234e-27
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.69827067523242,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.186935038415649,1.20554896813517,1.12762368214086,1.28885933985752,4.1824848960925e-08
primary,Circulatory system disorders,I63 (cerebral infarction),0.364885585078508,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.44889743462868,1.56658397169244,1.35839975670552,1.80667386625254,6.81628054623663e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55464549812705,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.441376533079139,1.5548460431035,1.44991388769066,1.66737227519432,3.31642860053765e-35
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355181181220037,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.512222378541884,1.66899621782027,1.44448121740183,1.9284074735902,3.67875355603455e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.174679269452477,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.728850731632726,2.07269715304902,1.68992255061399,2.54217182124509,2.6189025240493e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41102032102167,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.527711992424918,1.69504958217447,1.57537415463011,1.82381631537204,2.62531672818022e-45
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153329580963841,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.586626973857749,1.79791376604736,1.44500619808042,2.23701041174545,1.4267274950899e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246491858005162,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.644008837738487,1.90409882277167,1.60250449849915,2.26245375927247,2.483449628591e-13
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55419909554956,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.273613962145025,1.31470717752511,1.24457565119117,1.38879059780879,1.33780713841979e-22
primary,Circulatory system disorders,I85 (oesophageal varices),0.0524037808357432,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.19654943420771,3.30868038346947,2.3027556791834,4.75402839255522,9.76667277423421e-11
primary,Circulatory system disorders,I95 (hypotension),0.516274285270655,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.413575150057263,1.51221452613478,1.34095274414488,1.70534926233459,1.54095445031675e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0213496884886361,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.84325263913558,6.31705197155634,3.68342122123901,10.8337176810641,2.11999013542969e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,HSPB6;Heat shock protein beta-6,1.21177623586078,3.35944652552627,2.94009140677828,3.83861567427847,5.65424653010613e-71
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,HSPB6;Heat shock protein beta-6,1.39607682847267,4.03932188837515,2.85465139845938,5.71562654785527,3.20665843064489e-15
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,HSPB6;Heat shock protein beta-6,0.216992656900389,1.24233497951476,1.13739673713975,1.35695501044532,1.44129714316205e-06
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359334939010177,HSPB6;Heat shock protein beta-6,0.487109465793329,1.62760476667435,1.41562869208128,1.87132211385622,7.80421208435045e-12
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304949110403232,HSPB6;Heat shock protein beta-6,0.496833525426086,1.6435088935021,1.41200668826589,1.91296649333707,1.41800736800428e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382643151270297,HSPB6;Heat shock protein beta-6,0.377401608989982,1.45848993443667,1.26949621102421,1.67561972251725,9.8258295950102e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,HSPB6;Heat shock protein beta-6,0.252370882270731,1.28707330144359,1.21155364126473,1.36730032156038,2.83261837043377e-16
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,HSPB6;Heat shock protein beta-6,0.458340836951607,1.58144792710418,1.44604221635207,1.72953287107435,1.05833444116614e-23
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,HSPB6;Heat shock protein beta-6,0.239969992797703,1.27121100426331,1.18434460470541,1.36444866716988,3.03319756166012e-11
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,HSPB6;Heat shock protein beta-6,0.385568608390082,1.47045019409408,1.27076640322448,1.70151159790251,2.24444850250241e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,HSPB6;Heat shock protein beta-6,0.239547939241584,1.27067459834236,1.17949062478448,1.368907815751,2.88148434515644e-10
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0116541061300598,HSPB6;Heat shock protein beta-6,1.46007865858409,4.30629824234606,2.42987268268594,7.63175975604379,5.70697275784028e-07
primary,Circulatory system disorders,I95 (hypotension),0.518607722787662,HSPB6;Heat shock protein beta-6,0.300368811852766,1.35035674332045,1.19672287552081,1.52371394541736,1.09265018961217e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,CNTN3;Contactin-3,-0.474359708469361,0.622283371705034,0.522572005471618,0.741020549600829,1.01564311763009e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,CNTN3;Contactin-3,-0.26081975942388,0.770419768004485,0.721542043289406,0.822608501406504,6.23025376933465e-15
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,CNTN3;Contactin-3,-0.250547523235614,0.778374488260564,0.70358628902402,0.861112351713568,1.16681179149564e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311811086175051,CSTB;Cystatin-B,1.08659516933063,2.96416439362083,2.55687308769852,3.43633424540372,4.5909000090902e-47
primary,Circulatory system disorders,I15 (secondary hypertension),0.0397211574745288,CSTB;Cystatin-B,1.03840406910707,2.824705380601,1.88769391459921,4.22682958581785,4.42720551907219e-07
primary,Circulatory system disorders,I20 (angina pectoris),4.6275148457826,CSTB;Cystatin-B,0.187015310574564,1.20564574403767,1.15669329014969,1.25666991629911,9.3161534794741e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67919207165696,CSTB;Cystatin-B,0.236256593073662,1.26649924341094,1.20011120322028,1.33655975317652,7.95869267161166e-18
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.74570514984806,CSTB;Cystatin-B,0.250354775210339,1.2844810378918,1.22686333919462,1.34480466079186,1.11271708198653e-26
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01288951560048,CSTB;Cystatin-B,0.302332087086345,1.35301046941608,1.24105565537934,1.47506465355897,6.85063644861054e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544179857401044,CSTB;Cystatin-B,0.324317550757092,1.38308643753805,1.230065921191,1.55514274539817,5.91546299380647e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.19658000834144,CSTB;Cystatin-B,0.206882661327139,1.22983825572523,1.15919387498445,1.30478789431626,7.16877259423814e-12
primary,Circulatory system disorders,I50 (heart failure),0.921530853409068,CSTB;Cystatin-B,0.574307919243651,1.77590103457791,1.62392646352803,1.94209809092162,2.64290435186754e-36
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57692995173879,CSTB;Cystatin-B,0.266065399672088,1.30482039072224,1.21730681406145,1.39862541832332,5.84769004511993e-14
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.359476475144485,CSTB;Cystatin-B,0.395578427737527,1.4852430482796,1.28694460249351,1.71409624640311,6.29617684132031e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.1727870350142,CSTB;Cystatin-B,0.692711622254395,1.99912907307239,1.63351795016591,2.44657063633575,1.79190301548063e-11
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168814919266747,CSTB;Cystatin-B,0.552382324585373,1.73738711156581,1.41408868265011,2.13460019337548,1.45465968898395e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40612897459832,CSTB;Cystatin-B,0.293574699613147,1.34121336378768,1.24610325958224,1.44358284385335,5.16487384864487e-15
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0274235568353215,CDH2;Cadherin-2,1.19148567218856,3.29196836197039,2.02493228113195,5.3518114147284,1.54303168294564e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,CDH2;Cadherin-2,0.548838971436181,1.7312418293549,1.48258673543174,2.02160062550087,3.98353680191385e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358465064347417,CDH2;Cadherin-2,0.378493980232892,1.46008401740581,1.26186425475938,1.68944110259339,3.68771859062696e-07
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542594660241719,CDH2;Cadherin-2,0.418935150120512,1.52034175761346,1.35028805789387,1.71181182150753,4.44529435197046e-12
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,CDH2;Cadherin-2,0.260498932723949,1.29757732897844,1.22145656947336,1.37844190842149,3.02881274183754e-17
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,CDH2;Cadherin-2,0.427748099290398,1.53379966707613,1.39893760271995,1.68166286626995,8.29451906655884e-20
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71788995318407,CDH2;Cadherin-2,0.224734812222832,1.25199065954508,1.17010082830299,1.33961157335601,7.43861404142595e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,CDH2;Cadherin-2,0.212109086143471,1.23628273903926,1.15195687489172,1.32678144829864,3.99117842443138e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,CDH2;Cadherin-2,0.186860310907587,1.20545888383086,1.11860268069525,1.29905921529133,9.70347453099116e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0176294293941352,CDH2;Cadherin-2,1.41852753480178,4.13103315713842,2.33757337240466,7.30049167518613,1.0465761375107e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307389162561576,REG1A;Lithostathine-1-alpha,1.58255150402108,4.86735906726188,4.13927046655884,5.72351685666774,1.1115014947492e-81
primary,Circulatory system disorders,I15 (secondary hypertension),0.0394088669950738,REG1A;Lithostathine-1-alpha,1.64669197129847,5.18978344720427,3.371745852434,7.9881027241221,7.22247037944604e-14
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67192118226601,REG1A;Lithostathine-1-alpha,0.257776479358908,1.29404953951283,1.22528071363311,1.3666780127046,2.19832608718772e-20
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69852216748768,REG1A;Lithostathine-1-alpha,0.249087904524874,1.28285479685491,1.22438274813653,1.34411925708557,1.25079086119589e-25
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00886699507389,REG1A;Lithostathine-1-alpha,0.240026574242504,1.27128293325348,1.16560478550541,1.38654226241942,5.93664974967997e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352709359605911,REG1A;Lithostathine-1-alpha,0.420769962996421,1.52313386095638,1.31683220078386,1.76175579319136,1.45824865209965e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545812807881773,REG1A;Lithostathine-1-alpha,0.294431192675489,1.34236259581326,1.19330900960884,1.51003413544089,9.44402919039044e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1615763546798,REG1A;Lithostathine-1-alpha,0.205500254515537,1.22813929354236,1.15650713225904,1.30420823380178,2.05340811526841e-11
primary,Circulatory system disorders,I50 (heart failure),0.920197044334975,REG1A;Lithostathine-1-alpha,0.583272915858806,1.79189356070168,1.63583967680743,1.96283448702664,4.15558742712923e-36
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.69655172413793,REG1A;Lithostathine-1-alpha,0.184110670216004,1.20214885780843,1.12386986363911,1.28588008548486,8.35854398189299e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56650246305418,REG1A;Lithostathine-1-alpha,0.321228927408841,1.37882119472941,1.28559655652102,1.4788059888553,2.39556715946313e-19
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39901477832512,REG1A;Lithostathine-1-alpha,0.268381079167201,1.3078454377137,1.21476996375283,1.40805233911477,1.04034620724709e-12
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55960591133004,REG1A;Lithostathine-1-alpha,0.208602938816177,1.23195573959943,1.16605198987414,1.30158428398703,1.03374407921503e-13
primary,Circulatory system disorders,I95 (hypotension),0.520197044334975,REG1A;Lithostathine-1-alpha,0.382257709155914,1.46558973236213,1.29974277274216,1.65259873618964,4.41279696991512e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.198588850988271,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.728746300904871,2.0724807110785,1.7097901774926,2.51210724820708,1.13102068452542e-13
primary,Circulatory system disorders,I20 (angina pectoris),4.42502686790336,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.325827706029367,1.3851766907199,1.32387268468866,1.44931947513137,3.39906791061074e-45
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.560628008037,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.392689761394584,1.48095886743852,1.39661788346195,1.57039315693721,2.33759817916434e-39
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54422690528479,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.383087053462788,1.46680571502733,1.39486306319622,1.542458942677,2.1057354122994e-50
primary,Circulatory system disorders,I26 (pulmonary embolism),0.985935236671183,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.317310356155896,1.37342875785701,1.25175312284325,1.50693177311518,2.02515453593231e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549039764496986,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.343240243604426,1.4095073463788,1.24569604162369,1.59486013691289,5.17309194875657e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.385496004859586,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.366295540357521,1.4423814616018,1.24556441969715,1.67029841883121,9.90016354801692e-07
primary,Circulatory system disorders,I46 (cardiac arrest),0.0887808980888743,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.732282403538055,2.07982218803634,1.56349370056729,2.76666310345782,4.91478764504351e-07
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.693892808747254,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.281246792689421,1.3247805097395,1.18572943482207,1.48013817270972,6.65895446579201e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15644128779029,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.302907920859163,1.35378980290108,1.27027043520951,1.44280050896144,1.12800848829775e-20
primary,Circulatory system disorders,I50 (heart failure),0.897154338582309,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.556828240834754,1.74512858537709,1.58777956227946,1.91807090344964,7.39647829104405e-31
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65179197233774,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.237859280717006,1.26853067353781,1.17955734142031,1.36421521294479,1.44732584583298e-10
primary,Circulatory system disorders,I63 (cerebral infarction),0.355123592355497,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.406090006098896,1.50093763992023,1.28945428668029,1.74710637065638,1.59900660431504e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5536657165553,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.390521708867598,1.47775154889746,1.37271559284946,1.59082453178509,3.0217616675262e-25
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34344189523854,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.532582074511674,1.70332474679061,1.4639354808473,1.9818600143157,5.49557446024792e-12
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.128498668286528,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.718027906106097,2.05038566783277,1.61413097175823,2.6045478715241,4.03795421455801e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.1635437596374,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.660928607241808,1.93658983103018,1.5639544582983,2.39801111455008,1.34910758645402e-09
primary,Circulatory system disorders,I72 (other aneurysm),0.09812625578244,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.683453361765917,1.98070602962608,1.50384327016888,2.60878008607675,1.15342145684541e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39946731461146,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.441685425085575,1.55532639680235,1.44007474443176,1.6798018366364,2.47620475565915e-29
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.140180365403485,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.753770915211112,2.12499811477464,1.6931781242673,2.66694739500596,7.84601571930171e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.224288584645577,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.693668876155354,2.00104366340444,1.6676399955399,2.40110320786275,8.68448124313981e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.04906312789122,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.961460851273677,2.61551456169332,1.81005996886738,3.77938661706904,3.0662836193335e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.01635437596374,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,1.56659650149758,4.79031658191944,2.64027015144527,8.69120644432962,2.54631279375345e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,CXCL13;C-X-C motif chemokine 13,0.596964339848826,1.81659585409272,1.55181619737097,2.12655371344726,1.11135017945109e-13
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65462666278279,CXCL13;C-X-C motif chemokine 13,0.235779166335896,1.26589472712638,1.19771055208072,1.33796054262229,7.0364431284844e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70715603456646,CXCL13;C-X-C motif chemokine 13,0.222544480416696,1.24925138563703,1.19199932385728,1.30925327999843,1.43487449251795e-20
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359258180405864,CXCL13;C-X-C motif chemokine 13,0.422831625898861,1.5262772887638,1.32326409805203,1.76043645831957,6.38664893453011e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16720069909699,CXCL13;C-X-C motif chemokine 13,0.259818408789319,1.29669459694324,1.22094095512131,1.37714839582453,2.68456835887474e-17
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,CXCL13;C-X-C motif chemokine 13,0.430917958578231,1.53866931016065,1.40297133268415,1.68749224654559,5.80602550168561e-20
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.120400038838722,CXCL13;C-X-C motif chemokine 13,0.664902834459402,1.94430159304294,1.52148304295656,2.4846209770195,1.07002503865479e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40984561607923,CXCL13;C-X-C motif chemokine 13,0.326090575115239,1.38554085871251,1.28830542604006,1.49011517949014,1.582065548621e-18
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.93456011291611,6.92099892763537,5.86065923511775,8.17318056462083,4.53917748232663e-115
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,2.00835430395383,7.45104509643655,4.94268155765176,11.2323791006086,8.78313256245662e-22
primary,Circulatory system disorders,I20 (angina pectoris),4.61595707179507,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.22172226606237,1.24822465536962,1.19758904295221,1.30100120691801,9.22454236563119e-26
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.329414698784529,1.39015423133823,1.31716134289015,1.4671921532917,5.06909500541268e-33
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71117465042497,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.305916448982386,1.35786885048403,1.29676775237176,1.42184890990891,9.09260431762945e-39
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.318902429213,1.37561709831495,1.26110047484603,1.50053262124692,6.42528242348129e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354471035212095,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.413724965666959,1.51244109644746,1.30823276293353,1.74852528925652,2.26448646256406e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38580549136344,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.394078685640567,1.48301723624508,1.29130447882465,1.70319251506185,2.40875244594553e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.210384560747236,1.23415257534747,1.16284008175727,1.30983838889958,4.26977052581373e-12
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.598007391598064,1.8184916461087,1.66183027149917,1.98992154835639,1.06869630306202e-38
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7038110532294,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.209990884041253,1.2336668138497,1.15383492916991,1.31902213143172,7.64600042700084e-10
primary,Circulatory system disorders,I63 (cerebral infarction),0.36426305275939,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.446685742339835,1.56312299871685,1.35623251738736,1.80157419748673,6.98225974054756e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.469575305790647,1.59931482921969,1.4918333185337,1.71454001676006,5.95004138121434e-40
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348595824683717,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.474143065327859,1.60663682461023,1.3889553595119,1.85843401554731,1.73690240476098e-10
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.119462614077004,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.686445560128993,1.98664157069526,1.55552071408475,2.5372498705276,3.80540887737118e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.174297912341858,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.639287626300698,1.89513035730059,1.54887475227988,2.31879244327257,5.28880983659884e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.38234916009862,1.46572376805353,1.36205165604096,1.57728684863656,1.68723581938445e-24
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150797070228349,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.634512291081088,1.88610204831721,1.51733807519562,2.34448801807584,1.08830279403948e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246758842191845,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.591304268070185,1.8063428349504,1.52236479268919,2.14329341629934,1.23686756536299e-11
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0117504210567545,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.6733533030193,5.33001100561681,2.7139586465139,10.4677414139997,1.17843771722871e-06
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56746700090086,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.209444744915949,1.23299324408321,1.1670438089158,1.30266946993805,8.16275707382035e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.0489600877364772,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.13681566590017,3.11682752593532,2.15825819440328,4.50113607890829,1.3387862883432e-09
primary,Circulatory system disorders,I95 (hypotension),0.513101719478281,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.445360932794435,1.56105352957643,1.38388858996903,1.76089906359989,4.28936631669543e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195840350945908,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.52083694385723,4.57605349274473,2.6749359032176,7.82832423882488,2.8286282922732e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.308472178560201,CANT1;Soluble calcium-activated nucleotidase 1,0.944384262215022,2.5712296877966,2.20172986265958,3.00273989989878,8.17585428421297e-33
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00990254636906,CANT1;Soluble calcium-activated nucleotidase 1,0.252991809601673,1.28787272860079,1.18091537638563,1.40451737545334,1.0710551669537e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40089594467148,CANT1;Soluble calcium-activated nucleotidase 1,0.215534618401357,1.2405249271696,1.15227853465512,1.33552960386417,1.03653282190424e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,ACY1;Aminoacylase-1,-0.508419991925598,0.601445116616593,0.512386441713878,0.705983216675246,5.03292185883927e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.61106404536755,5.00813727902283,4.25517066178329,5.89434384637039,1.13034073061038e-83
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388387222060394,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.81092042514838,6.11607423084132,3.97846897497645,9.40220075421919,1.53400181332932e-16
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00786484124672,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.214988356279921,1.23984746044524,1.13658549506629,1.3524910636686,1.26250212343676e-06
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.285930831670796,1.33100038899521,1.21585864637074,1.45704604790484,5.87420649856495e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55549082435187,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.25931430608998,1.29604109442673,1.20858950415094,1.38982054094776,3.4594938338206e-13
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34566462763375,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.373592668842018,1.45294520005429,1.25415141954259,1.68324950358126,6.47025041808513e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40984561607923,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.296159782308567,1.34468499654084,1.24910279580918,1.4475812126821,3.48015643178203e-15
primary,Circulatory system disorders,I85 (oesophageal varices),0.0504903388678512,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.20266394623958,3.32897332698271,2.27659959381898,4.86781401606606,5.52526958689442e-10
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0194193611030197,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.69530176069572,5.44828979689805,2.97710385382537,9.97071757266436,3.84087873608526e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.310231795832357,PRSS2;Trypsin-2,1.3269306695486,3.76945590796021,3.21164957296561,4.42414326944638,2.6384566892175e-59
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390228674002965,PRSS2;Trypsin-2,1.38832747627998,4.00814073336038,2.59226934371101,6.19734680634083,4.26673847794266e-10
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6711152735503,PRSS2;Trypsin-2,0.201424923832801,1.22314440462181,1.16027668561818,1.28941850948297,7.33351783454184e-14
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351205806602669,PRSS2;Trypsin-2,0.405080955414913,1.49942388162592,1.29429711001522,1.73706018455352,6.78304965358868e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546320143604152,PRSS2;Trypsin-2,0.365466177552545,1.4411856999956,1.28158722927797,1.62065926877407,1.04036510148432e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.306329509092328,PRSS2;Trypsin-2,0.417353142679525,1.517938467153,1.30007769102916,1.77230730591093,1.2931416163564e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16772028408647,PRSS2;Trypsin-2,0.196306538858101,1.21689987526469,1.14752408087978,1.29046991788084,5.57947653574725e-11
primary,Circulatory system disorders,I50 (heart failure),0.917037383906969,PRSS2;Trypsin-2,0.475772661216875,1.60925712781255,1.47126636896754,1.76019010427924,2.43729736902232e-25
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70725044876297,PRSS2;Trypsin-2,0.198250536659498,1.21926782684733,1.14064022784768,1.30331545152512,5.57708173564855e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,1.02335752709011,2.78252148911499,2.37921016568658,3.2542000488437,1.460528077829e-37
primary,Circulatory system disorders,I15 (secondary hypertension),0.039488232506713,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,1.05311947595897,2.86657941058183,1.88596811283539,4.35706068477357,8.22369337299036e-07
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64571157794977,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.23608907505023,1.26628709973045,1.19861860870194,1.33777584237597,3.5903545339629e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69807297425367,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.250601370207738,1.28479782354727,1.22613893907758,1.34626296807246,7.7260682760064e-26
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01287316379718,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.258074565790329,1.29443533561959,1.18666195305335,1.41199676436012,5.93249288885633e-09
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361317327436424,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.449683513020883,1.5678159136402,1.35794310907858,1.81012497698179,8.63297357847986e-10
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0592323487600695,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.906948902810748,2.47675417565478,1.76216031045032,3.48113120596602,1.77072506004587e-07
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.546817797740311,1.72774622271232,1.57618543012111,1.89388060126105,1.74168843805765e-31
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56373400726583,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.313252492024072,1.36786686290187,1.27504557618007,1.46744539142713,2.39091788007032e-18
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357368504185752,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.443837641490503,1.55867740053767,1.34855248147847,1.80154296722908,1.88529494314701e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.165850576528194,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.618562921418106,1.85625853477726,1.50301173297356,2.2925275114895,9.28585268077198e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.362418286911513,1.43679981083913,1.33458608848625,1.54684191168881,6.24610549925799e-22
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242852629916284,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.516528826087882,1.67619916090322,1.40705283171929,1.99682880676168,7.29555933827037e-09
primary,Circulatory system disorders,I85 (oesophageal varices),0.0513347022587269,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.998569164334036,2.71439519509865,1.89235011065642,3.89354022476254,5.78712440726804e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197441162533565,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,1.58858621856283,4.89682099756312,2.83514212170082,8.45772622777373,1.21679623779568e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,CD99L2;CD99 antigen-like protein 2,1.27678794108296,3.58510564086395,3.07668690464839,4.17753994946176,3.51780677889e-60
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,CD99L2;CD99 antigen-like protein 2,1.59078202429126,4.90758527897104,3.26204419545215,7.3832210194917,2.27855370669069e-14
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,CD99L2;CD99 antigen-like protein 2,0.234554356543857,1.26434519600306,1.15870007951126,1.37962256404633,1.37440414011067e-07
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,CD99L2;CD99 antigen-like protein 2,0.291152911932352,1.33796915975824,1.22187676658415,1.4650916699797,3.23423361810274e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,CD99L2;CD99 antigen-like protein 2,0.210426624811935,1.23420448991311,1.14652218082929,1.32859245847289,2.1866783889129e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,NPPC;C-type natriuretic peptide,1.76445027525356,5.83836198369463,4.90499370514104,6.94934034613007,1.04569230267125e-87
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392356887825165,NPPC;C-type natriuretic peptide,1.61172326684466,5.01143983911717,3.12224364376777,8.04374421939209,2.45455568240634e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359006552360026,NPPC;C-type natriuretic peptide,0.461744674861706,1.58684009133163,1.34394045833124,1.87364065115209,5.11481286822422e-08
primary,Circulatory system disorders,I50 (heart failure),0.904382626437007,NPPC;C-type natriuretic peptide,0.507478102997046,1.66109679321989,1.493315811449,1.84772874919744,9.52785229034289e-21
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56942755130066,NPPC;C-type natriuretic peptide,0.244970793499507,1.27758399890228,1.17885353073964,1.38458326814109,2.3768217482248e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,SLC39A5;Zinc transporter ZIP5,1.02024436502086,2.77387251856705,2.39712503580425,3.20983204227393,1.03506702188073e-42
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392356887825165,SLC39A5;Zinc transporter ZIP5,1.28965453283474,3.63153176403656,2.47190922498869,5.33515665538523,4.99338278629872e-11
primary,Circulatory system disorders,I20 (angina pectoris),4.61107519931049,SFTPD;Pulmonary surfactant-associated protein D,0.188171039633643,1.20703994936563,1.15810422780173,1.25804345100277,5.04427271637311e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67575561693208,SFTPD;Pulmonary surfactant-associated protein D,0.299205361380847,1.34878658370876,1.27810702978305,1.423374729972,1.21629634289637e-27
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.111653052829523,SFTPD;Pulmonary surfactant-associated protein D,0.644008559392094,1.9040982927727,1.47351684097483,2.46050143963155,8.49051194317991e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72176842765078,SFTPD;Pulmonary surfactant-associated protein D,0.268562138074468,1.30808225621793,1.24932103535228,1.36960728316697,2.28839503489286e-30
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,SFTPD;Pulmonary surfactant-associated protein D,0.280720300184541,1.32408320630914,1.24777468746747,1.40505842508173,1.87693125933967e-20
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,SFTPD;Pulmonary surfactant-associated protein D,0.278065893855026,1.32057321200197,1.20599928088251,1.44603204653743,1.91318920350978e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,SFTPD;Pulmonary surfactant-associated protein D,0.194989718732329,1.2152984916164,1.12887601069691,1.30833715105107,2.2094598214039e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204006784944757,PALM;Paralemmin-1,1.56811051912237,4.79757469872473,3.94168531153855,5.83931013530343,3.84199729928525e-55
primary,Circulatory system disorders,I26 (pulmonary embolism),0.994819602989043,PALM;Paralemmin-1,0.266873917738408,1.3058757881779,1.18634606545854,1.43744867016534,5.07078765117947e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14550955852014,PALM;Paralemmin-1,0.25057491960797,1.2847638403237,1.20349483043012,1.3715207441426,5.65898683989957e-14
primary,Circulatory system disorders,I50 (heart failure),0.903131160317242,PALM;Paralemmin-1,0.511537361540394,1.66785331853305,1.51088051052915,1.84113480368311,3.55538814593784e-24
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5678723696878,PALM;Paralemmin-1,0.285186081834209,1.33000949570262,1.23227768020777,1.43549241138644,2.41317570648884e-13
primary,Circulatory system disorders,I95 (hypotension),0.504286434694906,PALM;Paralemmin-1,0.361072966564808,1.43486815445912,1.25472857300043,1.64087011723788,1.3259820716147e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,1.65606671711338,5.23866511646834,4.4025154595928,6.23362085934402,9.37238648043949e-78
primary,Circulatory system disorders,I15 (secondary hypertension),0.039488232506713,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,1.73945326337935,5.69422932775488,3.70333033407681,8.75542949509706,2.29146071455984e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,THY1;Thy-1 membrane glycoprotein,1.68616904261968,5.39875862357552,4.5908433477649,6.34885411409678,2.18396633282557e-92
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388387222060394,THY1;Thy-1 membrane glycoprotein,1.6588745442948,5.25339505265687,3.53908128327916,7.79811407826961,1.85544554589667e-16
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65462666278279,THY1;Thy-1 membrane glycoprotein,0.254335034841052,1.28960379410011,1.22128210794923,1.36174757243438,5.30249324095668e-20
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70715603456646,THY1;Thy-1 membrane glycoprotein,0.236543213405608,1.26686229987169,1.20925497634222,1.32721396085618,2.23665311250133e-23
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00786484124672,THY1;Thy-1 membrane glycoprotein,0.280186623257817,1.3233767621761,1.21084518748851,1.4463666146291,6.43239524703202e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359258180405864,THY1;Thy-1 membrane glycoprotein,0.372838108160265,1.45184927825533,1.25161936932006,1.68411130287607,8.47106133019553e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16720069909699,THY1;Thy-1 membrane glycoprotein,0.233807803896369,1.2634016479976,1.18954320220323,1.34184594658408,2.79772106351973e-14
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,THY1;Thy-1 membrane glycoprotein,0.604761037757154,1.83081466103151,1.67081203374348,2.00613968259372,2.03292243891869e-38
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70307796873482,THY1;Thy-1 membrane glycoprotein,0.214880494892816,1.23971373599034,1.15790276191938,1.32730501882172,6.87242090244036e-10
primary,Circulatory system disorders,I63 (cerebral infarction),0.363142052626468,THY1;Thy-1 membrane glycoprotein,0.410916174497596,1.50819892572639,1.30448375388069,1.74372735022216,2.85365188857746e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55549082435187,THY1;Thy-1 membrane glycoprotein,0.372911171451846,1.45195535901774,1.35219094220811,1.55908037746334,9.87193341267019e-25
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.120400038838722,THY1;Thy-1 membrane glycoprotein,0.64015961882075,1.89678361750719,1.47598115993898,2.43755692097886,5.67329117241919e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.174774249927177,THY1;Thy-1 membrane glycoprotein,0.535746241568605,1.70872288664598,1.38998419916096,2.10055186606454,3.65516775675937e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40984561607923,THY1;Thy-1 membrane glycoprotein,0.334122787613034,1.39671463230173,1.2952088260986,1.50617547130369,3.97837793780122e-18
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24662588600835,THY1;Thy-1 membrane glycoprotein,0.441404000495456,1.55488875129362,1.30390249150484,1.85418698457212,8.90713302628191e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55752985726769,THY1;Thy-1 membrane glycoprotein,0.213362424253306,1.23783319072776,1.16988896584826,1.30972344623858,1.2865495204464e-13
primary,Circulatory system disorders,I95 (hypotension),0.514613069230022,THY1;Thy-1 membrane glycoprotein,0.371100413627794,1.4493285984226,1.28035777453803,1.64059876698412,4.4234874979507e-09
primary,Circulatory system disorders,I08 (multiple valve diseases),0.171922009924588,CHRDL1;Chordin-like protein 1,0.554125246945393,1.74041788284285,1.4158790666548,2.1393454273434,1.42038956121864e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302817176571718,CHRDL1;Chordin-like protein 1,1.547681446326,4.70055904001172,4.0478621211426,5.45849997538924,1.53457905695888e-91
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390731840737701,CHRDL1;Chordin-like protein 1,1.68634324675981,5.39969919160236,3.73715283088223,7.80186218739899,2.6837258358386e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64720822099792,CHRDL1;Chordin-like protein 1,0.192872746591146,1.21272845986905,1.14926111927784,1.27970075094901,2.02810174747533e-12
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00808814910327,CHRDL1;Chordin-like protein 1,0.353697177313387,1.42432380360611,1.30519960109067,1.55432034749605,2.07003052192994e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.357519634274997,CHRDL1;Chordin-like protein 1,0.50417830314728,1.65562453990698,1.43291769692283,1.9129449116503,7.90911517840309e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545070917829093,CHRDL1;Chordin-like protein 1,0.411074585000656,1.50843785920122,1.34169585685406,1.69590206561921,6.06948810617755e-12
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384870863126636,CHRDL1;Chordin-like protein 1,0.340570718911004,1.40574964957585,1.22432969440102,1.61405223308694,1.35986226326237e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16856171609424,CHRDL1;Chordin-like protein 1,0.319144436753823,1.37595004831261,1.29681366362042,1.45991562902411,4.56796922554782e-26
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25424920876802,CHRDL1;Chordin-like protein 1,0.198996324590388,1.22017748123958,1.12810363907131,1.31976622905838,6.65671459286383e-07
primary,Circulatory system disorders,I50 (heart failure),0.904544211307779,CHRDL1;Chordin-like protein 1,0.61210377356395,1.84430732531101,1.68805816477968,2.01501913924855,7.69625040780012e-42
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70359082561637,CHRDL1;Chordin-like protein 1,0.191374091166438,1.2109123589786,1.13182295676122,1.29552836189421,2.80532350765924e-08
primary,Circulatory system disorders,I63 (cerebral infarction),0.363380611886062,CHRDL1;Chordin-like protein 1,0.358602173556815,1.43132726845526,1.24132527617938,1.65041169203384,8.01742753005598e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5629273629508,CHRDL1;Chordin-like protein 1,0.304267766508807,1.3556320003433,1.26415694379936,1.45372623974327,1.38791015966606e-17
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355565975071308,CHRDL1;Chordin-like protein 1,0.525147220223757,1.69070773642923,1.46471215812326,1.95157296549257,7.32717835952111e-13
primary,Circulatory system disorders,I70 (atherosclerosis),0.175829328331965,CHRDL1;Chordin-like protein 1,0.513279164101836,1.67076092121517,1.36859887051296,2.03963492591042,4.58623444621077e-07
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171922009924588,CHRDL1;Chordin-like protein 1,0.519245754503767,1.68075946624051,1.37691824791058,2.05164859107927,3.32759392721746e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40663462665572,CHRDL1;Chordin-like protein 1,0.299669167815628,1.34941230470093,1.2526745792808,1.45362059564082,2.88890857646591e-15
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246161059664752,CHRDL1;Chordin-like protein 1,0.43891639739979,1.55102561219302,1.30655978505845,1.84123258437127,5.28834938559481e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56320087523932,CHRDL1;Chordin-like protein 1,0.217736315107115,1.24325919572567,1.17571739608624,1.31468108994712,2.1716999332022e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.0527487984995897,CHRDL1;Chordin-like protein 1,1.0835827716395,2.95524858736471,2.09173177264994,4.1752457591907,7.97743818462459e-10
primary,Circulatory system disorders,I95 (hypotension),0.519673348181143,CHRDL1;Chordin-like protein 1,0.410836919283658,1.50807939783454,1.33666943258213,1.70147039704466,2.49372616983508e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214902512405735,CHRDL1;Chordin-like protein 1,1.35505870617737,3.87698855313012,2.31249256620279,6.49993018822263,2.75134817954768e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302811260671654,EPHA1;Ephrin type-A receptor 1,1.67482629869038,5.33786787390081,4.54010359745382,6.27581129540782,1.99429658999385e-91
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390724207318264,EPHA1;Ephrin type-A receptor 1,1.91486062191399,6.7859929123793,4.47321342399339,10.2945456525416,2.14763021141261e-19
primary,Circulatory system disorders,I50 (heart failure),0.904526539941782,EPHA1;Ephrin type-A receptor 1,0.264392451151701,1.30263931829984,1.18224781488704,1.43529061522757,9.10945503651378e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56094320823646,EPHA1;Ephrin type-A receptor 1,0.298190795956154,1.34741884542295,1.25162216161491,1.4505476178677,2.28853325334484e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,HAVCR2;Hepatitis A virus cellular receptor 2,1.59860907965941,4.94614793984318,4.24716207270976,5.76017091507088,5.67099877002006e-94
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,HAVCR2;Hepatitis A virus cellular receptor 2,1.69173609061779,5.42889758665133,3.69689880124682,7.97233859807269,6.17227176548276e-18
primary,Circulatory system disorders,I20 (angina pectoris),4.61595707179507,HAVCR2;Hepatitis A virus cellular receptor 2,0.187792675092657,1.2065833346381,1.15759253276647,1.25764749012949,6.70223475790915e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,HAVCR2;Hepatitis A virus cellular receptor 2,0.30324199115989,1.35424213941955,1.28328869107673,1.42911862695592,2.34344092878924e-28
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71117465042497,HAVCR2;Hepatitis A virus cellular receptor 2,0.276448039624849,1.31843844438173,1.25916949888954,1.38049717147428,4.95022505971755e-32
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,HAVCR2;Hepatitis A virus cellular receptor 2,0.368600683632472,1.44571019265494,1.3250174141911,1.57739659778159,1.15870382723762e-16
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,HAVCR2;Hepatitis A virus cellular receptor 2,0.514545906831219,1.67287868651337,1.5291258111724,1.83014574689904,3.10163566837379e-29
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7038110532294,HAVCR2;Hepatitis A virus cellular receptor 2,0.20979400337187,1.23342395260972,1.15335833059314,1.3190476944741,8.98135552252479e-10
primary,Circulatory system disorders,I63 (cerebral infarction),0.36426305275939,HAVCR2;Hepatitis A virus cellular receptor 2,0.479984659095275,1.61604961033962,1.40288609634506,1.86160255624665,2.91830350410247e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,HAVCR2;Hepatitis A virus cellular receptor 2,0.463143268098612,1.58906098785483,1.48224641429135,1.70357290041374,6.76712504521921e-39
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348595824683717,HAVCR2;Hepatitis A virus cellular receptor 2,0.556318791116785,1.74423975653748,1.50894606474927,2.01622337561247,5.28961678851941e-14
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.119462614077004,HAVCR2;Hepatitis A virus cellular receptor 2,0.677728673643444,1.96939949940198,1.54432957979005,2.51146804348073,4.67540816871171e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.174297912341858,HAVCR2;Hepatitis A virus cellular receptor 2,0.806853257298138,2.24084551634114,1.84127128581464,2.7271313395215,8.14023808519601e-16
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17038110532294,HAVCR2;Hepatitis A virus cellular receptor 2,0.55087385608318,1.73476829353075,1.41692057125022,2.12391653653826,9.56663965210474e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,HAVCR2;Hepatitis A virus cellular receptor 2,0.473332393873019,1.60533489778698,1.49156478618962,1.72778290149652,1.62111337027746e-36
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150797070228349,HAVCR2;Hepatitis A virus cellular receptor 2,0.659455462639186,1.93373905449169,1.5584783707897,2.39935747646702,2.08688191484094e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246758842191845,HAVCR2;Hepatitis A virus cellular receptor 2,0.652522121000149,1.92037815235856,1.62090895992614,2.27517543503747,4.56855383940888e-14
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56746700090086,HAVCR2;Hepatitis A virus cellular receptor 2,0.278607102944512,1.32128811166529,1.25025282788244,1.39635938835259,5.01205438932074e-23
primary,Circulatory system disorders,I85 (oesophageal varices),0.0489600877364772,HAVCR2;Hepatitis A virus cellular receptor 2,1.1120868879675,3.0406973725261,2.11477411247273,4.37202274075328,1.9460214336926e-09
primary,Circulatory system disorders,I95 (hypotension),0.513101719478281,HAVCR2;Hepatitis A virus cellular receptor 2,0.349054211153197,1.41772604482259,1.25569326760842,1.6006672887531,1.7310962241831e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195840350945908,HAVCR2;Hepatitis A virus cellular receptor 2,1.70304555035287,5.490643986392,3.2289232413669,9.33660205949658,3.23033588759577e-10
primary,Circulatory system disorders,I08 (multiple valve diseases),0.170782367874451,NPC2;NPC intracellular cholesterol transporter 2,0.681068402386225,1.97598775488558,1.59094707567897,2.4542158989113,7.32600380218059e-10
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.8052157858296,NPC2;NPC intracellular cholesterol transporter 2,0.18457719519421,1.20270982111965,1.17723030321509,1.22874080786669,4.90951663231127e-64
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.207708285252711,NPC2;NPC intracellular cholesterol transporter 2,1.47321774694824,4.36325241909745,3.64010021675455,5.23006800338418,3.6452275631452e-57
primary,Circulatory system disorders,I20 (angina pectoris),4.41726286637433,NPC2;NPC intracellular cholesterol transporter 2,0.355566188107417,1.42698836944474,1.36264932261572,1.49436525798267,1.49003271892561e-51
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.59635356565889,NPC2;NPC intracellular cholesterol transporter 2,0.482450247670066,1.62003903992015,1.52627583665323,1.71956236732435,1.19297263054349e-56
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.120009231479344,NPC2;NPC intracellular cholesterol transporter 2,0.786005355788603,2.19461219809043,1.69700663153976,2.83812839059873,2.08456534916853e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54950380798523,NPC2;NPC intracellular cholesterol transporter 2,0.456870012318532,1.57912360429172,1.49999691560848,1.66242432346584,5.9385729802603e-68
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00853911839372,NPC2;NPC intracellular cholesterol transporter 2,0.38460911614488,1.46903998518633,1.33823142825373,1.61263473007233,6.32049078654727e-16
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.390030002307869,NPC2;NPC intracellular cholesterol transporter 2,0.671393052125816,1.95696157216143,1.69399241359511,2.26075309675613,7.58715733725062e-20
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549273021001615,NPC2;NPC intracellular cholesterol transporter 2,0.454591299582503,1.57552933193523,1.39019529426757,1.7855711971001,1.08331463836635e-12
primary,Circulatory system disorders,I42 (cardiomyopathy),0.300023078698361,NPC2;NPC intracellular cholesterol transporter 2,0.462305135309666,1.58772970171249,1.34128578677514,1.87945449847866,7.79409067911584e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.380798522963304,NPC2;NPC intracellular cholesterol transporter 2,0.480502344517233,1.61688643225062,1.39165923845368,1.87856456707103,3.42485002653973e-10
primary,Circulatory system disorders,I46 (cardiac arrest),0.0876990537733671,NPC2;NPC intracellular cholesterol transporter 2,1.00509446281695,2.73216534867166,2.04589964156004,3.64862837885347,9.73415163568853e-12
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14170320793907,NPC2;NPC intracellular cholesterol transporter 2,0.394007105594063,1.48291108560152,1.38974027073952,1.5823282480184,1.17346471556912e-32
primary,Circulatory system disorders,I50 (heart failure),0.904684975767366,NPC2;NPC intracellular cholesterol transporter 2,0.775222710884525,2.17107559551086,1.9718413490009,2.39044040932153,3.93038385461992e-56
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65474267251327,NPC2;NPC intracellular cholesterol transporter 2,0.340453219617439,1.40558448468866,1.3060907646007,1.51265731076622,9.98301876859919e-20
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54165705054234,NPC2;NPC intracellular cholesterol transporter 2,0.503126553840083,1.65388415332977,1.53376007127185,1.78341635296783,4.41947728388913e-39
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.122317101315485,NPC2;NPC intracellular cholesterol transporter 2,0.733595420311065,2.08255482305932,1.61351625420473,2.6879398207149,1.75522782437099e-08
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.350796215093468,NPC2;NPC intracellular cholesterol transporter 2,0.606464927063048,1.83393682570965,1.57271349201718,2.13854862806585,1.03032016501201e-14
primary,Circulatory system disorders,I70 (atherosclerosis),0.16847449803831,NPC2;NPC intracellular cholesterol transporter 2,0.827194526250028,2.28689391129654,1.84427973117286,2.83573238545504,4.80568690812487e-14
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.143087929840757,NPC2;NPC intracellular cholesterol transporter 2,0.609223522918773,1.83900290065071,1.44517687813236,2.34015069004722,7.2420202818258e-07
primary,Circulatory system disorders,I72 (other aneurysm),0.0946226632817909,NPC2;NPC intracellular cholesterol transporter 2,0.795331971506103,2.21517625015178,1.66456593778152,2.94791915889881,4.90115624348479e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41703207939072,NPC2;NPC intracellular cholesterol transporter 2,0.475301551483598,1.60849916967104,1.48707925877248,1.73983300726561,1.71380449040741e-32
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.143087929840757,NPC2;NPC intracellular cholesterol transporter 2,0.880217968615224,2.41142526416312,1.91601076223329,3.03493692168321,6.29755165276243e-14
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.235402723286406,NPC2;NPC intracellular cholesterol transporter 2,0.756051741600634,2.12985039805685,1.77227558227717,2.55956960839823,7.45887525497632e-16
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54327255942764,NPC2;NPC intracellular cholesterol transporter 2,0.218362004520984,1.24403733325395,1.17171760589345,1.32082071545688,8.93595195885365e-13
primary,Circulatory system disorders,I85 (oesophageal varices),0.0530810062312485,NPC2;NPC intracellular cholesterol transporter 2,0.982125995959384,2.67012689088622,1.85288480305275,3.84782561856368,1.37716680051473e-07
primary,Circulatory system disorders,I95 (hypotension),0.510039233787214,NPC2;NPC intracellular cholesterol transporter 2,0.392627904808081,1.48086726321142,1.29972899231381,1.6872500838404,3.67730140911843e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0184629586891299,NPC2;NPC intracellular cholesterol transporter 2,1.84438064396792,6.32418165711028,3.6463768079988,10.9684971515821,5.20807335531188e-11
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.1086546501001,XG;Glycoprotein Xg,0.189310081436741,1.20841560163996,1.17806010121401,1.23955328321707,3.53104463923877e-48
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307219662058371,XG;Glycoprotein Xg,1.6406764908086,5.15865811689797,4.48269548188254,5.93655171862387,5.19447128087313e-116
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388885648175154,XG;Glycoprotein Xg,1.52911575221502,4.61409501460468,3.30669078786506,6.43842263145065,2.35155277144801e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66775554648155,XG;Glycoprotein Xg,0.238588463797601,1.26945600196809,1.18845536669099,1.35597733503426,1.31886584262598e-12
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71580236831359,XG;Glycoprotein Xg,0.24695866798173,1.28012620148526,1.20952525469953,1.35484818143477,1.43763486326071e-17
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00721382877364,XG;Glycoprotein Xg,0.386985050034517,1.47253447676897,1.32300098101531,1.63896914393005,1.40953020486937e-12
primary,Circulatory system disorders,I42 (cardiomyopathy),0.309164090299247,XG;Glycoprotein Xg,0.458733003687191,1.58206824000034,1.32030380614286,1.89573028902331,6.66279396468957e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17387077329911,XG;Glycoprotein Xg,0.284911519924976,1.32964437588247,1.23610470440297,1.43026246888188,1.93080873888284e-14
primary,Circulatory system disorders,I50 (heart failure),0.911936844970736,XG;Glycoprotein Xg,0.627021024676249,1.87202554664854,1.69567755295816,2.06671347461731,2.00476457314842e-35
primary,Circulatory system disorders,I63 (cerebral infarction),0.361663652802893,XG;Glycoprotein Xg,0.418286617716637,1.5193560863731,1.2823869938774,1.80011410613204,1.33195042355059e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56720916214587,XG;Glycoprotein Xg,0.41911349876046,1.52061293267932,1.3985599673052,1.65331751593531,9.4512341832557e-23
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35388593983939,XG;Glycoprotein Xg,0.465924882585321,1.59348729620663,1.34097365116663,1.89355082477783,1.20324477886074e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176942969919695,XG;Glycoprotein Xg,0.704623261596023,2.02308436775847,1.63879482302199,2.49748797199718,5.5384406042108e-11
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0116665694452546,XG;Glycoprotein Xg,1.58610682486153,4.88469488933556,2.55243273558436,9.3480403339359,1.67146277858444e-06
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56470084971514,XG;Glycoprotein Xg,0.264363952375468,1.30260219520238,1.21394404675284,1.39773532683383,1.97218510183244e-13
primary,Circulatory system disorders,I95 (hypotension),0.515273483832079,XG;Glycoprotein Xg,0.369561270518208,1.44709959011824,1.24615664958876,1.68044460895943,1.26555571495645e-06
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,MFGE8;Lactadherin,0.286718430977476,1.33204909690538,1.21941240601048,1.45508999893772,2.00921311075228e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301594140456699,CNTN4;Contactin-4,0.41597940712556,1.51585465274462,1.29244132205812,1.77788754431682,3.16505606011961e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,CNTN4;Contactin-4,0.256289299013243,1.29212648479038,1.21607716551516,1.37293166917535,1.22143023018961e-16
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303426102682608,AGR3;Anterior gradient protein 3,0.481609567848826,1.61867767810455,1.37825832604558,1.90103507889658,4.34061033899625e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,DLL1;Delta-like protein 1,1.77806680236658,5.91840390774638,4.98476123722091,7.02691726810893,1.314109252107e-91
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,DLL1;Delta-like protein 1,1.93326110403669,6.91201432537635,4.46262287398059,10.705798671173,4.70247187151663e-18
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00175746924428,DLL1;Delta-like protein 1,0.275089740679492,1.31664882652638,1.20601761942743,1.43742852879406,8.08655236962994e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359304823276703,DLL1;Delta-like protein 1,0.364501201936594,1.43979566172144,1.2440532179036,1.66633671106544,1.013596511493e-06
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,DLL1;Delta-like protein 1,0.475765590574706,1.60924574937147,1.46648532019485,1.76590371973588,1.03944297159058e-23
primary,Circulatory system disorders,I63 (cerebral infarction),0.363210310486233,DLL1;Delta-like protein 1,0.460320423671926,1.58458164112553,1.37027103136453,1.83241046473244,5.33927966192426e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56024214020699,DLL1;Delta-like protein 1,0.443315980872861,1.55786451196661,1.45123835655416,1.67232476090801,1.57423236337362e-34
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34954110525288,DLL1;Delta-like protein 1,0.63118844503346,1.87984334272757,1.62101954271347,2.17999283789127,6.75069158400176e-17
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126928334309705,DLL1;Delta-like protein 1,0.669471485378463,1.95320475052626,1.52876240569817,2.49548836579094,8.53720123864762e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.173794180824057,DLL1;Delta-like protein 1,0.701905069696083,2.01759270329735,1.63662174335168,2.48724565278123,4.90410482271712e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40597539543057,DLL1;Delta-like protein 1,0.368437341276409,1.44547406623114,1.34183365932498,1.5571194399743,2.84462524712275e-22
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146455770357352,DLL1;Delta-like protein 1,0.592648225125549,1.80877211420569,1.43979736216998,2.27230348317714,3.55532576592152e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246045694200351,DLL1;Delta-like protein 1,0.622187474223281,1.86299884979129,1.56219967799287,2.22171644458596,4.35559252997611e-12
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56004686584651,DLL1;Delta-like protein 1,0.260192978979977,1.29718039106196,1.22724068740837,1.37110591607671,3.54249990190201e-20
primary,Circulatory system disorders,I85 (oesophageal varices),0.0566295645381761,DLL1;Delta-like protein 1,1.49545790873885,4.46137898961401,3.11304159206012,6.3937155673521,3.79255532185208e-16
primary,Circulatory system disorders,I95 (hypotension),0.509666080843585,DLL1;Delta-like protein 1,0.370049140729143,1.44780575914592,1.28056551907757,1.63688736342519,3.44720320236351e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214801796524116,DLL1;Delta-like protein 1,2.05940593173503,7.8413101528606,4.37487246724169,14.054385670383,4.60781871541899e-12
primary,Circulatory system disorders,I50 (heart failure),0.904538527007501,CCL22;C-C motif chemokine 22,0.25531970177946,1.29087424970498,1.17762546017992,1.41501384344798,5.03681815287951e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56562357738059,CCL22;C-C motif chemokine 22,0.217992350509872,1.24357755484844,1.15893152183045,1.33440596428016,1.35351841462034e-09
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.154385131524256,CCL22;C-C motif chemokine 22,0.584359205580706,1.79384113388226,1.44113213688982,2.23287367704714,1.68182911226114e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,CCL7;C-C motif chemokine 7,0.412750118302508,1.51096741565433,1.29585303337837,1.76179124666409,1.38353832570705e-07
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0103189861498,CCL7;C-C motif chemokine 7,0.247894189086336,1.28132434692109,1.17639577023167,1.39561202408051,1.29530684367995e-08
primary,Circulatory system disorders,I50 (heart failure),0.904382626437007,CCL7;C-C motif chemokine 7,0.341538076102022,1.40711016955643,1.28545928362039,1.54027362398655,1.33050328013909e-13
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170675246203947,CCL7;C-C motif chemokine 7,0.509770399083869,1.66490888645277,1.35832822681727,2.04068615041915,9.13746001108749e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39875230509671,CCL7;C-C motif chemokine 7,0.340924746915978,1.40624741242557,1.3082577197036,1.51157662222827,2.21983029742243e-20
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149095617373563,CCL7;C-C motif chemokine 7,0.537800847579108,1.71223724803689,1.38100362168277,2.12291723753235,9.44452575106659e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24914662376898,CCL7;C-C motif chemokine 7,0.49216881656167,1.63586025620016,1.383328747061,1.93449227705324,8.76962926855405e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202881371386887,ATRAID;All-trans retinoic acid-induced differentiation factor,1.612941063205,5.01754646987495,4.07849330744198,6.17281203610573,1.4953057541409e-52
primary,Circulatory system disorders,I26 (pulmonary embolism),0.993890763198687,ATRAID;All-trans retinoic acid-induced differentiation factor,0.340107956320379,1.40509927172312,1.278380356934,1.54437914560256,1.75208486224812e-12
primary,Circulatory system disorders,I50 (heart failure),0.907267256314397,ATRAID;All-trans retinoic acid-induced differentiation factor,0.490449656500243,1.63305036659867,1.477635291462,1.80481172536791,7.11532162032497e-22
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5592231239172,ATRAID;All-trans retinoic acid-induced differentiation factor,0.320668407275892,1.37804855425053,1.27712003330882,1.48695327639008,1.4193385542816e-16
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40649220388438,ATRAID;All-trans retinoic acid-induced differentiation factor,0.329061517421082,1.38966334146308,1.28323476854615,1.50491885814025,5.75030858398134e-16
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.53487735935077,ATRAID;All-trans retinoic acid-induced differentiation factor,0.211223935897273,1.23518892723374,1.16361378470578,1.31116673419832,4.05389760364653e-12
primary,Circulatory system disorders,I85 (oesophageal varices),0.0524300173247013,ATRAID;All-trans retinoic acid-induced differentiation factor,0.977941114512608,2.65897607509497,1.78217594238605,3.96714690159134,1.66322094325139e-06
primary,Circulatory system disorders,I95 (hypotension),0.501504513540621,ATRAID;All-trans retinoic acid-induced differentiation factor,0.37913363929612,1.46101827215102,1.27953420485218,1.66824332125278,2.11406027515362e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0182365277651135,ATRAID;All-trans retinoic acid-induced differentiation factor,1.66632484006936,5.29268056223486,2.77277576421502,10.1026804602748,4.37419466223259e-07
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0460945488869,PRSS8;Prostasin,0.265619200541426,1.30423831086965,1.27753668277995,1.33149802621606,9.05759122190986e-140
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304806103988043,PRSS8;Prostasin,1.06414754922646,2.89836721530403,2.4949154177413,3.36706104544193,5.16788666633818e-44
primary,Circulatory system disorders,I15 (secondary hypertension),0.039329819869425,PRSS8;Prostasin,1.01854268773503,2.76915629659038,1.85113618594325,4.14244324819289,7.16727664362413e-07
primary,Circulatory system disorders,I20 (angina pectoris),4.58585699677495,PRSS8;Prostasin,0.418451502109816,1.51960662513382,1.45485114161113,1.58724437786352,4.03043854438195e-79
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64493038621883,PRSS8;Prostasin,0.529723526810807,1.69846266430998,1.60420633181898,1.79825709750439,6.83437373883913e-74
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.104224022653976,PRSS8;Prostasin,0.692412768897977,1.99853171590454,1.52728447096673,2.61518341566595,4.50047703891358e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68913710375206,PRSS8;Prostasin,0.509440804767784,1.66436023236859,1.58527568331894,1.74739006737967,1.74705551773562e-93
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00291040667033,PRSS8;Prostasin,0.273455233591099,1.31449851251698,1.20166318611782,1.43792899655322,2.34627111065028e-09
primary,Circulatory system disorders,I50 (heart failure),0.904585856996774,PRSS8;Prostasin,0.489938596760138,1.63221599352814,1.485045522903,1.79397130151347,2.9229126932954e-24
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56532683080311,PRSS8;Prostasin,0.44386619208693,1.55872190234237,1.45066239937064,1.6748307324267,9.49692028622576e-34
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.133721387556044,PRSS8;Prostasin,0.593436000162459,1.81019758112462,1.4243177211679,2.30062101595039,1.2253231706724e-06
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355934869818296,PRSS8;Prostasin,0.54297987566846,1.72112797563159,1.48631967752709,1.99303121212139,4.0003390400607e-13
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.125855423582159,PRSS8;Prostasin,0.620315618530301,1.85951484658119,1.45767237603534,2.37213486480452,5.92881413436994e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.173051207425469,PRSS8;Prostasin,0.733616772802669,2.08259929126845,1.69347707254998,2.56113287761316,3.60637499785475e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171084716431998,PRSS8;Prostasin,0.596299043827792,1.81538768203976,1.46630542418631,2.2475756972191,4.43084011091986e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40014158735153,PRSS8;Prostasin,0.399265429291946,1.49072924930821,1.38240213061471,1.60754504462089,3.30034794444147e-25
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153386297490757,PRSS8;Prostasin,0.748492594347958,2.11381124281389,1.69959385722045,2.62897983024827,1.74083980583958e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245811374183906,PRSS8;Prostasin,0.584992094391124,1.79497679519932,1.50450433442164,2.14153035095282,8.30015388219841e-11
primary,Circulatory system disorders,I95 (hypotension),0.523086604263352,PRSS8;Prostasin,0.302544655930648,1.3532981078583,1.19582960598369,1.5315022805664,1.63901730464463e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302321045445679,SMOC2;SPARC-related modular calcium-binding protein 2,1.42672209123791,4.16502422212402,3.54415941701038,4.89465194133759,3.14571720785557e-67
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390091671542812,SMOC2;SPARC-related modular calcium-binding protein 2,1.93174031994154,6.90151063287355,4.38397122326484,10.8647722783624,7.21456082581409e-17
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00643651258045,SMOC2;SPARC-related modular calcium-binding protein 2,0.222814852409467,1.24958919388853,1.14094654723507,1.36857695679696,1.5764739417169e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304271503803393,SMOC2;SPARC-related modular calcium-binding protein 2,0.409687440347346,1.50634688826483,1.27648153646664,1.7776057725567,1.23800673769812e-06
primary,Circulatory system disorders,I50 (heart failure),0.905012677979325,SMOC2;SPARC-related modular calcium-binding protein 2,0.494274818825948,1.63930901187271,1.48685143399055,1.80739916239955,3.2606433979088e-23
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56036668617125,SMOC2;SPARC-related modular calcium-binding protein 2,0.223303410692452,1.25019984019554,1.16120708751171,1.34601283202139,3.08593151165496e-09
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354983421103959,SMOC2;SPARC-related modular calcium-binding protein 2,0.538703016193161,1.71378267175345,1.4736108913335,1.99309808530568,2.69263370664831e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.175541252194265,SMOC2;SPARC-related modular calcium-binding protein 2,0.562047394905772,1.75426049001746,1.40955557658832,2.1832625246923,4.77040736251045e-07
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171640335478837,SMOC2;SPARC-related modular calcium-binding protein 2,0.588736370921078,1.80171028283853,1.43822381115496,2.25706174387369,3.03919344946658e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40433001755412,SMOC2;SPARC-related modular calcium-binding protein 2,0.271410876947759,1.31181395378298,1.21457626152726,1.41683639294568,4.94617082535424e-12
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152135751901696,SMOC2;SPARC-related modular calcium-binding protein 2,0.584790995657339,1.79461586393126,1.42160400261341,2.26550156946172,8.69554398690223e-07
primary,Circulatory system disorders,I95 (hypotension),0.51882192315194,SMOC2;SPARC-related modular calcium-binding protein 2,0.315555174097766,1.37102025464223,1.20879382034952,1.55501832239324,9.05251733023066e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204228457378913,MXRA8;Matrix remodeling-associated protein 8,0.874751501849978,2.39827925195515,1.95180721941408,2.9468808769368,8.58397882197956e-17
primary,Circulatory system disorders,I20 (angina pectoris),4.39787416742092,MXRA8;Matrix remodeling-associated protein 8,-0.266804450643502,0.765822812982237,0.729823012066036,0.803598367258609,1.77475532152412e-27
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53454477941005,MXRA8;Matrix remodeling-associated protein 8,-0.255690518511061,0.774381588478416,0.733896377559899,0.817100155975917,1.03080879524841e-20
primary,Circulatory system disorders,I85 (oesophageal varices),0.0533778922694887,MXRA8;Matrix remodeling-associated protein 8,1.01737191601932,2.76591614383167,1.86044451363043,4.1120775484887,4.94799054176413e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.297292443983319,GPR37;Prosaposin receptor GPR37,1.62023441981152,5.0542749998947,4.25549699133737,6.00298762437436,4.30595857711379e-76
primary,Circulatory system disorders,I15 (secondary hypertension),0.0399050260380294,GPR37;Prosaposin receptor GPR37,1.69796465921088,5.46281737385532,3.53137439101035,8.45063999333058,2.38319030550809e-14
primary,Circulatory system disorders,I20 (angina pectoris),4.6030447534867,GPR37;Prosaposin receptor GPR37,0.187106824607205,1.20575608259033,1.15497684394804,1.2587678604308,1.55238019986671e-17
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64171272371755,GPR37;Prosaposin receptor GPR37,0.302858092089594,1.35372234690159,1.2789471938537,1.43286931728502,1.51698405204667e-25
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71116742153674,GPR37;Prosaposin receptor GPR37,0.278699588450436,1.3214103173158,1.25934285461349,1.38653681188715,7.07557017499356e-30
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00560665615834,GPR37;Prosaposin receptor GPR37,0.251076042810014,1.28540782663799,1.17545660357935,1.40564379471852,3.72785852502895e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542708354117201,GPR37;Prosaposin receptor GPR37,0.360526109035042,1.43408370051646,1.26964899447396,1.61981466455543,6.54709094084498e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301282946587122,GPR37;Prosaposin receptor GPR37,0.538705194647973,1.71378640515563,1.45474121063445,2.01895967545685,1.17218772191469e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16285241126119,GPR37;Prosaposin receptor GPR37,0.200720317614374,1.22228287302418,1.14891817501031,1.30033230754213,2.07703978497718e-10
primary,Circulatory system disorders,I50 (heart failure),0.911829844968974,GPR37;Prosaposin receptor GPR37,0.633741741156634,1.88464927231647,1.71287194051358,2.07365349132756,1.27515606268807e-38
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.72589237614477,GPR37;Prosaposin receptor GPR37,0.196325604030154,1.21692307589134,1.13620324895489,1.30337751982229,2.0649286922549e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.58422953370977,GPR37;Prosaposin receptor GPR37,0.27971942008417,1.32275862076294,1.23104784653976,1.42130167703938,2.34849644929324e-14
primary,Circulatory system disorders,I70 (atherosclerosis),0.177577365869231,GPR37;Prosaposin receptor GPR37,0.622858279491056,1.86424897848316,1.50627359768809,2.30729945682496,1.03153546399476e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40864741914244,GPR37;Prosaposin receptor GPR37,0.313366850632093,1.36802329919702,1.26817158052581,1.47573701846397,5.32966032728072e-16
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153634350246413,GPR37;Prosaposin receptor GPR37,0.714439374525764,2.04304098031524,1.62505572541429,2.56853742426793,9.50641037560978e-10
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6462667343195,CPM;Carboxypeptidase M,0.18832481371329,1.20722557509479,1.14277249257812,1.27531385173179,1.72845182815562e-11
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.122376829986855,PROS1;Vitamin K-dependent protein S,-1.65765488537625,0.190585401053858,0.147570913429163,0.246137902455252,5.79859052156096e-37
primary,Circulatory system disorders,I07 (rheumatic tricuspid valve diseases),0.0521234646240311,PROS1;Vitamin K-dependent protein S,-1.12083766795676,0.326006594935431,0.221736052996687,0.479309965632797,1.20079219895251e-08
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172234057018537,PROS1;Vitamin K-dependent protein S,-1.14469785298745,0.318320082723741,0.257865512289796,0.392947758564064,1.70220781549604e-26
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0317273262928885,PROS1;Vitamin K-dependent protein S,-1.99212779241513,0.136404875181024,0.0831505986529091,0.22376615772567,3.06357037515244e-15
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.56538095453927,PROS1;Vitamin K-dependent protein S,-0.26031790399277,0.770806504384052,0.727211554249604,0.817014888898247,1.89186420351878e-18
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54892806961881,PROS1;Vitamin K-dependent protein S,-0.247934924273616,0.780410727420573,0.742348067906968,0.820424986341359,2.51564658107204e-22
primary,Circulatory system disorders,I26 (pulmonary embolism),0.99714454063364,PROS1;Vitamin K-dependent protein S,-0.522946381409816,0.592771441712338,0.540335928982639,0.650295424128668,1.82374146832936e-28
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.394325341068757,PROS1;Vitamin K-dependent protein S,-1.07071103622368,0.34276471262508,0.297375525116552,0.3950817679932,2.17105244704633e-49
primary,Circulatory system disorders,I33 (acute and subacute endocarditis),0.0475909894393328,PROS1;Vitamin K-dependent protein S,-1.35458711619435,0.258053818701969,0.175660243304878,0.379094165497033,5.09767529297089e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.5529619725332,PROS1;Vitamin K-dependent protein S,-0.697374124699117,0.49789098840766,0.440824148308234,0.562345409816848,2.97506742366881e-29
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.342201876444726,PROS1;Vitamin K-dependent protein S,-1.06322165582313,0.34534144496592,0.297279475492642,0.401173721843778,5.87378380883284e-44
primary,Circulatory system disorders,I36 (nonrheumatic tricuspid valve disorders),0.0203961383311426,PROS1;Vitamin K-dependent protein S,-1.68883624868295,0.184734383829516,0.100763995932173,0.338680421048832,4.73728400895598e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.305942074967139,PROS1;Vitamin K-dependent protein S,-0.602136822329706,0.547640175182876,0.465764163653876,0.643909052859643,3.15242465124727e-13
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.378461677922313,PROS1;Vitamin K-dependent protein S,-0.627652256859646,0.533843658699465,0.46157423450743,0.617428423485895,2.74028342320661e-17
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.695734940851198,PROS1;Vitamin K-dependent protein S,-0.324809486524995,0.722665017952037,0.64648549145968,0.80782126601551,1.0974883656419e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14159452476997,PROS1;Vitamin K-dependent protein S,-1.08541676527703,0.337760989504865,0.316301606237475,0.360676277899311,2.07397342182448e-230
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.2350994878303,PROS1;Vitamin K-dependent protein S,-0.420790676080933,0.656527513938997,0.604074801943815,0.713534772799561,3.969603056803e-23
primary,Circulatory system disorders,I50 (heart failure),0.899696324162625,PROS1;Vitamin K-dependent protein S,-0.80708082179592,0.446158583491059,0.406017037032141,0.490268790388198,3.51613694189731e-63
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.6543534424149,PROS1;Vitamin K-dependent protein S,-0.439349576123802,0.644455454008291,0.599537503072906,0.69273870287065,9.43065496530159e-33
primary,Circulatory system disorders,I63 (cerebral infarction),0.360331777183519,PROS1;Vitamin K-dependent protein S,-0.674633940120614,0.509342836463066,0.438815881124093,0.591204959108754,7.20052127151097e-19
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55917146353623,PROS1;Vitamin K-dependent protein S,-0.322735516934439,0.72416535851599,0.672265789840145,0.780071624051092,1.80183710608724e-17
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.140506730725649,PROS1;Vitamin K-dependent protein S,-0.577230825698127,0.561450971458384,0.444059236341207,0.709876447901081,1.41301703651539e-06
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54951729139282,PROS1;Vitamin K-dependent protein S,-0.416007901325828,0.659675058156221,0.621742498538016,0.699921886273961,3.96977685717837e-43
primary,Circulatory system disorders,I85 (oesophageal varices),0.0521234646240311,PROS1;Vitamin K-dependent protein S,-0.978852855454071,0.375741881969485,0.255499840204617,0.55257162490945,6.54618039413987e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,NBL1;Neuroblastoma suppressor of tumorigenicity 1,1.92232700414256,6.83684934980673,5.72685987636388,8.16197882278736,2.28458892893689e-100
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,NBL1;Neuroblastoma suppressor of tumorigenicity 1,2.06841064180229,7.91223773924837,5.11783223822581,12.2324263727895,1.33960766663533e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6654950205038,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.282735100512323,1.32675365889822,1.25605615058272,1.4014303983012,4.50723395530024e-24
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68677992579574,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.257515340017539,1.2937116563876,1.23457199654587,1.35568428131842,3.97781501152853e-27
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00175746924428,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.334291052541843,1.39694967016366,1.27965964022254,1.52499017678716,7.94858854036536e-14
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359304823276703,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.39359854649218,1.48230535252752,1.28091168877817,1.7153635003734,1.27174958196441e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.302675258738527,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.388267468384571,1.47442409338361,1.2578013121246,1.72835438013498,1.6757600543993e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386643233743409,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.376722157505655,1.4574992978687,1.26605303631157,1.67789511368066,1.57662084468817e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16754540128881,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.221589373712582,1.24805878688368,1.17527672080126,1.32534807160616,4.8971368880015e-13
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.62009244255869,1.85909989385404,1.69385598383739,2.04046415297838,5.8379707887609e-39
primary,Circulatory system disorders,I63 (cerebral infarction),0.363210310486233,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.458341594008129,1.5814491243501,1.36781897096748,1.82844468894793,6.01254425553263e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56024214020699,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.436891724210482,1.54788846913648,1.44205862151074,1.66148496125324,1.1770139755467e-33
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132786565123999,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.616778540755633,1.85294921636322,1.45881932492945,2.35356136277335,4.30816758558333e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34954110525288,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.574077779457343,1.77549237611939,1.53114499901203,2.05883386595793,2.97666455785974e-14
primary,Circulatory system disorders,I70 (atherosclerosis),0.173794180824057,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.740329312598181,2.09662584612547,1.70142251852473,2.58362628375984,3.72678201583425e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.167935950009763,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.589707801837469,1.8034613703022,1.45740678937848,2.23168502979139,5.79323198764288e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40597539543057,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.326542916721722,1.38616773826155,1.28700759047861,1.49296788364908,6.53250311087642e-18
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146455770357352,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.668587220895668,1.95147836434123,1.55400236994282,2.45061904675992,8.73521553790676e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246045694200351,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.588930674631961,1.80206039584545,1.51099121194565,2.14919957482284,5.66613564553716e-11
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56004686584651,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.194452355966314,1.21464561089002,1.1494161785569,1.2835768171514,5.03577359619335e-12
primary,Circulatory system disorders,I85 (oesophageal varices),0.0566295645381761,NBL1;Neuroblastoma suppressor of tumorigenicity 1,1.04801136722044,2.85197394615325,1.98633195325057,4.09486207792525,1.35819483409812e-08
primary,Circulatory system disorders,I95 (hypotension),0.509666080843585,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.41366974280849,1.51235757743295,1.33779007602555,1.70970429741413,3.83120557783008e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214801796524116,NBL1;Neuroblastoma suppressor of tumorigenicity 1,1.46124766838108,4.31133529078601,2.45562300249504,7.56940783283547,3.61437196835445e-07
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.114170714244247,BLMH;Bleomycin hydrolase,0.824041291470234,2.27969415510409,1.7742169200499,2.9291826619879,1.1730038923838e-10
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.373473692358302,BLMH;Bleomycin hydrolase,0.446825132923182,1.56334089852972,1.35520019346369,1.80344924447591,8.81438038490133e-10
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0307218448902,ASGR1;Asialoglycoprotein receptor 1,0.228202509475082,1.25633972037008,1.23167119308664,1.28150232126808,1.21282966708304e-112
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,ASGR1;Asialoglycoprotein receptor 1,1.39348611811767,4.02887071915341,3.48063597295529,4.66345788464337,8.35661287483743e-78
primary,Circulatory system disorders,I15 (secondary hypertension),0.039488232506713,ASGR1;Asialoglycoprotein receptor 1,1.30254595828594,3.67865044598599,2.55976732310814,5.28660123972574,1.92122573111858e-12
primary,Circulatory system disorders,I20 (angina pectoris),4.61025114515874,ASGR1;Asialoglycoprotein receptor 1,0.261256794045383,1.29856108537602,1.24559494187042,1.35377949586147,9.50227543368285e-35
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64571157794977,ASGR1;Asialoglycoprotein receptor 1,0.33040126695375,1.39152639000591,1.31779048575833,1.46938812733089,1.26942185283015e-32
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69807297425367,ASGR1;Asialoglycoprotein receptor 1,0.3398069432395,1.40467638211324,1.34101745089763,1.4713572423282,9.17516722601629e-47
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01287316379718,ASGR1;Asialoglycoprotein receptor 1,0.253231194922038,1.28818106333044,1.18171139816483,1.40424341721691,8.7509640252308e-09
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361317327436424,ASGR1;Asialoglycoprotein receptor 1,0.406690589412818,1.50183934877055,1.30293846541926,1.73110357041286,2.01550200836197e-08
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0592323487600695,ASGR1;Asialoglycoprotein receptor 1,0.809118567178187,2.24592747976672,1.61262396283891,3.12793953246939,1.68984742471553e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30405939030169,ASGR1;Asialoglycoprotein receptor 1,0.381746304863217,1.46484041510003,1.25410658911966,1.71098490377655,1.45644542014443e-06
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,ASGR1;Asialoglycoprotein receptor 1,0.554024681328377,1.74024286544511,1.59105926895522,1.90341446721922,8.71844348662936e-34
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.711814879166,ASGR1;Asialoglycoprotein receptor 1,0.208136469826919,1.2313812044626,1.15174426030188,1.31652461659008,1.05075351720973e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56373400726583,ASGR1;Asialoglycoprotein receptor 1,0.399800864279661,1.4915276516327,1.39176498289763,1.59844137690062,1.05638083111855e-29
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357368504185752,ASGR1;Asialoglycoprotein receptor 1,0.471227568744526,1.60195950210946,1.38991107579904,1.84635858443208,7.78448088465592e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.165850576528194,ASGR1;Asialoglycoprotein receptor 1,0.716710323953993,2.04768589524856,1.67356083423511,2.50544673359083,3.34343314260046e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.169799399778865,ASGR1;Asialoglycoprotein receptor 1,0.614028917191526,1.84786130166545,1.50871069566824,2.26325126480286,2.9372196733916e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,ASGR1;Asialoglycoprotein receptor 1,0.34090909500226,1.40622540213466,1.30714026236125,1.51282149173237,5.98671566095408e-20
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152029695150845,ASGR1;Asialoglycoprotein receptor 1,0.644841918097018,1.90568575102922,1.54070008752182,2.35713505249241,2.77011534490649e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242852629916284,ASGR1;Asialoglycoprotein receptor 1,0.581719717829415,1.78911255543934,1.50989948076032,2.11995816729392,1.82293694465227e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307333203656876,CD5;T-cell surface glycoprotein CD5,1.19961998650007,3.31885547318368,2.85252236906646,3.86142516228052,2.23827139153959e-54
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389029371717564,CD5;T-cell surface glycoprotein CD5,1.20351620114474,3.33181167015391,2.22987458872892,4.97829297732012,4.25267818404117e-09
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00369577903131,CD5;T-cell surface glycoprotein CD5,0.238033239999447,1.26875136541868,1.16191794831016,1.38540766118028,1.13360165438972e-07
primary,Circulatory system disorders,I50 (heart failure),0.912273876677689,CD5;T-cell surface glycoprotein CD5,0.36649014812416,1.44266218755153,1.31854133005618,1.57846715908577,1.41228735369968e-15
primary,Circulatory system disorders,I63 (cerebral infarction),0.367632756273098,CD5;T-cell surface glycoprotein CD5,0.41345332255844,1.51203030804302,1.31202520568334,1.74252418515841,1.11994495351671e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56778836802178,CD5;T-cell surface glycoprotein CD5,0.361097083710887,1.4349027598013,1.33815316486765,1.53864743150611,3.72642839372786e-24
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41023147247617,CD5;T-cell surface glycoprotein CD5,0.228518079856092,1.25673624653698,1.16651605063247,1.35393421505304,1.83032904276849e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306659161927682,BSG;Basigin,1.70482458229469,5.50042071139937,4.68851371393884,6.45292513754303,3.39251798135777e-97
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388176154338838,BSG;Basigin,1.85360677226431,6.38279935987016,4.26601559553041,9.54992469109657,1.94125124641956e-19
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0014944781942,BSG;Basigin,0.275452778452423,1.3171269065594,1.20664871322227,1.43772024862978,7.15741322772491e-10
primary,Circulatory system disorders,I50 (heart failure),0.904450439609494,BSG;Basigin,0.301664486981841,1.35210750092977,1.23294633739327,1.48278529131752,1.46775483351576e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55464549812705,BSG;Basigin,0.297709358376723,1.34677030348429,1.25496174830737,1.44529524728026,1.40436992342501e-16
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355181181220037,BSG;Basigin,0.474507408369057,1.60722229820715,1.38920216008183,1.85945832081208,1.7744534595798e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174679269452477,BSG;Basigin,0.552209747521028,1.73708730426914,1.41292858595735,2.13561558074679,1.60515759706767e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41102032102167,BSG;Basigin,0.298523851252787,1.34786768514628,1.2517196811964,1.45140107961323,2.65545888629272e-15
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246491858005162,BSG;Basigin,0.512702211217754,1.66979724890656,1.40244808200887,1.98811128071284,8.45246684732031e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0213496884886361,BSG;Basigin,1.57789785965614,4.84476073225675,2.84934211250961,8.23758805577187,5.66912922315714e-09
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172538870262533,TFF3;Trefoil factor 3,0.52051453265177,1.68289333053726,1.37048113103364,2.06652240431123,6.76508639099579e-07
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0061957139776,TFF3;Trefoil factor 3,0.205576511003968,1.22823295070312,1.20414990381237,1.25279765950798,4.94746814700267e-92
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.309785698880458,TFF3;Trefoil factor 3,1.59112430414631,4.90926533405706,4.16639411570183,5.78459105185121,1.49179399392772e-80
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392133796051212,TFF3;Trefoil factor 3,1.82126745009458,6.17968593188317,4.0017725952176,9.54290062917435,2.12350108413631e-16
primary,Circulatory system disorders,I20 (angina pectoris),4.5781620688979,TFF3;Trefoil factor 3,0.320286437047685,1.37752228124649,1.31996702045352,1.43758715629013,5.6937807215926e-49
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6684704821285,TFF3;Trefoil factor 3,0.426499047671126,1.53188506808373,1.44727996380483,1.62143601825912,5.27679134196475e-49
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69586102778267,TFF3;Trefoil factor 3,0.410418799209308,1.50744897137075,1.43657325373943,1.5818214597631,1.23792501934496e-62
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0038625178911,TFF3;Trefoil factor 3,0.336717352949481,1.40034320492042,1.28445356987413,1.52668896529981,2.17604645682258e-14
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352920416446091,TFF3;Trefoil factor 3,0.584474053230663,1.7940471641517,1.55620061635374,2.06824569620215,7.98819201901347e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547026645491441,TFF3;Trefoil factor 3,0.380332798689433,1.46277131681579,1.30084648075335,1.64485199211197,2.09757616166274e-10
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376448444209164,TFF3;Trefoil factor 3,0.405518803606666,1.50008054541019,1.30056991371117,1.73019659996369,2.56045760267846e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.303903691939689,TFF3;Trefoil factor 3,0.537994755609803,1.71256929678216,1.46117889350674,2.00721048552938,3.09124708410287e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.380369782169676,TFF3;Trefoil factor 3,0.470082667444923,1.60012646611646,1.38648956014342,1.84668156268085,1.28325519262323e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15869654726192,TFF3;Trefoil factor 3,0.40535103074681,1.49982889371783,1.41060892966577,1.59469195403707,2.2253250909141e-38
primary,Circulatory system disorders,I50 (heart failure),0.917593082759837,TFF3;Trefoil factor 3,0.819490730141677,2.26934383478548,2.06541548392288,2.49340700724173,3.04668744169505e-65
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71166401976354,TFF3;Trefoil factor 3,0.303820113125058,1.35502528290092,1.26705985979172,1.44909769109293,7.20434985681826e-19
primary,Circulatory system disorders,I63 (cerebral infarction),0.362723761347371,TFF3;Trefoil factor 3,0.514667599898004,1.67308227663859,1.44646810872778,1.93519946102661,4.1842853396948e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56657451522459,TFF3;Trefoil factor 3,0.474880126292897,1.60782145041574,1.49836411146525,1.72527478243523,8.66510402277511e-40
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.131364821677156,TFF3;Trefoil factor 3,0.641356786781191,1.89905574587023,1.48562979323562,2.42753123445927,3.05641012742115e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343117071544811,TFF3;Trefoil factor 3,0.498896522403481,1.64690294713917,1.42195305678508,1.90743942238708,2.77698493549747e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.170578201282277,TFF3;Trefoil factor 3,0.849918383143364,2.33945590509664,1.89008150874528,2.89567085153105,5.72972314964185e-15
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170578201282277,TFF3;Trefoil factor 3,0.779309089777404,2.17996558456022,1.74855489507578,2.71781570212644,4.31518043685787e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39991765190282,TFF3;Trefoil factor 3,0.349420368141808,1.41824525017137,1.31814514373341,1.52594697116332,8.23785221343118e-21
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.147050173519204,TFF3;Trefoil factor 3,0.721256887782856,2.05701702608992,1.64088976471848,2.57867355662965,3.98719610405288e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.247044291512263,TFF3;Trefoil factor 3,0.67222977075642,1.95859968359184,1.645555132401,2.3311967159489,3.8638647012223e-14
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54886967433288,TFF3;Trefoil factor 3,0.227291454544181,1.25519564710887,1.18844574935918,1.32569460017051,3.57074494026751e-16
primary,Circulatory system disorders,I95 (hypotension),0.515655941807344,TFF3;Trefoil factor 3,0.490610391023601,1.6333128752675,1.4498518901369,1.8399885992925,7.00743401927262e-16
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174335468453115,NPDC1;Neural proliferation differentiation and control protein 1,0.554238630348996,1.74061522853375,1.41634867706677,2.13912112381686,1.36989481988295e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,NPDC1;Neural proliferation differentiation and control protein 1,1.82989687232294,6.23324380542313,5.29794045438299,7.33366648273716,7.61117436856207e-108
primary,Circulatory system disorders,I15 (secondary hypertension),0.039176509764745,NPDC1;Neural proliferation differentiation and control protein 1,1.94342177159219,6.98260301187162,4.64887179057784,10.4878660926328,7.7154254218326e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67575561693208,NPDC1;Neural proliferation differentiation and control protein 1,0.228052787604391,1.25615163291767,1.19039088474055,1.32554520125181,9.36579616792625e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72176842765078,NPDC1;Neural proliferation differentiation and control protein 1,0.250802604498727,1.2850563949422,1.22731844750863,1.34551056535816,1.09843962356853e-26
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01075395193042,NPDC1;Neural proliferation differentiation and control protein 1,0.355694270687093,1.42717115350174,1.30873604190831,1.55632414494946,8.47153909536127e-16
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358465064347417,NPDC1;Neural proliferation differentiation and control protein 1,0.553990058835696,1.74018261494226,1.5065810747707,2.01000502665159,4.97460576059965e-14
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542594660241719,NPDC1;Neural proliferation differentiation and control protein 1,0.379030524381628,1.46086762714382,1.29882497290359,1.64312687895572,2.63871004801278e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.309494427141486,NPDC1;Neural proliferation differentiation and control protein 1,0.492652657620853,1.63665194406929,1.40229496126351,1.91017557647949,4.15743498930911e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.393723923135687,NPDC1;Neural proliferation differentiation and control protein 1,0.380800207447991,1.46345518875245,1.27572967643409,1.67880478838819,5.42892728194532e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,NPDC1;Neural proliferation differentiation and control protein 1,0.260669405045555,1.29779854885357,1.22300214236922,1.37716935650138,7.51709540817221e-18
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,NPDC1;Neural proliferation differentiation and control protein 1,0.713253357903884,2.04061933609242,1.86428477437069,2.23363261454512,5.68874916656901e-54
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71788995318407,NPDC1;Neural proliferation differentiation and control protein 1,0.253151193162556,1.2880780107011,1.2049889117083,1.37689645566908,9.99806600308803e-14
primary,Circulatory system disorders,I63 (cerebral infarction),0.366300366300366,NPDC1;Neural proliferation differentiation and control protein 1,0.355289726941886,1.42659391710481,1.23716096769938,1.64503266547849,1.02013797267797e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,NPDC1;Neural proliferation differentiation and control protein 1,0.342766847612232,1.40884024916309,1.31432149779812,1.51015626769182,3.89570364957452e-22
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35650623885918,NPDC1;Neural proliferation differentiation and control protein 1,0.430519268845621,1.53805598077699,1.33113503486324,1.77714216668252,5.22083234026256e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.176294293941352,NPDC1;Neural proliferation differentiation and control protein 1,0.770573897381712,2.16100609371948,1.76826854263047,2.64097178935602,5.07752292560823e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,NPDC1;Neural proliferation differentiation and control protein 1,0.362174629048398,1.43644976591483,1.33427136611795,1.54645297980139,6.58627284671938e-22
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248770837006131,NPDC1;Neural proliferation differentiation and control protein 1,0.562635115974521,1.75529180890175,1.47880023209484,2.08347907143147,1.2461788725874e-10
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55234961117314,NPDC1;Neural proliferation differentiation and control protein 1,0.225776573221082,1.25329561419178,1.18603900762707,1.32436613505232,1.03402798373322e-15
primary,Circulatory system disorders,I95 (hypotension),0.521047579871109,NPDC1;Neural proliferation differentiation and control protein 1,0.438129497788661,1.54980559082206,1.37441059422563,1.74758356741029,8.69320570200499e-13
primary,Circulatory system disorders,I20 (angina pectoris),4.43370980178709,APOF;Apolipoprotein F,-0.28228211965651,0.754060919114358,0.718443243622244,0.791444383092511,2.81960901492587e-30
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.57177847326166,APOF;Apolipoprotein F,-0.282301413017829,0.754046370884932,0.707701393477489,0.803426324555939,2.71433719130748e-18
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55150360593278,APOF;Apolipoprotein F,-0.307211565824181,0.735494978844297,0.696577194827765,0.77658710035566,1.64854827584633e-28
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56257087132036,APOF;Apolipoprotein F,-0.262311580824825,0.769271296177287,0.7103647880757,0.833062585668618,1.0927158835855e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,NFASC;Neurofascin,0.456941170149236,1.57923597529981,1.35113808167509,1.84584114644239,9.40222063983082e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.58852481252543,NFASC;Neurofascin,0.28779519206067,1.33348416800953,1.27905921443461,1.39022494522906,9.53056787059878e-42
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65274090724126,NFASC;Neurofascin,0.371905031973945,1.45049522408376,1.37393533024604,1.53132127020347,3.41686545858109e-41
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,NFASC;Neurofascin,0.358211602768971,1.43076834299344,1.36602987356422,1.49857487814006,6.23712744841707e-52
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354603057724727,NFASC;Neurofascin,0.512388569972903,1.66927361373985,1.44184788342521,1.93257168773493,7.04353780508798e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542562055535101,NFASC;Neurofascin,0.414610444564712,1.51378092422953,1.34513332515589,1.70357290515841,5.99435229564188e-12
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304222295425039,NFASC;Neurofascin,0.525569456711363,1.69142176565941,1.44589772749414,1.97863758614836,5.10430682999511e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.381731160501482,NFASC;Neurofascin,0.380861565897824,1.46354498684914,1.27246647869828,1.68331658585023,9.52260364362646e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16055961400585,NFASC;Neurofascin,0.429923067850951,1.53713926357241,1.44781284940287,1.63197689300134,5.43979931379039e-45
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,NFASC;Neurofascin,0.625679365887672,1.86951561123639,1.70578570317365,2.04896114098851,7.93255596680412e-41
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70131958842792,NFASC;Neurofascin,0.272158157247005,1.31279461287489,1.22757103680718,1.40393479800228,1.9080862560831e-15
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,NFASC;Neurofascin,0.208061149266167,1.23128845963262,1.14818507648175,1.32040670261104,5.35581495657121e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,NFASC;Neurofascin,0.203155070146842,1.22526245514531,1.13815983455185,1.31903098177755,6.68010563382578e-08
primary,Circulatory system disorders,I85 (oesophageal varices),0.0523184839265991,NFASC;Neurofascin,1.30643507217935,3.69298499281936,2.5282521907761,5.39429500227289,1.4013072025956e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.197501487209994,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,0.818062022205314,2.26610392023531,1.84576445289467,2.78216809802161,5.50048830434329e-15
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.54848304580606,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,0.192364120177442,1.21211179098205,1.13762841466328,1.2914717801529,2.76334963876423e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.52647233789411,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,0.189617257809714,1.20878685537878,1.14534569673437,1.27574204530792,5.43704261586403e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.166567519333729,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,0.577174540256196,1.78099917352477,1.41136195114523,2.24744478446657,1.15586515982076e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41820345032718,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,0.228122557446317,1.25623927747597,1.15869388432546,1.3619965925617,3.17379313381785e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.23081499107674,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,0.502640433258051,1.65308036158822,1.35889265339822,2.01095699136718,4.98020295945893e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,LSP1;Lymphocyte-specific protein 1,0.51996332623497,1.6819659645432,1.43938818417011,1.96542498889056,6.01191348407995e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,REG1B;Lithostathine-1-beta,1.35708750886529,3.88486218224702,3.32054023953706,4.54508998124871,2.06041409849659e-64
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,REG1B;Lithostathine-1-beta,1.32726529515235,3.77071747548386,2.45331230341324,5.79555658696111,1.42885236492424e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.59779011939547,REG1B;Lithostathine-1-beta,0.19066889802624,1.21005873291067,1.16092760261723,1.26126912116857,1.95297901637441e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66849855835284,REG1B;Lithostathine-1-beta,0.243338697307719,1.27550055957216,1.20828768515964,1.34645225425263,1.24932644053162e-18
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71538595506705,REG1B;Lithostathine-1-beta,0.251210373598858,1.28558050808329,1.22763713038221,1.34625876153579,1.31955250819035e-26
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00818545968225,REG1B;Lithostathine-1-beta,0.226771168254759,1.25454275588304,1.15113365931171,1.36724133953279,2.38210930037302e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1711786674923,REG1B;Lithostathine-1-beta,0.196197392609199,1.21676706245616,1.14658138429552,1.29124901603723,9.64820457181044e-11
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,REG1B;Lithostathine-1-beta,0.51293189914105,1.67018082521872,1.52534284879508,1.82877180112774,1.5246604590433e-28
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56549335294231,REG1B;Lithostathine-1-beta,0.294411603630719,1.34233630046982,1.25232018890577,1.43882272243285,9.33045587665307e-17
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40488031425972,REG1B;Lithostathine-1-beta,0.250595437532875,1.28479020128213,1.19433970180091,1.3820907559395,1.71996763873071e-11
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56400332836658,REG1B;Lithostathine-1-beta,0.206561537158446,1.22944338834185,1.1643218829854,1.29820719444165,1.01411523450989e-13
primary,Circulatory system disorders,I95 (hypotension),0.512800665673317,REG1B;Lithostathine-1-beta,0.339239083923668,1.40387894997999,1.2451019599359,1.5829033843127,3.02811740671456e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,IDUA;Alpha-L-iduronidase,0.191604879102993,1.21119185519422,1.12516170561321,1.30379989184693,3.45045985746949e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303320874346881,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,1.80083552403826,6.05470420251143,5.11222196717781,7.17094117103591,1.23186018293142e-96
primary,Circulatory system disorders,I15 (secondary hypertension),0.0391381773350815,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,1.86951229372388,6.48513278793072,4.17918714912023,10.0634275940352,7.48386188485675e-17
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00389424864484,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.294902780173391,1.34299578652177,1.23109527068076,1.46506750985882,3.05747230657746e-11
primary,Circulatory system disorders,I50 (heart failure),0.906048805307136,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.445379266710084,1.56108215006253,1.42459792860664,1.71064230145792,1.41095406099724e-21
primary,Circulatory system disorders,I63 (cerebral infarction),0.363985049216257,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.387880647648275,1.47385386586522,1.27684031673137,1.70126615635591,1.1702961078427e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56552709340326,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.377545429708525,1.45869971059175,1.36016253309365,1.56437542860471,3.69112635145159e-26
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356157413749241,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.508299916083137,1.66246246538859,1.43815776743851,1.92175122326701,6.2568543588427e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.176121798007866,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.618271169666432,1.85571704709201,1.51167311207993,2.27806245368066,3.42924713840921e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40310365746267,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.335024010203784,1.39797395045894,1.2985539720209,1.50500572811796,5.54523689927347e-19
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246570517211013,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.493588696929084,1.63818463183893,1.37663926665896,1.94942055844908,2.67206760777718e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56159370658108,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.210949478449972,1.23484996695105,1.16873708000357,1.30470271455266,5.74270172052071e-14
primary,Circulatory system disorders,I95 (hypotension),0.520537758556584,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.372307153609905,1.45107861688579,1.28663572349941,1.63653869850299,1.30373827629051e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215259975342948,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,1.43993290673737,4.22041264624319,2.41018271380837,7.39026249027594,4.71404234551323e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303814340036849,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,1.40950170117296,4.09391490272967,3.58258119333387,4.67823011575502,3.05051255430947e-95
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392018503273354,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,1.51323644745716,4.54140505410927,3.27380469980599,6.29981375086653,1.27919699929274e-19
primary,Circulatory system disorders,I20 (angina pectoris),4.59249676584734,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.257434351889873,1.29360688534547,1.24146789330967,1.34793560335417,1.40396313419474e-34
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65004508212787,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.389153146775726,1.47573053740173,1.3994256762889,1.55619598519531,8.41731363227985e-47
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69673448586773,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.343857546375616,1.41037770778035,1.34764113608726,1.47603484736232,1.23508336385726e-49
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00356736837978,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.392554068399445,1.48075792532764,1.35989800952019,1.6123591755195399,1.62032896067974e-19
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358696930495119,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.460208906092259,1.58440494226882,1.37684991715402,1.82324811862923,1.32772503512662e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546865812066329,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.373364698269528,1.45261400905757,1.29520931857116,1.62914783661231,1.76645149547866e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301854247520483,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.410501208167628,1.50757320378907,1.29419848237796,1.75612705139851,1.34898934935922e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384178133207887,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.415046031006767,1.51444045030625,1.32295198125662,1.73364559713291,1.76913254522375e-09
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.709553490924771,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.309443828854898,1.36266702725775,1.23083231589816,1.50862258261434,2.51486070960753e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16786232310165,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.313574951930451,1.36830801624573,1.29052146321901,1.45078317616837,8.56713295364694e-26
primary,Circulatory system disorders,I50 (heart failure),0.905562742561448,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.67776698641652,1.96947495400352,1.80705223032257,2.14649666974748,9.68021830220713e-54
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70332039672272,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.271226243342071,1.31157177120091,1.22754265787846,1.401352938711,9.85340140472348e-16
primary,Circulatory system disorders,I63 (cerebral infarction),0.362617115527852,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.479469145571009,1.61521672960869,1.40691613487228,1.85435721358377,1.00123682609214e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56807401309341,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.465148512002334,1.59225063965949,1.48788816458857,1.70393323895892,3.14770052638288e-41
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356736837978752,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.5162487616831,1.67572978291403,1.45811928236107,1.92581659080602,3.48884790490137e-13
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.125445921047473,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.584533605104936,1.79415400620415,1.42541332559794,2.25828434473775,6.37167169555587e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176408326473009,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.779262223290813,2.17986341962646,1.81063228882775,2.62438958895514,1.87616226085552e-16
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172488141440276,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.576168349043149,1.77920804906389,1.46466975957257,2.16129353471293,6.44195036704154e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39950605668587,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.333040812788942,1.39520423948399,1.29728190194394,1.5005180192194,2.96335096983422e-19
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152887216276608,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.7090163774601,2.03199156263305,1.65891189014243,2.48897469187311,7.36126964031745e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246971657062213,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.65158867258637,1.91858641479578,1.63162609392204,2.25601554470775,3.20351952333238e-15
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56184091889137,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.267216609432852,1.3063233776527,1.23689104301059,1.37965326585953,8.85345879641774e-22
primary,Circulatory system disorders,I85 (oesophageal varices),0.0529224979419028,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.901499305686901,2.46329357396364,1.77191249516207,3.42444406712959,8.16855956512395e-08
primary,Circulatory system disorders,I95 (hypotension),0.521384609353561,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.430980387815079,1.53876537110992,1.36889790495905,1.72971180593477,5.14972694322221e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215610176800345,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,1.31587843338378,3.72802436837695,2.36878912773227,5.86720258401287,1.29252853610579e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,LGALS1;Galectin-1,1.08754434722401,2.96697924862335,2.58204111880577,3.40930506398482,4.20681897215231e-53
primary,Circulatory system disorders,I15 (secondary hypertension),0.039176509764745,LGALS1;Galectin-1,1.22813162165035,3.41484335285611,2.35763640347863,4.94612108437917,8.17364094119983e-11
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67575561693208,LGALS1;Galectin-1,0.192514529278991,1.21229411733893,1.14959163371265,1.27841659928254,1.20470723385686e-12
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72176842765078,LGALS1;Galectin-1,0.198850732011109,1.21999984538446,1.1658448569851,1.27667040242999,9.18715657863817e-18
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01075395193042,LGALS1;Galectin-1,0.27871151776421,1.32142608092813,1.21315525545737,1.43935978474475,1.65844815388154e-10
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,LGALS1;Galectin-1,0.493815299005221,1.63855588993994,1.50125025760831,1.78841961281939,1.98060341247148e-28
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,LGALS1;Galectin-1,0.231555497980765,1.26055928313121,1.17696770322426,1.35008777380657,3.73088667640746e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.176294293941352,LGALS1;Galectin-1,0.530586992106263,1.69992986122189,1.39777375260469,2.06740291673737,1.0739920147436e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,LGALS1;Galectin-1,0.220037450037578,1.24612339708159,1.15832596697304,1.3405755935974,3.57461984536346e-09
primary,Circulatory system disorders,I95 (hypotension),0.521047579871109,LGALS1;Galectin-1,0.295080077285077,1.34323391690502,1.19314310879037,1.51220531906957,1.05542051473876e-06
primary,Circulatory system disorders,I08 (multiple valve diseases),0.17222361979217,"FABP4;Fatty acid-binding protein, adipocyte",0.600467592528096,1.82297100875447,1.46847429599941,2.26304492207512,5.25530680890015e-08
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0956711883429,"FABP4;Fatty acid-binding protein, adipocyte",0.263243801205146,1.30114390073657,1.27292690099426,1.32998638735784,1.89566791378991e-122
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,"FABP4;Fatty acid-binding protein, adipocyte",1.47204203226045,4.35812549363315,3.7644861283529,5.04537861760309,2.02504624938537e-86
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,"FABP4;Fatty acid-binding protein, adipocyte",1.43088739766627,4.18240900563078,2.9619770736291,5.90569901641714,4.35592256245376e-16
primary,Circulatory system disorders,I20 (angina pectoris),4.59779011939547,"FABP4;Fatty acid-binding protein, adipocyte",0.328978718183059,1.38954828316074,1.3285793031932,1.45331515145105,7.91783059718866e-47
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66849855835284,"FABP4;Fatty acid-binding protein, adipocyte",0.439587778247045,1.55206729072503,1.4663498488102,1.64279546036925,5.98337951600559e-52
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71538595506705,"FABP4;Fatty acid-binding protein, adipocyte",0.376911369832588,1.45777510079418,1.38789131989346,1.53117770392759,4.16576082396067e-51
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00818545968225,"FABP4;Fatty acid-binding protein, adipocyte",0.387726822251084,1.47362716714536,1.34155540587162,1.61870096325836,5.81053834006886e-16
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354122723842328,"FABP4;Fatty acid-binding protein, adipocyte",0.625075761311548,1.86838750355804,1.60533400151848,2.17454552146147,6.82323021536538e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545697312150473,"FABP4;Fatty acid-binding protein, adipocyte",0.537835242651837,1.71229614157439,1.51371777599631,1.93692518046883,1.21293351907607e-17
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30768039940399,"FABP4;Fatty acid-binding protein, adipocyte",0.692161484995831,1.99802958014836,1.70974997949888,2.33491577775477,3.13152570936629e-18
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387019370319484,"FABP4;Fatty acid-binding protein, adipocyte",0.528427782680982,1.69626331648671,1.4694912475885,1.9580308787686,5.32104496337859e-13
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.706310350833059,"FABP4;Fatty acid-binding protein, adipocyte",0.284574347885743,1.32919613254861,1.18696575673459,1.48846952724452,8.29495046445864e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1711786674923,"FABP4;Fatty acid-binding protein, adipocyte",0.503226269212538,1.6540490792268,1.55356740345956,1.7610297116164,8.3728167117004e-56
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25974805038992,"FABP4;Fatty acid-binding protein, adipocyte",0.276669645580468,1.31873065056924,1.21172677272645,1.43518371294035,1.47475673246461e-10
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,"FABP4;Fatty acid-binding protein, adipocyte",0.830455695855629,2.29436403425973,2.09561791569279,2.51195901804664,3.73321907542161e-72
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70869051996052,"FABP4;Fatty acid-binding protein, adipocyte",0.30621508840513,1.35827442421083,1.26300369749226,1.4607315997003,1.54586963667472e-16
primary,Circulatory system disorders,I63 (cerebral infarction),0.35992801439712,"FABP4;Fatty acid-binding protein, adipocyte",0.406557130633709,1.50163892849886,1.2893064675918,1.74893985895767,1.72483120989639e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56549335294231,"FABP4;Fatty acid-binding protein, adipocyte",0.445971287294481,1.56200661645386,1.45041239299426,1.68218686053057,4.27511331717059e-32
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35218762699073,"FABP4;Fatty acid-binding protein, adipocyte",0.585223746245233,1.79539265306727,1.54346449711558,2.08844115605631,3.28950972803377e-14
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127716392205429,"FABP4;Fatty acid-binding protein, adipocyte",0.750148341786679,2.11731407947128,1.66583354816737,2.69115657807421,8.75331190936804e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.176093813495365,"FABP4;Fatty acid-binding protein, adipocyte",0.834675722760581,2.30406677071916,1.89472654087308,2.80184162168647,6.08219574669741e-17
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170288522940573,"FABP4;Fatty acid-binding protein, adipocyte",0.612677532287804,1.84536581635858,1.50146573626757,2.26803377122013,5.7943052684853e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40488031425972,"FABP4;Fatty acid-binding protein, adipocyte",0.356887975934282,1.42887579241211,1.31863738712112,1.54833015511473,2.9825362392756e-18
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149002457573001,"FABP4;Fatty acid-binding protein, adipocyte",0.652449543688223,1.92023878153203,1.53509754003686,2.40200826457651,1.11321475843788e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249627493856067,"FABP4;Fatty acid-binding protein, adipocyte",0.670294593872883,1.95481311178486,1.64262655840153,2.32633174135732,4.33957716130244e-14
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56400332836658,"FABP4;Fatty acid-binding protein, adipocyte",0.223376773874679,1.2502915621987,1.17628109460913,1.32895869675158,7.23103819116997e-13
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298902686112058,CALB2;Calretinin,1.21652722437543,3.37544519203171,2.88454960581572,3.94988188847181,5.45080382808497e-52
primary,Circulatory system disorders,I15 (secondary hypertension),0.0401211659210816,CALB2;Calretinin,1.38281923766779,3.98612363120372,2.70526539832997,5.87342802412271,2.70783899486887e-12
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.63194848442295,CALB2;Calretinin,0.218360984471522,1.24403606427499,1.17426915004078,1.31794804382203,1.21264151025732e-13
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70318361451583,CALB2;Calretinin,0.212052427373813,1.23621269476464,1.1771867957549,1.29819824025231,1.98001267058974e-17
primary,Circulatory system disorders,I42 (cardiomyopathy),0.29489056951995,CALB2;Calretinin,0.441391008381926,1.55486855013366,1.31473736987654,1.83885866758452,2.50916389326786e-07
primary,Circulatory system disorders,I50 (heart failure),0.900720174928283,CALB2;Calretinin,0.494216653127892,1.63921366309275,1.48837999941587,1.80533293535554,1.0713229313859e-23
primary,Circulatory system disorders,I08 (multiple valve diseases),0.171326754385964,RNASE6;Ribonuclease K6,0.627125024352988,1.87222024682444,1.50266254690913,2.33266521470793,2.27205490929495e-08
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.8508771929824,RNASE6;Ribonuclease K6,0.186570923574187,1.20511008976967,1.17977491698662,1.23098932478927,2.22147928962922e-66
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.196454678362573,RNASE6;Ribonuclease K6,1.39070474331202,4.0176804889661,3.31690763379385,4.86650769136917,6.80477142375385e-46
primary,Circulatory system disorders,I20 (angina pectoris),4.4156615497076,RNASE6;Ribonuclease K6,0.30440760842629,1.35582158777746,1.29501237906121,1.41948618222166,1.19165640306691e-38
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.57218567251461,RNASE6;Ribonuclease K6,0.424802895491739,1.52928896020635,1.44068027356229,1.62334750237552,3.17723690637056e-44
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.121070906432748,RNASE6;Ribonuclease K6,0.6578931468714,1.93072030221223,1.48640797469957,2.5078450525186,8.20679268966173e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.5453216374269,RNASE6;Ribonuclease K6,0.413983475440428,1.51283212779322,1.43731075079262,1.59232166434521,1.5336369879618e-56
primary,Circulatory system disorders,I26 (pulmonary embolism),0.998263888888888,RNASE6;Ribonuclease K6,0.419130694690305,1.52063908125745,1.38505546097035,1.66949503511398,1.41534724080722e-18
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.390625,RNASE6;Ribonuclease K6,0.586122548879817,1.79700708213183,1.55185141229591,2.08089152585454,4.79406302874271e-15
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.550529970760233,RNASE6;Ribonuclease K6,0.388698358481186,1.47505954501873,1.30107646419585,1.67230806276683,1.27840381057296e-09
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.342653508771929,RNASE6;Ribonuclease K6,0.388112582555091,1.47419574366942,1.25794508935297,1.72762158622588,1.62464753334193e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301535087719298,RNASE6;Ribonuclease K6,0.4831800978333,1.62122185726509,1.37026783462599,1.91813618042889,1.78991825310345e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.376918859649122,RNASE6;Ribonuclease K6,0.491007603048668,1.63396177564924,1.40558645626161,1.8994428072277,1.63569444887853e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13815789473684,RNASE6;Ribonuclease K6,0.363826737364518,1.43882489796626,1.34859517378972,1.53509157324806,3.39470240679588e-28
primary,Circulatory system disorders,I50 (heart failure),0.897752192982456,RNASE6;Ribonuclease K6,0.815511279390262,2.26033103764201,2.05071795213694,2.49136961735958,1.2950564559597e-60
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.64245248538011,RNASE6;Ribonuclease K6,0.320712459190482,1.37810926126486,1.28052081205551,1.48313492299697,1.14333647024652e-17
primary,Circulatory system disorders,I63 (cerebral infarction),0.360928362573099,RNASE6;Ribonuclease K6,0.394873224845202,1.48419601981329,1.27159999355921,1.73233551147155,5.55292542500358e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55564692982456,RNASE6;Ribonuclease K6,0.410562549364602,1.50766568297028,1.39829641759526,1.6255893836268,1.19257295303618e-26
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.121070906432748,RNASE6;Ribonuclease K6,0.664601729936543,1.94371624316964,1.49853286714052,2.52115446835058,5.50660213596681e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349506578947368,RNASE6;Ribonuclease K6,0.466447122017988,1.59431969544509,1.36327094139761,1.86452686263397,5.23853481456108e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.169042397660818,RNASE6;Ribonuclease K6,0.718780466717683,2.05192928808599,1.64716004840719,2.55616556956718,1.44100127200454e-10
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.139345760233918,RNASE6;Ribonuclease K6,0.649485646360818,1.91455581696147,1.50023286897001,2.44330333781953,1.7895646388093e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40716374269005,RNASE6;Ribonuclease K6,0.47799741585775,1.61284131556685,1.49065712895205,1.74504053190831,1.30218141678896e-32
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.141630116959064,RNASE6;Ribonuclease K6,0.828375327353035,2.28959587307524,1.80588776684717,2.90286548158827,7.85057964603652e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.233004385964912,RNASE6;Ribonuclease K6,0.636110677799114,1.88911917940886,1.56440598362113,2.28123090257541,3.83243086804837e-11
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.53335160818713,RNASE6;Ribonuclease K6,0.26056592686514,1.29766426196919,1.22259535974708,1.3773424897837,1.03279060882924e-17
primary,Circulatory system disorders,I85 (oesophageal varices),0.0525402046783625,RNASE6;Ribonuclease K6,0.938125100343945,2.55518620672353,1.74884805083139,3.73330121386267,1.23909341538181e-06
primary,Circulatory system disorders,I95 (hypotension),0.502558479532163,RNASE6;Ribonuclease K6,0.396978023311463,1.48732324325246,1.30447997013512,1.69579486121958,3.00086135792193e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0182748538011695,RNASE6;Ribonuclease K6,1.60206493747787,4.96327069373245,2.75756998437342,8.93324779384007,9.15686459626368e-08
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.375227188336688,F9;Coagulation factor IX,-0.350241895099305,0.7045176497384,0.61175461396267,0.81134675156403,1.16064548269692e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1653735660263,F9;Coagulation factor IX,-0.394187150090074,0.674227862627018,0.635172991088482,0.715684100426858,2.42428476445951e-38
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.288748689753377,EFNA4;Ephrin-A4,1.79591098816188,6.02496089055755,5.10137277003345,7.11576184865041,2.57824821673904e-99
primary,Circulatory system disorders,I15 (secondary hypertension),0.0395546150347091,EFNA4;Ephrin-A4,1.74352688419349,5.71747276920579,3.8986109563155,8.38490817188486,4.47713761987297e-19
primary,Circulatory system disorders,I20 (angina pectoris),4.61206811304709,EFNA4;Ephrin-A4,0.210556806938782,1.2343651717373,1.18389753732533,1.28698415965988,4.79404182646258e-23
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6442260150703,EFNA4;Ephrin-A4,0.323526047988531,1.38199215391497,1.30853558530759,1.45957231498109,3.67301282088979e-31
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6983565057453,EFNA4;Ephrin-A4,0.281206932352167,1.32472770459402,1.26452487539399,1.38779673335581,2.14840442452587e-32
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01457587564029,EFNA4;Ephrin-A4,0.314031938705028,1.36893345781108,1.25447657931227,1.49383323915219,1.79937284196469e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361924727567589,EFNA4;Ephrin-A4,0.490024716049656,1.6323565648627,1.41170637673645,1.88749445264268,3.7565884677143e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555742341237663,EFNA4;Ephrin-A4,0.33241149240443,1.39432648523881,1.23987044604078,1.56802378316748,2.86798580337462e-08
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0593319225520637,EFNA4;Ephrin-A4,0.935026986525646,2.54728219910785,1.80277446951361,3.59925587566277,1.15055540120717e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30457053576726,EFNA4;Ephrin-A4,0.532051285479713,1.7024208805995,1.4553196873489,1.99147780374,2.94231611681029e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16759290390206,EFNA4;Ephrin-A4,0.211973806376838,1.23611550631069,1.16427846193363,1.31238496193089,3.94538289620175e-12
primary,Circulatory system disorders,I50 (heart failure),0.90580068429484,EFNA4;Ephrin-A4,0.722831877387636,2.06025935917307,1.88000108187704,2.2578011619133,5.25747149301453e-54
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7127148310029,EFNA4;Ephrin-A4,0.273288746060986,1.31427968312298,1.22865723134678,1.40586897744983,1.8496235769302e-15
primary,Circulatory system disorders,I63 (cerebral infarction),0.363902458319324,EFNA4;Ephrin-A4,0.408882792671812,1.50513529725996,1.30313276758691,1.73845084661086,2.68330206611852e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56438502462274,EFNA4;Ephrin-A4,0.473426613245776,1.60548615855985,1.49626661955163,1.72267814548965,1.29957246276452e-39
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357969266064118,EFNA4;Ephrin-A4,0.587437993979845,1.79937250174146,1.55637773880186,2.08030564772521,2.0848673325353e-15
primary,Circulatory system disorders,I70 (atherosclerosis),0.166129383145778,EFNA4;Ephrin-A4,0.7513932510027,2.11995158466866,1.72084848271308,2.61161558759295,1.65593242969611e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170084844649249,EFNA4;Ephrin-A4,0.572597979120583,1.77286694493937,1.44084173381458,2.18140350233853,6.23544508107488e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40418883373217,EFNA4;Ephrin-A4,0.40792298871218,1.50369135550322,1.39574865363337,1.61998199799737,7.13359495143553e-27
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.15228526788363,EFNA4;Ephrin-A4,0.632012410194374,1.88139290645554,1.50932645046162,2.34517805434249,1.89156749584944e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243260882463461,EFNA4;Ephrin-A4,0.597907607053643,1.81831019780128,1.52623979011356,2.16627295189448,2.19244671558957e-11
primary,Circulatory system disorders,I85 (oesophageal varices),0.0514209995451219,EFNA4;Ephrin-A4,0.980066493651116,2.66463341724363,1.843039840291,3.85247843973379,1.88213529031572e-07
primary,Circulatory system disorders,I95 (hypotension),0.520143187706425,EFNA4;Ephrin-A4,0.360002749800288,1.43333335593539,1.26929381092327,1.6185728564631,6.42372524970421e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197773075173545,EFNA4;Ephrin-A4,1.50060644902682,4.48440781061869,2.59049541524357,7.76296043359224,8.33938755102821e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,"DDAH1;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",0.764354412647766,2.14760745880275,1.83769269724459,2.50978730231704,7.05417654336204e-22
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,"DDAH1;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",0.260405952042332,1.29745668496281,1.18395567679742,1.42183857246095,2.47161385833911e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,"DDAH1;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",0.207746119298907,1.230900627962,1.14770213812311,1.32013028954968,5.95245694503522e-09
primary,Circulatory system disorders,I08 (multiple valve diseases),0.162454454733226,INHBB;Inhibin beta B chain,0.666231931551177,1.94688747670035,1.54032160413954,2.46076587950609,2.48145695768796e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204228457378913,INHBB;Inhibin beta B chain,1.53734717301929,4.65223231906488,3.76191262421258,5.7532610968289,1.1367840406389e-45
primary,Circulatory system disorders,I15 (secondary hypertension),0.0208870013228434,INHBB;Inhibin beta B chain,1.53501381538739,4.64138965210713,2.48111466481931,8.68258859944952,1.55777342382876e-06
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.55981805101069,INHBB;Inhibin beta B chain,0.238222372586271,1.26899135034023,1.1931379566477,1.34966710116473,3.58337781029487e-14
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53454477941005,INHBB;Inhibin beta B chain,0.188030682917103,1.2068705450904,1.14501877608332,1.27206343077539,2.4689249182412e-12
primary,Circulatory system disorders,I26 (pulmonary embolism),0.990972173872682,INHBB;Inhibin beta B chain,0.254587212158227,1.28992904393372,1.17179488420806,1.41997286454129,2.04729457728482e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.401494580983545,INHBB;Inhibin beta B chain,0.643992478177746,1.90406767280612,1.63989084983108,2.21080183659708,2.89862081270679e-17
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.55002436816821,INHBB;Inhibin beta B chain,0.396203381823592,1.48617154709577,1.30680898644328,1.69015203469668,1.56289131808227e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.36668291211214,INHBB;Inhibin beta B chain,0.403848668222307,1.49757729877418,1.2787522293135,1.75384856768365,5.41981593274617e-07
primary,Circulatory system disorders,I46 (cardiac arrest),0.0835480052913736,INHBB;Inhibin beta B chain,0.8142619875503,2.25750898767012,1.62860361860846,3.1292739198049,1.02180519594876e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15832347002715,INHBB;Inhibin beta B chain,0.315007324575734,1.37026934756185,1.28234130104943,1.46422647647001,1.28452740562134e-20
primary,Circulatory system disorders,I50 (heart failure),0.907424168581308,INHBB;Inhibin beta B chain,0.663489113733603,1.94155483561508,1.75434699225813,2.1487397854219,1.17926506379822e-37
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65935621620367,INHBB;Inhibin beta B chain,0.210336908191282,1.23409376622403,1.14516516981928,1.32992817452993,3.54209128292669e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54099654204089,INHBB;Inhibin beta B chain,0.302464195383765,1.35318922513288,1.25201233114348,1.46254236756866,2.37681612033503e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41799531202859,INHBB;Inhibin beta B chain,0.296075553049181,1.34457173948932,1.24061980865796,1.45723383587515,5.51974749717322e-13
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.225115458701756,INHBB;Inhibin beta B chain,0.538195030407653,1.71291231559974,1.40181769803967,2.09304576838796,1.41705778096196e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55749727308593,INHBB;Inhibin beta B chain,0.204131186302322,1.22645903752916,1.15470597734476,1.30267080992849,3.21022008740162e-11
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174523570712136,SORCS2;VPS10 domain-containing receptor SorCS2,0.54846838611447,1.73060037540866,1.40432368718584,2.13268328854176,2.66681983314578e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302908726178535,SORCS2;VPS10 domain-containing receptor SorCS2,1.6924389943933,5.43271492071394,4.62257127380655,6.38484290701779,9.26745424342406e-94
primary,Circulatory system disorders,I15 (secondary hypertension),0.0401203610832497,SORCS2;VPS10 domain-containing receptor SorCS2,1.77515586509252,5.90120085585849,3.93447576386016,8.85103216572329,9.26679423354464e-18
primary,Circulatory system disorders,I20 (angina pectoris),4.62587763289869,SORCS2;VPS10 domain-containing receptor SorCS2,0.280607706483232,1.32393413127271,1.26918496617903,1.3810450254747,9.10035591045216e-39
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66198595787362,SORCS2;VPS10 domain-containing receptor SorCS2,0.395118276467429,1.48455976902249,1.40461690469177,1.56905252986667,1.78518341909431e-44
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.110330992978936,SORCS2;VPS10 domain-containing receptor SorCS2,0.798429783043308,2.2220490885793,1.71452432543214,2.87980874859366,1.58758897940335e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72316950852557,SORCS2;VPS10 domain-containing receptor SorCS2,0.371970129491162,1.45058965079502,1.38382912927171,1.52057092200468,5.23345553722822e-54
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00100300902708,SORCS2;VPS10 domain-containing receptor SorCS2,0.337439318998284,1.40135457021281,1.28307981266355,1.53053193735446,6.35494579210955e-14
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359077231695085,SORCS2;VPS10 domain-containing receptor SorCS2,0.509504733564893,1.66446663631731,1.43853290848041,1.92588516194601,7.62717792812844e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541624874623871,SORCS2;VPS10 domain-containing receptor SorCS2,0.404981227773009,1.49927435507408,1.33049944413385,1.68945849747883,3.00517280097396e-11
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304914744232698,SORCS2;VPS10 domain-containing receptor SorCS2,0.392243469603801,1.48029807511756,1.26287518624121,1.73515357263359,1.30097684904779e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.391173520561685,SORCS2;VPS10 domain-containing receptor SorCS2,0.421588791565233,1.52438155723082,1.32486866815254,1.75393923026785,3.84924609729077e-09
primary,Circulatory system disorders,I46 (cardiac arrest),0.0802407221664995,SORCS2;VPS10 domain-containing receptor SorCS2,0.821429549532537,2.27374795062989,1.68300589577133,3.07184291866325,8.72544895251652e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17452357071213,SORCS2;VPS10 domain-containing receptor SorCS2,0.26271730808069,1.30045903772255,1.22410297213477,1.38157797774555,1.74308787402824e-17
primary,Circulatory system disorders,I50 (heart failure),0.910732196589769,SORCS2;VPS10 domain-containing receptor SorCS2,0.676770680690378,1.96751373197995,1.79395905257,2.15785877608742,8.71641523899978e-47
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71313941825476,SORCS2;VPS10 domain-containing receptor SorCS2,0.271152126993446,1.31147456589256,1.22554904298433,1.4034244870322,4.4085321720935e-15
primary,Circulatory system disorders,I63 (cerebral infarction),0.365095285857572,SORCS2;VPS10 domain-containing receptor SorCS2,0.371399213720195,1.44976172264729,1.2537661282521,1.67639642281882,5.39643187992946e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56469408224674,SORCS2;VPS10 domain-containing receptor SorCS2,0.348847468723469,1.41743297099183,1.32043450160264,1.52155690025989,5.14196620073892e-22
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353059177532597,SORCS2;VPS10 domain-containing receptor SorCS2,0.474508028664039,1.60722329515939,1.38695787042939,1.8624694921002,2.79592069331509e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.170511534603811,SORCS2;VPS10 domain-containing receptor SorCS2,0.711718864681542,2.03749042081541,1.65268681992912,2.51188982985451,2.65971100737704e-11
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170511534603811,SORCS2;VPS10 domain-containing receptor SorCS2,0.591935626161198,1.80748364420607,1.4638678112723,2.23175692430385,3.74936420806947e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40822467402206,SORCS2;VPS10 domain-containing receptor SorCS2,0.335586457584762,1.39876045840999,1.29825888905228,1.50704211348752,1.13138312100893e-18
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.156469408224674,SORCS2;VPS10 domain-containing receptor SorCS2,0.610026643085078,1.8404804342052,1.47775448895071,2.29224018875921,5.12294662058636e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240722166499498,SORCS2;VPS10 domain-containing receptor SorCS2,0.625378835315889,1.86895384905837,1.56552044335558,2.231199537978,4.55815321590743e-12
primary,Circulatory system disorders,I95 (hypotension),0.529588766298896,SORCS2;VPS10 domain-containing receptor SorCS2,0.398620975003298,1.48976885194962,1.32027348237119,1.68102386503535,9.89594045386582e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,DLK1;Protein delta homolog 1,1.07974804188505,2.94393770861726,2.51996271351963,3.4392450276035,3.5361301077091e-42
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,DLK1;Protein delta homolog 1,1.21278033621141,3.36282144105384,2.19641039210897,5.14865895965512,2.39962179041782e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,IL6;Interleukin-6,0.502165166499228,1.65229489411077,1.42862849859508,1.91097855025943,1.31707386210325e-11
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,IL6;Interleukin-6,0.253806697248735,1.2889226278952,1.22281335799704,1.35860598008309,3.45897853843433e-21
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,IL6;Interleukin-6,0.219209772222429,1.24509243510192,1.19021790869601,1.30249692986595,1.54151892337618e-21
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999744159959065,IL6;Interleukin-6,0.264344215812476,1.3025764865658,1.19749783471558,1.41687563364746,7.28121254175802e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352272056363529,IL6;Interleukin-6,0.417629041679813,1.51835732263684,1.32397309824346,1.74128081776248,2.29974196063078e-09
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541200086592013,IL6;Interleukin-6,0.2973972664697,1.34635005295376,1.20225223028671,1.50771894567941,2.61657123225216e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,IL6;Interleukin-6,0.263745663023206,1.30179705906405,1.2288887470511,1.37903092290041,2.99196902354219e-19
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,IL6;Interleukin-6,0.457429024644547,1.58000660063074,1.4509765870016,1.72051077901643,6.71204741513216e-26
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71019227363076,IL6;Interleukin-6,0.192379098212193,1.21212994617054,1.13550734361059,1.29392294525508,7.72952882115245e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,IL6;Interleukin-6,0.295091230635861,1.34324889854763,1.25605170709452,1.43649946356359,6.86202056887834e-18
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346368055418888,IL6;Interleukin-6,0.460083677120005,1.5842065412893,1.38161767832582,1.81650134102582,4.38815757422238e-11
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.129888020782083,IL6;Interleukin-6,0.560899236885796,1.75224747761603,1.40835617966858,2.18010988067967,4.85727197537166e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.173184027709444,IL6;Interleukin-6,0.640194538072663,1.89684985292859,1.57491680307005,2.28459011773919,1.51664018590309e-11
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.165312026449924,IL6;Interleukin-6,0.719226247396762,2.05284420242787,1.69993653667627,2.47901567412704,7.84319336008262e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,IL6;Interleukin-6,0.320035740656281,1.37717698466561,1.28359003390817,1.4775873892679,4.96237204888739e-19
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246000039360006,IL6;Interleukin-6,0.53892220987459,1.71415836325954,1.4615341874165,2.0104482807389,3.47132439350686e-11
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54265640682502,IL6;Interleukin-6,0.200765855780363,1.22233853481189,1.15820529989313,1.29002301562939,2.85154029381109e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216480034636805,IL6;Interleukin-6,1.26936695363024,3.55859909091888,2.22550106980596,5.69023653221285,1.15568145169142e-07
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.9787426776979,SCARB2;Lysosome membrane protein 2,0.2017981640629,1.2236010165285,1.19937220982009,1.24831927519327,4.79678892121563e-87
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.287859572840549,SCARB2;Lysosome membrane protein 2,1.75364477775711,5.77561519355699,4.94181742846149,6.75009373513651,1.06543305390731e-107
primary,Circulatory system disorders,I15 (secondary hypertension),0.0382470761116814,SCARB2;Lysosome membrane protein 2,1.76721786653187,5.85454256368832,4.03117185506958,8.5026562653074,1.66304528638071e-20
primary,Circulatory system disorders,I20 (angina pectoris),4.60374016144292,SCARB2;Lysosome membrane protein 2,0.207395595177163,1.23046924321023,1.179723730423,1.28339756117601,4.8307750894515e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.62495722366487,SCARB2;Lysosome membrane protein 2,0.308711712305415,1.36166976127767,1.28885154014768,1.43860210506908,3.45309044262232e-28
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68379733075668,SCARB2;Lysosome membrane protein 2,0.304551442719698,1.35601661544302,1.29394325716506,1.42106777184818,3.59233168837523e-37
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01254101495662,SCARB2;Lysosome membrane protein 2,0.377317571219751,1.45836737134471,1.33608165004005,1.59184537093159,3.05645568142286e-17
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360327717052156,SCARB2;Lysosome membrane protein 2,0.54984782136638,1.73298927386003,1.50016578433054,2.001946621289,8.03274880603776e-14
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547537089598808,SCARB2;Lysosome membrane protein 2,0.499744650263258,1.6483003239043,1.46593904689285,1.8533471521491,6.60537433249696e-17
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.356301709040401,SCARB2;Lysosome membrane protein 2,0.403585614347182,1.49718340707207,1.29443883808743,1.73168332752122,5.44271468976649e-08
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0583771161704611,SCARB2;Lysosome membrane protein 2,0.996998410971828,2.71013489653467,1.9455830187228,3.77513120063958,3.72895412420865e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307989612899329,SCARB2;Lysosome membrane protein 2,0.583111744574746,1.79160478218763,1.53682173386085,2.08862721344636,9.2957002591891e-14
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.378444753105058,SCARB2;Lysosome membrane protein 2,0.423610929423496,1.52746718561969,1.32692624247995,1.75831627143374,3.65664946217902e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1559272902953,SCARB2;Lysosome membrane protein 2,0.372324994098036,1.45110450506756,1.36624240681072,1.54123768529687,9.3770794206736e-34
primary,Circulatory system disorders,I50 (heart failure),0.901825794633331,SCARB2;Lysosome membrane protein 2,0.780634690066059,2.18285726375032,1.99621572247246,2.38694935635808,1.09282415109233e-65
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70702739698452,SCARB2;Lysosome membrane protein 2,0.306389630321961,1.35851152072346,1.26947391287903,1.45379399546135,8.08733084979565e-19
primary,Circulatory system disorders,I63 (cerebral infarction),0.362340721058034,SCARB2;Lysosome membrane protein 2,0.412183001559747,1.51011076366894,1.30721325688251,1.74450075880295,2.15507363178279e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56007810455542,SCARB2;Lysosome membrane protein 2,0.407192949768554,1.50259400285833,1.40037419106578,1.61227531314862,9.55643037254314e-30
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352275701028645,SCARB2;Lysosome membrane protein 2,0.580262692413846,1.78650767112691,1.54597159959687,2.06446849335884,3.70416030886643e-15
primary,Circulatory system disorders,I70 (atherosclerosis),0.163053324476115,SCARB2;Lysosome membrane protein 2,0.717149234207856,2.0485848428489,1.66831578982442,2.51553086289014,7.62909615275833e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171105340499627,SCARB2;Lysosome membrane protein 2,0.601117001197332,1.82415524641681,1.49015726510476,2.23301422000989,5.68648547466893e-09
primary,Circulatory system disorders,I72 (other aneurysm),0.106689212311532,SCARB2;Lysosome membrane protein 2,0.703873608881208,2.02156832539351,1.56377896452765,2.61337349263344,7.75196475511792e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40105078809106,SCARB2;Lysosome membrane protein 2,0.311689150595425,1.36573009065371,1.2672210520454,1.47189685454354,3.34317761336446e-16
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243573484711234,SCARB2;Lysosome membrane protein 2,0.527957863754755,1.69546639750874,1.42506158634267,2.01718040303001,2.58795053629964e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5585280914709,SCARB2;Lysosome membrane protein 2,0.239003423532949,1.26998288440464,1.20082042341767,1.34312882694846,6.00115117941995e-17
primary,Circulatory system disorders,I85 (oesophageal varices),0.0523381041528272,SCARB2;Lysosome membrane protein 2,1.02243161412392,2.77994630876991,1.95961561040634,3.94368234188591,1.00018399055512e-08
primary,Circulatory system disorders,I95 (hypotension),0.519355033516516,SCARB2;Lysosome membrane protein 2,0.405615622241743,1.50022578819209,1.32845576044364,1.69420577077025,6.24106009883761e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0181170360529017,SCARB2;Lysosome membrane protein 2,1.51870773994006,4.56632050715539,2.65668213577493,7.84861790324259,3.89252956940706e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,YAP1;Transcriptional coactivator YAP1,1.44673707761901,4.24922697271244,3.56384983002561,5.06641152876443,1.82686345910164e-58
primary,Circulatory system disorders,I15 (secondary hypertension),0.0204754862927994,YAP1;Transcriptional coactivator YAP1,1.46302393943452,4.3190001963243,2.6506075245362,7.03754234573577,4.27610155931271e-09
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.55488567853486,YAP1;Transcriptional coactivator YAP1,0.205294466815258,1.22788658358471,1.1575723855516,1.30247186350155,8.89339319687931e-12
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54453418268683,YAP1;Transcriptional coactivator YAP1,0.201169342903092,1.22283183218318,1.16264191471698,1.28613777885728,5.64778068888096e-15
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00102377431464,YAP1;Transcriptional coactivator YAP1,0.390788639931109,1.47814605934122,1.34749792107076,1.62146133109413,1.26488745401513e-16
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.398134455693322,YAP1;Transcriptional coactivator YAP1,0.549418656879142,1.73224569597694,1.50094408726149,1.99919182646267,5.76493518194861e-14
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555113183938118,YAP1;Transcriptional coactivator YAP1,0.406006433799808,1.50081220835225,1.32693094051536,1.69747890863435,1.03095224355156e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307132294391991,YAP1;Transcriptional coactivator YAP1,0.495183484018892,1.64079927188344,1.39515462836913,1.92969452695026,2.17169282158627e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14992606074394,YAP1;Transcriptional coactivator YAP1,0.441385214997837,1.55485954220904,1.45954059884039,1.65640352719155,1.44114514427239e-42
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.23990444773063,YAP1;Transcriptional coactivator YAP1,0.20563029037954,1.22829900608046,1.12926683486109,1.33601590143558,1.63137147944626e-06
primary,Circulatory system disorders,I50 (heart failure),0.910021613013309,YAP1;Transcriptional coactivator YAP1,0.668828329243258,1.95194893879245,1.77807785952294,2.14282217128288,7.61180579197308e-45
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65623933568422,YAP1;Transcriptional coactivator YAP1,0.277490527429898,1.31981361705753,1.22734368392045,1.41925037509167,7.02555290169468e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55841201228529,YAP1;Transcriptional coactivator YAP1,0.352400787534404,1.42247852114624,1.32054170135527,1.53228416872087,1.56249703939524e-20
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345808212945057,YAP1;Transcriptional coactivator YAP1,0.542037574682452,1.71950691892472,1.4756592950878,2.00364952402788,3.73990281206204e-12
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127403025821863,YAP1;Transcriptional coactivator YAP1,0.63303062236182,1.88330953920845,1.46883901968842,2.41473352282398,5.98642893054618e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.166078944374928,YAP1;Transcriptional coactivator YAP1,0.717508045001319,2.04932002909033,1.66176006402742,2.5272677280813,1.9674953956695e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40825844613809,YAP1;Transcriptional coactivator YAP1,0.323412344897252,1.38183502606807,1.27728058389138,1.49494798821035,7.85213059692763e-16
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.141053350017062,YAP1;Transcriptional coactivator YAP1,0.603200622218549,1.82796005714948,1.44806495630631,2.30751939405894,3.88229603856962e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.234330565350927,YAP1;Transcriptional coactivator YAP1,0.473908283014681,1.60625965897776,1.33319403757805,1.9352547486234,6.1988153405871e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.52758503014446,YAP1;Transcriptional coactivator YAP1,0.310128060757891,1.36359972656588,1.28498967257184,1.44701880021265,1.35519755516566e-24
primary,Circulatory system disorders,I85 (oesophageal varices),0.0523262427482652,YAP1;Transcriptional coactivator YAP1,0.987559524351476,2.68467458802984,1.87593187625518,3.84207856097688,6.67139271066343e-08
primary,Circulatory system disorders,I95 (hypotension),0.505061995222386,YAP1;Transcriptional coactivator YAP1,0.362473888790145,1.43687970182886,1.26192019390664,1.63609655150706,4.45860682514913e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0182004322602661,YAP1;Transcriptional coactivator YAP1,1.45976381653001,4.30494265197159,2.54575138680164,7.27978833001738,5.14634099293778e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,CCL20;C-C motif chemokine 20,0.523765965591648,1.68837405061494,1.44790380113691,1.96878199542786,2.36972488379111e-11
primary,Circulatory system disorders,I20 (angina pectoris),4.58852481252543,CCL20;C-C motif chemokine 20,0.200781814851271,1.22235804235491,1.17283752107567,1.27396946027046,1.80660698651487e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65274090724126,CCL20;C-C motif chemokine 20,0.213631258311612,1.23816600718212,1.17302522321974,1.30692420844401,9.37945023766993e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,CCL20;C-C motif chemokine 20,0.218731523713006,1.24449711386783,1.18855540215018,1.30307183293561,1.15105584120079e-20
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00180208111302,CCL20;C-C motif chemokine 20,0.294458239408042,1.34239890282637,1.23193672781021,1.46276571972375,1.80620885470501e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354603057724727,CCL20;C-C motif chemokine 20,0.439158800399114,1.55140163102565,1.34492645401703,1.78957519465862,1.67302559201494e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16055961400585,CCL20;C-C motif chemokine 20,0.377599185078262,1.45877812564162,1.37491631964541,1.54775500839157,7.46215502943554e-36
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,CCL20;C-C motif chemokine 20,0.479184098334773,1.6147563821575,1.47510053408207,1.76763421439673,2.9773694299649e-25
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70131958842792,CCL20;C-C motif chemokine 20,0.211212870234983,1.23517525912583,1.15583092238275,1.31996634733686,4.51476227172741e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,CCL20;C-C motif chemokine 20,0.269808235800918,1.30971327053398,1.22204569184727,1.40366997932774,2.2973761236172e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,CCL20;C-C motif chemokine 20,0.220843463398829,1.24712819407491,1.15963351610245,1.3412243703373,2.67118478177266e-09
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153080008525975,CCL20;C-C motif chemokine 20,0.763955785188947,2.14675153410779,1.73221854935914,2.6604853936584,2.97665069739533e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246090646617706,CCL20;C-C motif chemokine 20,0.47043338470988,1.6006877565156,1.34845870482726,1.90009622444253,7.56583828359193e-08
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55585482589571,CCL20;C-C motif chemokine 20,0.217990876087375,1.24357572129107,1.17777559291747,1.31305198026207,3.86471904274578e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202811385411567,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,1.40324455207439,4.06837864219729,3.28935809814587,5.03189506354352,2.69530156686869e-38
primary,Circulatory system disorders,I50 (heart failure),0.930134974473739,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,0.297222506951794,1.34611478602574,1.21960150856707,1.4857517020343,3.58507467014061e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5572184535049,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,0.247242840587009,1.28049002997562,1.1854983680635,1.38309318767374,3.23992732151639e-10
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0652048125461,ACE2;Angiotensin-converting enzyme 2,0.222307211869593,1.24895501273717,1.22220083654671,1.27629484221982,4.77098349578882e-90
primary,Circulatory system disorders,I20 (angina pectoris),4.6030447534867,ACE2;Angiotensin-converting enzyme 2,0.299835642901352,1.34963696692984,1.28821033581513,1.41399264690032,1.72730745966804e-36
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64171272371755,ACE2;Angiotensin-converting enzyme 2,0.383884795335387,1.4679763142211,1.37913543155678,1.56254013188655,1.8863099409264e-33
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71116742153674,ACE2;Angiotensin-converting enzyme 2,0.34987701052183,1.41889302894822,1.34632531438096,1.4953721853797,5.40669658667689e-39
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542708354117201,ACE2;Angiotensin-converting enzyme 2,0.318473124803341,1.37502666657518,1.20875217577183,1.56417367570452,1.27853600507098e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301282946587122,ACE2;Angiotensin-converting enzyme 2,0.459095106222934,1.58264121465329,1.32975120348332,1.8836254539631,2.36290506580502e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387078752568886,ACE2;Angiotensin-converting enzyme 2,0.41978217483418,1.52163007019465,1.30312305361938,1.77677623313451,1.11148597522286e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16285241126119,ACE2;Angiotensin-converting enzyme 2,0.230947725004847,1.25979338203495,1.17778111538193,1.34751639730987,1.76441715477819e-11
primary,Circulatory system disorders,I50 (heart failure),0.911829844968974,ACE2;Angiotensin-converting enzyme 2,0.464985090635719,1.59199045314456,1.43670357672282,1.76406159486605,6.70596073509014e-19
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.72589237614477,ACE2;Angiotensin-converting enzyme 2,0.266926919898843,1.30594500425022,1.21397778753976,1.40487937393191,7.82041703324691e-13
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40864741914244,ACE2;Angiotensin-converting enzyme 2,0.233147806205523,1.26256808093374,1.16566785169584,1.36752348164496,1.04975880607282e-08
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65462666278279,ROBO2;Roundabout homolog 2,0.221341079753534,1.24774893989452,1.17918497145737,1.32029957529371,1.64323914637731e-14
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549567919215457,ROBO2;Roundabout homolog 2,0.334593123466418,1.39737171178215,1.23706235488432,1.57845535690202,7.37492401639438e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16720069909699,ROBO2;Roundabout homolog 2,0.387693513301116,1.47357808298925,1.38493460457976,1.56789523453721,1.72458664721107e-34
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25060685503446,ROBO2;Roundabout homolog 2,0.219352250726648,1.24526984664805,1.14806178752236,1.35070865333601,1.22592460069439e-07
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,ROBO2;Roundabout homolog 2,0.380421644351282,1.46290128347497,1.3310003975222,1.60787342301076,3.00136670730425e-15
primary,Circulatory system disorders,I50 (heart failure),0.916126994155741,S100A11;Protein S100-A11,0.238233198954783,1.26900508898259,1.15879413755364,1.38969801768537,2.75662517213615e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.286858180617467,WFDC2;WAP four-disulfide core domain protein 2,1.71982439330538,5.58354786979346,4.7349165112097,6.58427804174948,6.47219796103172e-93
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392108304441142,WFDC2;WAP four-disulfide core domain protein 2,1.87550820227182,6.52413385762842,4.27851716460507,9.94838187033017,2.96562918266656e-18
primary,Circulatory system disorders,I20 (angina pectoris),4.60004952947003,WFDC2;WAP four-disulfide core domain protein 2,0.281500747981714,1.32511698748442,1.2702441126108,1.38236029837661,6.70879803596527e-39
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.68903747729899,WFDC2;WAP four-disulfide core domain protein 2,0.441752700445753,1.55543103546565,1.47294174870184,1.64253997703712,7.52989117528731e-57
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.111441307578008,WFDC2;WAP four-disulfide core domain protein 2,0.766626978298887,2.15249358766714,1.6774818202194,2.76201422221207,1.67737167623811e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72915634802707,WFDC2;WAP four-disulfide core domain protein 2,0.39130191129647,1.47890494412755,1.41136186861217,1.54968040614248,1.72671094217237e-60
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00297176820208,WFDC2;WAP four-disulfide core domain protein 2,0.43070630863978,1.53834368535631,1.41059296490092,1.67766418319111,2.09451645518481e-22
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.365279841505695,WFDC2;WAP four-disulfide core domain protein 2,0.586190705951826,1.79712956504692,1.56143189180406,2.06840573099489,3.02742660219586e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.55101535413571,WFDC2;WAP four-disulfide core domain protein 2,0.346461844252192,1.4140555384545,1.25729938383267,1.59035556013599,7.49762753007036e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30749545979858,WFDC2;WAP four-disulfide core domain protein 2,0.434766877081957,1.54460293463301,1.32240737369597,1.80413257906214,4.09938651931928e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.385917120686808,WFDC2;WAP four-disulfide core domain protein 2,0.365410380101867,1.44110528775101,1.2529174858682,1.65755883672166,3.08781017721603e-07
primary,Circulatory system disorders,I46 (cardiac arrest),0.0804853888063397,WFDC2;WAP four-disulfide core domain protein 2,0.7832245702141,2.18851792950257,1.63436108292082,2.93057071525135,1.4590211760641e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.19580650487039,WFDC2;WAP four-disulfide core domain protein 2,0.314618313482647,1.36973640125286,1.29004135027636,1.45435478367823,8.07029696787938e-25
primary,Circulatory system disorders,I50 (heart failure),0.920422651477629,WFDC2;WAP four-disulfide core domain protein 2,0.748990895689246,2.11486482026915,1.93498823526894,2.31146273992225,2.87089670458303e-61
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71702162786858,WFDC2;WAP four-disulfide core domain protein 2,0.224982905047708,1.25230130797776,1.17025756747096,1.34009692357894,7.6288359140889e-11
primary,Circulatory system disorders,I63 (cerebral infarction),0.371471025260029,WFDC2;WAP four-disulfide core domain protein 2,0.407833473866026,1.50355675882716,1.30465505198004,1.73278210480529,1.76772083647518e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56224203401023,WFDC2;WAP four-disulfide core domain protein 2,0.491114385506782,1.63413626342005,1.52415568801945,1.75205285681444,2.05995668900997e-43
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.13001485884101,WFDC2;WAP four-disulfide core domain protein 2,0.751877606088789,2.12097864271127,1.68232791434501,2.67400330487221,2.0148919088279e-10
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352897473997028,WFDC2;WAP four-disulfide core domain protein 2,0.676457532625765,1.96689770532149,1.70690310179914,2.26649455327675,8.63780310141357e-21
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.13207858675912099,WFDC2;WAP four-disulfide core domain protein 2,0.587547517402805,1.7995695859695,1.4251000737922,2.27243739180289,7.97829277693423e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.173353145121347,WFDC2;WAP four-disulfide core domain protein 2,0.97799209585434,2.65911163671844,2.18350038677647,3.23832078956955,2.3132365646203e-22
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.165098233448902,WFDC2;WAP four-disulfide core domain protein 2,0.683683033239854,1.98116099354345,1.61115305879575,2.43614277421402,9.06561031759112e-11
primary,Circulatory system disorders,I72 (other aneurysm),0.103186395905563,WFDC2;WAP four-disulfide core domain protein 2,0.790234441958668,2.20391305538723,1.70188306895453,2.85403436012211,2.07748230128282e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41778107974244,WFDC2;WAP four-disulfide core domain protein 2,0.508375208839683,1.66258764148263,1.54585063545046,1.78814020075445,1.22075526324189e-42
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.140333498431566,WFDC2;WAP four-disulfide core domain protein 2,0.93365820402604,2.54379790897383,2.04386858716363,3.16600971429364,6.11516759838541e-17
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24351989433713,WFDC2;WAP four-disulfide core domain protein 2,0.872892176578396,2.39382421369974,2.02429480194408,2.83081019651478,1.91154801746917e-24
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54870397886742,WFDC2;WAP four-disulfide core domain protein 2,0.250367675503742,1.28449760818094,1.21477971389872,1.35821670920668,1.45178605401799e-18
primary,Circulatory system disorders,I85 (oesophageal varices),0.0536569258708931,WFDC2;WAP four-disulfide core domain protein 2,0.880605267789036,2.41235938805667,1.69442404958582,3.43448726342597,1.03031513480396e-06
primary,Circulatory system disorders,I95 (hypotension),0.511804523691596,WFDC2;WAP four-disulfide core domain protein 2,0.363282901876356,1.43804262665822,1.27343376045759,1.62392945773872,4.71071733813101e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0206372791811127,WFDC2;WAP four-disulfide core domain protein 2,1.690021605289,5.41959779584299,3.1199346684392,9.41431260270591,1.9925394389212e-09
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0915050479506,GFRA1;GDNF family receptor alpha-1,0.217224838999569,1.24262346094701,1.21840504163267,1.26732327340569,9.1001444262244e-104
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307351138949948,GFRA1;GDNF family receptor alpha-1,1.63337730039093,5.12114117721574,4.39894542128745,5.96190323936754,1.85737078206002e-98
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389052074620187,GFRA1;GDNF family receptor alpha-1,1.58500262819615,4.8793042022644,3.34705955115778,7.11299250412192,1.69468228965547e-16
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69404944851868,GFRA1;GDNF family receptor alpha-1,0.186712681057491,1.20528093525213,1.15115735831536,1.26194922213604,1.65240350984073e-15
primary,Circulatory system disorders,I50 (heart failure),0.910381854611239,GFRA1;GDNF family receptor alpha-1,0.393146651337862,1.48163565724891,1.35486462643408,1.62026831168304,7.00531630166913e-18
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56982512109245,GFRA1;GDNF family receptor alpha-1,0.351940435826489,1.42182383143489,1.32701872535096,1.5234020206471,1.58424554657527e-23
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.344311086038866,GFRA1;GDNF family receptor alpha-1,0.626404745915625,1.87087221248897,1.62059727361631,2.15979805251237,1.24091779393882e-17
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126441924251561,GFRA1;GDNF family receptor alpha-1,0.671950245279016,1.95805228159021,1.54798416697449,2.4767493229172,2.09065996247057e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.175073433579084,GFRA1;GDNF family receptor alpha-1,0.627317266662686,1.87258020136709,1.53618456366332,2.28264018106651,5.32523959509966e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40836851012508,GFRA1;GDNF family receptor alpha-1,0.416593662118779,1.51678606006557,1.40992345985569,1.63174811790473,5.33655269907372e-29
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243157546637617,GFRA1;GDNF family receptor alpha-1,0.549010721847449,1.73153919638682,1.45990383905484,2.05371607938574,2.8650764722746e-10
primary,Circulatory system disorders,I95 (hypotension),0.517439259244849,GFRA1;GDNF family receptor alpha-1,0.360130704380647,1.4335167692375,1.2717210957468,1.61589701905383,3.77327983553449e-09
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00643651258045,CXCL10;C-X-C motif chemokine 10,0.284908906613279,1.32964090111181,1.22144373725547,1.44742231834758,4.73014252280847e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358884337819387,CXCL10;C-X-C motif chemokine 10,0.387487993295821,1.47327526433254,1.2808180987204,1.69465125973985,5.7902887271233e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546128340159937,CXCL10;C-X-C motif chemokine 10,0.282534516211526,1.32648755963178,1.18244710949266,1.48807437705424,1.45409013708653e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1650087770626,CXCL10;C-X-C motif chemokine 10,0.248485395432116,1.28208209797754,1.20878484713381,1.35982388416931,1.30767944756889e-16
primary,Circulatory system disorders,I50 (heart failure),0.905012677979325,CXCL10;C-X-C motif chemokine 10,0.349005472695664,1.41765694872579,1.29616510470653,1.55053643781403,2.26278436275746e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40433001755412,CXCL10;C-X-C motif chemokine 10,0.255939828465824,1.29167500353471,1.20172406373785,1.38835891291625,3.66583643760551e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,MFAP5;Microfibrillar-associated protein 5,1.56915748691461,4.80260023524352,4.09169778064812,5.63701677300021,3.83668139456186e-82
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,MFAP5;Microfibrillar-associated protein 5,2.10080909049506,8.17277975664541,5.26089323060349,12.696385579939,9.00154123161808e-21
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00818545968225,MFAP5;Microfibrillar-associated protein 5,0.234106077274023,1.2637785432806,1.15772470441553,1.37954748686367,1.65040346571803e-07
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,MFAP5;Microfibrillar-associated protein 5,0.276932626434843,1.31907749708741,1.20196390681027,1.44760207312702,5.28818266723576e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56549335294231,MFAP5;Microfibrillar-associated protein 5,0.193590107140659,1.21359873553683,1.13061958323678,1.30266794661396,8.44582761261569e-08
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170288522940573,MFAP5;Microfibrillar-associated protein 5,0.531385715023593,1.70128817654648,1.37213305885052,2.10940290446872,1.27418477455052e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,CALCB;Calcitonin gene-related peptide 2,1.29958641023386,3.66777939785384,2.98775518358117,4.50257965754631,2.00523327134809e-35
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.398134455693322,CALCB;Calcitonin gene-related peptide 2,0.394387548787008,1.48347535635946,1.28054324907114,1.71856681492182,1.48252357326066e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14992606074394,CALCB;Calcitonin gene-related peptide 2,0.185153984716651,1.20340373164393,1.12900518059577,1.28270495673929,1.29679607924548e-08
primary,Circulatory system disorders,I50 (heart failure),0.910021613013309,CALCB;Calcitonin gene-related peptide 2,0.426015215839576,1.53114407259857,1.38995397832155,1.68667611130892,6.09718551785512e-18
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40825844613809,CALCB;Calcitonin gene-related peptide 2,0.241523917589858,1.27318790613951,1.17640983694,1.37792748193637,2.12650385550577e-09
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0976463723011,HAVCR1;Hepatitis A virus cellular receptor 1,0.308165733949004,1.36092652197418,1.33420142535162,1.38818694315562,1.05143074372767e-203
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307333203656876,HAVCR1;Hepatitis A virus cellular receptor 1,1.07259046445578,2.92294147723472,2.53677033054678,3.36789924435044,8.57482581290449e-50
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389029371717564,HAVCR1;Hepatitis A virus cellular receptor 1,1.16248287951959,3.197863336735,2.18444121832114,4.68143973601332,2.25630662192445e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.59832717370161,HAVCR1;Hepatitis A virus cellular receptor 1,0.198537511079515,1.21961777573557,1.17067682307624,1.27060473870277,2.07462647155627e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66290604940673,HAVCR1;Hepatitis A virus cellular receptor 1,0.219004184828291,1.24483648610357,1.18060466160966,1.31256289893173,5.39205381250039e-16
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69577903131686,HAVCR1;Hepatitis A virus cellular receptor 1,0.225267843858311,1.25265818806505,1.19709835789816,1.31079666576562,2.20087149584677e-22
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00369577903131,HAVCR1;Hepatitis A virus cellular receptor 1,0.225804799785993,1.25333099092107,1.15014675277461,1.36577229732962,2.58782958910128e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359852168838747,HAVCR1;Hepatitis A virus cellular receptor 1,0.450717277839993,1.56943750460199,1.36328989306992,1.80675738401077,3.53382455132554e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.548531414121766,HAVCR1;Hepatitis A virus cellular receptor 1,0.335400129883576,1.39849985486885,1.2469298490806,1.56849388561054,1.00167256304039e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16883874732542,HAVCR1;Hepatitis A virus cellular receptor 1,0.28882870077389,1.33486304793559,1.25926330077986,1.41500141840104,2.74117607323843e-22
primary,Circulatory system disorders,I50 (heart failure),0.912273876677689,HAVCR1;Hepatitis A virus cellular receptor 1,0.578757722840088,1.78382105358449,1.63564382539268,1.9454220422636,4.26446378653733e-39
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71367438241587,HAVCR1;Hepatitis A virus cellular receptor 1,0.252742511197797,1.28755170400227,1.20558825483361,1.37508754239479,5.02620334839705e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56778836802178,HAVCR1;Hepatitis A virus cellular receptor 1,0.29506985739144,1.34322018926741,1.25445118672217,1.43827077207362,2.70688472658489e-17
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.342345847111456,HAVCR1;Hepatitis A virus cellular receptor 1,0.468768856217239,1.59802558238407,1.38455423624496,1.84441006000587,1.47961069823648e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.175063217272904,HAVCR1;Hepatitis A virus cellular receptor 1,0.780708782117989,2.18301900211575,1.80470798786434,2.64063327454872,8.95736872649575e-16
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41023147247617,HAVCR1;Hepatitis A virus cellular receptor 1,0.333377402346989,1.39567392970432,1.29827814368085,1.50037626955163,1.67581634679896e-19
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149776308111262,HAVCR1;Hepatitis A virus cellular receptor 1,0.569031592675781,1.76655547755405,1.42915340204412,2.18361321521723,1.42482332350134e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.021396615444466,HAVCR1;Hepatitis A virus cellular receptor 1,1.34249665749242,3.828590261479,2.29304809247656,6.39240992737342,2.85177812592732e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,IGSF8;Immunoglobulin superfamily member 8,1.28806454857418,3.62576227360498,3.10415029592784,4.23502434206967,2.11125642632522e-59
primary,Circulatory system disorders,I15 (secondary hypertension),0.039176509764745,IGSF8;Immunoglobulin superfamily member 8,1.35003039204149,3.85754276751527,2.54481483237008,5.84743377550596,2.00413509049587e-10
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01075395193042,IGSF8;Immunoglobulin superfamily member 8,0.267111948546475,1.30618666384452,1.19734782995874,1.42491894010788,1.77265010677005e-09
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,IGSF8;Immunoglobulin superfamily member 8,0.469437564795084,1.59909455317376,1.46097414030285,1.75027286209182,2.30634679787412e-24
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,IGSF8;Immunoglobulin superfamily member 8,0.220602810958318,1.24682810574131,1.16302476741855,1.33667000808334,5.15963722163481e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,IGSF8;Immunoglobulin superfamily member 8,0.203007828812614,1.22508205914783,1.1375832059423,1.31931101286143,7.89649507833554e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311227685562167,CTSZ;Cathepsin Z,1.13166030936613,3.10080051675402,2.65458303069642,3.62202414975112,3.11329862976902e-46
primary,Circulatory system disorders,I15 (secondary hypertension),0.0391481365487002,CTSZ;Cathepsin Z,1.40801832839043,4.08784660267724,2.65974906080242,6.28273174085773,1.35370050533382e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5600532414657,CTSZ;Cathepsin Z,0.202828277654444,1.22486211399155,1.14156369874754,1.31423870602918,1.65689402421215e-08
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.350375822110867,CTSZ;Cathepsin Z,0.361337044899052,1.43524712208758,1.23844450608566,1.66332386420082,1.57065323537342e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40150328844347,CTSZ;Cathepsin Z,0.266856359441874,1.30585285942487,1.21228309910767,1.40664477771183,1.99835770999005e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,SNCG;Gamma-synuclein,1.56507245797998,4.78302149141523,4.03998567763865,5.66271675515237,9.09412477089412e-74
primary,Circulatory system disorders,I15 (secondary hypertension),0.039488232506713,SNCG;Gamma-synuclein,1.64794093751748,5.19626936091423,3.43447256356361,7.86182296450187,6.17890152390556e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69807297425367,SNCG;Gamma-synuclein,0.194916261369,1.21520922227234,1.15842973167478,1.27477171339583,1.41962866478482e-15
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01287316379718,SNCG;Gamma-synuclein,0.254011907445273,1.2891871551019,1.17846181092871,1.41031597754531,2.95777577043255e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1659295529932,SNCG;Gamma-synuclein,0.223083129885494,1.24992447549577,1.17497963519948,1.32964959361031,1.53487886470558e-12
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,SNCG;Gamma-synuclein,0.499529542454544,1.64794579976535,1.49691909551963,1.81420984413426,2.29565379936494e-24
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56373400726583,SNCG;Gamma-synuclein,0.221295914329446,1.24769258605712,1.16056138506379,1.34136531624852,2.08004202893908e-09
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357368504185752,SNCG;Gamma-synuclein,0.375730794854343,1.45605510347895,1.25127724928746,1.69434588982927,1.18138274981352e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,SNCG;Gamma-synuclein,0.244611175378127,1.27712463914669,1.1831900267083,1.37851681225983,3.48515539701008e-10
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0961075285525,RTN4R;Reticulon-4 receptor,0.196418374738145,1.21703597594349,1.19310757241217,1.24144427626602,9.89776542059736e-84
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,RTN4R;Reticulon-4 receptor,0.998561208753832,2.71437360059587,2.34487718213334,3.14209379482664,8.46182001298031e-41
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,RTN4R;Reticulon-4 receptor,1.10839978104189,3.02950663957759,2.03325892776028,4.51389164160934,5.09538940256618e-08
primary,Circulatory system disorders,I20 (angina pectoris),4.60142957035195,RTN4R;Reticulon-4 receptor,0.281022193523284,1.32448299855333,1.2696525993838,1.38168126801632,8.52175793871047e-39
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,RTN4R;Reticulon-4 receptor,0.360653574607477,1.43426650846688,1.35686964770916,1.5160781441186,3.4321497755581e-37
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,RTN4R;Reticulon-4 receptor,0.359634692914893,1.43280590479664,1.36664726314747,1.50216724986672,2.82618651369585e-50
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,RTN4R;Reticulon-4 receptor,0.338702856277752,1.40312635307516,1.2789855913446,1.53931645205183,7.71070817970681e-13
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,RTN4R;Reticulon-4 receptor,0.295447758953366,1.34372789019939,1.25219245091492,1.44195458260463,2.25489780534137e-16
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,RTN4R;Reticulon-4 receptor,0.37491134023498,1.45486242113962,1.25474322462117,1.68689866014881,6.84858962656518e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.17222361979217,COL6A3;Collagen alpha-3(VI) chain,0.70779669272687,2.02951468435842,1.66245543257163,2.4776182105856,3.56006621392828e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,COL6A3;Collagen alpha-3(VI) chain,1.70490116959243,5.50084198989019,4.7275014679562,6.40068814422193,8.40876228141959e-108
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,COL6A3;Collagen alpha-3(VI) chain,1.75827487935389,5.8024188827046,4.03279476595344,8.34856888195921,2.73833453507524e-21
primary,Circulatory system disorders,I20 (angina pectoris),4.59779011939547,COL6A3;Collagen alpha-3(VI) chain,0.258071163106926,1.29443093107345,1.24173776816342,1.34936012923073,4.4473045818166e-34
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66849855835284,COL6A3;Collagen alpha-3(VI) chain,0.384639597511796,1.46908476421559,1.39161945523936,1.55086222481647,5.02581099028069e-44
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71538595506705,COL6A3;Collagen alpha-3(VI) chain,0.37104333540239,1.44924587567903,1.38373317984659,1.51786026291972,1.08408674489989e-55
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00818545968225,COL6A3;Collagen alpha-3(VI) chain,0.437118759291974,1.54823993401713,1.42117648280705,1.68666377630371,1.45377293930803e-23
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354122723842328,COL6A3;Collagen alpha-3(VI) chain,0.612099476637562,1.84429940047522,1.60114447872263,2.12438060636907,2.14713209591447e-17
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545697312150473,COL6A3;Collagen alpha-3(VI) chain,0.493933926332252,1.63875027897505,1.46013574015722,1.8392142613752,4.91591075544374e-17
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.373473692358302,COL6A3;Collagen alpha-3(VI) chain,0.391566317768347,1.47929602786633,1.28567070888741,1.70208181841119,4.48361674854956e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30768039940399,COL6A3;Collagen alpha-3(VI) chain,0.514851519161393,1.67339001699733,1.43601475670033,1.95000374189795,4.21732011265748e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387019370319484,COL6A3;Collagen alpha-3(VI) chain,0.511884690411981,1.6684327127585,1.45522872461597,1.91287298684768,2.16661936852317e-13
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1711786674923,COL6A3;Collagen alpha-3(VI) chain,0.427392961330134,1.53325505330315,1.44493895732788,1.62696911627816,2.86448699925781e-45
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,COL6A3;Collagen alpha-3(VI) chain,0.78741305954858,2.19770373740861,2.01121129815789,2.40148895436476,7.71476368052912e-68
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70869051996052,COL6A3;Collagen alpha-3(VI) chain,0.322360557352617,1.38038239326338,1.29161394574178,1.47525160897609,1.98988382250359e-21
primary,Circulatory system disorders,I63 (cerebral infarction),0.35992801439712,COL6A3;Collagen alpha-3(VI) chain,0.599946893790951,1.82202203713797,1.58319749429468,2.09687314171461,5.8015336797576e-17
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56549335294231,COL6A3;Collagen alpha-3(VI) chain,0.511604877259586,1.6679659286508,1.55667406667263,1.78721441996309,8.91320265925638e-48
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.133521682760222,COL6A3;Collagen alpha-3(VI) chain,0.616024538829269,1.8515526156706,1.47248222476362,2.32820948935187,1.35903007488414e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35218762699073,COL6A3;Collagen alpha-3(VI) chain,0.576737418950714,1.78022083096843,1.54411838488465,2.05242437240372,1.94898496902723e-15
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127716392205429,COL6A3;Collagen alpha-3(VI) chain,0.604742342197478,1.83078043324671,1.44807867164638,2.31462354938787,4.31817653852039e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176093813495365,COL6A3;Collagen alpha-3(VI) chain,0.884693513380663,2.42224189297943,1.99836531167378,2.93602763910586,1.98691410087373e-19
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170288522940573,COL6A3;Collagen alpha-3(VI) chain,0.701081566043725,2.01593189227304,1.64861543829126,2.46508755158556,8.41263891218285e-12
primary,Circulatory system disorders,I72 (other aneurysm),0.106430326837858,COL6A3;Collagen alpha-3(VI) chain,0.826827289872364,2.28605423484976,1.78210339838104,2.93251444861289,7.64733161825741e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40488031425972,COL6A3;Collagen alpha-3(VI) chain,0.412977181131076,1.51131053914342,1.40505521449916,1.62560127328529,1.21204739606212e-28
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149002457573001,COL6A3;Collagen alpha-3(VI) chain,0.765976260045505,2.15109337642028,1.74016897233921,2.65905368250481,1.42359424360468e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249627493856067,COL6A3;Collagen alpha-3(VI) chain,0.693042116902946,1.99978988372398,1.69293247058128,2.36226763237145,3.51293670524628e-16
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56400332836658,COL6A3;Collagen alpha-3(VI) chain,0.265140253906589,1.30361379988529,1.23432540367316,1.37679167437871,1.81799413803964e-21
primary,Circulatory system disorders,I95 (hypotension),0.512800665673317,COL6A3;Collagen alpha-3(VI) chain,0.508648789738382,1.66304255592887,1.47653239807262,1.87311199296448,5.25060274941333e-17
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0174158716643768,COL6A3;Collagen alpha-3(VI) chain,1.33674956480557,3.80665010483179,2.20639213422366,6.56754744356199,1.55636432530425e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,IL16;Pro-interleukin-16,0.746503421109865,2.10961068526271,1.81490133786269,2.45217585690672,2.39372281082855e-22
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.291140995424927,GFRA3;GDNF family receptor alpha-3,1.10612331612081,3.02261791792594,2.57563913806487,3.54716580546728,8.18701962162185e-42
primary,Circulatory system disorders,I15 (secondary hypertension),0.0376304687964191,GFRA3;GDNF family receptor alpha-3,1.47291380621964,4.36192645049625,2.85263837309461,6.66975615941762,1.06159862855675e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,LEPR;Leptin receptor,0.261868914153787,1.29935620405761,1.22510502146378,1.37810760338387,2.72072078317457e-18
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.2516894869836,LEPR;Leptin receptor,0.204654633700622,1.22710119237396,1.13539121597149,1.32621894122828,2.41896887234004e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298902686112058,PLIN1;Perilipin-1,0.519642355573397,1.68142618944544,1.44066890878089,1.96241760568389,4.37994353673171e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306754459662765,LGALS3;Galectin-3,0.894884958599134,2.44705426071874,2.09740989694131,2.85498536248649,5.51884621864733e-30
primary,Circulatory system disorders,I20 (angina pectoris),4.61108614524921,LGALS3;Galectin-3,0.207300258339224,1.23035193975516,1.17898301469647,1.28395903655067,1.62145327149425e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66700533401066,LGALS3;Galectin-3,0.240046205144124,1.27130788992863,1.20267746304733,1.34385469143126,2.29539936429396e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72013051718411,LGALS3;Galectin-3,0.264946496759616,1.30336123986311,1.24306693479938,1.36658008834549,5.7225710673397e-28
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01014048181942,LGALS3;Galectin-3,0.280181866675177,1.32337046744014,1.21057535157819,1.44667524562565,7.08318756122242e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.18245051874719,LGALS3;Galectin-3,0.210986619044973,1.23489583086526,1.16185149948243,1.31253237936839,1.1831293614217e-11
primary,Circulatory system disorders,I50 (heart failure),0.91830952892675,LGALS3;Galectin-3,0.472008160850959,1.60321046723486,1.46162108314046,1.75851582321793,1.44313644527991e-23
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56894159942166,LGALS3;Galectin-3,0.25729027974578,1.2934205260528,1.20403975930656,1.38943639052101,1.89181414632918e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872589437486,LGALS3;Galectin-3,0.216088969813215,1.24121280455971,1.15082837380959,1.33869590050433,2.12274578131146e-08
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.123096562414516,RBP7;Retinoid-binding protein 7,0.65591996006716,1.9269143865154,1.48965521569184,2.49252243998998,5.88475592570402e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202881371386887,RBP7;Retinoid-binding protein 7,0.794908148317598,2.21423760601397,1.82488447995425,2.68666221327577,7.87326235546271e-16
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.394364912920579,RBP7;Retinoid-binding protein 7,0.510361176188563,1.66589276710275,1.44199651008147,1.92455300139975,4.19505025203902e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547095832953405,RBP7;Retinoid-binding protein 7,0.354407854028808,1.42533639713925,1.25920774648327,1.61338258177313,2.07998733928822e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15191027628339,RBP7;Retinoid-binding protein 7,0.374034105218916,1.45358672450493,1.36505859110653,1.5478561721986,1.88745284302961e-31
primary,Circulatory system disorders,I50 (heart failure),0.907267256314397,RBP7;Retinoid-binding protein 7,0.51622391042674,1.67568813944105,1.52504712908182,1.84120915814188,6.53843572398325e-27
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.64584663080149,RBP7;Retinoid-binding protein 7,0.248505576223702,1.28210797167023,1.19238380087094,1.37858368238456,1.90184667849706e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5592231239172,RBP7;Retinoid-binding protein 7,0.229747879883693,1.2582827315464,1.16807227771168,1.35546015663483,1.42219871269609e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40649220388438,RBP7;Retinoid-binding protein 7,0.257148144236761,1.2932366981325,1.19536123839186,1.39912614168972,1.51255559221247e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202881371386887,EFCAB14;EF-hand calcium-binding domain-containing protein 14,1.60614011483635,4.98353817082079,4.07370213571593,6.09658042552566,5.6738420263028e-55
primary,Circulatory system disorders,I26 (pulmonary embolism),0.993890763198687,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.27445548435373,1.31581399845482,1.19789268639506,1.44534355889596,1.00909773704647e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.394364912920579,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.362730280110234,1.43724815254418,1.23950274864427,1.66654108210009,1.56314998225095e-06
primary,Circulatory system disorders,I50 (heart failure),0.907267256314397,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.48503736950004,1.62423570458636,1.47176675481246,1.79249980706985,5.20657239789016e-22
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5592231239172,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.26274306113632,1.30049252894775,1.20590375302114,1.40250066691621,9.13514854714334e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40649220388438,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.316044235117813,1.37169093119398,1.26741548524487,1.48454554376561,4.70484089723569e-15
primary,Circulatory system disorders,I95 (hypotension),0.501504513540621,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.370863107361485,1.44898470446997,1.27056578034841,1.65245806731248,3.1702537235018e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311643971574893,PI3;Elafin,1.41998017211797,4.1370384107286,3.5207692347412,4.86117824564037,1.04098567965253e-66
primary,Circulatory system disorders,I15 (secondary hypertension),0.0396998689904323,PI3;Elafin,1.71510610936288,5.55726515894277,3.56461137399412,8.66383254907107,3.72709681334411e-14
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.18746278137282,PI3;Elafin,0.212089387498563,1.23625838618444,1.16020424303712,1.31729805901292,5.87244563544185e-11
primary,Circulatory system disorders,I50 (heart failure),0.923021954027551,PI3;Elafin,0.458803144929503,1.58217921212394,1.43593175799607,1.74332174585414,1.83505532189678e-20
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.72098932073524,PI3;Elafin,0.192972592334083,1.21284955168826,1.13035257637346,1.30136743683096,7.91065427735398e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57806979236968,PI3;Elafin,0.38534870826346,1.47012687746019,1.36573467018012,1.58249847720847,1.13563212812442e-24
primary,Circulatory system disorders,I70 (atherosclerosis),0.174679423557902,PI3;Elafin,0.588292582377705,1.80091088185215,1.44513296002448,2.24427792742235,1.61551574192123e-07
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.164754456310294,PI3;Elafin,0.620217588057282,1.85933256639585,1.47744711258192,2.3399264603243,1.2400594347864e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.4053753622613,PI3;Elafin,0.201323725855434,1.22302063114495,1.13190108958413,1.32147541686328,3.46224358712636e-07
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.148874508714121,PI3;Elafin,0.607007097184354,1.83493140105107,1.44904947600958,2.3235736959343,4.67890457727969e-07
primary,Circulatory system disorders,I95 (hypotension),0.514113303426098,PI3;Elafin,0.379323747098731,1.4612960495273,1.28752836161307,1.65851581062555,4.29146716936636e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307650368985727,CKAP4;Cytoskeleton-associated protein 4,1.76194217967039,5.82373716168263,4.95112446709564,6.85014379132715,1.97975771142237e-100
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389430846817376,CKAP4;Cytoskeleton-associated protein 4,1.85883476005684,6.41625593608926,4.21183258703822,9.77444838716877,4.92499121160539e-18
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65202406682633,CKAP4;Cytoskeleton-associated protein 4,0.225780876226404,1.25330100714108,1.18779877796067,1.32241541551144,1.66746775778062e-16
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70932881593551,CKAP4;Cytoskeleton-associated protein 4,0.214413668099668,1.23913513946523,1.18370637922855,1.29715943142777,4.19242437737426e-20
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00083727632065,CKAP4;Cytoskeleton-associated protein 4,0.35025528608505,1.41942986303711,1.30133370867412,1.54824325432584,2.72552260100828e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352434916369725,CKAP4;Cytoskeleton-associated protein 4,0.382477850939296,1.46591240541513,1.26706362189437,1.69596786082232,2.71194694193735e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16134119983643,CKAP4;Cytoskeleton-associated protein 4,0.193612183830989,1.21362552807604,1.14382523548353,1.28768528329873,1.49065534028975e-10
primary,Circulatory system disorders,I50 (heart failure),0.9054267188504,CKAP4;Cytoskeleton-associated protein 4,0.549273307856352,1.73199393405492,1.58251708261154,1.89558964043069,8.48662122586263e-33
primary,Circulatory system disorders,I63 (cerebral infarction),0.366064996008333,CKAP4;Cytoskeleton-associated protein 4,0.421381352913417,1.52406537437114,1.32281928963311,1.7559278758335,5.47962201622269e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5577233872695,CKAP4;Cytoskeleton-associated protein 4,0.420016512517453,1.52198668724287,1.41961800604306,1.63173717597541,2.97028095547955e-32
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356329224837899,CKAP4;Cytoskeleton-associated protein 4,0.489877470430358,1.63211622520431,1.41297462962763,1.88524501199089,2.7510650243087e-11
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126565025215647,CKAP4;Cytoskeleton-associated protein 4,0.614845896967062,1.8493715838279,1.45574224727812,2.34943738252083,4.77335137069805e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.171349572599645,CKAP4;Cytoskeleton-associated protein 4,0.762788304428214,2.14424670544779,1.74978116399822,2.62763940338563,1.92452063066464e-13
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.165508109897385,CKAP4;Cytoskeleton-associated protein 4,0.532906985514669,1.70387826565983,1.38425272551566,2.09730570919155,4.96507031354824e-07
primary,Circulatory system disorders,I72 (other aneurysm),0.107093482874778,CKAP4;Cytoskeleton-associated protein 4,0.728010766767765,2.07095689124646,1.59682222641046,2.68587346447591,4.06323295047858e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41168681971298,CKAP4;Cytoskeleton-associated protein 4,0.379182886556044,1.46109022506935,1.35767182436313,1.57238635102014,4.34409562534573e-24
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153825184492863,CKAP4;Cytoskeleton-associated protein 4,0.563247917619575,1.75636778425586,1.41376141944819,2.18200026619477,3.62918479034935e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245341433494947,CKAP4;Cytoskeleton-associated protein 4,0.649513762658848,1.91460964794018,1.61236288891536,2.27351431193728,1.26915857638738e-13
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55466635512198,CKAP4;Cytoskeleton-associated protein 4,0.277914523024438,1.32037333086649,1.24963985090427,1.39511054453162,4.46245467802628e-23
primary,Circulatory system disorders,I95 (hypotension),0.51794302626711,CKAP4;Cytoskeleton-associated protein 4,0.42882040144049,1.53544524587811,1.3615128768428,1.73159735995791,2.7314124535139e-12
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214186965749557,CKAP4;Cytoskeleton-associated protein 4,1.79183350649159,6.0004442400262,3.46652203356506,10.3865865351603,1.54699237655689e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204225192312056,CYTL1;Cytokine-like protein 1,1.46983088930429,4.34849970106937,3.49404165778974,5.41191305147809,1.33866869874981e-39
primary,Circulatory system disorders,I50 (heart failure),0.909936690190383,CYTL1;Cytokine-like protein 1,0.434128713715391,1.54361754007903,1.39059496005845,1.71347889103488,3.62748464156202e-16
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55891896798202,CYTL1;Cytokine-like protein 1,0.228855741606682,1.25716066994975,1.16110091333374,1.36116760560522,1.67073575632577e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298173686172195,EFNA1;Ephrin-A1,1.88299632761929,6.57317075783274,5.54186049618791,7.79640228066875,1.05162058821852e-103
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372717107715244,EFNA1;Ephrin-A1,1.85982378293663,6.42260489912995,4.18403324553703,9.85887330946231,1.8019128571502e-17
primary,Circulatory system disorders,I20 (angina pectoris),4.61188379072915,EFNA1;Ephrin-A1,0.194065691420448,1.21417604128531,1.16496825229261,1.26546234743312,3.79442412255407e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66198481668203,EFNA1;Ephrin-A1,0.279847930398077,1.3229286198116,1.25397051584675,1.39567885448632,1.23515821587239e-24
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70755438727269,EFNA1;Ephrin-A1,0.266392710051899,1.3052475418816,1.24677524767528,1.36646211798365,4.58504674988528e-30
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0024128528552,EFNA1;Ephrin-A1,0.31104433409055,1.36484972921635,1.2505168830191,1.48963585269202,3.20858519502829e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.355062086823469,EFNA1;Ephrin-A1,0.466888495965898,1.59502354194163,1.37824738526881,1.84589510311448,3.74143582894397e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.551228985620966,EFNA1;Ephrin-A1,0.330213630225621,1.39126531304156,1.2376777862309,1.56391202363515,3.15192448151521e-08
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.058850069639249,EFNA1;Ephrin-A1,0.915417913935943,2.49781890714142,1.75528873205806,3.5544575538623,3.66109890568047e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.302097024148145,EFNA1;Ephrin-A1,0.393080786649653,1.48153807299203,1.26728161023417,1.7320183959107,8.13572014842764e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386448790631068,EFNA1;Ephrin-A1,0.411466584203917,1.50902928155116,1.31453353533778,1.73230222840506,5.07913731683496e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15979755576044,EFNA1;Ephrin-A1,0.258466965814613,1.29494337174689,1.22029801589397,1.37415476727032,1.43311705223954e-17
primary,Circulatory system disorders,I50 (heart failure),0.906291072444435,EFNA1;Ephrin-A1,0.698226183699082,2.01018384627978,1.83713193662333,2.19953668829649,3.42658994364433e-52
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70469035055024,EFNA1;Ephrin-A1,0.238542507813041,1.26939766420816,1.18702086912232,1.35749123862377,3.21100056064271e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5595268454401,EFNA1;Ephrin-A1,0.403735541634505,1.49740789254675,1.39645533186958,1.60565851659529,8.6009715602301e-30
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349177079859544,EFNA1;Ephrin-A1,0.513656328638038,1.67139119183352,1.44393020517275,1.93468389686083,5.90279908954336e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.174588539929772,EFNA1;Ephrin-A1,0.701535235079795,2.01684666563788,1.64966131359651,2.46576096509561,7.81502648338291e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170665201953822,EFNA1;Ephrin-A1,0.613034350183959,1.84602439339585,1.50770708310766,2.260257379695,2.93685579085795e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.410440002354,EFNA1;Ephrin-A1,0.399878347528082,1.49164322451768,1.38524787273607,1.60621037796998,3.27072390462093e-26
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151048512074072,EFNA1;Ephrin-A1,0.749744715379209,2.11645964804304,1.70367929403764,2.62925156012109,1.25979334662469e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.247170292484846,EFNA1;Ephrin-A1,0.614311112688894,1.84838283338803,1.55676702842008,2.19462452402458,2.34268575111254e-12
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56782470525923,EFNA1;Ephrin-A1,0.227025689275603,1.25486210402465,1.18725909024443,1.32631446080818,9.36155873413091e-16
primary,Circulatory system disorders,I95 (hypotension),0.511995605861467,EFNA1;Ephrin-A1,0.428235390302613,1.53454725600032,1.3585688704287,1.73332050524243,5.54728692236135e-12
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0196166898797496,EFNA1;Ephrin-A1,1.5070734079805,4.51350226679055,2.51234883449872,8.10862824166219,4.60990741858098e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",0.577560564044003,1.78168681428612,1.5333013958837,2.07030914647508,4.70882729874249e-14
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999744159959065,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",0.234467116231172,1.26423489894406,1.15741531293429,1.3809130239137,1.93272719614159e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",0.25314319898924,1.28806771362339,1.21413044794755,1.36650755912076,4.73969251589099e-17
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",0.33556218463683,1.39872650678227,1.27977194496443,1.52873787276974,1.3646579069763e-13
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0606844643067,"FABP1;Fatty acid-binding protein, liver",0.260621178613557,1.29773596216928,1.27211409391565,1.32387388486799,1.01347357105097e-144
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303814340036849,"FABP1;Fatty acid-binding protein, liver",1.31625405628213,3.7294249627265,3.21138762088738,4.33102826396407,1.1116402122661e-66
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392018503273354,"FABP1;Fatty acid-binding protein, liver",1.44908584187399,4.25921913516062,2.86165940966529,6.33931053431694,9.21583090921671e-13
primary,Circulatory system disorders,I20 (angina pectoris),4.59249676584734,"FABP1;Fatty acid-binding protein, liver",0.423309268559577,1.52700647804108,1.46415190066606,1.59255933958676,1.00697733205769e-86
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65004508212787,"FABP1;Fatty acid-binding protein, liver",0.536684193795278,1.71032633894555,1.61875731642034,1.80707519034393,1.84815688118127e-81
primary,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.160727586342075,"FABP1;Fatty acid-binding protein, liver",0.63109252616144,1.87966303892196,1.52078049719095,2.32323675008683,5.27887619031756e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69673448586773,"FABP1;Fatty acid-binding protein, liver",0.49150455425509,1.63477397672033,1.55982640329278,1.71332268085757,1.2364169813228e-93
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00356736837978,"FABP1;Fatty acid-binding protein, liver",0.251289771674653,1.28568258475421,1.17869977704621,1.40237551659047,1.43551238180074e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358696930495119,"FABP1;Fatty acid-binding protein, liver",0.48672375715028,1.62697710650313,1.41085769268877,1.87620234046471,2.18275594454493e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546865812066329,"FABP1;Fatty acid-binding protein, liver",0.305250249926303,1.35696454079612,1.20678876036045,1.52582856707088,3.3791229236638e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301854247520483,"FABP1;Fatty acid-binding protein, liver",0.49097678351845,1.63391141849091,1.39769078172212,1.91005518415571,7.16358505875038e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384178133207887,"FABP1;Fatty acid-binding protein, liver",0.419955590147595,1.52189396703139,1.32384988067583,1.74956487189025,3.54603838280623e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16786232310165,"FABP1;Fatty acid-binding protein, liver",0.380843396066076,1.46351839472456,1.37845003921334,1.55383657787082,1.16135006143522e-35
primary,Circulatory system disorders,I50 (heart failure),0.905562742561448,"FABP1;Fatty acid-binding protein, liver",0.640854962517745,1.89810299269664,1.73356452195588,2.07825836607404,1.23358435480357e-43
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70332039672272,"FABP1;Fatty acid-binding protein, liver",0.330021437074117,1.39099794707025,1.30099300472619,1.487229586727,4.06220459959773e-22
primary,Circulatory system disorders,I63 (cerebral infarction),0.362617115527852,"FABP1;Fatty acid-binding protein, liver",0.451409955382771,1.57052499531294,1.3614061594806,1.81176553648305,5.95087276452853e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56807401309341,"FABP1;Fatty acid-binding protein, liver",0.461629435622162,1.58665723562251,1.48015759647588,1.70081968930008,9.17849026714949e-39
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356736837978752,"FABP1;Fatty acid-binding protein, liver",0.378046839527634,1.45943130034759,1.26345914373236,1.68580023422225,2.76738481653103e-07
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.125445921047473,"FABP1;Fatty acid-binding protein, liver",0.651962635704704,1.91930402952661,1.51204230009994,2.43625985695876,8.42793787667294e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.176408326473009,"FABP1;Fatty acid-binding protein, liver",0.742456384283651,2.10109026598508,1.71976774248797,2.56696308271879,3.6964939676361e-13
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39950605668587,"FABP1;Fatty acid-binding protein, liver",0.267986970848981,1.30733010650258,1.21444806862559,1.40731584290983,1.02535356488472e-12
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152887216276608,"FABP1;Fatty acid-binding protein, liver",0.698352206332464,2.01043719090492,1.62109693526123,2.49328563311505,2.03220514485856e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246971657062213,"FABP1;Fatty acid-binding protein, liver",0.463263016177832,1.5892512862496,1.33733992485601,1.88861455782676,1.43126060076662e-07
primary,Circulatory system disorders,I95 (hypotension),0.521384609353561,"FABP1;Fatty acid-binding protein, liver",0.415195262928594,1.5146664700294,1.34473458112329,1.70607237118487,8.00464291987631e-12
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.116541061300598,ADM;Pro-adrenomedullin,0.628549139614758,1.87488840368184,1.48364552370881,2.36930349607591,1.41246927229565e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174811591950897,ADM;Pro-adrenomedullin,0.712093272167657,2.03825341530837,1.69166217781212,2.45585498068493,6.97852005466915e-14
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0961075285525,ADM;Pro-adrenomedullin,0.229966111891607,1.2585573590786,1.23402286587256,1.28357964013162,5.21518625805713e-116
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,ADM;Pro-adrenomedullin,1.37930396686149,3.97213592686102,3.49318871731297,4.51675105420491,2.83396473164604e-98
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,ADM;Pro-adrenomedullin,1.33399054248732,3.79616194741815,2.77476819202228,5.19353132721431,7.30523916906294e-17
primary,Circulatory system disorders,I20 (angina pectoris),4.60142957035195,ADM;Pro-adrenomedullin,0.338774378621527,1.40322671154943,1.3466721882385,1.46215628510263,1.32479168242527e-58
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,ADM;Pro-adrenomedullin,0.464509448871693,1.59123341605061,1.50895354433151,1.6779998256857,6.54320325748098e-66
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.110714008235568,ADM;Pro-adrenomedullin,0.735172901944547,2.08584260757147,1.65562509113598,2.62785301264996,4.43566463264811e-10
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,ADM;Pro-adrenomedullin,0.392703630972044,1.48097940785469,1.41488761967972,1.55015845497758,8.96936136758011e-64
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,ADM;Pro-adrenomedullin,0.350058648704855,1.41915077750769,1.30374262066577,1.54477494052638,6.01754998763287e-16
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359334939010177,ADM;Pro-adrenomedullin,0.734525020941372,2.08449166744189,1.83001443568081,2.37435586677117,2.02622443583314e-28
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547742988112811,ADM;Pro-adrenomedullin,0.632049301923898,1.88146231557408,1.68763938388951,2.09754552940507,4.45370304364413e-30
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376816098205267,ADM;Pro-adrenomedullin,0.41687280711809,1.51720952241021,1.32423531446262,1.7383048992515,1.90038611849082e-09
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0582705306502991,ADM;Pro-adrenomedullin,1.02442009724315,2.78547968476637,2.09285374552653,3.70732885220994,2.17098465601261e-12
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304949110403232,ADM;Pro-adrenomedullin,0.697693853893283,2.00911405027069,1.74305082041348,2.3157897748716,6.20369724679997e-22
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382643151270297,ADM;Pro-adrenomedullin,0.583772473867831,1.79278893910935,1.57307797511796,2.04318681656695,2.10293336876582e-18
primary,Circulatory system disorders,I46 (cardiac arrest),0.0815787429104187,ADM;Pro-adrenomedullin,0.801181934457304,2.22817292712052,1.71398789606258,2.8966100662426,2.16045207107631e-09
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.708958122911972,ADM;Pro-adrenomedullin,0.345636577020315,1.4128890461547,1.27752143230987,1.56260036525143,1.74060410565648e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,ADM;Pro-adrenomedullin,0.555891769470253,1.74349508741093,1.64609529470859,1.84665804561707,4.17116212839358e-80
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.26447051511149,ADM;Pro-adrenomedullin,0.296230007708807,1.34477943089873,1.24613919335774,1.45122770185525,2.50867598718697e-14
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,ADM;Pro-adrenomedullin,0.911421258061445,2.4878559071358,2.29035283915219,2.70239017712293,1.94245149568748e-103
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71121125009711,ADM;Pro-adrenomedullin,0.387337420918994,1.47305344647451,1.38014379239099,1.57221766900917,2.22416561965291e-31
primary,Circulatory system disorders,I63 (cerebral infarction),0.367104343096884,ADM;Pro-adrenomedullin,0.472283655620929,1.60365220417906,1.39918368502932,1.83800055667063,1.14790143153322e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,ADM;Pro-adrenomedullin,0.479124091211071,1.61465948817872,1.50960307799612,1.72702699190725,2.80694168105307e-44
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132079869474011,ADM;Pro-adrenomedullin,0.548582220147092,1.73079738784139,1.38524178272353,2.16255359542274,1.38006033263779e-06
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,ADM;Pro-adrenomedullin,0.547507939211195,1.72893902358511,1.50448170850503,1.98688367587117,1.19275530082897e-14
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126252816408981,ADM;Pro-adrenomedullin,0.662644394059967,1.9399154585525,1.55354908853143,2.42237082439949,4.98804182159578e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.174811591950897,ADM;Pro-adrenomedullin,0.933949997213656,2.54454028017851,2.13904243330392,3.02690827289959,5.36268208996785e-26
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.16704218786419,ADM;Pro-adrenomedullin,0.693575203109248,2.00085622832805,1.65290960777143,2.42204753824188,1.11292053199908e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,ADM;Pro-adrenomedullin,0.434445798083674,1.54410707467938,1.43796655171629,1.65808214052627,5.99745188953382e-33
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149561028669101,ADM;Pro-adrenomedullin,0.826835180129065,2.28607227247566,1.88354190697329,2.77462710844593,5.90087173041397e-17
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242793877709579,ADM;Pro-adrenomedullin,0.76547444442121,2.15001419495238,1.83938543047608,2.5131008226483,6.93268679536935e-22
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55613394452645,ADM;Pro-adrenomedullin,0.28174486829291,1.32544051494398,1.25550856049602,1.39926768636361,2.25273846412854e-24
primary,Circulatory system disorders,I95 (hypotension),0.518607722787662,ADM;Pro-adrenomedullin,0.460144885436631,1.58430351087253,1.41133007982818,1.77847666569156,6.15204894695716e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,NOTCH1;Neurogenic locus notch homolog protein 1,0.661658016157319,1.93800291221297,1.65978261028534,2.26285976517145,5.85230391830723e-17
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0561913029752,PLAUR;Urokinase plasminogen activator surface receptor,0.193932699792171,1.21401457677351,1.19032734059504,1.23817318342181,6.4910824000656e-83
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305816431220898,PLAUR;Urokinase plasminogen activator surface receptor,1.34868342496004,3.85235028223058,3.32713920116539,4.46046943025523,1.03874643041448e-72
primary,Circulatory system disorders,I15 (secondary hypertension),0.0394601846736642,PLAUR;Urokinase plasminogen activator surface receptor,1.28261978450603,3.60607449973759,2.45145959394563,5.30450239921277,7.33015501393924e-11
primary,Circulatory system disorders,I20 (angina pectoris),4.59316549601452,PLAUR;Urokinase plasminogen activator surface receptor,0.292196831851589,1.33936662170771,1.28589563079274,1.39506107990957,6.99308331946821e-45
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65369741930392,PLAUR;Urokinase plasminogen activator surface receptor,0.42392902940982,1.52795315019911,1.45075414069737,1.60926015215861,8.38797610807505e-58
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69544629468865,PLAUR;Urokinase plasminogen activator surface receptor,0.390051797746024,1.47705730014009,1.41248794198616,1.54457833093382,1.4107128026976e-65
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00426169994475,PLAUR;Urokinase plasminogen activator surface receptor,0.406432468255735,1.50145174228696,1.3783224311774,1.63558053139338,1.28118177103843e-20
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.353168652829295,PLAUR;Urokinase plasminogen activator surface receptor,0.592453279973284,1.80841953721817,1.57026831154906,2.08268943500884,1.97962309487053e-16
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544550548496567,PLAUR;Urokinase plasminogen activator surface receptor,0.38155329151474,1.46455770863047,1.30561955365617,1.64284402443454,7.51922290455998e-11
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.38079078210086,PLAUR;Urokinase plasminogen activator surface receptor,0.434734786454341,1.54455336815073,1.34921856209946,1.76816801523511,2.94164292668343e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.303843421987214,PLAUR;Urokinase plasminogen activator surface receptor,0.41033041893252,1.50731574850064,1.29627061854259,1.75272102381869,9.72820404619884e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384736800568226,PLAUR;Urokinase plasminogen activator surface receptor,0.424717817343759,1.52915885666845,1.33790356235671,1.74775437835641,4.66060621223394e-10
primary,Circulatory system disorders,I46 (cardiac arrest),0.0789203693473285,PLAUR;Urokinase plasminogen activator surface receptor,0.696822086452699,2.00736333327715,1.51252986872582,2.66408461419681,1.39790534857513e-06
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.714229342593323,PLAUR;Urokinase plasminogen activator surface receptor,0.290338732134717,1.33688025564052,1.20725605920694,1.48042232158729,2.41106429976598e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16439112935048,PLAUR;Urokinase plasminogen activator surface receptor,0.398939375721452,1.49024327094563,1.40686575639266,1.57856213111132,5.21527723672257e-42
primary,Circulatory system disorders,I50 (heart failure),0.909557256727961,PLAUR;Urokinase plasminogen activator surface receptor,0.754407407007149,2.12635108917416,1.95262292834831,2.31553613797657,2.05294900718987e-67
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.69876095020124,PLAUR;Urokinase plasminogen activator surface receptor,0.286757598495858,1.33210127098462,1.24673731857432,1.42331008282325,2.13119721967564e-17
primary,Circulatory system disorders,I63 (cerebral infarction),0.363033698997711,PLAUR;Urokinase plasminogen activator surface receptor,0.48031506834245,1.61658365629677,1.4089411791161,1.85482740978962,7.50397195588289e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56854234077815,PLAUR;Urokinase plasminogen activator surface receptor,0.470555972421463,1.60088399319249,1.49634188584038,1.71272994755513,1.84122717003316e-42
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.136137637124141,PLAUR;Urokinase plasminogen activator surface receptor,0.615324863577952,1.85025758323281,1.48920768985152,2.29884195981545,2.76649660881825e-08
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357114671296661,PLAUR;Urokinase plasminogen activator surface receptor,0.661114016275077,1.93694892556724,1.68717967351387,2.22369389529351,6.2456297256812e-21
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126272590955725,PLAUR;Urokinase plasminogen activator surface receptor,0.699729890935922,2.01320884806536,1.59974161013903,2.53354031691181,2.43562001779217e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.173624812564122,PLAUR;Urokinase plasminogen activator surface receptor,0.883228408356555,2.41869565265403,2.00328359384044,2.92024987283625,4.06138026638683e-20
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.169678794096756,PLAUR;Urokinase plasminogen activator surface receptor,0.71263252255207,2.03935284065223,1.68607398267881,2.46665333277286,2.09872147976351e-13
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39886354668139,PLAUR;Urokinase plasminogen activator surface receptor,0.507353323135984,1.66088953472394,1.54486503431482,1.7856278608694,6.57162336296376e-43
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.15389472022729,PLAUR;Urokinase plasminogen activator surface receptor,0.873915098665446,2.39627416220003,1.95698408536569,2.93417299781183,2.71910578148894e-17
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246626154210401,PLAUR;Urokinase plasminogen activator surface receptor,0.815114838286387,2.25943512710994,1.92197493288211,2.65614655335957,5.27773037161299e-23
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56491200378817,PLAUR;Urokinase plasminogen activator surface receptor,0.264786152342618,1.30315226991899,1.23333052644217,1.37692678660432,4.33363300478408e-21
primary,Circulatory system disorders,I85 (oesophageal varices),0.0532712493094467,PLAUR;Urokinase plasminogen activator surface receptor,0.970611347030326,2.63955765192554,1.85984728456523,3.74614875944901,5.52568600388977e-08
primary,Circulatory system disorders,I95 (hypotension),0.522847446926051,PLAUR;Urokinase plasminogen activator surface receptor,0.3443228045117,1.41103405015632,1.25328243720904,1.58864197852671,1.25341015939181e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0217031015705153,PLAUR;Urokinase plasminogen activator surface receptor,1.67168926740235,5.3211490528122,3.10676573997462,9.1138597538659,1.13727611323703e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56608021678056,GGH;Gamma-glutamyl hydrolase,0.209523536342023,1.23309039720662,1.14944143135449,1.3228267976137,5.03872427498241e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307351138949948,FGF21;Fibroblast growth factor 21,0.582730118861691,1.79092119018155,1.54245508414866,2.079411415219,2.05570489458898e-14
primary,Circulatory system disorders,I50 (heart failure),0.910381854611239,FGF21;Fibroblast growth factor 21,0.232360694860904,1.26157469027969,1.15292590021006,1.38046226462978,4.25985291919437e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56982512109245,FGF21;Fibroblast growth factor 21,0.205222946307388,1.227798767653,1.14585366633045,1.31560412829843,5.77137258570199e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,CD302;CD302 antigen,1.6242068000945,5.07439243284191,4.3564431970633,5.91066092169893,1.05259400545915e-96
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,CD302;CD302 antigen,1.60341253959097,4.96996371656014,3.42257356868065,7.21694913148235,3.61251944565304e-17
primary,Circulatory system disorders,I20 (angina pectoris),4.61102473776395,CD302;CD302 antigen,0.199044284796757,1.22023600260673,1.17041458134995,1.27217818863831,8.08986162143891e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,CD302;CD302 antigen,0.292282152166083,1.33948090176423,1.26830392400151,1.4146523181371,9.43434669324517e-26
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,CD302;CD302 antigen,0.245178726107682,1.27784967789604,1.21978920820461,1.33867375470756,4.94141002814992e-25
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999744159959065,CD302;CD302 antigen,0.369416160393574,1.44688961655137,1.32670046413093,1.57796700844266,6.8793290394479e-17
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352272056363529,CD302;CD302 antigen,0.537516957215941,1.71175122937399,1.48230568630685,1.97671256228104,2.4755069083795e-13
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541200086592013,CD302;CD302 antigen,0.366871337070635,1.44321221925726,1.2831948301115,1.62318415016719,9.43683938496945e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307008049121287,CD302;CD302 antigen,0.46883046620272,1.59812403974995,1.36902128496513,1.86556664565791,2.87633044601441e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383760061401609,CD302;CD302 antigen,0.346121168748303,1.41357388641959,1.22944581755177,1.62527791289448,1.16814294344732e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,CD302;CD302 antigen,0.406183996132382,1.50107871972921,1.41415279096454,1.59334785973661,1.25771466603374e-40
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25952020152323,CD302;CD302 antigen,0.209765771206639,1.23338913087244,1.14110468319328,1.33313688968235,1.24610838353489e-07
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,CD302;CD302 antigen,0.703904353400334,2.02163047849498,1.84806956336823,2.21149131644755,2.61339716860649e-53
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71019227363076,CD302;CD302 antigen,0.246213343165712,1.2791724471322,1.19641527121419,1.36765401518287,5.39066782752204e-13
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,CD302;CD302 antigen,0.42040684937233,1.52258089070175,1.42016282535067,1.63238505286018,2.6411258348659e-32
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346368055418888,CD302;CD302 antigen,0.639933129739759,1.89635406537509,1.64197395906273,2.19014358992478,3.09321088976982e-18
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.129888020782083,CD302;CD302 antigen,0.683859722095835,1.98151107353962,1.56822032225504,2.50372098795031,1.00459553422141e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.173184027709444,CD302;CD302 antigen,0.79125857654277,2.20617131515119,1.8073753074394,2.69296136323314,7.35686148253495e-15
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.165312026449924,CD302;CD302 antigen,0.515738737167003,1.67487533755495,1.35823851879294,2.06532752350654,1.40843069386383e-06
primary,Circulatory system disorders,I72 (other aneurysm),0.108240017318402,CD302;CD302 antigen,0.695206035462938,2.00412195160007,1.55199842466499,2.58795674857226,9.84309119502403e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,CD302;CD302 antigen,0.446164271186525,1.56230808765871,1.45218777436388,1.68077889364754,5.50287704235315e-33
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246000039360006,CD302;CD302 antigen,0.713087572476347,2.04028105918481,1.72225574948458,2.41703173394199,1.61223051605486e-16
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54265640682502,CD302;CD302 antigen,0.249780696057803,1.28374385572682,1.21491084511033,1.35647672728339,6.48791314401573e-19
primary,Circulatory system disorders,I95 (hypotension),0.511680081868813,CD302;CD302 antigen,0.370002792473887,1.44773865743007,1.28308900827436,1.63351662020414,1.89441478633626e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216480034636805,CD302;CD302 antigen,1.44268617915321,4.23204860309451,2.56034325317405,6.99524774920352,1.83808717913975e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.290714921388312,DKK4;Dickkopf-related protein 4,0.998102848397002,2.71312972443726,2.31351556439954,3.18176934484361,1.19497441597067e-34
primary,Circulatory system disorders,I15 (secondary hypertension),0.039553050529022,DKK4;Dickkopf-related protein 4,1.10086466540169,3.00676474571876,1.9708314965148,4.58721826400918,3.25630501566572e-07
primary,Circulatory system disorders,I50 (heart failure),0.905764857114605,DKK4;Dickkopf-related protein 4,0.371259390258132,1.44955902611526,1.32236412421626,1.58898848790046,2.3143035295422e-15
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.56235673271146,CD80;T-lymphocyte activation antigen CD80,0.250974868756799,1.28527778329676,1.21138917548509,1.3636732221705,9.72010510790867e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55416354599305,CD80;T-lymphocyte activation antigen CD80,0.225710384020352,1.25321266230209,1.19133502908351,1.31830420378262,2.40264459935454e-18
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00088513651528,CD80;T-lymphocyte activation antigen CD80,0.298858149384786,1.34831835011964,1.22772060416694,1.48076228996979,4.06730739448924e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.553777717255622,CD80;T-lymphocyte activation antigen CD80,0.30619495915957,1.35824708344659,1.19827592541214,1.53957456756602,1.67508367641293e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15383218719502,CD80;T-lymphocyte activation antigen CD80,0.245238608585227,1.27792620099186,1.19840416173224,1.36272505330833,7.35756389055072e-14
primary,Circulatory system disorders,I50 (heart failure),0.916910646603572,CD80;T-lymphocyte activation antigen CD80,0.376894191238011,1.45775005848184,1.32280978232121,1.6064556381454,2.85379499031598e-14
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66133315176686,CD80;T-lymphocyte activation antigen CD80,0.192126417718284,1.21182370326949,1.12647356809945,1.30364060852614,2.52364088404612e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55693243457933,CD80;T-lymphocyte activation antigen CD80,0.255799768674285,1.29149410447161,1.19784582185096,1.39246386426221,2.73159857170912e-11
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.347245863688976,CD80;T-lymphocyte activation antigen CD80,0.391433248109741,1.47909919154568,1.26378207374952,1.73110100536582,1.07975148678021e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39579219718118,CD80;T-lymphocyte activation antigen CD80,0.359068513457395,1.43199490913297,1.32256739289861,1.55047631658944,8.51603760602318e-19
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.52831302058509,CD80;T-lymphocyte activation antigen CD80,0.212063815871814,1.23622677345061,1.1646546692958,1.31219723381194,3.18749409833618e-12
primary,Circulatory system disorders,I85 (oesophageal varices),0.0522003585937677,CD80;T-lymphocyte activation antigen CD80,1.29838730460457,3.66338397874346,2.50598313587678,5.35533618865269,2.05580283848319e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0181566464673974,CD80;T-lymphocyte activation antigen CD80,1.66127783074123,5.26603564918769,2.90722534782326,9.53869347599041,4.2333352376437e-08
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.118089314885158,THOP1;Thimet oligopeptidase,0.69215993355485,1.99802648032579,1.56212456247999,2.5555643333239,3.54509373073784e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.309000373949497,THOP1;Thimet oligopeptidase,-0.420054745043984,0.657010850742579,0.560407812411931,0.770266310413587,2.2575626718845e-07
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.379853962880592,THOP1;Thimet oligopeptidase,0.367638315242637,1.44431955612432,1.24964580057751,1.6693202019637,6.45843779359017e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30457850265278,CD4;T-cell surface glycoprotein CD4,1.18010490002737,3.25471560473885,2.79397271110497,3.79143777089404,7.23637185325652e-52
primary,Circulatory system disorders,I15 (secondary hypertension),0.0393004519551974,CD4;T-cell surface glycoprotein CD4,1.15439950532297,3.17211800551276,2.09320983625199,4.80713040165882,5.24459236195758e-08
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64885046178031,CD4;T-cell surface glycoprotein CD4,0.264271117308411,1.30248127365321,1.23308259112355,1.37578575873941,3.0848857052697e-21
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68441737079976,CD4;T-cell surface glycoprotein CD4,0.254042028866497,1.28922598783608,1.23045042343262,1.35080911514916,1.3957350682727e-26
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00805659265081,CD4;T-cell surface glycoprotein CD4,0.312847993457055,1.36731367460544,1.25403416064924,1.49082596266366,1.33986331822825e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.355669090194537,CD4;T-cell surface glycoprotein CD4,0.41175492652091,1.50946446128797,1.30651792465937,1.74393547680214,2.28085476752496e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.530556101395166,CD4;T-cell surface glycoprotein CD4,0.436581940016202,1.54740903201909,1.37444870362715,1.74213465082782,5.22986892011921e-13
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.377284338769895,CD4;T-cell surface glycoprotein CD4,0.377955470904874,1.45929796021131,1.26765202977362,1.67991726961316,1.42788958171274e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30654352525054,CD4;T-cell surface glycoprotein CD4,0.436252331157044,1.54689907634096,1.32362357186279,1.80783781979411,4.12850079319256e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.389074474356455,CD4;T-cell surface glycoprotein CD4,0.358780368183662,1.4315823460098,1.24570164501212,1.64519973270726,4.2812670746926e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1693849479269,CD4;T-cell surface glycoprotein CD4,0.310096651237576,1.36355689722519,1.28432083065342,1.44768142631811,3.23949780376902e-24
primary,Circulatory system disorders,I50 (heart failure),0.899980349774022,CD4;T-cell surface glycoprotein CD4,0.654479751648649,1.92414122563835,1.75537674066015,2.10913097481781,2.24786587524283e-44
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70760463745333,CD4;T-cell surface glycoprotein CD4,0.232084610293313,1.26122643705273,1.17957049450228,1.34853502434538,1.07647655678498e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57201807820789,CD4;T-cell surface glycoprotein CD4,0.268960030620926,1.30860283595836,1.22036341662593,1.40322248188399,4.31615751559885e-14
primary,Circulatory system disorders,I70 (atherosclerosis),0.176852033798388,CD4;T-cell surface glycoprotein CD4,0.63186395521839,1.88111362504767,1.53388619023771,2.30694330052715,1.28733438808677e-09
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170956966005109,CD4;T-cell surface glycoprotein CD4,0.566329452396078,1.76178844034402,1.42902317644424,2.17204210519039,1.14320763991682e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39713106700727,CD4;T-cell surface glycoprotein CD4,0.28768664610031,1.33333943154531,1.23862976676186,1.43529090566042,1.96852366452332e-14
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.14934171742975,CD4;T-cell surface glycoprotein CD4,0.679394986836703,1.97268387140688,1.58247927088617,2.45910434853888,1.5256030511825e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249557869915504,CD4;T-cell surface glycoprotein CD4,0.432322738502036,1.54083232083822,1.29626809272141,1.83153797757631,9.45640167945765e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54863430929455,CD4;T-cell surface glycoprotein CD4,0.185828605104713,1.2042158462401,1.13977841222948,1.27229625405801,3.52534531284369e-11
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172456829063514,SHISA5;Protein shisa-5,0.674478227411649,1.96300846470456,1.5831515122306,2.43400723350378,7.90207573158472e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204225192312056,SHISA5;Protein shisa-5,1.61670810418055,5.03648341876105,4.18241341507918,6.06495884314075,3.34896513973486e-65
primary,Circulatory system disorders,I20 (angina pectoris),4.45210919240282,SHISA5;Protein shisa-5,0.279435530995899,1.3223831573216,1.26330327352153,1.38422598232746,4.37003000148248e-33
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.58231409834577,SHISA5;Protein shisa-5,0.419152147946441,1.52067170426709,1.43242119789218,1.61435926497132,5.76227048745395e-43
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.117996777780299,SHISA5;Protein shisa-5,0.711056426491267,2.03614115629986,1.56576943006369,2.64781693190259,1.12361857042119e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.56940252785404,SHISA5;Protein shisa-5,0.390087039436643,1.47710935505374,1.40348951870629,1.55459090909239,1.45489942885781e-50
primary,Circulatory system disorders,I26 (pulmonary embolism),1.005241779936,SHISA5;Protein shisa-5,0.424207516019191,1.52837872394673,1.39371371206529,1.67605549374376,1.98286250529181e-19
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40164287821371,SHISA5;Protein shisa-5,0.653075441440406,1.92144103087237,1.66733950600346,2.214267473317,1.81527673069939e-19
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.553677188046018,SHISA5;Protein shisa-5,0.451457526887816,1.57059970932779,1.38770349048047,1.77760124108823,8.87489385886315e-13
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0544600512832149,SHISA5;Protein shisa-5,0.924581826782359,2.5208139030606,1.75072172505952,3.62964750074577,6.66550337306374e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301799450861149,SHISA5;Protein shisa-5,0.473975486135281,1.60636760826656,1.35837757015915,1.89963155279846,3.02441109545811e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383489527785972,SHISA5;Protein shisa-5,0.532149325325166,1.70258779386147,1.46810747770675,1.97451837813272,1.9373325585566e-12
primary,Circulatory system disorders,I46 (cardiac arrest),0.0884975833352243,SHISA5;Protein shisa-5,0.888568569560592,2.4316464261751,1.81359784534756,3.26031725120238,2.87270959874378e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14890285688352,SHISA5;Protein shisa-5,0.416945958943696,1.51732051311614,1.42251338831623,1.61844630667984,9.16043554507319e-37
primary,Circulatory system disorders,I50 (heart failure),0.909936690190383,SHISA5;Protein shisa-5,0.812786773896798,2.25418113483909,2.04752211975938,2.48169850749236,1.20508092291523e-61
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66556990174499,SHISA5;Protein shisa-5,0.312988638685014,1.367505994273,1.27169338897894,1.47053736425734,3.03758952133499e-17
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55891896798202,SHISA5;Protein shisa-5,0.479951573963821,1.6159961440103,1.49967248217083,1.74134257213016,2.33497613183638e-36
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.120265946583766,SHISA5;Protein shisa-5,0.673780576488234,1.96163944764002,1.5135891822864,2.54232084080086,3.52534661961633e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349451995733962,SHISA5;Protein shisa-5,0.608895960877703,1.83840061175591,1.5770760884953,2.14302710817785,7.04672230163515e-15
primary,Circulatory system disorders,I70 (atherosclerosis),0.165649322653112,SHISA5;Protein shisa-5,0.659595140841492,1.93400917455105,1.54850154492811,2.41549096253648,6.05279004083525e-09
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.142957634618439,SHISA5;Protein shisa-5,0.593783248708708,1.81082627875394,1.4213435382221,2.30703677446448,1.54382543137134e-06
primary,Circulatory system disorders,I72 (other aneurysm),0.0975742585490934,SHISA5;Protein shisa-5,0.858556608373405,2.35975218784438,1.78559906339554,3.11852223838383,1.58377270893627e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40915382695318,SHISA5;Protein shisa-5,0.487784259759169,1.62870343519543,1.50661229682959,1.76068845674464,1.32228224288438e-34
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.142957634618439,SHISA5;Protein shisa-5,0.836738810894888,2.30882517034561,1.82808682061228,2.91598495602961,2.14992141435149e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.23372438675713,SHISA5;Protein shisa-5,0.735477980647076,2.08647905080557,1.73434678123774,2.51010632737684,6.27011168652955e-15
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54373822868683,SHISA5;Protein shisa-5,0.248352961145604,1.28191231759227,1.20841447403333,1.35988042621662,1.66413558950466e-16
primary,Circulatory system disorders,I85 (oesophageal varices),0.0521908824797476,SHISA5;Protein shisa-5,1.06319319915883,2.89560247782964,2.0154125269499,4.16019727847092,8.89570471413129e-09
primary,Circulatory system disorders,I95 (hypotension),0.503755474369738,SHISA5;Protein shisa-5,0.424891534521079,1.52942452090326,1.34327469945749,1.74137082019402,1.39219495122712e-10
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0181533504277383,SHISA5;Protein shisa-5,1.77326639503936,5.89006124086225,3.41998148286443,10.1441547549113,1.62459507046049e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.200211718138721,SERPINF1;Pigment epithelium-derived factor,1.28161985214913,3.6024704713565,2.97991206082315,4.35509277861395,5.17093618743001e-40
primary,Circulatory system disorders,I15 (secondary hypertension),0.0184102729322962,SERPINF1;Pigment epithelium-derived factor,1.5344066172247,4.63857226428094,2.62423274671008,8.19910226253016,1.29433655009183e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56487319924517,SERPINF1;Pigment epithelium-derived factor,0.207900714745416,1.23109093430406,1.13929997058466,1.33027729979478,1.45091653600594e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,NRCAM;Neuronal cell adhesion molecule,0.408596189990858,1.50470398325939,1.2872672133376,1.75886875217327,2.88062258260204e-07
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67575561693208,NRCAM;Neuronal cell adhesion molecule,0.184137490808742,1.20218110058574,1.13881649166647,1.26907136415867,2.64436560281389e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,NRCAM;Neuronal cell adhesion molecule,0.245854305636807,1.27871325865562,1.20452360270121,1.35747244320897,7.50716611050981e-16
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,NRCAM;Neuronal cell adhesion molecule,0.250792599909145,1.28504353854469,1.17262925939405,1.40823442936156,7.89638814651223e-08
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71788995318407,NRCAM;Neuronal cell adhesion molecule,0.203473361558836,1.22565250773412,1.14631284154708,1.31048350438744,2.53611539357518e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68619296111743,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,-0.229799801621489,0.794692682765501,0.75851482052344,0.832596071893776,4.17852436369807e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64571157794977,CDCP1;CUB domain-containing protein 1,0.24182374475944,1.27356969969894,1.20877417108107,1.34183854916474,1.11759889476268e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69807297425367,CDCP1;CUB domain-containing protein 1,0.209562401566133,1.23313832247256,1.17911535059909,1.28963643936772,4.79171944110804e-20
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01287316379718,CDCP1;CUB domain-containing protein 1,0.298672818089104,1.3480684876872,1.23861868980019,1.46718975134179,4.7361583755462e-12
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,CDCP1;CUB domain-containing protein 1,0.331425384972,1.39295220723272,1.27672314862001,1.51976241186805,8.95719398533272e-14
primary,Circulatory system disorders,I70 (atherosclerosis),0.165850576528194,CDCP1;CUB domain-containing protein 1,0.495717408020137,1.64167556791285,1.34724752300676,2.00044804258916,8.8507753788002e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,CDCP1;CUB domain-containing protein 1,0.292849642699098,1.34024126022284,1.24679031392133,1.44069665568244,2.00066854951615e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298902686112058,PXN;Paxillin,0.521487605625363,1.6845317055546,1.43590128971148,1.97621318913144,1.55060486738135e-10
primary,Circulatory system disorders,I50 (heart failure),0.900720174928283,PXN;Paxillin,0.279998507684426,1.32312783781168,1.20493967695536,1.45290864652727,4.48994136804608e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56481698275189,CD163;Scavenger receptor cysteine-rich type 1 protein M130,0.208728019914961,1.23210984361454,1.14929039380134,1.32089737712909,4.12069213525589e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40092093967064,CD163;Scavenger receptor cysteine-rich type 1 protein M130,0.203060804980108,1.2251469610193,1.13816417381148,1.31877729999911,6.50795389066897e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,IFNLR1;Interferon lambda receptor 1,0.424697865516663,1.5291283474597,1.30515245447983,1.79154051695572,1.47436077275488e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.312938164231574,CD59;CD59 glycoprotein,1.69719678130592,5.45862420722112,4.69175780358328,6.35083469417445,5.24801692423036e-107
primary,Circulatory system disorders,I15 (secondary hypertension),0.0386092540285708,CD59;CD59 glycoprotein,1.86834984352421,6.47759852397827,4.45048731816198,9.428019818552,1.73340441117566e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67013472597589,CD59;CD59 glycoprotein,0.214153691865326,1.23881303564932,1.16830381909467,1.31357760901946,7.91611765365102e-13
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00180853874133,CD59;CD59 glycoprotein,0.360006129041081,1.43333819952212,1.30926361438519,1.56917092298029,6.5374388825294e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.347483286257137,CD59;CD59 glycoprotein,0.503129772257251,1.65388947622749,1.42364959639826,1.92136492469517,4.76087915665685e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.548657820406006,CD59;CD59 glycoprotein,0.393723714843808,1.48249090185731,1.31191981023373,1.67523903286297,2.73203738090129e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.312938164231574,CD59;CD59 glycoprotein,0.490215578498271,1.63266815016771,1.38866014616975,1.91955194791498,2.93077376140259e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.390156672288715,CD59;CD59 glycoprotein,0.405278951083448,1.49972079045214,1.29540453483027,1.73626260279309,5.8379701953502e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.182438885615,CD59;CD59 glycoprotein,0.264165622525577,1.3023438759216,1.22212511973883,1.38782809039465,3.82162178040198e-16
primary,Circulatory system disorders,I50 (heart failure),0.930686228688707,CD59;CD59 glycoprotein,0.616247180931034,1.85196489513016,1.68451837959829,2.0360561299499498,3.31911296788771e-37
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.73944849728719,CD59;CD59 glycoprotein,0.246578534423577,1.27963967503578,1.19313959185037,1.37241083030881,5.01963018562474e-12
primary,Circulatory system disorders,I63 (cerebral infarction),0.365771880270671,CD59;CD59 glycoprotein,0.469694264160218,1.59950509242068,1.37648052767076,1.8586652620571,8.7598908226624e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5850114811729,CD59;CD59 glycoprotein,0.384104924237962,1.46829949380543,1.36466613961934,1.57980281104553,8.21077763447562e-25
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35967568226616,CD59;CD59 glycoprotein,0.510166570533873,1.66556860649293,1.4353053711187,1.93277252266716,1.81335914212723e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.178821808132328,CD59;CD59 glycoprotein,0.560234172031495,1.75108250683613,1.41346190253378,2.16934743005868,2.95307221027468e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40618967304058,CD59;CD59 glycoprotein,0.266696455665464,1.30564406531514,1.20867019914141,1.41039832578284,1.26089592054106e-11
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.57665968990672,CD59;CD59 glycoprotein,0.233770510766223,1.26335453267406,1.19290117618311,1.33796890060497,1.40823281246201e-15
primary,Circulatory system disorders,I95 (hypotension),0.520208896384954,CD59;CD59 glycoprotein,0.356901088836924,1.42889452924411,1.26051956374247,1.61976032299081,2.41523618377924e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298161988269679,FOLR1;Folate receptor alpha,1.56875514206847,4.80066832246444,4.11550976511825,5.59989349014491,1.07553494014859e-88
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392318405617999,FOLR1;Folate receptor alpha,1.58330618270129,4.87103374580523,3.33930755258738,7.10535623901698,2.04304924759978e-16
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67168834225857,FOLR1;Folate receptor alpha,0.25639236364348,1.29225966419168,1.22479537661798,1.36344002563757,7.10888083043878e-21
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68779301280919,FOLR1;Folate receptor alpha,0.230008405909412,1.25861058965161,1.20178502949875,1.31812310646262,1.71052566766683e-22
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00629671041016,FOLR1;Folate receptor alpha,0.314422201072757,1.36946780528466,1.25436697254781,1.49513030138372,2.2255216116268e-12
primary,Circulatory system disorders,I46 (cardiac arrest),0.0784636811235999,FOLR1;Folate receptor alpha,0.722513964350743,2.05960447996625,1.54010833001329,2.75433262143348,1.10474262009243e-06
primary,Circulatory system disorders,I50 (heart failure),0.900370740893309,FOLR1;Folate receptor alpha,0.419707359558544,1.52151623327995,1.39071344749264,1.66462160289615,5.62720177754285e-20
primary,Circulatory system disorders,I63 (cerebral infarction),0.362894525196649,FOLR1;Folate receptor alpha,0.412078898011972,1.50995356396358,1.31009323240277,1.74030344477451,1.28143241679272e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55750407030345,FOLR1;Folate receptor alpha,0.37685169729067,1.45768811424376,1.35934475386163,1.56314623819398,3.91352603747504e-26
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349163381000019,FOLR1;Folate receptor alpha,0.527104074921052,1.69401944501447,1.46562119616181,1.95801062894174,9.78650295315522e-13
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127503481825849,FOLR1;Folate receptor alpha,0.627860093245769,1.87359696361717,1.48029883179659,2.37138982121269,1.76208059190423e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.174581690500009,FOLR1;Folate receptor alpha,0.606914854246646,1.8347621493944,1.50496549833024,2.23683011244132,1.93298246227826e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40646148414052,FOLR1;Folate receptor alpha,0.370111874714796,1.44789658862066,1.3441473957066,1.559653753774,1.73231187284921e-22
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.247160595539339,FOLR1;Folate receptor alpha,0.557348938356073,1.74603750612173,1.47396541819651,2.06833005384483,1.12718110437539e-10
primary,Circulatory system disorders,I95 (hypotension),0.511975519331489,FOLR1;Folate receptor alpha,0.321920529751304,1.37977512052815,1.22078068204494,1.55947698978939,2.55560116117501e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215775123089899,FOLR1;Folate receptor alpha,1.47939230883036,4.39027693758779,2.57659631721519,7.48061753404479,5.30262040907001e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,NT5C1A;Cytosolic 5'-nucleotidase 1A,1.08467563812047,2.95848004494298,2.47870206753219,3.53112392609571,2.96690379491154e-33
primary,Circulatory system disorders,I15 (secondary hypertension),0.0204754862927994,NT5C1A;Cytosolic 5'-nucleotidase 1A,1.41876061912217,4.13199614841909,2.45509256888109,6.9542763425541,9.22242292538092e-08
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00102377431464,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.274938102194174,1.31644918702953,1.20180211366954,1.44203312868131,3.33691291569475e-09
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.398134455693322,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.426957131123657,1.53258696003487,1.33145608425417,1.76410083505282,2.71058901612399e-09
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555113183938118,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.360729449341442,1.43437533718526,1.27110444879388,1.61861805288904,4.89534308016903e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307132294391991,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.438768097012548,1.55079561154912,1.32056424423432,1.82116624715555,8.74218851588805e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382209077465589,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.360429225880262,1.43394476869352,1.23908426595185,1.65944936608808,1.32029368636299e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14992606074394,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.33207217981939,1.39385345297215,1.30877508694198,1.48446243189265,4.93828367480849e-25
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.23990444773063,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.224180485509074,1.25129683999624,1.15197845549575,1.3591780074661,1.0781665171658e-07
primary,Circulatory system disorders,I50 (heart failure),0.910021613013309,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.526797496729098,1.69350017519835,1.54222474242349,1.85961407861353,2.6081951522982e-28
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65623933568422,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.21983664339839,1.24587319235243,1.15956384672839,1.33860676650264,1.95368868780509e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55841201228529,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.253204239359205,1.28814634015284,1.19640724250187,1.38691988371725,1.85304519335511e-11
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345808212945057,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.373772103701048,1.45320593246298,1.24775658788669,1.69248353616978,1.53849566154513e-06
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127403025821863,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.71018916564039,2.03437605629984,1.60608634403629,2.57687636397247,3.90017788389918e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.166078944374928,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.534738711486143,1.70700216392061,1.37583432522196,2.11788318855875,1.17739045423706e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40825844613809,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.24799830740948,1.28145776320892,1.18616851976167,1.38440193912611,3.16411259468212e-10
primary,Circulatory system disorders,I95 (hypotension),0.505061995222386,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.330193336753058,1.39123707972358,1.22525488843442,1.57970446008256,3.5054803710705e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,CALB1;Calbindin,1.3937906380841,4.03009777755196,3.45548870802999,4.70025789952265,1.47332198745768e-70
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,CALB1;Calbindin,1.45624981176105,4.28984161106663,2.88776734264795,6.37265363322664,5.52059337822894e-13
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,CALB1;Calbindin,0.344488383611641,1.41126770724816,1.28915748425434,1.54494432669993,8.60981708598986e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,CALB1;Calbindin,0.331069682133288,1.39245681828927,1.29832832903865,1.49340960020179,1.84718607749807e-20
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,CALB1;Calbindin,0.222245509125418,1.24887795116301,1.15950432433892,1.345140422646,4.45504399795342e-09
primary,Circulatory system disorders,I50 (heart failure),0.904382626437007,PSPN;Persephin,0.361493720886148,1.43547200846385,1.26751717856172,1.62568201988506,1.24160680128355e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15222025672427,SHBG;Sex hormone-binding globulin,0.200718930818839,1.22228117796892,1.13774806313389,1.31309498686555,4.03698901965537e-08
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.123493493722414,APCS;Serum amyloid P-component,-0.918671630638028,0.399048773331,0.30005520883851,0.530702080171783,2.6986485858299e-10
primary,Circulatory system disorders,I08 (multiple valve diseases),0.173805657831545,APCS;Serum amyloid P-component,-0.672588244275439,0.510385863481663,0.40147632691976,0.648839575774004,3.96776517699447e-08
primary,Circulatory system disorders,I20 (angina pectoris),4.42518352505317,APCS;Serum amyloid P-component,-0.313778595691495,0.730680786125998,0.695403996949858,0.76774711326861,1.8366779326286e-35
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.57278111921696,APCS;Serum amyloid P-component,-0.433967021793026,0.647933622822139,0.607665027313113,0.690870727643671,4.16914166610068e-40
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54700756969378,APCS;Serum amyloid P-component,-0.392691882225458,0.675236767987337,0.639019476647058,0.713506723197751,2.68700806694896e-44
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.395636563221808,APCS;Serum amyloid P-component,-0.506409907945401,0.602655287675733,0.512772801904139,0.708293018691381,7.98051038532681e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.558007638301278,APCS;Serum amyloid P-component,-0.478094904027449,0.619963357170504,0.541251510064382,0.710121924996389,5.14866477029098e-12
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.343037482562261,APCS;Serum amyloid P-component,-0.759425003862712,0.467935410723866,0.39546692428891,0.553683595671198,9.07601519451318e-19
primary,Circulatory system disorders,I42 (cardiomyopathy),0.308733734306035,APCS;Serum amyloid P-component,-0.499820554236293,0.606639508836042,0.506553668541668,0.726500500411561,5.5352026543145e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.381915063919317,APCS;Serum amyloid P-component,-0.492788216816999,0.610920638083603,0.519454963916053,0.718491595927441,2.59837694189869e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14741464083975,APCS;Serum amyloid P-component,-0.795391535297232,0.451404459538711,0.420431492380778,0.484659188914631,1.30086072827416e-106
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.23722185377455,APCS;Serum amyloid P-component,-0.391386378023955,0.676118868092367,0.616830241766869,0.741106211785377,6.35122047471606e-17
primary,Circulatory system disorders,I50 (heart failure),0.901045120863539,APCS;Serum amyloid P-component,-0.667484487264905,0.512997407584885,0.46166122194819,0.570042116767491,2.378122624232e-35
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65344066595009,APCS;Serum amyloid P-component,-0.333727190759149,0.716249154964478,0.661454551756943,0.775582918924171,2.05868739224699e-16
primary,Circulatory system disorders,I63 (cerebral infarction),0.359045898415166,APCS;Serum amyloid P-component,-0.525493926457169,0.591263251668507,0.500105758621259,0.699036607251647,7.6952699503998e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56425092048391,APCS;Serum amyloid P-component,-0.281450797478519,0.754688047316649,0.695647580569946,0.818739351175459,1.27256825007287e-11
primary,Circulatory system disorders,I85 (oesophageal varices),0.0525990806595467,APCS;Serum amyloid P-component,-1.258310223242,0.284133743674379,0.192078949210879,0.42030625753676,2.99862143583635e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17680162576207,LDLR;Low-density lipoprotein receptor,-0.279611251768261,0.756077608165173,0.711732236804856,0.803185973611458,1.22375581935563e-19
primary,Circulatory system disorders,I50 (heart failure),0.914491167734875,LDLR;Low-density lipoprotein receptor,-0.259169194850951,0.771692445609184,0.703507615289928,0.846485834222085,3.9956041683284e-08
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.117529529294235,REN;Renin,0.746595823904598,2.10980562819232,1.6171637126914,2.75252267523605,3.7392347058869e-08
primary,Circulatory system disorders,I07 (rheumatic tricuspid valve diseases),0.0489706372059313,REN;Renin,1.04472328130399,2.84261181097415,1.89179977584894,4.27129869188386,4.94067355594677e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174335468453115,REN;Renin,0.886077184928016,2.4255957999853,1.94300263911149,3.02805300748166,4.94005807849091e-15
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0875986758339,REN;Renin,0.428425885286491,1.53483960739997,1.502242480137,1.56814405902625,0.0
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,REN;Renin,1.37077706293533,3.9384098990764,3.32213396540458,4.6690087439788,3.75132189018069e-56
primary,Circulatory system disorders,I15 (secondary hypertension),0.039176509764745,REN;Renin,1.60306517546447,4.96823762926278,3.1131872795682,7.92865411689793,1.79338140320283e-11
primary,Circulatory system disorders,I20 (angina pectoris),4.61107519931049,REN;Renin,0.692784312704301,1.99927439594586,1.90849022302665,2.09437704320316,1.13265960076308e-187
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67575561693208,REN;Renin,0.951493182390355,2.58957347942188,2.43162649561961,2.75777995403706,5.60507534069814e-193
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.111653052829523,REN;Renin,1.23694105261801,3.44505907589152,2.59442316370797,4.57459376804982,1.23926702253737e-17
primary,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.160623690035454,REN;Renin,0.960186625969757,2.61218392929473,2.0618926441922,3.30934052249791,1.78654685156429e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72176842765078,REN;Renin,0.865156538896352,2.37537789590924,2.25231927373156,2.50515999848727,5.75133549100288e-223
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01075395193042,REN;Renin,0.302936920486948,1.35382906287073,1.23518340386526,1.48387124190455,9.56720349365144e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358465064347417,REN;Renin,0.956961617797648,2.60377318442595,2.23040406595107,3.03964420592318,8.48022907736012e-34
primary,Circulatory system disorders,I31 (other diseases of pericardium),0.199800199800199,REN;Renin,0.549486605220342,1.7323634031975,1.40296776020098,2.13909616875878,3.27937621156628e-07
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542594660241719,REN;Renin,0.642561082576399,1.90134414840004,1.67512502134498,2.15811328980833,2.73049924596663e-23
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.378053319229789,REN;Renin,0.493124733801444,1.6374247508655,1.40682399682331,1.90582462397652,1.92269844682718e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.309494427141486,REN;Renin,1.15949347788529,3.18831791351038,2.69181154641406,3.77640519863033,4.31794555700277e-41
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.393723923135687,REN;Renin,0.798206373357341,2.22155271673942,1.91111931494903,2.58241148768042,2.64425057892536e-25
primary,Circulatory system disorders,I46 (cardiac arrest),0.0822706705059646,REN;Renin,1.25856261351535,3.52035773432371,2.54294561891104,4.87345009875586,3.34101732051762e-14
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,REN;Renin,0.540839778747315,1.71744853353572,1.60934482590585,1.83281383694991,9.1038123456569e-60
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.2516894869836,REN;Renin,0.245000676324241,1.27762217729144,1.1762318253338,1.38775230592293,6.34079075798282e-09
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,REN;Renin,1.34985126206784,3.85685182786683,3.4708852042119,4.28573840588811,6.19917168054216e-139
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71788995318407,REN;Renin,0.428240071337069,1.53455443928571,1.42881856757582,1.64811500954024,6.52443430335448e-32
primary,Circulatory system disorders,I63 (cerebral infarction),0.366300366300366,REN;Renin,0.702992946524373,2.01978878996751,1.72925112442711,2.35914072771237,7.19299941118887e-19
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,REN;Renin,0.616105137437669,1.85170185424893,1.71695711770978,1.9970211961977,1.67734659336905e-57
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.133200133200133,REN;Renin,0.867586211145149,2.38115630263792,1.83601753977693,3.08815423314594,6.13286987242677e-11
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35650623885918,REN;Renin,0.458401236919152,1.5815434493924,1.35381062497588,1.84758461499042,7.53100406728716e-09
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127323656735421,REN;Renin,0.801048123356933,2.22787479279661,1.71615296831111,2.89218163184085,1.78474604568798e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.176294293941352,REN;Renin,1.06735754358069,2.90768590617249,2.32191092789025,3.64124102582876,1.41689728885532e-20
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172376642964878,REN;Renin,0.752542812728186,2.12239000115688,1.68565854004259,2.67227271123182,1.53256863033085e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,REN;Renin,0.568190786639878,1.76507077130822,1.63120986940192,1.909916612305,2.85678706765006e-45
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152788388082505,REN;Renin,0.973074571124334,2.64606748823259,2.08155307571756,3.36367745505018,1.89631019155669e-15
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248770837006131,REN;Renin,0.718468630692107,2.05128952236821,1.69977724238238,2.47549419986353,6.81330456925028e-14
primary,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0117529529294235,REN;Renin,1.92754769567441,6.87263576494736,3.15311986297405,14.9798055292078,1.24246060969745e-06
primary,Circulatory system disorders,I95 (hypotension),0.521047579871109,REN;Renin,0.459886861867771,1.58389477596038,1.3934878431504,1.80031901508582,1.95503974701079e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,NECTIN4;Nectin-4,2.07000291995501,7.9248462580103,6.56275499379744,9.56963779273431,1.18425981604396e-102
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,NECTIN4;Nectin-4,2.35799453356213,10.5697329383712,6.43789870779187,17.3533724992093,1.14584669741264e-20
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00175746924428,NECTIN4;Nectin-4,0.329500433097016,1.39027342036472,1.27264704372573,1.51877159727971,2.76413294121254e-13
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,NECTIN4;Nectin-4,0.416705480583616,1.51695567423712,1.38137010454776,1.66584936942265,2.71019739490726e-18
primary,Circulatory system disorders,I63 (cerebral infarction),0.363210310486233,NECTIN4;Nectin-4,0.4302810118528,1.5376895718357,1.32792975257614,1.78058305775981,8.90956610793934e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56024214020699,NECTIN4;Nectin-4,0.41369422563488,1.51239460467422,1.40814692908295,1.62435992509483,7.16743789153265e-30
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132786565123999,NECTIN4;Nectin-4,0.663920610700888,1.94239279141316,1.52254768154115,2.47801090361571,9.13173972988765e-08
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34954110525288,NECTIN4;Nectin-4,0.517652128379035,1.67808309717797,1.44489699881071,1.94890215935959,1.19091022786535e-11
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126928334309705,NECTIN4;Nectin-4,0.65678621891226,1.92858431633778,1.50376497765496,2.47341673765027,2.29567707874898e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.173794180824057,NECTIN4;Nectin-4,0.673798425624761,1.96167446152282,1.58603538463081,2.42628047916258,5.20148384865237e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40597539543057,NECTIN4;Nectin-4,0.297298740291938,1.34621740876368,1.24922008061957,1.45074622140204,6.58564829081198e-15
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146455770357352,NECTIN4;Nectin-4,0.682146920450667,1.97812004302329,1.56901895759523,2.49388886327268,7.90781228780003e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246045694200351,NECTIN4;Nectin-4,0.546911583607414,1.72790826848863,1.44563610879191,2.06529635373209,1.8571260083381e-09
primary,Circulatory system disorders,I85 (oesophageal varices),0.0566295645381761,NECTIN4;Nectin-4,1.00834365684306,2.74105712172614,1.89391865249139,3.96711555413532,9.00206576741539e-08
primary,Circulatory system disorders,I95 (hypotension),0.509666080843585,NECTIN4;Nectin-4,0.366541445950754,1.44273619488445,1.27496288619999,1.63258691728157,6.20204459608748e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214801796524116,NECTIN4;Nectin-4,1.62458729094359,5.07632356009217,2.82654024133761,9.11682080795426,5.38822498457218e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,MSR1;Macrophage scavenger receptor types I and II,0.648396480169067,1.91247168268374,1.64525533592622,2.22308832993885,3.06585160606074e-17
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65462666278279,MSR1;Macrophage scavenger receptor types I and II,0.263516165541831,1.30149833419735,1.23417163090694,1.37249785321488,2.3909069075149e-22
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70715603456646,MSR1;Macrophage scavenger receptor types I and II,0.214845875365019,1.23967081842909,1.18465757090476,1.29723877667955,1.7476652874105e-20
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00786484124672,MSR1;Macrophage scavenger receptor types I and II,0.228875951026466,1.2571860766942,1.15358528600109,1.37009101157368,1.82756317218545e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359258180405864,MSR1;Macrophage scavenger receptor types I and II,0.348646787319721,1.41714854709374,1.22874248312527,1.63444336963253,1.66692527604157e-06
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549567919215457,MSR1;Macrophage scavenger receptor types I and II,0.316725611712088,1.37262588778167,1.22310384790502,1.54042670296195,7.3506654087721e-08
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376735605398582,MSR1;Macrophage scavenger receptor types I and II,0.352668537798524,1.42285944113942,1.23931474139298,1.63358743474967,5.59095290915466e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16720069909699,MSR1;Macrophage scavenger receptor types I and II,0.265414859994501,1.3039718293273,1.22976579872434,1.38265557022564,6.77436679962541e-19
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,MSR1;Macrophage scavenger receptor types I and II,0.481776312649934,1.61894760669601,1.4820608344153,1.76847757687408,1.15038503458991e-26
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70307796873482,MSR1;Macrophage scavenger receptor types I and II,0.206428746534719,1.2292801406266,1.1504259442576,1.31353927793599,1.04238911827211e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55549082435187,MSR1;Macrophage scavenger receptor types I and II,0.216071682542805,1.24119134756378,1.158292605188,1.33002313436782,8.98289259779259e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174774249927177,MSR1;Macrophage scavenger receptor types I and II,0.69599031425305,2.00569435846159,1.64984881816139,2.43828999074455,2.85907572275459e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168948441596271,MSR1;Macrophage scavenger receptor types I and II,0.699662223927209,2.01307262485366,1.65233651229062,2.45256421000907,3.80220691527734e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40984561607923,MSR1;Macrophage scavenger receptor types I and II,0.332383974297781,1.39428811654181,1.29656983319298,1.49937111149828,3.08438066690849e-19
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153412952713855,MSR1;Macrophage scavenger receptor types I and II,0.520577346786502,1.68299904334576,1.36075151456614,2.08155989508918,1.58219607663315e-06
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55752985726769,MSR1;Macrophage scavenger receptor types I and II,0.188010976198931,1.20684676186704,1.14259594616878,1.27471054970277,1.63203920029871e-11
primary,Circulatory system disorders,I85 (oesophageal varices),0.0504903388678512,MSR1;Macrophage scavenger receptor types I and II,0.958574504727448,2.60797616471813,1.82588602695493,3.72506255885037,1.36489796864081e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0194193611030197,MSR1;Macrophage scavenger receptor types I and II,1.41754917154863,4.12699348255675,2.40987589113474,7.06761508662007,2.41132794275865e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.201695145719077,B2M;Beta-2-microglobulin,1.32439674915506,3.75991649791948,3.12466386293506,4.52431771590559,1.08262352749407e-44
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.56538095453927,B2M;Beta-2-microglobulin,0.294853416621952,1.34292949311643,1.26537313224258,1.42523938396396,2.6059383819723e-22
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54892806961881,B2M;Beta-2-microglobulin,0.249795553229629,1.28376292867155,1.22013317393397,1.35071096519546,5.92281943429275e-22
primary,Circulatory system disorders,I26 (pulmonary embolism),0.99714454063364,B2M;Beta-2-microglobulin,0.340575961275829,1.40575701904768,1.28203221501212,1.54142210582683,4.31105258781628e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.394325341068757,B2M;Beta-2-microglobulin,0.556641254882024,1.74480230135213,1.51270682814326,2.01250831566643,2.11867695256457e-14
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.5529619725332,B2M;Beta-2-microglobulin,0.378648411499898,1.46030951744223,1.2910046757301,1.65181732244802,1.71755778877623e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.305942074967139,B2M;Beta-2-microglobulin,0.52651859300935,1.69302791756036,1.43765471860989,1.99376351813482,2.76423818854337e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.378461677922313,B2M;Beta-2-microglobulin,0.474935948068675,1.60791120436932,1.38642199051219,1.86478464625426,3.37093705521359e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14159452476997,B2M;Beta-2-microglobulin,0.3002547333052,1.35020270537086,1.26617691142502,1.43980460324382,5.23942118658532e-20
primary,Circulatory system disorders,I50 (heart failure),0.899696324162625,B2M;Beta-2-microglobulin,0.704239762296716,2.02230866507122,1.83778173099768,2.22536347371454,3.55209885700151e-47
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.6543534424149,B2M;Beta-2-microglobulin,0.261330363250202,1.29865662299675,1.2079163149379,1.39621346578138,1.53507300156982e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55917146353623,B2M;Beta-2-microglobulin,0.375298723288542,1.45542611936335,1.35126271086186,1.56761906615036,3.94142335511412e-23
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.344468114037075,B2M;Beta-2-microglobulin,0.498897903541591,1.64690522174116,1.41137851200582,1.92173593853548,2.35998628428646e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40280106966414,B2M;Beta-2-microglobulin,0.369230047736228,1.44662035713702,1.33839613320016,1.56359571413247,1.31760379376518e-20
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.231156234419616,B2M;Beta-2-microglobulin,0.49948475576421,1.64787199537987,1.36547003952764,1.98867938112842,1.91210742451744e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54951729139282,B2M;Beta-2-microglobulin,0.227327269519996,1.25524060271565,1.18383351139174,1.33095486446706,2.7993358096704e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.0521234646240311,B2M;Beta-2-microglobulin,1.00591637720976,2.73441187779611,1.8955996778054,3.94440261041235,7.40024881617417e-08
primary,Circulatory system disorders,I95 (hypotension),0.505370983093867,B2M;Beta-2-microglobulin,0.352167841386244,1.42214719884553,1.24998668510024,1.61801935915981,8.83341366768874e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0181299007387934,B2M;Beta-2-microglobulin,1.56493720050512,4.78237459575584,2.67679187325562,8.54422303154785,1.25422330844564e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72316950852557,BAIAP2;Brain-specific angiogenesis inhibitor 1-associated protein 2,0.189083459119498,1.20814177872449,1.1522436655337,1.26675164390988,5.15578796616009e-15
primary,Circulatory system disorders,I50 (heart failure),0.910732196589769,BAIAP2;Brain-specific angiogenesis inhibitor 1-associated protein 2,0.311208502583871,1.36507381293324,1.24252014041355,1.49971533993477,8.91446013130301e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302352063454666,RETN;Resistin,1.37399573349521,3.95110676562511,3.38054970567163,4.61796040069377,8.27587894178594e-67
primary,Circulatory system disorders,I15 (secondary hypertension),0.0373031766599913,RETN;Resistin,1.58770515411751,4.89250848276777,3.20345917976226,7.47212244974851,2.00632217926087e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351435190638865,RETN;Resistin,0.410199763887452,1.50711882295853,1.3027749063034,1.74351465899891,3.43062421502314e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30824203871677,RETN;Resistin,0.398491582674136,1.48957609975855,1.27635714294721,1.7384138673353,4.28570560033982e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388738367298857,RETN;Resistin,0.413297876320374,1.51179528688684,1.31763227981547,1.7345696705103,3.79439140897908e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16358424627949,RETN;Resistin,0.244047061044029,1.27640439799959,1.20282957789611,1.35447965129223,7.8438211282388e-16
primary,Circulatory system disorders,I50 (heart failure),0.914909490713472,RETN;Resistin,0.501683613030762,1.65149941732126,1.50965673093311,1.80666920467851,6.67967196084932e-28
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70023952566065,RETN;Resistin,0.207358430564853,1.2304235141476,1.15076277389601,1.31559871287959,1.26382307904538e-09
primary,Circulatory system disorders,I63 (cerebral infarction),0.363215141163073,RETN;Resistin,0.415328113246607,1.51486770731855,1.3139527704953,1.74650430533475,1.05908925364946e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5745867200691,RETN;Resistin,0.34421928899571,1.41088799379822,1.31646513425367,1.51208328975038,2.04231054163074e-22
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357325165900969,RETN;Resistin,0.39999304809946,1.49181432666039,1.29181201545256,1.72278161110736,5.14432408860071e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40770408764283,RETN;Resistin,0.217579376377222,1.24306409551636,1.1549164080484,1.33793955544628,6.71285565233622e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302908726178535,CFC1;Cryptic protein,0.960756479456748,2.61367291562723,2.23369743634537,3.05828622924878,4.1851878087981e-33
primary,Circulatory system disorders,I15 (secondary hypertension),0.0401203610832497,CFC1;Cryptic protein,1.22465258525431,3.40298363070943,2.23344452036951,5.18494974254406,1.19871115783472e-08
primary,Circulatory system disorders,I20 (angina pectoris),4.62587763289869,CFC1;Cryptic protein,0.239216492282644,1.27025350689953,1.21813714829227,1.32459959377531,4.48528816274797e-29
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66198595787362,CFC1;Cryptic protein,0.31717775171947,1.37324664718521,1.30009097445328,1.45051876450295,6.93926053225912e-30
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72316950852557,CFC1;Cryptic protein,0.272483101860393,1.31322126772867,1.25348040116366,1.37580938354834,1.85541263461968e-30
primary,Circulatory system disorders,I50 (heart failure),0.910732196589769,CFC1;Cryptic protein,0.461119900235508,1.58584898354847,1.44647846724328,1.73864807224865,8.79036499711479e-23
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56469408224674,CFC1;Cryptic protein,0.239612918232262,1.27075716817786,1.18421506824854,1.36362374012328,2.76893724348804e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40822467402206,CFC1;Cryptic protein,0.197526907968997,1.21838584881721,1.1309934020427,1.31253115528076,1.97755837670977e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306665113931912,VEGFD;Vascular endothelial growth factor D,0.691743880334743,1.99719536788029,1.72370896815183,2.31407355370395,3.37082203258573e-20
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16024222662163,VEGFD;Vascular endothelial growth factor D,0.437767901425076,1.54924528806398,1.46226237747316,1.64140239095531,7.0829634877963e-50
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25965606925197,VEGFD;Vascular endothelial growth factor D,0.222628825392935,1.24935675815923,1.15686467144381,1.34924364766891,1.40278769919909e-08
primary,Circulatory system disorders,I50 (heart failure),0.904467994254881,VEGFD;Vascular endothelial growth factor D,0.434296181987569,1.54387606868844,1.4146478033824,1.68490935324668,2.08726307092056e-22
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40910678933271,VEGFD;Vascular endothelial growth factor D,0.207371117875102,1.23043912501149,1.14316614815976,1.32437480133244,3.30275100759777e-08
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66754678884833,PLAT;Tissue-type plasminogen activator,0.206315058978473,1.22914039471531,1.16427464226794,1.29762004176092,8.75846658841653e-14
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.108720975382464,PLAT;Tissue-type plasminogen activator,0.641072494744445,1.89851593617978,1.47054740738556,2.45103472477413,8.70212673828788e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.7178690688825,PLAT;Tissue-type plasminogen activator,0.192997462916911,1.21287971633859,1.15799886035228,1.27036153201227,3.10391979300023e-16
primary,Circulatory system disorders,I50 (heart failure),0.914421060806088,PLAT;Tissue-type plasminogen activator,0.275668596973975,1.3174111976176,1.20261502901629,1.44316528708933,3.09868496191749e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40560689601615,PLAT;Tissue-type plasminogen activator,0.185923674570584,1.20433033583954,1.11770362657014,1.29767097765818,1.05194052132846e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298613021099367,CA6;Carbonic anhydrase 6,-0.424201281374986,0.654292171825922,0.554667821037615,0.771810135500271,4.82173738504691e-07
primary,Circulatory system disorders,I20 (angina pectoris),4.61474991159483,CA6;Carbonic anhydrase 6,-0.245982519425121,0.781935893494946,0.74850182744685,0.816863391798673,2.65922555339359e-28
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65804879965423,CA6;Carbonic anhydrase 6,-0.31872555946346,0.727075060797855,0.686924385632039,0.769572539702175,3.95013980559592e-28
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70908805155003,CA6;Carbonic anhydrase 6,-0.287823067531783,0.749894261144502,0.714386948321806,0.78716640081188,2.91418687710527e-31
primary,Circulatory system disorders,I50 (heart failure),0.905661860044792,CA6;Carbonic anhydrase 6,-0.37044041151548,0.690430190262381,0.627586044410165,0.759567316500429,2.7865519462737e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55593100467565,CA6;Carbonic anhydrase 6,-0.245696235597944,0.782159781141319,0.726620488227713,0.841944224181186,6.23403025114607e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,CD300LG;CMRF35-like molecule 9,1.52854043402309,4.61144120526908,3.91728490637401,5.42860437724393,2.56520274756292e-75
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,CD300LG;CMRF35-like molecule 9,1.91721051491414,6.80195802042432,4.36093688991848,10.6093332876641,2.83334429934137e-17
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,CD300LG;CMRF35-like molecule 9,0.237338749949933,1.26787053611908,1.15800307396052,1.38816185596213,2.86643966386949e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56746700090086,CD300LG;CMRF35-like molecule 9,0.185063033764599,1.20329428590601,1.13646671716578,1.27405151125321,2.1816202831895e-10
primary,Circulatory system disorders,I85 (oesophageal varices),0.0489600877364772,CD300LG;CMRF35-like molecule 9,0.989378584491986,2.68956261702465,1.80205159100345,4.01417312745661,1.28290239511557e-06
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174394946421997,PGF;Placenta growth factor,0.55043738505716,1.73401128265244,1.41498223867683,2.12497022660698,1.11998422978424e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,PGF;Placenta growth factor,1.58231836360804,4.86622442142953,4.22449328694275,5.60543916424458,1.35109882410715e-106
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387544325382215,PGF;Placenta growth factor,1.71973950790579,5.58307392821703,3.9260625873508,7.93943392251674,1.03988913423552e-21
primary,Circulatory system disorders,I20 (angina pectoris),4.58852481252543,PGF;Placenta growth factor,0.197915665735116,1.21885959785891,1.16672553868803,1.2733232195837,7.07841984166491e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65274090724126,PGF;Placenta growth factor,0.32514173455126,1.38422682484562,1.30688361243062,1.46614731747882,1.50703608346942e-28
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,PGF;Placenta growth factor,0.307610576047902,1.36017120254286,1.29543936008521,1.42813763208893,4.06276011553372e-35
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00180208111302,PGF;Placenta growth factor,0.294090881529897,1.34190585258229,1.22753542262144,1.4669322644467,9.76821733043237e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354603057724727,PGF;Placenta growth factor,0.621120995686026,1.86101306059205,1.61828845379961,2.14014355942693,3.01284581230665e-18
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542562055535101,PGF;Placenta growth factor,0.32834386795905,1.38866640808082,1.23039675239164,1.56729476827997,1.04790603915934e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304222295425039,PGF;Placenta growth factor,0.511361243165458,1.66755960478192,1.42271189119293,1.95454543728371,2.76275475729653e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.381731160501482,PGF;Placenta growth factor,0.386571302608275,1.47192534544111,1.2733831576138,1.70142365210159,1.70334648492793e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16055961400585,PGF;Placenta growth factor,0.337075478354142,1.40084479320774,1.31620043350387,1.4909326001612,2.98160895792054e-26
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,PGF;Placenta growth factor,0.734667802428772,2.08478931551145,1.90209225453557,2.28503453484276,1.50643660671095e-55
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70131958842792,PGF;Placenta growth factor,0.265619947541642,1.30423928513631,1.21693401413438,1.3978080102419,5.73768650300959e-14
primary,Circulatory system disorders,I63 (cerebral infarction),0.366229387486193,PGF;Placenta growth factor,0.493454720358646,1.63796516818203,1.41647711847522,1.89408629139429,2.79312148356486e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,PGF;Placenta growth factor,0.388967035342886,1.47545591263313,1.3730585764033,1.58548964154653,3.00508336747339e-26
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354603057724727,PGF;Placenta growth factor,0.478615453401742,1.61383842014466,1.39475126224577,1.86733973062795,1.27971774031635e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174394946421997,PGF;Placenta growth factor,0.865621062440893,2.3764815711908,1.95411690715882,2.89013653048061,4.31785718312834e-18
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.166644059914352,PGF;Placenta growth factor,0.540166964809231,1.71629339886334,1.37713325497625,2.13898184532091,1.51880187625276e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,PGF;Placenta growth factor,0.445577732026777,1.56139200147218,1.45018637065325,1.68112528954683,3.08285101620835e-32
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246090646617706,PGF;Placenta growth factor,0.611296379196733,1.84281884294214,1.55062205163967,2.19007674004867,3.921664507848e-12
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55585482589571,PGF;Placenta growth factor,0.241508896214821,1.27316878125012,1.20327289936362,1.34712478474934,5.14862518713986e-17
primary,Circulatory system disorders,I85 (oesophageal varices),0.0523184839265991,PGF;Placenta growth factor,0.844532775189787,2.32689037963571,1.66419345821935,3.25347922268276,7.88375430443014e-07
primary,Circulatory system disorders,I95 (hypotension),0.519309396012168,PGF;Placenta growth factor,0.420246349597309,1.52233653642127,1.34847016280909,1.71862054796625,1.10818972525668e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0213149378960218,PGF;Placenta growth factor,1.44414752941137,4.23823762947941,2.79809635908742,6.41959957726177,9.29569916062704e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,FGFR2;Fibroblast growth factor receptor 2,1.21892322349027,3.38354245236457,2.88151277982713,3.97303791504963,4.78778164566967e-50
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,FGFR2;Fibroblast growth factor receptor 2,1.31249323220193,3.71542559260587,2.4349209531946,5.66933695160798,1.14704028049241e-09
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6654950205038,FGFR2;Fibroblast growth factor receptor 2,0.192544135101391,1.21233000883456,1.14636872394097,1.28208666167038,1.52429839676249e-11
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00175746924428,FGFR2;Fibroblast growth factor receptor 2,0.217655593956615,1.24315884246339,1.13734805155399,1.35881351841535,1.62204690316733e-06
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542862722124585,FGFR2;Fibroblast growth factor receptor 2,0.298620369921566,1.34799778581941,1.19469352259651,1.5209742048528,1.2480189547063e-06
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,FGFR2;Fibroblast growth factor receptor 2,0.480822698518608,1.61740449126567,1.47150837239037,1.77776582005907,2.0879207354957e-23
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56024214020699,FGFR2;Fibroblast growth factor receptor 2,0.282694401774079,1.32669966279714,1.23476911730229,1.42547458516905,1.20275982381497e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40597539543057,FGFR2;Fibroblast growth factor receptor 2,0.18621758078357,1.20468434802837,1.11733699583279,1.29886004293885,1.24098819948271e-06
primary,Circulatory system disorders,I85 (oesophageal varices),0.0566295645381761,FGFR2;Fibroblast growth factor receptor 2,1.03556059352599,2.81668480838223,1.96276699458164,4.04210654228079,1.91916928498391e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214801796524116,FGFR2;Fibroblast growth factor receptor 2,1.85694367426536,6.40413371135011,3.74391762072691,10.9545488837139,1.20232707648551e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,CLEC7A;C-type lectin domain family 7 member A,1.62243020662547,5.0653853037589,4.30595547678941,5.95875373394891,2.43199965996323e-85
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387544325382215,CLEC7A;C-type lectin domain family 7 member A,1.86563038123972,6.4600068698597,4.19073295648764,9.95808828477846,2.92511071969824e-17
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65274090724126,CLEC7A;C-type lectin domain family 7 member A,0.218129355792989,1.24374794321521,1.1780928583509,1.31306198427978,3.19080095337768e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,CLEC7A;C-type lectin domain family 7 member A,0.213103450485061,1.23751266590745,1.1816276912791,1.29604071534885,1.58807616813198e-19
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00180208111302,CLEC7A;C-type lectin domain family 7 member A,0.273027468035004,1.31393633557832,1.20407803451592,1.43381794573394,8.85559025330724e-10
primary,Circulatory system disorders,I46 (cardiac arrest),0.0833220299571763,CLEC7A;C-type lectin domain family 7 member A,0.746923698869923,2.11049749405606,1.56817582691735,2.84037006307689,8.268282478933e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16055961400585,CLEC7A;C-type lectin domain family 7 member A,0.190419611188407,1.20975711879133,1.13966339817473,1.28416187517317,4.02862025752126e-10
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,CLEC7A;C-type lectin domain family 7 member A,0.493856199135689,1.63862290846014,1.49490670347182,1.79615559278344,5.36380489639442e-26
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70131958842792,CLEC7A;C-type lectin domain family 7 member A,0.184829127792255,1.2030128611008,1.1249690310595,1.28647091965804,6.63045335536285e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,CLEC7A;C-type lectin domain family 7 member A,0.347669047307084,1.41576362141435,1.31976924928437,1.5187402137208,2.86674834642095e-22
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354603057724727,CLEC7A;C-type lectin domain family 7 member A,0.442837057588479,1.55711859301116,1.34561838457312,1.80186176147572,2.7560883169267e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.174394946421997,CLEC7A;C-type lectin domain family 7 member A,0.704043082777316,2.02191095748664,1.64539506869815,2.48458500804862,2.13462473907548e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,CLEC7A;C-type lectin domain family 7 member A,0.297555468105163,1.34656306458299,1.25067289191232,1.44980521975386,2.91427733313309e-15
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246090646617706,CLEC7A;C-type lectin domain family 7 member A,0.569745125131671,1.76781642203132,1.48444802029463,2.10527742250169,1.63828390308259e-10
primary,Circulatory system disorders,I85 (oesophageal varices),0.0523184839265991,CLEC7A;C-type lectin domain family 7 member A,1.13893714182332,3.12344681934141,2.14845364056962,4.54090321011877,2.4367647846781e-09
primary,Circulatory system disorders,I95 (hypotension),0.519309396012168,CLEC7A;C-type lectin domain family 7 member A,0.373612645186968,1.4529742248787,1.28721180731315,1.64008291888537,1.49323137641146e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303565405448304,PIGR;Polymeric immunoglobulin receptor,0.833282149235763,2.30085812053232,1.96989714740335,2.68742360371344,7.26069934811525e-26
primary,Circulatory system disorders,I20 (angina pectoris),4.62094006071308,PIGR;Polymeric immunoglobulin receptor,0.359308682297004,1.43233887099143,1.373980942291,1.49317547151137,2.69748979060851e-64
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6586774071943,PIGR;Polymeric immunoglobulin receptor,0.483724303791462,1.6221043759735,1.53648723092058,1.71249233550474,1.89505295011849e-68
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.7181801948374,PIGR;Polymeric immunoglobulin receptor,0.416061670638535,1.51597935740276,1.44754940556101,1.58764419593721,9.3550968974446e-70
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00394833435844,PIGR;Polymeric immunoglobulin receptor,0.243769847313954,1.27605061021502,1.16941407368701,1.39241111978094,4.37703874234663e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.353167595881034,PIGR;Polymeric immunoglobulin receptor,0.373340151335234,1.45257835227457,1.25507326343417,1.68116390570166,5.53257821374969e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.299597230213686,PIGR;Polymeric immunoglobulin receptor,0.394962911058685,1.4843291377037,1.26823819739159,1.73723910348044,8.64635368801474e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14479871431122,PIGR;Polymeric immunoglobulin receptor,0.272147044222996,1.3127800238379,1.23667973516443,1.39356321769007,4.17922557166863e-19
primary,Circulatory system disorders,I50 (heart failure),0.908712128727604,PIGR;Polymeric immunoglobulin receptor,0.634369024513748,1.88583185230659,1.72216357904958,2.06505457346668,1.0869676724996e-42
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7082994385032,PIGR;Polymeric immunoglobulin receptor,0.249841961566382,1.28382250735632,1.20063279955803,1.37277628180854,2.68305930049403e-13
primary,Circulatory system disorders,I63 (cerebral infarction),0.359119858732961,PIGR;Polymeric immunoglobulin receptor,0.397937489749475,1.48875096480276,1.2892817663306,1.71908072624741,5.89896942602484e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56147695482232,PIGR;Polymeric immunoglobulin receptor,0.387888868164154,1.47386598175412,1.37446584535356,1.58045464681101,1.31333264491005e-27
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353167595881034,PIGR;Polymeric immunoglobulin receptor,0.472242098646254,1.60358556262975,1.38639903762279,1.85479547149989,2.01827183032002e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.176583797940517,PIGR;Polymeric immunoglobulin receptor,0.745907356508217,2.10835359570048,1.72157927684342,2.58202160324182,5.44815456479874e-13
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41068629590682,PIGR;Polymeric immunoglobulin receptor,0.435170953094966,1.5452271977449,1.43536223306623,1.66350140587848,6.24063302790518e-31
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.148806571298188,PIGR;Polymeric immunoglobulin receptor,0.679522726011891,1.97293587651264,1.58079973494467,2.46234604345183,1.85146312780336e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249995039780956,PIGR;Polymeric immunoglobulin receptor,0.763308194562232,2.14536176798474,1.80737089873036,2.54655926946917,2.62276129679375e-18
primary,Circulatory system disorders,I85 (oesophageal varices),0.0496021904327295,PIGR;Polymeric immunoglobulin receptor,1.0723056903252,2.92210921762544,1.99380464876972,4.282627330115,3.84068280738889e-08
primary,Circulatory system disorders,I95 (hypotension),0.511894605265768,PIGR;Polymeric immunoglobulin receptor,0.304938199837111,1.35654116595065,1.20105148842654,1.53216073802927,9.13796831356839e-07
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0198408761730918,PIGR;Polymeric immunoglobulin receptor,1.7804066621971,5.93226835741977,3.22925169365001,10.8978212920488,9.58638909714693e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.313023810004644,LCN2;Neutrophil gelatinase-associated lipocalin,1.48087597991154,4.39679549902324,3.75014426280582,5.15495119800195,2.26254725137804e-74
primary,Circulatory system disorders,I15 (secondary hypertension),0.0403901690328574,LCN2;Neutrophil gelatinase-associated lipocalin,1.72634463351042,5.6200728896518,3.71439713885155,8.5034577898595,3.07492413017124e-16
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65565361391037,LCN2;Neutrophil gelatinase-associated lipocalin,0.259148712371004,1.29582649593053,1.22511138418878,1.37062338104668,1.41487976366005e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6795443988933,LCN2;Neutrophil gelatinase-associated lipocalin,0.246158671535448,1.27910251460081,1.21930476298139,1.3418328973452,6.98682583145358e-24
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.349374962134216,LCN2;Neutrophil gelatinase-associated lipocalin,0.548328960224446,1.73035910173133,1.49212422448211,2.00663093046671,4.00963039362717e-13
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.537189248137003,LCN2;Neutrophil gelatinase-associated lipocalin,0.308270428608148,1.36106901117132,1.20577776965041,1.53636009868383,6.1204379669754e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.306965284649716,LCN2;Neutrophil gelatinase-associated lipocalin,0.427550407479227,1.53349647741202,1.30712642471779,1.79906962461017,1.54929714772193e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.379667588908859,LCN2;Neutrophil gelatinase-associated lipocalin,0.481156203663775,1.61794399394378,1.40092997731805,1.86857502510594,5.82953569142695e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16289355170951,LCN2;Neutrophil gelatinase-associated lipocalin,0.322925487740045,1.38116243353708,1.29884012491093,1.46870244553377,7.10856704115294e-25
primary,Circulatory system disorders,I50 (heart failure),0.922915362400791,LCN2;Neutrophil gelatinase-associated lipocalin,0.672333176045558,1.9588022236301,1.78444691584008,2.15019349538449,2.30492384626346e-45
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70446513318658,LCN2;Neutrophil gelatinase-associated lipocalin,0.247826920891663,1.28123815744443,1.19634623925102,1.37215394860881,1.38736874438589e-12
primary,Circulatory system disorders,I63 (cerebral infarction),0.365531029747359,LCN2;Neutrophil gelatinase-associated lipocalin,0.403323851755342,1.49679155175175,1.29244912878821,1.73344149451823,7.22702724327368e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56915806692651,LCN2;Neutrophil gelatinase-associated lipocalin,0.419850461253835,1.52173398041197,1.41671700692641,1.63453554649164,1.20722127217575e-30
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351394470585859,LCN2;Neutrophil gelatinase-associated lipocalin,0.378797954877576,1.46052791338935,1.25819560552055,1.69539758081329,6.39906162164095e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.165599693034715,LCN2;Neutrophil gelatinase-associated lipocalin,0.626715360257216,1.87145342249086,1.50668794538234,2.32452773202748,1.46397576658995e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3995193569885,LCN2;Neutrophil gelatinase-associated lipocalin,0.259645639704516,1.29647058755596,1.20234794320023,1.3979613754101,1.45793124192611e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248399539552073,LCN2;Neutrophil gelatinase-associated lipocalin,0.515303660644044,1.67414679711361,1.4023422811293,1.99863295573511,1.19150818148231e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,XCL1;Lymphotactin,0.855806997863404,2.35327270054314,2.01473480122884,2.74869546093307,3.46598315614636e-27
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,XCL1;Lymphotactin,0.233723626027477,1.26329530201537,1.19686982925413,1.33340734396208,2.23353499299701e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,XCL1;Lymphotactin,0.199326723307177,1.22058069292028,1.16563362917379,1.27811791856568,2.22341255739955e-17
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359334939010177,XCL1;Lymphotactin,0.3713197414513,1.44964651137194,1.25535802422615,1.67400452092404,4.24719184567753e-07
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547742988112811,XCL1;Lymphotactin,0.293177951171508,1.34068134502148,1.19293743111928,1.50672317088932,8.59302294864384e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,XCL1;Lymphotactin,0.222959571045766,1.24977004581861,1.17774348111928,1.32620149673089,1.81408355043084e-13
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,XCL1;Lymphotactin,0.448813498595556,1.56645248436664,1.43026010521782,1.71561338866033,3.99955053602055e-22
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,XCL1;Lymphotactin,0.254870151682569,1.2902940674812,1.20363911956296,1.38318766274538,6.69887572959996e-13
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,XCL1;Lymphotactin,0.216901663220152,1.24222194002591,1.15443646224619,1.33668278744357,6.60928655281549e-09
primary,Circulatory system disorders,I85 (oesophageal varices),0.0563281796286224,XCL1;Lymphotactin,0.991720504872044,2.6958687398675,1.88714303456852,3.85116979977963,5.04024941770404e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,SPINK5;Serine protease inhibitor Kazal-type 5,1.24883645384628,3.48628414410478,2.95841504340068,4.10834076866552,2.91381997961792e-50
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,SPINK5;Serine protease inhibitor Kazal-type 5,1.77499336254906,5.90024197362241,3.69569989850612,9.41982744902196,1.03464434757978e-13
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.1010764961722,ADGRG1;Adhesion G-protein coupled receptor G1,0.214334966988388,1.23903762199015,1.21476751414342,1.26379262766962,4.47567834746587e-100
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,ADGRG1;Adhesion G-protein coupled receptor G1,0.491493974553199,1.63475668139049,1.39052165983087,1.92188980909214,2.63015072383551e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.61102473776395,ADGRG1;Adhesion G-protein coupled receptor G1,0.310730740517206,1.36442178821596,1.30823627823347,1.42302032678092,1.55259155033781e-47
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,ADGRG1;Adhesion G-protein coupled receptor G1,0.410287249002494,1.50725067918978,1.42708382701899,1.5919209277731,5.28881782773245e-49
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,ADGRG1;Adhesion G-protein coupled receptor G1,0.386024088610852,1.47112010762771,1.40388741003688,1.54157260446529,7.72012771041116e-59
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541200086592013,ADGRG1;Adhesion G-protein coupled receptor G1,0.329880374790495,1.39080174356211,1.23168194763815,1.57047807155462,1.02947773646322e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383760061401609,ADGRG1;Adhesion G-protein coupled receptor G1,0.354339813516641,1.42523941982001,1.23682921548215,1.64235076143235,9.67761730169809e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,ADGRG1;Adhesion G-protein coupled receptor G1,0.332280782132755,1.39414424435576,1.31263999869252,1.48070923940021,3.05360446661024e-27
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,ADGRG1;Adhesion G-protein coupled receptor G1,0.548504540643565,1.73066294558137,1.57613878332075,1.90033660925331,1.40438309492326e-30
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71019227363076,ADGRG1;Adhesion G-protein coupled receptor G1,0.197437191658724,1.21827654463762,1.13834094617509,1.3038253119166,1.18390925489896e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,ADGRG1;Adhesion G-protein coupled receptor G1,0.235655732326627,1.26573848230806,1.17951808186573,1.35826142068238,5.87750137157587e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,ADGRG1;Adhesion G-protein coupled receptor G1,0.225275128886192,1.25266731374812,1.16137908450092,1.35113109911674,5.37291866046873e-09
primary,Circulatory system disorders,I85 (oesophageal varices),0.0570720091315214,ADGRG1;Adhesion G-protein coupled receptor G1,1.37119857333931,3.9400703297438,2.65350487339702,5.85043365059035,1.05833327155151e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304309413958967,AGER;Advanced glycosylation end product-specific receptor,1.14752906899234,3.15039886613855,2.71275196278979,3.65865112325278,4.15953151381639e-51
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392657308334151,AGER;Advanced glycosylation end product-specific receptor,1.13252847816378,3.10349370391177,2.09042516945858,4.60751875309394,1.94029443751453e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16943162854618,AGER;Advanced glycosylation end product-specific receptor,0.312742369614859,1.36716926130851,1.28831643831745,1.45084835796087,5.83073812852778e-25
primary,Circulatory system disorders,I08 (multiple valve diseases),0.176173511333829,MMP12;Macrophage metalloelastase,0.50385337868816,1.6550866743864,1.35070696807936,2.02805787226123,1.17795511223296e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305367419645304,MMP12;Macrophage metalloelastase,0.810033275139612,2.24798278737306,1.93328514151838,2.61390650752978,6.47225693385768e-26
primary,Circulatory system disorders,I20 (angina pectoris),4.60400109619073,MMP12;Macrophage metalloelastase,0.397964456685098,1.48879111239552,1.42834272016885,1.55179771986786,5.38493319821139e-79
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66609247151861,MMP12;Macrophage metalloelastase,0.509182140075299,1.66392977681513,1.57691443274504,1.75574669410087,4.65217689749677e-77
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69377128763262,MMP12;Macrophage metalloelastase,0.51627815579732,1.67577904023061,1.60009143123988,1.75504682848039,2.95886722278319e-106
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358219473045452,MMP12;Macrophage metalloelastase,0.42993000053138,1.53714992010463,1.33156288327328,1.77447862700207,4.38505659686485e-09
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.5500528520534,MMP12;Macrophage metalloelastase,0.394619643256469,1.48381970274415,1.32152170198459,1.66604975684116,2.43812907350482e-11
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.3777943076381,MMP12;Macrophage metalloelastase,0.626382121204913,1.87082988502521,1.63065256996069,2.14638269560253,4.07151786281007e-19
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38170927455663,MMP12;Macrophage metalloelastase,0.352859313299668,1.4231309137567,1.23915994584613,1.63441499580352,5.84941619260729e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16497670594683,MMP12;Macrophage metalloelastase,0.238875274801537,1.26982014813653,1.19693276250643,1.34714602116576,2.3712940422004e-15
primary,Circulatory system disorders,I50 (heart failure),0.910229808558117,MMP12;Macrophage metalloelastase,0.601401994932958,1.82467519332213,1.66887458599708,1.99502082964249,8.0322963369317e-40
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70692557647887,MMP12;Macrophage metalloelastase,0.225765724895778,1.253282018107,1.17250070803867,1.33962888563011,3.10818871020364e-11
primary,Circulatory system disorders,I63 (cerebral infarction),0.366049406882511,MMP12;Macrophage metalloelastase,0.401396634926084,1.49390968776369,1.29748027057055,1.72007714168387,2.39575080773063e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56011431703402,MMP12;Macrophage metalloelastase,0.389591294364547,1.47637726684957,1.37758843019843,1.58225039227155,2.88208253279424e-28
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.131151391770739,MMP12;Macrophage metalloelastase,0.694921868332964,2.00355252692669,1.59214325620827,2.52126981193533,3.1052381637039e-09
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.342559605371334,MMP12;Macrophage metalloelastase,0.473682090823847,1.6058963766738,1.38786056593201,1.85818607136676,1.98565426948268e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.176173511333829,MMP12;Macrophage metalloelastase,1.06285832495424,2.89463297759245,2.38506490907051,3.51307003977139,5.41204572195582e-27
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.16834357749677,MMP12;Macrophage metalloelastase,1.59464245037613,4.92656726489862,4.00904907782827,6.0540703155269,5.98037789181304e-52
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41330305758916,MMP12;Macrophage metalloelastase,0.435840381662916,1.54626196328721,1.4374930928153,1.66326090264979,1.11324797437427e-31
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150726226363387,MMP12;Macrophage metalloelastase,0.961488828992073,2.61558773884684,2.1184979025711,3.22931602212258,3.87559430458923e-19
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242727948948831,MMP12;Macrophage metalloelastase,0.671834557838615,1.95782577263595,1.65088399114934,2.32183592338853,1.14582573701259e-14
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,KYNU;Kynureninase,-0.472283490996485,0.623576709475089,0.53216561391505,0.730689662075483,5.23609643347701e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.202811385411567,AHNAK;Neuroblast differentiation-associated protein AHNAK,0.899002449410774,2.45715075600168,2.02657150088034,2.97921382744053,5.91616119114494e-20
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16798377508916,AHNAK;Neuroblast differentiation-associated protein AHNAK,0.200945573996352,1.22255823105382,1.14630750059314,1.30388105071637,9.61616780636304e-10
primary,Circulatory system disorders,I50 (heart failure),0.930134974473739,AHNAK;Neuroblast differentiation-associated protein AHNAK,0.297022642596269,1.34584577254556,1.22165933745072,1.48265624299035,1.81894258386348e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.165512739818635,AHNAK;Neuroblast differentiation-associated protein AHNAK,0.591490433883171,1.8066791455366,1.44883914163001,2.25289988455489,1.50317362543014e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40569270578362,AHNAK;Neuroblast differentiation-associated protein AHNAK,0.202715513164362,1.22472400082712,1.1309735053184,1.32624581490945,6.06634710914632e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.290726420505112,EPHB6;Ephrin type-B receptor 6,1.87025112295843,6.4899259640757,5.42931932609849,7.75771998097794,8.90384790805031e-94
primary,Circulatory system disorders,I15 (secondary hypertension),0.0395546150347091,EPHB6;Ephrin type-B receptor 6,1.98961814336844,7.31274081051658,4.69722553437416,11.3846307294502,1.25480276138639e-18
primary,Circulatory system disorders,I50 (heart failure),0.903822953543104,EPHB6;Ephrin type-B receptor 6,0.31993484581408,1.3770380416205,1.25669062689309,1.50891056835369,7.04988825323911e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56438502462274,EPHB6;Ephrin type-B receptor 6,0.289586154551119,1.33587452801967,1.24501695125108,1.43336261632304,7.75797235874999e-16
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357969266064118,EPHB6;Ephrin type-B receptor 6,0.382163841166615,1.46545216685742,1.26617911494315,1.69608709226224,2.98001316831851e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40616656448391,EPHB6;Ephrin type-B receptor 6,0.231210918190436,1.26012499470554,1.16932312388633,1.35797793599094,1.36543814846485e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306243094993506,CXCL16;C-X-C motif chemokine 16,1.17434456220973,3.23602123798134,2.77520501979138,3.77335489738106,9.49721588962317e-51
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387649487333553,CXCL16;C-X-C motif chemokine 16,1.55423962195981,4.73148743785419,3.14391730314055,7.12072590211231,9.17666148177049e-14
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00595041963057,CXCL16;C-X-C motif chemokine 16,0.259115619652482,1.29578361421859,1.18750730786948,1.41393249856273,5.88125848433613e-09
primary,Circulatory system disorders,I50 (heart failure),0.912914542670517,CXCL16;C-X-C motif chemokine 16,0.294129371193732,1.34195750308145,1.22492252757394,1.47017456168705,2.658302354394e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56610392882755,CXCL16;C-X-C motif chemokine 16,0.22532960549664,1.25273555667619,1.16792980520998,1.34369922572415,2.96881248748705e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.176380516736766,CXCL16;C-X-C motif chemokine 16,0.562033591637524,1.75423627565646,1.43000267945675,2.15198541585819,7.03045688964173e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40716763902079,CXCL16;C-X-C motif chemokine 16,0.318025403971502,1.37441117628642,1.27639212114054,1.47995749128651,3.62011503789948e-17
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,CXCL17;C-X-C motif chemokine 17,0.370442119539954,1.4483748279401,1.25392039691778,1.67298470251143,4.74889031209427e-07
primary,Circulatory system disorders,I20 (angina pectoris),4.58852481252543,CXCL17;C-X-C motif chemokine 17,0.200021669927064,1.22142922615563,1.17358626182793,1.27122257905732,1.00639426327664e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65274090724126,CXCL17;C-X-C motif chemokine 17,0.391406417327169,1.47905950668926,1.40621602582038,1.55567635708862,4.13556334394276e-52
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.110450132733931,CXCL17;C-X-C motif chemokine 17,0.661488985568174,1.93767535812306,1.54658038130896,2.42766935288525,8.87785135765501e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,CXCL17;C-X-C motif chemokine 17,0.279396531845175,1.32233158650715,1.26567214508792,1.38152746069405,7.06450019021242e-36
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00180208111302,CXCL17;C-X-C motif chemokine 17,0.24459448733509,1.27710332661358,1.17580330697168,1.38713073621824,6.5992583398851e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16055961400585,CXCL17;C-X-C motif chemokine 17,0.196716161654765,1.21739844730112,1.1497436495456,1.28903428175222,1.54943478897747e-11
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,CXCL17;C-X-C motif chemokine 17,0.466491049115875,1.59438973082063,1.46717374046626,1.73263639038308,4.01923436488049e-28
primary,Circulatory system disorders,I60 (subarachnoid haemorrhage),0.189896719437285,CXCL17;C-X-C motif chemokine 17,0.52417908732535,1.68907169872674,1.41462420633146,2.01676402161832,6.87109006998269e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,CXCL17;C-X-C motif chemokine 17,0.263527378887517,1.3015129284299,1.21821812479156,1.39050295542108,5.74266115556512e-15
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354603057724727,CXCL17;C-X-C motif chemokine 17,0.42333116631994,1.52703991642912,1.337059468471,1.74401435489961,4.23530954178721e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174394946421997,CXCL17;C-X-C motif chemokine 17,0.728687005533976,2.07235782620935,1.73465453979777,2.47580533260058,9.82163063602855e-16
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,CXCL17;C-X-C motif chemokine 17,0.347798393016277,1.41594675620761,1.32223550362097,1.51629963869854,2.39526492136528e-23
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153080008525975,CXCL17;C-X-C motif chemokine 17,0.868658313539015,2.38371051495407,1.9800964731041,2.86959544460735,4.41308632813115e-20
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246090646617706,CXCL17;C-X-C motif chemokine 17,0.592570034587184,1.80863069086935,1.5510994462435,2.10892021390163,3.9996831300169e-14
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311917606669936,NECTIN2;Nectin-2,1.77829971514502,5.91978254018879,5.00978036921118,6.99508216737291,7.76836157974453e-97
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392349190779794,NECTIN2;Nectin-2,1.92950985358436,6.88613420027575,4.50380294883644,10.5286232019671,5.24687559405804e-19
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00833742030407,NECTIN2;Nectin-2,0.294807534129232,1.34286787757729,1.23097910235705,1.46492668573823,3.10091195200963e-11
primary,Circulatory system disorders,I50 (heart failure),0.9122118685630209,NECTIN2;Nectin-2,0.487056713551121,1.62751890913809,1.48643103262712,1.7819984523066,6.45775232293646e-26
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57920549288867,NECTIN2;Nectin-2,0.351997308050714,1.42190469601809,1.32641947144586,1.52426363460605,3.25302404157258e-23
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357037763609612,NECTIN2;Nectin-2,0.48629881133586,1.62628587626967,1.40661039237442,1.88026888304846,5.09804170714254e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.176557135850907,NECTIN2;Nectin-2,0.626904898404123,1.87180816792241,1.52697111237496,2.29452003977448,1.59584508993928e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40264835703776,NECTIN2;Nectin-2,0.329017728806105,1.38960249136236,1.29049894270592,1.49631667264412,2.89014283193973e-18
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.15105443845022,NECTIN2;Nectin-2,0.589778011269336,1.80358799474547,1.44621746851621,2.2492672959672,1.65321320370608e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249141736145169,NECTIN2;Nectin-2,0.585487107011203,1.79586555132029,1.51152475471049,2.13369517658787,2.78608061912837e-11
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55223148602256,NECTIN2;Nectin-2,0.223386046266774,1.25030315544605,1.18306866523513,1.32135862140145,2.35610432628762e-15
primary,Circulatory system disorders,I95 (hypotension),0.521824423737126,NECTIN2;Nectin-2,0.410291155591684,1.50725656741049,1.33607278237438,1.70037320569074,2.55177588261512e-11
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.55981805101069,GNPDA2;Glucosamine-6-phosphate isomerase 2,-0.270527207062285,0.762977141347223,0.718352105301517,0.810374346956271,1.39611344576967e-18
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,1.63201039504602,5.11414584403694,4.37141948105326,5.98306518682085,2.32783818759105e-92
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,1.64359061309916,5.17371300274102,3.44019839328629,7.7807449381318,2.91841693722519e-15
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6654950205038,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.255579964921505,1.29121026041689,1.22357228147867,1.3625872062017,1.27825152198127e-20
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68677992579574,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.257196350507868,1.29329904175404,1.23502184987844,1.3543261696678,8.01495240750851e-28
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00175746924428,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.328191664344464,1.38845506411812,1.2734490169515,1.51384738565365,1.01025451439257e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359304823276703,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.517485240064947,1.67780306808642,1.45580436705819,1.93365482270715,8.91393188119906e-13
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542862722124585,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.351194934111226,1.4207642543371,1.26416865805596,1.59675772179497,3.76433054187647e-09
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0585823081429408,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.840831932420296,2.31829483938088,1.64956515766106,3.25812589902215,1.28216320440858e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.302675258738527,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.575390206709827,1.77782411048155,1.52465043583143,2.07303818208397,2.12183065401823e-13
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386643233743409,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.349715935782733,1.41866449952943,1.2362118856138,1.62804530974543,6.39117920067478e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16754540128881,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.290265693631994,1.33678261547412,1.25988604868713,1.41837252892511,7.78265483370033e-22
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.664944041697627,1.94438171399264,1.77790381098723,2.12644813872673,5.03321938650453e-48
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70474516695957,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.215452987065658,1.24042366559594,1.16019692095875,1.32619802929573,2.69150804175955e-10
primary,Circulatory system disorders,I63 (cerebral infarction),0.363210310486233,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.391310040997077,1.47891696723085,1.28331350202407,1.70433443777658,6.43632494760593e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56024214020699,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.36620459814116,1.44225029419927,1.34564772760338,1.54578785253294,4.06586812648757e-25
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34954110525288,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.451667700724788,1.57092984298656,1.35962634403776,1.81507263551319,8.8932096257694e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.173794180824057,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.67982382215488,1.97353000933648,1.61505976085345,2.41156444619331,2.98856794905894e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40597539543057,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.318939362695128,1.37566790558271,1.27846733379988,1.48025853803046,1.4542761666855e-17
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146455770357352,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.560383321619006,1.75134369954763,1.40501788741592,2.18303608901829,6.20059142950002e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246045694200351,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.462892725668678,1.58866291052333,1.33849118088378,1.88559318082769,1.19182823194148e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56004686584651,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.19673764284439,1.2174245987489,1.15221466229736,1.28632511122864,2.48234742450074e-12
primary,Circulatory system disorders,I95 (hypotension),0.509666080843585,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.362363174156171,1.43672062702472,1.27363150704012,1.62069338635895,3.76097955950681e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307398976633786,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,1.11343056402958,3.04478583096433,2.61985500760661,3.53863886723657,9.26472295299743e-48
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389112628650362,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,1.24443381721448,3.47096903998028,2.30511348146013,5.22647851110145,2.53772943732787e-09
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66153037996848,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,0.209980812416133,1.23365438888259,1.16857169384521,1.30236181419168,3.11472095160661e-14
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70046109846495,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,0.208619534607783,1.23197618504981,1.17634564625138,1.29023754656336,8.82607566862318e-19
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00001945563143,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,0.21205314300456,1.23621357943678,1.1336627414847,1.34804113962716,1.59220409518614e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16930290472577,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,0.219438421450974,1.24537715707616,1.17347287022004,1.32168736297779,4.76017815671951e-13
primary,Circulatory system disorders,I50 (heart failure),0.910523551041849,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,0.354736674681815,1.4258051542484,1.30208591086845,1.56127972886628,1.86261573698437e-14
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,TGFBR2;TGF-beta receptor type-2,1.78675367665584,5.97004029316643,5.09862739450655,6.99038747966405,3.84151361732164e-109
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390548720952938,TGFBR2;TGF-beta receptor type-2,1.87846192333234,6.54343281704563,4.46432410408091,9.59081644454318,6.01198322126264e-22
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00175746924428,TGFBR2;TGF-beta receptor type-2,0.29923920154861,1.34883222764533,1.23641815851209,1.47146688667535,1.58645854087426e-11
primary,Circulatory system disorders,I50 (heart failure),0.902167545401288,TGFBR2;TGF-beta receptor type-2,0.36694326343612,1.44331602800006,1.31847330058612,1.57997978097533,1.87032666560931e-15
primary,Circulatory system disorders,I63 (cerebral infarction),0.363210310486233,TGFBR2;TGF-beta receptor type-2,0.35492270011953,1.42607041494817,1.23678498023984,1.64432529573255,1.03519797376803e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56024214020699,TGFBR2;TGF-beta receptor type-2,0.421575047403457,1.52436060602807,1.42196244541423,1.63413264865329,1.46011495588163e-32
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34954110525288,TGFBR2;TGF-beta receptor type-2,0.600270677323976,1.82261207338726,1.57788076094998,2.1053015235809,3.36283926984933e-16
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126928334309705,TGFBR2;TGF-beta receptor type-2,0.736916920350446,2.08948352946543,1.65024412823783,2.6456336642563,9.34528576672909e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.173794180824057,TGFBR2;TGF-beta receptor type-2,0.573696620296098,1.77481575989194,1.45030309677843,2.17193977490489,2.56864083078031e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40597539543057,TGFBR2;TGF-beta receptor type-2,0.356719208266794,1.42863466472534,1.32720515482897,1.53781576105911,2.22858584989437e-21
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146455770357352,TGFBR2;TGF-beta receptor type-2,0.640554100853588,1.8975320121689,1.52354366166811,2.36332428652781,1.06992115933532e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246045694200351,TGFBR2;TGF-beta receptor type-2,0.555882508322091,1.74347894071937,1.46922213908341,2.06893071910031,1.94224041848261e-10
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56004686584651,TGFBR2;TGF-beta receptor type-2,0.222315417680987,1.24896526146849,1.18199844838025,1.31972611850099,2.64248669721342e-15
primary,Circulatory system disorders,I85 (oesophageal varices),0.0566295645381761,TGFBR2;TGF-beta receptor type-2,1.10983683322274,3.03386332834568,2.16546567781814,4.25050684911096,1.11214614100777e-10
primary,Circulatory system disorders,I95 (hypotension),0.509666080843585,TGFBR2;TGF-beta receptor type-2,0.437940233796062,1.54951229618412,1.37279231879012,1.7489814906175,1.35762241951539e-12
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214801796524116,TGFBR2;TGF-beta receptor type-2,1.58036316657131,4.85671928909199,2.96004524155376,7.96870328936482,3.9629470814967e-10
primary,Circulatory system disorders,I20 (angina pectoris),4.59972050309443,SIT1;Signaling threshold-regulating transmembrane adapter 1,0.249096572358451,1.28286591647498,1.22995243687689,1.33805577379244,4.58397392344558e-31
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64723497704132,SIT1;Signaling threshold-regulating transmembrane adapter 1,0.288733207262507,1.33473558326204,1.2632156676735,1.41030476649086,9.07355766977097e-25
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68935915352365,SIT1;Signaling threshold-regulating transmembrane adapter 1,0.248927110924878,1.2826485385968,1.22386619932706,1.34425419581741,2.4788869022489e-25
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56318626472349,SIT1;Signaling threshold-regulating transmembrane adapter 1,0.234848096314573,1.26471663902216,1.17842342784104,1.35732890167496,7.35535031356205e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.291198668806085,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,0.891018267389709,2.43761052728669,2.09005595786431,2.84295980707167,7.18695178109002e-30
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01424298250827,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,0.220712786393764,1.24696523374539,1.1436415513122,1.35962381953121,5.69439643433201e-07
primary,Circulatory system disorders,I50 (heart failure),0.903310156296428,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,0.425087533481631,1.52972431589839,1.3955571794942,1.67679011439641,1.12235046210835e-19
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56098334026663,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,0.191088509915991,1.21056659448722,1.12801825652257,1.2991558170398,1.13950224433778e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40646976090014,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,0.305111875881934,1.35677678511511,1.26108026033988,1.45973519887715,2.93764681755762e-16
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64340626848018,OSM;Oncostatin-M,0.25620107374336,1.29201249161115,1.22244059427566,1.36554388515573,1.16968099257996e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68223930613049,OSM;Oncostatin-M,0.219305940416712,1.24521217915081,1.18795423747472,1.30522988360359,6.77898071827504e-20
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.35679085353834,OSM;Oncostatin-M,0.419799911821729,1.52165705956761,1.31630941507144,1.75903946323008,1.38134381758378e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17031342400946,OSM;Oncostatin-M,0.184801000330821,1.20297902387882,1.13254465941983,1.27779378928314,1.93341510102413e-09
primary,Circulatory system disorders,I50 (heart failure),0.902818844864971,OSM;Oncostatin-M,0.416171985241809,1.5161466012887,1.381979163547,1.66333948964861,1.32731059240835e-18
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57500492805046,OSM;Oncostatin-M,0.210458547794712,1.23424389003067,1.15056299993685,1.32401092348846,4.21967720226677e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39956633155923,OSM;Oncostatin-M,0.202130285200348,1.22400746778168,1.13673670368596,1.31797827617187,8.51361153709607e-08
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149812734082397,OSM;Oncostatin-M,0.551044333018805,1.73506405672313,1.38733086131133,2.16995625548688,1.37343728668523e-06
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248373743347131,OSM;Oncostatin-M,0.583220103987876,1.79179892994906,1.50604934829572,2.1317650772863,4.71439423998475e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,CCL27;C-C motif chemokine 27,0.603409930361095,1.82834270411785,1.57106544613091,2.1277516171802,6.27354748178099e-15
primary,Circulatory system disorders,I20 (angina pectoris),4.58162668227033,PON3;Serum paraoxonase/lactonase 3,-0.377243998358846,0.685748731916097,0.657095997693757,0.715650871371915,3.1304775288515e-67
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64287107470255,PON3;Serum paraoxonase/lactonase 3,-0.429806066198138,0.65063526265892,0.615038359359728,0.688292426924291,1.11569924752373e-50
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.690267212795,PON3;Serum paraoxonase/lactonase 3,-0.403257356246391,0.668140127160264,0.63696325396171,0.700842987009372,1.89666916667393e-61
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546128340159937,PON3;Serum paraoxonase/lactonase 3,-0.341147676508037,0.710953909262966,0.631588806740466,0.800291986973095,1.61618437477058e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388141213185098,PON3;Serum paraoxonase/lactonase 3,-0.368031161319915,0.692095614739842,0.600890518218281,0.797144114309552,3.3162119529063e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1650087770626,PON3;Serum paraoxonase/lactonase 3,-0.34422577970659,0.708768884352131,0.666816458676698,0.753360726012505,2.01622358056735e-28
primary,Circulatory system disorders,I50 (heart failure),0.905012677979325,PON3;Serum paraoxonase/lactonase 3,-0.413930554486604,0.661046856410262,0.602028366149026,0.725851090979522,4.13488816286076e-18
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70470060464209,PON3;Serum paraoxonase/lactonase 3,-0.234051644698816,0.791320947308279,0.739408494749653,0.846878073615973,1.3734971350634e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56036668617125,PON3;Serum paraoxonase/lactonase 3,-0.273950631455181,0.760369612675592,0.708180448697888,0.816404842781922,4.3127090672562e-14
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171640335478837,PON3;Serum paraoxonase/lactonase 3,-0.548703817650278,0.577698127414272,0.466853968437728,0.714859782674146,4.46028650549668e-07
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.123163944895538,"GSR;Glutathione reductase, mitochondrial",0.770157036183734,2.16010544186687,1.66208630388538,2.80734851678595,8.43431838230678e-09
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0319313931210656,"GSR;Glutathione reductase, mitochondrial",1.35253528516134,3.86721761202016,2.3667291582873,6.3190044396721,6.71130922124551e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554237752029924,"GSR;Glutathione reductase, mitochondrial",0.358707601568363,1.43147817839797,1.26295373556497,1.62248997530611,1.98838577107619e-08
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.342122069154274,"GSR;Glutathione reductase, mitochondrial",0.578173504918792,1.78277921771583,1.52283963327941,2.08708892890779,6.45546670335573e-13
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14396496670011,"GSR;Glutathione reductase, mitochondrial",0.269786924170585,1.30968535870634,1.22796550998365,1.39684357977822,2.26473961793659e-16
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.6490283733236,"GSR;Glutathione reductase, mitochondrial",0.205315891219887,1.22791289060552,1.14114427506753,1.3212790878927,3.99441763961723e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298902686112058,MUC13;Mucin-13,0.78411507519881,2.19046768363196,1.86094805905707,2.57833562290135,4.22903065901122e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.63194848442295,MUC13;Mucin-13,0.201785366209367,1.22358535716211,1.15812754916971,1.29274286526978,6.32579017740166e-13
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70318361451583,MUC13;Mucin-13,0.186728900083024,1.20530048389292,1.15033257364913,1.26289500075969,4.48404731060425e-15
primary,Circulatory system disorders,I50 (heart failure),0.900720174928283,MUC13;Mucin-13,0.344311585421849,1.41101821972733,1.28557764896263,1.54869868654691,4.22146361043143e-13
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544146041776373,ACP5;Tartrate-resistant acid phosphatase type 5,-0.404565343406906,0.667266779740632,0.592019524638684,0.752078160964658,3.42367738894081e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386168158680007,ACP5;Tartrate-resistant acid phosphatase type 5,-0.386312714462061,0.679557984840087,0.590385883372857,0.782198673385743,7.33911480656337e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17658416710549,ACP5;Tartrate-resistant acid phosphatase type 5,-0.570653333932996,0.565156082410099,0.531836294231406,0.600563370626518,1.17703661944018e-75
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25992237629941,ACP5;Tartrate-resistant acid phosphatase type 5,-0.246932968270828,0.78119305649776,0.721968963176232,0.84527538252548,8.31753846967981e-10
primary,Circulatory system disorders,I50 (heart failure),0.918612135041834,ACP5;Tartrate-resistant acid phosphatase type 5,-0.412980870851191,0.661674939985177,0.603892432364599,0.724986276926978,8.14747835057502e-19
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.205722835234711,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,1.63460355252547,5.12742483940531,4.11608881096738,6.38724932603474,3.63302908076752e-48
primary,Circulatory system disorders,I15 (secondary hypertension),0.0187020759304282,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,1.74861977618355,5.74666551512742,2.85080233954568,11.5841649505653,1.01387370279775e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57331213764727,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,0.22396341453133,1.25102524924604,1.1544451006888,1.35568523208017,4.66743368194591e-08
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0475368685283,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.199118579649594,1.22032666322874,1.19653072477631,1.24459584208787,2.07427458428674e-87
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296124882334483,VSIG4;V-set and immunoglobulin domain-containing protein 4,1.65651836436309,5.24103167954595,4.50984245008481,6.09076999252771,1.51453046030378e-103
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372607467838092,VSIG4;V-set and immunoglobulin domain-containing protein 4,1.95372442600532,7.0549142166639,4.76165179624775,10.4526363401261,2.02815653409762e-22
primary,Circulatory system disorders,I20 (angina pectoris),4.61248823344838,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.287865069530076,1.33357735176437,1.27911572338839,1.39035782347183,1.02096275151424e-41
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65335738939441,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.398424977003546,1.48947688884757,1.41045570039534,1.57292526223207,1.52232879018825e-46
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70842485095701,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.382560485798885,1.46603354588607,1.39945321337852,1.53578150174424,1.51627293193328e-58
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00211797929086,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.366094925950502,1.44209212812339,1.32228569608727,1.57275368866895,1.30756854719464e-16
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354957640414182,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.538481081562972,1.71340236623301,1.48527132674421,1.97657331408141,1.50794054141915e-13
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.553027925949168,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.352101596098773,1.42205299141595,1.26575611513043,1.5976495678922,3.08287108832745e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386335111390021,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.398284947619437,1.4892683329185,1.29618594861495,1.7111126453761,1.89078110071283e-08
primary,Circulatory system disorders,I46 (cardiac arrest),0.0843269532475682,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.783402595824475,2.18890757642532,1.64773384762961,2.90782178506853,6.42861582056235e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15131785378098,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.298750434424712,1.34817312388405,1.26976890881855,1.43141855131294,1.47377161114664e-22
primary,Circulatory system disorders,I50 (heart failure),0.902102290555381,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.694475496532497,2.00265839714992,1.83028195197135,2.19126930217245,1.14329252794109e-51
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70614998431126,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.282018267539646,1.32580293892333,1.23989721028873,1.41766060788894,1.56821210731147e-16
primary,Circulatory system disorders,I63 (cerebral infarction),0.364763100094132,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.51434959653608,1.67255031543706,1.45197115053913,1.92663921499396,1.01779663302544e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56299027298399,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.48795718280359,1.62898509990436,1.51960725780447,1.74623570799756,4.44758387226629e-43
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.133354251647317,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.59356577472728,1.81043251397178,1.43656742025189,2.28159558781547,4.91785949532035e-07
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349074364606212,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.552423877527999,1.73745930661273,1.50446119177446,2.0065421817725,5.49709301734952e-14
primary,Circulatory system disorders,I70 (atherosclerosis),0.174537182303106,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.80938916936567,2.24653531489272,1.84448836111573,2.73621727708124,8.62373357961007e-16
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170614998431126,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.572957163082405,1.77350384468767,1.44365163604006,2.1787222128945,4.8389807482078e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41002510197678,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.476635717977974,1.61064660757076,1.49728952542417,1.73258574940227,1.62375535876751e-37
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149042987135236,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.71835523626379,2.05105693075306,1.65440855055513,2.54280270237878,5.70390235857748e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245136491998744,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.717137421174354,2.04856064299046,1.73062991464989,2.42489782043231,7.80853501256933e-17
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56510825227486,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.244474430960422,1.27695001142153,1.20853098474375,1.34924247061417,3.28612758812906e-18
primary,Circulatory system disorders,I87 (other disorders of veins),0.121587700031377,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.652176193870742,1.91971395634528,1.51016326369402,2.44033328235797,9.9886391399558e-08
primary,Circulatory system disorders,I95 (hypotension),0.513806087229369,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.4051151846181,1.49947520658903,1.32949323904251,1.69119016866494,4.13081371612205e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0196109193598995,VSIG4;V-set and immunoglobulin domain-containing protein 4,1.45123780850065,4.26839470181074,2.54909150403187,7.14732809772772,3.43483475053094e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,KIAA0319;Dyslexia-associated protein KIAA0319,1.24730968223705,3.4809654457039,2.86500812926734,4.2293494075646,3.79522677952833e-36
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.1010764961722,RBP5;Retinol-binding protein 5,0.241467678115251,1.27311630473403,1.24793662590228,1.29880403518707,4.40108595117864e-124
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,RBP5;Retinol-binding protein 5,0.984041837672774,2.67524733477763,2.31026603368959,3.09788924646261,1.72403066250427e-39
primary,Circulatory system disorders,I20 (angina pectoris),4.61102473776395,RBP5;Retinol-binding protein 5,0.197810949989945,1.21873197075026,1.16843862600618,1.27119010230406,3.58708073418357e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,RBP5;Retinol-binding protein 5,0.26970755542435,1.30958141474646,1.23889727344993,1.38429837453238,1.61803031515278e-21
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,RBP5;Retinol-binding protein 5,0.237811679502401,1.26847029137413,1.21006643140208,1.32969301382441,4.67581763907778e-23
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352272056363529,RBP5;Retinol-binding protein 5,0.387527139949246,1.4733329392576,1.27520367944599,1.70224567642755,1.44688211139627e-07
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541200086592013,RBP5;Retinol-binding protein 5,0.383105710451418,1.46683308146017,1.30456154562155,1.64928921604907,1.50710392518349e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307008049121287,RBP5;Retinol-binding protein 5,0.478781853298989,1.61410698503591,1.38237717172731,1.88468199014478,1.40372907409497e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383760061401609,RBP5;Retinol-binding protein 5,0.360826260982755,1.43451420813797,1.24653023096148,1.65084725764128,4.78233127173694e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,RBP5;Retinol-binding protein 5,0.291250099569192,1.33809920013809,1.25971639046306,1.42135919081916,3.17800823547877e-21
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,RBP5;Retinol-binding protein 5,0.514894867613134,1.67346255743597,1.52756522466144,1.83329450417465,1.89386008071342e-28
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71019227363076,RBP5;Retinol-binding protein 5,0.237985592433922,1.26869091394505,1.18616348818158,1.35696019238821,4.06861895085834e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,RBP5;Retinol-binding protein 5,0.247224855314427,1.28046700022049,1.19331918156595,1.37397920353721,6.2242258793965e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.173184027709444,RBP5;Retinol-binding protein 5,0.525369169341642,1.69108302916633,1.37588514331983,2.07848876442851,5.97643039341719e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,RBP5;Retinol-binding protein 5,0.26476435167605,1.30312386064054,1.21075879732587,1.40253517044128,1.68173482151665e-12
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6734937168989,PROC;Vitamin K-dependent protein C,-0.281384390660968,0.754738165412187,0.714635052961842,0.797091740698829,5.46830415925983e-24
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1653735660263,PROC;Vitamin K-dependent protein C,-0.438729332161995,0.644855297599762,0.60703859441085,0.685027869185256,6.07659814491309e-46
primary,Circulatory system disorders,I50 (heart failure),0.918524888115851,PROC;Vitamin K-dependent protein C,-0.389784981560153,0.67720246986329,0.617912872781041,0.742180986010057,7.54645613134876e-17
primary,Circulatory system disorders,I85 (oesophageal varices),0.0508120150872598,PROC;Vitamin K-dependent protein C,-0.982677661461461,0.374307487051912,0.255135462803901,0.549143946213404,5.03324297383166e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311917606669936,FAM3C;Protein FAM3C,1.8251743905122,6.20387682203071,5.23638854740836,7.3501206555764,8.02062534623413e-99
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392349190779794,FAM3C;Protein FAM3C,1.93368941484102,6.91497544988716,4.50917361920159,10.604356698292,7.73035510200736e-19
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67778322707209,FAM3C;Protein FAM3C,0.196555659440332,1.21720306783432,1.15237878908226,1.28567387944132,1.93212032764649e-12
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72143207454634,FAM3C;Protein FAM3C,0.191556349976678,1.21113307853789,1.15591485442395,1.26898908541119,8.57975255867228e-16
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00833742030407,FAM3C;Protein FAM3C,0.284512400572297,1.32911379496948,1.21772311582435,1.45069388683016,1.88036542968211e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358999509563511,FAM3C;Protein FAM3C,0.447183527069085,1.56390129117053,1.35151526770814,1.80966305521087,1.91404951232788e-09
primary,Circulatory system disorders,I50 (heart failure),0.9122118685630209,FAM3C;Protein FAM3C,0.590936276112101,1.80567823760434,1.64608541526016,1.98074405345641,6.07880491988462e-36
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7145659637077,FAM3C;Protein FAM3C,0.193107392278583,1.21301305476037,1.1339305885833,1.29761088185953,1.97663887107004e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57920549288867,FAM3C;Protein FAM3C,0.299318464061688,1.34893914371457,1.25736064802906,1.4471876595611,7.14772042394382e-17
primary,Circulatory system disorders,I70 (atherosclerosis),0.176557135850907,FAM3C;Protein FAM3C,0.637779899070869,1.89227517061904,1.53756463503078,2.32881612893604,1.72387623207302e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40264835703776,FAM3C;Protein FAM3C,0.279681079716721,1.32270790668358,1.22787140071643,1.42486925372025,1.7332601192669e-13
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.249141736145169,FAM3C;Protein FAM3C,0.504630065506804,1.65637265772862,1.39058077286771,1.97296729165404,1.56112544447951e-08
primary,Circulatory system disorders,I95 (hypotension),0.521824423737126,FAM3C;Protein FAM3C,0.372988038220243,1.45206697042359,1.28630410191523,1.63919129501004,1.62984445146814e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303814340036849,PRELP;Prolargin,1.45416683468332,4.28091526923384,3.63887034410052,5.03624306704707,7.10979388537902e-69
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392018503273354,PRELP;Prolargin,1.38336954258732,3.98831781832844,2.60152476389715,6.11436771263616,2.21363554597014e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16786232310165,PRELP;Prolargin,0.269495366979286,1.30930356618155,1.23212279974063,1.39131897305738,3.50846387902175e-18
primary,Circulatory system disorders,I50 (heart failure),0.905562742561448,PRELP;Prolargin,0.518871037919147,1.68012977577885,1.52937775627293,1.84574154546219,2.83951940435836e-27
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.289223454833597,SFRP1;Secreted frizzled-related protein 1,0.819664835590419,2.26973897430916,1.94279626139493,2.651701114454,5.21821236412953e-25
primary,Circulatory system disorders,I15 (secondary hypertension),0.0396196513470681,SFRP1;Secreted frizzled-related protein 1,1.0062245070923,2.73525456162821,1.82209760584526,4.10604651084936,1.20555337590363e-06
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6485736925515,SFRP1;Secreted frizzled-related protein 1,0.299064254163409,1.3485962736144,1.27664240951796,1.42460558700487,1.13046969598116e-26
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69849445324881,SFRP1;Secreted frizzled-related protein 1,0.268809938131838,1.30840643924069,1.24871484137263,1.37095144025412,1.59313673412843e-29
primary,Circulatory system disorders,I42 (cardiomyopathy),0.305071315372424,SFRP1;Secreted frizzled-related protein 1,0.555470796812311,1.74276127811753,1.49325335216591,2.03395952073402,1.84134805633615e-12
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384310618066561,SFRP1;Secreted frizzled-related protein 1,0.442506531751628,1.55660401013128,1.35470470337753,1.78859351290045,4.2924949514176e-10
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16917591125198,SFRP1;Secreted frizzled-related protein 1,0.372981356508053,1.45205726816243,1.36776465692379,1.54154466512204,2.31841506565598e-34
primary,Circulatory system disorders,I50 (heart failure),0.905309033280507,SFRP1;Secreted frizzled-related protein 1,0.627633429184114,1.87317233464537,1.71102303081906,2.05068811587016,4.82262799711515e-42
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71156893819334,SFRP1;Secreted frizzled-related protein 1,0.198526110081222,1.21960387095466,1.14035496494578,1.30436017535847,6.9802150216455e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56695721077654,SFRP1;Secreted frizzled-related protein 1,0.226937941575521,1.25475199759196,1.16968282764452,1.3460081128416,2.36476524066423e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40451664025356,SFRP1;Secreted frizzled-related protein 1,0.231675158844306,1.26071013176874,1.17096865485582,1.35732927585499,7.79118936437709e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,2.0233792338022,7.56384178551204,6.33198156836661,9.035355194664,3.03368579156123e-110
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,2.13152521190651,8.42771105910245,5.43856760555296,13.0597463977826,1.45683530243012e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.215434130633401,1.24040027585165,1.17324147451159,1.31140338775813,3.30933103687886e-14
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.194776912115928,1.21503989557293,1.15882272674896,1.27398428918947,7.71570475444986e-16
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.334504107182466,1.39724732848122,1.27878338289173,1.52668553804097,1.36030928155188e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359334939010177,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.396935658863741,1.48726023495934,1.28344206411582,1.72344593366211,1.30336964424578e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304949110403232,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.417428412367304,1.51805272620756,1.29250279204862,1.78296255429638,3.64831102149418e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382643151270297,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.425214471389454,1.52991850822752,1.32500950176518,1.76651611833644,6.79993272209487e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.239539737738362,1.27066417694328,1.19543042716627,1.35063272096418,1.44479449465664e-14
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.650616122748474,1.91672140094554,1.74389858453505,2.1066712029141,1.67311725756206e-41
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71121125009711,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.192167873783348,1.21187394175312,1.13211269864416,1.29725463945339,3.16319026487961e-08
primary,Circulatory system disorders,I63 (cerebral infarction),0.367104343096884,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.444139554823787,1.55914805707235,1.34640027393313,1.80551260344828,2.96254822106641e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.417697678991986,1.51846154217901,1.41352699545937,1.63118600669339,2.87949296192852e-30
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.497717735075422,1.64496274258347,1.41443310212538,1.91306497311309,1.04152588437319e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174811591950897,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.734688386157613,2.08483222869107,1.68530331808108,2.57907604830328,1.30069678217781e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.315039589214111,1.37031355952006,1.27134885767021,1.47698190003144,1.76362656535994e-16
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242793877709579,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.57884503822636,1.78397681540893,1.49040114227909,2.13538032656756,2.79244901882819e-10
primary,Circulatory system disorders,I95 (hypotension),0.518607722787662,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.367546369536369,1.44418676324762,1.27716930997662,1.63304535338216,4.58748894291972e-09
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.109738821604581,NPPB;Natriuretic peptides B,1.4367378441952,4.20694968284266,3.16350245440217,5.59456674653175,5.15843235371144e-23
primary,Circulatory system disorders,I07 (rheumatic tricuspid valve diseases),0.0498812825475368,NPPB;Natriuretic peptides B,1.35746161492206,3.88631580460663,2.5563217627182,5.90827444080254,2.13284797090342e-10
primary,Circulatory system disorders,I08 (multiple valve diseases),0.179572617171132,NPPB;Natriuretic peptides B,1.21026177075094,3.35436261165181,2.70923804465513,4.15310443194363,1.17970496654171e-28
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0259382669247191,NPPB;Natriuretic peptides B,1.60838071155973,4.99471678882798,2.76014455480058,9.03836567443931,1.06603798849077e-07
primary,Circulatory system disorders,I11 (hypertensive heart disease),0.033919272132325,NPPB;Natriuretic peptides B,1.24378724454428,3.46872553163366,2.1872404079069,5.50102163909882,1.24787011027371e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.297292443983319,NPPB;Natriuretic peptides B,0.914373399284679,2.49521126079619,2.12499603313973,2.929925109933,6.48747582649825e-29
primary,Circulatory system disorders,I20 (angina pectoris),4.6030447534867,NPPB;Natriuretic peptides B,0.602357471727667,1.82641946129832,1.74860932726542,1.90769201364491,6.14864163638221e-162
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64171272371755,NPPB;Natriuretic peptides B,0.894215837175657,2.44541743196814,2.30803408044644,2.59097838599374,7.9677829537586e-202
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.111734072906482,NPPB;Natriuretic peptides B,1.06806770900276,2.90975157755867,2.25811946803872,3.74942706218234,1.49710511861224e-16
primary,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.159620104152117,NPPB;Natriuretic peptides B,0.742851987216036,2.10192162788927,1.69276440227154,2.60997603911095,1.75179291313058e-11
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71116742153674,NPPB;Natriuretic peptides B,0.793491224859631,2.21110242249057,2.10498200550088,2.32257278683023,1.95267293442955e-219
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00560665615834,NPPB;Natriuretic peptides B,0.23947819426282,1.27058597825992,1.1623637317569,1.38888429158968,1.34601122190631e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359145234342265,NPPB;Natriuretic peptides B,1.07451662933531,2.92857697015502,2.51447753198732,3.41087281990698,2.08939175019308e-43
primary,Circulatory system disorders,I31 (other diseases of pericardium),0.197529878888245,NPPB;Natriuretic peptides B,0.588692583317442,1.80163139199003,1.48133373013582,2.19118461057815,3.76172772222394e-09
primary,Circulatory system disorders,I33 (acute and subacute endocarditis),0.0458907799437339,NPPB;Natriuretic peptides B,1.20311380903978,3.33047124514895,2.24142676284001,4.94865096582937,2.60583924836428e-09
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542708354117201,NPPB;Natriuretic peptides B,0.977673649005813,2.65826498581165,2.35079932509145,3.00594468416284,8.61173836516942e-55
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.377102496059378,NPPB;Natriuretic peptides B,0.761202365044394,2.14084875533266,1.85347895285541,2.47277336823739,4.15429206263858e-25
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0558670364532412,NPPB;Natriuretic peptides B,1.11647017058775,3.05405486191142,2.08256827977386,4.47872523083738,1.09453149048332e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301282946587122,NPPB;Natriuretic peptides B,1.142405072967,3.13429752171146,2.66539242346174,3.68569403444453,2.01703289635443e-43
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387078752568886,NPPB;Natriuretic peptides B,0.810719825805598,2.2495266713695,1.9534858045566,2.59043103021235,2.04353854564912e-29
primary,Circulatory system disorders,I45 (other conduction disorders),0.267363674454797,NPPB;Natriuretic peptides B,0.413247857488033,1.51171967054299,1.27642414745553,1.79038947740231,1.68990212751845e-06
primary,Circulatory system disorders,I46 (cardiac arrest),0.0798100520760589,NPPB;Natriuretic peptides B,1.01434264665052,2.75755011665296,2.0316955555956,3.742727410566,7.6052490307033e-11
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.714299966080727,NPPB;Natriuretic peptides B,0.624455275813116,1.86722855579895,1.67812630321515,2.07764008758525,2.04128445290825e-30
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16285241126119,NPPB;Natriuretic peptides B,1.20560442058286,3.33877649355655,3.12247023610348,3.57006716830602,1.26300333664401e-272
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25900357149983,NPPB;Natriuretic peptides B,0.502720875737798,1.65321334482041,1.52606489587948,1.79095552939587,7.80046944784578e-35
primary,Circulatory system disorders,I50 (heart failure),0.911829844968974,NPPB;Natriuretic peptides B,1.34732707962849,3.84712870684001,3.48406061271862,4.24803151614624,2.38398344328045e-156
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.72589237614477,NPPB;Natriuretic peptides B,0.701281033865166,2.01633404592279,1.8809608982972,2.16145002717913,4.67383154032076e-87
primary,Circulatory system disorders,I63 (cerebral infarction),0.373111993455575,NPPB;Natriuretic peptides B,0.368285873084997,1.44525513946923,1.2512382259172,1.6693563023389,5.5171859620836e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.58422953370977,NPPB;Natriuretic peptides B,0.309204772840467,1.36234131244281,1.26927939115524,1.46222641328729,1.0794523673822e-17
primary,Circulatory system disorders,I70 (atherosclerosis),0.177577365869231,NPPB;Natriuretic peptides B,0.799241466112427,2.22385342037698,1.8109605184817,2.73088451396427,2.40097811800946e-14
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.169596360661625,NPPB;Natriuretic peptides B,0.531250887895205,1.70105881220969,1.38076827379,2.09564569053556,5.99840827810456e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40864741914244,NPPB;Natriuretic peptides B,0.295549448794614,1.34386454062308,1.24595636258005,1.44946641614671,1.89457866964842e-14
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243420658831979,NPPB;Natriuretic peptides B,0.549260682141642,1.73197206653167,1.4488656743243,2.07039706468646,1.62271925915663e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55591691773578,NPPB;Natriuretic peptides B,0.210961712070535,1.2348650737294,1.16701005190352,1.30666548058387,2.5544308616859e-13
primary,Circulatory system disorders,I95 (hypotension),0.512779584588679,NPPB;Natriuretic peptides B,0.372953533459579,1.4520168680647,1.28176582614715,1.64488157051425,4.59605381303966e-09
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.8472395561505,PRAP1;Proline-rich acidic protein 1,0.207279668496601,1.23032660726314,1.20363657577635,1.257608476681,1.33549390120182e-76
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204225192312056,PRAP1;Proline-rich acidic protein 1,1.13231623691788,3.10283508443699,2.55218572329723,3.77229034444055,6.63769336294914e-30
primary,Circulatory system disorders,I20 (angina pectoris),4.45210919240282,PRAP1;Proline-rich acidic protein 1,0.280520827136132,1.32381911373618,1.26263043939706,1.3879730689291,3.33467479476529e-31
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.58231409834577,PRAP1;Proline-rich acidic protein 1,0.346285842130609,1.41380668357983,1.32873167594881,1.5043288082281,7.74240233100693e-28
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.56940252785404,PRAP1;Proline-rich acidic protein 1,0.349902034086037,1.41892853515328,1.34569054202243,1.49615243995575,2.64787346686123e-38
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301799450861149,PRAP1;Proline-rich acidic protein 1,0.430452367786108,1.53795308664419,1.29144577228535,1.83151298140281,1.36854004438782e-06
primary,Circulatory system disorders,I50 (heart failure),0.909936690190383,PRAP1;Proline-rich acidic protein 1,0.474839623853,1.60775633104283,1.45208912127958,1.78011141473913,6.31107390704059e-20
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55891896798202,PRAP1;Proline-rich acidic protein 1,0.308785966444318,1.36177087464726,1.2596907520301,1.47212314772415,8.03100349202954e-15
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.120265946583766,PRAP1;Proline-rich acidic protein 1,0.674605499716253,1.9632583172151299,1.4967573545559,2.57515569132314,1.09638215180668e-06
primary,Circulatory system disorders,I70 (atherosclerosis),0.165649322653112,PRAP1;Proline-rich acidic protein 1,0.578242462979194,1.78290215895165,1.41061089662586,2.25344927931432,1.30646067689442e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40915382695318,PRAP1;Proline-rich acidic protein 1,0.347526169415169,1.41556135454275,1.30513272963682,1.53533345917432,5.02126741421791e-17
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.142957634618439,PRAP1;Proline-rich acidic protein 1,0.668718303938072,1.95173418682904,1.5217909243584,2.50314696655406,1.38446966941725e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.312260649266482,ANG;Angiogenin,1.05099226207931,2.86048806416778,2.44379686479397,3.34822917695172,4.07472556621326e-39
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392780690901235,ANG;Angiogenin,1.5505842665723,4.71422374145269,3.0342172360833,7.32442793488438,5.30623550144653e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.349574814902099,ANG;Angiogenin,0.410613927022548,1.50774314529193,1.29894503573274,1.75010437673556,6.69997102775344e-08
primary,Circulatory system disorders,I50 (heart failure),0.921070720163396,ANG;Angiogenin,0.45765049656657,1.58035656648177,1.43649692326947,1.73862319978915,5.55833995525124e-21
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57308666705944,ANG;Angiogenin,0.219810757596958,1.24584094234378,1.15849021476364,1.33977795741391,3.09322633047505e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.168895697087531,ANG;Angiogenin,0.589446969843791,1.80299103121987,1.44697600429292,2.24660025391908,1.5043200083479e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.298902686112058,GPKOW;G-patch domain and KOW motifs-containing protein,0.523121707899466,1.68728665296531,1.43588586063892,1.98270372828109,2.08546354685719e-10
primary,Circulatory system disorders,I50 (heart failure),0.900720174928283,GPKOW;G-patch domain and KOW motifs-containing protein,0.251537171337105,1.28600070154106,1.17109737082123,1.41217788167724,1.38397259395326e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.305745302552392,CCL16;C-C motif chemokine 16,1.14041187770855,3.12805647662959,2.68542769317219,3.64364207081888,1.34868172849787e-48
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387019370319484,CCL16;C-C motif chemokine 16,1.221468414946,3.39216518430139,2.2391816901916,5.13883473055816,8.22478512026433e-09
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00818545968225,CCL16;C-C motif chemokine 16,0.25939669013142,1.29614787192829,1.18562959777369,1.41696808940906,1.16627923729556e-08
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354122723842328,CCL16;C-C motif chemokine 16,0.475375641926081,1.60861834850121,1.38681127937584,1.86590131593059,3.39094565458195e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545697312150473,CCL16;C-C motif chemokine 16,0.348212134680534,1.41653271358415,1.25536884437753,1.59838675114566,1.59977443614632e-08
primary,Circulatory system disorders,I50 (heart failure),0.913365713953983,CCL16;C-C motif chemokine 16,0.549051660865725,1.73161008535268,1.57594167082939,1.9026551192831,3.17451730641232e-30
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40488031425972,CCL16;C-C motif chemokine 16,0.213400335587709,1.23788011952535,1.14764704329436,1.33520771849631,3.27289778101254e-08
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.1010764961722,AREG;Amphiregulin,0.18440367573912,1.202501145672,1.17898194407484,1.22648952565357,8.61850623793388e-75
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301104048176647,AREG;Amphiregulin,1.14876674049623,3.15430043897576,2.66834009261467,3.72876429315019,2.78955691135957e-41
primary,Circulatory system disorders,I15 (secondary hypertension),0.039360006297601,AREG;Amphiregulin,1.38455857498434,3.9930628778798,2.52372850329072,6.31785515989987,3.329427998553e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.61102473776395,AREG;Amphiregulin,0.383109871517769,1.46683918506265,1.4045886243855,1.53184865481633,3.61137877759216e-67
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64499242319878,AREG;Amphiregulin,0.52687627350099,1.69363358893024,1.59649258651559,1.79668528233701,1.93818727248996e-68
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69393659102985,AREG;Amphiregulin,0.486799279938283,1.62709998499024,1.54837344834743,1.70982934638981,1.76966942542893e-82
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999744159959065,AREG;Amphiregulin,0.324689708334812,1.38360125942791,1.26805634291728,1.50967459433732,2.93016696263913e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352272056363529,AREG;Amphiregulin,0.41960979849711,1.52136779978203,1.31461691569731,1.76063456553493,1.79659709182609e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541200086592013,AREG;Amphiregulin,0.294558979802767,1.3425341434337,1.19123136189787,1.51305446106932,1.37714172409924e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.307008049121287,AREG;Amphiregulin,0.399068076994907,1.4904350794951,1.26702406904131,1.75323956384694,1.46219681046631e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,AREG;Amphiregulin,0.301492183577003,1.3518745482735,1.27018125933339,1.43882204279159,2.54241500559611e-21
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,AREG;Amphiregulin,0.614728683423425,1.84915482513483,1.67782348922777,2.03798170026408,2.90379405995607e-35
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71019227363076,AREG;Amphiregulin,0.246279541472729,1.27925712898545,1.1954853268052,1.3688991118222,1.02508486828439e-12
primary,Circulatory system disorders,I63 (cerebral infarction),0.369984059197449,AREG;Amphiregulin,0.414018506150518,1.51288512430515,1.30547166780154,1.75325244951373,3.7307431252259e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56456025032964,AREG;Amphiregulin,0.427622780008905,1.5336074644475,1.42716822432188,1.64798502021485,2.24489333457255e-31
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.129888020782083,AREG;Amphiregulin,0.67213928322714,1.95842246276388,1.51698833056566,2.52831117113998,2.49850786838383e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.173184027709444,AREG;Amphiregulin,0.722186456975115,2.05893005475382,1.65255154056027,2.56524100236617,1.21194808906815e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41105622576899,AREG;Amphiregulin,0.376127192120816,1.45663239415246,1.35355967676184,1.56755403409352,9.66408716332874e-24
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246000039360006,AREG;Amphiregulin,0.778503239087709,2.17820956543003,1.81825465292487,2.60942376982161,2.97625844571106e-17
primary,Circulatory system disorders,I95 (hypotension),0.511680081868813,AREG;Amphiregulin,0.368564184724912,1.44565742677522,1.27973927861029,1.63308685645709,3.11227938189715e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,SEMA3F;Semaphorin-3F,1.30914734958559,3.70301498849352,3.18624727125477,4.30359568408753,2.42595455994316e-65
primary,Circulatory system disorders,I15 (secondary hypertension),0.039176509764745,SEMA3F;Semaphorin-3F,1.4456735303764,4.24471012145049,2.84280019179705,6.33796355689515,1.5712585003522e-12
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01075395193042,SEMA3F;Semaphorin-3F,0.231321607583618,1.26026448489644,1.15573014437309,1.3742538252758,1.64089585522306e-07
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,SEMA3F;Semaphorin-3F,0.291887931579661,1.33895295488824,1.2225692636561,1.46641590681134,3.14796987884078e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,SEMA3F;Semaphorin-3F,0.187111488320618,1.20576170590426,1.12471259960219,1.29265137772919,1.36163915588831e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176294293941352,SEMA3F;Semaphorin-3F,0.553512267448086,1.73935136927279,1.41997754825043,2.13055705670747,8.91523361396448e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,SEMA3F;Semaphorin-3F,0.28215195785426,1.32598019778398,1.23185758395102,1.42729444362876,5.87838314725684e-14
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55234961117314,SEMA3F;Semaphorin-3F,0.191161088196163,1.21065445851716,1.14577217413609,1.27921086845436,1.03188207294891e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0176294293941352,SEMA3F;Semaphorin-3F,1.5512833175382,4.71752037623623,2.61898351172225,8.49757106167081,2.38541101762657e-07
primary,Circulatory system disorders,I50 (heart failure),0.925502969156521,CCL18;C-C motif chemokine 18,0.244624337081961,1.27714144839357,1.16593710601954,1.39895219972309,1.4172484395892e-07
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.117529529294235,COL4A1;Collagen alpha-1(IV) chain,0.685670063497974,1.98510153407393,1.55705150945465,2.53082706426512,3.14391433742281e-08
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174335468453115,COL4A1;Collagen alpha-1(IV) chain,0.551325580115311,1.73555210707949,1.41992145928711,2.12134347057502,7.30906690337506e-08
primary,Circulatory system disorders,I11 (hypertensive heart disease),0.0293823823235587,COL4A1;Collagen alpha-1(IV) chain,1.11405744129924,3.04669513638028,1.94224368110632,4.77918983304709,1.23493964706283e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,COL4A1;Collagen alpha-1(IV) chain,0.461644764485027,1.5866815574601,1.36447208396221,1.84507868968152,2.0102255323898e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.61107519931049,COL4A1;Collagen alpha-1(IV) chain,0.239394073823556,1.27047910050467,1.21905525049791,1.32407218143713,6.92873314273791e-30
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67575561693208,COL4A1;Collagen alpha-1(IV) chain,0.310515634955578,1.36412832506482,1.29291987919571,1.43925862475077,7.2635041835805e-30
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72176842765078,COL4A1;Collagen alpha-1(IV) chain,0.322316576633657,1.3803216843883,1.31852735061619,1.4450120822311,2.81325408559675e-43
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358465064347417,COL4A1;Collagen alpha-1(IV) chain,0.484130854767122,1.62276397816205,1.40935409408619,1.86848921777019,1.70048476038061e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542594660241719,COL4A1;Collagen alpha-1(IV) chain,0.471973415260723,1.60315476370864,1.42935927562685,1.79808200795043,7.52731101564612e-16
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.378053319229789,COL4A1;Collagen alpha-1(IV) chain,0.367720688479149,1.44443853430095,1.25788970258335,1.65865311965637,1.86984708544405e-07
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0587647646471175,COL4A1;Collagen alpha-1(IV) chain,0.92334370270666,2.51769475402208,1.80682646285701,3.50824332316189,4.90513196347904e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.309494427141486,COL4A1;Collagen alpha-1(IV) chain,0.530353985812766,1.69953381300838,1.46220362624315,1.97538504878423,4.81346984762357e-12
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.393723923135687,COL4A1;Collagen alpha-1(IV) chain,0.378418479992158,1.45997378487235,1.27507872054036,1.67167988781992,4.31822849657788e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,COL4A1;Collagen alpha-1(IV) chain,0.624635763253234,1.86756559751609,1.76173162804822,1.97975741906255,8.89892885803236e-98
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.2516894869836,COL4A1;Collagen alpha-1(IV) chain,0.234232563137654,1.2639384035109,1.17001014225134,1.36540721330474,2.76159309640138e-09
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,COL4A1;Collagen alpha-1(IV) chain,0.580520434964261,1.78696818951544,1.63610673085532,1.95174021970483,4.49649695302438e-38
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71788995318407,COL4A1;Collagen alpha-1(IV) chain,0.288378800381635,1.33426262760151,1.2491191891872,1.42520967960832,1.02063676211533e-17
primary,Circulatory system disorders,I63 (cerebral infarction),0.366300366300366,COL4A1;Collagen alpha-1(IV) chain,0.485966839217433,1.62574608430505,1.41484830052734,1.86808036568167,7.12665625514026e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,COL4A1;Collagen alpha-1(IV) chain,0.2725632557152,1.3133265316941,1.22594588312171,1.40693533262627,8.55755002326009e-15
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,COL4A1;Collagen alpha-1(IV) chain,0.236315012389955,1.26657323359203,1.17739251674423,1.36250887723305,2.24352787836043e-10
primary,Circulatory system disorders,I85 (oesophageal varices),0.0509294626941685,COL4A1;Collagen alpha-1(IV) chain,0.99761161741179,2.71179727834592,1.90497720854305,3.86033200075324,3.08005264067813e-08
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.8472395561505,ADAMTSL2;ADAMTS-like protein 2,0.229744570687192,1.25827856764848,1.23169230497622,1.28543869877799,1.08074787868819e-98
primary,Circulatory system disorders,I20 (angina pectoris),4.45210919240282,ADAMTSL2;ADAMTS-like protein 2,0.294861988569411,1.34294100468683,1.28327022161866,1.40538641954492,4.85614035332767e-37
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.58231409834577,ADAMTSL2;ADAMTS-like protein 2,0.339376550993672,1.40407195037118,1.32448562878468,1.48844049265227,4.22355848712917e-30
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.56940252785404,ADAMTSL2;ADAMTS-like protein 2,0.345703144731,1.41298310207446,1.34366130947085,1.48588132491083,2.37522590078732e-41
primary,Circulatory system disorders,I26 (pulmonary embolism),1.005241779936,ADAMTSL2;ADAMTS-like protein 2,0.257124403563278,1.29320599618675,1.17616898492317,1.42188900575593,1.08125873631668e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40164287821371,ADAMTSL2;ADAMTS-like protein 2,0.54042615867861,1.71673830924692,1.47675931802019,1.99571479690211,2.00090368350051e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.553677188046018,ADAMTSL2;ADAMTS-like protein 2,0.449415488942595,1.56739575753351,1.38017602935611,1.78001168581386,4.37250276380164e-12
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301799450861149,ADAMTSL2;ADAMTS-like protein 2,0.565842258567305,1.76093031694147,1.48642960948611,2.08612339348893,5.97770213311649e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383489527785972,ADAMTSL2;ADAMTS-like protein 2,0.38660585188403,1.47197620027425,1.26686329886746,1.71029813249054,4.43026120010594e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14890285688352,ADAMTSL2;ADAMTS-like protein 2,0.529565038524739,1.69819349920369,1.59156770544143,1.81196260195402,1.15722167400653e-57
primary,Circulatory system disorders,I50 (heart failure),0.909936690190383,ADAMTSL2;ADAMTS-like protein 2,0.657785768628824,1.93051299598957,1.75079104876104,2.12868373431654,9.57272409338158e-40
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66556990174499,ADAMTSL2;ADAMTS-like protein 2,0.333317027561488,1.39558966873383,1.2965067540083,1.50224479545143,7.25100754617548e-19
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55891896798202,ADAMTSL2;ADAMTS-like protein 2,0.267279635710564,1.3064057129473,1.21145637589527,1.40879681743397,3.85129939982852e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40915382695318,ADAMTSL2;ADAMTS-like protein 2,0.252050137481554,1.28666054558705,1.18731027079788,1.39432412932625,7.87251252445946e-10
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.113354310395372,F7;Coagulation factor VII,-1.44335359289141,0.236134530260848,0.184131196351768,0.302824928563368,5.73859233147512e-30
primary,Circulatory system disorders,I06 (rheumatic aortic valve diseases),0.0175894619579025,F7;Coagulation factor VII,-1.55233164657852,0.211753663067711,0.114132953736039,0.39287175486842,8.53638235182329e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.173940234917036,F7;Coagulation factor VII,-0.84446080816305,0.429789034485153,0.351094728930492,0.526121866672199,2.74645120804425e-16
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0273613852678484,F7;Coagulation factor VII,-1.74737749939712,0.174230263810588,0.105042441088359,0.288989712281841,1.30398558383134e-11
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.66968944827721,F7;Coagulation factor VII,-0.307706464037821,0.735131073748545,0.696295474882562,0.776132712454919,1.09833944162888e-28
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70746770379346,F7;Coagulation factor VII,-0.277091070163013,0.757985464107354,0.723591376801177,0.794014387426717,1.35069043101054e-31
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00846248558641,F7;Coagulation factor VII,-0.282483519815503,0.75390906641745,0.691000955533306,0.822544275626598,2.09317615278408e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351789239158051,F7;Coagulation factor VII,-0.967255002080022,0.380125049760109,0.329582625982983,0.438418296547542,2.73184535285281e-40
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547227705356968,F7;Coagulation factor VII,-0.642013850680016,0.526231604361062,0.468606831080991,0.590942519530954,1.99989541633436e-27
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.375241855101921,F7;Coagulation factor VII,-0.817234780257702,0.441651230232492,0.384704899863955,0.507027098523705,3.96980924262743e-31
primary,Circulatory system disorders,I42 (cardiomyopathy),0.3068383919323,F7;Coagulation factor VII,-0.695631190025476,0.498759536566526,0.427905263359866,0.581346145085504,5.67272482233634e-19
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386968163073856,F7;Coagulation factor VII,-0.594495578064395,0.551840856306911,0.481083257544964,0.633005464051267,2.040920636564e-17
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.715304786288037,F7;Coagulation factor VII,-0.354973173129468,0.701192253750066,0.632565430217547,0.777264379670584,1.43025258369847e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16741259014599,F7;Coagulation factor VII,-1.08138636386357,0.339125048881301,0.3186990951091,0.360860135920295,3.95524804020169e-255
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25080618367307,F7;Coagulation factor VII,-0.344303319891887,0.70871392841218,0.655463551856082,0.766290407610197,5.64776217457019e-18
primary,Circulatory system disorders,I50 (heart failure),0.918560791134911,F7;Coagulation factor VII,-0.723141985442001,0.485225287570304,0.443663054543085,0.530681059165858,2.00596874207313e-56
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70617780991654,F7;Coagulation factor VII,-0.423547217556106,0.654720260645932,0.612287032419421,0.700094231959241,3.00370147382504e-35
primary,Circulatory system disorders,I63 (cerebral infarction),0.365469931791975,F7;Coagulation factor VII,-0.375295666441421,0.687086100453673,0.5955255066689,0.792723912158318,2.70005062241662e-07
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170031465593058,F7;Coagulation factor VII,-0.566711672491918,0.567388132451227,0.461943185760866,0.69690235243159,6.57696407946477e-08
primary,Circulatory system disorders,I20 (angina pectoris),4.4282282554503,ADIPOQ;Adiponectin,-0.230197258613268,0.794376889363725,0.754519091810609,0.836340192321579,1.8746753875416e-18
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54892806961881,ADIPOQ;Adiponectin,-0.233301417954502,0.791914840195594,0.747717409077162,0.838724772900526,1.68931243398293e-15
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14159452476997,ADIPOQ;Adiponectin,0.33374716697298,1.39619009597707,1.29856625308172,1.50115312135852,1.80996751215487e-19
primary,Circulatory system disorders,I50 (heart failure),0.899696324162625,ADIPOQ;Adiponectin,0.272045728787958,1.31264702569617,1.17465507810724,1.4668495000638,1.58251078518408e-06
primary,Circulatory system disorders,I83 (varicose veins of lower extremities),3.12060916466482,ADIPOQ;Adiponectin,0.246398208788198,1.27940894400231,1.20432461586433,1.35917444884104,1.40436922905827e-15
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,SNRPB2;U2 small nuclear ribonucleoprotein B'',0.697763488181211,2.00925395836809,1.64143333225545,2.45949767796574,1.34446477678686e-11
primary,Circulatory system disorders,I50 (heart failure),0.910021613013309,SNRPB2;U2 small nuclear ribonucleoprotein B'',0.344143032970525,1.41078040918987,1.27839936777571,1.55686979603007,7.62531671108979e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40825844613809,SNRPB2;U2 small nuclear ribonucleoprotein B'',0.266341857294051,1.30518116813208,1.20593259743301,1.41259792236543,4.0991971270598e-11
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,1.43175653324029,4.1860456662293,3.57216347815549,4.90542452127783,4.56806082177259e-70
primary,Circulatory system disorders,I15 (secondary hypertension),0.039488232506713,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,1.51919545329465,4.56854810581869,3.05522920168862,6.83144550452838,1.3555843895785e-13
primary,Circulatory system disorders,I20 (angina pectoris),4.61025114515874,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.197001622023188,1.21774601591658,1.16793174661296,1.2696849482696,2.3637322158602e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64571157794977,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.27326238129258,1.31424503290029,1.24427856263631,1.38814575639998,1.24118111220232e-22
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69807297425367,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.299744833543942,1.34951441282875,1.28809623817982,1.41386108929719,1.79926855857304e-36
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01287316379718,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.306196909855737,1.35824973297655,1.24570019744547,1.48096816626829,3.97561271361585e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361317327436424,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.353577425966368,1.4241532491243,1.23305024114184,1.64487415785517,1.512284014683e-06
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.502081570068557,1.65215677392847,1.50845825306618,1.80954428144719,2.93434585432656e-27
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.711814879166,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.191665648079479,1.21126546032002,1.13274643266817,1.29522722213159,2.08113188899326e-08
primary,Circulatory system disorders,I63 (cerebral infarction),0.365266150687095,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.415083901402862,1.51449780385196,1.31310978385505,1.74677214812802,1.186259607675e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56373400726583,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.405561652393415,1.5001448234187,1.39893575673989,1.60867608136229,5.26462629227494e-30
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357368504185752,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.539858617367891,1.71576426576783,1.48599934753391,1.98105538913679,1.84408463424602e-13
primary,Circulatory system disorders,I70 (atherosclerosis),0.165850576528194,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.643545073040886,1.90321597368986,1.54505986237374,2.34439527601427,1.44817635434429e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.422296791912469,1.52546120205202,1.41726649333114,1.64191553946677,2.29452407012003e-29
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152029695150845,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.556204883161456,1.74404108506855,1.40084250099876,2.17132140425383,6.53020610503e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242852629916284,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.527709976166387,1.69504616451973,1.42428522294452,2.01727958246532,2.80112567356748e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55686305480966,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.229880144035011,1.25844916825057,1.19108198335349,1.32962661781824,2.62839961281594e-16
primary,Circulatory system disorders,I85 (oesophageal varices),0.0513347022587269,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,1.06215808452985,2.89260674807445,2.00132149517684,4.18082442984327,1.58904385374342e-08
primary,Circulatory system disorders,I95 (hypotension),0.519270257463275,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.299278688204926,1.34888548957149,1.19574521551942,1.52163859019594,1.13030812348578e-06
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197441162533565,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,1.4403391056691,4.22212732157759,2.38956465428958,7.46008654237973,7.07215442063539e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.289642311583708,HNMT;Histamine N-methyltransferase,1.10783546999784,3.02779753780069,2.59297948230804,3.53553045539404,1.43285646726062e-44
primary,Circulatory system disorders,I15 (secondary hypertension),0.0396770289840696,HNMT;Histamine N-methyltransferase,1.13330413686193,3.10590188964222,2.07523967456246,4.64843972786758,3.61615339340484e-08
primary,Circulatory system disorders,I50 (heart failure),0.904636260836788,HNMT;Histamine N-methyltransferase,0.333190631656228,1.39541328306172,1.27197145293777,1.5308348517161,1.78194018218798e-12
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40655067748527,HNMT;Histamine N-methyltransferase,0.185444781716929,1.2037537287258,1.11690654795288,1.29735387627291,1.21091872771243e-06
primary,Circulatory system disorders,I08 (multiple valve diseases),0.173748223029537,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.523060793563629,1.6871838761498,1.37259099545478,2.07388030474199,6.76793431808192e-07
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0307218448902,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.255776946103548,1.2914646295924,1.26596576393491,1.31747708903604,1.8641128996893e-139
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,1.3900305298954,4.01497262781746,3.44491524584745,4.67936191508766,8.24832291850101e-71
primary,Circulatory system disorders,I15 (secondary hypertension),0.039488232506713,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,1.44451925367899,4.23981337811212,2.90172527239584,6.1949412138443,8.26764834393401e-14
primary,Circulatory system disorders,I20 (angina pectoris),4.61025114515874,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.426971097793899,1.53260836532104,1.47000212781213,1.59788095337521,1.4986668715907e-89
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64571157794977,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.545254149703878,1.72504674678885,1.63446692631445,1.82064637142392,2.28610130236634e-87
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.110567051018796,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.640029529994322,1.89653688320144,1.48037302758804,2.42969311269049,4.11397487103375e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69807297425367,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.517043126996358,1.67706145337436,1.6011708814551,1.75654900483711,3.7210130239141e-106
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01287316379718,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.385151813064794,1.46983744503145,1.34750099196712,1.60328053759926,3.72780245589626e-18
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361317327436424,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.514443401913334,1.67270721700936,1.44833625886489,1.93183690369531,2.54758271277918e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554809666719317,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.397555329537904,1.48818213211861,1.32480707989165,1.67170457644159,2.07668948418497e-11
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0592323487600695,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.911200954280349,2.4873078834407,1.7647677504381,3.50567405002184,1.9503586503611e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30405939030169,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.462038266157006,1.58730604216569,1.35975492295051,1.85293719402654,4.84259394660941e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383035855315116,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.373378287836589,1.45263374958719,1.26488721968202,1.66824739597749,1.23790346363169e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1659295529932,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.347432471625629,1.41542872578648,1.33399516684488,1.50183338558865,1.44539121700918e-30
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.750792254394797,2.11867788374066,1.93833626996565,2.31579837028553,1.85864163565467e-61
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.711814879166,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.264518057919475,1.30280294889053,1.21833562483834,1.39312640050484,1.0400544071318e-14
primary,Circulatory system disorders,I63 (cerebral infarction),0.365266150687095,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.546300511473999,1.72685271443934,1.50017769338938,1.98777805489774,2.76011180606092e-14
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56373400726583,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.509011599059174,1.66364603273592,1.55201998376796,1.78330057034354,8.70032001864123e-47
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.130311167272152,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.576287580021836,1.779420198428,1.41144785758642,2.24332498402597,1.08561100765427e-06
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357368504185752,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.583216108004475,1.79179176996459,1.55269967971617,2.06770039876591,1.44856650709322e-15
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.124387932396145,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.854952671399245,2.35126309594911,1.85608013419358,2.97855574472497,1.38307010862467e-12
primary,Circulatory system disorders,I70 (atherosclerosis),0.165850576528194,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.713279466065038,2.04067261360639,1.6653871302699,2.50052653838403,6.0193242183913e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.169799399778865,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.61648911688858,1.85241300623531,1.51578599335089,2.26379842584771,1.69357121339997e-09
primary,Circulatory system disorders,I72 (other aneurysm),0.106618227768125,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.669113050294903,1.95250477887299,1.50683169188246,2.52999384872192,4.16109813585004e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.466728072580009,1.59476768338786,1.48099522407536,1.71728032787286,4.33050116265004e-35
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152029695150845,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.652719571157188,1.92075736876326,1.54875734143246,2.38210904378737,2.80035049874595e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242852629916284,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.701491220227294,2.01675789638297,1.70073508527809,2.3915026201497,7.19310513917353e-16
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55686305480966,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.204264176799891,1.22662215577316,1.16024450508006,1.29679727544134,6.19035286570467e-13
primary,Circulatory system disorders,I85 (oesophageal varices),0.0513347022587269,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.94006868672175,2.5601572610996,1.77171379023133,3.69947179826669,5.58200303205721e-07
primary,Circulatory system disorders,I95 (hypotension),0.519270257463275,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.371863570120786,1.45043508511052,1.28528388929771,1.6368072093933,1.64725302132329e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197441162533565,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,1.54869750882341,4.70533752897975,2.72560349987083,8.12304550631612,2.70940976926944e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.308304714330315,SORD;Sorbitol dehydrogenase,-0.378083008065729,0.6851736233681,0.587879772754783,0.798569564588837,1.30763781221705e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29023850892434,CRIP2;Cysteine-rich protein 2,0.800536155118043,2.22673448358843,1.9068789882597,2.60024180397889,4.58470082560488e-24
primary,Circulatory system disorders,I15 (secondary hypertension),0.039488232506713,CRIP2;Cysteine-rich protein 2,1.05941772403635,2.88469081402905,1.92003636057984,4.33400182589798,3.3813493985232e-07
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01287316379718,CRIP2;Cysteine-rich protein 2,0.281262721007038,1.32480161143229,1.21477040760328,1.44479919717206,2.04739714807671e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361317327436424,CRIP2;Cysteine-rich protein 2,0.363671455092034,1.43860149131239,1.24675214010962,1.65997248709296,6.35895985960842e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30405939030169,CRIP2;Cysteine-rich protein 2,0.392549938401715,1.4807518098134,1.26438817656554,1.73413984953695,1.1120274005331e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1659295529932,CRIP2;Cysteine-rich protein 2,0.241454281955455,1.2730992499788,1.19788790860723,1.35303285779139,7.75496150314973e-15
primary,Circulatory system disorders,I50 (heart failure),0.906254936029063,CRIP2;Cysteine-rich protein 2,0.38551559410774,1.47037224129864,1.33981778688323,1.61364817600381,4.42698712216239e-16
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40380666561364,CRIP2;Cysteine-rich protein 2,0.216410055983107,1.24161140481423,1.15281707399736,1.33724501079718,1.08885742386915e-08
primary,Circulatory system disorders,I20 (angina pectoris),4.4506479653208,HEPH;Hephaestin,0.200001898386845,1.2214050768573,1.16687175023989,1.27848699864924,9.30634544567337e-18
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.56235673271146,HEPH;Hephaestin,0.250309367047432,1.2844227132918,1.20960538855461,1.36386768943811,2.96963645656221e-16
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55416354599305,HEPH;Hephaestin,0.272076825603895,1.3126878454738,1.24713957961302,1.38168125510806,2.22466929495589e-25
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15383218719502,HEPH;Hephaestin,0.289696568776705,1.33602203571449,1.25208173328364,1.42558974583357,2.12888501691719e-18
primary,Circulatory system disorders,I50 (heart failure),0.916910646603572,HEPH;Hephaestin,0.307346661008026,1.35981228027028,1.23188203575302,1.50102800747764,1.08192918971833e-09
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66133315176686,HEPH;Hephaestin,0.220987421208838,1.2473077408418,1.15927825328228,1.34202172425729,3.26147485623866e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39579219718118,HEPH;Hephaestin,0.228077694032226,1.25618291955728,1.16003830106405,1.36029605741468,1.97542033722012e-08
primary,Circulatory system disorders,I20 (angina pectoris),4.4282282554503,CFP;Properdin,-0.361913248722419,0.696342773846849,0.66527689482917,0.728859310247404,1.79017586504026e-54
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.56538095453927,CFP;Properdin,-0.44470081882391,0.641016027275639,0.604063933588859,0.680228572467484,8.69970394423079e-49
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54892806961881,CFP;Properdin,-0.444302859672498,0.64127117623596,0.609427982898359,0.674778206795333,1.54180771830879e-65
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14159452476997,CFP;Properdin,-0.454944780022044,0.634483003118343,0.594957637649931,0.676634193379228,1.0607093476185e-43
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.2350994878303,CFP;Properdin,-0.237872911861324,0.788302868672237,0.724664661722991,0.857529621051704,3.0449000876425e-08
primary,Circulatory system disorders,I50 (heart failure),0.899696324162625,CFP;Properdin,-0.502583682469752,0.604965599759367,0.548681486462072,0.667023374985899,6.29681378902328e-24
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55917146353623,CFP;Properdin,-0.229646834805075,0.794814253673131,0.737279999690338,0.856838240705441,2.09726079347488e-09
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.113587403548627,THBS2;Thrombospondin-2,0.729180195979967,2.07338014536821,1.58995369652545,2.70379271836755,7.30808716629105e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,THBS2;Thrombospondin-2,0.529891120327743,1.69874733949547,1.45420850733671,1.98440767529822,2.35821033354506e-11
primary,Circulatory system disorders,I20 (angina pectoris),4.61595707179507,THBS2;Thrombospondin-2,0.223140648557988,1.24999637155999,1.1994779354555,1.30264249364435,2.93938322755883e-26
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,THBS2;Thrombospondin-2,0.284058581092303,1.32851075408439,1.25985328658791,1.40090980632983,9.39347776903318e-26
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71117465042497,THBS2;Thrombospondin-2,0.274491244461548,1.31586105294661,1.25732437816404,1.37712299286689,2.9814278105861e-32
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,THBS2;Thrombospondin-2,0.222483696807383,1.2491754539366,1.14400063175702,1.3640196267384,7.12527000187313e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354471035212095,THBS2;Thrombospondin-2,0.519688894211004,1.68150444255042,1.45137884450093,1.94811795764395,4.49019852819976e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552269789667463,THBS2;Thrombospondin-2,0.464181554324663,1.59071174482169,1.41508255879576,1.78813867741187,7.46705502200784e-15
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0587521052837726,THBS2;Thrombospondin-2,0.917927292316751,2.50409475084619,1.74623038713015,3.59087241146954,6.0059574685699e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301594140456699,THBS2;Thrombospondin-2,0.506715739713693,1.65983091660488,1.42053278562649,1.93944039841528,1.77963905564678e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38580549136344,THBS2;Thrombospondin-2,0.36537140327724,1.44104911913759,1.25558352805807,1.65391032723963,2.01591570930474e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,THBS2;Thrombospondin-2,0.515445017463128,1.67438346590651,1.57788753989621,1.77678061332908,5.87175710700104e-65
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,THBS2;Thrombospondin-2,0.623764547223029,1.86593925298166,1.70599941083284,2.04087368008997,2.23597211793614e-42
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7038110532294,THBS2;Thrombospondin-2,0.293058180785384,1.34052078071473,1.25339022187655,1.43370829942938,1.26773698692136e-17
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,THBS2;Thrombospondin-2,0.202357871128066,1.22428606635812,1.14176813731835,1.31276773566218,1.31738296139988e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,THBS2;Thrombospondin-2,0.234640523693966,1.26445414571923,1.17394319379366,1.3619434867711,5.94381820967319e-10
primary,Circulatory system disorders,I85 (oesophageal varices),0.0489600877364772,THBS2;Thrombospondin-2,1.24153522006735,3.46092266625236,2.32118383087049,5.16029171945738,1.11741188632759e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195840350945908,THBS2;Thrombospondin-2,1.71712345605146,5.56848740518343,2.94558425635269,10.5269614728595,1.25784416810463e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.296817027924233,DCXR;L-xylulose reductase,-0.408898964210475,0.664381355226022,0.562288096801312,0.78501143396592,1.55907261979024e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204228457378913,PENK;Proenkephalin-A,1.81357011962542,6.13230144804174,4.90327123121871,7.6693944259551,7.1954495527643e-57
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.55981805101069,PENK;Proenkephalin-A,0.246930754496583,1.28009046920026,1.20473060641275,1.36016433932611,1.50480155384063e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53454477941005,PENK;Proenkephalin-A,0.20693154886747,1.22989838096223,1.16780018914448,1.29529866629124,4.9480564429523e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.401494580983545,PENK;Proenkephalin-A,0.495479882042938,1.64128567362618,1.41291989117839,1.90656149670585,9.05950666082832e-11
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301701130218849,PENK;Proenkephalin-A,0.471684347550509,1.60269141040544,1.34795412850285,1.90556911594633,9.25040784221615e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15832347002715,PENK;Proenkephalin-A,0.209278292484737,1.23278802644002,1.15466425699748,1.31619759503581,3.7221732933249e-10
primary,Circulatory system disorders,I50 (heart failure),0.907424168581308,PENK;Proenkephalin-A,0.536286180863088,1.70964574239649,1.54552897473029,1.8911897559245,2.11350018735347e-25
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65935621620367,PENK;Proenkephalin-A,0.195452897567339,1.21586152253788,1.12896521091598,1.30944623243855,2.38909116065442e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54099654204089,PENK;Proenkephalin-A,0.1902383610958,1.20953787007154,1.11991501073613,1.30633293161734,1.27732296035931e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41799531202859,PENK;Proenkephalin-A,0.290363593226893,1.33691349235694,1.23394200894463,1.44847786451058,1.2431193039946e-12
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,ITGA5;Integrin alpha-5,0.271995832940492,1.31258153169436,1.1979541457119,1.43817714852622,5.4158315149887e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,ITGA5;Integrin alpha-5,0.224066427435419,1.25115412762801,1.16223119231779,1.34688060467454,2.5726585931975e-09
primary,Circulatory system disorders,I85 (oesophageal varices),0.0489600877364772,ITGA5;Integrin alpha-5,1.05634453057399,2.87583920939178,1.96679721023652,4.20503502609735,5.05680128382333e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195840350945908,ITGA5;Integrin alpha-5,1.57852510443433,4.8478005363786,2.78092469291028,8.4508473388103,2.59058571294784e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17488658268268,PRCP;Lysosomal Pro-X carboxypeptidase,-0.306687248856043,0.735880712456189,0.693253693454785,0.781128796106942,7.24811836514334e-24
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,CCDC80;Coiled-coil domain-containing protein 80,1.10849126691229,3.02978380930774,2.6073846541063,3.52061208793518,1.87016657103494e-47
primary,Circulatory system disorders,I15 (secondary hypertension),0.039176509764745,CCDC80;Coiled-coil domain-containing protein 80,1.25802336859135,3.51845991102657,2.35069443076253,5.26634171736449,9.74254024963593e-10
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01075395193042,CCDC80;Coiled-coil domain-containing protein 80,0.256890213555205,1.29290317572422,1.18563866283436,1.40987188946899,6.11955665489234e-09
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,CCDC80;Coiled-coil domain-containing protein 80,0.448126571737431,1.56537681557834,1.42915715134588,1.71458021424906,5.04383714234632e-22
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,CCDC80;Coiled-coil domain-containing protein 80,0.318653862641293,1.37527520838181,1.2828103541398,1.47440492095022,2.87648010211491e-19
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35650623885918,CCDC80;Coiled-coil domain-containing protein 80,0.45537108697677,1.57675838898689,1.36472751603368,1.82173143578589,6.40504657480881e-10
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127323656735421,CCDC80;Coiled-coil domain-containing protein 80,0.629898111503355,1.87741928209079,1.47875861231439,2.38355545754003,2.31361273470475e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176294293941352,CCDC80;Coiled-coil domain-containing protein 80,0.566027499826524,1.76125654410521,1.43650374644266,2.15942674833618,5.23518604979023e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,CCDC80;Coiled-coil domain-containing protein 80,0.199894495259861,1.22127390117719,1.13445469964455,1.31473732901268,1.07894163085197e-07
primary,Circulatory system disorders,I95 (hypotension),0.521047579871109,CCDC80;Coiled-coil domain-containing protein 80,0.32984749219154,1.39075601113805,1.23331055954046,1.56830108001129,7.41188865673088e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.309718137016187,RARRES2;Retinoic acid receptor responder protein 2,0.921882513456425,2.51401861193585,2.18585556260389,2.89144886299388,3.57984486031963e-38
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389582562284512,RARRES2;Retinoic acid receptor responder protein 2,1.04404370219343,2.84068068761786,1.96362334662149,4.10947791127509,2.9953693865346e-08
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00512301069404,RARRES2;Retinoic acid receptor responder protein 2,0.247168442782577,1.28039476787248,1.17476436535822,1.39552305972043,1.83967365945861e-08
primary,Circulatory system disorders,I50 (heart failure),0.917466934180026,RARRES2;Retinoic acid receptor responder protein 2,0.438540626334433,1.55044289113805,1.42068996685853,1.69204626959956,7.98875673401805e-23
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56417398757231,RARRES2;Retinoic acid receptor responder protein 2,0.256681181077925,1.29263294521497,1.20668298402919,1.38470497485254,2.63851586024093e-13
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348676393244638,RARRES2;Retinoic acid receptor responder protein 2,0.367802636650404,1.44455690824753,1.25168776211447,1.66714473395548,4.89914372413293e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.171416327405185,RARRES2;Retinoic acid receptor responder protein 2,0.632479104372291,1.88227114649018,1.54944544240147,2.28658884782562,1.88087871977386e-10
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171416327405185,RARRES2;Retinoic acid receptor responder protein 2,0.497048765390353,1.64386268037078,1.34979601162175,2.00199473746338,7.7018308570275e-07
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.146093460856692,RARRES2;Retinoic acid receptor responder protein 2,0.570167542924061,1.76856333688562,1.42912402445002,2.18862479607374,1.57209240452842e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303975058456742,CD300E;CMRF35-like molecule 2,1.52993567502623,4.61787976775095,3.97493016091938,5.36482722616471,5.4713600136948e-89
primary,Circulatory system disorders,I15 (secondary hypertension),0.0389711613406079,CD300E;CMRF35-like molecule 2,1.52440221282568,4.59239747228937,3.12751544448102,6.74340859953434,7.40581200402869e-15
primary,Circulatory system disorders,I20 (angina pectoris),4.59859703819173,CD300E;CMRF35-like molecule 2,0.19404083991188,1.21414586755395,1.16475130399858,1.26563514686576,5.34422586252586e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6539360872954,CD300E;CMRF35-like molecule 2,0.279363643515632,1.3222880979453,1.25338630621766,1.39497759413384,1.43091320045491e-24
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6925175370226,CD300E;CMRF35-like molecule 2,0.267346921118158,1.30649361794551,1.24788644305914,1.367853287634,3.43923270520237e-30
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00545596258768,CD300E;CMRF35-like molecule 2,0.331093381514782,1.39248981904567,1.27611821683741,1.51947356487968,1.03894522151335e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.352689010132502,CD300E;CMRF35-like molecule 2,0.465699706727663,1.59312852173323,1.37761956314266,1.84235078730301,3.3853103441954e-10
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0584567420109119,CD300E;CMRF35-like molecule 2,0.91988816300147,2.50900977412255,1.78391762285237,3.5288232853359,1.24983212477154e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17264224473889,CD300E;CMRF35-like molecule 2,0.272253829224809,1.31292021654023,1.23749462067459,1.39294302068189,1.89845648725936e-19
primary,Circulatory system disorders,I50 (heart failure),0.909976617303195,CD300E;CMRF35-like molecule 2,0.656783944993131,1.928579930898,1.7655648274277,2.10664626530958,3.98019917719741e-48
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70693686671862,CD300E;CMRF35-like molecule 2,0.226550015666791,1.25426534118248,1.17272279971234,1.34147775286495,3.96323988676048e-11
primary,Circulatory system disorders,I63 (cerebral infarction),0.366328916601714,CD300E;CMRF35-like molecule 2,0.426377527096384,1.53169892384023,1.33023552320661,1.76367383998128,3.10521883167248e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56858924395947,CD300E;CMRF35-like molecule 2,0.41651503442271,1.51666680336074,1.41520009582022,1.62540844874894,4.42073619321293e-32
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34489477786438,CD300E;CMRF35-like molecule 2,0.614457930888776,1.84865422955078,1.5998694553257,2.13612582517882,7.92914855917504e-17
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126656274356975,CD300E;CMRF35-like molecule 2,0.643882065744362,1.90385745166676,1.50271650652799,2.41208050921183,9.6249951396922e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.175370226032735,CD300E;CMRF35-like molecule 2,0.758621296996764,2.13533020395745,1.75596049446087,2.59666153897892,2.92986966951789e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40880748246297,CD300E;CMRF35-like molecule 2,0.415602996820571,1.51528417680571,1.40747954732757,1.63134600487617,2.52996325904878e-28
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.15003897116134,CD300E;CMRF35-like molecule 2,0.555854052442486,1.74342932919841,1.40326916452908,2.1660461889571,5.18380141251043e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243569758378799,CD300E;CMRF35-like molecule 2,0.546983269138503,1.72803213895034,1.45628646497841,2.0504860445088,3.70508879260923e-10
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55845674201091,CD300E;CMRF35-like molecule 2,0.277317266514293,1.31958496475064,1.24811291344697,1.39514979809552,1.65655635582747e-22
primary,Circulatory system disorders,I85 (oesophageal varices),0.0565081839438815,CD300E;CMRF35-like molecule 2,1.23644842294103,3.44336235551349,2.460148055641,4.81952469656469,5.69398436619601e-13
primary,Circulatory system disorders,I95 (hypotension),0.518316445830085,CD300E;CMRF35-like molecule 2,0.407950267135519,1.50373237439205,1.33304507288381,1.69627501709527,3.21707031850706e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214341387373343,CD300E;CMRF35-like molecule 2,1.58690559711176,4.88859820678729,2.92851960651541,8.16057108657715,1.27975728432918e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,CTSO;Cathepsin O,0.511364076146394,1.66756432895318,1.42628006761638,1.94966672698744,1.43047241693557e-10
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,CTSO;Cathepsin O,0.271215108861276,1.31155716761151,1.1968401272146,1.43726982810687,6.33715944072426e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,CTSO;Cathepsin O,0.241635236559783,1.27332964399465,1.18732543258633,1.3655635917305,1.26802173515024e-11
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354603057724727,CTSO;Cathepsin O,0.360296980440792,1.43375514857588,1.23953264541816,1.65841039658489,1.22648880103328e-06
primary,Circulatory system disorders,I70 (atherosclerosis),0.174394946421997,CTSO;Cathepsin O,0.568027950028799,1.76478337656533,1.43481726937509,2.17063206073466,7.5076337921632e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,CTSO;Cathepsin O,0.268073473573324,1.30744319900974,1.2146694001918,1.40730285818256,9.42634011971869e-13
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16676834668293,IGSF3;Immunoglobulin superfamily member 3,0.212018113352529,1.23617027606371,1.16443877779141,1.31232056211817,3.61637043210182e-12
primary,Circulatory system disorders,I50 (heart failure),0.911184145789463,IGSF3;Immunoglobulin superfamily member 3,0.255945492114471,1.29168231914881,1.17903135301283,1.41509656154453,3.85583268017487e-08
primary,Circulatory system disorders,I85 (oesophageal varices),0.0570720091315214,IGSF3;Immunoglobulin superfamily member 3,1.05954977055183,2.88507175254951,2.0696079716237,4.02184333046844,4.06607002760497e-10
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216480034636805,IGSF3;Immunoglobulin superfamily member 3,1.32154434177227,3.74920696557795,2.28132437266578,6.1615757229266,1.84960757081352e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.17404030615272,ACVRL1;Serine/threonine-protein kinase receptor R3,0.520327210626833,1.68257811707497,1.36703084481926,2.07096213723974,9.08889672123899e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.288748689753377,ACVRL1;Serine/threonine-protein kinase receptor R3,1.72715916213933,5.62465246476128,4.75923862171853,6.64743205036467,2.79511400691837e-91
primary,Circulatory system disorders,I15 (secondary hypertension),0.0395546150347091,ACVRL1;Serine/threonine-protein kinase receptor R3,1.9790225756625,7.23566721047763,4.73624414902578,11.0540923004466,5.54081492724546e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.6442260150703,ACVRL1;Serine/threonine-protein kinase receptor R3,0.273846313166848,1.31501268657251,1.24430915422742,1.38973370080229,2.68638358030813e-22
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6983565057453,ACVRL1;Serine/threonine-protein kinase receptor R3,0.221418188871769,1.24784515642459,1.19058230952365,1.30786214607482,2.50624719055551e-20
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01457587564029,ACVRL1;Serine/threonine-protein kinase receptor R3,0.304788986373362,1.35633876684528,1.24315280145397,1.47983003239484,7.10683673374184e-12
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361924727567589,ACVRL1;Serine/threonine-protein kinase receptor R3,0.490098973686601,1.63247778430454,1.41333641241212,1.88559757807384,2.66616606510923e-11
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555742341237663,ACVRL1;Serine/threonine-protein kinase receptor R3,0.322230035421944,1.38020223484591,1.22731063263995,1.55214023117853,7.47620052750927e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30457053576726,ACVRL1;Serine/threonine-protein kinase receptor R3,0.526017320708941,1.69217946223281,1.44583680515331,1.98049414857641,5.63981477175161e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383679765836678,ACVRL1;Serine/threonine-protein kinase receptor R3,0.365390537016888,1.44107669206004,1.25140802231323,1.65949234411963,3.88042316793122e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16759290390206,ACVRL1;Serine/threonine-protein kinase receptor R3,0.298243480297467,1.3474898351673,1.26850506753725,1.43139267027477,3.76825815007418e-22
primary,Circulatory system disorders,I50 (heart failure),0.90580068429484,ACVRL1;Serine/threonine-protein kinase receptor R3,0.701879492928179,2.01754110045697,1.84015561411959,2.21202601606094,1.60398577672049e-50
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7127148310029,ACVRL1;Serine/threonine-protein kinase receptor R3,0.238926775472981,1.26988554641079,1.18697641312435,1.35858580099189,4.03937904580001e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56438502462274,ACVRL1;Serine/threonine-protein kinase receptor R3,0.320842822474054,1.37828892782398,1.28439691413211,1.47904463772855,4.96912118881836e-19
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357969266064118,ACVRL1;Serine/threonine-protein kinase receptor R3,0.588219737271573,1.80077969908589,1.55842112498347,2.08082877769915,1.51267201551112e-15
primary,Circulatory system disorders,I70 (atherosclerosis),0.166129383145778,ACVRL1;Serine/threonine-protein kinase receptor R3,0.75717519538173,2.13224453113683,1.72683341921796,2.63283458031632,1.96206926296129e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170084844649249,ACVRL1;Serine/threonine-protein kinase receptor R3,0.527112720356236,1.69403409061309,1.37208750473023,2.09152221725361,9.51383247188139e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40418883373217,ACVRL1;Serine/threonine-protein kinase receptor R3,0.467580595993122,1.59612783987667,1.48230737785097,1.71868812049149,3.05138146931725e-35
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.15228526788363,ACVRL1;Serine/threonine-protein kinase receptor R3,0.790659596681912,2.20485025864643,1.7710613609618,2.74488776629015,1.51084989847123e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243260882463461,ACVRL1;Serine/threonine-protein kinase receptor R3,0.700181139308167,2.01411751028179,1.69137018040617,2.39845149939296,3.90465964404749e-15
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56116132349741,ACVRL1;Serine/threonine-protein kinase receptor R3,0.207951199523187,1.23115308722517,1.16473236196529,1.3013615605447,1.99634088148269e-13
primary,Circulatory system disorders,I85 (oesophageal varices),0.0514209995451219,ACVRL1;Serine/threonine-protein kinase receptor R3,1.09211293901538,2.98056517631216,2.06230321694067,4.30769282483272,6.17274652519837e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197773075173545,ACVRL1;Serine/threonine-protein kinase receptor R3,1.68592407512569,5.39743626517889,3.04413607725653,9.56997896852339,7.94100810144887e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204651162790697,GM2A;Ganglioside GM2 activator,1.514741648953,4.54824593094739,3.77303949894251,5.48272581142535,7.67655449619128e-57
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.60232558139534,GM2A;Ganglioside GM2 activator,0.184732672915412,1.2028968302394,1.13316118250244,1.27692406565196,1.33907964449972e-09
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00930232558139,GM2A;Ganglioside GM2 activator,0.318663596270038,1.37528859486526,1.25208209617399,1.51061877247993,2.84140024010069e-11
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.381395348837209,GM2A;Ganglioside GM2 activator,0.400984594683596,1.49329426365214,1.28365758156818,1.73716713076411,2.04269525661881e-07
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.548837209302325,GM2A;Ganglioside GM2 activator,0.384721763049613,1.46920547731451,1.29452557751219,1.66745622648821,2.5667788516258e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14418604651162,GM2A;Ganglioside GM2 activator,0.229544480246791,1.25802682332238,1.17852619552328,1.34289037800802,5.50698812992993e-12
primary,Circulatory system disorders,I50 (heart failure),0.899999999999999,GM2A;Ganglioside GM2 activator,0.567357552619173,1.76360066684819,1.59723986194079,1.94728881129232,3.13705476646561e-29
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65348837209302,GM2A;Ganglioside GM2 activator,0.193184295994603,1.21310634355894,1.12664505978937,1.3062028613147,3.04197698047786e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54186046511627,GM2A;Ganglioside GM2 activator,0.391120206993724,1.47863624514847,1.3701105667035,1.59575818083586,8.61512779173304e-24
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348837209302325,GM2A;Ganglioside GM2 activator,0.435476955016309,1.54570011258906,1.31976492482578,1.8103139378198,6.61882020271659e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.167441860465116,GM2A;Ganglioside GM2 activator,0.632043917774569,1.88145218552729,1.50177532636813,2.357118447928,3.8843289031792e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41395348837209,GM2A;Ganglioside GM2 activator,0.347644826863687,1.41572933140696,1.30759229965592,1.53280922527106,9.88182101962192e-18
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.144186046511627,GM2A;Ganglioside GM2 activator,0.749910467341658,2.11681048445826,1.66563449184443,2.6901980290709,8.6939459936692e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.234883720930232,GM2A;Ganglioside GM2 activator,0.587830496372332,1.80007889837548,1.48809217756442,2.17747535349599,1.42056356559692e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54186046511627,GM2A;Ganglioside GM2 activator,0.196876189422902,1.21759328044652,1.14674630274784,1.29281724565935,1.22021319181123e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306341463414634,SCG2;Secretogranin-2,1.6722433858766,5.32409841687971,4.51252524680072,6.28163221307574,2.10539921853668e-87
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390243902439024,SCG2;Secretogranin-2,1.51834370583926,4.56465851330514,2.97765723507339,6.99748349059915,3.26209997855342e-12
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65365853658536,SCG2;Secretogranin-2,0.297028435083052,1.34585356836199,1.2756022679915,1.41997382171852,1.80199983614566e-27
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69170731707317,SCG2;Secretogranin-2,0.249926001495896,1.2839304042431,1.22644317100301,1.34411224418307,1.09152120019043e-26
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360975609756097,SCG2;Secretogranin-2,0.382432028312526,1.46584523499707,1.26983762556099,1.69210788033971,1.77190834395123e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.300487804878048,SCG2;Secretogranin-2,0.381288455862679,1.46416989289071,1.25256031546958,1.71152913657806,1.68931617488897e-06
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.380487804878048,SCG2;Secretogranin-2,0.381654592234058,1.46470607689462,1.27489227897645,1.68278051963295,7.06401087512451e-08
primary,Circulatory system disorders,I50 (heart failure),0.909268292682926,SCG2;Secretogranin-2,0.502690245361223,1.65316270704863,1.51088593228629,1.80883736990047,6.79322250038503e-28
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71317073170731,SCG2;Secretogranin-2,0.189859314161783,1.20907948533047,1.13136049356074,1.29213739578799,2.13196911179208e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57073170731707,SCG2;Secretogranin-2,0.231253568325631,1.26017874035305,1.17593239538933,1.35046067602553,5.73163996141867e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.175609756097561,SCG2;Secretogranin-2,0.574800367606337,1.77677578950281,1.45088904776004,2.17586052568057,2.69779667594029e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40878048780487,SCG2;Secretogranin-2,0.224042407244185,1.25112407502753,1.16267809383185,1.34629822254128,2.10721985730794e-09
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172234057018537,CFD;Complement factor D,0.620092322485697,1.85909967062637,1.48787132545276,2.32295059807765,4.86276761050481e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.201695145719077,CFD;Complement factor D,1.38250656840921,3.9848774877089,3.29631790984011,4.81726854823278,2.7572884466089e-46
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.56538095453927,CFD;Complement factor D,0.245745458974777,1.27857408256029,1.20355592650603,1.35826815239125,1.64157011248057e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54892806961881,CFD;Complement factor D,0.209858666685149,1.23350371246791,1.17150798436227,1.29878022939843,1.50723975160786e-15
primary,Circulatory system disorders,I26 (pulmonary embolism),0.99714454063364,CFD;Complement factor D,0.242857455354787,1.27488688286724,1.15955927478207,1.40168476028309,5.16481451641097e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.394325341068757,CFD;Complement factor D,0.578049036783444,1.78255733231998,1.53707701463673,2.06724231300712,2.06519038163593e-14
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.5529619725332,CFD;Complement factor D,0.417690251251294,1.51845026348231,1.33776470503362,1.72354016666299,1.03403438287549e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.305942074967139,CFD;Complement factor D,0.506057357003593,1.65873847229039,1.39995352332335,1.96536047348534,4.98820043827734e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.378461677922313,CFD;Complement factor D,0.428152800302488,1.53442052297577,1.31631880726187,1.788659653224,4.41211732931374e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14159452476997,CFD;Complement factor D,0.382769346330175,1.46633977440976,1.37310040226036,1.56591049749643,3.35633117073623e-30
primary,Circulatory system disorders,I50 (heart failure),0.899696324162625,CFD;Complement factor D,0.695589742043003,2.00489109393321,1.81461096100105,2.21512400449473,1.49698896623311e-42
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.6543534424149,CFD;Complement factor D,0.247389659230471,1.2806780435864,1.18933125325336,1.37904073977521,5.65829066510193e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55917146353623,CFD;Complement factor D,0.371866141810148,1.45043881518379,1.34386233714165,1.56546745782489,1.29627937380676e-21
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.344468114037075,CFD;Complement factor D,0.413319638355415,1.51182818698683,1.28810161458428,1.77441316825424,4.22951723727819e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,HGF;Hepatocyte growth factor,0.47360958745528,1.60577994799771,1.37711417859994,1.87241499758069,1.51669707517451e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.58852481252543,HGF;Hepatocyte growth factor,0.247970207699531,1.28142175512337,1.22921510163088,1.33584570538131,1.52836465475996e-31
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65274090724126,HGF;Hepatocyte growth factor,0.293420172049996,1.34100612536735,1.27012152006635,1.41584675156028,3.33188489896823e-26
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,HGF;Hepatocyte growth factor,0.293889307663052,1.34163538669099,1.28099587846195,1.40514543495852,1.33143401972755e-35
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00180208111302,HGF;Hepatocyte growth factor,0.222596303793995,1.24931612774049,1.14576692657537,1.36222363452016,4.5967982015912e-07
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354603057724727,HGF;Hepatocyte growth factor,0.498823374074349,1.64678248334626,1.42846994014958,1.89845965339116,6.22442717418912e-12
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542562055535101,HGF;Hepatocyte growth factor,0.287747420674017,1.3334204671433,1.18612334604297,1.49900948171055,1.45045598080494e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304222295425039,HGF;Hepatocyte growth factor,0.390710849439052,1.47803107810421,1.26575127809219,1.72591243291858,7.84933163288538e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16055961400585,HGF;Hepatocyte growth factor,0.317741690858704,1.37402129312343,1.29466945630592,1.45823669876589,1.19893038018718e-25
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,HGF;Hepatocyte growth factor,0.587079950044843,1.79872836265233,1.64401800592977,1.96799774147251,1.76980692574215e-37
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70131958842792,HGF;Hepatocyte growth factor,0.233071915042765,1.26247226680978,1.18100049706643,1.34956439766356,7.50248262143059e-12
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,HGF;Hepatocyte growth factor,0.30723704161034,1.35966322663689,1.26836983133023,1.45752764233582,4.56299192115943e-18
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354603057724727,HGF;Hepatocyte growth factor,0.4287876784832,1.53539500239097,1.33053636855027,1.77179509639094,4.39630666695703e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.174394946421997,HGF;Hepatocyte growth factor,0.611824535823942,1.84379239699867,1.50866776569729,2.25335920904948,2.2601879839292e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,HGF;Hepatocyte growth factor,0.335881231682184,1.39917283753798,1.30094176936799,1.50482110375712,1.51476556570491e-19
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153080008525975,HGF;Hepatocyte growth factor,0.65619290304283,1.92744039604395,1.55741464967957,2.38538046439104,1.60543831497443e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246090646617706,HGF;Hepatocyte growth factor,0.565502936265258,1.76033289537754,1.4857813876518,2.08561766105154,6.29190162317895e-11
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0213149378960218,HGF;Hepatocyte growth factor,1.31430975646254,3.7221808870539,2.22573888755826,6.22473311375197,5.45657651775734e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,TGFA;Protransforming growth factor alpha,1.00474580100178,2.73121291299049,2.34342196025378,3.18317575861506,7.57815495282313e-38
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392356887825165,TGFA;Protransforming growth factor alpha,1.19642207862456,3.30825903138113,2.19870977130668,4.97772737518264,9.48691517449044e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.58272844979793,TGFA;Protransforming growth factor alpha,0.262551640552503,1.3002436117333,1.24682566168299,1.35595015551028,1.36953933276651e-34
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64840899281986,TGFA;Protransforming growth factor alpha,0.314107524251963,1.36903693330578,1.29621906753785,1.44594549771238,1.97775234770314e-29
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68619296111743,TGFA;Protransforming growth factor alpha,0.315903815239235,1.37149833204266,1.30894702925158,1.43703880505487,3.7587942477619e-40
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359006552360026,TGFA;Protransforming growth factor alpha,0.509150862996907,1.66387773476693,1.43986069178284,1.92274789641293,5.16333889818135e-12
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388433318946914,TGFA;Protransforming growth factor alpha,0.393615339711101,1.48233024541483,1.28995454894909,1.70339564154544,2.85957529353274e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17169537411229,TGFA;Protransforming growth factor alpha,0.254496143293015,1.28981157690836,1.21483954731934,1.36941039464657,8.12031379799986e-17
primary,Circulatory system disorders,I50 (heart failure),0.904382626437007,TGFA;Protransforming growth factor alpha,0.544940429819673,1.72450565020402,1.57420122666331,1.88916111054565,1.10385363187311e-31
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70675246203947,TGFA;Protransforming growth factor alpha,0.226521907773966,1.25423008692216,1.17265335954373,1.34148177561428,4.06823334291626e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56942755130066,TGFA;Protransforming growth factor alpha,0.321003718446807,1.37851070680296,1.28530258679824,1.47847813292286,2.54735435006692e-19
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353121199042649,TGFA;Protransforming growth factor alpha,0.404132380274795,1.49800223978096,1.29469311759929,1.73323753705417,5.61978801029321e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.176560599521324,TGFA;Protransforming growth factor alpha,0.654383848014109,1.92395670234981,1.57082428035148,2.35647579351683,2.53523044207725e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39875230509671,TGFA;Protransforming growth factor alpha,0.329531586469911,1.39031673274567,1.29104864077037,1.49721749925642,2.80855825189157e-18
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149095617373563,TGFA;Protransforming growth factor alpha,0.70393088879019,2.02168412395962,1.62187148280211,2.52005583698218,3.81773795378005e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24914662376898,TGFA;Protransforming growth factor alpha,0.703295049088806,2.02039906551884,1.7032262931942,2.39663537385514,6.92513078366549e-16
primary,Circulatory system disorders,I95 (hypotension),0.519872876368344,TGFA;Protransforming growth factor alpha,0.297438930391385,1.34640614834549,1.1931037552104,1.51940642914402,1.41641680490518e-06
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.312782783176614,IGFBP6;Insulin-like growth factor-binding protein 6,1.88992261141225,6.61885643727028,5.6117614340399,7.80668619864262,1.54255482211793e-111
primary,Circulatory system disorders,I15 (secondary hypertension),0.0393437463115237,IGFBP6;Insulin-like growth factor-binding protein 6,2.0978110191363,8.14831387329346,5.35049124211824,12.4091445015469,1.43995900292428e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67734193649919,IGFBP6;Insulin-like growth factor-binding protein 6,0.2017504356608,1.22354261740083,1.14958305280943,1.30226044385176,2.26972052215696e-10
primary,Circulatory system disorders,I50 (heart failure),0.922610851005232,IGFBP6;Insulin-like growth factor-binding protein 6,0.533722824676083,1.70526892347466,1.53890797770772,1.88961402727923,2.18087931330112e-24
primary,Circulatory system disorders,I63 (cerebral infarction),0.367864028012747,IGFBP6;Insulin-like growth factor-binding protein 6,0.438068849575732,1.54971160073279,1.31979428079757,1.81968211287781,8.9705706428152e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57178266514537,IGFBP6;Insulin-like growth factor-binding protein 6,0.36996733479023,1.44768732488081,1.3384355932873,1.56585688630195,2.43636316218897e-20
primary,Circulatory system disorders,I70 (atherosclerosis),0.169178109139552,IGFBP6;Insulin-like growth factor-binding protein 6,0.647006422836411,1.90981508423758,1.51098248819746,2.41392185844097,6.17798569287086e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.301000097096805,STC1;Stanniocalcin-1,0.728764778593399,2.07251900608536,1.77515069087564,2.41970163584605,2.9065713239338e-20
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549567919215457,STC1;Stanniocalcin-1,0.335697182408188,1.39891534448947,1.24416313884154,1.57291602680838,1.9963823136953e-08
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,STC1;Stanniocalcin-1,0.397975701212285,1.48880785324178,1.35915782349217,1.63082519598737,1.1166326721644e-17
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70307796873482,STC1;Stanniocalcin-1,0.20041163182675,1.22190562990061,1.14238247058786,1.30696452967673,5.31737816084511e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40984561607923,STC1;Stanniocalcin-1,0.230520435065415,1.25925519998512,1.16947919849085,1.3559229276894,1.00440817383797e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304303439610491,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.481661591291076,0.617756080433425,0.528020861604114,0.722741472284084,1.80328430806859e-09
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64842154861002,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.23037006606718,0.794239626976351,0.752308037077331,0.838508368872696,8.46647233609751e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69090623527564,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.264638300506779,0.767483498170652,0.732690101101911,0.803929136040466,5.1152462890573e-29
primary,Circulatory system disorders,I33 (acute and subacute endocarditis),0.0451547039422019,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.980969186935232,0.374947528450045,0.2512837108219,0.559469806582246,1.55358332809748e-06
primary,Circulatory system disorders,I50 (heart failure),0.905057326841526,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.304519834383243,0.737477400680141,0.673008345406719,0.808122098672133,6.82209971937175e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56863514999214,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.264853163123473,0.767318612372497,0.715285260451584,0.823137125070267,1.44151683970265e-13
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172765823778859,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.589458199606012,0.55462770085121,0.451409447405798,0.681447604429443,2.0180031438235e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13784886118876,TTR;Transthyretin,-0.253752575794008,0.775883750720086,0.72495144061628,0.830394369752149,2.39086463061452e-13
primary,Circulatory system disorders,I85 (oesophageal varices),0.0527015260528848,TTR;Transthyretin,-1.52705644438642,0.217173991104963,0.145960221412701,0.323132850553175,4.99452018923344e-14
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0183309655836121,TTR;Transthyretin,-2.39220982331014,0.0914274220299533,0.0464561150520786,0.17993268463522,4.35241764987923e-12
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306659161927682,LAMP3;Lysosome-associated membrane glycoprotein 3,0.687555904733834,1.98884865252899,1.71649274585589,2.30441927134044,5.67951583494425e-20
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65318401490596,LAMP3;Lysosome-associated membrane glycoprotein 3,0.260861005686518,1.29804723171051,1.22995529643797,1.36990882565485,2.34065263273486e-21
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.110630203986569,LAMP3;Lysosome-associated membrane glycoprotein 3,0.61869240393574,1.85649890336715,1.44894367163261,2.3786902456463,9.96214291420743e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70708227393591,LAMP3;Lysosome-associated membrane glycoprotein 3,0.195648367475439,1.21609921010758,1.16150870793612,1.27325544674746,6.87685564803242e-17
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0014944781942,LAMP3;Lysosome-associated membrane glycoprotein 3,0.259947314533955,1.29686175909967,1.19071111206511,1.41247562500546,2.42945331133369e-09
primary,Circulatory system disorders,I50 (heart failure),0.904450439609494,LAMP3;Lysosome-associated membrane glycoprotein 3,0.295463080688266,1.34374847859962,1.2277606354192,1.47069381575529,1.40748143957014e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55464549812705,LAMP3;Lysosome-associated membrane glycoprotein 3,0.253693208614502,1.28877635812666,1.20277269357134,1.38092967203507,6.04006391097524e-13
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355181181220037,LAMP3;Lysosome-associated membrane glycoprotein 3,0.483809219557492,1.62224212405758,1.41087490814274,1.8652748687204,1.10091683861513e-11
primary,Circulatory system disorders,I70 (atherosclerosis),0.174679269452477,LAMP3;Lysosome-associated membrane glycoprotein 3,0.723092481165027,2.06079634051112,1.69754864716133,2.50177310922178,2.69476931626565e-13
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41102032102167,LAMP3;Lysosome-associated membrane glycoprotein 3,0.395465409086727,1.48507519759948,1.38291972713675,1.59477683284725,1.50398576965793e-27
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153329580963841,LAMP3;Lysosome-associated membrane glycoprotein 3,0.648327946951201,1.9123406193364,1.55298124562035,2.35485563954965,1.03002958608976e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246491858005162,LAMP3;Lysosome-associated membrane glycoprotein 3,0.678096554727378,1.97012413750667,1.67219081188626,2.32114008138109,5.23936476183163e-16
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306802415336212,CES1;Liver carboxylesterase 1,-0.485457884866988,0.61541534286848,0.529864960048456,0.714778429966937,2.05779894826052e-10
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,RSPO3;R-spondin-3,1.62272347358436,5.06687103174935,4.3474721096823,5.90531265173702,8.09477949344912e-96
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,RSPO3;R-spondin-3,1.56284022967243,4.77235660310771,3.28191626665952,6.93966137363023,2.81249319839908e-16
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65907854867531,RSPO3;R-spondin-3,0.252104135146739,1.28673002412822,1.21845088476582,1.35883536685291,1.27652291151592e-19
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69629399425064,RSPO3;R-spondin-3,0.232154492929104,1.2613145779602,1.20401383913972,1.32134234080867,1.28554801668358e-22
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,RSPO3;R-spondin-3,0.257273816365251,1.29339923215378,1.18613103869648,1.41036826384244,5.73651844778256e-09
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304949110403232,RSPO3;R-spondin-3,0.431032911268304,1.53884619450345,1.31718347867429,1.79781150361917,5.5864648090084e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382643151270297,RSPO3;R-spondin-3,0.345958687427852,1.41334422572626,1.22907431939871,1.62524093853902,1.21103064301893e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,RSPO3;R-spondin-3,0.324860205387959,1.38383717947664,1.30369193262033,1.46890940366014,1.37071679026298e-26
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,RSPO3;R-spondin-3,0.665136156565662,1.94475529451307,1.77734173546608,2.12793807744846,1.5713944137856e-47
primary,Circulatory system disorders,I63 (cerebral infarction),0.367104343096884,RSPO3;R-spondin-3,0.425756969182397,1.53074871081279,1.32823256689293,1.76414257115856,4.09386826369466e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,RSPO3;R-spondin-3,0.324422679016379,1.38323184665084,1.29016273942491,1.48301472606624,6.92952198287619e-20
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,RSPO3;R-spondin-3,0.468784574294255,1.59805070047065,1.38114815862777,1.84901672229866,2.99977734050541e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.174811591950897,RSPO3;R-spondin-3,0.644895367642021,1.90578761178771,1.55749911946561,2.33196049734505,3.77510334458727e-10
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,RSPO3;R-spondin-3,0.287256670165683,1.33276625091283,1.23865853912755,1.43402384391048,1.48845224685406e-14
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55613394452645,RSPO3;R-spondin-3,0.182685600312658,1.2004369317487,1.13641785599811,1.26806246443617,6.43137571932634e-11
primary,Circulatory system disorders,I95 (hypotension),0.518607722787662,RSPO3;R-spondin-3,0.321084609417468,1.37862222038226,1.22278325624502,1.55432225361684,1.55223452705837e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.307860176922177,DPY30;Protein dpy-30 homolog,0.713483107471055,2.04108822136268,1.75647725310186,2.37181615647366,1.25514597908283e-20
primary,Circulatory system disorders,I50 (heart failure),0.909941155839601,DPY30;Protein dpy-30 homolog,0.343269277947314,1.40954827109251,1.28806377333003,1.54249065122245,8.34302230690309e-14
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40875258173882,DPY30;Protein dpy-30 homolog,0.212350454590599,1.23658117469922,1.14983932638087,1.3298666748801,1.04866764498725e-08
primary,Circulatory system disorders,I00 (rheumatic fever without mention of heart involvement),0.360423889835654,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.386560937632886,1.47191008905019,1.27063288882598,1.70507101563342,2.57112066473461e-07
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.117529529294235,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.58032334756008,4.85652590318234,3.73786107192847,6.30998407763519,2.7107587212987e-32
primary,Circulatory system disorders,I07 (rheumatic tricuspid valve diseases),0.0489706372059313,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.48161044255267,4.40002596724183,2.96140402803196,6.53751677553722,2.23264543251947e-13
primary,Circulatory system disorders,I08 (multiple valve diseases),0.174335468453115,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.31665928755443,3.73093654859935,3.04283710913744,4.57464104400262,1.00841225599808e-36
primary,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0274235568353215,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.79467176264706,6.01749922959143,3.55823888352382,10.1764659887796,2.1595642487603e-11
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0875986758339,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.192185506536539,1.21189531061563,1.18800752131287,1.23626342219541,7.67144049498136e-80
primary,Circulatory system disorders,I11 (hypertensive heart disease),0.0293823823235587,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.31802080659527,3.73601974940256,2.33820281711778,5.96947513096031,3.54178989440501e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.27161519937223,3.56660869657964,3.07111029808427,4.14205168809878,2.45290716760232e-62
primary,Circulatory system disorders,I15 (secondary hypertension),0.039176509764745,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.21040800183756,3.35485315960723,2.25240504781419,4.99689864105431,2.60759893143065e-09
primary,Circulatory system disorders,I20 (angina pectoris),4.61107519931049,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.732004513949503,2.07924430740147,1.99279616933596,2.16944259347006,3.28315476102579e-250
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67575561693208,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.997942383840879,2.71269439820848,2.56654860109988,2.86716210825624,3.09254426300873e-273
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.111653052829523,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.16704426327721,3.21248333698521,2.54210465413801,4.05964765203855,1.47185823200895e-22
primary,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.160623690035454,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.855573654816791,2.35272364478335,1.9251477506928,2.87526427347233,6.23996087099704e-17
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72176842765078,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.904855265074044,2.47157417406363,2.35657583238484,2.59218430994276,2.96459455846164e-303
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01075395193042,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.288699424727388,1.33469049327196,1.22248853724996,1.45719052453275,1.16476084545623e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358465064347417,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.26109571386613,3.52928645763712,3.04953259215793,4.08451542118023,3.37033302306551e-64
primary,Circulatory system disorders,I31 (other diseases of pericardium),0.199800199800199,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.58303228216349,1.79146242260781,1.49112043093152,2.15229940187389,4.7479211864195e-10
primary,Circulatory system disorders,I33 (acute and subacute endocarditis),0.047011811717694,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.34452758352521,3.83637374627554,2.65139046321165,5.5509604207011,9.82315614868795e-13
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542594660241719,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.14511587941269,3.14280552219725,2.79501219244632,3.5338760156565,1.2402056035343e-81
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.378053319229789,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.959083050965625,2.60930277847958,2.27749037039333,2.98945764087046,1.90623597241104e-43
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0587647646471175,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.5910298647482,4.90880172788543,3.46601008272092,6.95218243126824,3.24252406847857e-19
primary,Circulatory system disorders,I42 (cardiomyopathy),0.309494427141486,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.27065908425877,3.56320023780018,3.0638446905067,4.14394240478277,4.03379502754861e-61
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.393723923135687,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.03984118278755,2.82876772167058,2.47913456031451,3.22770976261579,7.80855719778188e-54
primary,Circulatory system disorders,I45 (other conduction disorders),0.264441440912029,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.623022817828927,1.86455574414812,1.58793331691959,2.18936657225627,2.873901237242e-14
primary,Circulatory system disorders,I46 (cardiac arrest),0.0822706705059646,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.23896174277958,3.45202751102522,2.60960918442103,4.56639025031587,3.95861290173829e-18
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.711053652230122,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.655458000845819,1.92602443622201,1.73740211640601,2.13512467487834,1.16672406695448e-35
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.38563452597543,3.99736152999551,3.73878832564659,4.27381756059288,0.0
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.2516894869836,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.67809942097537,1.97012978437911,1.82315995470144,2.12894724749114,7.11369351253033e-66
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.5072720543638,4.51439894675004,4.09375847575332,4.97826092358016,2.10586248838562e-200
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71788995318407,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.781725370020639,2.18523936122844,2.04350600822697,2.33680304664497,1.52822827053616e-115
primary,Circulatory system disorders,I63 (cerebral infarction),0.366300366300366,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.551918163299769,1.73658087085785,1.51127791590282,1.99547223531542,7.00467955218642e-15
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.410648619397112,1.50779545338921,1.40745165214059,1.61529323284641,1.48605201703989e-31
primary,Circulatory system disorders,I70 (atherosclerosis),0.176294293941352,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.926386637400377,2.52536760280564,2.08400342326922,3.06020683943782,3.32512116315793e-21
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172376642964878,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.788066787447438,2.19914090736304,1.81806290301548,2.66009538086723,4.78750442353105e-16
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.3829663869817,1.46662873142147,1.36101210166368,1.58044137388756,9.85091984212525e-24
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152788388082505,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.567550759298165,1.76394143919479,1.42488124844358,2.18368330996517,1.87697003482451e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248770837006131,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.66999366939,1.95422494916077,1.65287253947015,2.31052005567632,4.47803905441891e-15
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55234961117314,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.302488881881908,1.35322263104851,1.27900732050888,1.43174433783012,7.69002242368716e-26
primary,Circulatory system disorders,I83 (varicose veins of lower extremities),3.12628547922665,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.191395647576909,1.2109384621838,1.15010496324172,1.27498968012703,3.38672876775938e-13
primary,Circulatory system disorders,I95 (hypotension),0.521047579871109,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.487276246737418,1.62787624277183,1.44270009269125,1.83682046962206,2.60251976411164e-15
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0795240955684,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.21211458139823,1.23628953274653,1.21228430102621,1.26077010770891,9.10330929131903e-100
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30616001705195,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,1.89459243613001,6.64983761870655,5.63522180786898,7.8471339483773,2.03006750950573e-111
primary,Circulatory system disorders,I15 (secondary hypertension),0.0387544325382215,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,1.93349029615397,6.91359868612881,4.59492250301932,10.4023183767373,1.7608553664767e-20
primary,Circulatory system disorders,I20 (angina pectoris),4.58852481252543,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.232826395140162,1.26216234278961,1.21078206441295,1.31572297474406,4.76474799700687e-28
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65274090724126,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.33157791573849,1.39316469150536,1.31969264311649,1.47072719377576,3.77161510723604e-33
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70298602902707,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.315410003443888,1.37082123718148,1.30889643323805,1.43567574682663,8.65379385737748e-41
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00180208111302,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.270397123610129,1.31048477185412,1.20104300640956,1.42989911942914,1.22337426860912e-09
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354603057724727,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.481708617616994,1.61883801569387,1.39886662897457,1.87339984153937,1.01563011848821e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304222295425039,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.418217078704345,1.519250435525,1.29894505170994,1.77692034224579,1.67564146086577e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.381731160501482,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.381447685788985,1.46440305111725,1.27323532384853,1.68427332791829,9.06662961899639e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16055961400585,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.1998022993842,1.22116130995075,1.15063286970864,1.29601281536329,4.62019521017333e-11
primary,Circulatory system disorders,I50 (heart failure),0.902978278140562,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.670284605956141,1.95479358737176,1.78398067243786,2.14196152921766,8.2677028820061e-47
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70131958842792,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.18651995116937,1.20504866397585,1.12698085378539,1.28852435928474,4.81200956325325e-08
primary,Circulatory system disorders,I63 (cerebral infarction),0.366229387486193,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.564424065783102,1.75843474828949,1.52456415049749,2.02818147270677,9.08552239466874e-15
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55986590966341,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.483063969089993,1.62103359773957,1.51115443966258,1.73890229617247,1.81757442442821e-41
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354603057724727,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.528179185705025,1.69584168296638,1.46601553938545,1.96169749666624,1.17343915772272e-12
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.127889627376131,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.709448773798,2.03287037832802,1.59904757911421,2.58438962608776,6.92449502348971e-09
primary,Circulatory system disorders,I70 (atherosclerosis),0.174394946421997,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.797152127608619,2.21921188835323,1.81098719931477,2.71945677322942,1.51927611530035e-14
primary,Circulatory system disorders,I72 (other aneurysm),0.106574689480109,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.655884877949497,1.92684678746393,1.48112063307143,2.50670908193405,1.02760210655173e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40872362276435,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.33415446076516,1.39675887135735,1.29734800831306,1.50378721223171,7.28046879221899e-19
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246090646617706,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.616783627697175,1.85295864223154,1.55777061138291,2.20408300473232,3.2503712186734e-12
primary,Circulatory system disorders,I95 (hypotension),0.519309396012168,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.418994925117195,1.52043263875316,1.34733865127037,1.71576418950517,1.08645738522559e-11
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0175683769215,MVK;Mevalonate kinase,0.189362855383624,1.20847937618353,1.18450726382248,1.2329366372546,1.32493368292792e-76
primary,Circulatory system disorders,I20 (angina pectoris),4.59972050309443,MVK;Mevalonate kinase,0.21286470596333,1.23721725180354,1.18569186559943,1.29098172347371,1.04203214222098e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64723497704132,MVK;Mevalonate kinase,0.22236787966404,1.24903078638164,1.18140983743651,1.32052218958519,4.86469610976033e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68935915352365,MVK;Mevalonate kinase,0.227496777445106,1.25545339398013,1.19730817876676,1.31642233170049,5.3172426201044e-21
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,SMOC1;SPARC-related modular calcium-binding protein 1,1.11138200136061,3.03855478090337,2.61327451604265,3.53304450025105,2.62362763799189e-47
primary,Circulatory system disorders,I15 (secondary hypertension),0.0388470204335327,SMOC1;SPARC-related modular calcium-binding protein 1,1.08917031184971,2.97180737604529,1.96146500832945,4.50257284367207,2.77659373854294e-07
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00419547820682,SMOC1;SPARC-related modular calcium-binding protein 1,0.348793619100076,1.41735664481525,1.30009238021401,1.54519777915416,2.45030249733438e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359334939010177,SMOC1;SPARC-related modular calcium-binding protein 1,0.402708824539185,1.49587126723953,1.29615283468155,1.72636342588608,3.63615118139895e-08
primary,Circulatory system disorders,I42 (cardiomyopathy),0.304949110403232,SMOC1;SPARC-related modular calcium-binding protein 1,0.395152344029282,1.48461034521575,1.26940945810346,1.73629388299547,7.59079332693622e-07
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1696060912128,SMOC1;SPARC-related modular calcium-binding protein 1,0.231968526858794,1.26108003805362,1.18766033566643,1.33903845621396,3.46584352803359e-14
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,SMOC1;SPARC-related modular calcium-binding protein 1,0.479406410585348,1.61511540218874,1.47414131870931,1.76957102367314,7.97392347151787e-25
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56747727449304,SMOC1;SPARC-related modular calcium-binding protein 1,0.226569517087891,1.25428980137758,1.16944000046308,1.34529595807978,2.30066227467186e-10
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343796130836764,SMOC1;SPARC-related modular calcium-binding protein 1,0.39517319820517,1.48464130586384,1.28201834037526,1.71928882579941,1.3038539209499e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40820449071556,SMOC1;SPARC-related modular calcium-binding protein 1,0.19815977236485,1.21915716588514,1.13272983681749,1.31217890340482,1.27739243733382e-07
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55613394452645,SMOC1;SPARC-related modular calcium-binding protein 1,0.182352139772122,1.20003670013499,1.13592055533028,1.26777183044475,7.56294674516973e-11
primary,Circulatory system disorders,I85 (oesophageal varices),0.0563281796286224,SMOC1;SPARC-related modular calcium-binding protein 1,1.09960920843799,3.0029922505787,2.13927899982466,4.2154213909335,2.08596574432203e-10
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172456829063514,CKB;Creatine kinase B-type,0.541127690664747,1.7179430786254,1.38771028740832,2.12676121822862,6.75506024490198e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204225192312056,CKB;Creatine kinase B-type,1.18690286473845,3.27691642125221,2.74842117250643,3.90703627933403,6.14155518293058e-40
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.58231409834577,CKB;Creatine kinase B-type,0.197516981529813,1.2183737546442,1.1479610598337,1.29310536563048,7.8688476777346e-11
primary,Circulatory system disorders,I26 (pulmonary embolism),1.005241779936,CKB;Creatine kinase B-type,0.289779501820929,1.33613284068369,1.2189520319467,1.46457852414617,6.10451436296707e-10
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40164287821371,CKB;Creatine kinase B-type,0.434648549104636,1.54442017570495,1.33964551114129,1.78049615311476,2.11143409053778e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14890285688352,CKB;Creatine kinase B-type,0.354384567940978,1.42530320701716,1.33749380609505,1.51887748763827,8.91776276687483e-28
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24577367310354,CKB;Creatine kinase B-type,0.209363965002413,1.23289364701834,1.13423840880528,1.34012984665125,8.6516060535355e-07
primary,Circulatory system disorders,I50 (heart failure),0.909936690190383,CKB;Creatine kinase B-type,0.569865594437941,1.76802940247784,1.60912883696625,1.94262130925425,1.90290204956123e-32
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55891896798202,CKB;Creatine kinase B-type,0.302735592631903,1.35355652680487,1.25666535321452,1.45791818527467,1.36387655395547e-15
primary,Circulatory system disorders,I70 (atherosclerosis),0.165649322653112,CKB;Creatine kinase B-type,0.61161260960508,1.84340169044955,1.48641781641141,2.2861201977222,2.558816103139e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40915382695318,CKB;Creatine kinase B-type,0.317129097744954,1.37317983490319,1.27074061214501,1.48387707212868,1.08246018279105e-15
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.23372438675713,CKB;Creatine kinase B-type,0.566530528188983,1.76214272896983,1.46790721127655,2.11535645673467,1.21804816019948e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54373822868683,CKB;Creatine kinase B-type,0.252999731536102,1.28788293108451,1.2148232175659,1.36533647052135,2.05287592281793e-17
primary,Circulatory system disorders,I85 (oesophageal varices),0.0521908824797476,CKB;Creatine kinase B-type,1.05745380514117,2.87903107468625,2.03812176849739,4.06689141793527,1.97244950724361e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0181533504277383,CKB;Creatine kinase B-type,1.43761911089736,4.21065876161955,2.43149868796164,7.29165402991293,2.87673057496727e-07
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0562143515161,LGALS9;Galectin-9,0.20558631198647,1.22824498865177,1.2042790433347,1.25268787204904,6.19894183928678e-93
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303808385111429,LGALS9;Galectin-9,1.20391675281948,3.33314650021468,2.90923306509006,3.81882968580568,2.08653134768628e-67
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392010819498618,LGALS9;Galectin-9,1.27521832395244,3.57948281163426,2.52429028029198,5.07576220485352,8.29108978159238e-13
primary,Circulatory system disorders,I20 (angina pectoris),4.5943668045238,LGALS9;Galectin-9,0.23186522652032,1.26094977478708,1.20969515087039,1.31437605035581,6.54458800349455e-28
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64607303161567,LGALS9;Galectin-9,0.3014054923341,1.35175735766843,1.28061228865175,1.42685492728989,8.64770169615833e-28
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69862208196946,LGALS9;Galectin-9,0.301895981330705,1.35242054240756,1.29154446576268,1.4161659718358,8.92064028590204e-38
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00746780611144,LGALS9;Galectin-9,0.41759598111126,1.51830712571026,1.39557565050031,1.65183200721229,2.7248229312382e-22
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354769791646249,LGALS9;Galectin-9,0.508287164651042,1.66244126674651,1.44634902947878,1.91081883352714,8.39856042312874e-13
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542934985005586,LGALS9;Galectin-9,0.389110750211836,1.47566797282399,1.31581831552586,1.65493665829404,2.89513102163838e-11
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.378290440816166,LGALS9;Galectin-9,0.431003725834688,1.53880128326538,1.34261477169559,1.76365509995749,5.86971831325063e-10
primary,Circulatory system disorders,I42 (cardiomyopathy),0.303808385111429,LGALS9;Galectin-9,0.504193925635977,1.65565040508468,1.42434217790832,1.92452228570703,5.1397466521527e-11
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386130657206138,LGALS9;Galectin-9,0.39083011536616,1.47820736736348,1.29028566026982,1.69349864778837,1.76243853837166e-08
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17173994002234,LGALS9;Galectin-9,0.316118420870372,1.37179269489265,1.29329274817775,1.45505741094761,7.4160125711214e-26
primary,Circulatory system disorders,I50 (heart failure),0.905544993041808,LGALS9;Galectin-9,0.67534044109436,1.96470172733431,1.80194706643972,2.14215664226868,6.85856260635989e-53
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70328701072149,LGALS9;Galectin-9,0.257270234907532,1.29339459990741,1.21044290518386,1.38203097717818,2.79918875847794e-14
primary,Circulatory system disorders,I63 (cerebral infarction),0.364570062133714,LGALS9;Galectin-9,0.388489654189365,1.4747517258837,1.28237805369734,1.69598399374219,5.10624120393276e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56608322389697,LGALS9;Galectin-9,0.381741567517517,1.46483347566103,1.36803177081344,1.56848485334614,7.12885297842346e-28
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356729845743742,LGALS9;Galectin-9,0.536242596686521,1.70957123051836,1.48874159095075,1.96315721276357,2.98630866281091e-14
primary,Circulatory system disorders,I70 (atherosclerosis),0.172484760579392,LGALS9;Galectin-9,0.744544124006947,2.10548137774989,1.74075598582841,2.54662449426645,1.70195790783573e-14
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170524706481898,LGALS9;Galectin-9,0.501616211524373,1.651388107524,1.35112675107746,2.01837664711839,9.62488864974145e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40731884200003,LGALS9;Galectin-9,0.488249704477272,1.62946168305424,1.51763033607211,1.74953367327509,2.71407658180318e-41
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152884219604461,LGALS9;Galectin-9,0.586196882431363,1.79714066501518,1.45925869333047,2.21325703565282,3.45698609528795e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.245006762186636,LGALS9;Galectin-9,0.519227791330923,1.68072927473888,1.4221978955802,1.98625725979705,1.10860943029322e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56375075952096,LGALS9;Galectin-9,0.254660303229777,1.29002332967544,1.2218752655316,1.36197223894445,3.69888609674119e-20
primary,Circulatory system disorders,I85 (oesophageal varices),0.0529214606323134,LGALS9;Galectin-9,0.84425775532603,2.32625052655071,1.66122921717467,3.25749237753051,8.90053249881444e-07
primary,Circulatory system disorders,I95 (hypotension),0.521374389933162,LGALS9;Galectin-9,0.344611452140528,1.41144140057663,1.25481980313452,1.5876118804352,9.33066336120812e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.021560595072424,LGALS9;Galectin-9,1.32114889386581,3.7477246426426,2.34732012489929,5.98360651710135,3.12298870783501e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,DSG2;Desmoglein-2,1.04293352332337,2.83752877385962,2.44097672155395,3.2985032062721,5.33801635034328e-42
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,DSG2;Desmoglein-2,1.47222317853614,4.35891502334334,2.95169321237701,6.43703082049891,1.34466081237221e-13
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15816066742391,DSG2;Desmoglein-2,0.21311951484951,1.2375325459216,1.16433508872197,1.31533165756968,7.32876549548572e-12
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,DSG2;Desmoglein-2,0.258680507320569,1.29521992543142,1.18027667700019,1.42135711729759,4.87879281596976e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,DSG2;Desmoglein-2,0.231118806334582,1.26000892759933,1.17323614008583,1.35319944841954,2.17417075958457e-10
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0875986758339,LEP;Leptin,0.321365620083013,1.37900968236787,1.33962913543548,1.41954788363582,8.61463457085504e-105
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.311453252629723,LEP;Leptin,1.35340568053743,3.87058508565213,3.15387728696442,4.7501622739711,2.23085090908368e-38
primary,Circulatory system disorders,I20 (angina pectoris),4.61107519931049,LEP;Leptin,0.493548531311592,1.63811883446303,1.54146277389922,1.74083562785925,5.77777164854238e-57
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67575561693208,LEP;Leptin,0.525442458549519,1.69120697184377,1.56356496450156,1.82926906559636,2.4173652176369e-39
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.111653052829523,LEP;Leptin,0.997774738391048,2.71223966545384,1.91501898514802,3.84134259759967,1.92304482265895e-08
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.72176842765078,LEP;Leptin,0.532293284480039,1.70283291460463,1.5920584024789,1.82131505386112,2.97734917025245e-54
primary,Circulatory system disorders,I26 (pulmonary embolism),1.01075395193042,LEP;Leptin,0.379378891367639,1.46137663385147,1.28702475360856,1.65934777864931,4.8346324796122e-09
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358465064347417,LEP;Leptin,0.516004643151536,1.67532075614767,1.35646825961566,2.06912297142466,1.66447736077652e-06
primary,Circulatory system disorders,I42 (cardiomyopathy),0.309494427141486,LEP;Leptin,0.67668526472044,1.96734568206334,1.57496952527641,2.45747550706037,2.48923983430034e-09
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17429629194335,LEP;Leptin,0.309930027039462,1.3633297145782,1.2500523255284,1.48687208742739,2.50969324611755e-12
primary,Circulatory system disorders,I50 (heart failure),0.910853852030322,LEP;Leptin,0.791827543171517,2.20742691016877,1.93877167778329,2.51330964835866,5.82644626008405e-33
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71788995318407,LEP;Leptin,0.300693669392946,1.35079548815138,1.22488102154331,1.48965362244826,1.71229870973867e-09
primary,Circulatory system disorders,I63 (cerebral infarction),0.366300366300366,LEP;Leptin,0.509843980964858,1.66503139808757,1.35344613238411,2.04834864889227,1.4141938878261e-06
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57685451803098,LEP;Leptin,0.440149952675441,1.55294006857073,1.40315202082528,1.71871815796128,1.81193517284069e-17
primary,Circulatory system disorders,I70 (atherosclerosis),0.176294293941352,LEP;Leptin,0.975506678753754,2.65251084144682,2.00380481300046,3.51122710073623,9.28007836872984e-12
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172376642964878,LEP;Leptin,0.751183730555421,2.11950745799286,1.58294158052516,2.83795177267186,4.56265033956795e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40251904957787,LEP;Leptin,0.330738453796389,1.39199567350947,1.24899134396274,1.5513734057767,2.23256656330165e-09
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.248770837006131,LEP;Leptin,0.75334380903625,2.1240907087514,1.66167390973543,2.71519057534121,1.81093972814944e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.304076588064503,CCL3;C-C motif chemokine 3,0.881257492478303,2.4139333016258,2.09575139948397,2.7804223278261,2.43235173882733e-34
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64840899281986,CCL3;C-C motif chemokine 3,0.21585224790637,1.24091901707215,1.17528001035019,1.31022394099299,6.99122746716939e-15
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68619296111743,CCL3;C-C motif chemokine 3,0.183725177605434,1.20168552761786,1.14726272878006,1.25868998535475,7.87014604901795e-15
primary,Circulatory system disorders,I26 (pulmonary embolism),1.0103189861498,CCL3;C-C motif chemokine 3,0.311062227332448,1.3648741510212,1.2545158430364,1.48494055174062,4.79157667563582e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359006552360026,CCL3;C-C motif chemokine 3,0.384199337102963,1.46843812671158,1.27729642371689,1.68818333156013,6.67286194919403e-08
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.531643583003099,CCL3;C-C motif chemokine 3,0.331867456653118,1.39356812808725,1.24117663224999,1.5646702307794,1.94721129139657e-08
primary,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376662612312159,CCL3;C-C motif chemokine 3,0.349884771130213,1.41890404046409,1.23668699647191,1.62796947149031,6.06246546416915e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.308000156942755,CCL3;C-C motif chemokine 3,0.374853166166995,1.45477778833597,1.24993655252873,1.69318867358033,1.29072885914985e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17169537411229,CCL3;C-C motif chemokine 3,0.260357312656015,1.29739357900061,1.22306683135479,1.37623722243166,5.16742642332042e-18
primary,Circulatory system disorders,I50 (heart failure),0.904382626437007,CCL3;C-C motif chemokine 3,0.50148997650533,1.65117965767191,1.51163468347644,1.8036065801556,8.80352655956881e-29
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70675246203947,CCL3;C-C motif chemokine 3,0.197754791324923,1.21866353031154,1.14068683972538,1.30197066222745,4.58489044629322e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56942755130066,CCL3;C-C motif chemokine 3,0.224189692592873,1.25130836084414,1.1679196205236,1.34065100577426,1.87379193104179e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.176560599521324,CCL3;C-C motif chemokine 3,0.594914786066855,1.81287645604482,1.49316866021011,2.20103805582094,1.85608446012556e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39875230509671,CCL3;C-C motif chemokine 3,0.293815805384625,1.34153677705731,1.24836087781506,1.44166719430303,1.24516131911025e-15
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24914662376898,CCL3;C-C motif chemokine 3,0.538018919048478,1.7126106788453,1.45307647379642,2.01850032684921,1.39240446991418e-10
primary,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.115265893017622,ANGPTL4;Angiopoietin-related protein 4,0.629522645280006,1.87671450688122,1.46180922166593,2.4093823517713,7.87767927588525e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.171922009924588,ANGPTL4;Angiopoietin-related protein 4,0.518022393812259,1.67870454838678,1.36600883660845,2.06298003735551,8.41114305784525e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.302817176571718,ANGPTL4;Angiopoietin-related protein 4,1.24244677473485,3.46407892479517,2.9618707046407,4.05144045565816,1.6522966499184e-54
primary,Circulatory system disorders,I15 (secondary hypertension),0.0390731840737701,ANGPTL4;Angiopoietin-related protein 4,1.64671104752321,5.18988244962396,3.37419741901293,7.98260341530169,6.57191983170446e-14
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64720822099792,ANGPTL4;Angiopoietin-related protein 4,0.207792520930284,1.23095774508435,1.16560523105767,1.29997440798049,8.28975798043261e-14
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69632321337865,ANGPTL4;Angiopoietin-related protein 4,0.183615278646454,1.20155347088594,1.1470838125742,1.25860963913189,8.67597021836618e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.357519634274997,ANGPTL4;Angiopoietin-related protein 4,0.622764571488117,1.86407429161932,1.61627584427317,2.14986382243351,1.15657844939665e-17
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545070917829093,ANGPTL4;Angiopoietin-related protein 4,0.53339892627279,1.70471667903353,1.51791623637065,1.91450548201759,2.10337830414305e-19
primary,Circulatory system disorders,I42 (cardiomyopathy),0.302817176571718,ANGPTL4;Angiopoietin-related protein 4,0.458090944815226,1.5810527850766,1.35247719247686,1.84825882691641,8.93734677592147e-09
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384870863126636,ANGPTL4;Angiopoietin-related protein 4,0.405936194929021,1.50070679669951,1.30598641720823,1.72445965745525,1.03548810999032e-08
primary,Circulatory system disorders,I47 (paroxysmal tachycardia),0.715039268549994,ANGPTL4;Angiopoietin-related protein 4,0.250558133034014,1.28474227372149,1.15993300587394,1.42298107005194,1.54496663922714e-06
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16856171609424,ANGPTL4;Angiopoietin-related protein 4,0.440229014583679,1.55306285182961,1.46320266622588,1.6484416529629,1.69993726148575e-47
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25424920876802,ANGPTL4;Angiopoietin-related protein 4,0.236631529025471,1.26697418854167,1.17249457996648,1.36906696359885,2.17005517416363e-09
primary,Circulatory system disorders,I50 (heart failure),0.904544211307779,ANGPTL4;Angiopoietin-related protein 4,0.653863736023518,1.92295628958543,1.75539315896815,2.10651435706277,7.02130081953738e-45
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70359082561637,ANGPTL4;Angiopoietin-related protein 4,0.213466920097892,1.2379625459109,1.15806667103764,1.3233704961952,3.58118584503058e-10
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5629273629508,ANGPTL4;Angiopoietin-related protein 4,0.241616858871491,1.27330624335439,1.18757220372311,1.36522965448531,1.0929306920335e-11
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355565975071308,ANGPTL4;Angiopoietin-related protein 4,0.359342785336964,1.43238771893411,1.23997997234585,1.65465138398299,1.0471159919766e-06
primary,Circulatory system disorders,I70 (atherosclerosis),0.175829328331965,ANGPTL4;Angiopoietin-related protein 4,0.623071330335443,1.86464620061493,1.5207630035135,2.28629013556669,2.09328442444545e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40663462665572,ANGPTL4;Angiopoietin-related protein 4,0.22311666980221,1.24996639856163,1.16178300015958,1.3448432257302,2.26928364306106e-09
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152385417887703,ANGPTL4;Angiopoietin-related protein 4,0.634881885288374,1.88679926954515,1.51665863428337,2.34727275016518,1.21023867926699e-08
primary,Circulatory system disorders,I95 (hypotension),0.519673348181143,ANGPTL4;Angiopoietin-related protein 4,0.357470187488777,1.42970794262862,1.26878184874635,1.61104511641228,4.4301012001008e-09
primary,Circulatory system disorders,I08 (multiple valve diseases),0.170091168866512,RNASE1;Ribonuclease pancreatic,0.685257938445588,1.98428359255888,1.5854326105691,2.48347444694294,2.16134535592273e-09
primary,Circulatory system disorders,I10 (essential (primary) hypertension),27.8858801651018,RNASE1;Ribonuclease pancreatic,0.196228920753764,1.21680542546876,1.19121919347562,1.24294122488928,3.33269315556048e-73
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.197305755885154,RNASE1;Ribonuclease pancreatic,1.50261554367873,4.49342646700149,3.69490284336021,5.46452295779109,3.35504338159877e-51
primary,Circulatory system disorders,I20 (angina pectoris),4.43370980178709,RNASE1;Ribonuclease pancreatic,0.29216774750663,1.33932766767333,1.27887665269554,1.40263613196349,2.65885007314336e-35
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.57177847326166,RNASE1;Ribonuclease pancreatic,0.407125049079104,1.50249197915335,1.41418929726746,1.5963083243397,1.23331191012762e-39
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.120197759332335,RNASE1;Ribonuclease pancreatic,0.765888031238755,2.15090359639062,1.64844999166088,2.80650690307253,1.67923655470636e-08
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55150360593278,RNASE1;Ribonuclease pancreatic,0.379615825535676,1.46172292493087,1.38795381958403,1.53941282420248,8.25584057527186e-47
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00013607293509,RNASE1;Ribonuclease pancreatic,0.410722912546766,1.5079074764237,1.37198044645739,1.65730128539781,1.57555270819266e-17
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.396879394021862,RNASE1;Ribonuclease pancreatic,0.642130434522419,1.90052551452678,1.63916546640016,2.20355864335024,1.78493015581711e-17
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.553363269379053,RNASE1;Ribonuclease pancreatic,0.460659004065342,1.58511824023682,1.39670871291626,1.79894333893378,9.67376041941583e-13
primary,Circulatory system disorders,I42 (cardiomyopathy),0.303896221708168,RNASE1;Ribonuclease pancreatic,0.607386613941778,1.83562792042852,1.54955771740419,2.17451071645227,2.1135932903776e-12
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.378736336009434,RNASE1;Ribonuclease pancreatic,0.571165350508402,1.77032890349795,1.52017363630477,2.06164897990108,2.00569112941373e-13
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15222025672427,RNASE1;Ribonuclease pancreatic,0.412583465998383,1.51071563043393,1.41502557929361,1.61287665002967,4.4162956398981e-35
primary,Circulatory system disorders,I50 (heart failure),0.895813489363632,RNASE1;Ribonuclease pancreatic,0.788873184009198,2.20091500224544,1.99130488713157,2.43258924256784,7.68588045382397e-54
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.6532861613825,RNASE1;Ribonuclease pancreatic,0.334174006704526,1.39678617258837,1.2973007214969,1.50390081467224,7.6974659272868e-19
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56257087132036,RNASE1;Ribonuclease pancreatic,0.410590244298964,1.50770743825061,1.39716125895173,1.62700025125356,4.18591653217917e-26
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346985984487685,RNASE1;Ribonuclease pancreatic,0.452009664202219,1.57146713548044,1.33987685512898,1.84308651085503,2.74852317162492e-08
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.131537170590102,RNASE1;Ribonuclease pancreatic,0.675567158312435,1.96514720954161,1.52241621331639,2.53662797426252,2.13664977455589e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.167823286614958,RNASE1;Ribonuclease pancreatic,0.679461017107218,1.97281413255709,1.57307140822914,2.47413790706318,4.06942612942569e-09
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40608699596316,RNASE1;Ribonuclease pancreatic,0.404272745592387,1.49821252209893,1.38309905096415,1.62290673239152,3.72219925362733e-23
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.14287658184787,RNASE1;Ribonuclease pancreatic,0.649478385566754,1.91454191581643,1.49738920702788,2.44790781863155,2.2216838094969e-07
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.231323989658456,RNASE1;Ribonuclease pancreatic,0.595671103759624,1.81424808521165,1.49467202740962,2.20215274945537,1.68764619710093e-09
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.53322447498525,RNASE1;Ribonuclease pancreatic,0.214121897037891,1.23877364842878,1.16686178448385,1.31511732790217,2.25961669041007e-12
primary,Circulatory system disorders,I95 (hypotension),0.501201977593323,RNASE1;Ribonuclease pancreatic,0.398144008961787,1.48905845222928,1.30370465495917,1.70076486704337,4.35301664872902e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56096130073124,CTSD;Cathepsin D,0.189899511800939,1.20912808844819,1.12367594509439,1.30107860781122,3.81189745570387e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.37657929473882,CTSD;Cathepsin D,0.201976376739818,1.22381909717292,1.1327343748026,1.3222280668106,3.08142437643484e-07
primary,Circulatory system disorders,I08 (multiple valve diseases),0.172759040402057,FSTL3;Follistatin-related protein 3,0.502999680890562,1.65367433347958,1.35140956408953,2.02354554376083,1.03906800759405e-06
primary,Circulatory system disorders,I10 (essential (primary) hypertension),28.0537123561977,FSTL3;Follistatin-related protein 3,0.18302313522752,1.20084218951673,1.17748558718375,1.22466209337839,1.63073747483511e-74
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.30429149161726,FSTL3;Follistatin-related protein 3,1.61572144493263,5.03151657651229,4.36535091137872,5.79934112369498,3.90667834388387e-110
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392634182731948,FSTL3;Follistatin-related protein 3,1.65245089365796,5.21975723265041,3.75489271334624,7.25609695077696,8.15548807517559e-23
primary,Circulatory system disorders,I20 (angina pectoris),4.59185676705013,FSTL3;Follistatin-related protein 3,0.19917614469773,1.2203969134138,1.17098315423436,1.27189586023017,3.55969822551066e-21
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64831756252699,FSTL3;Follistatin-related protein 3,0.281917641679301,1.32566953557397,1.25672500167724,1.39839639953329,4.37705119706443e-25
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69665083042129,FSTL3;Follistatin-related protein 3,0.274301107359351,1.31561088272318,1.25685302498344,1.37711566932218,5.79701048402062e-32
primary,Circulatory system disorders,I26 (pulmonary embolism),0.999253995052809,FSTL3;Follistatin-related protein 3,0.340657587601231,1.40587177051086,1.28973837497852,1.53246229891567,9.63118400520082e-15
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359260277199733,FSTL3;Follistatin-related protein 3,0.423183611117824,1.52681461036856,1.32488523189657,1.75952059719003,5.00894225879207e-09
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545761513997408,FSTL3;Follistatin-related protein 3,0.381112980899565,1.46391299027341,1.30449642584669,1.64281112667693,9.25151751474425e-11
primary,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0569319564961325,FSTL3;Follistatin-related protein 3,0.837142559435531,2.30975754334819,1.66294159233163,3.20815832236995,5.91710739423e-07
primary,Circulatory system disorders,I42 (cardiomyopathy),0.30429149161726,FSTL3;Follistatin-related protein 3,0.422605845727665,1.5259327245156,1.3102869953757,1.77706921305431,5.43593729628694e-08
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384781499077309,FSTL3;Follistatin-related protein 3,0.452380418077179,1.57204987102935,1.37377417115614,1.79894254011455,4.81295047499521e-11
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16930385959401,FSTL3;Follistatin-related protein 3,0.336154851702498,1.39955573161957,1.31986696142045,1.48405582014201,2.63489569369428e-29
primary,Circulatory system disorders,I50 (heart failure),0.906984962110801,FSTL3;Follistatin-related protein 3,0.69376848894062,2.00124300286541,1.83634259098657,2.18095118861568,2.54997591405918e-56
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70599552397031,FSTL3;Follistatin-related protein 3,0.298305711249047,1.34757369335125,1.26109327129116,1.43998457556838,1.19706478378812e-18
primary,Circulatory system disorders,I63 (cerebral infarction),0.365149789940712,FSTL3;Follistatin-related protein 3,0.41347149211238,1.51205778120884,1.31522951698274,1.73834201878258,6.21395986829838e-09
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56464721818681,FSTL3;Follistatin-related protein 3,0.430628301116252,1.5382236876555,1.43656094203146,1.64708091667765,5.26812075420351e-35
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353370764458753,FSTL3;Follistatin-related protein 3,0.540046094864419,1.71608596311157,1.49149821818018,1.97449182097031,4.48057821039804e-14
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.125642938474223,FSTL3;Follistatin-related protein 3,0.604483845781539,1.83030724422781,1.45319180952154,2.30528728989726,2.8206687326221e-07
primary,Circulatory system disorders,I70 (atherosclerosis),0.176685382229376,FSTL3;Follistatin-related protein 3,0.739873813748483,2.09567105293442,1.73700927213991,2.52839016610242,1.11507270876499e-14
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172759040402057,FSTL3;Follistatin-related protein 3,0.548642661908728,1.73090200344609,1.42406381623291,2.10385357129508,3.57120292100351e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40563037418037,FSTL3;Follistatin-related protein 3,0.411045911774505,1.50839460804142,1.40272294561131,1.62202685903657,1.36837062375498e-28
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.153127331265459,FSTL3;Follistatin-related protein 3,0.718658491033878,2.0516790178717,1.67449393108003,2.51382624579593,4.10245961448507e-12
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.247359535121127,FSTL3;Follistatin-related protein 3,0.619741925619392,1.85844836204254,1.57769916893823,2.18915645160857,1.20038309652932e-13
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56390121323962,FSTL3;Follistatin-related protein 3,0.240491420388303,1.27187402159715,1.20393787197552,1.34364369164607,8.95172239010333e-18
primary,Circulatory system disorders,I85 (oesophageal varices),0.053005614668813,FSTL3;Follistatin-related protein 3,1.0536514814691,2.86810485235921,2.08441810879672,3.94643733395461,9.77138881892828e-11
primary,Circulatory system disorders,I95 (hypotension),0.522203463033491,FSTL3;Follistatin-related protein 3,0.475337589764293,1.60855713826016,1.43066527263706,1.80856844471971,1.87538982350971e-15
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215948800502571,FSTL3;Follistatin-related protein 3,1.58390244157232,4.87393900894562,3.17027786659095,7.49312283104896,5.27115764111796e-13
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.29963573694724,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.80306538976545,6.06822044400217,5.19741610468549,7.08492424222288,3.34547968615448e-115
primary,Circulatory system disorders,I15 (secondary hypertension),0.0372096666797226,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.9553786401133,7.06659421323578,4.75690774017218,10.4977343480556,3.55001952085782e-22
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65951196584544,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.26408772157192,1.30224242604324,1.23376479943699,1.37452076519031,9.50547113761439e-22
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71117465042497,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.251376351249515,1.28579390342469,1.22789501685984,1.34642289396376,1.09545304776555e-26
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00074419333359,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.324584603856801,1.38345584438179,1.26874273380712,1.50854071700645,1.98693887023436e-13
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354471035212095,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.370890064228555,1.4490237650845,1.25414967778344,1.67417805783005,4.82801041001851e-07
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38580549136344,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.354300764344835,1.42518376648766,1.24125399931248,1.63636835763267,5.02119660290798e-07
primary,Circulatory system disorders,I50 (heart failure),0.906740824879558,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.586965152019654,1.79852188404034,1.64468872226856,1.96674356890484,6.96292002843736e-38
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7038110532294,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.225109775509214,1.25246019810167,1.17149041074996,1.33902636627187,4.06643642221111e-11
primary,Circulatory system disorders,I63 (cerebral infarction),0.36426305275939,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.377847363862299,1.45914020835179,1.26617395003055,1.68151472992912,1.78090671108093e-07
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56084759703889,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.478200792782049,1.61316936363056,1.50540947910697,1.72864289209867,7.22839998485054e-42
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348595824683717,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.603510476649424,1.82852654643272,1.58525168072438,2.10913470186725,1.17888397687165e-16
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.119462614077004,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.699266698453529,2.01227656079234,1.58221325796393,2.5592358910739,1.19754994584072e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.174297912341858,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.786714280361184,2.19616856421285,1.80505795505241,2.67202299457288,3.77682082283637e-15
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17038110532294,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.548618891970897,1.73086086050206,1.4121731356409,2.12146743399017,1.26269021720562e-07
primary,Circulatory system disorders,I72 (other aneurysm),0.10575378951079,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.673582480248148,1.96125089272794,1.51851198847271,2.53307520350557,2.46933087570354e-07
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.41200893032,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.454696908909919,1.57569573131481,1.46517699968747,1.69455092334464,1.58070246095345e-34
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150797070228349,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.711857216086304,2.03777232997814,1.64775978851651,2.5200979522404,5.11489648963461e-11
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246758842191845,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.715786096564673,2.0457942421529,1.73086130153743,2.41802972745905,4.76727951910165e-17
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56746700090086,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.23125790469696,1.26018420496786,1.19295529688317,1.33120179322695,1.36842982454624e-16
primary,Circulatory system disorders,I85 (oesophageal varices),0.0489600877364772,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.09314890635115,2.98365454444289,2.09082578919351,4.25774088237572,1.68804331617981e-09
primary,Circulatory system disorders,I95 (hypotension),0.513101719478281,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.451402320699842,1.57051300489834,1.39362680100797,1.76985050572425,1.32076788805867e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195840350945908,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.68234272882353,5.37814074935531,3.20964690391151,9.01170713969402,1.68150584378341e-10
primary,Circulatory system disorders,I20 (angina pectoris),4.60627245363627,NTRK3;NT-3 growth factor receptor,-0.351360562141254,0.703729969721147,0.674794083212666,0.733906657755398,1.8642304426235e-60
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65462666278279,NTRK3;NT-3 growth factor receptor,-0.398838489942301,0.671099081852371,0.635206816051765,0.709019434744846,6.72528225613008e-46
primary,Circulatory system disorders,I22 (subsequent myocardial infarction),0.110690358287212,NTRK3;NT-3 growth factor receptor,-0.686266134419965,0.503452387466526,0.388195602019903,0.652929361195467,2.29506047336228e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70715603456646,NTRK3;NT-3 growth factor receptor,-0.406760239957465,0.665803804314667,0.635319361134136,0.69775097841901,6.86416720734335e-65
primary,Circulatory system disorders,I50 (heart failure),0.908826099621322,NTRK3;NT-3 growth factor receptor,-0.260989290699425,0.770289168829145,0.702703197270845,0.844375557020272,2.5428083966951e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55549082435187,NTRK3;NT-3 growth factor receptor,-0.325420267640848,0.722223762574927,0.673150462173538,0.774874552627752,1.25534018444651e-19
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132051655500534,NTRK3;NT-3 growth factor receptor,-0.675541244294563,0.508880917163913,0.401068298851769,0.645675034887997,2.67840693867074e-08
primary,Circulatory system disorders,I70 (atherosclerosis),0.174774249927177,NTRK3;NT-3 growth factor receptor,-0.553464412553536,0.574954476540138,0.467167133035288,0.707611102574233,1.73971442839824e-07
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168948441596271,NTRK3;NT-3 growth factor receptor,-0.575854152256385,0.562224438383159,0.455177021437612,0.694447004633303,9.11033033357607e-08
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24662588600835,NTRK3;NT-3 growth factor receptor,-0.464466880303039,0.628470065665649,0.527718860761138,0.748456522603924,1.88709143411558e-07
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.306891461424908,ANGPTL7;Angiopoietin-related protein 7,0.648441644700573,1.9125580605219,1.63485570754709,2.23743191401002,5.45666898021218e-16
primary,Circulatory system disorders,I50 (heart failure),0.910962629166342,ANGPTL7;Angiopoietin-related protein 7,0.251796285628694,1.28633396587674,1.17277937993491,1.41088349614401,9.3002980557864e-08
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.64840899281986,CLEC4A;C-type lectin domain family 4 member A,-0.240868377101549,0.785945067948423,0.743915641358577,0.830349055041185,8.70614917834455e-18
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40836851012508,VWA1;von Willebrand factor A domain-containing protein 1,0.278050738293465,1.32055319812502,1.22779171569133,1.42032294793284,7.29790516774174e-14
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.67335497196813,ICAM1;Intercellular adhesion molecule 1,0.226667016241993,1.2544120995341,1.18890378928267,1.323529901782,1.20151066012288e-16
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70217369922297,ICAM1;Intercellular adhesion molecule 1,0.182577535953407,1.20030721430989,1.14638688301859,1.25676368952401,6.9374946552201e-15
primary,Circulatory system disorders,I50 (heart failure),0.91865840464247,ICAM1;Intercellular adhesion molecule 1,0.301450983307219,1.35181885182476,1.23544600440032,1.47915344065224,5.25837269829705e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57568604308055,ICAM1;Intercellular adhesion molecule 1,0.228892046057577,1.25720631130605,1.17279868389409,1.34768884966664,1.08184234937717e-10
primary,Circulatory system disorders,I70 (atherosclerosis),0.169174781154716,ICAM1;Intercellular adhesion molecule 1,0.513998806028957,1.67196370355867,1.36028601181811,2.05505504116837,1.04387385625545e-06
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40257696468968,ICAM1;Intercellular adhesion molecule 1,0.308841506551573,1.36184650964806,1.26484731323843,1.46628442534471,2.56614778216463e-16
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.145568997737779,ICAM1;Intercellular adhesion molecule 1,0.70321250543855,2.02023230128775,1.61864039053537,2.5214609588585,5.00631848896226e-10
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.24786072587784,ICAM1;Intercellular adhesion molecule 1,0.452027741596274,1.57149554376786,1.32279038092339,1.86696114493841,2.71223574189226e-07
primary,Circulatory system disorders,I85 (oesophageal varices),0.0511458640700304,ICAM1;Intercellular adhesion molecule 1,1.03757866559302,2.82237482081212,1.93987647282308,4.10634374959027,5.83980427782489e-08
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0177043375627028,ICAM1;Intercellular adhesion molecule 1,1.72945079233323,5.63755686859312,3.01061707637813,10.5566555428086,6.53443698913613e-08
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.204754862927994,PRND;Prion-like protein doppel,0.847371368354353,2.33350485822749,1.89189966300839,2.87818906564664,2.44145883062584e-15
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.55488567853486,PRND;Prion-like protein doppel,0.184036705546006,1.20205994455314,1.13025134059469,1.27843078649995,4.74370531113734e-09
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54453418268683,PRND;Prion-like protein doppel,0.195813768319186,1.21630037057861,1.15430687538925,1.28162330400291,2.19615725847157e-13
primary,Circulatory system disorders,I50 (heart failure),0.910021613013309,PRND;Prion-like protein doppel,0.291797791157893,1.33883226654369,1.21008089697559,1.48128265012571,1.54658496471496e-08
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55841201228529,PRND;Prion-like protein doppel,0.319372655420644,1.3762641016333,1.27483304851159,1.48576543387852,2.92616424292739e-16
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345808212945057,PRND;Prion-like protein doppel,0.442812014659213,1.55707959868864,1.32599275377557,1.82843900899834,6.57622701522385e-08
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40825844613809,PRND;Prion-like protein doppel,0.30427784581109,1.35564566423688,1.2520369993748,1.46782816153351,6.33391549907829e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.0523262427482652,PRND;Prion-like protein doppel,1.03724542590451,2.82143445019907,1.86148343890619,4.2764239479067,1.01638432009264e-06
primary,Circulatory system disorders,I95 (hypotension),0.505061995222386,PRND;Prion-like protein doppel,0.403977832882097,1.49777074532944,1.31177383031508,1.71014023433131,2.35345485798535e-09
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0182004322602661,PRND;Prion-like protein doppel,1.7792249014175,5.92526197608964,2.92256527647696,12.0129838562976,8.05348022230425e-07
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55416354599305,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,0.197826338134824,1.21875072491869,1.15751201370907,1.28322929861457,5.43670454149994e-14
primary,Circulatory system disorders,I85 (oesophageal varices),0.0522003585937677,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,0.965718823253544,2.62667509316308,1.76900769875648,3.9001650755354,1.68287320697325e-06
primary,Circulatory system disorders,I08 (multiple valve diseases),0.170528048923909,COLEC12;Collectin-12,0.605905312407778,1.83291081489726,1.49164712899997,2.25224987200537,8.20766615823041e-09
primary,Circulatory system disorders,I12 (hypertensive renal disease),0.303814340036849,COLEC12;Collectin-12,1.69635724642328,5.45404342492026,4.69984152658188,6.32927504314175,1.5169440869812e-110
primary,Circulatory system disorders,I15 (secondary hypertension),0.0392018503273354,COLEC12;Collectin-12,1.6609100376943,5.26409919402022,3.67295318245472,7.5445394885117,1.50040279013321e-19
primary,Circulatory system disorders,I20 (angina pectoris),4.59249676584734,COLEC12;Collectin-12,0.211130926317003,1.23507404817257,1.18474574126776,1.28754031463079,2.60744475474e-23
primary,Circulatory system disorders,I21 (acute myocardial infarction),2.65004508212787,COLEC12;Collectin-12,0.349609697431225,1.41851379095732,1.34440446827077,1.49670833638648,2.41001888214768e-37
primary,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69673448586773,COLEC12;Collectin-12,0.326701852711854,1.3863880677122,1.32405998282043,1.4516501512269,4.7650596142229e-44
primary,Circulatory system disorders,I26 (pulmonary embolism),1.00356736837978,COLEC12;Collectin-12,0.333342183973786,1.39562477720453,1.27879237179859,1.52313116789062,7.83589356192452e-14
primary,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358696930495119,COLEC12;Collectin-12,0.473931716371336,1.60629729947425,1.39051208919717,1.85556891906488,1.20255769231964e-10
primary,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.546865812066329,COLEC12;Collectin-12,0.389733515997447,1.47658725456729,1.31357075796471,1.65983439196591,6.59348252640569e-11
primary,Circulatory system disorders,I42 (cardiomyopathy),0.301854247520483,COLEC12;Collectin-12,0.485078702746339,1.62430284090826,1.39195761760759,1.89543107175726,7.32452303472726e-10
primary,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384178133207887,COLEC12;Collectin-12,0.504007437855757,1.65534167530387,1.44411729364303,1.89746087389157,4.60715013884178e-13
primary,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16786232310165,COLEC12;Collectin-12,0.307526953421379,1.36005746620992,1.28176009784009,1.44313769363736,2.82601045516111e-24
primary,Circulatory system disorders,I49 (other cardiac arrhythmias),1.2564193029911,COLEC12;Collectin-12,0.192584376090819,1.21237879517523,1.12115707969157,1.31102266543677,1.39717078310954e-06
primary,Circulatory system disorders,I50 (heart failure),0.905562742561448,COLEC12;Collectin-12,0.723887534004604,2.06243543399006,1.88889598728289,2.25191855349138,1.29468000110947e-58
primary,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70332039672272,COLEC12;Collectin-12,0.238802708292065,1.26972800506402,1.18704902807968,1.35816564329442,3.62020449561715e-12
primary,Circulatory system disorders,I63 (cerebral infarction),0.362617115527852,COLEC12;Collectin-12,0.472543049123014,1.60406823509596,1.39253930028067,1.8477287515873,5.77970824107577e-11
primary,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56807401309341,COLEC12;Collectin-12,0.448998025977031,1.56674156441256,1.46184310075083,1.67916729804803,6.01179171391613e-37
primary,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.135246383629307,COLEC12;Collectin-12,0.659294679192531,1.93342816625508,1.54741199009748,2.41573963365309,6.54836349921156e-09
primary,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356736837978752,COLEC12;Collectin-12,0.567745733793486,1.76428539631702,1.53004791072702,2.03438267379382,5.63889733628976e-15
primary,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.125445921047473,COLEC12;Collectin-12,0.585800059471634,1.79642765981521,1.41645791460165,2.27832560620535,1.35548817559834e-06
primary,Circulatory system disorders,I70 (atherosclerosis),0.176408326473009,COLEC12;Collectin-12,0.778709219299984,2.17865827971025,1.79771084997483,2.64033111877612,2.00384203280069e-15
primary,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172488141440276,COLEC12;Collectin-12,0.658478872735515,1.93185150628501,1.58852694102646,2.3493779966515,4.23213315981773e-11
primary,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39950605668587,COLEC12;Collectin-12,0.343945466092557,1.41050171324038,1.30951849719534,1.51927222663528,1.14019796106624e-19
primary,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152887216276608,COLEC12;Collectin-12,0.810850953188108,2.24982166525427,1.82952892677308,2.76666711926512,1.52772983457273e-14
primary,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.246971657062213,COLEC12;Collectin-12,0.625379180679151,1.86895449452648,1.57988199730144,2.21091885886225,2.99333664979829e-13
primary,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56184091889137,COLEC12;Collectin-12,0.241016181697022,1.27254162702468,1.20365387797943,1.3453719729039,2.10584950797164e-17
primary,Circulatory system disorders,I95 (hypotension),0.521384609353561,COLEC12;Collectin-12,0.452070423151506,1.57156261907314,1.39382887289631,1.77196004021346,1.5510617880374e-13
primary,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215610176800345,COLEC12;Collectin-12,1.3610442262552,3.90026393409699,2.34806080284106,6.47856253859001,1.4656595432547e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,CDH3;Cadherin-3,1.73264230601022,5.65557795041206,4.76793608175817,6.70847121368969,4.89777199720011e-88
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390846377831193,CDH3;Cadherin-3,2.16936032070413,8.75268333929006,5.4517890500858,14.0521698352727,2.67727540627937e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,CDH3;Cadherin-3,0.326790043594332,1.38651033989091,1.26466730999958,1.52009220719483,3.32245338030822e-12
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54775165621152,CDH3;Cadherin-3,0.300907070414849,1.35108378004873,1.2591738102756,1.44970246824878,5.69977068084867e-17
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345899044380606,CDH3;Cadherin-3,0.406296952865245,1.50124828625382,1.29558843065938,1.73955429335921,6.48131209524154e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173926638134881,CDH3;Cadherin-3,0.543193928470258,1.72149642732968,1.39804398929581,2.11978304831565,3.12882263523714e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39923003263567,CDH3;Cadherin-3,0.205054816504595,1.22759235544084,1.140091922703,1.32180832187981,5.47799711372232e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0508100291180551,CDH3;Cadherin-3,0.932553574475824,2.54098950604181,1.74003602970809,3.71062872238211,1.38534020315477e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,COL1A1;Collagen alpha-1(I) chain,0.550089355632733,1.73340790070721,1.47848980127092,2.03227844226678,1.21897978885422e-11
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,COL1A1;Collagen alpha-1(I) chain,1.26271753534794,3.53501497428962,2.32050039009812,5.38518800590396,4.11534787299865e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,CHRDL2;Chordin-like protein 2,0.496531063923084,1.64301187050092,1.39103963286101,1.94062623582823,5.04572450399712e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,CHRDL2;Chordin-like protein 2,0.260989571419369,1.29821412683239,1.2186587422161,1.38296297455874,6.02171790958526e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,CHRDL2;Chordin-like protein 2,0.272308019198893,1.31299136558051,1.18980158304657,1.44893598281714,6.05277872338957e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0524754734200319,CSF1R;Macrophage colony-stimulating factor 1 receptor,1.4263921701482,4.16365031944616,2.83685819434683,6.1109801036832,3.18827150478341e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309735409032937,CST6;Cystatin-M,1.43823280179251,4.2132435976282,3.57225013226395,4.96925493896052,2.08023718857415e-65
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0404882887624754,CST6;Cystatin-M,1.9161179926583,6.79453078785098,4.29960270767105,10.7371894023346,2.26630654770624e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.90693766827945,CST6;Cystatin-M,0.35878096769855,1.43158320426499,1.30118679702,1.57504708426742,1.79817313348817e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56284794623155,CST6;Cystatin-M,0.201941547505647,1.22377647323329,1.13735117256369,1.31676907938954,6.5112469762351e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.289046147712548,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,1.81107654285135,6.11702913283808,5.15361640258736,7.26054143129554,2.67842219266587e-95
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039868434167248,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,1.7938251044049,6.01240662042543,4.02476299184208,8.9816551788533,1.95565390865095e-18
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68384331705372,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.196426676437134,1.21704607945176,1.16223352487231,1.27444367057958,6.58531093934032e-17
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01465164955646,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.240306235311254,1.27163851131563,1.16570320694351,1.38720087053805,6.13456092601085e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.899033190471444,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.421544345927724,1.52431380662632,1.39260369587265,1.6684808376985,6.09536174409104e-20
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.165454001794079,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.532129959531259,1.70255482221641,1.38397629867883,2.0944671707308,4.79555651917639e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39539519585368,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.253496921238184,1.2885234124225,1.19618616996464,1.38798844699066,2.36124106399254e-11
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.237217183295126,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.466573900688675,1.59452183398989,1.33797489109851,1.90025978513171,1.85692359362643e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173964034401876,KLK4;Kallikrein-4,0.532371264821838,1.70296570727488,1.39294556298517,2.08198531027958,2.07531833355657e-07
sensitivity,Circulatory system disorders,I11 (hypertensive heart disease),0.0332290852228303,KLK4;Kallikrein-4,1.02394578478167,2.78415881031907,1.80932667911125,4.28421266903821,3.21676563593945e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,KLK4;Kallikrein-4,1.00831592836272,2.74098111743137,2.36717921590316,3.17381017695733,2.07638719602842e-41
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,KLK4;Kallikrein-4,0.942797270989324,2.56715240500455,1.72405024173966,3.82255186709101,3.46014046716436e-06
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6446442533229,KLK4;Kallikrein-4,0.334047430799605,1.3966093843034,1.32416574558845,1.47301633411271,1.00231905011585e-34
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67865519937451,KLK4;Kallikrein-4,0.306711388817258,1.3589487036761,1.29828678634144,1.42244502420536,1.41478351323396e-39
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0027365129007,KLK4;Kallikrein-4,0.202900187921711,1.22495019732054,1.12321504045788,1.33590001190151,4.50629379742093e-06
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361610633307271,KLK4;Kallikrein-4,0.432486062743796,1.54108399666052,1.33843291824375,1.77441831592089,1.82882298255191e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545347928068803,KLK4;Kallikrein-4,0.285278876207709,1.33013291882692,1.18447189702469,1.49370667737349,1.42915779817753e-06
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.379202501954652,KLK4;Kallikrein-4,0.439248571166068,1.55154090779132,1.35334833169646,1.77875801238276,2.98905566656773e-10
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383111806098514,KLK4;Kallikrein-4,0.398570979601251,1.48969437221875,1.30018011464769,1.70683222856515,9.40481469978119e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,KLK4;Kallikrein-4,0.415581781859056,1.5152520304512,1.42941198493337,1.60624700225492,2.48497645111403e-44
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,KLK4;Kallikrein-4,0.575510643502716,1.77803823880995,1.62873781929998,1.94102447994309,7.45763492340818e-38
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71032056293979,KLK4;Kallikrein-4,0.198920261352032,1.22008467411864,1.14158363804702,1.30398383649388,4.56033009819136e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,KLK4;Kallikrein-4,0.18751887952869,1.20625302269455,1.12528438309007,1.29304767454795,1.22656574421126e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173964034401876,KLK4;Kallikrein-4,0.928447884540026,2.53057837805634,2.08786460155248,3.06716581272777,3.00244150193544e-21
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168100078186082,KLK4;Kallikrein-4,0.76714890456482,2.153617323836,1.76993814626611,2.62046873632906,1.81130647235422e-14
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3975762314308,KLK4;Kallikrein-4,0.421851801771584,1.52478253786743,1.41817742787853,1.63940120755087,3.83156866795263e-30
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.14855355746677,KLK4;Kallikrein-4,0.6443098816577,1.9046721264343,1.53964801510866,2.35623718773134,2.92862281804717e-09
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236512900703674,KLK4;Kallikrein-4,0.441227504453337,1.55461434379971,1.30841311747823,1.84714271483755,5.28075260837399e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.521892103205629,KLK4;Kallikrein-4,0.313350416286527,1.36800081681412,1.21496424575373,1.5403138333862,2.25704693766279e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30849454661253,ACAN;Aggrecan core protein,0.596372099557755,1.81552031135664,1.55156198270563,2.12438435440441,1.00831700792538e-13
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0378154605525037,ACAN;Aggrecan core protein,1.2164013702385,3.37502040502147,2.19000984835669,5.20123813272281,3.53900653514478e-08
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65902396306026,ACAN;Aggrecan core protein,-0.226601444805077,0.797238462510208,0.753177852217482,0.843876601302547,5.62923700248773e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0090757105326,ACAN;Aggrecan core protein,0.236340544799103,1.26660557267089,1.15987736361858,1.38315457051072,1.42279025485799e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,NPTXR;Neuronal pentraxin receptor,0.726900555923819,2.06865896827398,1.78827970656345,2.39299809269995,1.34659998786364e-22
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,NPTXR;Neuronal pentraxin receptor,0.284079643225476,1.32853873564949,1.21507176075137,1.45260159040294,4.47055067825349e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,CCN5;CCN family member 5,1.05787841810918,2.88025380819176,2.46649853317614,3.36341655509539,9.05479720675976e-41
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,CCN5;CCN family member 5,1.3789136882006,3.97058598944402,2.63053694486982,5.99328328397585,5.23374085775714e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356734597343214,CCN5;CCN family member 5,0.424834006299503,1.5293365383613,1.31842992260775,1.77398146648616,2.00930357054886e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549883716346722,CCN5;CCN family member 5,0.323105014758572,1.38141041176961,1.22341635820083,1.55980808410297,1.84866065061013e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386298238007016,CCN5;CCN family member 5,0.335934419710842,1.3992472587621,1.20876360758884,1.61974837665631,6.81600050762099e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1522330403248,CCN5;CCN family member 5,0.305395401796832,1.35716152103314,1.27420061530345,1.4455238618248,2.32123796342547e-21
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,CCN5;CCN family member 5,0.444528697106521,1.55975490557394,1.41626816367567,1.71777875677725,1.74373403515706e-19
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.196342549256866,SRPX;Sushi repeat-containing protein SRPX,0.562507971948341,1.75506864822112,1.42555600574976,2.160747068193,1.14645361088821e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999977169471016,SRPX;Sushi repeat-containing protein SRPX,0.279638918530569,1.32265214092488,1.20207915665735,1.45531904134982,9.81452602077886e-09
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.399534257208739,SRPX;Sushi repeat-containing protein SRPX,0.483077771758682,1.62105597248366,1.3966104996174,1.88157146652187,2.10876221243437e-10
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554781854295564,SRPX;Sushi repeat-containing protein SRPX,0.360739776344273,1.43439015005992,1.26332053734976,1.62862475655241,2.58586291362961e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.310495194173649,SRPX;Sushi repeat-containing protein SRPX,0.384041241106029,1.46820599087236,1.24157583752942,1.73620391640588,7.13941710406766e-06
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383552886920389,SRPX;Sushi repeat-containing protein SRPX,0.37712258613314,1.45808303917767,1.25378748328567,1.69566707075923,9.75512834255817e-07
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.710029451382388,SRPX;Sushi repeat-containing protein SRPX,0.342123364755461,1.40793397623164,1.25773142610838,1.5760742240185,2.78379806028196e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15291888313052,SRPX;Sushi repeat-containing protein SRPX,0.514322218206228,1.67250452442967,1.56756842941799,1.78446524677478,1.42190602870141e-54
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.23741467089792,SRPX;Sushi repeat-containing protein SRPX,0.229023167465855,1.25737116877602,1.15415038164066,1.36982344867552,1.60316737567366e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.915504212232597,SRPX;Sushi repeat-containing protein SRPX,0.564016018817168,1.75771737069749,1.59546339858922,1.93647209831554,3.56620916560518e-30
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66434556288669,SRPX;Sushi repeat-containing protein SRPX,0.246829542807945,1.27996091563854,1.1885540733252,1.37839748508774,6.60309725148566e-11
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5296226113559,SRPX;Sushi repeat-containing protein SRPX,0.200577513255373,1.22210833816444,1.14986437657984,1.29889126111852,1.10602748721881e-10
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.05251021666172,SRPX;Sushi repeat-containing protein SRPX,0.900247490380825,2.460211914601,1.66672806327011,3.63145182356229,5.85988199148297e-06
sensitivity,Circulatory system disorders,I00 (rheumatic fever without mention of heart involvement),0.367474589523064,ANGPT2;Angiopoietin-2,0.333896052175531,1.39639798349762,1.20939545904259,1.6123157348878,5.32114062824372e-06
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.117279124315871,ANGPT2;Angiopoietin-2,1.06848836139938,2.91097582900744,2.26920218799528,3.73425529108612,4.15610612814685e-17
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173964034401876,ANGPT2;Angiopoietin-2,0.712072888489295,2.03821186862977,1.65891674222123,2.50422912476051,1.21882148976297e-11
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0273651290070367,ANGPT2;Angiopoietin-2,1.5869752891626,4.88893891509423,2.97338081247686,8.03856795443982,3.97745761496455e-10
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0824863174354,ANGPT2;Angiopoietin-2,0.182490256690073,1.20020245695209,1.17672975103088,1.22414338246474,2.70040616506475e-73
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,ANGPT2;Angiopoietin-2,0.788220280835607,2.19947848685942,1.88464666454977,2.56690323186554,1.51561253979219e-23
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.57584050039093,ANGPT2;Angiopoietin-2,0.310459675284779,1.36405199102866,1.30788769449165,1.42262813700716,1.82355965667896e-47
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6446442533229,ANGPT2;Angiopoietin-2,0.431831439868548,1.5400754979528,1.4579818874034,1.62679149849982,7.43736014910917e-54
sensitivity,Circulatory system disorders,I22 (subsequent myocardial infarction),0.111415168100078,ANGPT2;Angiopoietin-2,0.793062581102508,2.21015485034076,1.71623103576175,2.84622778675989,7.9750185958369e-10
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67865519937451,ANGPT2;Angiopoietin-2,0.394649620745713,1.48386418460005,1.41599027615552,1.55499155284944,2.61122229926903e-61
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0027365129007,ANGPT2;Angiopoietin-2,0.294951830512653,1.34306166253633,1.23067253225566,1.46571454395648,3.71458078816954e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361610633307271,ANGPT2;Angiopoietin-2,0.674103989560255,1.96227397008087,1.70001184296331,2.26499547611685,3.28843531775818e-20
sensitivity,Circulatory system disorders,I31 (other diseases of pericardium),0.193510555121188,ANGPT2;Angiopoietin-2,0.470283664567107,1.60044811925587,1.31560738588782,1.94695941198377,2.56234561188221e-06
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545347928068803,ANGPT2;Angiopoietin-2,0.784798319187399,2.1919648189051,1.95041100354839,2.46343450615098,1.23802264338446e-39
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.379202501954652,ANGPT2;Angiopoietin-2,0.639550682152395,1.89562894800653,1.64849950130968,2.17980600277131,2.86657565166718e-19
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0586395621579358,ANGPT2;Angiopoietin-2,1.50310202592763,4.49561297101902,3.17788120884184,6.35975187774877,2.0181211322914e-17
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304925723221266,ANGPT2;Angiopoietin-2,0.885800438963644,2.42492461901406,2.07781372509545,2.83002241099853,2.6447829418066e-29
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383111806098514,ANGPT2;Angiopoietin-2,0.626085498004981,1.87027503577283,1.62766565087536,2.1490462169266,1.02826498340175e-18
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.080140734949179,ANGPT2;Angiopoietin-2,0.938847140649236,2.55703182037584,1.90018909261634,3.44092688239357,5.72350776509438e-10
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.709538702111024,ANGPT2;Angiopoietin-2,0.28499705593212,1.32975811321756,1.19875032948483,1.4750833398543,7.21903975705867e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,ANGPT2;Angiopoietin-2,0.944530714078067,2.57160627675009,2.41760445654637,2.73541803942055,1.90145832415846e-197
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.26270523846755,ANGPT2;Angiopoietin-2,0.395967604294807,1.48582118254671,1.37458925288188,1.6060540134997,1.98627400939538e-23
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,ANGPT2;Angiopoietin-2,0.946184065970404,2.57586156362806,2.35016084181937,2.82323774480044,6.10039261347306e-91
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71032056293979,ANGPT2;Angiopoietin-2,0.445224841899758,1.56084109886022,1.45952206471976,1.66919363179272,1.19537161455079e-38
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.367474589523064,ANGPT2;Angiopoietin-2,0.433713284716215,1.54297640977053,1.33772646788376,1.77971824454865,2.59680717581527e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,ANGPT2;Angiopoietin-2,0.309840920912517,1.36320823895978,1.27073495727756,1.46241093953152,5.37727061883e-18
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173964034401876,ANGPT2;Angiopoietin-2,0.706327531832111,2.02653518996306,1.65176846842809,2.486332046323,1.28608273076344e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3975762314308,ANGPT2;Angiopoietin-2,0.395373442679026,1.48493862684845,1.37885089592869,1.5991886664594,1.39752315716965e-25
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.14855355746677,ANGPT2;Angiopoietin-2,0.667615613974832,1.94958321527564,1.56236404507328,2.43277149475507,3.42701045351595e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55277560594214,ANGPT2;Angiopoietin-2,0.225295963980685,1.25269341346186,1.18521934163595,1.32400875770785,1.5212893047222e-15
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0566849100860046,ANGPT2;Angiopoietin-2,0.944846245587225,2.57241782758775,1.79887548543944,3.67859450709829,2.25037059576346e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.521892103205629,ANGPT2;Angiopoietin-2,0.410737188111132,1.50792900280759,1.3368136746843,1.70094749969197,2.3311485607676e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215011727912431,ANGPT2;Angiopoietin-2,1.46264643698131,4.3173700708623,2.44404244171414,7.62657964143394,4.69785099486924e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309945907529513,SOST;Sclerostin,0.506770571522932,1.65992193063228,1.41438556796626,1.94808323713024,5.47307088684355e-10
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.171372930866601,GDF15;Growth/differentiation factor 15,0.474654941542564,1.60745943430563,1.33350387807074,1.93769652674464,6.39039393629057e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,GDF15;Growth/differentiation factor 15,0.981320767054085,2.66797769294714,2.38224285471334,2.98798460282088,1.17465202159401e-64
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,GDF15;Growth/differentiation factor 15,1.08971543628399,2.97342782249228,2.27546190991461,3.88548495452643,1.42420884860921e-15
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.57254138266796,GDF15;Growth/differentiation factor 15,0.199208008609258,1.22043580065263,1.17125283123339,1.27168404958828,2.26841965203252e-21
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65433300876338,GDF15;Growth/differentiation factor 15,0.334128069792182,1.39672201001812,1.32488299653704,1.47245634397008,2.54593389165185e-35
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6981499513145,GDF15;Growth/differentiation factor 15,0.282704450240965,1.32671299416175,1.2679305030834,1.3882206986875,2.24091848153282e-34
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00681596884128,GDF15;Growth/differentiation factor 15,0.313498543162453,1.36820346951016,1.25959543490362,1.48617618173797,1.09337373128281e-13
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356377799415774,GDF15;Growth/differentiation factor 15,0.505288500791565,1.65746363105944,1.45887753951581,1.88308176243258,8.48927175066239e-15
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543330087633885,GDF15;Growth/differentiation factor 15,0.399807458699666,1.49153748742491,1.33722000319225,1.66366347428471,7.23396605261916e-13
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0584225900681596,GDF15;Growth/differentiation factor 15,0.649188255190439,1.91398652962102,1.44102761660895,2.54217503769384,7.36401332038811e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307692307692307,GDF15;Growth/differentiation factor 15,0.510620385152143,1.66632463741026,1.44973075776124,1.91527825589371,6.60165887448491e-13
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387536514118792,GDF15;Growth/differentiation factor 15,0.417710821581983,1.51848149882763,1.3341456659918,1.72828658898178,2.51733361635582e-10
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0798442064264849,GDF15;Growth/differentiation factor 15,0.690588486964345,1.99488915414143,1.55977071079156,2.55138957910778,3.77561375116625e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16553067185978,GDF15;Growth/differentiation factor 15,0.333599064548788,1.39598333215072,1.31799548024134,1.47858584711215,5.65209337125406e-30
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,GDF15;Growth/differentiation factor 15,0.610871189322885,1.8420354615855,1.69904408489811,1.99706097793334,1.13921716901992e-49
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7078870496592,GDF15;Growth/differentiation factor 15,0.266036370547451,1.30478251347826,1.22294676580584,1.39209445176204,8.2807468094133e-16
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.360272638753651,GDF15;Growth/differentiation factor 15,0.357316350645959,1.42948801778927,1.24714927889396,1.6384854865292,2.86288037953903e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55793573515092,GDF15;Growth/differentiation factor 15,0.384078401123142,1.46826055044582,1.37425526827829,1.56869621951408,5.44003354778504e-30
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352482960077896,GDF15;Growth/differentiation factor 15,0.387299942907706,1.47299824039533,1.28575329054245,1.68751177396742,2.35843472330569e-08
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.124634858812074,GDF15;Growth/differentiation factor 15,0.568210878212048,1.76510623471126,1.43306707394714,2.1740782943503,9.08796988409946e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175267770204479,GDF15;Growth/differentiation factor 15,0.610053524457569,1.84052990951029,1.54308772404592,2.1953063944543,1.17445052330505e-11
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171372930866601,GDF15;Growth/differentiation factor 15,0.46271933556107,1.58838747596983,1.30870472396916,1.92784111466022,2.83398235908521e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39435248296007,GDF15;Growth/differentiation factor 15,0.3988622316733,1.49012831198124,1.39079466968442,1.59655658349042,9.11672763288175e-30
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243427458617332,GDF15;Growth/differentiation factor 15,0.577551853951817,1.78167129569731,1.53193582300802,2.0721185301867,6.6003228240387e-14
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56085686465433,GDF15;Growth/differentiation factor 15,0.196082870821504,1.21662772409575,1.15291173545971,1.28386499461574,9.03594830372567e-13
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.050632911392405,GDF15;Growth/differentiation factor 15,0.676280501975705,1.96654953496144,1.46259326138073,2.6441507530304,7.57201246969414e-06
sensitivity,Circulatory system disorders,I95 (hypotension),0.516066212268743,GDF15;Growth/differentiation factor 15,0.379577037782496,1.4616662290824,1.30605819715464,1.63581390928402,3.86333026249847e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40391305362938,COL5A1;Collagen alpha-1(V) chain,0.385368827900387,1.47015645617676,1.26478973798395,1.70886902441458,5.16981384803711e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1549812052018398,COL5A1;Collagen alpha-1(V) chain,0.393312159218527,1.4818808999207,1.38795424320529,1.58216383018398,5.41022027599514e-32
sensitivity,Circulatory system disorders,I50 (heart failure),0.905885923746818,COL5A1;Collagen alpha-1(V) chain,0.486497487445354,1.62660901251915,1.47289942911837,1.79635949834827,7.55585500519003e-22
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0536994233148887,COL5A1;Collagen alpha-1(V) chain,1.16139706688555,3.19439294076289,2.11896129302416,4.81563598806119,2.92996216889106e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199020908633389,VGF;Neurosecretory protein VGF,1.49694591216229,4.468022478365,3.64762003884692,5.47294527789841,2.09991312009446e-47
sensitivity,Circulatory system disorders,I50 (heart failure),0.915038660383401,VGF;Neurosecretory protein VGF,0.232426300591809,1.26165745952438,1.14270020158764,1.39299839359609,4.22514091920901e-06
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0513286216290914,DPP10;Inactive dipeptidyl peptidase 10,0.994142027159351,2.70240475646586,1.86165191963116,3.92285549772173,1.71047954362614e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197417775496505,DPP10;Inactive dipeptidyl peptidase 10,1.7230151886617,5.60139228220255,3.14188194383673,9.98624265964743,5.19848763936655e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199352690088653,PRRT3;Proline-rich transmembrane protein 3,1.71374778951171,5.54972173970699,4.52229764103043,6.81056706854851,1.7154501186429e-60
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0187626061259909,PRRT3;Proline-rich transmembrane protein 3,1.4603219967645,4.30734625663046,2.3372105969555,7.93819427255561,2.84604487265546e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1647356817862,PRRT3;Proline-rich transmembrane protein 3,-0.227938525068733,0.79617320302398,0.744867328996758,0.851012985181181,1.98793330247345e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5455696796285,PRRT3;Proline-rich transmembrane protein 3,0.190100674595348,1.20937134449947,1.12010402811005,1.30575286954754,1.17928288676716e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39546883062057,PRRT3;Proline-rich transmembrane protein 3,0.205132537484578,1.22768776882948,1.13234161372003,1.33106232206898,6.58780766091417e-07
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.126159381351774,C7;Complement component C7,0.771648446587191,2.16332944915684,1.64587788492219,2.84346387326936,3.15971589777679e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.175221362988575,C7;Complement component C7,0.61620466100554,1.8518861513949,1.47504832038521,2.32499659186256,1.105808240802e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.198584211387052,C7;Complement component C7,0.740259822046,2.09648015549983,1.7016697282252,2.58289194989011,3.55899745962476e-12
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.56524075415274,C7;Complement component C7,0.282633218000286,1.32661849278825,1.24922989519392,1.4088012400108,3.0769352926643e-20
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53012639300983,C7;Complement component C7,0.227040660583441,1.25488089109213,1.19168393867468,1.32142928147501,7.20246643091806e-18
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.399504707613952,C7;Complement component C7,0.660944548085552,1.93662070215212,1.66486769326922,2.25273140872804,1.05567739582357e-17
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.556035791883746,C7;Complement component C7,0.439232128068782,1.55151539586298,1.36497092953752,1.76355405929081,1.81200600204835e-11
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0537345513164965,C7;Complement component C7,0.939805852566805,2.55948445275173,1.69912363760301,3.85549380804296,6.92399158121293e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.31072588369974,C7;Complement component C7,0.454073424986753,1.57471361655673,1.3298652143977,1.86464233166085,1.39268845198634e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38081442889517,C7;Complement component C7,0.409328323837339,1.5058060313486,1.29225357675267,1.75464927691958,1.55756919988476e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15405462233955,C7;Complement component C7,0.48255227847937,1.62020434224732,1.51740880964227,1.7299636682984,3.4064176889906e-47
sensitivity,Circulatory system disorders,I50 (heart failure),0.90414223302105,C7;Complement component C7,0.696815456970759,2.0073500255423,1.81877806539737,2.21547323541331,1.38006345273187e-43
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66109852113169,C7;Complement component C7,0.278847721238257,1.32160607600875,1.22656240609658,1.42401447448709,2.4250045893557e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55596570333855,C7;Complement component C7,0.223932686141018,1.25098680784451,1.15843537133126,1.35093250096686,1.12841155187278e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40877975842814,C7;Complement component C7,0.264752627383476,1.3031085825247,1.20145115805187,1.41336746522677,1.67309845861538e-10
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0537345513164965,C7;Complement component C7,1.69975886646068,5.47262759854817,3.6659129812283,8.16976643628791,9.21394938697476e-17
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0186902787187813,C7;Complement component C7,1.7582374398702,5.80220164720414,3.05283985016596,11.02761546859,8.03467067035846e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.307989970583009,CLC;Galectin-10,0.444937501790006,1.5603926710363,1.33330818599574,1.82615340804004,2.9421555634588e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.29525815404602,KLK6;Kallikrein-6,1.53990579437702,4.6641508610535,3.9426535964084,5.51768059828625,4.02977521682401e-72
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393677538728027,KLK6;Kallikrein-6,2.07572431871676,7.97031741886038,5.04474896156617,12.5924917654707,5.84404684187438e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.899553175993543,KLK6;Kallikrein-6,0.243396764625899,1.27557462661941,1.16214438807795,1.40007613921904,3.0166215672178e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.898050620971545,PLA2G15;Phospholipase A2 group XV,0.243654943147364,1.27590399510663,1.16413057513155,1.39840928458142,1.89954945007071e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55242886338626,PLA2G15;Phospholipase A2 group XV,0.194754398695003,1.21501254117625,1.13256965629316,1.30345667219027,5.55908807658841e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39522087722056,PLA2G15;Phospholipase A2 group XV,0.202737731024627,1.22475121187612,1.13694542336297,1.31933820231681,9.22420544455798e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0569878949850652,PLA2G15;Phospholipase A2 group XV,0.931586937304491,2.5385344778852,1.76742202432681,3.64607728472003,4.58399287143644e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216160980977833,PLA2G15;Phospholipase A2 group XV,1.57519393908952,4.83167857859514,2.73478835200361,8.53635268328957,5.81032442854212e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30127790359107,GFAP;Glial fibrillary acidic protein,0.516121855581905,1.675517136074,1.42663671655637,1.96781538053643,3.15755312208082e-10
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67773750816944,CDHR2;Cadherin-related family member 2,-0.238026584289668,0.788181737563631,0.746702971114092,0.831964617071148,6.15982876113043e-18
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0574337036816984,CDHR2;Cadherin-related family member 2,1.00669373062327,2.7365383085903,1.9975842408061,3.74884911554983,3.64239811317032e-10
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0217851979482304,CDHR2;Cadherin-related family member 2,1.54433110369431,4.68483690863718,3.05101184689997,7.19357969154706,1.69043950385358e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304271503803393,SPP1;Osteopontin,1.23015712406935,3.42176713603044,2.93757145618276,3.98577209367109,2.98574914243487e-56
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390091671542812,SPP1;Osteopontin,1.83084915790588,6.23918246083314,4.14166508405854,9.39897287431601,1.99620784302483e-18
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00838697093817,SPP1;Osteopontin,0.324545259422124,1.38340141416446,1.26844232903597,1.50877925539329,2.26649824609616e-13
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16890969377803,SPP1;Osteopontin,0.192024248698337,1.21169989875398,1.14072541602999,1.28709032341031,4.50971147044738e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.910864053052467,SPP1;Osteopontin,0.425036083638358,1.52964561384671,1.39568308129771,1.67646633774834,9.96610895990845e-20
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55841622781353,SPP1;Osteopontin,0.240662861083096,1.27209209125557,1.18551123787794,1.36499616109214,2.20572699289199e-11
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353032962746245,SPP1;Osteopontin,0.387276610010769,1.47296387148017,1.27302584766333,1.70430362483859,1.95846365584559e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175541252194265,SPP1;Osteopontin,0.556648721710222,1.7448153295398,1.42157220070179,2.14155885483279,1.00960261092175e-07
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171640335478837,SPP1;Osteopontin,0.510108180004805,1.66547135590008,1.35307518632834,2.04999313072213,1.48690122437946e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39262726740784,SPP1;Osteopontin,0.19778715577974,1.21870297233056,1.13178676918383,1.31229395430943,1.61160868736297e-07
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56290228203627,SPP1;Osteopontin,0.197773340094248,1.2186861352299,1.15371849986049,1.28731219650303,1.4870429684946e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,PODXL2;Podocalyxin-like protein 2,1.23119755077247,3.42532908658353,2.9288642350553,4.00594852126139,1.37993691466122e-53
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,PODXL2;Podocalyxin-like protein 2,1.56040330628444,4.7607408947299,3.13610012205825,7.22701858506949,2.35892627930556e-13
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216160980977833,PODXL2;Podocalyxin-like protein 2,1.31843155504339,3.73755462891985,2.12445008818735,6.57549672822829,4.77930498492168e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,SEZ6L;Seizure 6-like protein,1.28965022570436,3.63151612258947,3.12264639098904,4.22331179946707,6.37831329144792e-63
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,SEZ6L;Seizure 6-like protein,1.63624726374184,5.13585977552533,3.52580068103676,7.48115336630515,1.51430752452116e-17
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0569878949850652,SEZ6L;Seizure 6-like protein,0.902704095231613,2.46626311278257,1.72369185843212,3.52873613210926,7.85899728315106e-07
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.114631302251121,TFPI;Tissue factor pathway inhibitor,-0.689455418517888,0.501849292494596,0.386792054741811,0.651132072879423,2.11310421659971e-07
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.58129928651896,TFPI;Tissue factor pathway inhibitor,-0.279609213696855,0.756079149106898,0.724624476141664,0.78889921405643,4.68233570437687e-38
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.66221317469415,TFPI;Tissue factor pathway inhibitor,-0.310126459981666,0.733354210400092,0.693854977352838,0.77510202486889,4.84642465341622e-28
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69784769848014,TFPI;Tissue factor pathway inhibitor,-0.315014657132359,0.729778177735322,0.69606694962648,0.765122074801103,5.97732121416586e-39
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351799513805166,TFPI;Tissue factor pathway inhibitor,-0.340000712164836,0.711769815864994,0.613433347458643,0.825870117552818,7.39650186545262e-06
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543510484811352,TFPI;Tissue factor pathway inhibitor,-0.343312194178232,0.709416701220826,0.62939236351446,0.799615764577792,1.8882969107449e-08
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.377492736723521,TFPI;Tissue factor pathway inhibitor,-0.450939872664224,0.637029143891714,0.551939402178285,0.735236746218616,7.07763442414567e-10
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.715457438188034,TFPI;Tissue factor pathway inhibitor,-0.275917337743669,0.758875658542805,0.683639190320816,0.842392117483088,2.22383685797849e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1661363321936,TFPI;Tissue factor pathway inhibitor,-0.543025143403698,0.580988019163643,0.546450844095381,0.617708037345031,1.48392392743298e-67
sensitivity,Circulatory system disorders,I50 (heart failure),0.917050418008972,TFPI;Tissue factor pathway inhibitor,-0.297688990974754,0.742532238067757,0.676858145143411,0.814578547256888,2.96591983517108e-10
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70365831966322,TFPI;Tissue factor pathway inhibitor,-0.250634645132903,0.778306677752279,0.727116060944113,0.833101229874153,5.18438939686455e-13
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.367610727908769,TFPI;Tissue factor pathway inhibitor,-0.329515311529196,0.719272271936381,0.621996493520322,0.831761282525012,8.80181666468759e-06
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56531019625669,TFPI;Tissue factor pathway inhibitor,-0.239977077910698,0.786645892427289,0.73274042723829,0.844517017308621,3.45278742373906e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.50865285540077,4.52063673908098,3.96945204008135,5.14835708313783,1.75817971541351e-114
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.56221985625096,4.76939687807568,3.4934630178219,6.51134603817286,7.95674354702735e-23
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6446442533229,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.281577349793067,1.3252184977338,1.25719659059563,1.39692079971661,1.14313891559907e-25
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67865519937451,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.283908876470826,1.32831188477102,1.26962968623763,1.38970637056584,7.49045055324723e-35
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0027365129007,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.395710422829711,1.48543910601172,1.36570816395606,1.61566679903063,2.73240500787918e-20
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361610633307271,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.551508048760576,1.73586881981545,1.51755904540079,1.98558373642173,8.81065927809618e-16
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545347928068803,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.313288463230801,1.36791606760854,1.21995250795644,1.5338255840435,8.14699056821747e-08
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0586395621579358,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.7286323303357,2.07224452273178,1.51391523728634,2.83648466983469,5.38923331006238e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304925723221266,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.459793584057717,1.58374704061465,1.36656447270948,1.8354455561709,9.96629178985297e-10
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383111806098514,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.350575236607775,1.41988408302384,1.24124148653064,1.6242373712947,3.22056173292355e-07
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.080140734949179,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.672577277694405,1.95928042884562,1.49740147665789,2.56362763006312,9.42496232512268e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.334751672500867,1.39759328128217,1.31909581854331,1.4807620132115,7.39766596445929e-30
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.6252653776944,1.8687418140287,1.71874395188544,2.03183025817685,1.41803098644215e-48
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.367474589523064,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.505418573272783,1.65767923548826,1.45083574189025,1.8940120982881,1.06519053806462e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.393702819774934,1.48245992543144,1.38596202663744,1.58567651080753,1.99344282760934e-30
sensitivity,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.132916340891321,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.521521450615624,1.68458871947858,1.35526205229493,2.09394127799049,2.61405032538832e-06
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34401876465989,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.482380543277072,1.61992612001779,1.4092712949826,1.86206917267005,1.1467978926333e-11
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.125097732603596,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.552175277621585,1.73702742807641,1.38568159926028,2.17745857886867,1.67575866839056e-06
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173964034401876,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.806893173980829,2.24093496524581,1.87766315805461,2.67448903011133,3.8310606497807e-19
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168100078186082,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.55389233763176,1.74001257051066,1.43630152281304,2.10794439569026,1.51821267153218e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3975762314308,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.398085425331279,1.48897122033432,1.38617908041595,1.59938591362857,1.06585789100599e-27
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.14855355746677,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.582941205463738,1.79129926955246,1.46022178409334,2.19744227079281,2.25722013207266e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236512900703674,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.532881762548852,1.70383528933858,1.44503816711607,2.00898132607061,2.30315786572268e-10
sensitivity,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0117279124315871,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.45298075453232,4.27584077058085,2.4763351255614,7.38301294790084,1.8499839269606e-07
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55277560594214,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.232411741214557,1.26163909071118,1.19454172086773,1.33250531764958,7.72806894672163e-17
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0566849100860046,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.937012135430894,2.55234395608514,1.89779595458643,3.43264493446766,5.72768937134653e-10
sensitivity,Circulatory system disorders,I95 (hypotension),0.521892103205629,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.38012156246415,1.46246235915704,1.30210155412741,1.64257245924606,1.41033980448269e-10
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215011727912431,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.36832215207838,3.92875331173628,2.60355184477467,5.92847905658459,7.11816892114399e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300312089033701,CRLF1;Cytokine receptor-like factor 1,0.465225329445074,1.59237295697982,1.35510873467868,1.87117946274761,1.59103267852206e-08
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.62822148507272,CRLF1;Cytokine receptor-like factor 1,0.211431664921404,1.23544553847609,1.16798644071846,1.30680085429894,1.58108103309128e-13
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15910652246452,CRLF1;Cytokine receptor-like factor 1,0.300367128381068,1.35035447003501,1.27034043421988,1.43540829341807,5.52675606468672e-22
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,CRLF1;Cytokine receptor-like factor 1,0.327102920335125,1.38694421459825,1.262356488867,1.52382807184209,9.66358415482987e-12
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70373132863564,CRLF1;Cytokine receptor-like factor 1,0.215094686526155,1.23997930074018,1.15878140982784,1.3268668734447,4.8223254541633e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39360511904528,CRLF1;Cytokine receptor-like factor 1,0.237475399608392,1.26804380203291,1.17709726083566,1.366017182584,4.00211948435323e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199020908633389,VWC2L;von Willebrand factor C domain-containing protein 2-like,0.947700641893337,2.57977101699839,2.146043336111,3.10115755267333,6.06827646879113e-24
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38784696174043,ITGA11;Integrin alpha-11,-0.22668168577466,0.797174493889474,0.739826566655042,0.85896776670396,2.66523280374215e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,PTPRR;Receptor-type tyrosine-protein phosphatase R,1.39651574852925,4.04109521691318,3.32907545611897,4.90540114437557,2.78423087506513e-45
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0206001510677745,PTPRR;Receptor-type tyrosine-protein phosphatase R,1.34158730015249,3.82511028733299,2.12933493462585,6.87137963705629,7.16115752514744e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.908695552656275,PTPRR;Receptor-type tyrosine-protein phosphatase R,0.308536164008758,1.36143074345067,1.2359949099918,1.49959652279226,3.94576532803623e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30631574704768,CHI3L1;Chitinase-3-like protein 1,0.615633822838715,1.85082932576597,1.58110497388549,2.16656657824379,1.85066305701634e-14
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.995526177904961,CHI3L1;Chitinase-3-like protein 1,0.239756056752493,1.27093907549715,1.16280301857518,1.38913135571733,1.2603376679555e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.918947241143041,CHI3L1;Chitinase-3-like protein 1,0.302444184775109,1.35316214726379,1.23431399030286,1.48345381416139,1.13152659122693e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55979202772963,CHI3L1;Chitinase-3-like protein 1,0.1927680333728,1.2126014778175,1.12942572569987,1.30190264888293,1.05499431499746e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38245133207045,CHI3L1;Chitinase-3-like protein 1,0.194836362593674,1.21511213242244,1.12659329225922,1.31058608683823,4.44877903351639e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,COL9A1;Collagen alpha-1(IX) chain,0.46921681887384,1.59874159853155,1.36159179037516,1.87719602669678,1.01820135157965e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,TIMP4;Metalloproteinase inhibitor 4,0.888890227025158,2.4324287092061,2.08130109249044,2.8427935999833,5.38795432852357e-29
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,TIMP4;Metalloproteinase inhibitor 4,1.1059340623852,3.02204593032076,1.98279044621592,4.60601452987519,2.69764070828101e-07
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64693129409909,TIMP4;Metalloproteinase inhibitor 4,0.221215600421635,1.24759238301369,1.18049721586859,1.31850099536961,4.38989643666122e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,TIMP4;Metalloproteinase inhibitor 4,0.242287681422907,1.27416069245711,1.16480162316143,1.39378709466117,1.21078023944163e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356734597343214,TIMP4;Metalloproteinase inhibitor 4,0.385576747996114,1.47046216302806,1.26715686963517,1.7063861820989,3.80017032061398e-07
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549883716346722,TIMP4;Metalloproteinase inhibitor 4,0.321516956555404,1.37921839262093,1.22356422609044,1.55467390593949,1.42217673530117e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301549134770783,TIMP4;Metalloproteinase inhibitor 4,0.38605799231348,1.47116998489188,1.25401395646238,1.72593065116473,2.16096225955802e-06
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386298238007016,TIMP4;Metalloproteinase inhibitor 4,0.348935553704912,1.41755783104785,1.23059369906553,1.63292742835511,1.32935538016787e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1522330403248,TIMP4;Metalloproteinase inhibitor 4,0.350634357562233,1.41996803040755,1.33606660761752,1.50913823897971,1.57858657167115e-29
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,TIMP4;Metalloproteinase inhibitor 4,0.561023522962633,1.75246527111474,1.59891549787188,1.92076099740785,3.94224700458269e-33
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70286570223501,TIMP4;Metalloproteinase inhibitor 4,0.18661428796798,1.20516234977127,1.12489044374672,1.29116243931151,1.11861756583639e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,TIMP4;Metalloproteinase inhibitor 4,0.247590315543324,1.28093504550424,1.19218031286756,1.37629733781994,1.3991157873679e-11
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.116283653277622,TIMP4;Metalloproteinase inhibitor 4,0.718983976889526,2.05234691906265,1.59409781541332,2.64232711158556,2.44654791616384e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,TIMP4;Metalloproteinase inhibitor 4,0.278492875903713,1.32113719345388,1.22455850093912,1.42533287106222,6.4634597688102e-13
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),27.8249448848445,FSHB;Follitropin subunit beta,0.196131881387785,1.21668735317067,1.18272006501438,1.25163016943275,5.53771231536366e-42
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.116379990531797,ESM1;Endothelial cell-specific molecule 1,0.61209037957649,1.84428262284726,1.43847744658296,2.36456845466447,1.38211704932009e-06
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0276155909736468,ESM1;Endothelial cell-specific molecule 1,1.21785874463606,3.37994265926343,2.08180423867002,5.48755361705242,8.41940065929807e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301798958497711,ESM1;Endothelial cell-specific molecule 1,0.473383442513505,1.6054168500428,1.3766422481594,1.8722099120867,1.58851531917089e-09
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394508442480669,ESM1;Endothelial cell-specific molecule 1,1.0205975344055,2.77485233842849,1.87351746990811,4.10981249107845,3.52884511858531e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0040239861133,ESM1;Endothelial cell-specific molecule 1,0.201316879739175,1.22301225823218,1.12151710557881,1.33369252804595,5.25196537437004e-06
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360975224869812,ESM1;Endothelial cell-specific molecule 1,0.403223593347753,1.49664149333671,1.29809579924138,1.72555504831475,2.81123981244282e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544421650623323,ESM1;Endothelial cell-specific molecule 1,0.38499980543105,1.46961403549985,1.30874949502862,1.65025119134119,7.55993102610782e-11
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.382673189206249,ESM1;Endothelial cell-specific molecule 1,0.346733000741485,1.41443902077948,1.23208005478018,1.623788759295,8.50173294181605e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16190626479406,ESM1;Endothelial cell-specific molecule 1,0.472785521819218,1.60445722500363,1.51271007072862,1.70176892233314,8.42344503977304e-56
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25453684708852,ESM1;Endothelial cell-specific molecule 1,0.273861564581975,1.31503274252983,1.21733542007635,1.42057076907945,3.57374189737211e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.901451791068328,ESM1;Endothelial cell-specific molecule 1,0.431055410152293,1.53888081721495,1.40668165155352,1.68350398754174,5.16026443315795e-21
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70230392930408,ESM1;Endothelial cell-specific molecule 1,0.221392095603304,1.24781259649072,1.1673671982838,1.33380163349629,7.45026048882522e-11
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.362947767082215,ESM1;Endothelial cell-specific molecule 1,0.334390432785501,1.39708850626093,1.21248188092633,1.60980244326223,3.75448259915982e-06
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0532586397348903,ESM1;Endothelial cell-specific molecule 1,1.2975601362659,3.66035499641569,2.6005565507288,5.15205050858459,1.00860942165695e-13
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216979643364368,ESM1;Endothelial cell-specific molecule 1,1.28524652716707,3.61555918091978,2.11840872592844,6.1707960464542,2.45095390537488e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.192382566475047,GSN;Gelsolin,0.750986672947017,2.11908983407153,1.71233138531769,2.62247235749415,4.9809492916348e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309945907529513,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.768165907076405,2.15580867217784,1.84991930618461,2.51227770611385,7.65889334703641e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357326173648675,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.364901067500569,1.4403715015473,1.24572923443144,1.66542616575626,8.38225004166099e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39179531725036,LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,0.222723148158519,1.24947460650166,1.15991509953111,1.34594919311214,4.37911497734069e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199020908633389,OCLN;Occludin,1.27086892885603,3.56394803457682,2.93261195811693,4.33119886796067,2.25463599763228e-37
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0205883698586265,OCLN;Occludin,1.45767855562319,4.29597507647013,2.42210382602136,7.61957504025255,6.17480467952704e-07
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.5575330557716,OCLN;Occludin,0.287198984318042,1.33268937137939,1.2543714786301,1.41589711727759,1.48260398602034e-20
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.54119961568376,OCLN;Occludin,0.236725759945907,1.26709358231083,1.20332481569316,1.3342416988288,2.58172993630009e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.997392139817907,OCLN;Occludin,0.315889121946486,1.37147818036421,1.24938069267273,1.50550781698996,3.13451857320079e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.398041817266779,OCLN;Occludin,0.505878453990374,1.658441745523,1.43459943292306,1.91721044925359,8.0140789112089e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555885986182916,OCLN;Occludin,0.371662227743239,1.45014308045944,1.28029113273507,1.64252871869227,4.99163730167991e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.308825547879397,OCLN;Occludin,0.580010209714139,1.78605666578498,1.51379348352728,2.10728771665865,6.26963674239527e-12
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0846410760854646,OCLN;Occludin,0.771964171143206,2.16401257322053,1.58478956021139,2.95493517538816,1.19166865416175e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14347806194811,OCLN;Occludin,0.375043364574964,1.45505451107053,1.36350565490194,1.55275016467678,1.15071456620595e-29
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24674017477238,OCLN;Occludin,0.191876489817796,1.21152087256007,1.11346694244584,1.31820961062803,8.3532313109448e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.915038660383401,OCLN;Occludin,0.657727198620347,1.93039992913822,1.75098807097154,2.12819490217842,7.15095518341534e-40
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66308276524683,OCLN;Occludin,0.285116798981448,1.32991735204258,1.23637038122191,1.43054232787101,1.83515372455023e-14
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54641533604794,OCLN;Occludin,0.279397498787188,1.32233286512573,1.22571888852346,1.42656217715467,5.28624866635936e-13
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.128105412453676,OCLN;Occludin,0.595157483006286,1.81331648900743,1.40679038999499,2.33731813402417,4.3224528549194e-06
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.164706958869012,OCLN;Occludin,0.67347945048208,1.96104883591638,1.56510407126458,2.45716090543532,4.82975012587723e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38857116713181,OCLN;Occludin,0.276234816086502,1.31815735224032,1.21757275796637,1.42705131491879,9.04872427642508e-12
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.53694468591298,OCLN;Occludin,0.207984386559279,1.2311939462251,1.16041639330043,1.30628845126017,5.77043898318675e-12
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0526147229720455,OCLN;Occludin,1.04232726632054,2.83580902352775,1.9468242192186,4.13073390937635,5.58942998680727e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.018300773207668,OCLN;Occludin,1.532605899392,4.63022702045607,2.53474223928986,8.45806012487008,6.17916591069703e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,OMG;Oligodendrocyte-myelin glycoprotein,-0.383092956370091,0.681749523379434,0.580951203953385,0.800036921285697,2.693159227502e-06
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.370348365119917,OMG;Oligodendrocyte-myelin glycoprotein,-0.360599674728244,0.697258072630334,0.60382308571666,0.805151096982569,8.9987414671672e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,OMG;Oligodendrocyte-myelin glycoprotein,-0.280631334684631,0.755306739555429,0.703714813536253,0.810681059776303,7.59535540336199e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346582694630938,OMG;Oligodendrocyte-myelin glycoprotein,-0.400198489144876,0.670187007986649,0.577033920282449,0.778378202540059,1.59541619758613e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172301111045095,OMG;Oligodendrocyte-myelin glycoprotein,-0.507872229898878,0.601774655658878,0.487359472983823,0.7430505740993,2.35555216740741e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300312089033701,OMD;Osteomodulin,0.514358156155117,1.67256463189185,1.42404690824258,1.96445245705275,3.67444148113856e-10
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392564822266276,OMD;Osteomodulin,1.08674614686189,2.96461194962784,1.96405071565137,4.47489667239137,2.30163755749281e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00496594500166,OMD;Osteomodulin,0.211092446015655,1.23502652306541,1.13084607316491,1.34880471256904,2.66897697209703e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,OMD;Osteomodulin,0.217217839231813,1.24261476290181,1.12974733944363,1.36675820785022,7.78798588324056e-06
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0529962510059473,OMD;Osteomodulin,1.01089979998015,2.74807261856338,1.90463585809584,3.96501151902486,6.50002293956912e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,PAEP;Glycodelin,0.521683300889916,1.68486139269042,1.40624979772551,2.01867258375442,1.54345131976302e-08
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63450687435428,PAEP;Glycodelin,0.209418892036915,1.23296136807006,1.16279182029343,1.3073653500328,2.47128791735244e-12
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68155447826432,PAEP;Glycodelin,0.196258630626376,1.21684157713997,1.15826419099108,1.27838142228114,6.35387342096081e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,PAEP;Glycodelin,0.240982141551498,1.27249831025977,1.15296284929549,1.40442682138751,1.6850355036329e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,SUSD2;Sushi domain-containing protein 2,0.227764684497533,1.25578978385696,1.14497715167176,1.37732703131846,1.34944910105275e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.308260195166008,TFRC;Transferrin receptor protein 1,0.528039456452475,1.69560474082984,1.44633226451305,1.98783883044509,7.58065064273588e-11
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65457187174805,TFRC;Transferrin receptor protein 1,0.18878977653965,1.20778702062577,1.14265775748153,1.27662852471875,2.4702504786222e-11
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00528165557322,TFRC;Transferrin receptor protein 1,0.250010116990144,1.28403840722594,1.17665395223399,1.40122304276546,2.01530747904055e-08
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376980620839959,TFRC;Transferrin receptor protein 1,0.414656164407389,1.51385013563739,1.31204907669067,1.74668941420218,1.34167987646673e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1597848068956,TFRC;Transferrin receptor protein 1,0.264872931706933,1.30326536155152,1.22639611700429,1.38495269111659,1.34819941514256e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.911036500363236,TFRC;Transferrin receptor protein 1,0.289238108453451,1.33540966300514,1.21661073149942,1.4658090068379,1.16790845487243e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,MOG;Myelin-oligodendrocyte glycoprotein,1.56118181442408,4.76444861332448,4.09102146272774,5.54872928333992,1.11470692066772e-89
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,MOG;Myelin-oligodendrocyte glycoprotein,1.63458113987117,5.12730992149273,3.4992356063004,7.51287137788141,5.03396809379249e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,MOG;Myelin-oligodendrocyte glycoprotein,0.352533729132574,1.42266764028483,1.30046872999837,1.55634900557443,1.43062574379977e-14
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.171640335478837,IGFBP2;Insulin-like growth factor-binding protein 2,0.547142873693856,1.72830796276229,1.42178695737431,2.10091139087666,3.95267414300752e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304271503803393,IGFBP2;Insulin-like growth factor-binding protein 2,1.23548588334859,3.44004957751095,3.01769785203357,3.92151291348092,2.67829447532203e-76
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390091671542812,IGFBP2;Insulin-like growth factor-binding protein 2,1.37755014938432,3.96517563077932,2.85883065848125,5.49966740292299,1.54138746705159e-16
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70001950458357,IGFBP2;Insulin-like growth factor-binding protein 2,0.186398808728286,1.20490269028106,1.1504981567788,1.26187989480252,2.63589538286535e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00838697093817,IGFBP2;Insulin-like growth factor-binding protein 2,0.255886769599591,1.29160647054163,1.1866934191479,1.40579466256996,3.21703389383337e-09
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356933879461673,IGFBP2;Insulin-like growth factor-binding protein 2,0.375981318513921,1.45641992542837,1.26697625010948,1.67419002447876,1.23482804639678e-07
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542227423444509,IGFBP2;Insulin-like growth factor-binding protein 2,0.281421265061447,1.32501166750219,1.18115785304361,1.48638551104151,1.59146279444115e-06
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376438463038814,IGFBP2;Insulin-like growth factor-binding protein 2,0.337336616506454,1.40121065499687,1.22204752333288,1.60664070929257,1.34637254145246e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16890969377803,IGFBP2;Insulin-like growth factor-binding protein 2,0.305907837801154,1.35785715767961,1.2806957238616,1.43966753875177,1.20486290299333e-24
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25804564072557,IGFBP2;Insulin-like growth factor-binding protein 2,0.182612306072537,1.2003489498603,1.11162786544976,1.29615102878674,3.14474131754379e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.910864053052467,IGFBP2;Insulin-like growth factor-binding protein 2,0.52207953809185,1.68552912973669,1.54608423930013,1.83755087528541,2.16353768653564e-32
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.358884337819387,IGFBP2;Insulin-like growth factor-binding protein 2,0.406274814010959,1.50121505070467,1.30667971988139,1.72471233323096,9.60743461082603e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55841622781353,IGFBP2;Insulin-like growth factor-binding protein 2,0.314846675481115,1.37004923271288,1.27963541817574,1.46685131827084,1.58485928328444e-19
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353032962746245,IGFBP2;Insulin-like growth factor-binding protein 2,0.33394310323802,1.3964636870521,1.21256381257285,1.60825418756093,3.56619485654315e-06
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175541252194265,IGFBP2;Insulin-like growth factor-binding protein 2,0.653764697896871,1.92276585302728,1.59397485121619,2.31937694797814,8.335460037823e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39262726740784,IGFBP2;Insulin-like growth factor-binding protein 2,0.290853993824845,1.33756927631828,1.24468550661222,1.43738443120475,2.36128237899657e-15
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243807294714257,IGFBP2;Insulin-like growth factor-binding protein 2,0.512737545634887,1.66985625126148,1.41627541347779,1.96884015166925,1.05129765588619e-09
sensitivity,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0117027501462843,IGFBP2;Insulin-like growth factor-binding protein 2,1.39633726715936,4.04037402106493,2.20692440542453,7.39700108892319,6.02379553719253e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56290228203627,IGFBP2;Insulin-like growth factor-binding protein 2,0.23475922544,1.2646042475426,1.19847970438156,1.33437712550003,1.05777369363856e-17
sensitivity,Circulatory system disorders,I95 (hypotension),0.516871464794226,IGFBP2;Insulin-like growth factor-binding protein 2,0.279810316771592,1.32287886060445,1.17602597326149,1.48806958317493,3.15181875868463e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30570252792475,C1QA;Complement C1q subcomponent subunit A,0.932724239339348,2.54142320067624,2.17575091229082,2.96855299402588,5.73118791973032e-32
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0391926317852243,C1QA;Complement C1q subcomponent subunit A,1.66144788333561,5.26693122835758,3.48534836146156,7.95919422889925,3.09571223321577e-15
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.5679012345679,C1QA;Complement C1q subcomponent subunit A,0.200914211485703,1.22251988915953,1.17212747066148,1.27507879202524,8.36473225842091e-21
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63962375073486,C1QA;Complement C1q subcomponent subunit A,0.268019336665351,1.30737241999349,1.23714957888539,1.38158123619907,1.81983015595729e-21
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68802665098961,C1QA;Complement C1q subcomponent subunit A,0.249355561520304,1.28319820787154,1.22438827535225,1.34483290458741,2.06344339930353e-25
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.382128159905937,C1QA;Complement C1q subcomponent subunit A,0.335660853414914,1.39886452422646,1.21519521876827,1.61029431890191,2.95500798446852e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1575543797766,C1QA;Complement C1q subcomponent subunit A,0.29133670636195,1.33821509363672,1.25985939040918,1.42144405198704,2.97136351622749e-21
sensitivity,Circulatory system disorders,I50 (heart failure),0.90143053106016,C1QA;Complement C1q subcomponent subunit A,0.45819353343937,1.58121499142664,1.44161156841813,1.73433739287752,2.58406402929509e-22
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55202821869488,C1QA;Complement C1q subcomponent subunit A,0.202951908787516,1.22501355444375,1.14149944546602,1.31463770265631,1.76567324376027e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174407211444248,C1QA;Complement C1q subcomponent subunit A,0.515935975588454,1.67520571990364,1.36146660566048,2.06124350926438,1.08092388129323e-06
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168528316676464,C1QA;Complement C1q subcomponent subunit A,0.537593881426601,1.71188290955079,1.38539330208229,2.11531490126837,6.38210143007307e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39917695473251,C1QA;Complement C1q subcomponent subunit A,0.231220685052977,1.26013730223325,1.17036785129239,1.35679224162402,8.66809194549227e-10
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.241034685479129,C1QA;Complement C1q subcomponent subunit A,0.539044872864275,1.71436863994549,1.4370905023445,2.04514595902883,2.1184647015435e-09
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0529100529100529,C1QA;Complement C1q subcomponent subunit A,0.995085929670853,2.70495676733785,1.86225803576758,3.92898887943368,1.74508340818127e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215559474818734,C1QA;Complement C1q subcomponent subunit A,1.42548645042918,4.15988092651319,2.33776691250647,7.40219618568168,1.24661383039961e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,APLP1;Amyloid-like protein 1,0.442546708787499,1.55666655112278,1.33030517041512,1.8215450148392,3.39344007714182e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200789148046975,CHAD;Chondroadherin,0.643332275492798,1.90281101708559,1.53105121853363,2.36483908762375,6.61016729257871e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309286632390745,DPP4;Dipeptidyl peptidase 4,-0.513041907314547,0.59867170235668,0.509490396482036,0.703463322718944,4.5494864807339e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.35146208226221,DPP4;Dipeptidyl peptidase 4,-0.376740123876531,0.686094350270212,0.591413285596144,0.795933180632243,6.61399757565404e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16902313624678,DPP4;Dipeptidyl peptidase 4,-0.255377768021678,0.774623814575372,0.72812688514243,0.824089957878598,6.17366782137151e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.925851542416452,DPP4;Dipeptidyl peptidase 4,-0.361222024560892,0.696824269188272,0.634004151131918,0.76586890048412,6.69898821141212e-14
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170710154241645,DPP4;Dipeptidyl peptidase 4,-0.500636768265858,0.606144563176315,0.486406987565588,0.75535763436923,8.24733057076057e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302293877067156,MMP10;Stromelysin-2,0.860176214273032,2.36357715304145,2.00926823469487,2.78036394639361,3.02947225117269e-25
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0395155394859028,MMP10;Stromelysin-2,1.34807823235794,3.85001957367402,2.47347656846668,5.99263842101474,2.34843133566288e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55098492482168,MMP10;Stromelysin-2,0.219519478871818,1.24547810822786,1.15961075829949,1.3377038001524,1.71261358342428e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,NCAN;Neurocan core protein,0.417119397414499,1.51758369768816,1.28807379216879,1.78798784160579,6.16864977095882e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.17344002522764,OGN;Mimecan,0.519491699538298,1.68117289152334,1.36194481188652,2.07522527089624,1.33017501847131e-06
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0618077180811,OGN;Mimecan,0.186478952367609,1.20499925943734,1.18097113845154,1.22951625824522,1.38354244550776e-73
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,OGN;Mimecan,1.76139802385693,5.82056900331411,4.94359130221693,6.85311981739836,3.41590236572362e-99
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,OGN;Mimecan,1.91258937286738,6.77059772222029,4.43292139978674,10.3410345868843,8.68535063606598e-19
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64693129409909,OGN;Mimecan,0.273286408409158,1.31427661079826,1.24463914129175,1.38781029166306,7.66234174403462e-23
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69348417359769,OGN;Mimecan,0.283828070964989,1.32820455419377,1.2676613470611,1.39163929062834,8.90497540627261e-33
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,OGN;Mimecan,0.303472362866466,1.35455415443066,1.23854642251775,1.48142768323168,3.06869833140171e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356734597343214,OGN;Mimecan,0.426263409230304,1.53152413960075,1.31985719008695,1.77713635065723,1.94383871246219e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549883716346722,OGN;Mimecan,0.390898900966488,1.47830905024177,1.31219430452764,1.66545277668569,1.29706506636831e-10
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.384327328629429,OGN;Mimecan,0.349060604124013,1.41773510833279,1.23068882292293,1.63320963021799,1.32868539263551e-06
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386298238007016,OGN;Mimecan,0.380788726347561,1.46343838677291,1.27180058151376,1.68395261254826,1.05226510871867e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1522330403248,OGN;Mimecan,0.302579166936934,1.35334481234371,1.27392909211281,1.437711245027,1.05339434147523e-22
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,OGN;Mimecan,0.629243986898299,1.87619161751094,1.71321579506228,2.05467110200812,5.88440680164741e-42
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70286570223501,OGN;Mimecan,0.243253904078633,1.27539241034624,1.19089618480975,1.36588379500825,3.51867554774039e-12
sensitivity,Circulatory system disorders,I61 (intracerebral haemorrhage),0.0906618313689936,OGN;Mimecan,0.673149586258217,1.96040206274369,1.47124480754011,2.61219358458462,4.29889720481105e-06
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.364618234853561,OGN;Mimecan,0.407530733345285,1.50310164016594,1.30104268923398,1.73654143662246,3.1510363918741e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,OGN;Mimecan,0.392430735437523,1.48057531032828,1.37889393288925,1.58975480076302,3.07310202711183e-27
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348850959832866,OGN;Mimecan,0.501706998717531,1.65153803922093,1.42343310171565,1.91619675818007,3.69786775571919e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17344002522764,OGN;Mimecan,0.709564660506919,2.03310597463681,1.65988527719992,2.49024433247385,7.02956832332266e-12
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171469115850053,OGN;Mimecan,0.734039052484517,2.08347891634541,1.7037876652903,2.54778484625091,8.6102937141592e-13
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.104458197012101,OGN;Mimecan,0.803452474968618,2.23323783187753,1.7146340790852,2.90869712352268,2.53459674278509e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,OGN;Mimecan,0.286778604706221,1.33212925367805,1.23479773159048,1.43713282192308,1.27961254055522e-13
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149789112696598,OGN;Mimecan,0.665616331020309,1.94568934056061,1.56041233125319,2.42609400999211,3.37929378780219e-09
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240450944065591,OGN;Mimecan,0.492252723886292,1.63599752261646,1.37098964956091,1.95223056196259,4.7754636557538e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.516378256927746,OGN;Mimecan,0.444097220941581,1.55908205367926,1.37787722589675,1.76411715385075,1.85648855702966e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301305657850686,SCG3;Secretogranin-3,1.18829983835029,3.28149738601935,2.80603532152014,3.83752300331638,4.4880171525597e-50
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393863605033576,SCG3;Secretogranin-3,1.42251932472636,4.14755633025059,2.7439586286879,6.26912641202154,1.48978532329817e-11
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63297819964946,SCG3;Secretogranin-3,0.198721039399578,1.2198416306783,1.1538968368865,1.28955514597902,2.41513631246926e-12
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67671675298844,SCG3;Secretogranin-3,0.185080548757451,1.20331536178139,1.14773706223044,1.26158499847098,1.70589357473509e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.901947655526891,SCG3;Secretogranin-3,0.249396312056487,1.283250499952,1.16886056068415,1.40883515195618,1.64679219673217e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,BCAN;Brevican core protein,0.382410433787793,1.46581358110767,1.24807877009497,1.72153353301266,3.14692459301956e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.198353890700166,TF;Serotransferrin,-0.557185313584364,0.572819103056105,0.464190110905733,0.706869269975971,2.06398523903766e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,SYT1;Synaptotagmin-1,1.07812179232185,2.93915402199295,2.40363609856814,3.59398262080662,8.14364289803561e-26
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39852136693446,SYT1;Synaptotagmin-1,0.223810764297618,1.25083429452437,1.15511428737859,1.35448626118975,3.58787365601502e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309837335398915,PTGDS;Prostaglandin-H2 D-isomerase,1.75423926355409,5.77904973555047,4.89386217816724,6.82434744381651,5.21702299195212e-95
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0397227353075532,PTGDS;Prostaglandin-H2 D-isomerase,1.99429620144306,7.3470303784746,4.76342038735181,11.3319528810762,1.87653475073817e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00697134004647,PTGDS;Prostaglandin-H2 D-isomerase,0.267793115379966,1.30707669797473,1.19364006291947,1.43129369351923,7.40961182839542e-09
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351546207471846,PTGDS;Prostaglandin-H2 D-isomerase,0.364535695464635,1.43984532621001,1.23611082310247,1.67715913869719,2.82600132571699e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309837335398915,PTGDS;Prostaglandin-H2 D-isomerase,0.377716380694921,1.45894909806204,1.23794215325372,1.71941190074314,6.5818664604792e-06
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.389282806014022,PTGDS;Prostaglandin-H2 D-isomerase,0.334911359991151,1.39781647726603,1.20657691378723,1.61936705550208,8.13351650232111e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.911636775308347,PTGDS;Prostaglandin-H2 D-isomerase,0.486156666810157,1.62605472506395,1.47534562097902,1.7921590245059,1.16566171586521e-22
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70410534469403,PTGDS;Prostaglandin-H2 D-isomerase,0.194358885327369,1.21453208249455,1.13211729277284,1.30294642509671,5.92355901243177e-08
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.36544916482949,PTGDS;Prostaglandin-H2 D-isomerase,0.365198597698384,1.44080011932529,1.23807023570787,1.67672634716145,2.35744097826601e-06
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56110349758684,PTGDS;Prostaglandin-H2 D-isomerase,0.355738154997361,1.42723378529772,1.32569739250208,1.53654694458642,3.4642755495288e-21
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.170807761822479,PTGDS;Prostaglandin-H2 D-isomerase,0.694746027392724,2.00320025133968,1.60515894134142,2.49994635647349,7.90210192584084e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39228187252974,PTGDS;Prostaglandin-H2 D-isomerase,0.26267446192398,1.3004033192445,1.20363038239322,1.40495688496973,2.78679443989764e-11
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242308685376075,PTGDS;Prostaglandin-H2 D-isomerase,0.573790930238048,1.77498315055641,1.47557674346415,2.13514152938105,1.14716038731295e-09
sensitivity,Circulatory system disorders,I95 (hypotension),0.522353969294325,PTGDS;Prostaglandin-H2 D-isomerase,0.327310265593331,1.38723182072039,1.2234692639848,1.57291415572751,3.27643360453511e-07
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.05251021666172,PTPRZ1;Receptor-type tyrosine-protein phosphatase zeta,1.06109683195581,2.88953859005063,1.92873453620255,4.32896964650762,2.6775285447904e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16567299719666,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,-0.253727954527089,0.775902854196186,0.729985678769918,0.824708287653322,3.57662354290296e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.908121767283926,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,-0.307442422833373,0.735325204270785,0.67030772214164,0.806649152583711,7.56574190825796e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294065404882669,STC2;Stanniocalcin-2,0.881548959777914,2.41463698679229,2.05494684446469,2.83728593451971,8.95915776028687e-27
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64066786397994,STC2;Stanniocalcin-2,0.236884055588915,1.26729417358014,1.19736192576416,1.34131083328475,2.85495703396766e-16
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69061951094357,STC2;Stanniocalcin-2,0.214016758798751,1.23864341279519,1.1805666810435,1.29957716806373,2.4404943246281e-18
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14529594031853,STC2;Stanniocalcin-2,0.360821273549508,1.43450705361196,1.34854209094561,1.52595198969244,2.52484027213727e-30
sensitivity,Circulatory system disorders,I50 (heart failure),0.897984961218891,STC2;Stanniocalcin-2,0.432597112951752,1.54125514386161,1.40134509640882,1.69513378579439,5.12332872701177e-19
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70518462965521,STC2;Stanniocalcin-2,0.214683442742422,1.23946947179997,1.15782481304047,1.32687134894768,6.61321447801705e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173676212279697,STC2;Stanniocalcin-2,0.642404608692944,1.90104666097247,1.53595903680506,2.35291327476544,3.54146915036142e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39927766484438,STC2;Stanniocalcin-2,0.276457611422285,1.31845106426785,1.22373885020318,1.42049360333734,3.63375244590542e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,RTBDN;Retbindin,1.31502480369153,3.72484337397147,3.1859535304713,4.35488403327926,4.12512060355746e-61
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,RTBDN;Retbindin,1.21836293106501,3.38164721015247,2.24094466278994,5.10299876824934,6.49373657999354e-09
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.998158160537104,RTBDN;Retbindin,0.209885441775971,1.233536740084,1.13013361178797,1.34640087974176,2.61841510030226e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.306973243815974,RTBDN;Retbindin,0.391844549853891,1.47970767274905,1.26679805201674,1.72840082387771,7.66858845210025e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,RTBDN;Retbindin,0.185596362860745,1.2039362089228,1.13417225070317,1.27799141114303,1.10223050226979e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,RTBDN;Retbindin,0.458744368859162,1.58208622058014,1.44510426747746,1.73205274226939,3.14011524157449e-23
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,RTBDN;Retbindin,0.185277576845021,1.20355247206379,1.11761446992507,1.29609860286435,9.49191717481164e-07
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.125559309652086,BGLAP;Osteocalcin,1.1055886100766,3.02100213787809,2.33256967441245,3.91261792399099,5.34618922914687e-17
sensitivity,Circulatory system disorders,I07 (rheumatic tricuspid valve diseases),0.0525066203999634,BGLAP;Osteocalcin,0.925419565369866,2.52292657094727,1.69010148276977,3.76613981307229,5.9733393288939e-06
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173500136973792,BGLAP;Osteocalcin,0.842887177878747,2.32306440395493,1.8634524696619,2.89603749641205,6.69689683286166e-14
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200894895443338,BGLAP;Osteocalcin,0.642637681574773,1.90148979503549,1.54569669768601,2.33918041361994,1.20196799976269e-09
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00447447721669,BGLAP;Osteocalcin,0.507895373270438,1.66179006416355,1.51378176325662,1.82426970940101,1.38815059106365e-26
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.404072687425805,BGLAP;Osteocalcin,0.712772562767667,2.03963845206179,1.76343926229978,2.35909742062995,7.91708391875784e-22
sensitivity,Circulatory system disorders,I33 (acute and subacute endocarditis),0.0479408273217057,BGLAP;Osteocalcin,1.08534071652415,2.96044832058484,1.96633461594785,4.4571530134147,2.00478289139154e-07
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554743859008309,BGLAP;Osteocalcin,0.50584712508102,1.65838978916576,1.46309909177949,1.87974738571142,2.50933834342995e-15
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.342434480869327,BGLAP;Osteocalcin,0.598203754109644,1.81884876475683,1.55080244398096,2.13322518409576,1.92358201030988e-13
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303625239704136,BGLAP;Osteocalcin,0.493783395614742,1.63850361528543,1.38195244205875,1.94268197341432,1.3207131731386e-08
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383526618573646,BGLAP;Osteocalcin,0.526938194986356,1.69373846448472,1.45563471511694,1.97078975671764,9.28308457257993e-12
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14592274678111,BGLAP;Osteocalcin,0.701182056047649,2.01613448345583,1.88741337920291,2.15363433372309,2.28723258953161e-96
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24874440690347,BGLAP;Osteocalcin,0.193285223993258,1.21322878613319,1.11447670998709,1.320731132658,8.11662108495028e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.90859282257328,BGLAP;Osteocalcin,0.66465483711475,1.94381947119561,1.75991159893318,2.14694541412737,3.01105719505479e-39
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66879737010318,BGLAP;Osteocalcin,0.243194252494072,1.2753163334371,1.18502012061023,1.37249294087421,8.53560468554045e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54780385352935,BGLAP;Osteocalcin,0.22968163668375,1.25819938163254,1.16535008728367,1.35844644559172,4.29902215849839e-09
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.143822481965117,BGLAP;Osteocalcin,0.605730841173507,1.83259105258056,1.43406188816858,2.34187240711575,1.28920130210459e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54542964112866,BGLAP;Osteocalcin,0.284430255830331,1.32900461974389,1.25259033178113,1.41008056224502,4.76982232647201e-21
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.202272032363525,SLITRK1;SLIT and NTRK-like protein 1,1.02519859246475,2.78764901168659,2.29924491856391,3.37979958099065,1.7747665789024e-25
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0188160030105604,SLITRK1;SLIT and NTRK-like protein 1,1.41677453298371,4.12379779216027,2.37269054197438,7.16726767767825,5.06963660160066e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1.72266314668601,5.59942070405641,4.7325334839572,6.6251009796974,1.26647077116491e-89
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1.93931566733358,6.95399049908949,4.50785629886344,10.7274901095714,1.81443942629605e-18
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354504584793931,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.512157655359388,1.66888819856919,1.40993839467618,1.97539681864128,2.62647400108913e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.538688531083516,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.405019624724003,1.49933192374324,1.30461331129976,1.72311304666666,1.1544038618691e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.306973243815974,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.587879732954111,1.80016753028932,1.49965684465224,2.1608964401849,2.8158256630121e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.317219906118249,1.37330453679214,1.27890300358475,1.47467426809345,2.54254819245649e-18
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.59807901466122,1.81862189671514,1.63216725148856,2.02637664748841,2.30537581000206e-27
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70914780266571,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.20461751032223,1.22705563907762,1.13339928957611,1.32845110742509,4.39129797124904e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.233772353699487,1.2633568609543,1.16236894117383,1.37311872468692,3.80617587874767e-08
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.123352445348013,SERPIND1;Heparin cofactor 2,-1.23214331393818,0.291666773811734,0.22654002186927,0.375516459492692,1.21242961501799e-21
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173607145304612,SERPIND1;Heparin cofactor 2,-0.568097859649617,0.566602171179155,0.452621813178209,0.70928534824841,7.14151948540142e-07
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0319802636087443,SERPIND1;Heparin cofactor 2,-1.53413727100634,0.215641651246403,0.133878983324457,0.34733847387815,2.82873145390152e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.397468990565822,SERPIND1;Heparin cofactor 2,-0.397986212100151,0.671671288534622,0.577885549120895,0.780677628170591,2.14098375921483e-07
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555086004066062,SERPIND1;Heparin cofactor 2,-0.52345964046291,0.592467274468437,0.522181079418916,0.672214075061223,4.49494628272987e-16
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.34264568152226,SERPIND1;Heparin cofactor 2,-0.811095489035575,0.444370995927801,0.379640979177605,0.52013769021886,5.65569590912793e-24
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14039335724238,SERPIND1;Heparin cofactor 2,-0.306053964258583,0.736346881970361,0.689822375872286,0.786009195340827,3.90087081129088e-20
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65840509856774,SERPIND1;Heparin cofactor 2,-0.270332883986524,0.763125419818562,0.708497778110507,0.821965042609385,9.786135667328e-13
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0525390045000799,SERPIND1;Heparin cofactor 2,-1.38799535863463,0.2495751120904,0.171017362314341,0.364218788852833,6.15612109346047e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.303270564915758,LY6D;Lymphocyte antigen 6D,1.76423163514469,5.83708562313181,4.93008496604775,6.9109495691077,3.55126569325432e-93
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396432111000991,LY6D;Lymphocyte antigen 6D,1.97553511068066,7.21047702493687,4.73379555273632,10.9829371268663,3.53653071084582e-20
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00495540138751,LY6D;Lymphocyte antigen 6D,0.235667938210041,1.26575393185869,1.15935952569086,1.38191215107412,1.43418595577609e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.358771060455896,LY6D;Lymphocyte antigen 6D,0.414160616792881,1.5131001366594,1.30683600534643,1.75191991511726,3.04319508705569e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1625371655104,LY6D;Lymphocyte antigen 6D,0.189849260681922,1.20906732993531,1.13829497689568,1.28423988332409,6.87412394902509e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.901883052527254,LY6D;Lymphocyte antigen 6D,0.504538759956271,1.65622142861536,1.5094921590752,1.81721342778305,1.56638527324389e-26
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55797819623389,LY6D;Lymphocyte antigen 6D,0.271674594453886,1.31215994770769,1.22247187932228,1.40842808533378,5.44281049102464e-14
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174430128840436,LY6D;Lymphocyte antigen 6D,0.528705190589417,1.69673393861962,1.37703414212008,2.09065699273897,6.92383633041377e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39345887016848,LY6D;Lymphocyte antigen 6D,0.229716704011516,1.25824350409628,1.16763233055622,1.35588633011412,1.7000627376827e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.308787664227834,CST3;Cystatin-C,1.65620796968725,5.23940514366379,4.51062811078383,6.08592984950829,3.63131183183973e-104
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393360081818897,CST3;Cystatin-C,1.90367814429771,6.71053140817949,4.61101148487809,9.7660203033205,2.68967452638856e-23
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65518055227755,CST3;Cystatin-C,0.218251922068261,1.24390039411047,1.1763243266774,1.31535849032264,1.88573944837507e-14
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00503500904728,CST3;Cystatin-C,0.317268443634467,1.37337119520107,1.25802138433992,1.49929759802746,1.35877816502615e-12
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354024073637007,CST3;Cystatin-C,0.567292599868095,1.76348611985319,1.52735524214093,2.03612310293686,1.03808433304901e-14
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542836912910078,CST3;Cystatin-C,0.441973924831438,1.55577517280533,1.38220867674988,1.7511367342946,2.42389868434335e-13
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.306820863818739,CST3;Cystatin-C,0.58881831873252,1.80185793510287,1.5419538917866,2.1055701052976,1.27390950295587e-13
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383526079773424,CST3;Cystatin-C,0.457289000476557,1.57978537700976,1.37136940606009,1.81987568512558,2.37349094179621e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16151364959483,CST3;Cystatin-C,0.283910759139044,1.32831438554395,1.24963941958019,1.41194258055314,7.94822420502559e-20
sensitivity,Circulatory system disorders,I50 (heart failure),0.914562190228935,CST3;Cystatin-C,0.673984928368415,1.9620403533109,1.79067035532483,2.14981073237349,2.37874051510748e-47
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70324915427582,CST3;Cystatin-C,0.261181668856986,1.29846353439415,1.21308766203146,1.38984807357443,5.20684630162202e-14
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55770592400283,CST3;Cystatin-C,0.331356675577307,1.3928565016177,1.29725177962225,1.49550709012219,6.6525494044042e-20
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.350090472818818,CST3;Cystatin-C,0.361655885823389,1.43570481056767,1.23842797986412,1.66440708430482,1.62297283834468e-06
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17111163559122,CST3;Cystatin-C,0.747437775792051,2.1115827310357,1.72010116454386,2.59216243899852,9.05229778456516e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3885610888207,CST3;Cystatin-C,0.282435323525046,1.32635598829272,1.23062031067416,1.42953938954268,1.47913149121195e-13
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.145543230272991,CST3;Cystatin-C,0.573867724544394,1.77511946439023,1.41602912197118,2.22527140435546,6.47213243390497e-07
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239949649909527,CST3;Cystatin-C,0.554766461476333,1.74153422194742,1.45997650355884,2.07739058732856,7.01091254607138e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55094013059554,CST3;Cystatin-C,0.217740022625965,1.24326380514112,1.17591013083351,1.31447535712474,1.82864528446538e-14
sensitivity,Circulatory system disorders,I95 (hypotension),0.521202108410038,CST3;Cystatin-C,0.353389748123384,1.42388599219431,1.26133825437375,1.60738113803882,1.10349989644381e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.196342549256866,IGSF9;Protein turtle homolog A,-0.594740535778308,0.551705695187362,0.451884704745454,0.673577067127393,5.20784874418854e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.193519458145517,RNASE4;Ribonuclease 4,1.19370883045331,3.29929506983954,2.72736192797458,3.99116371252981,1.02975555011596e-34
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.998277204823826,RNASE4;Ribonuclease 4,0.282876964350804,1.32694189061631,1.20615231443662,1.45982788408845,6.28135037806824e-09
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.389398909683052,RNASE4;Ribonuclease 4,0.583313609247244,1.79196648040605,1.54441139699446,2.07920238943326,1.47168740063564e-14
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552238453732329,RNASE4;Ribonuclease 4,0.351993936117365,1.42189990145831,1.25207168626777,1.61476323755377,5.82979137896259e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.302079154178368,RNASE4;Ribonuclease 4,0.557757796071851,1.7467515329859,1.47735720733527,2.06526959278316,6.73859684717651e-11
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.368158969154886,RNASE4;Ribonuclease 4,0.433768731876541,1.5430619658028,1.32292852976567,1.79982529421218,3.32445469854413e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.11455407924857,RNASE4;Ribonuclease 4,0.240457303565405,1.2718306300366,1.19082259519277,1.35834939480423,8.00825373450113e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.892077502182994,RNASE4;Ribonuclease 4,0.618012083967877,1.85523631962203,1.68192180639571,2.04641011761454,4.83728742253243e-35
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.63783541406084,RNASE4;Ribonuclease 4,0.249138861563397,1.28292016900179,1.19057888549663,1.38242344130353,6.27963260926408e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54579567177211,RNASE4;Ribonuclease 4,0.188728692772007,1.20771324669726,1.11834832652819,1.30421913427996,1.49670066275443e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39475609468293,RNASE4;Ribonuclease 4,0.234814825059081,1.26467456101174,1.16619212037579,1.37147363399681,1.37189803487571e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,MIA;Melanoma-derived growth regulatory protein,1.33705256683114,3.80780370228652,3.23760922941599,4.4784184896095,1.05214328382189e-58
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,MIA;Melanoma-derived growth regulatory protein,1.7084166643788,5.52021420273163,3.59416102220179,8.47840835616551,6.03181931579295e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.898050620971545,MIA;Melanoma-derived growth regulatory protein,0.32947392835783,1.39023657201865,1.26646222384915,1.52610767994638,4.35164873875508e-12
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55242886338626,MIA;Melanoma-derived growth regulatory protein,0.185553882106319,1.20388506589067,1.12156786200225,1.2922439211901,2.8244323693131e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,SCARA5;Scavenger receptor class A member 5,1.43966062820051,4.21926367489011,3.58854892927026,4.96083133019097,5.13087184759054e-68
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390846377831193,SCARA5;Scavenger receptor class A member 5,1.65070484219234,5.21065121998101,3.37263682383628,8.05034385688945,1.02723892512261e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,SCARA5;Scavenger receptor class A member 5,0.456335755999395,1.57828017285178,1.44011846002789,1.72969680839228,1.6211656004669e-22
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.195253480858185,BCHE;Cholinesterase,-0.652421667768702,0.520783084856875,0.421842280950205,0.64292991414262,1.28816160050923e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13616605843657,BCHE;Cholinesterase,-0.22360993818252,0.799626977498511,0.748512919563617,0.854231485431375,3.2516762325705e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.901885125868761,BCHE;Cholinesterase,-0.351295726341376,0.703775598095792,0.636417829204904,0.778262439777784,7.70571274068725e-12
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0534622626159317,BCHE;Cholinesterase,-1.16258281444234,0.312677548969765,0.212503631160587,0.460073313080743,3.63721527656476e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,ERBB2;Receptor tyrosine-protein kinase erbB-2,-0.525090296640248,0.591501951316437,0.503503941496368,0.694879482713397,1.66568873186627e-10
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.302625373368967,ERBB2;Receptor tyrosine-protein kinase erbB-2,0.431933232856435,1.54023227481857,1.3099061828073,1.81105753337892,1.72765793906223e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216160980977833,ERBB2;Receptor tyrosine-protein kinase erbB-2,1.42771580458544,4.16916511937802,2.48486567233361,6.99512170262084,6.39757581651389e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.29857461297777,EPHA2;Ephrin type-A receptor 2,1.77234557349061,5.88464004190968,4.98484000617225,6.94686055720323,2.67331126075346e-97
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0388556003190249,EPHA2;Ephrin type-A receptor 2,1.82390100224988,6.19598190581829,4.1726855843282,9.20035574245368,1.53455535366201e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00206548191169,EPHA2;Ephrin type-A receptor 2,0.325433913503753,1.38463132587978,1.26628986226049,1.51403242318085,9.38477374246298e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.905948996912002,EPHA2;Ephrin type-A receptor 2,0.45180444127245,1.57114466748091,1.43084772526042,1.72519795263637,2.87929285710749e-21
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.370150718828605,EPHA2;Ephrin type-A receptor 2,0.360132085767754,1.43351874948045,1.23893327222938,1.65866560465697,1.30826978635062e-06
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56649420233542,EPHA2;Ephrin type-A receptor 2,0.36548120116574,1.44120735197475,1.34157736211457,1.54823619572129,1.52858436776764e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345610339679748,EPHA2;Ephrin type-A receptor 2,0.571892691922867,1.77161700541483,1.52417639079904,2.05922807414017,9.27669965506494e-14
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.124746927340027,EPHA2;Ephrin type-A receptor 2,0.712015055891471,2.03809399695093,1.59080507073679,2.61114778725438,1.77898329188971e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173827685637743,EPHA2;Ephrin type-A receptor 2,0.725822164008349,2.06642934558635,1.67742646439133,2.54564377690909,9.04454278443663e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39471154829342,EPHA2;Ephrin type-A receptor 2,0.37946615654614,1.46150416670879,1.35454701773057,1.57690681928918,1.29089180621066e-22
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.235178633509887,EPHA2;Ephrin type-A receptor 2,0.605241824345264,1.83169510380143,1.52824124660809,2.19540400492181,5.77752541470293e-11
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56037955786416,EPHA2;Ephrin type-A receptor 2,0.258621068461405,1.29514294132463,1.22402080547757,1.37039765252074,2.84219071890944e-19
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0572608846806683,EPHA2;Ephrin type-A receptor 2,1.20950256769621,3.35181693577509,2.3758546584851,4.72868857142643,5.64571222614786e-12
sensitivity,Circulatory system disorders,I95 (hypotension),0.519438025317491,EPHA2;Ephrin type-A receptor 2,0.383171947630537,1.46693024356356,1.29628737277416,1.66003648934436,1.25734451360467e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0224953475531196,EPHA2;Ephrin type-A receptor 2,1.52174218690646,4.58019780888564,2.75134713396435,7.62470562494739,4.85243268217965e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.198353890700166,AFM;Afamin,-0.496757220398896,0.608500697436118,0.498186732096061,0.743241589799795,1.12979163767583e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304283373644378,IGFBP1;Insulin-like growth factor-binding protein 1,0.700227394241191,2.01421067530698,1.72965918357371,2.34557459819235,2.039653298122e-19
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16704376999297,IGFBP1;Insulin-like growth factor-binding protein 1,0.253084980966537,1.28799272705081,1.21408931911308,1.36639474445558,4.67852347297236e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.910899586486697,IGFBP1;Insulin-like growth factor-binding protein 1,0.3085960955927,1.36151233859659,1.24461391207962,1.48939026806584,1.61048808835505e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,1.30180148515595,3.67591280874947,3.21532247055387,4.20248205313006,5.54589666918774e-81
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039736151951045,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,1.42614644360784,4.1626273257514,3.00385108697498,5.76841719225895,1.05649533757447e-17
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.5855519351506,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.188068568150898,1.20691626852927,1.15731399190766,1.258644490109,1.58717769503033e-18
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63450687435428,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.31587665248476,1.37146107887616,1.29836534775607,1.4486719736651,1.25898053365147e-29
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68155447826432,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.292249065913367,1.33943658409376,1.27832874963046,1.40346555088228,1.36788947518725e-34
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01128506715409,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.315014985320263,1.37027984488546,1.25686952194408,1.49392345069759,8.88255556295765e-13
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.363585790352062,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.504510920049034,1.65617532020625,1.44040322483333,1.90427002937156,1.4017469848547e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552332512119526,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.315666071422046,1.37117230555086,1.22033999310449,1.54064728037532,1.10220611128396e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303981562425494,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.477746275821901,1.61243631739879,1.3830729856953,1.87983635322002,1.04390823419118e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383453866327584,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.434927531344651,1.54485110161264,1.34594731981787,1.77314883800707,6.21961791969889e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15965985853929,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.319932570500061,1.3770349084301,1.29702618434636,1.4619790732989,1.11769864956533e-25
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.688658352983438,1.99104246430448,1.82364138582918,2.17381011720194,2.64563774658653e-53
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71064134149248,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.252819444171899,1.28765076299458,1.20412133782174,1.37697459164699,1.48906042390218e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55567034888341,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.311902959137319,1.36602212663179,1.27360157745413,1.46514929274642,2.62982869871732e-18
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357625367559405,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.458789865921214,1.58215820249256,1.37253190217558,1.8238006517347,2.50682483104699e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.164905030596837,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.752040238374081,2.12132361036567,1.74296824113404,2.58181058822217,6.23681393346141e-14
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170865453389493,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.569641740078664,1.76763366568412,1.44464935376338,2.1628284870099,3.14304990398438e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39275212588412,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.38138659366378,1.4643135903554,1.36062741337976,1.57590113929378,2.47754679757722e-24
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150997377413971,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.634590414119849,1.88624940209643,1.52814597641026,2.3282702450109,3.46961101379256e-09
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236430104108718,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.603887435228135,1.8292159551319,1.54386838486659,2.16730327747352,2.97469013274439e-12
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55304776285464,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.195452253816313,1.21586073982603,1.15040293810629,1.28504308332504,4.44405633555732e-12
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0516569975363585,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.843693373183982,2.32493800271295,1.66271262601733,3.25091457891083,8.11557995331833e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.522530398156242,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.331674400722194,1.39329911746286,1.23620791406721,1.57035269604109,5.50450431063096e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0198680759755225,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,1.20316246154118,3.33063328484764,2.07733644953274,5.34006808604845,5.87481536552651e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,GGT5;Glutathione hydrolase 5 proenzyme,0.973276614246583,2.64660216198135,2.25543282095103,3.10561367145965,8.53099781354497e-33
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.363585790352062,GGT5;Glutathione hydrolase 5 proenzyme,0.434539565182564,1.54425186790846,1.33638342534645,1.78445331355449,3.8378382238606e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552332512119526,GGT5;Glutathione hydrolase 5 proenzyme,0.369272031111007,1.44668109241656,1.28663969524588,1.62662957694277,6.68288850933368e-10
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303981562425494,GGT5;Glutathione hydrolase 5 proenzyme,0.520616391203791,1.68306475634556,1.4386138222706,1.96905307748372,7.9295600015795e-11
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15965985853929,GGT5;Glutathione hydrolase 5 proenzyme,0.378911828924721,1.46069423908373,1.3757727435099,1.55085763267052,2.64615844673886e-35
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,GGT5;Glutathione hydrolase 5 proenzyme,0.588887881390552,1.80198328148989,1.64440297431797,1.97466423831777,1.79613861830575e-36
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71064134149248,GGT5;Glutathione hydrolase 5 proenzyme,0.254433286672493,1.28973050625947,1.20592604805104,1.3793588599107,1.14986484895577e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55567034888341,GGT5;Glutathione hydrolase 5 proenzyme,0.186340505188056,1.20483244223646,1.12302767738795,1.2925961159228,2.05521351873387e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39275212588412,GGT5;Glutathione hydrolase 5 proenzyme,0.202182586093308,1.22407148613933,1.13618974076935,1.31875068874039,1.0439228684086e-07
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0516569975363585,GGT5;Glutathione hydrolase 5 proenzyme,1.1158164379853,3.05205897913644,2.10112643376889,4.43336672292419,4.69096930035591e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,DPT;Dermatopontin,1.21635381167845,3.37485989772764,2.89040828752226,3.94050881270264,2.06151665810136e-53
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,DPT;Dermatopontin,1.63032220470274,5.10551947593333,3.39123347444718,7.68638588747821,5.71001321123583e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00681596884128,DPT;Dermatopontin,0.219953854221675,1.24601923073349,1.14202205766374,1.35948680932993,7.55721944115033e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387536514118792,DPT;Dermatopontin,0.347477098710193,1.41549189365341,1.22962022550652,1.62946026702932,1.31203997472832e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,DPT;Dermatopontin,0.364870149794473,1.44032696925297,1.31289930781839,1.58012253186778,1.16217310624393e-14
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352482960077896,DPT;Dermatopontin,0.395605083723334,1.48528263942488,1.28249282511571,1.72013790313245,1.27888691867587e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39435248296007,DPT;Dermatopontin,0.189365134905932,1.20848213094237,1.12210129489472,1.30151267755558,5.598816725853e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.905885923746818,GHR;Growth hormone receptor,-0.260638557585161,0.770559382131819,0.695668891965361,0.853512020228347,5.84230592722137e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14921286789869,LCAT;Phosphatidylcholine-sterol acyltransferase,-0.310834950488941,0.732834819916893,0.68650489297607,0.78229139919815,1.07237405801192e-20
sensitivity,Circulatory system disorders,I50 (heart failure),0.894364590463153,LCAT;Phosphatidylcholine-sterol acyltransferase,-0.2776096648735,0.75759247876391,0.685178286402535,0.837659883959688,6.10211447652807e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0524754734200319,LCAT;Phosphatidylcholine-sterol acyltransferase,-0.979744341092908,0.37540706274324,0.254587040296785,0.553564952062041,7.63624690999611e-07
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0574337036816984,"KRT18;Keratin, type I cytoskeletal 18",0.912907364187783,2.49155587363133,1.73970216444802,3.56834106336612,6.31446394716383e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0217851979482304,"KRT18;Keratin, type I cytoskeletal 18",1.65030490375391,5.20856769693714,3.08569904359501,8.79190649194684,6.47694071435416e-10
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.172301111045095,TAFA5;Chemokine-like protein TAFA-5,0.523273574590132,1.68754291506385,1.36421597361327,2.08750017978422,1.42164851629907e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,TAFA5;Chemokine-like protein TAFA-5,1.84764946428131,6.34488809495124,5.32963655230556,7.55353663281953,8.34482527374405e-96
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,TAFA5;Chemokine-like protein TAFA-5,1.90727328740368,6.73470014791619,4.42598915186346,10.2476948148971,5.33281447779129e-19
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63006753411363,TAFA5;Chemokine-like protein TAFA-5,0.221733052398296,1.24823811921268,1.18141615422333,1.31883959490964,2.81473329296124e-15
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67773750816944,TAFA5;Chemokine-like protein TAFA-5,0.188255489811637,1.20714188840852,1.15196141018154,1.26496558467254,3.12423969345366e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.998158160537104,TAFA5;Chemokine-like protein TAFA-5,0.253289904577118,1.28825669421646,1.17915074528012,1.40745813615143,2.02594791970861e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354504584793931,TAFA5;Chemokine-like protein TAFA-5,0.364038686101139,1.43912988740552,1.24072183998291,1.66926604020476,1.51125900375269e-06
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384211672905155,TAFA5;Chemokine-like protein TAFA-5,0.390620399102022,1.47789739574095,1.28249187952432,1.70307566637225,6.71705350123195e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,TAFA5;Chemokine-like protein TAFA-5,0.195188108826188,1.21553961871604,1.14437490080929,1.29112982434641,2.27985691892855e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,TAFA5;Chemokine-like protein TAFA-5,0.55233885847275,1.73731159574315,1.58297929023686,1.90669050398758,2.68185920107008e-31
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,TAFA5;Chemokine-like protein TAFA-5,0.283576556383399,1.32787053338837,1.23682696344628,1.4256158747769,5.0704536853015e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346582694630938,TAFA5;Chemokine-like protein TAFA-5,0.447733502612922,1.56476163519605,1.34714018811649,1.81753836503441,4.62694893507045e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172301111045095,TAFA5;Chemokine-like protein TAFA-5,0.561685039226256,1.75362493892029,1.41976647891198,2.16599030339117,1.86118340753293e-07
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.16635969342285,TAFA5;Chemokine-like protein TAFA-5,0.593028416114398,1.80945992380561,1.46057115220829,2.24168826757142,5.75398992670257e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,TAFA5;Chemokine-like protein TAFA-5,0.19238815001111,1.21214091817673,1.12487157939928,1.30618075203125,4.49881242551624e-07
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239637177430534,TAFA5;Chemokine-like protein TAFA-5,0.459557793028594,1.5833736512927299,1.32332814698675,1.8945203616478,5.15381527757864e-07
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6566918001885,AOC3;Membrane primary amine oxidase,0.211845365187987,1.23595674836125,1.16847870091462,1.30733156079268,1.40767392670387e-13
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68952246308514,AOC3;Membrane primary amine oxidase,0.18539646691107,1.20369557100304,1.14748645013639,1.26265807102134,3.00053689439195e-14
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543905120955073,AOC3;Membrane primary amine oxidase,0.324426258480956,1.3832367978891,1.22603125507871,1.56059972460625,1.35991434395121e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.30631479736098,AOC3;Membrane primary amine oxidase,0.408685875062078,1.50483893879495,1.28161673332854,1.76694028161772,6.07745024879359e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16187558906691,AOC3;Membrane primary amine oxidase,0.391913041809172,1.47980902429164,1.39135360006774,1.57388800968234,1.19627253021217e-35
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25078542255733,AOC3;Membrane primary amine oxidase,0.209164030485467,1.23264717366266,1.13795794117861,1.33521547656221,2.91287274579769e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.913053722902922,AOC3;Membrane primary amine oxidase,0.422386373035706,1.52559786070088,1.38907156409036,1.6755427817711,1.0425117121665e-18
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70633050581212,AOC3;Membrane primary amine oxidase,0.188333737756088,1.20723634847556,1.12726802675945,1.29287761781928,7.21094215173442e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.05105246622683,AOC3;Membrane primary amine oxidase,1.22152156272671,3.39234547514373,2.32775236654772,4.94382821304811,2.05820754347419e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301305657850686,SPON1;Spondin-1,1.17190382918637,3.22813260502117,2.76801295808618,3.76473675282423,1.89947732022477e-50
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393863605033576,SPON1;Spondin-1,1.79583680379209,6.02451394920912,3.96457537438228,9.15476813954391,4.04109324431451e-17
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63297819964946,SPON1;Spondin-1,0.23786749223832,1.26854109014724,1.20106850731091,1.3398040891063,1.46421450830665e-17
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67671675298844,SPON1;Spondin-1,0.204833841965342,1.22732111875501,1.17138132061662,1.28593234502758,7.57170899518338e-18
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00435219283562,SPON1;Spondin-1,0.340114387975533,1.40510830886615,1.28682521826415,1.53426380803133,3.43893259210462e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360385198605722,SPON1;Spondin-1,0.55992796735383,1.75054639926507,1.51382433993714,2.02428552318504,4.23728509961535e-14
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543531774946336,SPON1;Spondin-1,0.384006734126829,1.46815532839288,1.30403174960927,1.65293526705486,2.16822393756994e-10
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.382047696882569,SPON1;Spondin-1,0.420130005943118,1.52215943252837,1.32255420638987,1.75188988613149,4.68291624100823e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303274975875854,SPON1;Spondin-1,0.385440470161073,1.4702617852818,1.25610379799037,1.72093239485341,1.59645993754173e-06
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384017014907737,SPON1;Spondin-1,0.409005362951798,1.5053197934214,1.30884252622906,1.73129130132625,9.94805922881629e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16231119163433,SPON1;Spondin-1,0.463349331182373,1.58938846840194,1.49677685250104,1.68773033820505,1.0764762111804e-51
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25445558203194,SPON1;Spondin-1,0.255551109562914,1.29117300261936,1.19351343466588,1.39682359181805,1.91037019622626e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.901947655526891,SPON1;Spondin-1,0.632394237653918,1.88211141109309,1.71841410973113,2.06140262914919,2.97616226135329e-42
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70346009177021,SPON1;Spondin-1,0.239855625032627,1.2710656270152,1.18783729129953,1.36012553235471,3.87128781807449e-12
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55773055790779,SPON1;Spondin-1,0.219131561428428,1.24499505924194,1.16006748585507,1.3361401094647,1.21061778110517e-09
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356446562555387,SPON1;Spondin-1,0.396501880690211,1.48661523383487,1.28454077768369,1.72047854911626,1.04259387250279e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175269304239941,SPON1;Spondin-1,0.576372267533481,1.77957089947794,1.45088310560367,2.18272069888847,3.16288209232214e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39230784379369,SPON1;Spondin-1,0.294990700335724,1.34311386812014,1.24615012355007,1.44762242417268,1.20070507424034e-14
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151637487937927,SPON1;Spondin-1,0.62762637773261,1.87315912610807,1.50412781666583,2.33273068474969,2.06539680635024e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240256799070481,SPON1;Spondin-1,0.476853974110017,1.61099817943438,1.3510102730562,1.92101806026231,1.09455668568919e-07
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56011343271824,SPON1;Spondin-1,0.221355703892751,1.24776718728215,1.18009026034883,1.31932531431773,7.2532299617252e-15
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0531715866795328,SPON1;Spondin-1,1.35509812324082,3.87714137564579,2.70252101958172,5.56229725423973,1.85353804309996e-13
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216624982768467,SPON1;Spondin-1,1.52412213648276,4.59111143050347,2.63156887899616,8.00978622886745,7.98469163566302e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305367419645304,AMBP;Protein AMBP,1.56360401186546,4.77600303646313,4.10573833524841,5.55568892651434,2.56176100547845e-91
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0391496691852953,AMBP;Protein AMBP,1.64249451785988,5.16804522732758,3.52659283746081,7.57351151740385,3.64700900789343e-17
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00223153114356,AMBP;Protein AMBP,0.24794741002584,1.28139254202134,1.17449150067913,1.39802360919466,2.42393085655719e-08
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.379751791097365,AMBP;Protein AMBP,0.344542823418854,1.41134453848139,1.22610205400508,1.6245739086683,1.59126105600533e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.908272325098852,AMBP;Protein AMBP,0.266072606082781,1.30482979382773,1.19056173862339,1.43006509921036,1.26883272852114e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56207180049328,AMBP;Protein AMBP,0.256187586177215,1.29199506562473,1.20453040055123,1.38581080961904,7.88657055031507e-13
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.342559605371334,AMBP;Protein AMBP,0.394175891878114,1.48316140177761,1.27975019000029,1.71890401807436,1.62875682296799e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174216027874564,AMBP;Protein AMBP,0.574518830549552,1.77627563168625,1.44738332590623,2.17990290702492,3.8139422836961e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39960067337431,AMBP;Protein AMBP,0.205445225973247,1.22807171268676,1.14053962056812,1.32232156104332,5.16416427242705e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,IL12A_IL12B;Interleukin-12,0.896785900160639,2.4517103919808,2.09623064579345,2.8674725551832,3.22696421535379e-29
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,IL12A_IL12B;Interleukin-12,0.222903508579954,1.24969998259212,1.16403892813394,1.34166479208247,7.62176469097493e-10
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0512527351219223,CDHR5;Cadherin-related family member 5,-0.965894865444387,0.380642423536163,0.262086328813817,0.552827975618716,3.91900359638164e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.308278353754319,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.684530583415346,1.98284083866717,1.6943020310858,2.32051766411842,1.44509182934884e-17
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.56134150172792,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.190296777589269,1.20960852909643,1.15791508574057,1.26360975142408,1.34645345337325e-17
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6566918001885,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.267175146020247,1.30626921415041,1.23430410879317,1.38243018692167,2.44751038981566e-20
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68952246308514,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.257164667471184,1.29325806676216,1.23211273227884,1.35743782482633,2.31483835727348e-25
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16187558906691,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.241974310480802,1.27376147007614,1.19679067164744,1.35568259436474,2.76703283980599e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.913053722902922,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.329853511337788,1.39076438232707,1.26522940430075,1.52875483337236,8.25534340230027e-12
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.365221489161168,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.40900122967612,1.50531357153257,1.29831692618686,1.74531264511451,5.99750424217656e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55710021991831,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.297889923635469,1.34701350536885,1.25229800493564,1.44889265693539,1.16679999652266e-15
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.170829406220546,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.543517169912127,1.72205297626201,1.39165095620357,2.13089815361653,5.71322566411846e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39019792648444,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.209370589205508,1.2329018139833,1.14127858687876,1.33188066472046,1.0721138147543e-07
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5526233113415,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.191667992606153,1.21126830016753,1.14373130055163,1.28279333990693,5.83775442331602e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,OPTC;Opticin,0.979918320660648,2.66423861979158,2.30610044002264,3.0779957802355,2.18706558153793e-40
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,OPTC;Opticin,1.33301170594668,3.79244794338779,2.62800120321741,5.47285190954169,1.05554849692542e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,OPTC;Opticin,0.189403744185566,1.20852879046764,1.12092625110766,1.30297763652686,8.08428500027529e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15252996614511,BPIFB2;BPI fold-containing family B member 2,-0.236183561282209,0.789635714084546,0.739227429905459,0.843481364101375,2.26014467285587e-12
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.11489776046738,NOTCH3;Neurogenic locus notch homolog protein 3,0.69655021055881,2.00681765375847,1.56239608333652,2.57765437227432,4.93427213250197e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.171372930866601,NOTCH3;Neurogenic locus notch homolog protein 3,0.520841771545874,1.68344412880604,1.3706903728935,2.06755966982465,6.80352612138549e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,NOTCH3;Neurogenic locus notch homolog protein 3,0.826224977307487,2.28467773024474,1.96913999473865,2.65077767199027,1.21153777081052e-27
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65433300876338,NOTCH3;Neurogenic locus notch homolog protein 3,0.188893705106608,1.20791255072299,1.14361791743709,1.27582185269004,1.29973428337627e-11
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6981499513145,NOTCH3;Neurogenic locus notch homolog protein 3,0.189420170517526,1.20854864232578,1.15348487278771,1.26624098445051,1.70196802935408e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00681596884128,NOTCH3;Neurogenic locus notch homolog protein 3,0.286464593108618,1.33171101531218,1.22085888720447,1.45262834787127,1.04529258522961e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356377799415774,NOTCH3;Neurogenic locus notch homolog protein 3,0.511581587530552,1.66792708262864,1.44514311860565,1.92505553059013,2.68100864810836e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543330087633885,NOTCH3;Neurogenic locus notch homolog protein 3,0.428853885041676,1.53549665897511,1.36654992086712,1.7253303035045,5.5575218140451e-13
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.37585199610516,NOTCH3;Neurogenic locus notch homolog protein 3,0.380095500283617,1.46242424469569,1.2710539104383,1.68260736536052,1.08554671242328e-07
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0584225900681596,NOTCH3;Neurogenic locus notch homolog protein 3,0.853408084759277,2.34763416970103,1.67028178827302,3.29967448214011,8.94427600829314e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387536514118792,NOTCH3;Neurogenic locus notch homolog protein 3,0.415133293146149,1.51457260938607,1.3198830520092,1.73797988057394,3.34811416231694e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16553067185978,NOTCH3;Neurogenic locus notch homolog protein 3,0.609397754440062,1.83932334083833,1.73367155833612,1.95141365495987,1.18566672899751e-90
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25803310613437,NOTCH3;Neurogenic locus notch homolog protein 3,0.237050518219276,1.26750514826093,1.17235283506369,1.37038036060251,2.62214558767525e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,NOTCH3;Neurogenic locus notch homolog protein 3,0.496951253944772,1.64370239275954,1.50262507550759,1.79802506959415,1.91015603698743e-27
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7078870496592,NOTCH3;Neurogenic locus notch homolog protein 3,0.249776876168639,1.28373895197694,1.20040114503912,1.37286248320694,3.0180336779138e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39435248296007,NOTCH3;Neurogenic locus notch homolog protein 3,0.223892563627994,1.25093661611694,1.1614260131391,1.34734576274269,3.41008177742966e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56085686465433,NOTCH3;Neurogenic locus notch homolog protein 3,0.237113969983465,1.26758557625032,1.19953522218324,1.33949646780144,3.6950797922023e-17
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.050632911392405,NOTCH3;Neurogenic locus notch homolog protein 3,1.36038118509234,3.8976787556972,2.75922908066157,5.5058493653491,1.1744572360257e-14
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,EGLN1;Egl nine homolog 1,0.450186254574618,1.56860431801381,1.34288075360547,1.83226954432505,1.35446027601693e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16567299719666,EGLN1;Egl nine homolog 1,0.196695646015252,1.21737347184963,1.14635317770974,1.29279370335419,1.42191454363331e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.900225056264065,EGLN1;Egl nine homolog 1,0.341152011342204,1.40656703875536,1.28316247783178,1.54183968803084,3.29408309180791e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300312089033701,AGRN;Agrin,1.52578970358305,4.59877380386399,3.94064834359584,5.36681242655807,1.5868259304749e-83
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392564822266276,AGRN;Agrin,1.74243667666569,5.71124293387654,3.85113139879228,8.4697956190183,4.46520329525112e-18
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.62822148507272,AGRN;Agrin,0.200886151917784,1.22248558626094,1.15762971487006,1.2909749891687,5.09049699333472e-13
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00496594500166,AGRN;Agrin,0.261968298816735,1.29948534655328,1.19084709497548,1.41803441687152,4.07311884940129e-09
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361159636484974,AGRN;Agrin,0.443517085382143,1.55817783704931,1.34846933989968,1.80049935139963,1.8121622284778e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543702278838793,AGRN;Agrin,0.334995701948629,1.39793437681579,1.24214020263935,1.57326887716132,2.74912993938631e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304237737256364,AGRN;Agrin,0.446343727326506,1.56258847859577,1.3360390505949,1.82755343292774,2.3357681742205e-08
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388639174043613,AGRN;Agrin,0.365399766282719,1.44108999220129,1.2538780042548,1.6562539246846,2.6548726070555e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15910652246452,AGRN;Agrin,0.244792437337057,1.27735615424238,1.20310918540997,1.35618509489219,1.12860721998692e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,AGRN;Agrin,0.578136703946148,1.78271361091381,1.62684947027534,1.95351068221418,3.14821801409883e-35
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70373132863564,AGRN;Agrin,0.219369278984506,1.24529105160465,1.16430758535019,1.3319073264821,1.61507728533658e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55259387206312,AGRN;Agrin,0.234098324713579,1.26376874579903,1.17792601437033,1.35586736634916,6.90680268084179e-11
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35527116415098,AGRN;Agrin,0.494538076166184,1.63974062881367,1.4178116430629,1.89640799110222,2.64303015068566e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174691345908493,AGRN;Agrin,0.611221925709084,1.84268164375972,1.50174325687232,2.26102273122289,4.76066021085847e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39360511904528,AGRN;Agrin,0.311726050979168,1.36578048754797,1.26793991533751,1.47117092663672,2.04463884813947e-16
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239464541582428,AGRN;Agrin,0.46655956719968,1.59449897909253,1.33651602668104,1.90227946659248,2.20511423013192e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.522111213614148,AGRN;Agrin,0.367699107160516,1.44440736174907,1.28019909403868,1.62967825581971,2.34897122858255e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.287064170803181,VWC2;Brorin,1.63810308194554,5.14539984716967,4.35816241446849,6.07484005170617,2.72781074748624e-83
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0398700237226641,VWC2;Brorin,1.77452564460847,5.89748296986566,3.93473791156744,8.83929404233187,8.36779468564859e-18
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.58903973047864,VWC2;Brorin,0.22379423026769,1.25081361336369,1.19865447685132,1.3052424410792,7.21219320293773e-25
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63142156569583,VWC2;Brorin,0.334077222724457,1.39665099260501,1.32144275858563,1.47613960761522,2.759578977193e-32
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68399019197416,VWC2;Brorin,0.331520094835981,1.39308413979436,1.32872940842381,1.46055578227076,6.00772541774347e-43
sensitivity,Circulatory system disorders,I50 (heart failure),0.899069034946075,VWC2;Brorin,0.525095239772778,1.69061985496269,1.5409346169795,1.85484540518444,1.23492430427836e-28
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71042401770229,VWC2;Brorin,0.22657751953531,1.25429983880592,1.17103968173916,1.34347973869855,1.00990027604864e-10
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.364810717062376,VWC2;Brorin,0.367044358351041,1.44346194728684,1.24725763230489,1.6705308825529,8.47585765358585e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55692442637003,VWC2;Brorin,0.350359963569783,1.41957845316181,1.32139789610782,1.5250538771229,9.578837870992e-22
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.358830213503977,VWC2;Brorin,0.415845094230936,1.51565106759074,1.30712854295765,1.75743860163214,3.65875172136267e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.165460598449056,VWC2;Brorin,0.76531903191057,2.14968008181178,1.74129432344796,2.65384455224546,1.08364329098375e-12
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171441102007455,VWC2;Brorin,0.560612769897284,1.75174558844876,1.42246469665331,2.15725044977872,1.31333356211077e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39545083029324,VWC2;Brorin,0.203044459141029,1.2251269351279,1.13524216951816,1.32212848278261,1.76356694159229e-07
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151506090146123,VWC2;Brorin,0.593457139745178,1.8102358483506,1.44733195801211,2.26413422885685,2.00581583380999e-07
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.237226641149851,VWC2;Brorin,0.466306711553077,1.59409585199079,1.33102973349545,1.90915463523184,4.03059118557761e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.524290811953033,VWC2;Brorin,0.423258647897572,1.52692918191869,1.3497868357859,1.72731920684155,1.72694735294845e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200789148046975,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,1.44467236363944,4.24046258546954,3.41184283975171,5.27032568126015,9.02821140194193e-39
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40391305362938,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,0.392608367148377,1.4808383308134,1.27360368780511,1.7217931943848,3.32201401240545e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.905885923746818,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,0.382650110770715,1.46616494498955,1.32318842900758,1.62459072252354,2.68463876581583e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,NPY;Pro-neuropeptide Y,0.498218136323962,1.64578608997852,1.40344913760629,1.92996794923865,8.76333362822269e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,PALM2;Paralemmin-2,1.01756810546424,2.76645884061855,2.32057839798022,3.29801161792155,7.6040506038677e-30
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.54068529835885,PALM2;Paralemmin-2,0.185978719470926,1.20439662990741,1.13558517332814,1.27737775747903,5.79348364301969e-10
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00254068529835,PALM2;Paralemmin-2,0.241185514419152,1.27275712820759,1.15993278275647,1.39655567243617,3.53142452795316e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.400558492984504,PALM2;Paralemmin-2,0.406146753670261,1.50102281690284,1.30086185332122,1.73198214023313,2.66689727346133e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.556204078829911,PALM2;Paralemmin-2,0.355758572307121,1.4272629258695,1.2630760301686,1.61279242967633,1.15928482372617e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309002266016617,PALM2;Paralemmin-2,0.514586385202638,1.67294640328871,1.42824469788339,1.95957294462516,1.79766002741946e-10
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.382247247590926,PALM2;Paralemmin-2,0.379387205729192,1.46138878431568,1.26304374644287,1.69088140053607,3.43545772283097e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14699352239694,PALM2;Paralemmin-2,0.298779111312751,1.34821178584813,1.26555869668799,1.43626291238542,2.1187393414595e-20
sensitivity,Circulatory system disorders,I50 (heart failure),0.908695552656275,PALM2;Paralemmin-2,0.513072043680095,1.67041490834295,1.52168925179415,1.83367659508963,4.1043019546263e-27
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65945661379294,PALM2;Paralemmin-2,0.240628746333852,1.2720486948931,1.18336284271074,1.36738101263397,6.75525474883921e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54730023575728,PALM2;Paralemmin-2,0.238336259694905,1.26913588032589,1.17778980377804,1.36756650258293,4.00833780882064e-10
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.123600906406646,PALM2;Paralemmin-2,0.64274467179315,1.90169324672738,1.48953488625124,2.42789694825486,2.50934831734826e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.164801208542196,PALM2;Paralemmin-2,0.545181654077555,1.72492169297749,1.39265935930151,2.13645557115749,5.91591952477076e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39852136693446,PALM2;Paralemmin-2,0.242418409121104,1.27432727143958,1.17775108739834,1.37882275135221,1.65289304624707e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.52924076998786,PALM2;Paralemmin-2,0.196720753015214,1.21740403682903,1.14723413083077,1.29186584417114,8.32366271999434e-11
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0526448305065348,PALM2;Paralemmin-2,0.984413089592808,2.67624070987202,1.90116094617354,3.76731089053338,1.67682426089431e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0183112453935773,PALM2;Paralemmin-2,1.40866261547993,4.090481198094,2.44182074854782,6.85227875220213,8.72380829123542e-08
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.62575571976133,IL1RN;Interleukin-1 receptor antagonist protein,0.253456514556532,1.28847134851904,1.22044222668318,1.36029250681233,5.28134789610203e-20
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67289682696487,IL1RN;Interleukin-1 receptor antagonist protein,0.214386561711334,1.23910155144217,1.18298827989437,1.29787647171238,1.22362856123554e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.898960761844549,IL1RN;Interleukin-1 receptor antagonist protein,0.343817243481431,1.41032086662227,1.2892570089987,1.54275286692058,5.99468587126864e-14
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55885723317659,IL1RN;Interleukin-1 receptor antagonist protein,0.204470192975337,1.22687488581076,1.14422602001847,1.31549358177404,9.12390698875684e-09
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17188920061643,IL1RN;Interleukin-1 receptor antagonist protein,0.492642942606313,1.6366360440491,1.34437841059753,1.99242826243405,9.17623702289703e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3909195084364,IL1RN;Interleukin-1 receptor antagonist protein,0.247630296900505,1.28098626004963,1.19038390762772,1.37848452748836,3.67908834272416e-11
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239064290512506,IL1RN;Interleukin-1 receptor antagonist protein,0.442636343319199,1.55680608845369,1.31473303981598,1.84345043719727,2.84618873341237e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.172759040402057,COL18A1;Collagen alpha-1(XVIII) chain,0.639383377885876,1.89531182772432,1.53807566758049,2.33552028682862,1.96965607677098e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30429149161726,COL18A1;Collagen alpha-1(XVIII) chain,1.64622837660662,5.18737804875433,4.41357426125517,6.09684791234161,9.41354177288154e-89
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392634182731948,COL18A1;Collagen alpha-1(XVIII) chain,1.64633782788998,5.18794584501149,3.44451950432309,7.81379871909341,3.30711597810989e-15
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65028073344065,COL18A1;Collagen alpha-1(XVIII) chain,0.205498177276169,1.22813674240572,1.16279736364046,1.29714764172213,1.74070249548999e-13
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70254034316227,COL18A1;Collagen alpha-1(XVIII) chain,0.189242753474744,1.2083342442191,1.15341024945571,1.26587365288417,1.54682486824604e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00710667870744,COL18A1;Collagen alpha-1(XVIII) chain,0.273543941464549,1.31461512405678,1.20461096140278,1.43466478371266,8.50654010963998e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.353370764458753,COL18A1;Collagen alpha-1(XVIII) chain,0.651853340726109,1.91909427069679,1.65826708898566,2.22094670049445,2.21161860192774e-18
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541835172170089,COL18A1;Collagen alpha-1(XVIII) chain,0.469349679869879,1.59895402304389,1.42002811421072,1.80042489456575,9.07251829459139e-15
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.308217833444579,COL18A1;Collagen alpha-1(XVIII) chain,0.620786500797176,1.86039066533502,1.59097321886954,2.17543160790909,7.39622877281918e-15
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388707840904629,COL18A1;Collagen alpha-1(XVIII) chain,0.514247071363635,1.67237884571767,1.45417352621474,1.92332686105508,5.6304802108859e-13
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17323020142133,COL18A1;Collagen alpha-1(XVIII) chain,0.347858760857412,1.41603223643655,1.33337562484006,1.50381277208964,8.72431208760266e-30
sensitivity,Circulatory system disorders,I50 (heart failure),0.908948133024461,COL18A1;Collagen alpha-1(XVIII) chain,0.726623491567516,2.06808589600114,1.88574724567641,2.26805542632767,1.03265133447534e-53
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70992186579763,COL18A1;Collagen alpha-1(XVIII) chain,0.283781578271054,1.32814280382143,1.24163691523473,1.42067563045127,1.47814994806378e-16
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.357297106286073,COL18A1;Collagen alpha-1(XVIII) chain,0.411885350339218,1.50966134424544,1.3046406846843,1.74690043094928,3.18553427806977e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56072087635949,COL18A1;Collagen alpha-1(XVIII) chain,0.308726516554198,1.36168991992479,1.26901288938421,1.46113522844085,9.12803631320917e-18
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351407593545094,COL18A1;Collagen alpha-1(XVIII) chain,0.376215557510566,1.45676111572888,1.25727059018117,1.68790470792277,5.5331511312359e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.170795869488397,COL18A1;Collagen alpha-1(XVIII) chain,0.730084947071884,2.07525688718277,1.68420828571832,2.55710127085778,7.20589415583512e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39385134869841,COL18A1;Collagen alpha-1(XVIII) chain,0.241438506789853,1.27307916678572,1.18175515846862,1.37146053756519,2.05552314425917e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55801170049864,COL18A1;Collagen alpha-1(XVIII) chain,0.188631731345016,1.20759615077445,1.14262959918039,1.27625650903084,2.29942501321431e-11
sensitivity,Circulatory system disorders,I95 (hypotension),0.518277121206172,COL18A1;Collagen alpha-1(XVIII) chain,0.367290032268548,1.44381661180233,1.27862914189651,1.63034482807455,3.12629441858424e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288568699251711,LAYN;Layilin,1.91616401549257,6.79484349861121,5.72025427650434,8.07130171822249,1.64147567409066e-105
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0398025792071326,LAYN;Layilin,1.98488309177218,7.2781964546648,4.82098215247275,10.9878323456404,3.56619980125474e-21
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63294061455182,LAYN;Layilin,0.247791956059347,1.28119335995027,1.21317490635648,1.35302536920288,5.44067674293827e-19
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68372870562012,LAYN;Layilin,0.220586060990256,1.24680722158527,1.19009682496628,1.30621997738817,1.5812417317254e-20
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01297564082152,LAYN;Layilin,0.348689778725112,1.41720947361108,1.2983947421771,1.54689681562114,5.94741088715216e-15
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0597038688106989,LAYN;Layilin,0.945442001356321,2.57395081694735,1.81875146166063,3.64273126247535,9.51952288219632e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.302499601974207,LAYN;Layilin,0.391798712819173,1.47963984889151,1.26435781308649,1.73157792815248,1.04026664285931e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15530966406623,LAYN;Layilin,0.231263619112196,1.26019140620425,1.18665282459239,1.33828727944633,4.753615233795e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.899538290081197,LAYN;Layilin,0.594382285474443,1.81191135523918,1.65474251131837,1.98400822894738,9.91865959774109e-38
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70952077694634,LAYN;Layilin,0.20767372440796,1.23081152027078,1.15034308306816,1.31690886026001,1.74420418035985e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55628084699888,LAYN;Layilin,0.348487561594957,1.41692291855264,1.32049480099246,1.52039262525745,3.29688974221729e-22
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.358223212864193,LAYN;Layilin,0.462312564600532,1.58774149746208,1.37333004475916,1.83562798497226,4.21408492596253e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.1651807037096,LAYN;Layilin,0.61724341228627,1.85381079994895,1.50517031114653,2.28320639635097,6.36753995224579e-09
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.105476834898901,LAYN;Layilin,0.650332620341307,1.91617808283414,1.47208923226203,2.49423633069572,1.33448452097418e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39508040120999,LAYN;Layilin,0.365880090209406,1.44178234846938,1.33780988614091,1.5538353856498,9.59842881610214e-22
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236825346282439,LAYN;Layilin,0.490144704389697,1.63255244036843,1.36798074737325,1.94829311426391,5.53040031752391e-08
sensitivity,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0119407737621397,LAYN;Layilin,1.77254215575246,5.88579697147148,2.87118681174189,12.065605013129,1.29942913667568e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55333545613755,LAYN;Layilin,0.214628728458003,1.23940165697,1.17203574580588,1.31063960531662,5.18724029651142e-14
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0517433529692724,LAYN;Layilin,0.989703644124589,2.69043702737086,1.84910710597214,3.91456577873169,2.3067921972761e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.523403916573794,LAYN;Layilin,0.3766936299676,1.45745771959508,1.29099789726166,1.64538068490499,1.14538504429723e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,RGMB;RGM domain family member B,1.9046338376185,6.71694768373269,5.59926151350096,8.05773869950792,1.7115109509665e-93
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390846377831193,RGMB;RGM domain family member B,2.32376894444875,10.214098220577,6.24385222342,16.708883991244,2.16461598750704e-20
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.57190474729325,4.81581236886003,4.12658119733395,5.62016053071945,1.60122939902671e-88
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.76613209404265,5.84818931215275,3.91211372672453,8.74241410650737,7.32700779288926e-18
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64693129409909,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.194653403935222,1.21488983747284,1.15019399866615,1.28322467245213,3.13017950823539e-12
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69348417359769,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.203104638766804,1.22520066502688,1.16942066598514,1.28364130483169,1.30618755476322e-17
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.282469337978712,1.32640110433433,1.21547079249155,1.4474555048525,2.31345784770689e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.466944003134857,1.59511207964008,1.45524847725859,1.74841794124865,2.00141904266089e-23
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70286570223501,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.195336024400212,1.21571942925456,1.13660011400562,1.30034628050347,1.27643894281171e-08
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.364618234853561,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.382471234876093,1.46590270687809,1.26973169367416,1.69238175020616,1.80983520086451e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.411031725852212,1.5083732102245,1.40595963881033,1.61824683904023,2.15233499925554e-30
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348850959832866,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.489315383178666,1.63119909125964,1.40935465586932,1.88796373165917,5.36181979152123e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17344002522764,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.660917412155587,1.9365681508614,1.57798008417043,2.37664355878252,2.51694525653563e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.438803501354578,1.55085051741932,1.44060900122105,1.66952818241536,1.95791708930407e-31
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240450944065591,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.582319048217664,1.79018514634787,1.50296039576603,2.13230027034155,6.74397359320534e-11
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56415310024045,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.228979367053485,1.25731609660643,1.189935325699,1.32851234234684,3.70207024991899e-16
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0492727344396704,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.15062478830474,3.16016672822902,2.19914912816206,4.54114440094932,4.96319798060947e-10
sensitivity,Circulatory system disorders,I95 (hypotension),0.516378256927746,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.356734740553447,1.42865685486081,1.26590966505525,1.61232706036073,7.42167065831513e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197090937758681,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.53144396784562,4.62485013800372,2.70012791805021,7.92156499549783,2.43811483328176e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.997958291879449,2.71273755219884,2.34087517289608,3.14367255132422,3.60899823756799e-40
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",1.00136637805595,2.7219985677566,1.83435592401381,4.03917042809037,6.59820581580399e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.412748984701749,1.51096570282149,1.38039900069478,1.65388221373223,3.51781577616862e-19
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.183776785496784,1.20174754567431,1.12045069519803,1.28894307417871,2.71405738248718e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",0.227118155774786,1.2549781420951,1.16623573082902,1.35047323238578,1.28037218692295e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,CCL15;C-C motif chemokine 15,1.19950440629244,3.31847190134609,2.83359868291664,3.88631453932232,4.2047957658557e-50
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,CCL15;C-C motif chemokine 15,1.41072693920995,4.09893399715352,2.65176365951738,6.33588134927483,2.16810045751969e-10
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65433300876338,CCL15;C-C motif chemokine 15,0.215729671550378,1.24076691906296,1.17433006248112,1.31096239177283,1.55125494589703e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,CCL15;C-C motif chemokine 15,0.463633527109994,1.58984023032348,1.45040404116296,1.74268127102592,4.17612735208505e-23
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39435248296007,CCL15;C-C motif chemokine 15,0.18666013477693,1.20521760388588,1.11986684523746,1.29707337876265,6.32967236562654e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297685344565723,NEFL;Neurofilament light polypeptide,1.17152799679635,3.22691959618719,2.83489161629368,3.67315985570934,2.56838727486164e-70
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0405014074239079,NEFL;Neurofilament light polypeptide,1.27527029755724,3.57966885509394,2.6196814803729,4.89144547080798,1.18901176560347e-15
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.364512666815171,NEFL;Neurofilament light polypeptide,0.349211757061757,1.41794941935582,1.2316893352122,1.6323763617756,1.17248799159295e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15872501569429,NEFL;Neurofilament light polypeptide,0.221711855624933,1.24821166087258,1.17661220456374,1.32416810253636,1.89274863747281e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.897106174439561,NEFL;Neurofilament light polypeptide,0.385423348102657,1.47023661158914,1.34612926556368,1.60578612274057,1.07357050057529e-17
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.370587877928758,NEFL;Neurofilament light polypeptide,0.458633678677691,1.58191110886103,1.38207996862507,1.81063528388118,2.8064405782433e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55120390433567,NEFL;Neurofilament light polypeptide,0.264311860337836,1.30253434176713,1.21543042088734,1.39588057228658,7.17204810920838e-14
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.350337174216804,NEFL;Neurofilament light polypeptide,0.482204187328856,1.61964046160038,1.40923180259658,1.86146467885528,1.10965731817928e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.176181122293999,NEFL;Neurofilament light polypeptide,0.529294684328804,1.69773444752174,1.40327624624902,2.05398064850479,5.14890404097638e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39324841538243,NEFL;Neurofilament light polypeptide,0.314033906066047,1.36893615100005,1.27253015163537,1.47264580183544,3.50564808175481e-17
sensitivity,Circulatory system disorders,I95 (hypotension),0.528543366881999,NEFL;Neurofilament light polypeptide,0.332065473961209,1.39384410601991,1.2395473058325,1.56734751690791,2.8967157642882e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300312089033701,IL10RB;Interleukin-10 receptor subunit beta,1.49270827382843,4.44912867585891,3.80727711515866,5.19918707664787,1.12189374569982e-78
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392564822266276,IL10RB;Interleukin-10 receptor subunit beta,1.5891750810911,4.89970540113147,3.32107710611419,7.22871292981397,1.15310335601946e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00496594500166,IL10RB;Interleukin-10 receptor subunit beta,0.232689177182741,1.26198916333294,1.15632983555395,1.37730308377524,1.82995690944513e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,IL10RB;Interleukin-10 receptor subunit beta,0.272849107302293,1.31370200182936,1.19782581316516,1.44078790976306,6.98441608070366e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55259387206312,IL10RB;Interleukin-10 receptor subunit beta,0.235736468592436,1.26584067743198,1.17956860580342,1.3584225730983,5.92781417385172e-11
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35527116415098,IL10RB;Interleukin-10 receptor subunit beta,0.359759703199383,1.43298503146652,1.23798934915275,1.65869448054011,1.43120017954142e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39360511904528,IL10RB;Interleukin-10 receptor subunit beta,0.251171890965702,1.28553103651211,1.19330645409979,1.38488318751497,3.76939428420166e-11
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0529962510059473,IL10RB;Interleukin-10 receptor subunit beta,0.973370288372935,2.64685009173879,1.84673677538082,3.7936188316242,1.15740820023292e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.522111213614148,IL10RB;Interleukin-10 receptor subunit beta,0.361490974751216,1.43546806646943,1.27191935970643,1.62004654943619,4.70748109044512e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215910652246452,IL10RB;Interleukin-10 receptor subunit beta,1.53740438612953,4.65249849535971,2.81652877740413,7.68525513496591,1.92858936799322e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.898292332596156,LGALS3BP;Galectin-3-binding protein,0.246842097277992,1.27997698497039,1.16029235953962,1.41200712784486,8.29915765478926e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301798958497711,MEPE;Matrix extracellular phosphoglycoprotein,1.45639885072581,4.29048101226598,3.63837820469217,5.05945953965838,3.65427444146639e-67
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394508442480669,MEPE;Matrix extracellular phosphoglycoprotein,1.85647448630482,6.40112967369932,4.10247568832326,9.98774013850666,2.86647330753485e-16
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.175690784219773,IGFBP4;Insulin-like growth factor-binding protein 4,0.553915499519049,1.74005287295244,1.41510027404335,2.13962505428594,1.50509067414382e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.295479955278709,IGFBP4;Insulin-like growth factor-binding protein 4,1.80318622032647,6.06895371478264,5.1826015854723,7.10689382248114,5.46576889170076e-111
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0379332375019964,IGFBP4;Insulin-like growth factor-binding protein 4,1.99943589232751,7.38488905113511,4.97286857912751,10.9668263759231,3.76441705407805e-23
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64135122184954,IGFBP4;Insulin-like growth factor-binding protein 4,0.243623498986684,1.27586387600716,1.20699529133435,1.34866195567376,7.62388894658889e-18
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69948889953681,IGFBP4;Insulin-like growth factor-binding protein 4,0.234677880764323,1.26450138290403,1.2062650116851,1.32554930456992,1.74828173020024e-22
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.998243092157802,IGFBP4;Insulin-like growth factor-binding protein 4,0.340078237563169,1.40505751453949,1.28638671482767,1.53467584545784,4.23231026107706e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361363999361124,IGFBP4;Insulin-like growth factor-binding protein 4,0.630700311284828,1.87892595167282,1.62802911007763,2.16848870208548,6.43775795691215e-18
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.551030186871106,IGFBP4;Insulin-like growth factor-binding protein 4,0.428086090297373,1.53431816518901,1.36339774294947,1.72666578348313,1.21143991244979e-12
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0578980993451525,IGFBP4;Insulin-like growth factor-binding protein 4,0.999330461381931,2.71646244294249,1.93860129886144,3.80643931697092,6.40759658656944e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301469413831656,IGFBP4;Insulin-like growth factor-binding protein 4,0.449744014146643,1.56791077113742,1.33745770828551,1.83807246466141,2.94225103474692e-08
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387318319757227,IGFBP4;Insulin-like growth factor-binding protein 4,0.505611404862427,1.65799891923193,1.44129234660731,1.90728856823883,1.49632098464677e-12
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13823670340201,IGFBP4;Insulin-like growth factor-binding protein 4,0.327211728334433,1.38709513343383,1.30489296248533,1.47447565778212,8.83381752404465e-26
sensitivity,Circulatory system disorders,I50 (heart failure),0.89442581057339,IGFBP4;Insulin-like growth factor-binding protein 4,0.728415619568097,2.07179549368707,1.88953809109579,2.27163272753755,3.25390919473143e-54
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70699568758984,IGFBP4;Insulin-like growth factor-binding protein 4,0.264251538447164,1.30245577280271,1.21691336318656,1.39401134988361,2.46064608109051e-14
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55725922376617,IGFBP4;Insulin-like growth factor-binding protein 4,0.363106646559969,1.43778918633584,1.33920425300764,1.54363140626352,1.2548520879059e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351381568439546,IGFBP4;Insulin-like growth factor-binding protein 4,0.505319302334851,1.65751468428347,1.43114226170562,1.91969380132837,1.53539486937825e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173694298035457,IGFBP4;Insulin-like growth factor-binding protein 4,0.742621252617455,2.10143669779344,1.7140682430299,2.57634794459929,9.09474466179147e-13
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171697811851142,IGFBP4;Insulin-like growth factor-binding protein 4,0.709668940867384,2.03331799871548,1.6546339778743,2.49866867185441,1.48717787856479e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40153330138955,IGFBP4;Insulin-like growth factor-binding protein 4,0.380503032003492,1.46302035042107,1.35779420473341,1.57640129725434,1.66249187397598e-23
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.14973646382367,IGFBP4;Insulin-like growth factor-binding protein 4,0.665046823770419,1.94458157184623,1.55884249237124,2.42577265379253,3.74024666133598e-09
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239578342117872,IGFBP4;Insulin-like growth factor-binding protein 4,0.635543351766248,1.88804773687655,1.58395801047229,2.25051689069824,1.31269124196859e-12
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54951285737102,IGFBP4;Insulin-like growth factor-binding protein 4,0.22566842944529,1.25316008540031,1.18511599315878,1.32511096694829,2.32565969111495e-15
sensitivity,Circulatory system disorders,I95 (hypotension),0.521082894106372,IGFBP4;Insulin-like growth factor-binding protein 4,0.444996520429327,1.56048476600619,1.38227893125475,1.76166521088977,6.36419327206334e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,1.24705131929774,3.48006620940935,2.98733191210172,4.05407272382809,1.09749818699442e-57
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,1.38241059872722,3.98449507863377,2.73502945516266,5.80476418697746,5.98118441208479e-13
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.306973243815974,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.420957649444918,1.52341975937012,1.29731708383716,1.78892869920043,2.81432128488112e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.481087007558494,1.61783204239419,1.47288290175404,1.77704589705015,9.62769179679683e-24
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.238151552892637,1.26890148394376,1.18057034969855,1.36384161804997,9.86084520140808e-11
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346582694630938,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.452236784710179,1.57182408842862,1.35083636925329,1.82896390798997,4.91229231094987e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172301111045095,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.558516281534829,1.74807692121141,1.41452274026343,2.16028546978529,2.33749700393764e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,0.2360097368628,1.26618663879244,1.17352714206702,1.36616235516513,1.15200004558271e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,VMO1;Vitelline membrane outer layer protein 1 homolog,0.793504894113065,2.21113264681652,1.87946141405257,2.60133437444493,1.07364377813438e-21
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354504584793931,VMO1;Vitelline membrane outer layer protein 1 homolog,0.408664305540024,1.50480648048833,1.29796533121772,1.74460942003376,6.06645450138881e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,VMO1;Vitelline membrane outer layer protein 1 homolog,0.319693292730422,1.37670545400563,1.25453407002922,1.51077436027282,1.55531675959403e-11
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15802648578811,"NOS3;Nitric oxide synthase, endothelial",0.208458939011822,1.23177835098622,1.15740634729306,1.31092931147902,5.36190370674275e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.896317829457364,"NOS3;Nitric oxide synthase, endothelial",0.328441913366727,1.3888025671197,1.26153985606288,1.52890339624921,2.11330766574079e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39494509043927,"NOS3;Nitric oxide synthase, endothelial",0.229851900886675,1.25841362618595,1.16782372124809,1.35603073114324,1.63953701230615e-09
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0824863174354,CLMP;CXADR-like membrane protein,0.182341150173908,1.20002351228628,1.17551443481788,1.22504359571136,3.38284242267344e-67
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,CLMP;CXADR-like membrane protein,1.65599635198668,5.23829651010233,4.55474013800381,6.0244381669107,3.43979266166017e-119
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,CLMP;CXADR-like membrane protein,1.6518504206833,5.21662385034779,3.76235569746689,7.23301212969828,3.89211090401343e-23
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0027365129007,CLMP;CXADR-like membrane protein,0.269865767258194,1.30978862241458,1.19628529249234,1.43406112753632,5.37338791682333e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,CLMP;CXADR-like membrane protein,0.472933212044668,1.60469420515231,1.4678769920722,1.75426381499052,2.44314403109056e-25
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.367474589523064,CLMP;CXADR-like membrane protein,0.411977511467418,1.50980048274961,1.3096438067036,1.74054768635794,1.36711822271544e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,CLMP;CXADR-like membrane protein,0.417103483554594,1.51755954726596,1.4143051243539,1.62835228398833,4.04491624145359e-31
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34401876465989,CLMP;CXADR-like membrane protein,0.546308736687258,1.7268669182296,1.49272614356092,1.99773372104412,2.00086300018536e-13
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.125097732603596,CLMP;CXADR-like membrane protein,0.672266462339474,1.95867154903322,1.55029747497596,2.47461812904758,1.74865389071432e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173964034401876,CLMP;CXADR-like membrane protein,0.740907744903102,2.0978389530625,1.73881170382984,2.53099761365366,1.02333943114082e-14
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168100078186082,CLMP;CXADR-like membrane protein,0.529212326522565,1.69759463159461,1.3931666719809,2.06854469833193,1.53509666256445e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3975762314308,CLMP;CXADR-like membrane protein,0.364043262416099,1.43913647333222,1.33327549322645,1.55340272839122,9.76167976876201e-21
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236512900703674,CLMP;CXADR-like membrane protein,0.488189022596917,1.62936280725536,1.36839755867264,1.94009638561638,4.21126310684275e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.521892103205629,CLMP;CXADR-like membrane protein,0.359794865831482,1.43303541987788,1.26640880210989,1.62158578746704,1.1638884233487e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,SERPINB8;Serpin B8,0.827541033284165,2.28768647342938,1.9591938474908,2.67125655147113,1.26857259228874e-25
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.03900079951639,SERPINB8;Serpin B8,1.05749336714091,2.87914497716598,1.89248281969191,4.38021191700412,7.83075956771776e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0003705075954,SERPINB8;Serpin B8,0.218756653593502,1.24452838832454,1.14083958014729,1.35764128129716,8.27943312884542e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356857315574969,SERPINB8;Serpin B8,0.384472160862609,1.46883880617707,1.27129184229092,1.69708273644217,1.81738821672022e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.898968428852791,SERPINB8;Serpin B8,0.355345387796517,1.42667332475138,1.30107887716791,1.56439153019504,4.09906562615849e-14
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39817866266258,SERPINB8;Serpin B8,0.209604808766686,1.23319061752554,1.1454898544879,1.32760590868166,2.56621488691654e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301293790984817,SCGB1A1;Uteroglobin,1.38944627055306,4.01262752769045,3.42059981864613,4.70712171245801,2.95476144290923e-65
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039384809279061,SCGB1A1;Uteroglobin,1.64682536560107,5.19047578092351,3.41637400893551,7.88585756766951,1.18838540675209e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.899942892026545,SCGB1A1;Uteroglobin,0.332315430024889,1.39419254935199,1.27100370164595,1.5293211673195,1.91254188859559e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304794654370677,FAS;Tumor necrosis factor receptor superfamily member 6,1.11413139489658,3.04692045877724,2.6543380685445,3.49756664086351,1.90366946972296e-56
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390762377398304,FAS;Tumor necrosis factor receptor superfamily member 6,1.39074774146964,4.01785324553908,2.79597817877307,5.77370196421664,5.55661103422703e-14
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39502168731194,FAS;Tumor necrosis factor receptor superfamily member 6,0.194129226591896,1.21425318661895,1.12791348171395,1.30720203731744,2.48999509449311e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.295162941991446,"CA5A;Carbonic anhydrase 5A, mitochondrial",0.590417989248212,1.80474262077328,1.53313161484924,2.12447248213317,1.29556948024383e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.308278353754319,IL18BP;Interleukin-18-binding protein,1.35847807675511,3.89026810463396,3.33793022375035,4.53400308318254,1.0180204127846e-67
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392711278667923,IL18BP;Interleukin-18-binding protein,1.50589179944292,4.50817222361013,3.02259204448083,6.72390335799377,1.54937288664962e-13
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00534087338988,IL18BP;Interleukin-18-binding protein,0.287237264451371,1.33274038788267,1.22181537492018,1.45373595549137,9.26651704761506e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.913053722902922,IL18BP;Interleukin-18-binding protein,0.28357421292093,1.32786742157726,1.21162379957366,1.45526349837852,1.30493697808969e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55710021991831,IL18BP;Interleukin-18-binding protein,0.306644751780979,1.35885815037917,1.26672766607015,1.45768938526494,1.12397840810612e-17
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.170829406220546,IL18BP;Interleukin-18-binding protein,0.521606031142737,1.68473120890627,1.36794237381885,2.07488217382953,9.20080622549906e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39019792648444,IL18BP;Interleukin-18-binding protein,0.32264604733601,1.38077653486897,1.28226113097908,1.48686082201446,1.30581717045313e-17
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5526233113415,IL18BP;Interleukin-18-binding protein,0.240402383215871,1.27176078257189,1.20359828110553,1.34378348114811,1.19495221309267e-17
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.05105246622683,IL18BP;Interleukin-18-binding protein,1.21390731691759,3.3666134122741,2.35861422596159,4.80540045207395,2.28848378967489e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0176720075400565,IL18BP;Interleukin-18-binding protein,1.45367998016801,4.27883159356997,2.40683772360249,7.60682767541509,7.3489539359159e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,SLITRK2;SLIT and NTRK-like protein 2,0.544033406500181,1.72294219251816,1.47566101823921,2.01166105363507,5.88157902174215e-12
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,SLITRK2;SLIT and NTRK-like protein 2,0.234381669374216,1.26412687866056,1.19071271927584,1.34206743531215,1.61426632763636e-14
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300312089033701,CSF1;Macrophage colony-stimulating factor 1,1.41079062964494,4.09919506835655,3.52003328603356,4.77364810017835,1.21133018349857e-73
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392564822266276,CSF1;Macrophage colony-stimulating factor 1,1.48925366452561,4.43378519267526,2.98432873815832,6.58722709848578,1.66612436263947e-13
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00496594500166,CSF1;Macrophage colony-stimulating factor 1,0.273554729237652,1.31462930590295,1.20508920549847,1.4341263734281,7.15381916111252e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15910652246452,CSF1;Macrophage colony-stimulating factor 1,0.208090048094899,1.23132404294109,1.15967369312935,1.30740130409742,1.02465604177223e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,CSF1;Macrophage colony-stimulating factor 1,0.399578663710437,1.49119627015743,1.36044170419371,1.63451789905935,1.41357584362472e-17
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70373132863564,CSF1;Macrophage colony-stimulating factor 1,0.185347328022736,1.20363642419401,1.12545104623166,1.28725336077241,6.34460173663184e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55259387206312,CSF1;Macrophage colony-stimulating factor 1,0.303145058200452,1.3541108750832,1.26221892880886,1.45269273037203,2.79490924820177e-17
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35527116415098,CSF1;Macrophage colony-stimulating factor 1,0.509886594033769,1.66510235169704,1.4409332226483,1.92414596183111,4.79865719171861e-12
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174691345908493,CSF1;Macrophage colony-stimulating factor 1,0.614976867267988,1.84961381244278,1.50767736054323,2.2691003690249,3.70752266362105e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39360511904528,CSF1;Macrophage colony-stimulating factor 1,0.314013150368638,1.36890773807039,1.27123972118552,1.47407948644135,9.20302277501791e-17
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239464541582428,CSF1;Macrophage colony-stimulating factor 1,0.55160251183574,1.73603280306731,1.45678511872874,2.06880881372247,7.05795609457304e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55755981706479,CSF1;Macrophage colony-stimulating factor 1,0.268455066780932,1.30794220565653,1.23782774219925,1.38202817324021,1.30026390749804e-21
sensitivity,Circulatory system disorders,I95 (hypotension),0.522111213614148,CSF1;Macrophage colony-stimulating factor 1,0.403490085667485,1.49704038994916,1.32778308911594,1.68787352957726,4.35846986937778e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215910652246452,CSF1;Macrophage colony-stimulating factor 1,1.3817199186128,3.98174401727798,2.34075736460791,6.77314345298861,3.43833482191946e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,CD83;CD83 antigen,1.38066166544647,3.97753255285501,3.39513330307643,4.65983624109417,1.69040629721421e-65
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394835550993011,CD83;CD83 antigen,1.35052083001703,3.85943511698282,2.55878630969439,5.82121272330052,1.19070286955431e-10
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63355312512338,CD83;CD83 antigen,0.202935921180006,1.2249939695644,1.15956091076322,1.29411936151026,4.30331468119846e-13
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00880483278714,CD83;CD83 antigen,0.337547771012875,1.40150655818066,1.28243611159528,1.5316323478914,9.23602834275143e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.900225056264065,CD83;CD83 antigen,0.337591369349869,1.40156766286791,1.27736558392766,1.53784628168614,9.98736705037644e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56157460417736,CD83;CD83 antigen,0.278175758500715,1.32071830428013,1.23001073803984,1.41811513128764,1.82234675589323e-14
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17570182019189,CD83;CD83 antigen,0.694023084863382,2.00175257603927,1.62735960195677,2.46227900143382,5.05638039477947e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38784696174043,CD83;CD83 antigen,0.372101641530404,1.45078043334293,1.34462418992019,1.56531756720487,8.17000379174692e-22
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242823863860702,CD83;CD83 antigen,0.523064820087651,1.68719066964989,1.41225629563795,2.01564855086572,8.23905020733696e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54866348165988,CD83;CD83 antigen,0.202539746822973,1.22450875448737,1.15740373429689,1.29550445137202,1.87564128883675e-12
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0513286216290914,CD83;CD83 antigen,1.05535759990231,2.87300235558849,1.96344461227252,4.20390902988781,5.51276493153187e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.52315710506574,CD83;CD83 antigen,0.332306027513302,1.39417944050201,1.23304090824871,1.57637617642322,1.14019366336871e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301798958497711,CRHBP;Corticotropin-releasing factor-binding protein,0.825981178274743,2.28412079591676,1.94714942976184,2.67940802621274,3.57795218441868e-24
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394508442480669,CRHBP;Corticotropin-releasing factor-binding protein,1.08230163985152,2.95146494864546,1.92242042718515,4.53134247841812,7.49956709638007e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.174766150974122,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.564782816755699,1.75906570163649,1.43208696437579,2.1607012839633,7.33735768036969e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.311798701169741,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,1.69752822672459,5.46043374307146,4.69001326136539,6.35740988369681,4.45396216989893e-106
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039719579766846,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,1.86678883432621,6.46749482113962,4.49644429244605,9.30257032912405,7.84645969808478e-24
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.66121184437868,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.192058233864101,1.21174107927566,1.14687186766082,1.28027941447281,7.82974330064752e-12
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68796298135165,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.183670247859257,1.20161952114972,1.1464575838218,1.25943558137998,1.85395871261487e-14
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00689134708954,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.341970739456078,1.40771910628472,1.28971425939605,1.53652102995826,1.92374634676394e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.35350425992493,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.581666882858136,1.789018030226,1.54860368494475,2.06675571263923,2.7934083734945e-15
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544158242805791,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.466359906112617,1.59418065147292,1.41676364834012,1.79381504636156,9.39590269069236e-15
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307826743193057,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.520070897255783,1.68214690507079,1.43926772906783,1.96601240553894,6.28626252925243e-11
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387265902726749,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.458274889976109,1.58134363883527,1.37487511794522,1.8188180667798,1.3648354793016e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16471709729311,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.368409631662117,1.44543401325722,1.3605622361144,1.53560008592302,7.98944894064634e-33
sensitivity,Circulatory system disorders,I50 (heart failure),0.915536313625802,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.666779600247596,1.94795401805579,1.7787580673123,2.1332439336133,6.65400374719429e-47
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70198399300935,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.281057826769388,1.32453019502286,1.23769561380273,1.41745694010912,4.50912828719726e-16
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5589935058487,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.337588032955218,1.40156298669285,1.30580181524009,1.50434681797882,8.81909197902827e-21
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351518280936587,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.385564085294553,1.47044354312242,1.2693679913215,1.70337067603178,2.75927616238854e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.170794192997438,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.689944477121636,1.99360483949108,1.62344661461739,2.44816196618757,4.58580252972883e-11
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170794192997438,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.518740214317004,1.67990998952644,1.36213213479223,2.07182365119166,1.24293802023226e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39217127082795,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.334892729257128,1.39779043516162,1.29717933353607,1.50620507906433,1.53903132260684e-18
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.144976466148988,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.63348259747341,1.88416094063922,1.50614645285736,2.35704996914181,2.94546991988585e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242289436577761,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.523100271982793,1.68725048481687,1.41583776833921,2.0106923703936,5.03656277991102e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55198300001986,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.243749501303375,1.27602464793992,1.20690924178179,1.34909804795793,9.56481502355168e-18
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0516354536968998,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.944309584450956,2.57103768128201,1.80909736414,3.65388557277254,1.39620847497567e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.520326494945683,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.431964026922884,1.54027970556387,1.36511427684808,1.73792158767083,2.33491984956936e-12
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0178738108950807,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,1.33500252521128,3.80000554222401,2.21459382582786,6.52040204958813,1.25929607302044e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300312089033701,BTN2A1;Butyrophilin subfamily 2 member A1,1.83198942773968,6.24630087006319,5.27528951333163,7.39604422861547,3.16586410088629e-100
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392564822266276,BTN2A1;Butyrophilin subfamily 2 member A1,2.00115264412222,7.39757796140571,4.82444533248889,11.3430987240234,4.48931777528518e-20
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00496594500166,BTN2A1;Butyrophilin subfamily 2 member A1,0.280409505090217,1.32367175168649,1.21273033079415,1.44476217154182,3.41787762552686e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,BTN2A1;Butyrophilin subfamily 2 member A1,0.310295554916397,1.3638281406831,1.24404947555342,1.49513924797217,3.69039755384247e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55259387206312,BTN2A1;Butyrophilin subfamily 2 member A1,0.315872262587863,1.37145505831664,1.27806610115435,1.47166799532785,1.65633895893488e-18
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35527116415098,BTN2A1;Butyrophilin subfamily 2 member A1,0.444658105829271,1.55995676452495,1.34758818340752,1.80579285062732,2.59535615649315e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39360511904528,BTN2A1;Butyrophilin subfamily 2 member A1,0.323873772879822,1.38247279054627,1.28310817792405,1.48953225416502,1.73253611058096e-17
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55755981706479,BTN2A1;Butyrophilin subfamily 2 member A1,0.215934139475281,1.24102064203841,1.17416079686684,1.3116876649903,2.13703970452814e-14
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0529962510059473,BTN2A1;Butyrophilin subfamily 2 member A1,1.02568654222225,2.78900957626241,1.92010761456545,4.05111378001793,7.2380376497382e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.522111213614148,BTN2A1;Butyrophilin subfamily 2 member A1,0.415187325634551,1.51465444772396,1.3417947583919,1.70978317038552,1.87708554715171e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30079134366925,CD28;T-cell-specific surface glycoprotein CD28,0.685477433388027,1.98471918057475,1.69546914347777,2.32331578601386,1.47290611949608e-17
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.365390826873385,CD28;T-cell-specific surface glycoprotein CD28,0.404987407018125,1.49928361948644,1.29646983334224,1.73382466282728,4.72613612614873e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55846253229974,CD28;T-cell-specific surface glycoprotein CD28,0.229448139076154,1.25790562938361,1.17121093069099,1.35101759296375,3.02321065489607e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3969638242894,CD28;T-cell-specific surface glycoprotein CD28,0.185285168968792,1.20356160961781,1.1158705014405,1.29814395691601,1.58345701483907e-06
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0504683462532299,CD28;T-cell-specific surface glycoprotein CD28,1.12996565677936,3.09555018713608,2.11047803988113,4.54040780335149,7.39437474790681e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305828383226489,SCLY;Selenocysteine lyase,-0.419088784668947,0.657645803810746,0.560013406881665,0.772299373470664,3.20123156986186e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215648218941755,SCLY;Selenocysteine lyase,1.33971508171659,3.8179555450438,2.21744240413267,6.57369251925726,1.3482523109389e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301798958497711,TREM2;Triggering receptor expressed on myeloid cells 2,0.7845929016995,2.19151459724172,1.88442789619633,2.54864420104252,2.28878465148513e-24
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0040239861133,TREM2;Triggering receptor expressed on myeloid cells 2,0.314785674991202,1.36996566158744,1.25557649993478,1.49477623547925,1.4829922974776e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.901451791068328,TREM2;Triggering receptor expressed on myeloid cells 2,0.225473850407732,1.25291627043839,1.1445132554919,1.37158671880526,1.04270677561343e-06
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56028089001104,TREM2;Triggering receptor expressed on myeloid cells 2,0.217935021688681,1.24350626405669,1.15965629026778,1.33341908436609,9.44265404495734e-10
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357030140445005,TREM2;Triggering receptor expressed on myeloid cells 2,0.370963528540538,1.44913022052874,1.25452505522512,1.67392304147552,4.60922865275269e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175556256903897,TREM2;Triggering receptor expressed on myeloid cells 2,0.601067372218142,1.82406471770049,1.49494666865618,2.22563932488014,3.20689507399025e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38866971753195,TREM2;Triggering receptor expressed on myeloid cells 2,0.242780488525387,1.27478876264207,1.183221661383,1.37344205434764,1.72815706645869e-10
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240650149913208,TREM2;Triggering receptor expressed on myeloid cells 2,0.510659676573831,1.66639011096052,1.40287584746985,1.97940253010643,6.08291886703446e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,RELT;Tumor necrosis factor receptor superfamily member 19L,1.86693573251272,6.4684449541848,5.46136274763852,7.66123439491556,1.13322158561821e-103
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,RELT;Tumor necrosis factor receptor superfamily member 19L,2.18532516132102,8.8935399184543,5.62830489118674,14.0530859308978,7.84263811175336e-21
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64693129409909,RELT;Tumor necrosis factor receptor superfamily member 19L,0.203863296433967,1.22613052558353,1.15550756240075,1.30106986287845,1.63545227044584e-11
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,RELT;Tumor necrosis factor receptor superfamily member 19L,0.350045512149701,1.41913213487768,1.29281861947098,1.557786982575,1.84320988913503e-13
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356734597343214,RELT;Tumor necrosis factor receptor superfamily member 19L,0.617033274987181,1.85342128608155,1.59250358562969,2.15708805600077,1.57767613865985e-15
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549883716346722,RELT;Tumor necrosis factor receptor superfamily member 19L,0.439854277916668,1.55248097126566,1.36991473666493,1.7593775011207,5.54182272873156e-12
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301549134770783,RELT;Tumor necrosis factor receptor superfamily member 19L,0.565433432848061,1.76021055047765,1.48743087285702,2.08301524363389,4.65425356997223e-11
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386298238007016,RELT;Tumor necrosis factor receptor superfamily member 19L,0.425447319559387,1.5302747884303,1.31636186419257,1.77894923258185,3.06246751024309e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1522330403248,RELT;Tumor necrosis factor receptor superfamily member 19L,0.313290331486683,1.36791862322817,1.28191853306714,1.45968820288243,3.18265082939226e-21
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,RELT;Tumor necrosis factor receptor superfamily member 19L,0.663653177473338,1.94187340049407,1.75919637270482,2.14351982646973,1.37939635513106e-39
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70286570223501,RELT;Tumor necrosis factor receptor superfamily member 19L,0.270077166332752,1.31006553978623,1.21878152370528,1.40818652494637,2.31866651657928e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,RELT;Tumor necrosis factor receptor superfamily member 19L,0.334041980029028,1.3966017717268,1.29481800503093,1.50638661279958,5.06189201305831e-18
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348850959832866,RELT;Tumor necrosis factor receptor superfamily member 19L,0.456298712800868,1.57822170938885,1.34942144369971,1.84581605369875,1.12921034471984e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17344002522764,RELT;Tumor necrosis factor receptor superfamily member 19L,0.625141341372679,1.86851003654256,1.49520545260198,2.33501673671977,3.85367541923307e-08
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171469115850053,RELT;Tumor necrosis factor receptor superfamily member 19L,0.575454883744877,1.77793909859237,1.41725718070387,2.23041201084867,6.54232878248497e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,RELT;Tumor necrosis factor receptor superfamily member 19L,0.330034818157507,1.39101656025431,1.28534717278672,1.50537310997984,2.66847464367325e-16
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240450944065591,RELT;Tumor necrosis factor receptor superfamily member 19L,0.488704270118899,1.63020254872298,1.34896982086258,1.97006657136597,4.23156089039529e-07
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56415310024045,RELT;Tumor necrosis factor receptor superfamily member 19L,0.194179209776148,1.21431388037653,1.14468384440676,1.28817944559994,1.15570639290751e-10
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0492727344396704,RELT;Tumor necrosis factor receptor superfamily member 19L,0.980492831707521,2.66576969407759,1.80700118091501,3.93266376188203,7.71605012041909e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197090937758681,RELT;Tumor necrosis factor receptor superfamily member 19L,1.41096840967559,4.09992388816434,2.34862429141842,7.1571157422496,6.91767580911354e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,ISM1;Isthmin-1,0.683870580551478,1.98153258980654,1.69394817867363,2.31794068667429,1.25502871587365e-17
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200894895443338,COL15A1;Collagen alpha-1(XV) chain,1.56875663254172,4.8006754777375,3.92338116497247,5.87413867617725,2.03381169829575e-52
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0182631723130307,COL15A1;Collagen alpha-1(XV) chain,1.55778352702606,4.7482851272839,2.60138827613626,8.66699210448988,3.89608445307307e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00447447721669,COL15A1;Collagen alpha-1(XV) chain,0.251153255469595,1.2855070802267,1.16814963223699,1.41465477342009,2.71889507248642e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.404072687425805,COL15A1;Collagen alpha-1(XV) chain,0.411504141787471,1.5090859581088,1.29921083315311,1.75286440879974,7.20554128881399e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14592274678111,COL15A1;Collagen alpha-1(XV) chain,0.228971655645498,1.25730640096642,1.17639078285081,1.34378763328989,1.5152905579187e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.90859282257328,COL15A1;Collagen alpha-1(XV) chain,0.520866008039813,1.6834849300839,1.52106976240204,1.86324229162507,8.07828895577088e-24
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54780385352935,COL15A1;Collagen alpha-1(XV) chain,0.287133245342587,1.33260176462514,1.23297459102824,1.4402790422478,4.40392785107548e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39941557848598,COL15A1;Collagen alpha-1(XV) chain,0.263158290285026,1.30103264348133,1.19942566897216,1.41124705197826,2.25390555358728e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199541284403669,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,1.11384915561168,3.04606061947172,2.47669936068801,3.74631069267889,5.06065363761634e-26
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.201807090767325,HIP1R;Huntingtin-interacting protein 1-related protein,0.837049253725001,2.30954203983346,1.88613539940313,2.8279965666548,5.45586135155438e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.910425170848048,HIP1R;Huntingtin-interacting protein 1-related protein,0.387489085898475,1.47327687403789,1.33352634977252,1.62767293495558,2.52923168080987e-14
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54795211668119,HIP1R;Huntingtin-interacting protein 1-related protein,0.193405390322859,1.21337458414322,1.12402539245787,1.30982617592414,7.20179019153683e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39889006100077,HIP1R;Huntingtin-interacting protein 1-related protein,0.211507220518446,1.23553888682781,1.14056290657972,1.33842362578798,2.18598295386283e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200789148046975,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,0.538499760228992,1.71343437060247,1.392379363216,2.10851828167066,3.6413834083179e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,LPL;Lipoprotein lipase,0.73836132933948,2.0925037789705,1.76662676010043,2.47849300367039,1.24754026411264e-17
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,CD74;HLA class II histocompatibility antigen gamma chain,1.29606597323308,3.65488991317249,3.15724130170528,4.2309785666984,1.79994175643026e-67
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390846377831193,CD74;HLA class II histocompatibility antigen gamma chain,1.4386445770482,4.21497886433333,2.89199740611151,6.14317522873038,7.13835505740485e-14
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00642942291532,CD74;HLA class II histocompatibility antigen gamma chain,0.242843440485596,1.27486901561954,1.16982828464866,1.38934151987518,3.1062388537197e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,CD74;HLA class II histocompatibility antigen gamma chain,0.390332785227889,1.47747239306665,1.34928117277222,1.61784268269977,3.48125693789012e-17
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54775165621152,CD74;HLA class II histocompatibility antigen gamma chain,0.241776287774804,1.27350926135539,1.1875047514395,1.36574261011753,1.22560724460596e-11
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345899044380606,CD74;HLA class II histocompatibility antigen gamma chain,0.41857563145148,1.51979526461139,1.31538893140679,1.75596554842903,1.34937373509909e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173926638134881,CD74;HLA class II histocompatibility antigen gamma chain,0.540140451347977,1.71624789458805,1.40178617523321,2.10125259309815,1.68879386069675e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39923003263567,CD74;HLA class II histocompatibility antigen gamma chain,0.317559764415382,1.37377134505329,1.27727753129935,1.47755492619499,1.27275216647269e-17
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55418107912684,CD74;HLA class II histocompatibility antigen gamma chain,0.18535416846099,1.20364465762281,1.13973252172717,1.27114075820918,2.76774924571953e-11
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0508100291180551,CD74;HLA class II histocompatibility antigen gamma chain,1.02130780720483,2.77682394067149,1.95871572112302,3.93663619193571,9.73414822128296e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195423188915596,CD74;HLA class II histocompatibility antigen gamma chain,1.40751470929671,4.08578840339368,2.3882164397525,6.99001422125554,2.7840189296508e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30079134366925,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.702411674072891,2.01861508354074,1.72518728784868,2.36195042949773,1.87517509341714e-18
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0403746770025839,LTBP3;Latent-transforming growth factor beta-binding protein 3,1.05221309198278,2.86398236607515,1.8987535775434,4.31988389130601,5.23284362359588e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999273255813953,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.216322317558235,1.24150247256411,1.13633302934947,1.35640551631698,1.66848151068853e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17013888888888,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.20520886503413,1.22778147880477,1.15433926686152,1.30589628454256,6.99775247718247e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.908430232558139,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.394902724151857,1.4842398032126,1.35076526161781,1.63090350043655,2.14353597871935e-16
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3969638242894,LTBP3;Latent-transforming growth factor beta-binding protein 3,0.207261985707081,1.23030485184906,1.14133190810548,1.32621371376173,6.24710171930516e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304699402320403,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.49987095290618,4.48111075870366,3.82361960751007,5.25166091112447,1.25798736922787e-76
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390640259385132,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.51583383800101,4.55321618907748,3.00485562599778,6.89942554481071,8.76816379355843e-13
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64072815344349,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.221941736368977,1.2484986336814,1.18214478028609,1.31857693262166,1.64771561921997e-15
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69155045118949,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.238848524368269,1.26978618035173,1.21210760602823,1.33020941028125,7.49487789794743e-24
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00003906402593,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.292554590666213,1.33984587764654,1.22797221343655,1.46191172422583,4.82064480235554e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.900425797882729,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.396263531282413,1.48626094219854,1.35541327179013,1.62974026762144,3.52864145171235e-17
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.365248642525098,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.381937178070406,1.46512004057374,1.26905146597456,1.69148122896841,1.8830447574948e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54888862846204,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.359247321700138,1.4322509845198,1.33484517641957,1.53676465173303,1.57015889420955e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35548263604047,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.429310005711145,1.53619719049047,1.32839503609453,1.77650604221536,7.06115305115514e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173834915426383,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.684191392230934,1.98216839058528,1.6116935494146,2.43780309852484,9.10188432832068e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40044532989569,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.479466401404281,1.61521229719077,1.50008694962491,1.73917302970246,5.27851212206873e-37
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240243759521856,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.559534065911576,1.74985699230178,1.46661872430017,2.08779517319237,5.27199040369187e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55088089378491,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.248313799802885,1.28186211716763,1.21314050522875,1.35447664994059,1.02303823516837e-18
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0527364350169928,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.08867461472295,2.97033462471717,2.06060313271448,4.28170162547074,5.37515804826996e-09
sensitivity,Circulatory system disorders,I95 (hypotension),0.519551544982225,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.373340173838661,1.45257838496256,1.28751696324711,1.63880090491318,1.30971526765262e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214852142661822,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.59401001608903,4.92345251988217,2.85406903784595,8.49327202464206,1.00606969777646e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,HSPB6;Heat shock protein beta-6,1.16529024049554,3.20685350689493,2.80178623342939,3.67048324100614,3.55802221429385e-64
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,HSPB6;Heat shock protein beta-6,1.36688786823902,3.9231224034781,2.76491322256148,5.5664999780403,1.90197899766776e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361610633307271,HSPB6;Heat shock protein beta-6,0.468818957684498,1.59810564781615,1.38986649664593,1.83754458989056,4.65349553311333e-11
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304925723221266,HSPB6;Heat shock protein beta-6,0.507855992275011,1.66172462250522,1.42826678200298,1.93334239501648,4.87357938654979e-11
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383111806098514,HSPB6;Heat shock protein beta-6,0.363959761825644,1.4390163096039,1.25253374371478,1.65326319526091,2.75150559188293e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,HSPB6;Heat shock protein beta-6,0.245598871527499,1.27838667338562,1.20336718143299,1.35808297908195,1.72456469639833e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,HSPB6;Heat shock protein beta-6,0.431731075767414,1.53992093741607,1.40738635070265,1.68493640165577,5.33776404609753e-21
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,HSPB6;Heat shock protein beta-6,0.197485890120502,1.21833587427598,1.13461755824435,1.30823138753874,5.41687094721002e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3975762314308,HSPB6;Heat shock protein beta-6,0.220564874898419,1.24678080689278,1.15686869415015,1.34368091063104,7.66333736592351e-09
sensitivity,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0117279124315871,HSPB6;Heat shock protein beta-6,1.42785091261338,4.16972844510952,2.32844133476398,7.46707037294449,1.56225951086604e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,CNTN3;Contactin-3,-0.561321358543721,0.570454790314682,0.480049787366947,0.677885245149,1.81577254575972e-10
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.384327328629429,CNTN3;Contactin-3,-0.395006189070355,0.67367586980861,0.579410630269449,0.783277271511801,2.80555644983359e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1522330403248,CNTN3;Contactin-3,-0.256202634991651,0.77398511643329,0.725389261983164,0.825836543020341,9.64037100095221e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,CNTN3;Contactin-3,-0.253223423624842,0.77629441993347,0.702398430587408,0.857964653929918,6.99337731050324e-07
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240450944065591,CNTN3;Contactin-3,-0.473486805668752,0.622826801749265,0.514594384394198,0.753823276625699,1.16475377778084e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309801726894787,CSTB;Cystatin-B,1.04015325202999,2.82965063082774,2.44006867341145,3.28143333824675,4.25891855875023e-43
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0399744163735209,CSTB;Cystatin-B,1.04692669028864,2.84888215290531,1.9095050967643,4.25038379572558,2.91614274122821e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01135273425008,CSTB;Cystatin-B,0.271700223482336,1.31219357752327,1.20299309388947,1.43130662481719,8.85035242556596e-10
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541653341861208,CSTB;Cystatin-B,0.290743925893702,1.33742206093727,1.18836980059998,1.50516932370599,1.41686309992394e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.19259673808762,CSTB;Cystatin-B,0.190578087351223,1.20994885164959,1.14005530066228,1.28412737764363,3.4381231790098e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.917412855772305,CSTB;Cystatin-B,0.506310496291033,1.65915841731536,1.51604825820251,1.81577772267768,3.76850888147775e-28
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56899584266069,CSTB;Cystatin-B,0.194945161446315,1.2152443424203,1.13301527882695,1.30344121512073,4.93935282985821e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173888711224816,CSTB;Cystatin-B,0.575476016602209,1.7779766719227,1.4500988640885,2.17999001598306,3.144309497357e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39510713143588,CSTB;Cystatin-B,0.228475221967076,1.25668238662857,1.16672352953257,1.35357741648973,1.65054455499868e-09
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.027597626604112,CDH2;Cadherin-2,1.20026431661205,3.32099460078053,2.03561059912055,5.4180328709127,1.53839601809911e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,CDH2;Cadherin-2,0.442702117337187,1.55690848921297,1.33042996221053,1.82194035960823,3.39779873043704e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540124977823335,CDH2;Cadherin-2,0.371605728333967,1.45006115054656,1.28663488233705,1.63424555729835,1.12211947603306e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309487669774685,CDH2;Cadherin-2,0.391020799073292,1.47848926429992,1.26317414342334,1.73050605574145,1.12021143559832e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,CDH2;Cadherin-2,0.247341594389589,1.28061648947932,1.20521224189465,1.36073841280289,1.367505365014e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,CDH2;Cadherin-2,0.368164471920425,1.44507969446203,1.31696960401578,1.58565187607887,7.65657180393332e-15
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71696662658439,CDH2;Cadherin-2,0.195124573402888,1.21546239134519,1.13577559867756,1.3007400638777,1.70116390811757e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0177413313883577,CDH2;Cadherin-2,1.410190544116,4.0967359386336,2.30628820014882,7.27716741984332,1.50495051832235e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305373785445171,REG1A;Lithostathine-1-alpha,1.42766608104792,4.16895781889367,3.56736851314037,4.87199716869586,4.33282764175746e-72
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396589331746976,REG1A;Lithostathine-1-alpha,1.55606067248445,4.74011156563815,3.13555091367876,7.16577669228002,1.58303366957998e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.916121356335514,REG1A;Lithostathine-1-alpha,0.450943326214107,1.56979231349866,1.43218348014125,1.72062304983187,5.75749858995168e-22
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55859607376561,REG1A;Lithostathine-1-alpha,0.211612951495852,1.23566952846825,1.15140244787183,1.32610381922248,4.30521084790814e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39004560777315,REG1A;Lithostathine-1-alpha,0.196713136392307,1.21739476435687,1.13003829285654,1.31150423985825,2.24464361640046e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.523497917906008,REG1A;Lithostathine-1-alpha,0.316382888068066,1.37215553704029,1.21636033741356,1.54790546840248,2.67230079829859e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.195101311644962,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.653847108059683,1.92292431500363,1.57612607925848,2.34602927385846,1.16547984774437e-10
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.4027079121809,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.216510763142221,1.24173645026792,1.18572851654711,1.30038992096949,3.77053796205694e-20
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.54807014244746,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.278531564754389,1.32118830772225,1.24405572500795,1.40310318048722,1.1355194378613e-19
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53062855531004,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.267791511713281,1.30707460186106,1.24159343025269,1.3760092258885,1.7498874406499e-24
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.984909031075172,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.276568656790912,1.31859748028155,1.20018325715828,1.44869485941809,8.36866620313728e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.550044661746039,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.32175437665704,1.37954588566706,1.21729242129827,1.56342618861552,4.65620846854349e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15316628273235,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.288387513626927,1.33427425340972,1.25076956190571,1.42335393947352,2.21405066254878e-18
sensitivity,Circulatory system disorders,I50 (heart failure),0.895585538996756,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.484087132138618,1.62269302820655,1.47246648316916,1.7882462479709,1.56856081718044e-22
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65483522166329,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.210089191831397,1.23378809886947,1.14636746968903,1.32787532197235,2.10717233405059e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54200554745898,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.290306240537789,1.33683681897178,1.239400216453,1.44193349075986,5.54101334799475e-14
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345540877250716,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.415829633622286,1.51562763488388,1.29716742205472,1.77087944745408,1.63835914997396e-07
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.124582765267265,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.636870094418191,1.8905543527874,1.47416299337033,2.42455941230205,5.23589726153556e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38921536364063,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.353987981166396,1.42473806268728,1.31672468940555,1.54161197371206,1.36720267801639e-18
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.220958111983451,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.526644704905502,1.69324144198499,1.39834788003163,2.0503242589323,6.88156025076151e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0493629824643881,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.949019920441601,2.58317669958857,1.78599919256477,3.73617294401732,4.65046050321709e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0164543274881293,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,1.45896601966677,4.30150955186779,2.40815210748508,7.68347828498806,8.25227757860604e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,CXCL13;C-X-C motif chemokine 13,0.545896704044851,1.72615553925594,1.47238927855259,2.02365840957021,1.71144743100075e-11
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64212151413886,CXCL13;C-X-C motif chemokine 13,0.183322584495424,1.2012018346763,1.13609668463398,1.27003790007061,1.13385527176674e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361532899493853,CXCL13;C-X-C motif chemokine 13,0.394170826064947,1.48315388837808,1.28576292548182,1.71084840993274,6.32415306123797e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16138046940649,CXCL13;C-X-C motif chemokine 13,0.246243307376399,1.27921077709918,1.2040923350481,1.35901555438546,1.52324558335917e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,CXCL13;C-X-C motif chemokine 13,0.38376582604106,1.46780168050314,1.33742317571153,1.61089011497175,6.16624263747593e-16
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39923003263567,CXCL13;C-X-C motif chemokine 13,0.295582221861067,1.34390858390669,1.24890680570301,1.44613695245374,2.74271996867518e-15
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.85579201000821,6.39676254482601,5.42542079260339,7.54200874348294,4.42788422293711e-108
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,2.03578233722896,7.65824110959898,5.09828071346399,11.5036146867839,1.05562999418378e-22
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64693129409909,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.204741377785505,1.22720764076077,1.16231197695613,1.29572664086765,1.5126296271576e-13
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69348417359769,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.185429846007839,1.20373574994455,1.14924553404033,1.26080955964257,4.31269327631025e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.270305975946714,1.31036532967275,1.20038458707497,1.43042264595583,1.50884193972156e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.476544656992893,1.61049994718168,1.46988321741319,1.76456881005607,1.56076278014804e-24
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.364618234853561,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.361185000448905,1.43502891731691,1.24306646693199,1.65663546424698,8.23960578283925e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.378441099065146,1.46000680849943,1.36080008677037,1.56644602068165,5.60793411004049e-26
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348850959832866,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.39800446197569,1.48885067310796,1.28534301552252,1.72457958696177,1.1120449863098e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17344002522764,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.568414660081068,1.76546596801111,1.43782470025002,2.16776779788483,5.73095663102511e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.322755482344334,1.38092764842896,1.2821407247442,1.48732594901078,1.55927560785432e-17
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240450944065591,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.503793044379109,1.65498681888787,1.38820736143311,1.97303475459533,1.93911085990534e-08
sensitivity,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0118254562655209,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.70475633910491,5.50004535795273,2.77783033424801,10.8899735763475,1.0011133164997e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56415310024045,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.185490279146092,1.20380849767171,1.13902498352113,1.27227665769611,4.96040703431234e-11
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0492727344396704,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.03787240519176,2.82320398583282,1.94681805231399,4.09410665580618,4.42419252700842e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.516378256927746,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.391087624969138,1.47858806897082,1.30968710108671,1.66927098532836,2.62883264845149e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.306481591331514,CANT1;Soluble calcium-activated nucleotidase 1,0.921606033582393,2.51332363246505,2.14965642415588,2.938514085565,6.8153358284388e-31
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00842330051014,CANT1;Soluble calcium-activated nucleotidase 1,0.241983766138685,1.27377351438577,1.16753618273067,1.38967767333422,5.15222242457575e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3900423142326,CANT1;Soluble calcium-activated nucleotidase 1,0.195850105997894,1.21634456891371,1.12918632962365,1.31023027069322,2.4344842603244e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,ACY1;Aminoacylase-1,-0.610987690177543,0.54281447169897,0.464598793529235,0.634197838628893,1.39917416408516e-14
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.60334199063304,4.96961310316684,4.22228004125893,5.84922225760369,7.4572772341949e-83
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390846377831193,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.82655061801818,6.21242064573099,4.05604605562508,9.51521993345732,4.58215928057638e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.283066054932174,1.32719282655392,1.21180181539116,1.45357167854019,1.06380375074862e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54775165621152,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.251441485399911,1.2858776552457,1.19866824469846,1.3794320084588,2.26452891343897e-12
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345899044380606,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.363781353867761,1.43875960054289,1.24148303927505,1.66738418703095,1.33335350783237e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39923003263567,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,0.2933817359903,1.3409545833664,1.24507662504024,1.44421568800493,9.10524825971584e-15
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0508100291180551,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.13711185336926,3.11775082792032,2.13027552114447,4.56296386477543,4.86445269278059e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195423188915596,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.50624706555765,4.50977410897149,2.46633516926296,8.24626870160042,9.99840859033084e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.308278353754319,PRSS2;Trypsin-2,1.2994389155335,3.66723845972431,3.12208144737426,4.30758714888484,2.09329038429279e-56
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392711278667923,PRSS2;Trypsin-2,1.36077756645946,3.89922402916955,2.51730292626427,6.03977688621535,1.09489077419318e-09
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.353440150801131,PRSS2;Trypsin-2,0.401432416476408,1.49396314312471,1.28929517823635,1.73112093389518,9.28944379549364e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543905120955073,PRSS2;Trypsin-2,0.355058326397426,1.42626384068708,1.26732013940595,1.60514181065961,3.86675401611272e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.30631479736098,PRSS2;Trypsin-2,0.420042016447445,1.52202550437979,1.30246950014718,1.77859184857746,1.25835963689644e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16187558906691,PRSS2;Trypsin-2,0.194438938989076,1.21462931412683,1.14496819618499,1.28852869071121,1.10078238918951e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.913053722902922,PRSS2;Trypsin-2,0.443167727868148,1.55763357099105,1.42313073821366,1.70484852609097,6.70855045431859e-22
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70633050581212,PRSS2;Trypsin-2,0.195483678455239,1.2158989484111,1.13716369057373,1.30008570006427,1.04603034541338e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.961680446997583,2.61608898057454,2.23480348103288,3.06242656787003,5.40044370378431e-33
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039736151951045,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,1.04005390241469,2.82936952009051,1.86595844931286,4.29019836115061,9.73707919020472e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01128506715409,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.233924780616699,1.26354944522309,1.15787147706683,1.37887255377259,1.52650153968482e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.363585790352062,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.431156996467736,1.5390371543878,1.33279080637104,1.77719965598763,4.27372648221815e-09
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0596042279265675,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.905707543571012,2.47368154149025,1.76317754259705,3.4704958637895,1.58171048179663e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.497227042716904,1.64415576993949,1.49867981880338,1.80375298439911,7.02862724804243e-26
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55567034888341,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.239083920461649,1.27008511824103,1.18322238465222,1.3633246197007,3.7248892126185e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39275212588412,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.290718711382524,1.33738833891891,1.24136461540808,1.44083982004618,2.04869684232319e-14
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0516569975363585,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,0.973288700611586,2.6466341499744,1.84932017882615,3.7877012342216,1.02900113615353e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0198680759755225,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,1.48516901155655,4.41571165601522,2.57802610962904,7.56334831375093,6.33437236600483e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,CD99L2;CD99 antigen-like protein 2,1.3254005966104,3.76369277561447,3.23431977821716,4.3797101958239,7.79159646670444e-66
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,CD99L2;CD99 antigen-like protein 2,1.62228308874827,5.06464014983988,3.39546847101092,7.55435665692789,1.8323533590529e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,CD99L2;CD99 antigen-like protein 2,0.241162397033688,1.27272770573054,1.16613910550023,1.38905882265159,6.51124611729754e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,CD99L2;CD99 antigen-like protein 2,0.380118621087256,1.46245805751038,1.33553876619524,1.60143877820194,2.27704062503745e-16
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,CD99L2;CD99 antigen-like protein 2,0.219652787815058,1.24564415266565,1.15668684856587,1.34144289527795,6.23167853907128e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,NPPC;C-type natriuretic peptide,1.68182560721949,5.37536031555741,4.51779051476742,6.39571454843275,3.2654625302217e-80
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394835550993011,NPPC;C-type natriuretic peptide,1.54065509493639,4.66764702157658,2.92203503865985,7.45608058417566,1.14059724821509e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361274529158605,NPPC;C-type natriuretic peptide,0.433460823432102,1.54258691713274,1.3076627993777,1.81971560102611,2.71746475384613e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.900225056264065,NPPC;C-type natriuretic peptide,0.458666567282422,1.58196313656577,1.42253404044644,1.75926009100463,2.61155263130272e-17
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,SLC39A5;Zinc transporter ZIP5,0.989685391994615,2.69038792161269,2.32349884768393,3.11521013921505,5.8454472422315e-40
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394835550993011,SLC39A5;Zinc transporter ZIP5,1.26116051105158,3.52951515287553,2.40986354827279,5.16937036676063,9.31294273590055e-11
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.66119970825366,SFTPD;Pulmonary surfactant-associated protein D,0.224174261539227,1.25128905198668,1.18533750122297,1.32091011210418,4.87792810383347e-16
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70399574208046,SFTPD;Pulmonary surfactant-associated protein D,0.197295493696714,1.21810392956397,1.16310206875766,1.27570676991749,5.80710274815762e-17
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,SFTPD;Pulmonary surfactant-associated protein D,0.26610140060629,1.30486736632085,1.22918276405173,1.38521210472932,2.57883485118362e-18
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200636502006365,PALM;Paralemmin-1,1.53488937676517,4.64081211990804,3.80903278796001,5.65422728845028,2.20352348613491e-52
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0184493335178266,PALM;Paralemmin-1,1.4554246901167,4.28630342981819,2.43476616037431,7.54585692518688,4.56638077196731e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.993957843272911,PALM;Paralemmin-1,0.248141762157566,1.28164160759588,1.1642335659161,1.4108897547791,4.14922758673086e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14473502144735,PALM;Paralemmin-1,0.228734997616516,1.25700888451796,1.17743062097358,1.34196555415773,7.13674587817423e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.904017342373506,PALM;Paralemmin-1,0.466852954400719,1.59496685331586,1.44469700866266,1.76086698312691,2.31024407769145e-20
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55666251556662,PALM;Paralemmin-1,0.264258152829377,1.3024643877715,1.2063731943215,1.40620952902314,1.39838026238493e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39984318066509,PALM;Paralemmin-1,0.204048939291799,1.22635816908792,1.13074210541973,1.33005957033006,8.36051018456572e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.507356671740233,PALM;Paralemmin-1,0.347502196844812,1.41552742030533,1.238247581525,1.61818840394466,3.57724303582568e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,1.62253076268351,5.06589468454773,4.26460121212481,6.01774648517307,3.64030519549244e-76
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039736151951045,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,1.74606603547191,5.73200874420699,3.74295066362874,8.77808103722426,9.76471387378827e-16
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,THY1;Thy-1 membrane glycoprotein,1.64472291485144,5.17957452491946,4.40305037837017,6.09304685474101,1.17816418051826e-87
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390846377831193,THY1;Thy-1 membrane glycoprotein,1.69110129996426,5.42545246678496,3.63798157853198,8.09117194079388,1.10391572871395e-16
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64212151413886,THY1;Thy-1 membrane glycoprotein,0.20590034340945,1.22863075674181,1.16340500514248,1.29751335926828,1.38219957744072e-13
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68958980672646,THY1;Thy-1 membrane glycoprotein,0.191607424088575,1.21119493766395,1.15604297022566,1.26897806985187,7.7488527032554e-16
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00642942291532,THY1;Thy-1 membrane glycoprotein,0.236458477032996,1.26675495510387,1.15894171208225,1.38459777532481,1.88676864138503e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16138046940649,THY1;Thy-1 membrane glycoprotein,0.193370781698396,1.21333259164455,1.14231753556793,1.28876247812738,3.29924386819883e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,THY1;Thy-1 membrane glycoprotein,0.529420353785949,1.6979478142947,1.54875987834634,1.86150662886905,1.59330897150801e-29
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70213597545484,THY1;Thy-1 membrane glycoprotein,0.19335426934872,1.21331255683794,1.13324689124521,1.29903498695068,2.83681894644156e-08
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.363487131383009,THY1;Thy-1 membrane glycoprotein,0.373915617725228,1.45341450286034,1.25680666309428,1.68077857888179,4.59875819742747e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54775165621152,THY1;Thy-1 membrane glycoprotein,0.325399012707381,1.3845830019871,1.28916624180941,1.48706196859523,4.18596750132784e-19
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173926638134881,THY1;Thy-1 membrane glycoprotein,0.560494681465283,1.75153873977242,1.4237493756395,2.15479494454251,1.14630829369995e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39923003263567,THY1;Thy-1 membrane glycoprotein,0.321250102845432,1.37885039217932,1.27824524952871,1.48737372950461,9.50914898208435e-17
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240370522366183,THY1;Thy-1 membrane glycoprotein,0.440172552936431,1.55297516581819,1.29909494871135,1.8564708207359,1.34456646402075e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55418107912684,THY1;Thy-1 membrane glycoprotein,0.191267680620212,1.21078351198851,1.1443251093756,1.28110158633429,3.12470599284491e-11
sensitivity,Circulatory system disorders,I95 (hypotension),0.517871450626331,THY1;Thy-1 membrane glycoprotein,0.344297658845499,1.4109985692112,1.24682800851153,1.59678556202215,4.88500253232947e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.171047716414682,CHRDL1;Chordin-like protein 1,0.511393110955655,1.6676127470683,1.35508801504243,2.05221523865194,1.36671548680223e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300808053005131,CHRDL1;Chordin-like protein 1,1.50837113625361,4.51936336852906,3.89585656185435,5.24265843275314,3.09016930934289e-88
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393213141183178,CHRDL1;Chordin-like protein 1,1.71407526601596,5.55153944079285,3.83947670642645,8.02702881647733,8.17422926289061e-20
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00662564142893,CHRDL1;Chordin-like protein 1,0.316725229808585,1.37262536357113,1.25740070039545,1.49840889075872,1.44086536207887e-12
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359790024182608,CHRDL1;Chordin-like protein 1,0.465671829851054,1.59308411090502,1.37870221458221,1.84080141278885,2.70184035140837e-10
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542634134832786,CHRDL1;Chordin-like protein 1,0.38688716825129,1.47239034952236,1.30891431409486,1.65628362225203,1.17044388311209e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16267227650748,CHRDL1;Chordin-like protein 1,0.291602658059151,1.33857104154247,1.26133600615528,1.4205353882806,6.79891245464914e-22
sensitivity,Circulatory system disorders,I50 (heart failure),0.900458093309478,CHRDL1;Chordin-like protein 1,0.549983034504104,1.73322361261987,1.5854024678296,1.89482743486302,1.16278128723475e-33
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55515797337947,CHRDL1;Chordin-like protein 1,0.256672796823642,1.2926221074971,1.20494448094004,1.38667958501017,7.93802013387945e-13
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355857892770776,CHRDL1;Chordin-like protein 1,0.487152087135548,1.62767413885246,1.40958293824318,1.87950849177492,3.1992688215193e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174979847826514,CHRDL1;Chordin-like protein 1,0.497800515999923,1.64509891975643,1.34637026171819,2.01010861033876,1.12218956721111e-06
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.173013782120598,CHRDL1;Chordin-like protein 1,0.500762391983856,1.64997872185495,1.35170422821417,2.01407210671442,8.5558581294401e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39590665120028,CHRDL1;Chordin-like protein 1,0.27410482596616,1.31535267812743,1.2205739108907,1.41749111005858,6.77686054858107e-13
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55981754910249,CHRDL1;Chordin-like protein 1,0.197941795102391,1.21889144630508,1.15256988370386,1.28902930649317,4.08191058942565e-12
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.053083774059729,CHRDL1;Chordin-like protein 1,0.972907693088002,2.64562595452831,1.86567963846549,3.75162838622752,4.77805567316247e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.522973477773627,CHRDL1;Chordin-like protein 1,0.392546106839029,1.48074613623089,1.312587703515,1.67044770729688,1.74275555127072e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300802139037433,EPHA1;Ephrin type-A receptor 1,1.59712662666066,4.93882094030556,4.20043409949832,5.80700749080053,2.99175179824008e-83
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393205410506448,EPHA1;Ephrin type-A receptor 1,1.89566308501365,6.65696107260793,4.40236873265147,10.0662014959222,2.59012604601271e-19
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55316137150047,EPHA1;Ephrin type-A receptor 1,0.217946677201271,1.24352075784408,1.15479849817869,1.33905947888566,7.88432416862968e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,HAVCR2;Hepatitis A virus cellular receptor 2,1.52108607287075,4.57719366245599,3.9430934248791,5.31326538991899,6.41636300543611e-89
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,HAVCR2;Hepatitis A virus cellular receptor 2,1.70915158575751,5.52427261728942,3.81244078114364,8.00473756892798,1.68273801284692e-19
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64693129409909,HAVCR2;Hepatitis A virus cellular receptor 2,0.212295704485192,1.2365134736029,1.17106987376526,1.30561429736513,1.98108058131225e-14
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69348417359769,HAVCR2;Hepatitis A virus cellular receptor 2,0.199185387371543,1.22040819319652,1.16507798093777,1.27836606852907,3.95624048728044e-17
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,HAVCR2;Hepatitis A virus cellular receptor 2,0.308698985668606,1.36165243191143,1.24705869531798,1.48677632599928,5.88595247920836e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,HAVCR2;Hepatitis A virus cellular receptor 2,0.414361409227039,1.51340398622329,1.38141580076875,1.65800306051368,5.59225689728258e-19
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.364618234853561,HAVCR2;Hepatitis A virus cellular receptor 2,0.41488018820463,1.51418931208361,1.31217166501008,1.74730893370618,1.35836834095796e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,HAVCR2;Hepatitis A virus cellular receptor 2,0.373502413193504,1.45281406946073,1.35405770185456,1.5587730992056,2.50668704104197e-25
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348850959832866,HAVCR2;Hepatitis A virus cellular receptor 2,0.466406426909385,1.59425481575209,1.37709888612411,1.84565425414168,4.29377678415494e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17344002522764,HAVCR2;Hepatitis A virus cellular receptor 2,0.740654710152625,2.09730819405954,1.71828410717408,2.55993851220766,3.27123072979704e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,HAVCR2;Hepatitis A virus cellular receptor 2,0.408998498532697,1.50530946031092,1.39749286216928,1.62144411083732,3.99626779161736e-27
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240450944065591,HAVCR2;Hepatitis A virus cellular receptor 2,0.563892777110977,1.75750075995774,1.47709577605665,2.09113652027231,2.03677718127056e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56415310024045,HAVCR2;Hepatitis A virus cellular receptor 2,0.245945828555185,1.27883029558052,1.20971706971945,1.35189207942138,4.09136651395778e-18
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0492727344396704,HAVCR2;Hepatitis A virus cellular receptor 2,0.974364769880624,2.64948364450136,1.83696682853554,3.82138831982966,1.84546392103269e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.516378256927746,HAVCR2;Hepatitis A virus cellular receptor 2,0.308761019324881,1.36173690281035,1.2055266938956,1.5381885792038,6.81144612636909e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197090937758681,HAVCR2;Hepatitis A virus cellular receptor 2,1.47113509059028,4.35417471985063,2.57059994414368,7.37525787868244,4.46651615306498e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.171809338069698,NPC2;NPC intracellular cholesterol transporter 2,0.642925947485213,1.90203800873432,1.523892896544,2.37401761952865,1.30856605136889e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.204313807434236,NPC2;NPC intracellular cholesterol transporter 2,1.40844641295799,4.0895969213379,3.41242708306527,4.9011458917367,1.6590149212732e-52
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0185739824940215,NPC2;NPC intracellular cholesterol transporter 2,1.48170668432115,4.40044945390049,2.50370215815732,7.73412897106926,2.60929167718042e-07
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.39971210327134,NPC2;NPC intracellular cholesterol transporter 2,0.202236361382559,1.22413731270746,1.16827130967056,1.28267479305403,2.1447927393923e-17
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.58410531448074,NPC2;NPC intracellular cholesterol transporter 2,0.325059749672179,1.38411334382869,1.30248610038106,1.4708561941691,1.05279972035146e-25
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53834366511109,NPC2;NPC intracellular cholesterol transporter 2,0.296390142222038,1.34499479374135,1.2765911427236,1.41706372122544,9.03361910766499e-29
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00763855030066,NPC2;NPC intracellular cholesterol transporter 2,0.339136942251393,1.40373556275939,1.27646504885308,1.543695639709,2.67761845772299e-12
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.392375380186204,NPC2;NPC intracellular cholesterol transporter 2,0.623437389971211,1.86532889727018,1.60925306275543,2.16215334649327,1.28687274940331e-16
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.550254231385386,NPC2;NPC intracellular cholesterol transporter 2,0.415430643553704,1.51502303513256,1.33331826265137,1.7214905557642,1.8521999143458e-10
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301827215527849,NPC2;NPC intracellular cholesterol transporter 2,0.453488829673159,1.57379331538433,1.32508812071694,1.86917787641798,2.37535399488671e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38076664112744,NPC2;NPC intracellular cholesterol transporter 2,0.436980660765205,1.54802613912587,1.32764789885719,1.80498528975922,2.44733616599149e-08
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0859046690348494,NPC2;NPC intracellular cholesterol transporter 2,0.98815681279686,2.68627859211975,1.99391003219816,3.61906633596982,8.14625528955876e-11
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13832973462422,NPC2;NPC intracellular cholesterol transporter 2,0.354580556737996,1.42558257785397,1.33432114857785,1.52308586913041,8.22329600760349e-26
sensitivity,Circulatory system disorders,I50 (heart failure),0.903159898771795,NPC2;NPC intracellular cholesterol transporter 2,0.668894670685815,1.95207843819639,1.76727449518837,2.15620733465351,1.11716563631605e-39
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65772793759141,NPC2;NPC intracellular cholesterol transporter 2,0.30011249660277,1.35001067064795,1.25300209658209,1.45452973768741,3.07055834703349e-15
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.53003180794502,NPC2;NPC intracellular cholesterol transporter 2,0.37859666575116,1.46023395458791,1.35127431960575,1.5779795199198,1.08302184923513e-21
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352905667386408,NPC2;NPC intracellular cholesterol transporter 2,0.481374775470561,1.61829766953616,1.38082438325369,1.89661145833419,2.76021746679536e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.167165842446193,NPC2;NPC intracellular cholesterol transporter 2,0.661313254308233,1.93733487790841,1.54454234474948,2.4300184724098,1.0630153823042e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40697917392212,NPC2;NPC intracellular cholesterol transporter 2,0.374477102044838,1.45423080146158,1.34161680715336,1.57629750361188,8.54453125002231e-20
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.143948364328666,NPC2;NPC intracellular cholesterol transporter 2,0.645161140753386,1.90629418620484,1.49378575641821,2.43271667891108,2.1533389701142e-07
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.234496528987021,NPC2;NPC intracellular cholesterol transporter 2,0.55230205329238,1.7372476548532,1.43229566256638,2.1071273851973,2.04579231552065e-08
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54463560168094,NPC2;NPC intracellular cholesterol transporter 2,0.184213601182936,1.20227260252124,1.13168823722359,1.27725937517861,2.40917151552102e-09
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0534001996703118,NPC2;NPC intracellular cholesterol transporter 2,0.941101180044051,2.56280197146367,1.76874584943133,3.71333956602624,6.55727226154866e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.513106266397343,NPC2;NPC intracellular cholesterol transporter 2,0.339755528149753,1.40460416240759,1.22988910220713,1.60413881992465,5.35372230390902e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0185739824940215,NPC2;NPC intracellular cholesterol transporter 2,1.64150731816159,5.1629458521034,3.039253405951,8.77057826753045,1.26668598784649e-09
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0947908105357,XG;Glycoprotein Xg,0.285298716536152,1.3301593093627,1.29731730038486,1.36383272446869,8.28165888834002e-111
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305271809322531,XG;Glycoprotein Xg,1.57092822864844,4.81111193369679,4.19709563131402,5.51495607244785,1.32340672451582e-112
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0391374114516065,XG;Glycoprotein Xg,1.48300750615684,4.40617737933453,3.20832387990983,6.05125910751409,5.10699863141837e-20
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65351649641892,XG;Glycoprotein Xg,0.21271489294215,1.23703191443252,1.15955552387121,1.31968493601393,1.14860555953407e-10
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69848538217682,XG;Glycoprotein Xg,0.245437033817788,1.27817979895477,1.20936810856423,1.3509067974313,3.53806805812088e-18
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00583147430628,XG;Glycoprotein Xg,0.331252788555927,1.39271180942049,1.25341858427313,1.5474847815697,7.22478185195101e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.168212594419,XG;Glycoprotein Xg,0.227305095123564,1.25521276882151,1.16816061415236,1.34875211158855,5.7031914476848e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.907987945677273,XG;Glycoprotein Xg,0.536977591314231,1.71082821807144,1.54952098898473,1.88892774770821,2.22059166569302e-26
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.36202105592736,XG;Glycoprotein Xg,0.403484786183268,1.49703245642826,1.26916388038836,1.76581307601809,1.6748802768623e-06
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55962584634652,XG;Glycoprotein Xg,0.398926170277307,1.49022359175129,1.37317443536897,1.61724999840636,1.19673106260578e-21
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354193573637039,XG;Glycoprotein Xg,0.485564776359983,1.62509256357592,1.37655656532098,1.91850150347723,9.82210930750942e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.176118351532229,XG;Glycoprotein Xg,0.781562060780937,2.18488252058827,1.79647775457149,2.65726175379824,5.03263143595449e-15
sensitivity,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0117412234354819,XG;Glycoprotein Xg,1.5463545494382,4.69432601905321,2.50515529820557,8.79653919617068,1.3924376522109e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56154357950765,XG;Glycoprotein Xg,0.221553571847437,1.24801410485115,1.16492322530911,1.33703163613562,2.92747287196268e-10
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,MFGE8;Lactadherin,0.27053876485332,1.31067040369264,1.19953175195584,1.43210624005147,2.1743656071531e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301549134770783,CNTN4;Contactin-4,0.434412790777836,1.54405610870605,1.31593634231474,1.81172081822651,1.00412965572814e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1522330403248,CNTN4;Contactin-4,0.269170080843144,1.30887773714537,1.23151626821007,1.39109890386161,4.74324555938322e-18
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,CNTN4;Contactin-4,0.242939639933668,1.27499166321443,1.16139110590567,1.399703969662,3.35539382734109e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301308365857111,AGR3;Anterior gradient protein 3,0.41201575612165,1.5098582256512,1.28430934407624,1.77501773391385,6.00311643663654e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,DLL1;Delta-like protein 1,1.6800537509578,5.36584438264571,4.53422692065182,6.34998786841296,3.82841036237178e-85
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,DLL1;Delta-like protein 1,1.91798144728793,6.8072038919137,4.46261700815359,10.383598848259,5.44527406643562e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00023581197924,DLL1;Delta-like protein 1,0.233374613306133,1.26285447281612,1.15615353085985,1.37940280156876,2.20061300728594e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.898050620971545,DLL1;Delta-like protein 1,0.397505865297543,1.48810852214047,1.35502042771624,1.63426833158477,9.11730959666136e-17
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.363543468008174,DLL1;Delta-like protein 1,0.399419284457978,1.49095862334911,1.28810080328988,1.72576370642851,8.66091509863135e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55242886338626,DLL1;Delta-like protein 1,0.361881727545397,1.43602908923083,1.33705539028179,1.54232918105399,3.01660715606853e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351752869045747,DLL1;Delta-like protein 1,0.540317102869362,1.71655109916969,1.47926394223722,1.99190123677615,1.09293237165026e-12
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172928784782266,DLL1;Delta-like protein 1,0.635519516897078,1.88800273604205,1.52790160619145,2.33297374442032,3.95934871836626e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39522087722056,DLL1;Delta-like protein 1,0.314632524168193,1.36975586628445,1.27069646841648,1.47653761528021,2.12401308036002e-16
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239742178902688,DLL1;Delta-like protein 1,0.576929704072108,1.78056317385969,1.48729116002578,2.13166412960481,3.32225782414828e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55659487501965,DLL1;Delta-like protein 1,0.236939781152803,1.2673647962303,1.19865901523888,1.34000871499204,7.95086550584305e-17
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0569878949850652,DLL1;Delta-like protein 1,1.41280937849124,4.10747867211613,2.87974376038152,5.8586396727373,6.30043659025607e-15
sensitivity,Circulatory system disorders,I95 (hypotension),0.512891054865587,DLL1;Delta-like protein 1,0.337821129990572,1.40188972494929,1.23936406053273,1.58572840983757,7.72928173437542e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216160980977833,DLL1;Delta-like protein 1,1.79994921415749,6.04934023577112,3.47084330878579,10.5434080517225,2.15106323014891e-10
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00880483278714,CCL7;C-C motif chemokine 7,0.22026924837083,1.24641227988804,1.14380892882646,1.35821948255784,5.0205378861602e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.900225056264065,CCL7;C-C motif chemokine 7,0.300735631975722,1.35085217220816,1.23308779511584,1.47986347637807,1.03292093370302e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38784696174043,CCL7;C-C motif chemokine 7,0.289596784645372,1.33588872856729,1.24188792140271,1.43700463170415,7.30054423418661e-15
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199541284403669,ATRAID;All-trans retinoic acid-induced differentiation factor,1.55743037545425,4.74660855898659,3.86042299187618,5.83622386967883,2.24909575636397e-49
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.993119266055046,ATRAID;All-trans retinoic acid-induced differentiation factor,0.305761881924058,1.35765898490978,1.23461983571075,1.49295991040444,2.82089286388023e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.905963302752293,ATRAID;All-trans retinoic acid-induced differentiation factor,0.440005150813878,1.55271521623782,1.40413140058194,1.71702202638389,1.00230996351646e-17
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54816513761467,ATRAID;All-trans retinoic acid-induced differentiation factor,0.278807907726284,1.32155345927685,1.22398235351964,1.42690255354126,1.04285770036473e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39678899082568,ATRAID;All-trans retinoic acid-induced differentiation factor,0.307075330474653,1.35944337172933,1.25454404462463,1.4731139084812,6.63954188507129e-14
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.53669724770642,ATRAID;All-trans retinoic acid-induced differentiation factor,0.196055785055071,1.21659477124766,1.14585235242142,1.29170467233355,1.41460094100272e-10
sensitivity,Circulatory system disorders,I95 (hypotension),0.504587155963302,ATRAID;All-trans retinoic acid-induced differentiation factor,0.363805461615963,1.43879428621516,1.25963870352772,1.64343076490729,8.22917395654544e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302784429360194,PRSS8;Prostasin,0.918987002221539,2.50674977138351,2.14696155856304,2.9268313590752,3.0572090076162e-31
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63006867071698,PRSS8;Prostasin,0.269178621108787,1.30888891535667,1.2356259347139,1.38649581933567,5.22684593711221e-20
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67497179948942,PRSS8;Prostasin,0.221386284539946,1.24780534539373,1.18828206676195,1.31031025675244,6.84087465970429e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00136549840691,PRSS8;Prostasin,0.236246404419024,1.26648633955329,1.15721952662681,1.38607032751215,2.86790982182667e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.900437355286853,PRSS8;Prostasin,0.327144305794828,1.38700161510992,1.25962103976021,1.52726369248622,2.81459736125058e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55745977716649,PRSS8;Prostasin,0.248949597925257,1.28267738183927,1.19229908583192,1.37990650620525,2.42304263148675e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38924620529971,PRSS8;Prostasin,0.226959194759235,1.25477866535007,1.16204835209572,1.35490876621286,6.87405207691894e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300312089033701,SMOC2;SPARC-related modular calcium-binding protein 2,1.36781540871913,3.9267629464302,3.34011592477299,4.61644672961619,1.18677034931716e-61
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392564822266276,SMOC2;SPARC-related modular calcium-binding protein 2,1.90519791631568,6.7207376396474,4.25070634503423,10.6260726464296,3.60651688287488e-16
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304237737256364,SMOC2;SPARC-related modular calcium-binding protein 2,0.408885218070857,1.5051389478181,1.27607616506096,1.77531977656737,1.20894092749011e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,SMOC2;SPARC-related modular calcium-binding protein 2,0.451705139021201,1.57098865702461,1.42485870706861,1.73210532964175,1.21284841252442e-19
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35527116415098,SMOC2;SPARC-related modular calcium-binding protein 2,0.477085672054505,1.61137148764683,1.38543177600849,1.87415801785772,6.03572083866629e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39360511904528,SMOC2;SPARC-related modular calcium-binding protein 2,0.2277856252854,1.25581608135978,1.16252493924502,1.3565937185193,7.30739786497059e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200789148046975,MXRA8;Matrix remodeling-associated protein 8,1.01918688616477,2.77094075744006,2.26973198043234,3.38282790542519,1.35516489614868e-23
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0536994233148887,MXRA8;Matrix remodeling-associated protein 8,0.998443008004182,2.71405277856252,1.84528845912655,3.99183252265589,3.93135308703783e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.295162941991446,GPR37;Prosaposin receptor GPR37,1.54708936694119,4.69777675965378,3.94718961112761,5.59109357739687,6.01399050294434e-68
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0401582234001967,GPR37;Prosaposin receptor GPR37,1.7492410566065,5.75023691521481,3.63717441899125,9.09090980307445,7.14693116202498e-14
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.62835572154287,GPR37;Prosaposin receptor GPR37,0.202433712489913,1.22437892140177,1.15657432022448,1.29615859262896,3.30126327380027e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540128104732646,GPR37;Prosaposin receptor GPR37,0.305604857171328,1.35744581558025,1.20078399619945,1.53454671953362,1.03745801348217e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301186675501475,GPR37;Prosaposin receptor GPR37,0.540464737319901,1.71680453995588,1.45521945359404,2.02541123342854,1.47454815197339e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15649659659056,GPR37;Prosaposin receptor GPR37,0.186317711798212,1.20480498033388,1.13218492195046,1.2820829994244,4.25448758283954e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.907575848844447,GPR37;Prosaposin receptor GPR37,0.549883378962881,1.73305089588892,1.57377469641197,1.9084468790793,5.15199836935983e-29
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57621026845772,GPR37;Prosaposin receptor GPR37,0.193318833990648,1.21326956343478,1.128774972048,1.30408900800348,1.52993292418018e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39750617432684,GPR37;Prosaposin receptor GPR37,0.248420367980264,1.28199873015627,1.18780249607116,1.38366500285906,1.77047702288812e-10
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.123116208020792,PROS1;Vitamin K-dependent protein S,-1.60911706933481,0.200064178914987,0.15511344511239,0.258041304259128,2.84853334768183e-35
sensitivity,Circulatory system disorders,I07 (rheumatic tricuspid valve diseases),0.0524383848977451,PROS1;Vitamin K-dependent protein S,-1.06730897660401,0.343932804445332,0.232847371283318,0.508014212579198,8.18758458662557e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173274663140375,PROS1;Vitamin K-dependent protein S,-1.13598126740523,0.321106874979187,0.260172481372593,0.396312571625268,3.66322962277432e-26
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0319190168942796,PROS1;Vitamin K-dependent protein S,-1.91744223248553,0.14698242862879,0.089694953430262,0.24085897254425,2.76035606917287e-14
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.5512414217642,PROS1;Vitamin K-dependent protein S,-0.234712266841069,0.790798355805623,0.745731592509685,0.838588636751037,4.50682483930424e-15
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53389115615239,PROS1;Vitamin K-dependent protein S,-0.237999941628936,0.788202737102001,0.74952585275837,0.828875418357806,1.84225577026992e-20
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.996329313057157,PROS1;Vitamin K-dependent protein S,-0.487894446644642,0.613917670693007,0.559378041821398,0.673774939684644,8.81648988885375e-25
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.396707781400332,PROS1;Vitamin K-dependent protein S,-1.03908312515249,0.353778904279332,0.306969154445181,0.407726676445063,1.07151655631726e-46
sensitivity,Circulatory system disorders,I33 (acute and subacute endocarditis),0.0478785253414194,PROS1;Vitamin K-dependent protein S,-1.33696303509029,0.262642093432598,0.178512692145843,0.386419970554814,1.15070291221713e-11
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554022936093568,PROS1;Vitamin K-dependent protein S,-0.692799260755823,0.500173990167618,0.442721101279108,0.565082666530677,9.11030717392487e-29
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.344269396502587,PROS1;Vitamin K-dependent protein S,-1.09182611674112,0.33560308338882,0.289047053346918,0.3896577677438,1.43464974030406e-46
sensitivity,Circulatory system disorders,I36 (nonrheumatic tricuspid valve disorders),0.0205193680034654,PROS1;Vitamin K-dependent protein S,-1.72781643564068,0.177671944838635,0.0970868043102406,0.325145319253375,2.09913851057826e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307790520051982,PROS1;Vitamin K-dependent protein S,-0.534725289869588,0.585830201532849,0.497771502544284,0.689467000970966,1.24211209063374e-10
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.37846834317503,PROS1;Vitamin K-dependent protein S,-0.596885691071321,0.550523469277583,0.475592714886246,0.637259740822389,1.28542350218223e-15
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.699938441895989,PROS1;Vitamin K-dependent protein S,-0.297490864704836,0.742679367785029,0.664317078808243,0.830285207062669,1.70325922317196e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13857413191673,PROS1;Vitamin K-dependent protein S,-1.05378977055297,0.348614075128795,0.326472377236857,0.372257446116899,1.91444859007309e-217
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.23800186954241,PROS1;Vitamin K-dependent protein S,-0.404629282328691,0.667224116786118,0.613784722607113,0.725316231609732,2.10319377393025e-21
sensitivity,Circulatory system disorders,I50 (heart failure),0.898292332596156,PROS1;Vitamin K-dependent protein S,-0.757910788334876,0.46864450251222,0.426248120178283,0.515257802528407,2.59075256558545e-55
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65750894872437,PROS1;Vitamin K-dependent protein S,-0.430984379398444,0.649869062041146,0.604467650386066,0.698680562191379,1.95469464417728e-31
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.360228904949727,PROS1;Vitamin K-dependent protein S,-0.666902811389249,0.513295892603502,0.441968366567486,0.596134685859685,2.40423865212396e-18
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54807231937256,PROS1;Vitamin K-dependent protein S,-0.309241744226892,0.734003307514747,0.68102929641196,0.791097913527478,5.90449610959586e-16
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.141355646246095,PROS1;Vitamin K-dependent protein S,-0.593144607347173,0.552586880959613,0.436796309633785,0.699072437825046,7.65496771349366e-07
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5512414217642,PROS1;Vitamin K-dependent protein S,-0.399387989471405,0.67073041452345,0.632086419382289,0.711736995403961,9.8495165748024e-40
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,NBL1;Neuroblastoma suppressor of tumorigenicity 1,1.84638419538261,6.33686518202046,5.31896769283811,7.54955898475794,6.90404405176607e-95
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,NBL1;Neuroblastoma suppressor of tumorigenicity 1,2.06883979672162,7.91563404371531,5.15602972662418,12.1522306185477,3.10665826017438e-21
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65091966671906,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.192480505165608,1.21225287080812,1.14739048139771,1.2807819540148,6.86724805236295e-12
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00023581197924,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.293327121404785,1.34088134968747,1.22772048299529,1.46447242580262,7.0012184714288e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.898050620971545,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.522982904415678,1.68705246795296,1.53615582039051,1.85277169922947,7.46245138112995e-28
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.363543468008174,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.397973166994278,1.48880408028289,1.28677586466645,1.7225514173298,8.86086138136814e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55242886338626,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.364505699834247,1.43980213778953,1.3408114419987,1.54610121233237,1.12933823572773e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351752869045747,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.509037049273225,1.66368837342235,1.43388034038147,1.9303277448691,1.92533299086607e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172928784782266,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.690515472702782,1.99474350410027,1.61525497288259,2.46338919486457,1.42252882318947e-10
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168998585128124,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.532924556338061,1.70390820446694,1.37573965815943,2.11035798236276,1.04786788552917e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39522087722056,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.285288947963663,1.33014631566853,1.23426009648952,1.43348166737203,7.80164750332869e-14
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.145417387203269,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.563277970412317,1.75642056880602,1.39527315744334,2.21104605794736,1.61781004741899e-06
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239742178902688,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.530651080844367,1.70003881107275,1.42043532797409,2.03468042665184,7.11712229441675e-09
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0569878949850652,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.963299601931883,2.62032826505903,1.82245427235389,3.76751302944845,1.99785534994875e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.512891054865587,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.374778310852636,1.45466889456299,1.2862797546955,1.64510215222196,2.36101526735257e-09
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.11489776046738,BLMH;Bleomycin hydrolase,0.843963694405655,2.32556656774756,1.81509839480006,2.97959596929781,2.47823735087564e-11
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0272638753651411,BLMH;Bleomycin hydrolase,1.22721951793306,3.41173008156899,2.08231400451318,5.58988804006244,1.10694095450281e-06
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.37585199610516,BLMH;Bleomycin hydrolase,0.455133783312825,1.57638426283654,1.367943043988,1.81658684916746,3.18002781202971e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,ASGR1;Asialoglycoprotein receptor 1,1.30077450694066,3.67213966417382,3.17088154269088,4.25263748634246,1.36517834185758e-67
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039736151951045,ASGR1;Asialoglycoprotein receptor 1,1.3205215944997999,3.74537443456938,2.59257211434605,5.41077703393576,1.98479904627524e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,ASGR1;Asialoglycoprotein receptor 1,0.452419443620578,1.57211122232694,1.43498862528321,1.72233678498916,2.57176220156373e-22
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55567034888341,ASGR1;Asialoglycoprotein receptor 1,0.282540962973153,1.32649611120844,1.23650651404634,1.42303490767149,3.20255853276841e-15
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.164905030596837,ASGR1;Asialoglycoprotein receptor 1,0.527613509869029,1.69488265757897,1.37458427491759,2.08981528115778,7.93553254992483e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39275212588412,ASGR1;Asialoglycoprotein receptor 1,0.243612858293126,1.27585030000286,1.18471281866902,1.3739987973171,1.17491020978137e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305367419645304,CD5;T-cell surface glycoprotein CD5,1.1289847895958,3.09251535217078,2.66025091756652,3.59501847749023,6.78740110864384e-49
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0391496691852953,CD5;T-cell surface glycoprotein CD5,1.24273951571592,3.46509315110371,2.32846537458577,5.15655962801759,8.94697719028242e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.908272325098852,CD5;T-cell surface glycoprotein CD5,0.27799815920983,1.32048376647332,1.20543126366558,1.44651746646859,2.27306987280933e-09
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.368006890341776,CD5;T-cell surface glycoprotein CD5,0.355019300934309,1.42620818116624,1.2361342388043,1.64550880654601,1.14527884395494e-06
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56207180049328,CD5;T-cell surface glycoprotein CD5,0.276114664457021,1.31799898300089,1.22829661159327,1.4142523090885,1.61935255239497e-14
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304699402320403,BSG;Basigin,1.74083670176136,5.70211239477428,4.84980116503273,6.70421006062402,1.35684023451183e-98
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390640259385132,BSG;Basigin,1.91790518714402,6.80668479335882,4.533170858099,10.2204305388946,2.29441551736279e-20
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00003906402593,BSG;Basigin,0.268579986934669,1.30810560420362,1.19787719115013,1.42847721318241,2.23236344459433e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.900425797882729,BSG;Basigin,0.321446959614036,1.37912185493068,1.25662605486442,1.51355853508277,1.25920903788292e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54888862846204,BSG;Basigin,0.282024491540777,1.325811190748,1.2348403468466,1.42348386817894,7.47043871000728e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35548263604047,BSG;Basigin,0.453254666198146,1.57342483361681,1.3585807159054,1.82224410964956,1.44006150722554e-09
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.105472870033985,BSG;Basigin,0.660423161638067,1.93561123754755,1.48331938796203,2.52581533911446,1.15262231638517e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40044532989569,BSG;Basigin,0.267960787472634,1.30729587663452,1.21332771944271,1.40854155203062,1.91288094927739e-12
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240243759521856,BSG;Basigin,0.453509643692839,1.57382607269027,1.31716153420665,1.88050473898145,5.95248715192494e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.519551544982225,BSG;Basigin,0.313554358579242,1.36827983848833,1.21138695584836,1.54549271591134,4.50943680431082e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214852142661822,BSG;Basigin,1.54542979212695,4.68998691336478,2.73695598559053,8.03665728032781,1.86598798300249e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.307813733228097,TFF3;Trefoil factor 3,1.43621572105176,4.20475371038387,3.59846617069721,4.9131916006206104,4.72720451350541e-73
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394632991318074,TFF3;Trefoil factor 3,1.74231944681566,5.71057344496674,3.78621784281909,8.61298805936598,9.59507704845909e-17
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.55209155485398,TFF3;Trefoil factor 3,0.192838789955257,1.21268728038947,1.16167439553241,1.26594030622875,1.4364770373584e-18
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65390686661404,TFF3;Trefoil factor 3,0.276751462197953,1.31883854906433,1.24558958583734,1.3963950391644,2.25638422910855e-21
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67797947908445,TFF3;Trefoil factor 3,0.274720826098777,1.31616318516219,1.25397556446496,1.3814348373809,9.5420210759514e-29
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0023677979479,TFF3;Trefoil factor 3,0.271142100740522,1.31146141678278,1.20248816029098,1.43031017227954,9.00961812181898e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.355169692186266,TFF3;Trefoil factor 3,0.509713771451321,1.66481460927349,1.44543873392005,1.91748540993765,1.54748466321658e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544593528018942,TFF3;Trefoil factor 3,0.316161769508027,1.37185216152601,1.21909891107647,1.54374541391541,1.52769791746401e-07
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.378847671665351,TFF3;Trefoil factor 3,0.351483032922315,1.42117363379765,1.23216556550248,1.6391745995417,1.38439794713363e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303867403314917,TFF3;Trefoil factor 3,0.486468362505382,1.62656163831919,1.38780526172454,1.90639337969072,1.89867452918517e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.380820836621941,TFF3;Trefoil factor 3,0.407968330077628,1.50375953646819,1.30220107736667,1.73651579838333,2.75739755532656e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15272296764009,TFF3;Trefoil factor 3,0.352373722080388,1.42244002164025,1.33741888628429,1.51286604063539,3.81745550817244e-29
sensitivity,Circulatory system disorders,I50 (heart failure),0.913575374901341,TFF3;Trefoil factor 3,0.677149862861554,1.96825991957023,1.79204881116922,2.16179776289631,1.85165610468995e-45
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71073401736385,TFF3;Trefoil factor 3,0.258564961596559,1.29507027695317,1.21069511865824,1.38532566655289,5.38301436235114e-14
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.363062352012628,TFF3;Trefoil factor 3,0.421203981682001,1.52379507299148,1.31677063908321,1.76336816417,1.57145480987804e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55880031570639,TFF3;Trefoil factor 3,0.362312493599894,1.43664781506922,1.33826502173791,1.54226323711491,1.37257432145561e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.343330702446724,TFF3;Trefoil factor 3,0.381252646035949,1.46411746215931,1.26316679565331,1.69703632994179,4.15846259813053e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.169692186266771,TFF3;Trefoil factor 3,0.718813503830532,2.05199707902524,1.65687269532217,2.54134914783502,4.48653951382693e-11
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171665351223362,TFF3;Trefoil factor 3,0.660658161897103,1.93606616014114,1.55413159927455,2.41186279089451,3.79966573938263e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38910812943962,TFF3;Trefoil factor 3,0.269816834477474,1.30972453238319,1.21658092296262,1.40999938298315,7.58720105432224e-13
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240726124704025,TFF3;Trefoil factor 3,0.547243140489983,1.72848126335244,1.44754277401191,2.06394417588097,1.4763885688727e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54538279400157,TFF3;Trefoil factor 3,0.193850247461314,1.21391448256852,1.14918883714393,1.28228566390524,4.09183295947648e-12
sensitivity,Circulatory system disorders,I95 (hypotension),0.518942383583267,TFF3;Trefoil factor 3,0.42872965812998,1.5353059208149,1.36343925595317,1.72883702753696,1.46253428246898e-12
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173470795797275,NPDC1;Neural proliferation differentiation and control protein 1,0.530072069048835,1.69905475346625,1.37973672874634,2.09227383393589,6.02186375853291e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,NPDC1;Neural proliferation differentiation and control protein 1,1.78643617638007,5.96814510460435,5.07300441839799,7.02123496294153,5.72495339393903e-103
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394251808630172,NPDC1;Neural proliferation differentiation and control protein 1,1.98263264959423,7.26183571074281,4.81443488144631,10.9533640371884,3.24894618207929e-21
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70399574208046,NPDC1;Neural proliferation differentiation and control protein 1,0.183365624090344,1.20125353502926,1.14702174928645,1.25804942784909,7.27890125828528e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00928463009324,NPDC1;Neural proliferation differentiation and control protein 1,0.332652222063946,1.39466218138324,1.27822500939965,1.52170594838715,7.50963215462689e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360740404896607,NPDC1;Neural proliferation differentiation and control protein 1,0.521248983224403,1.68412978650987,1.45714187212221,1.9464769986185,1.70367334589909e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540124977823335,NPDC1;Neural proliferation differentiation and control protein 1,0.346311258253216,1.41384261752049,1.25580974235524,1.5917625733403,1.02566320664994e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309487669774685,NPDC1;Neural proliferation differentiation and control protein 1,0.470622884456484,1.60099111518214,1.37055324909452,1.8701736343229,2.9321138052381e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.394251808630172,NPDC1;Neural proliferation differentiation and control protein 1,0.352464784644648,1.42256955857402,1.23918166553632,1.63309723284649,5.57353273245832e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,NPDC1;Neural proliferation differentiation and control protein 1,0.244420267381944,1.27688084911243,1.2028803712166,1.35543379195809,1.02190656263452e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,NPDC1;Neural proliferation differentiation and control protein 1,0.655072574883575,1.92528223944052,1.75744107525284,2.10915276403894,5.33963082396009e-45
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71696662658439,NPDC1;Neural proliferation differentiation and control protein 1,0.23139823045886,1.26036105368448,1.17868059786515,1.3477018188997,1.29783883565414e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56912219834808,NPDC1;Neural proliferation differentiation and control protein 1,0.280224308459406,1.32342663483589,1.23398631446863,1.41934966154567,4.19371906118546e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356797886810305,NPDC1;Neural proliferation differentiation and control protein 1,0.375754221382752,1.45608921419474,1.25880962018926,1.68428630166926,4.22424274226234e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175442054840426,NPDC1;Neural proliferation differentiation and control protein 1,0.708319167966704,2.03057533258696,1.65698887035121,2.48839099349938,8.60163697269713e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3917088844645,NPDC1;Neural proliferation differentiation and control protein 1,0.330088607464802,1.39109138408386,1.29127000703266,1.49862943329668,3.67453123573727e-18
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242464862307555,NPDC1;Neural proliferation differentiation and control protein 1,0.565032850872649,1.75950558306624,1.47703983010899,2.09598944709083,2.47541267473955e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54883794279406,NPDC1;Neural proliferation differentiation and control protein 1,0.215702531173828,1.24073324463853,1.17380320335353,1.31147962448319,2.46206218909373e-14
sensitivity,Circulatory system disorders,I95 (hypotension),0.524354905478128,NPDC1;Neural proliferation differentiation and control protein 1,0.420669357666054,1.522980633279,1.35008295487257,1.71802036383892,7.80359147740547e-12
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.111152278621711,NFASC;Neurofascin,0.654815576193827,1.92478750800298,1.47495344515649,2.51181280543485,1.42525772102639e-06
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6403541272596,NFASC;Neurofascin,0.255486358720242,1.29108940078608,1.22222587771541,1.3638328816421,6.50734702322969e-20
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68752559427468,NFASC;Neurofascin,0.224757329880183,1.25201885175917,1.19498437658522,1.31177548081405,3.44613307494838e-21
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356857315574969,NFASC;Neurofascin,0.447063304666276,1.56371328650096,1.34930262371362,1.81219483265349,2.82393445639989e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540161073302002,NFASC;Neurofascin,0.348105470039027,1.41638162768798,1.25678941092221,1.59623951142299,1.14813355653669e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304206236227842,NFASC;Neurofascin,0.543318262814378,1.72171048176576,1.46811347661087,2.01911298428042,2.33951483397855e-11
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15479417328055,NFASC;Neurofascin,0.397426049874901,1.48798975286971,1.40039864686041,1.58105944304441,9.89340752514244e-38
sensitivity,Circulatory system disorders,I50 (heart failure),0.898968428852791,NFASC;Neurofascin,0.548225449593569,1.73018000043867,1.57598456012488,1.899462031329,1.16053231360896e-30
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7004348589146,NFASC;Neurofascin,0.223783508298846,1.25080020225099,1.16909158956964,1.33821948588907,8.44470155688142e-11
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0526510793471266,NFASC;Neurofascin,1.34787380444792,3.8492326026612,2.61711840653658,5.661414322097,7.51257721668209e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.193895870736086,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,0.772764800573159,2.16574583913271,1.76222138822855,2.6616718370645,2.0480398404253e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,LSP1;Lymphocyte-specific protein 1,0.4989416447856,1.64697726099986,1.4086002402819,1.92569475758981,3.98027620686267e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.900225056264065,LSP1;Lymphocyte-specific protein 1,0.231836143767543,1.26091310342977,1.1496073026178,1.38299561144096,8.79664417808797e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,REG1B;Lithostathine-1-beta,1.23295735675809,3.43136230830564,2.94308003156732,4.0006548121596,7.67929518584296e-56
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,REG1B;Lithostathine-1-beta,1.24522339858831,3.47371073473651,2.28598463299538,5.27854216273206,5.45091020666548e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,REG1B;Lithostathine-1-beta,0.398616354129577,1.48976196793179,1.36009933683914,1.63178575342433,9.4956700266043e-18
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55793573515092,REG1B;Lithostathine-1-beta,0.203176627109096,1.2252888683665,1.14261997880291,1.31393887626204,1.19224700144743e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39435248296007,REG1B;Lithostathine-1-beta,0.193738304695567,1.21377860122957,1.12774402233571,1.30637668089918,2.40545475522015e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301305657850686,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,1.70920072693755,5.52454409323498,4.67458452853682,6.52904814358993,1.92127922380057e-89
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393863605033576,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,1.86728331651806,6.47069367297702,4.18074396338744,10.014934417457,5.34725296252868e-17
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00435219283562,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.252145728970349,1.28678354526295,1.17902655923773,1.40438896764972,1.59735746851903e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.901947655526891,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.357920981414765,1.43035259157609,1.3042846648055,1.56860583539371,2.89052575997782e-14
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55773055790779,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.288583218227142,1.33453540257227,1.24372878021539,1.43197196129071,1.00395872166364e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356446562555387,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.427454180723408,1.53334892112048,1.32514964051445,1.77425917950562,9.40520443392473e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175269304239941,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.512362908054661,1.66923077752648,1.35646198593989,2.05411682562634,1.29855678055731e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39230784379369,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.272603830975766,1.31337982134144,1.21912105354214,1.41492639315432,7.26982722593557e-13
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56011343271824,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.191172331350134,1.21066807016816,1.14553310058039,1.2795066117095,1.2412038420108e-11
sensitivity,Circulatory system disorders,I95 (hypotension),0.523838594694657,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.335407543993265,1.39851022353861,1.23939202116946,1.57805666966981,5.2524065118198e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301798958497711,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,1.33705198558451,3.8078014890141,3.33741278749833,4.34448871115114,6.76591080970412e-88
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394508442480669,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,1.496223990686,4.46479808100221,3.23507167384456,6.16197225714969,8.83612244027715e-20
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63531639577086,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.292708054727934,1.34005151161532,1.27004673981486,1.41391493516551,1.10397983565208e-26
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67879122613223,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.249154854268393,1.28294068652965,1.22539168231532,1.343192408523,1.93270114651394e-26
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0040239861133,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.344976111614237,1.41195618991064,1.29586184447487,1.53845125599392,3.26289594237467e-15
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360975224869812,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.397014545816603,1.48737756501523,1.29124605719785,1.71330011702926,3.73798086885425e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544421650623323,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.325045816007895,1.38409405819239,1.2325679777944,1.55424803859623,3.915778017076e-08
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384645731418652,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.365945259877089,1.44187631200765,1.25790302538067,1.65275641856386,1.48400380010517e-07
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.710115196465204,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.274316299722724,1.3156308701136,1.18758912151773,1.45747763686468,1.51316209489662e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16190626479406,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.266779798402959,1.30575288580037,1.23091042191971,1.3851459605947,8.11052027940204e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.901451791068328,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.579697220695982,1.78549773713661,1.6358776519071,1.94880232369663,1.54094347914151e-38
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70230392930408,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.237207915275599,1.26770466554144,1.18600276207547,1.35503488729083,2.97829657490018e-12
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.362947767082215,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.412537357198062,1.51064597475446,1.31341822173414,1.73749017889276,7.49817799766892e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56028089001104,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.381752455917192,1.46484942544021,1.36762752838198,1.5689826320995,1.21620526593946e-27
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357030140445005,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.443829275004105,1.55866435993895,1.35374941444004,1.79459696235495,6.76173998159379e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175556256903897,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.724806972173431,2.06433258787301,1.70978448238317,2.49240128054891,4.74570982041679e-14
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.173583714691494,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.517248865256383,1.67740652457569,1.37767149038263,2.04235383277593,2.60553885211587e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38866971753195,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.281468173973555,1.32507382381587,1.23108374252691,1.42623980636608,6.46990710964403e-14
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151885750355057,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.599167681362622,1.82060284791869,1.47791896774447,2.24274456326128,1.78672550844708e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240650149913208,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.59038818004408,1.80468882363392,1.52786496068411,2.13166859241989,3.67667867663801e-12
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56035979169954,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.241585217175598,1.27326595442287,1.20527766583873,1.34508938200909,6.20901338675544e-18
sensitivity,Circulatory system disorders,I95 (hypotension),0.524696228499289,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.386536833671334,1.47187461061359,1.30858092174068,1.65554520425617,1.17509309042879e-10
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216979643364368,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,1.16144634984207,3.19455037377068,1.99916448800277,5.1047085679046,1.1939023009988e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,LGALS1;Galectin-1,1.05394463187148,2.8689457617012,2.49381522029923,3.30050507214232,3.50640372179575e-49
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394251808630172,LGALS1;Galectin-1,1.23176439777928,3.42727127453331,2.37458514560328,4.9466275871346,4.72714556322671e-11
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00928463009324,LGALS1;Galectin-1,0.252528208618279,1.28727580791452,1.18113972570878,1.40294917660787,8.8218140067938e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,LGALS1;Galectin-1,0.429227068446128,1.53606978778026,1.40577739759244,1.67843813463798,2.28345364420768e-21
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0817916260954,"FABP4;Fatty acid-binding protein, adipocyte",0.260808938586885,1.29797964791543,1.26990946197472,1.32667029961557,6.74515556042838e-121
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,"FABP4;Fatty acid-binding protein, adipocyte",1.42768379887574,4.16903168442487,3.59315657043683,4.83720228857866,4.82013821666394e-79
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,"FABP4;Fatty acid-binding protein, adipocyte",1.44036741590874,4.22224685270584,2.98251151599965,5.97730080489199,4.60225257277834e-16
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.57254138266796,"FABP4;Fatty acid-binding protein, adipocyte",0.231801445977685,1.2608693532909,1.20512331962519,1.31919406103822,9.46700947821028e-24
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65433300876338,"FABP4;Fatty acid-binding protein, adipocyte",0.336532367586791,1.40008418588287,1.32179422644102,1.48301126479975,2.03030584356376e-30
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6981499513145,"FABP4;Fatty acid-binding protein, adipocyte",0.277109673242529,1.3193110562222,1.25548665083781,1.38638006378532,6.42100897183135e-28
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00681596884128,"FABP4;Fatty acid-binding protein, adipocyte",0.324672076563096,1.38357686430143,1.25851599419405,1.5210652453059,1.85707688666616e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356377799415774,"FABP4;Fatty acid-binding protein, adipocyte",0.547128709948453,1.72828348362169,1.48160070087892,2.01603832799727,3.32929660513523e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543330087633885,"FABP4;Fatty acid-binding protein, adipocyte",0.482728032683077,1.62048912499648,1.43000837836406,1.83634239069004,3.84455665061159e-14
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307692307692307,"FABP4;Fatty acid-binding protein, adipocyte",0.621690503031386,1.86207322305637,1.58804676426326,2.18338449852395,1.9402678193506e-14
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387536514118792,"FABP4;Fatty acid-binding protein, adipocyte",0.463000220905031,1.58883369339739,1.37327985094978,1.8382214692285,4.84315010389784e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16553067185978,"FABP4;Fatty acid-binding protein, adipocyte",0.449435579762228,1.5674272481153,1.4712562734539,1.66988458942418,5.37440571624888e-44
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25803310613437,"FABP4;Fatty acid-binding protein, adipocyte",0.236301128403018,1.26655564862788,1.16335146961728,1.37891536046189,5.06605110276805e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,"FABP4;Fatty acid-binding protein, adipocyte",0.722355294841433,2.05927770945898,1.87733284795361,2.25885606236375,7.04671464798168e-53
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7078870496592,"FABP4;Fatty acid-binding protein, adipocyte",0.26962167963544,1.30946895823804,1.21726232549414,1.40866016854087,4.57686410159572e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55793573515092,"FABP4;Fatty acid-binding protein, adipocyte",0.370482967525006,1.44843399234179,1.34357412901338,1.56147769212537,4.35122769233863e-22
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352482960077896,"FABP4;Fatty acid-binding protein, adipocyte",0.523620620316339,1.68812867125653,1.44788729983404,1.96823220360105,2.30629963974618e-11
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.124634858812074,"FABP4;Fatty acid-binding protein, adipocyte",0.638919348455898,1.89443255127813,1.47361071060131,2.43542929317996,6.19509711980178e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175267770204479,"FABP4;Fatty acid-binding protein, adipocyte",0.836711886999793,2.30876300861575,1.8948617677489,2.81307413589591,1.03547852082811e-16
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171372930866601,"FABP4;Fatty acid-binding protein, adipocyte",0.576234184480152,1.77932518785922,1.44385076474561,2.19274609360896,6.44925026224809e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39435248296007,"FABP4;Fatty acid-binding protein, adipocyte",0.318565065483482,1.37515309327391,1.26827613177364,1.49103652001733,1.18858892890974e-14
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.148003894839337,"FABP4;Fatty acid-binding protein, adipocyte",0.584891542134684,1.79479631530629,1.42675883765894,2.25777035923086,5.87259994726669e-07
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243427458617332,"FABP4;Fatty acid-binding protein, adipocyte",0.630558771570038,1.87866002784935,1.57167413017275,2.24560768195057,4.30281237769404e-12
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56085686465433,"FABP4;Fatty acid-binding protein, adipocyte",0.187759404314217,1.2065431913391,1.1350630818675,1.28252472996622,1.68292603854077e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.296753875968992,CALB2;Calretinin,1.17218809569673,3.22905038545272,2.75690446775081,3.78205574903322,7.43487537431766e-48
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0403746770025839,CALB2;Calretinin,1.36326203204432,3.90892356116514,2.6559175357542,5.75307147203762,4.72224367489823e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.896317829457364,CALB2;Calretinin,0.4257164612488,1.53068670460154,1.38932111006846,1.68643646934039,7.26066743651612e-18
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.172354360565322,RNASE6;Ribonuclease K6,0.595041927530875,1.81310696246468,1.45231608178809,2.26352713335688,1.47052447169093e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.19303688383316,RNASE6;Ribonuclease K6,1.30039178459455,3.67073452317291,3.03289200463141,4.4427206504674,1.14053377571535e-40
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.39618522348615,RNASE6;Ribonuclease K6,0.188743999449753,1.20773173291622,1.15313436176466,1.2649141219421,1.2774790672752e-15
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.55773871078938,RNASE6;Ribonuclease K6,0.304124901863704,1.35543834229245,1.27595448085258,1.4398735435522,5.97389711508421e-23
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.5298173043778,RNASE6;Ribonuclease K6,0.291411776290928,1.3383155571196,1.27090131302497,1.40930575180951,2.17681946719324e-28
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.997357233137998,RNASE6;Ribonuclease K6,0.378324902816985,1.4598371710418,1.32851128916818,1.60414486751533,3.65928935105728e-15
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.392967942088934,RNASE6;Ribonuclease K6,0.54652046972643,1.72723259172165,1.49002097687606,2.00220833948277,4.14362959775196e-13
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.551533953809031,RNASE6;Ribonuclease K6,0.352310447779797,1.42235002059015,1.25319322324537,1.6143397071951,4.93490086449284e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303343674594967,RNASE6;Ribonuclease K6,0.476529375503592,1.61047533653201,1.35943535021596,1.90787359558207,3.55765484537334e-08
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.376881535102838,RNASE6;Ribonuclease K6,0.459065687161764,1.58259465551946,1.35879155638698,1.8432597935319,3.60916193327353e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13489601286912,RNASE6;Ribonuclease K6,0.340391344028402,1.40549751601138,1.31643235553569,1.50058851045962,2.17840442892646e-24
sensitivity,Circulatory system disorders,I50 (heart failure),0.896242674939675,RNASE6;Ribonuclease K6,0.723061844437118,2.06073320542149,1.86717660139142,2.27435441337587,8.22156445821871e-47
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.64540962886361,RNASE6;Ribonuclease K6,0.293216299089812,1.34073275834596,1.24511079430289,1.44369829377986,8.03735535704592e-15
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54429507066528,RNASE6;Ribonuclease K6,0.305819214665439,1.35773682545263,1.25786322141145,1.46554033523745,4.32995289148457e-15
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39721934964954,RNASE6;Ribonuclease K6,0.398014248629527,1.48886524404542,1.37456954352921,1.61266465226269,1.56623123548505e-22
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.142479604733999,RNASE6;Ribonuclease K6,0.600832801599392,1.82363689589019,1.42893410727871,2.3273652095725,1.37791726439008e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.53475812938067,RNASE6;Ribonuclease K6,0.230705401606358,1.25948814160617,1.18624365521343,1.3372551009018,4.45071160049832e-14
sensitivity,Circulatory system disorders,I95 (hypotension),0.505572790991612,RNASE6;Ribonuclease K6,0.356377338536282,1.42814634125377,1.25136212033852,1.62990547571057,1.25175327731227e-07
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.377610824843645,F9;Coagulation factor IX,-0.409015261130316,0.664304094213505,0.577635264044133,0.763976780952053,9.78536454333272e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15946190457459,F9;Coagulation factor IX,-0.39127934288452,0.676191240442811,0.637083611871911,0.717699506204715,6.40939903108824e-38
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.286584273687981,EFNA4;Ephrin-A4,1.70819417079834,5.51898612713328,4.68488488855457,6.50159152168351,8.51698273061906e-93
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0398033713455529,EFNA4;Ephrin-A4,1.75793338404706,5.8004377221857,3.93879773906342,8.54196635569185,5.49807768775495e-19
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63299301450832,EFNA4;Ephrin-A4,0.203608067206724,1.22581762116986,1.16022946954866,1.29511349246721,3.95762283443964e-13
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01299580074432,EFNA4;Ephrin-A4,0.248475556759074,1.28206948405302,1.17408133923327,1.39999002370091,3.11612797569306e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.364200847811809,EFNA4;Ephrin-A4,0.416038269192241,1.51594388170834,1.30945438126574,1.75499496994129,2.56566774080475e-08
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0597050570183294,EFNA4;Ephrin-A4,0.913130564097176,2.4921120507436,1.75485795776023,3.53910266412003,3.35000481008974e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.30449579079348,EFNA4;Ephrin-A4,0.502758930420982,1.65327625852755,1.41023622364981,1.93820179993448,5.74213130645945e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.901546360976774,EFNA4;Ephrin-A4,0.618904175212973,1.85689209814331,1.69200966590665,2.03784194240962,6.77436089815723e-39
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71154496785877,EFNA4;Ephrin-A4,0.23896777118106,1.26993760733507,1.18662210516624,1.35910288498965,5.11757936223858e-12
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55631181961112,EFNA4;Ephrin-A4,0.362917271001822,1.43751692998634,1.33867877644893,1.5436525627746,1.76500253830672e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.358230342109976,EFNA4;Ephrin-A4,0.489343386426581,1.63124477077177,1.407947467014,1.88995652502126,7.26258730524736e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.165183991084044,EFNA4;Ephrin-A4,0.644893620260821,1.90578428165318,1.53927881658021,2.35955545484963,3.25841840111039e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39311799709435,EFNA4;Ephrin-A4,0.329982673215596,1.3909440276677,1.28997956541069,1.49981080319553,9.27394749568293e-18
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.23683005950604,EFNA4;Ephrin-A4,0.479467219346565,1.61521361834174,1.34924289293283,1.93361406351799,1.76060623780488e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.523414333194021,EFNA4;Ephrin-A4,0.306603599519754,1.3588022314442,1.2025249423407,1.53538894634804,8.7249955928166e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,"DDAH1;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",0.697405691898066,2.00853518336507,1.71720091595696,2.34929619785765,2.72337744830892e-18
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.163433027480096,INHBB;Inhibin beta B chain,0.64475775161512,1.9055253629137,1.50418476985195,2.41395005552727,9.13210338415121e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200789148046975,INHBB;Inhibin beta B chain,1.50322913803449,4.49618445417585,3.62093324053685,5.58300120522944,3.54892559049451e-42
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0210128178188695,INHBB;Inhibin beta B chain,1.58159233593002,4.86269269003463,2.57591149484559,9.17957788729602,1.06793940066738e-06
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40391305362938,INHBB;Inhibin beta B chain,0.610571109931576,1.84148278763259,1.58389848308937,2.14095719729012,1.99142137482637e-15
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.551002778361467,INHBB;Inhibin beta B chain,0.371261864636823,1.44956261287766,1.2733066098089,1.65021665046415,1.99167349029825e-08
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0817165137400481,INHBB;Inhibin beta B chain,0.828397798386171,2.28964732323804,1.63552685227368,3.20537987959238,1.39291914320281e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1549812052018398,INHBB;Inhibin beta B chain,0.293756737949199,1.3414575382606,1.25464605656502,1.43427568081064,7.58179747767823e-18
sensitivity,Circulatory system disorders,I50 (heart failure),0.905885923746818,INHBB;Inhibin beta B chain,0.595797430854054,1.81447728837781,1.63720243879208,2.01094730378483,6.73542588784796e-30
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66234736522612,INHBB;Inhibin beta B chain,0.193078005457987,1.21297740868711,1.12513408773973,1.30767897801497,4.80649208273257e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.52926618570661,INHBB;Inhibin beta B chain,0.227176344084815,1.25505116927695,1.1601797060444,1.35768056387909,1.47239147432503e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40785879386425,INHBB;Inhibin beta B chain,0.239114097739001,1.27012344653023,1.17095177865814,1.37769428154804,8.17967298075131e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30079134366925,SORCS2;VPS10 domain-containing receptor SorCS2,1.61473771156386,5.02656933954045,4.28058879700506,5.90255231777598,2.13534351851724e-86
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0403746770025839,SORCS2;VPS10 domain-containing receptor SorCS2,1.81588402771479,6.14650745933261,4.08076582525042,9.25795685551573,3.65184310720106e-18
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6485788113695,SORCS2;VPS10 domain-containing receptor SorCS2,0.273671849814735,1.3147832850628,1.24361008317475,1.39002980923693,5.5253459770495e-22
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.7063953488372,SORCS2;VPS10 domain-containing receptor SorCS2,0.245845456189577,1.27870194280019,1.21963723986633,1.34062703652782,2.22510355089544e-24
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999273255813953,SORCS2;VPS10 domain-containing receptor SorCS2,0.29620093480472,1.34474033482363,1.23044012788067,1.46965831748049,6.33915517680062e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361353359173126,SORCS2;VPS10 domain-containing receptor SorCS2,0.450048882261473,1.56838885001024,1.35422361359656,1.81642349176261,1.87970967516283e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.539001937984496,SORCS2;VPS10 domain-containing receptor SorCS2,0.354266828429407,1.42513540239253,1.26318762548602,1.60784579754815,8.60757842868159e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.391634366925064,SORCS2;VPS10 domain-containing receptor SorCS2,0.353769197240199,1.42442638699618,1.23662437730066,1.64074926001372,9.38074406571337e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17013888888888,SORCS2;VPS10 domain-containing receptor SorCS2,0.213406764686339,1.23788807800431,1.16477576434015,1.3155896101026,6.39324551876596e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.908430232558139,SORCS2;VPS10 domain-containing receptor SorCS2,0.558550550182429,1.74813682646983,1.59246857931084,1.91902207915621,8.14671469761093e-32
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71390503875969,SORCS2;VPS10 domain-containing receptor SorCS2,0.233647555490515,1.26319920611848,1.18001635334267,1.35224586491386,1.78469348792659e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55846253229974,SORCS2;VPS10 domain-containing receptor SorCS2,0.254342158084466,1.28961298029456,1.20067586469595,1.38513789428538,3.03289513264798e-12
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353278423772609,SORCS2;VPS10 domain-containing receptor SorCS2,0.395703311171522,1.4854285421141,1.2802398414262,1.72350358294516,1.81669135990547e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.169573643410852,SORCS2;VPS10 domain-containing receptor SorCS2,0.630218628676559,1.87802112365713,1.51814696690501,2.32320283726724,6.37924877033212e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3969638242894,SORCS2;VPS10 domain-containing receptor SorCS2,0.28351253619825,1.32778552559211,1.23147105769778,1.43163283534072,1.59279556826153e-13
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.234173126614987,SORCS2;VPS10 domain-containing receptor SorCS2,0.533940903289883,1.70564084671042,1.42212433230336,2.04567957377897,8.57758423649972e-09
sensitivity,Circulatory system disorders,I95 (hypotension),0.532945736434108,SORCS2;VPS10 domain-containing receptor SorCS2,0.346322305482905,1.41385823665091,1.25235229974608,1.59619231245946,2.19439025797365e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,DLK1;Protein delta homolog 1,1.05568905482603,2.87395478419997,2.45910790127826,3.35878555688121,3.32612869737209e-40
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,DLK1;Protein delta homolog 1,1.24500161450055,3.47294040639652,2.26950895919218,5.31450427526615,9.71469592135598e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,IL6;Interleukin-6,0.467977309147758,1.5967611704042,1.37779453981748,1.85052717341175,5.01238494377764e-10
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63006753411363,IL6;Interleukin-6,0.22255168244635,1.24926038281496,1.18438108555957,1.31769370779306,2.86374207599509e-16
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67773750816944,IL6;Interleukin-6,0.194247398852021,1.21439668614104,1.16029982873217,1.2710157105873,6.55630654848797e-17
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.998158160537104,IL6;Interleukin-6,0.241329256198792,1.27294008973154,1.16949382104249,1.38553658248603,2.39773923745951e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354504584793931,IL6;Interleukin-6,0.403095865800182,1.496450343197,1.30453470033744,1.71659951174559,8.59611156684167e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.538688531083516,IL6;Interleukin-6,0.287149993264305,1.33262408312207,1.18897875993502,1.49362377761397,8.03633283173705e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,IL6;Interleukin-6,0.276876731686592,1.3190037696433,1.24477933762689,1.39765409960132,7.2859704556666e-21
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,IL6;Interleukin-6,0.434889875426762,1.54479292992166,1.41729553401889,1.68375976573433,4.36626811688319e-23
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70914780266571,IL6;Interleukin-6,0.185718772147105,1.20408359091524,1.12757880633941,1.28577912759645,2.94093682357452e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,IL6;Interleukin-6,0.241986972600259,1.27377759869814,1.18984153985881,1.36363483421308,3.45823448930592e-12
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346582694630938,IL6;Interleukin-6,0.394758666807107,1.48402600296769,1.29162368744585,1.70508887293583,2.5190607300202e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172301111045095,IL6;Interleukin-6,0.551868793702994,1.73649513867679,1.4348325509756,2.10157998199709,1.44158131162726e-08
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.16635969342285,IL6;Interleukin-6,0.696285060027194,2.00628561552895,1.65968036936176,2.42527539963992,6.22444756724273e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,IL6;Interleukin-6,0.267684381186957,1.30693458177136,1.21685667134209,1.40368051657721,2.03174707219872e-13
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239637177430534,IL6;Interleukin-6,0.513927941945662,1.67184522558148,1.42039393124595,1.96781075785631,6.41533436236005e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.53896579723922,IL6;Interleukin-6,0.183179499585352,1.2010299731155,1.13764188877645,1.26794996787014,3.55797349912898e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0217851979482304,IL6;Interleukin-6,1.16567568009891,3.20808979348029,2.0088279137574,5.12330600971293,1.0581501176032e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.285627468854451,SCARB2;Lysosome membrane protein 2,1.70715239468504,5.51323957304753,4.71512503536882,6.44644847417917,1.43281942544811e-101
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0384888078598197,SCARB2;Lysosome membrane protein 2,1.79745920217589,6.03429604398522,4.13338496482482,8.80942110554148,1.26565661911804e-20
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.61318748100881,SCARB2;Lysosome membrane protein 2,0.22451083749582,1.2517102766794,1.18418959966119,1.32308087927229,2.09880977618742e-15
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.66656538033019,SCARB2;Lysosome membrane protein 2,0.221434692505234,1.24786575057361,1.19033267391324,1.30817960859246,3.76263306818547e-20
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01083763800263,SCARB2;Lysosome membrane protein 2,0.335211172713573,1.39823562325903,1.27993125611591,1.52747489274029,1.07175387113099e-13
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.36260508457409,SCARB2;Lysosome membrane protein 2,0.497872424316492,1.64521722030369,1.42204988480899,1.90340699781244,2.17075316926759e-11
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544920490225868,SCARB2;Lysosome membrane protein 2,0.457021412188212,1.5793627014988,1.40221157232538,1.77889456349943,5.10813674750697e-14
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.358553631115162,SCARB2;Lysosome membrane protein 2,0.372323932410662,1.45110296444905,1.25333841708987,1.6800728236848,6.33476150811065e-07
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0587460751544616,SCARB2;Lysosome membrane protein 2,0.984808800327218,2.67729993660866,1.91271234508882,3.74752375545099,9.48340636120321e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307910462878557,SCARB2;Lysosome membrane protein 2,0.548494807703592,1.73064610122478,1.48133380958053,2.02191829303664,4.81012093340912e-12
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.378810898409804,SCARB2;Lysosome membrane protein 2,0.38535819243409,1.47014082046046,1.27532099827249,1.69472159159288,1.07874192226021e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14929605996151,SCARB2;Lysosome membrane protein 2,0.33640621243548,1.39990756919134,1.31728993000786,1.48770681202088,2.24461007319969e-27
sensitivity,Circulatory system disorders,I50 (heart failure),0.897396941152638,SCARB2;Lysosome membrane protein 2,0.703250645492932,2.02030935452698,1.84446253288789,2.21292100826714,9.34229933420437e-52
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70566190620885,SCARB2;Lysosome membrane protein 2,0.280282606826857,1.32350379069715,1.2361439874001,1.41703741784472,8.64015381446018e-16
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55170667476957,SCARB2;Lysosome membrane protein 2,0.331868770002906,1.39356995833085,1.29764414001936,1.49658690612458,7.48576176241269e-20
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354502177656234,SCARB2;Lysosome membrane protein 2,0.512869686651559,1.67007692234375,1.4422979747323,1.93382849827744,7.1164496862259e-12
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.162058138357135,SCARB2;Lysosome membrane protein 2,0.672970222108337,1.96005046842693,1.58901584443799,2.41772154269451,3.27286596035016e-10
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.172186772004456,SCARB2;Lysosome membrane protein 2,0.559854324743382,1.75041748920522,1.42606485526359,2.14854280659569,8.58696264963664e-08
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.107363516661602,SCARB2;Lysosome membrane protein 2,0.659195757095704,1.93323691694636,1.48950864777686,2.5091529227591,7.23497257475e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38964853641243,SCARB2;Lysosome membrane protein 2,0.267743378631025,1.30701168984582,1.21173947176645,1.40977462333823,4.10736946106811e-12
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.23701002734731,SCARB2;Lysosome membrane protein 2,0.484248837254182,1.62295544718688,1.3577098443424,1.94002009673084,1.04540418725154e-07
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55444140585435,SCARB2;Lysosome membrane protein 2,0.217923076175573,1.24349140982504,1.17537449888625,1.31555592517437,3.41206414735209e-14
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.052668894966069,SCARB2;Lysosome membrane protein 2,0.9684555559756,2.63387344633229,1.84226147198014,3.76563774296264,1.09597475182323e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.522637496201762,SCARB2;Lysosome membrane protein 2,0.372047474698259,1.450701851291,1.28361814759943,1.639534206707,2.53426402164423e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0182315405651777,SCARB2;Lysosome membrane protein 2,1.39407548805116,4.03124591428673,2.30834721391788,7.04007764666879,9.55103634343693e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,YAP1;Transcriptional coactivator YAP1,1.41536177377055,4.11797597221937,3.44542265858842,4.92181302212821,1.4252056397925e-54
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0206001510677745,YAP1;Transcriptional coactivator YAP1,1.50326058332621,4.49632584023055,2.75350716950712,7.34225292216828,1.8758362076016e-09
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00254068529835,YAP1;Transcriptional coactivator YAP1,0.367569651460533,1.44422038708573,1.3157822066615,1.58519587505763,1.03417887295261e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.400558492984504,YAP1;Transcriptional coactivator YAP1,0.525471232749106,1.69125563567085,1.46405128263202,1.95371955826996,9.39862496167307e-13
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.556204078829911,YAP1;Transcriptional coactivator YAP1,0.381020770884875,1.46377800905848,1.29298488809009,1.65713155624592,1.75274703846599e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309002266016617,YAP1;Transcriptional coactivator YAP1,0.501907861243812,1.65186980464224,1.40379363362152,1.94378560077192,1.49289346545871e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14699352239694,YAP1;Transcriptional coactivator YAP1,0.43323185533848,1.54223375438012,1.44701042462118,1.64372344019019,1.69606698614117e-40
sensitivity,Circulatory system disorders,I50 (heart failure),0.908695552656275,YAP1;Transcriptional coactivator YAP1,0.635324777208779,1.88763510277529,1.7175543004809,2.0745581552978,1.03492115814657e-39
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65945661379294,YAP1;Transcriptional coactivator YAP1,0.262157480536128,1.29973120868104,1.20824140617516,1.39814875254705,1.9302340669649e-12
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54730023575728,YAP1;Transcriptional coactivator YAP1,0.305713524537506,1.35759333365682,1.259164171633,1.46371672662761,1.70657848027681e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.347913662477969,YAP1;Transcriptional coactivator YAP1,0.491708771143139,1.63510785926558,1.40111151145244,1.90818338838753,4.37431328584061e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.164801208542196,YAP1;Transcriptional coactivator YAP1,0.690129212373022,1.99397316260235,1.6106002376792,2.46860076148229,2.37595686297537e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39852136693446,YAP1;Transcriptional coactivator YAP1,0.30341167803277,1.35447195603119,1.25104915220626,1.46644460486592,7.05342272495188e-14
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.52924076998786,YAP1;Transcriptional coactivator YAP1,0.305291659449889,1.35702073321472,1.27843069928209,1.44044199768415,1.1275738036821e-23
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0526448305065348,YAP1;Transcriptional coactivator YAP1,0.967724325736101,2.6319481824127,1.83164390153027,3.78193120896377,1.67560334826459e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.50813705967177,YAP1;Transcriptional coactivator YAP1,0.3515185418754,1.42122409908151,1.24746015343937,1.61919235194893,1.27014746065006e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0183112453935773,YAP1;Transcriptional coactivator YAP1,1.39037378117902,4.01635100887768,2.34223006896387,6.88705846631396,4.34291594860667e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,CCL20;C-C motif chemokine 20,0.436125207510805,1.54670244138876,1.32542035359532,1.80492810126888,3.08818480157764e-08
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0003705075954,CCL20;C-C motif chemokine 20,0.256377613101442,1.29224060280177,1.18571480269045,1.40833678700848,5.19642132615321e-09
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356857315574969,CCL20;C-C motif chemokine 20,0.390848404285971,1.4782344024267,1.28221444113011,1.70422113370668,7.25017701142011e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15479417328055,CCL20;C-C motif chemokine 20,0.368699194304593,1.44585261755279,1.36260573229996,1.53418537888848,3.68861265427604e-34
sensitivity,Circulatory system disorders,I50 (heart failure),0.898968428852791,CCL20;C-C motif chemokine 20,0.398506494904024,1.48959831282541,1.36026773050225,1.63122529765007,7.99936139929024e-18
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152103118113921,CCL20;C-C motif chemokine 20,0.529121314869768,1.69744013773188,1.36770687936789,2.10666705318824,1.57470733166655e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55260232834773,CCL20;C-C motif chemokine 20,0.196828546975907,1.21753527270502,1.15299075631111,1.2856929963807,1.41616459688134e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199352690088653,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,1.35957174069266,3.8945250779922,3.15237256904911,4.81140006483602,2.00465474475609e-36
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0187626061259909,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,1.65147712798316,5.21467688616142,2.69623568204358,10.0854888940775,9.24244552631472e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5455696796285,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,0.226984340652019,1.25481021827657,1.1615978166443,1.35550244786095,8.23307741242629e-09
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.62835572154287,ACE2;Angiotensin-converting enzyme 2,0.219461467759243,1.24540585875277,1.17066280168873,1.32492101976614,3.65643388488813e-12
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301186675501475,ACE2;Angiotensin-converting enzyme 2,0.502005634303625,1.6520313209033,1.39143761580983,1.96143000177343,9.95570460099558e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387526855811898,ACE2;Angiotensin-converting enzyme 2,0.392524142242507,1.48071361259664,1.2700789986998,1.72628065244249,5.33827476864381e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15649659659056,ACE2;Angiotensin-converting enzyme 2,0.222445239646433,1.24912741511884,1.16874583841629,1.33503730915164,5.57238003781966e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.907575848844447,ACE2;Angiotensin-converting enzyme 2,0.381624641960408,1.46466220920373,1.32237310306764,1.62226181256487,2.49956716722642e-13
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.72479569503845,ACE2;Angiotensin-converting enzyme 2,0.213469209310175,1.23796537987321,1.15158569634209,1.33082434649255,7.27113675548939e-09
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64212151413886,ROBO2;Roundabout homolog 2,0.21714931431485,1.24252961574575,1.17407661827987,1.31497367545503,5.88635754079945e-14
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.54718492896367,ROBO2;Roundabout homolog 2,0.325702249529444,1.38500292220093,1.22581561731691,1.56486266564605,1.70991535081559e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16138046940649,ROBO2;Roundabout homolog 2,0.379538139951306,1.46160937454193,1.37359645648375,1.55526170271112,4.65248322439198e-33
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24875417717066,ROBO2;Roundabout homolog 2,0.211175157561566,1.23512867824302,1.13863994112238,1.33979390386973,3.61050695732531e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,ROBO2;Roundabout homolog 2,0.3521144038047,1.42207120476911,1.29344385106346,1.5634899881976,3.3530565383526e-13
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16376244312424,S100A11;Protein S100-A11,0.184986914358681,1.20320269534577,1.13325073706957,1.27747256518966,1.41977705600029e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.911999046275507,S100A11;Protein S100-A11,0.226834842280912,1.25462264021454,1.14501882116028,1.37471798738107,1.15345486599624e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.284533427485513,WFDC2;WAP four-disulfide core domain protein 2,1.66392820969625,5.28001115125607,4.53962721374353,6.14114693668842,2.44743736303966e-103
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394608403082099,WFDC2;WAP four-disulfide core domain protein 2,1.82034709883833,6.17400106661027,4.30192443949744,8.86075283436589,5.32429838860203e-23
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.67295270929822,WFDC2;WAP four-disulfide core domain protein 2,0.299339607092022,1.34896766467732,1.27494603212525,1.42728689253743,2.59103174620683e-25
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.71139587530374,WFDC2;WAP four-disulfide core domain protein 2,0.269058223466187,1.30873133770301,1.2471605522082,1.37334179729571,7.15509599326557e-28
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00105921202932,WFDC2;WAP four-disulfide core domain protein 2,0.396743121905481,1.48697390996252,1.35986916011767,1.62595893322406,3.24858590708959e-18
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.367608880765955,WFDC2;WAP four-disulfide core domain protein 2,0.592391585128218,1.80830797049659,1.56650042554001,2.08744132005853,6.04649387047231e-16
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.550374877982928,WFDC2;WAP four-disulfide core domain protein 2,0.352746205831882,1.42296995612565,1.26134887468941,1.60530011693618,9.78358087249718e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307379177137635,WFDC2;WAP four-disulfide core domain protein 2,0.429960901413807,1.53719742012748,1.31007347409051,1.80369723926136,1.35716522493343e-07
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0789216806164198,WFDC2;WAP four-disulfide core domain protein 2,0.756804047792118,2.13145330055938,1.58089448868607,2.87374850439348,6.90561705376345e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.19111508027165,WFDC2;WAP four-disulfide core domain protein 2,0.308941901264435,1.36198323870068,1.28060005175954,1.44853839413238,8.55569019014106e-23
sensitivity,Circulatory system disorders,I50 (heart failure),0.917983758748883,WFDC2;WAP four-disulfide core domain protein 2,0.689395507040355,1.99251071042984,1.81829358563138,2.18342019272925,2.37051877602948e-49
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71966188290514,WFDC2;WAP four-disulfide core domain protein 2,0.201739452198444,1.22352917874035,1.1418489439276,1.31105227113469,1.04691156111644e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55558786267627,WFDC2;WAP four-disulfide core domain protein 2,0.381070216562472,1.46385038834339,1.36170912274023,1.57365323009728,5.36901330068147e-25
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.355147562773889,WFDC2;WAP four-disulfide core domain protein 2,0.568963751031152,1.76643563559031,1.52563641779802,2.04524146007664,2.75736778655916e-14
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172381565556917,WFDC2;WAP four-disulfide core domain protein 2,0.767563818004624,2.15451107400951,1.75891921127099,2.63907400538049,1.20908576851823e-13
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.166150906560883,WFDC2;WAP four-disulfide core domain protein 2,0.552638434314297,1.73783213029237,1.40192263277629,2.1542276602638,4.58890434954875e-07
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.103844316600552,WFDC2;WAP four-disulfide core domain protein 2,0.692764919524733,1.99923562403445,1.53505932446865,2.6037710834348,2.7569525454546e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40812893310349,WFDC2;WAP four-disulfide core domain protein 2,0.398060445960997,1.4889340272354,1.38047211181308,1.60591765562563,6.01967975116736e-25
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.13915138424474,WFDC2;WAP four-disulfide core domain protein 2,0.633461224804983,1.88412067152251,1.49568963537824,2.37342736145971,7.54597332414692e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236765041849259,WFDC2;WAP four-disulfide core domain protein 2,0.733656362604612,2.08268174259402,1.74892119586207,2.48013646995479,1.82694669767268e-16
sensitivity,Circulatory system disorders,"I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",0.0124613179920662,WFDC2;WAP four-disulfide core domain protein 2,1.52692410458508,4.60399361759637,2.4970424161604,8.48874536278861,1.0005969284743e-06
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54418575671353,WFDC2;WAP four-disulfide core domain protein 2,0.221455093651504,1.247891208725,1.17878223934816,1.32105185914089,2.56857935284128e-14
sensitivity,Circulatory system disorders,I95 (hypotension),0.51506781033874,WFDC2;WAP four-disulfide core domain protein 2,0.322023950564814,1.37991782537278,1.21809891334463,1.56323364541317,4.19106379874561e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0207688633201104,WFDC2;WAP four-disulfide core domain protein 2,1.3698582580849,3.93479293085656,2.37340489064723,6.52336879802109,1.09038547859938e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305385353248634,GFRA1;GDNF family receptor alpha-1,1.59977693445398,4.95192769673086,4.24541494850111,5.77601676422886,3.16935866784985e-92
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0391519683652095,GFRA1;GDNF family receptor alpha-1,1.66070355034228,5.26301233633194,3.58696749592065,7.72220514512156,2.0717762988469e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.906368067654601,GFRA1;GDNF family receptor alpha-1,0.313112306494174,1.36767512120088,1.24877107031672,1.49790084156693,1.5055510279039e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56412113619012,GFRA1;GDNF family receptor alpha-1,0.262629971958467,1.30034546563264,1.21252943643231,1.39452146825118,1.81480042418163e-13
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.344537321613844,GFRA1;GDNF family receptor alpha-1,0.541908767420403,1.71928544821024,1.48508851650067,1.99041499519007,4.06961353850488e-13
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174226259225182,GFRA1;GDNF family receptor alpha-1,0.552907272910841,1.73829938944914,1.41918243001758,2.12917289803385,9.14772213274621e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39772527063798,GFRA1;GDNF family receptor alpha-1,0.355875516222631,1.42742984534443,1.32546675138354,1.53723657062932,4.88547944267612e-21
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236869408609517,GFRA1;GDNF family receptor alpha-1,0.485315257332005,1.6246871226438,1.3630157425381,1.93659410093775,6.08180713147139e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.520721179257287,GFRA1;GDNF family receptor alpha-1,0.331254673827933,1.39271443506356,1.23446160162475,1.57125462232402,7.3419696510582e-08
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00496594500166,CXCL10;C-X-C motif chemokine 10,0.277856783906242,1.32029709587557,1.2126545349836,1.43749466240278,1.51812116868743e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361159636484974,CXCL10;C-X-C motif chemokine 10,0.371506118704745,1.44991671768657,1.26077202036451,1.66743745440925,1.89752464887643e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15910652246452,CXCL10;C-X-C motif chemokine 10,0.238327719697617,1.2691250419552,1.1963460898895,1.346331455195,2.57988336455191e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,CXCL10;C-X-C motif chemokine 10,0.335567528507404,1.39873398141566,1.27844588009118,1.53033990819178,2.59128209205679e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39360511904528,CXCL10;C-X-C motif chemokine 10,0.278906447690836,1.32168369152432,1.22940151033244,1.42089282123053,4.2678261032917e-14
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55755981706479,CXCL10;C-X-C motif chemokine 10,0.183709587176569,1.20166679297117,1.13823992280466,1.26862803913216,3.13660460204911e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,MFAP5;Microfibrillar-associated protein 5,1.54685772767828,4.69668869613182,3.99906512638671,5.51601037022954,2.68729347034147e-79
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,MFAP5;Microfibrillar-associated protein 5,2.13457829557424,8.4534808847929,5.41479189346067,13.1974303861726,5.87612784695223e-21
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00681596884128,MFAP5;Microfibrillar-associated protein 5,0.225532563072752,1.25298983465123,1.14753645090729,1.36813390502587,4.95668859909911e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,MFAP5;Microfibrillar-associated protein 5,0.248100658212575,1.28158892815242,1.16733642608822,1.4070238399626,1.91263808735668e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,CALCB;Calcitonin gene-related peptide 2,1.26384322754644,3.53899655366374,2.88042041448162,4.34814881323419,2.46777279010935e-33
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.400558492984504,CALCB;Calcitonin gene-related peptide 2,0.375961750647546,1.45639142667672,1.257250842376,1.68707462043848,5.39898722200816e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.908695552656275,CALCB;Calcitonin gene-related peptide 2,0.385431766946901,1.47024898933428,1.33428848013023,1.62006351911806,6.95663133567097e-15
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39852136693446,CALCB;Calcitonin gene-related peptide 2,0.224369592629882,1.25153349151447,1.15583889515789,1.3551508665647,3.22939679523872e-08
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0840151900716,HAVCR1;Hepatitis A virus cellular receptor 1,0.19511714831172,1.21545336645963,1.1918284607388,1.23954657461551,1.5296112782279e-84
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305367419645304,HAVCR1;Hepatitis A virus cellular receptor 1,0.998367632162443,2.71384821225959,2.34836412447571,3.1362138615658,1.07320585378266e-41
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0391496691852953,HAVCR1;Hepatitis A virus cellular receptor 1,1.11283083437582,3.04296033007037,2.07287628401059,4.46703338824761,1.33485162767729e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.362134439963982,HAVCR1;Hepatitis A virus cellular receptor 1,0.42246897595907,1.52572388474895,1.32319759328779,1.75924849342372,6.09790316471775e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.54613788513487,HAVCR1;Hepatitis A virus cellular receptor 1,0.286304334843375,1.33149761471512,1.18484462535159,1.49630243498464,1.51875521023405e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303409936186039,HAVCR1;Hepatitis A virus cellular receptor 1,0.3871488200734,1.47277565354572,1.26173747925778,1.71911206676128,9.28294480575583e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16301922248757,HAVCR1;Hepatitis A virus cellular receptor 1,0.287062045041199,1.33250688635559,1.25592690496816,1.41375632225195,1.98506134755317e-21
sensitivity,Circulatory system disorders,I50 (heart failure),0.908272325098852,HAVCR1;Hepatitis A virus cellular receptor 1,0.540219309785644,1.71638324055219,1.57050552626048,1.8758109278756,9.24175901972527e-33
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71279802685667,HAVCR1;Hepatitis A virus cellular receptor 1,0.224523861680397,1.25172657929125,1.17111222479949,1.33789008100605,3.83099470874474e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56207180049328,HAVCR1;Hepatitis A virus cellular receptor 1,0.202055068230131,1.22391540511081,1.14163054631484,1.3121310775215,1.26924557687227e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174216027874564,HAVCR1;Hepatitis A virus cellular receptor 1,0.631981779952841,1.88133527981896,1.54335632549614,2.29332810357563,3.97104215549149e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39960067337431,HAVCR1;Hepatitis A virus cellular receptor 1,0.253767580434989,1.28887221033492,1.19741153741447,1.3873188312187,1.4056699528883e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215323180519124,HAVCR1;Hepatitis A virus cellular receptor 1,1.3756564219546,3.95767377440118,2.38851897764279,6.55769615029004,9.3324764598214e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,IGSF8;Immunoglobulin superfamily member 8,1.19984962038918,3.31961768238457,2.84259262254212,3.87669392716051,6.6070568305677e-52
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394251808630172,IGSF8;Immunoglobulin superfamily member 8,1.33666587241665,3.80633153052204,2.51751717793111,5.75493976654912,2.33740612718667e-10
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00928463009324,IGSF8;Immunoglobulin superfamily member 8,0.235367753181288,1.26537402850176,1.15927942753876,1.38117816461748,1.3793378007014e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,IGSF8;Immunoglobulin superfamily member 8,0.387804934027277,1.47374227927658,1.34524697648552,1.61451119659936,7.96519947187155e-17
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30926819659214,CTSZ;Cathepsin Z,1.07620855917016,2.93353611098064,2.51061251365522,3.42770302769598,8.03363778848979e-42
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039397222495814,CTSZ;Cathepsin Z,1.40104082718871,4.05942292653023,2.65468080317755,6.2074937509303,1.00986968936648e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39072195410223,CTSZ;Cathepsin Z,0.227848805814528,1.25589542699081,1.1652462073516,1.35359661639345,2.50724221566525e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,SNCG;Gamma-synuclein,1.52186263859354,4.58074953466637,3.86217098160694,5.43302365412513,2.00840973711201e-68
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039736151951045,SNCG;Gamma-synuclein,1.65541830997283,5.23526942961263,3.44043708316553,7.96644302398304,1.0885571980291e-14
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01128506715409,SNCG;Gamma-synuclein,0.239053964884859,1.27004707267859,1.16041895890981,1.39003206939573,2.10030865345085e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15965985853929,SNCG;Gamma-synuclein,0.215723704983889,1.24075951596672,1.16598213828107,1.32033255563548,1.03190338422974e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,SNCG;Gamma-synuclein,0.463800219106347,1.5901052660544,1.44342367885423,1.75169272485607,5.85737938208536e-21
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39275212588412,SNCG;Gamma-synuclein,0.230948387245653,1.25979421632182,1.16642384427258,1.36063873802893,4.14925376563867e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,RTN4R;Reticulon-4 receptor,0.803623990678887,2.23362090010064,1.92524282424277,2.591393803703,2.93466659159294e-26
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,RTN4R;Reticulon-4 receptor,0.98370894015756,2.67435689980732,1.79808036887391,3.9776780567524,1.19394450337175e-06
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6446442533229,RTN4R;Reticulon-4 receptor,0.182775783718282,1.20054519612119,1.13563007328612,1.26917101073153,1.16036057109708e-10
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.171372930866601,COL6A3;Collagen alpha-3(VI) chain,0.657950156475678,1.93083037495021,1.57302022231654,2.37003052086647,3.13437261678173e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,COL6A3;Collagen alpha-3(VI) chain,1.6726079037811,5.32603949983621,4.56641637491466,6.21202589182326,1.04093172590103e-100
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,COL6A3;Collagen alpha-3(VI) chain,1.83316005115702,6.25361721764185,4.27600896040893,9.14584807162018,3.33717159311422e-21
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65433300876338,COL6A3;Collagen alpha-3(VI) chain,0.262776236416444,1.30053567386736,1.23128550109048,1.37368062687626,4.84172043853069e-21
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6981499513145,COL6A3;Collagen alpha-3(VI) chain,0.24946946160504,1.28334437258008,1.22489397324463,1.344583951434,9.69487348295071e-26
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00681596884128,COL6A3;Collagen alpha-3(VI) chain,0.397273649264749,1.48776299960258,1.36408596106966,1.62265341492906,2.92078425589457e-19
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356377799415774,COL6A3;Collagen alpha-3(VI) chain,0.554704465132032,1.74142625653894,1.5082091317469,2.01070617007254,3.985159804378e-14
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543330087633885,COL6A3;Collagen alpha-3(VI) chain,0.445061538637802,1.56058622922847,1.38746046683213,1.75531443026852,1.18534830012202e-13
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.37585199610516,COL6A3;Collagen alpha-3(VI) chain,0.348602855023335,1.41708628987131,1.23003517899159,1.63258221166288,1.38907637949046e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307692307692307,COL6A3;Collagen alpha-3(VI) chain,0.462944400138565,1.58874500595816,1.35953381803476,1.85660015254763,5.75431608869249e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387536514118792,COL6A3;Collagen alpha-3(VI) chain,0.454424419643012,1.57526642963282,1.37070986705825,1.8103497931723,1.52166943224115e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16553067185978,COL6A3;Collagen alpha-3(VI) chain,0.381261056702139,1.46412977641434,1.37876575794862,1.55477896794634,1.59894702302896e-35
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,COL6A3;Collagen alpha-3(VI) chain,0.681441224995423,1.97672458514106,1.80496093397815,2.16483360495179,7.1790678217029e-49
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7078870496592,COL6A3;Collagen alpha-3(VI) chain,0.280556016936295,1.32386569948591,1.23792356631144,1.41577431593575,2.56035793438832e-16
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.360272638753651,COL6A3;Collagen alpha-3(VI) chain,0.514366851506001,1.67257917549143,1.44883259512378,1.93087945957523,2.21788135417934e-12
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55793573515092,COL6A3;Collagen alpha-3(VI) chain,0.419219751944946,1.52077451122975,1.4176201485005,1.63143499085592,1.30814744670816e-31
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.352482960077896,COL6A3;Collagen alpha-3(VI) chain,0.495606215732138,1.64149303639853,1.41936251306064,1.89838703203074,2.37721235794156e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175267770204479,COL6A3;Collagen alpha-3(VI) chain,0.812489104703823,2.25351023441801,1.84571785727432,2.75140014309995,1.49482759408944e-15
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171372930866601,COL6A3;Collagen alpha-3(VI) chain,0.624132323336637,1.86662562707661,1.5188961285769,2.29396281029676,2.95713728820915e-09
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.105160662122687,COL6A3;Collagen alpha-3(VI) chain,0.793806825553461,2.21180035807792,1.71039856313325,2.86018763663595,1.43120050103056e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39435248296007,COL6A3;Collagen alpha-3(VI) chain,0.34881911064901,1.41739277589203,1.3162357349953,1.52632406774618,2.62084108991716e-20
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.148003894839337,COL6A3;Collagen alpha-3(VI) chain,0.632177941333318,1.88170436134318,1.50836903900209,2.34744363742741,2.10957903951994e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243427458617332,COL6A3;Collagen alpha-3(VI) chain,0.632440201375611,1.88219792192635,1.58358170985758,2.2371242325238,7.20888052508243e-13
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56085686465433,COL6A3;Collagen alpha-3(VI) chain,0.24659680545177,1.27966305558195,1.21111480784462,1.35209108600993,1.65247462973767e-18
sensitivity,Circulatory system disorders,I95 (hypotension),0.516066212268743,COL6A3;Collagen alpha-3(VI) chain,0.461893961222675,1.58707700259768,1.40708736915403,1.79009027256693,5.4438195477014e-14
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,IL16;Pro-interleukin-16,0.735958276657313,2.08748141906658,1.79481472630645,2.42787102817888,1.30841931943596e-21
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288982780612244,GFRA3;GDNF family receptor alpha-3,1.08368153171744,2.95554046235807,2.51812616378406,3.46893636636105,3.89375645263264e-40
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0378667091836734,GFRA3;GDNF family receptor alpha-3,1.50718701026944,4.51401504010475,2.94309064100663,6.92344690251284,4.97268541615126e-12
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,LEPR;Leptin receptor,0.263812707240413,1.30188433995465,1.22728304168658,1.38102033275873,1.91276325182746e-18
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24977823335764,LEPR;Leptin receptor,0.208479518149865,1.23180370018378,1.13949746416295,1.3315873036199,1.55545157718912e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.296753875968992,PLIN1;Perilipin-1,0.513991674852779,1.67195178053345,1.43184852909618,1.95231737130289,8.12198301324281e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304782129935504,LGALS3;Galectin-3,0.814540736398123,2.25813835341279,1.93161338432692,2.63985995568708,1.58609784187065e-24
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00873053327041,LGALS3;Galectin-3,0.253285663264933,1.28825123032924,1.1780273329772,1.4087883922443,2.85404927279932e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.914346389806512,LGALS3;Galectin-3,0.371250041390713,1.44954547444345,1.32045929187026,1.59125093474365,6.1240347672693e-15
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.123853211009174,RBP7;Retinoid-binding protein 7,0.636982533681028,1.89076693727638,1.46115018973191,2.44670235559663,1.27549264177086e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199541284403669,RBP7;Retinoid-binding protein 7,0.752927873433951,2.12320740751407,1.7449447146217,2.58346849475969,5.42451443324904e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.396788990825688,RBP7;Retinoid-binding protein 7,0.48871250647029,1.63021597569931,1.41072399125008,1.88385831949329,3.50166590391827e-11
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.548165137614678,RBP7;Retinoid-binding protein 7,0.335573766987902,1.39874270741754,1.23504946473432,1.58413182420562,1.26108748437583e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14908256880733,RBP7;Retinoid-binding protein 7,0.364856835079274,1.44030779183725,1.35214891573404,1.53421454625871,1.02313261505712e-29
sensitivity,Circulatory system disorders,I50 (heart failure),0.905963302752293,RBP7;Retinoid-binding protein 7,0.482828833593134,1.62065248000804,1.47397948729154,1.78192063295432,1.94667015327798e-23
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.64908256880733,RBP7;Retinoid-binding protein 7,0.234614341468447,1.26442103992902,1.17562615351924,1.35992259225375,2.69711011576234e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54816513761467,RBP7;Retinoid-binding protein 7,0.190505408864696,1.20986091759378,1.12226861264287,1.30428974260787,6.75425457954337e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39678899082568,RBP7;Retinoid-binding protein 7,0.224423983283179,1.25160156508996,1.15608068276265,1.35501483684704,3.01362442032798e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199541284403669,EFCAB14;EF-hand calcium-binding domain-containing protein 14,1.55444044330725,4.73243771695183,3.86870460713471,5.78900924705531,1.22700117231524e-51
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.993119266055046,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.252902190565148,1.28775731585935,1.17175877032734,1.41523916572522,1.51241209435948e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.905963302752293,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.427544932507902,1.53348808158576,1.38860873649974,1.69348329342447,3.07501595989664e-17
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54816513761467,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.212933077097488,1.23730184464207,1.14657377207732,1.33520920505709,4.24939214579301e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39678899082568,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.286793516075982,1.33214911769802,1.23003364888266,1.44274205294762,1.81296249067325e-12
sensitivity,Circulatory system disorders,I95 (hypotension),0.504587155963302,EFCAB14;EF-hand calcium-binding domain-containing protein 14,0.354417873828616,1.42535067879616,1.24931210482697,1.62619456715026,1.36821104837629e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309609891536663,PI3;Elafin,1.36144902926587,3.90184309228234,3.32271248339354,4.58191299815461,6.08406520422544e-62
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0399496634240856,PI3;Elafin,1.68467408301037,5.39069372734199,3.48814394611286,8.33095746934065,3.31796497341776e-14
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.18524658929748,PI3;Elafin,0.198592071944436,1.21968432095165,1.1446457109611,1.29964217620333,8.79027586346331e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.91884225875397,PI3;Elafin,0.400106708407881,1.49198389637336,1.3536848363355,1.64441226442588,7.53535167765086e-16
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57201925573777,PI3;Elafin,0.312917248679406,1.36740837149708,1.26992938074255,1.4723697890563,1.10555518827263e-16
sensitivity,Circulatory system disorders,I95 (hypotension),0.517348141341909,PI3;Elafin,0.348604695587674,1.4170888981122,1.2488090503385,1.60804483648523,6.48569131952342e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305684557051319,CKAP4;Cytoskeleton-associated protein 4,1.70508295772799,5.50184206859803,4.68640483467729,6.45916586715015,2.19424539605225e-96
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0391903278270922,CKAP4;Cytoskeleton-associated protein 4,1.88568005230861,6.59083503090345,4.36435768484545,9.95314993439232,3.07485629961246e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999353359590853,CKAP4;Cytoskeleton-associated protein 4,0.30205412361421,1.35263443419262,1.23952987625512,1.47605955097367,1.20439111094601e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.901377540023122,CKAP4;Cytoskeleton-associated protein 4,0.465925185925923,1.5934877795761,1.45485613493834,1.74532948150641,1.09011460604081e-23
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.366429565183312,CKAP4;Cytoskeleton-associated protein 4,0.373991500776212,1.45352479657182,1.2603295308061,1.67633486529341,2.75231985996881e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55193698195285,CKAP4;Cytoskeleton-associated protein 4,0.354831228159904,1.42593997545862,1.32945820268814,1.52942364754275,3.18879210806518e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356631983226539,CKAP4;Cytoskeleton-associated protein 4,0.425729268605022,1.53070630877697,1.32448501397124,1.76903610007965,8.10360767618225e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172437442439206,CKAP4;Cytoskeleton-associated protein 4,0.733246370507539,2.08182803455757,1.69787935762413,2.55260065799639,1.79683712772513e-12
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.105813885133149,CKAP4;Cytoskeleton-associated protein 4,0.676313619597044,1.96661466348273,1.51304220896851,2.55615686839426,4.28902023883542e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40105421981854,CKAP4;Cytoskeleton-associated protein 4,0.336082678141978,1.39945472434434,1.29968158216528,1.50688718865036,5.29580385361104e-19
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239060999745262,CKAP4;Cytoskeleton-associated protein 4,0.57231291857774,1.77236164254996,1.48732304173315,2.11202657650079,1.57901093561314e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5512903415437,CKAP4;Cytoskeleton-associated protein 4,0.251408592041392,1.28583535910661,1.21668968963972,1.35891064484849,4.89649058358067e-19
sensitivity,Circulatory system disorders,I95 (hypotension),0.521231360100327,CKAP4;Cytoskeleton-associated protein 4,0.396325250604759,1.48635267604757,1.31773778470566,1.67654316604973,1.10955337690436e-10
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215546803049007,CKAP4;Cytoskeleton-associated protein 4,1.51508440500564,4.54980513696749,2.63855418396339,7.84548102524887,5.03384293776934e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215011727912431,HAO1;Hydroxyacid oxidase 1,1.47901652357112,4.38862744617736,2.50580783539235,7.68616435359078,2.30712488777887e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200894895443338,CYTL1;Cytokine-like protein 1,1.45114428890383,4.26799554192405,3.42167368483517,5.32364790558955,6.74439508152845e-38
sensitivity,Circulatory system disorders,I50 (heart failure),0.90859282257328,CYTL1;Cytokine-like protein 1,0.398111197508933,1.48900959485962,1.34134736082231,1.65292722701211,7.93689914321153e-14
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.296132509426884,EFNA1;Ephrin-A1,1.81024352532707,6.11193566214361,5.16369930065158,7.23430148875421,2.53178695387287e-98
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0375101178607387,EFNA1;Ephrin-A1,1.91896055332829,6.81387213028579,4.45318995868217,10.425976398641,9.35495266327651e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00092788186287,EFNA1;Ephrin-A1,0.254989615624275,1.29044822030413,1.18171667845227,1.40918431604701,1.36416068556802e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.357333228041774,EFNA1;Ephrin-A1,0.400039169061724,1.49188313215933,1.28817998673837,1.72779836896628,9.25864440226118e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.548832250804493,EFNA1;Ephrin-A1,0.289348093650283,1.33555654637713,1.18689369415237,1.50283997409276,1.54222751686162e-06
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0592265018853769,EFNA1;Ephrin-A1,0.877412650619817,2.40466992933643,1.68539962326095,3.43089994162149,1.30737264360719e-06
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386946478984462,EFNA1;Ephrin-A1,0.352709643291156,1.42291792967979,1.2380586247947,1.6353792898458,6.78329009429253e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1538704518982,EFNA1;Ephrin-A1,0.208664428185369,1.23203149410976,1.16051138162191,1.30795925530426,7.99581482679941e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.902217045387242,EFNA1;Ephrin-A1,0.589506395624335,1.80309817855284,1.64614284059031,1.97501879018876,6.99364416291227e-37
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70374903756934,EFNA1;Ephrin-A1,0.20803198482017,1.23125255031047,1.15093344149729,1.31717681317335,1.50133510434552e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55173434939687,EFNA1;Ephrin-A1,0.323845169631542,1.38243324789933,1.2883660603904,1.48336854225916,2.11819091219349e-19
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349436361123724,EFNA1;Ephrin-A1,0.444614618328386,1.55988892737882,1.34604088900113,1.80771140434278,3.4187099167324e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173731072197105,EFNA1;Ephrin-A1,0.650046767025612,1.91563041525573,1.56229198898224,2.34888222799083,4.13839992360577e-10
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.171756855467593,EFNA1;Ephrin-A1,0.555031108626448,1.74199517500835,1.42039637440451,2.13640871269091,9.81759639642272e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3997196612244,EFNA1;Ephrin-A1,0.344244682151756,1.41092382115209,1.30933216281904,1.52039802093332,1.73399973323358e-19
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.150040471442955,EFNA1;Ephrin-A1,0.613507363943151,1.84689779488291,1.48062872945308,2.30377230759485,5.32917345821421e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240854441000533,EFNA1;Ephrin-A1,0.533300844381712,1.70454948539737,1.43008853858675,2.03168466131454,2.62218703537052e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56450753163682,EFNA1;Ephrin-A1,0.194120507945283,1.21424260002067,1.14853232078963,1.28371232138361,7.99765535964556e-12
sensitivity,Circulatory system disorders,I95 (hypotension),0.515270566402779,EFNA1;Ephrin-A1,0.383555335513306,1.46749275466689,1.29849355180685,1.65848723854129,8.03327830638329e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",0.588010447130885,1.80040285308577,1.54920170183772,2.09233596216314,1.72862422488817e-14
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.998158160537104,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",0.233328352775537,1.2627960538494,1.15596564814788,1.37949936157067,2.2950418333809e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",0.243067468712947,1.27515465425958,1.20178348687809,1.3530052709443,9.049847973321e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",0.328471305720785,1.38884338789638,1.27041118283392,1.5183162602526,5.08490543849472e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301798958497711,"FABP1;Fatty acid-binding protein, liver",1.15728637114856,3.1812887155132,2.74032770691832,3.69320715398411,3.44162666194391e-52
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394508442480669,"FABP1;Fatty acid-binding protein, liver",1.36906422271153,3.93166980618241,2.65828137443082,5.81504562065265,7.08342863866736e-12
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.56643522171374,"FABP1;Fatty acid-binding protein, liver",0.220381447497793,1.24655213410329,1.19510545300662,1.30021348252427,1.20313585648363e-24
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63531639577086,"FABP1;Fatty acid-binding protein, liver",0.339187476534865,1.40380650132264,1.32844778775766,1.48344008045819,1.97351976322021e-33
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67879122613223,"FABP1;Fatty acid-binding protein, liver",0.270005266016197,1.30997134904542,1.24985096582496,1.37298364544386,1.9723945038949e-29
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360975224869812,"FABP1;Fatty acid-binding protein, liver",0.403743229831926,1.4974194049585,1.29786634959119,1.72765468112533,3.15003292002617e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301798958497711,"FABP1;Fatty acid-binding protein, liver",0.470525151504769,1.60083465324065,1.36926507204421,1.87156719274979,3.58857163068105e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384645731418652,"FABP1;Fatty acid-binding protein, liver",0.344142877038753,1.4107801892044,1.2263965711971,1.62288511644226,1.46642465992765e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16190626479406,"FABP1;Fatty acid-binding protein, liver",0.325430083452351,1.38462602268079,1.30385710752459,1.47039826037736,2.61331486683668e-26
sensitivity,Circulatory system disorders,I50 (heart failure),0.901451791068328,"FABP1;Fatty acid-binding protein, liver",0.49608694850401,1.64228234560413,1.49868645948564,1.79963679901978,2.2411478149646e-26
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70230392930408,"FABP1;Fatty acid-binding protein, liver",0.266104008121423,1.30487076878669,1.22015652510452,1.39546663743662,7.8540397503839e-15
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56028089001104,"FABP1;Fatty acid-binding protein, liver",0.300702448086036,1.35080734642244,1.25930514476936,1.44895817723593,4.37345340706275e-17
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175556256903897,"FABP1;Fatty acid-binding protein, liver",0.516128000325835,1.67552743172938,1.36544715959133,2.05602403195002,7.68775409550363e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.524696228499289,"FABP1;Fatty acid-binding protein, liver",0.339448894202369,1.40417352911553,1.24618545561133,1.58219090986062,2.49125859060334e-08
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.117279124315871,ADM;Pro-adrenomedullin,0.614953805852426,1.84957115822186,1.45973069566653,2.34352369206303,3.5429401195394e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173964034401876,ADM;Pro-adrenomedullin,0.685916716522749,1.98559122576128,1.6399815688715,2.40403464932423,2.06432033279852e-12
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0824863174354,ADM;Pro-adrenomedullin,0.214598758023707,1.2393645121207,1.21512258125711,1.26409007420064,1.33497757844224e-100
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,ADM;Pro-adrenomedullin,1.3732668979482,3.94822810772584,3.46416473781334,4.49993183652004,4.28960799772392e-94
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,ADM;Pro-adrenomedullin,1.38083119867499,3.97820693395361,2.89283459751989,5.47080376559543,1.98358953773428e-17
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.57584050039093,ADM;Pro-adrenomedullin,0.268544830838064,1.30805961712499,1.25459281741297,1.36380500366755,1.81772370940711e-36
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6446442533229,ADM;Pro-adrenomedullin,0.387544928179381,1.47335914747609,1.39566101720243,1.5553828262702,1.17136025823805e-44
sensitivity,Circulatory system disorders,I22 (subsequent myocardial infarction),0.111415168100078,ADM;Pro-adrenomedullin,0.657141983449404,1.92927056030782,1.51767502473667,2.45249136620422,7.98790538610583e-08
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67865519937451,ADM;Pro-adrenomedullin,0.32127257125566,1.37888137310362,1.31635651116329,1.44437606755323,6.08817459406432e-42
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0027365129007,ADM;Pro-adrenomedullin,0.312704875957096,1.36711800209308,1.25444633083394,1.48990960052032,1.03511387013751e-12
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361610633307271,ADM;Pro-adrenomedullin,0.716715619451787,2.04769673879341,1.79373956608928,2.33760910074973,2.71354779594861e-26
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545347928068803,ADM;Pro-adrenomedullin,0.623639380054299,1.86570571326439,1.66995597122618,2.0844009473804,2.81604728220825e-28
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.379202501954652,ADM;Pro-adrenomedullin,0.393748935983276,1.48252829243862,1.29170980222987,1.7015355415642,2.12977640148386e-08
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0586395621579358,ADM;Pro-adrenomedullin,1.02580713421782,2.7893459287732,2.08700848746924,3.72803980294224,4.175485554976e-12
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304925723221266,ADM;Pro-adrenomedullin,0.696532976862764,2.00678306917102,1.73645702671614,2.31919260007682,3.89299121783529e-21
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383111806098514,ADM;Pro-adrenomedullin,0.564546673022737,1.75865035833747,1.53900188175277,2.00964736921442,1.09729960129057e-16
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.080140734949179,ADM;Pro-adrenomedullin,0.79663602696659,2.21806684717652,1.69138955609026,2.90874477782399,8.42523050286096e-09
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.709538702111024,ADM;Pro-adrenomedullin,0.331290507359437,1.3927643418343,1.25791730393621,1.54206680026997,1.81427302315363e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,ADM;Pro-adrenomedullin,0.547569565337697,1.72904557468322,1.63089084314565,1.8331077226268,2.57833379929053e-75
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.26270523846755,ADM;Pro-adrenomedullin,0.285177080580549,1.32999752400366,1.23137826641277,1.43651505155193,4.02052362809434e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,ADM;Pro-adrenomedullin,0.867519907656106,2.38099842890095,2.18769188436768,2.59138572435093,1.0839557154296e-89
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71032056293979,ADM;Pro-adrenomedullin,0.371108789264083,1.44934073752264,1.35680308489434,1.54818970919886,2.91593835184481e-28
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.367474589523064,ADM;Pro-adrenomedullin,0.436212002476446,1.54683669320012,1.34571739437892,1.77801354535851,8.34536601525041e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,ADM;Pro-adrenomedullin,0.417032675467259,1.51745209558127,1.41667988836338,1.62539249783813,1.2599311862392e-32
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34401876465989,ADM;Pro-adrenomedullin,0.4859579874527,1.62573169364689,1.40963387943458,1.87495744695646,2.42334838224427e-11
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.125097732603596,ADM;Pro-adrenomedullin,0.590653312850737,1.80516736928314,1.43453012933262,2.27156555620105,4.72065951301409e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173964034401876,ADM;Pro-adrenomedullin,0.887689119821077,2.42950885543979,2.0285860491397,2.90966867348986,5.06111653082241e-22
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168100078186082,ADM;Pro-adrenomedullin,0.63282026802294,1.88291341853973,1.5452270377631,2.29439613407835,3.49011417355032e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3975762314308,ADM;Pro-adrenomedullin,0.379980218438186,1.46225566344733,1.35979415927493,1.57243771838519,1.16388095770868e-24
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.14855355746677,ADM;Pro-adrenomedullin,0.693703093051526,2.00111213407913,1.62830944292035,2.45926828623975,4.25216750856814e-11
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236512900703674,ADM;Pro-adrenomedullin,0.682211538941329,1.97824787028478,1.67840398619924,2.33165833045257,4.12462144298296e-16
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55277560594214,ADM;Pro-adrenomedullin,0.261915820240767,1.29941715320216,1.23023742022008,1.37248705841996,6.39623027006486e-21
sensitivity,Circulatory system disorders,I95 (hypotension),0.521892103205629,ADM;Pro-adrenomedullin,0.434133129247642,1.54362435598711,1.37306767606173,1.73536686788153,3.67015130924967e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,NOTCH1;Neurogenic locus notch homolog protein 1,0.662179394893096,1.93901360917633,1.66068456901693,2.2639903126195,5.47843305735934e-17
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.303782388563486,PLAUR;Urokinase plasminogen activator surface receptor,1.49736438521083,4.4698926166264,3.80989105883117,5.2442286920143,2.3054354246987e-75
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0397101161520897,PLAUR;Urokinase plasminogen activator surface receptor,1.53375778133888,4.63556356831739,3.06024780731149,7.0218005040545,4.51770605538783e-13
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.57063436910553,PLAUR;Urokinase plasminogen activator surface receptor,0.197512516917709,1.21836831509013,1.16808759859564,1.27081338163358,4.09813095700388e-20
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63873721830636,PLAUR;Urokinase plasminogen activator surface receptor,0.337077030795872,1.40084696793934,1.32649241417487,1.47936935531253,8.95396218236033e-34
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68112776729871,PLAUR;Urokinase plasminogen activator surface receptor,0.315383695095483,1.37078517361316,1.30822506879477,1.43633694004103,5.66526303227013e-40
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00466593864787,PLAUR;Urokinase plasminogen activator surface receptor,0.376300511456312,1.45688487859067,1.33225366917458,1.59317523274766,1.62139818996168e-16
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.355405539561203,PLAUR;Urokinase plasminogen activator surface receptor,0.606614142323107,1.83421049748753,1.57950850776117,2.12998418974147,1.82392101270672e-15
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542043085476025,PLAUR;Urokinase plasminogen activator surface receptor,0.382751617186857,1.4663137776922,1.30000565368404,1.65389749541238,4.61678997450504e-10
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.383202620867666,PLAUR;Urokinase plasminogen activator surface receptor,0.437967391135643,1.54955437738714,1.34433291929387,1.78610427076418,1.52105484176557e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303782388563486,PLAUR;Urokinase plasminogen activator surface receptor,0.419390459487056,1.52103414106842,1.29789326719611,1.7825386083509,2.20442093096379e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.38518812667527,PLAUR;Urokinase plasminogen activator surface receptor,0.436677348935006,1.54755667568493,1.34440507173511,1.7814062999376,1.18809399357531e-09
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.077434726496575,PLAUR;Urokinase plasminogen activator surface receptor,0.752922667580671,2.12319635443659,1.56043990836502,2.88890506794082,1.65176468007324e-06
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.714782090737615,PLAUR;Urokinase plasminogen activator surface receptor,0.291901019604543,1.33897047925251,1.20488577986356,1.48797668150146,5.89158780516599e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15824481286607,PLAUR;Urokinase plasminogen activator surface receptor,0.417189817801079,1.51769057028178,1.42854539750427,1.6123986477058,1.40408025257948e-41
sensitivity,Circulatory system disorders,I50 (heart failure),0.905390648267646,PLAUR;Urokinase plasminogen activator surface receptor,0.742093864566572,2.10032871738283,1.91565492300328,2.30280551475682,2.93647288028592e-56
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.69760746550183,PLAUR;Urokinase plasminogen activator surface receptor,0.274638926376578,1.31605539617696,1.22883048446331,1.40947171127753,4.17950907931484e-15
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.363347562791621,PLAUR;Urokinase plasminogen activator surface receptor,0.443079004265112,1.55749537825899,1.34664479207759,1.80135984453303,2.37196527581216e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56060756477712,PLAUR;Urokinase plasminogen activator surface receptor,0.384882152138106,1.46944114074024,1.36839279718634,1.57795135325163,3.38217364186523e-26
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357391045368807,PLAUR;Urokinase plasminogen activator surface receptor,0.580289658534635,1.78655584695811,1.54090889164959,2.0713630842141,1.48201158751146e-14
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.123101360071478,PLAUR;Urokinase plasminogen activator surface receptor,0.652304224650008,1.91995975455361,1.49631871604573,2.46354297354982,2.92205536450521e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174724511069194,PLAUR;Urokinase plasminogen activator surface receptor,0.793767631638356,2.21171367066128,1.80177684818097,2.71491853496093,3.21727798743232e-14
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170753499453985,PLAUR;Urokinase plasminogen activator surface receptor,0.657396462469103,1.92976158166341,1.57071615595564,2.37088015421752,3.87868870163608e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38786855951553,PLAUR;Urokinase plasminogen activator surface receptor,0.410737795389925,1.50792991854117,1.39701167193793,1.62765471821527,5.8495647016313e-26
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152883947185545,PLAUR;Urokinase plasminogen activator surface receptor,0.60709332206322,1.83508962461016,1.4699629368089,2.29091077470454,8.17150400093041e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240246202720142,PLAUR;Urokinase plasminogen activator surface receptor,0.714956563743626,2.04409789237011,1.71195798127157,2.44067683862687,2.7302972605759e-15
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56328799761739,PLAUR;Urokinase plasminogen activator surface receptor,0.239197369488581,1.27022921633556,1.20026812101751,1.3442681962299,1.28083350501956e-16
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0536086568053211,PLAUR;Urokinase plasminogen activator surface receptor,0.952949804391031,2.59334825766947,1.77481961397291,3.78937393558685,8.44331208528725e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.526159039015189,PLAUR;Urokinase plasminogen activator surface receptor,0.315257214133346,1.37061180634957,1.2119549600725,1.55003839713026,5.09765685242273e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0218405638836493,PLAUR;Urokinase plasminogen activator surface receptor,1.52010316626281,4.57269691886084,2.58809884777694,8.07911843464549,1.6546847781694e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305385353248634,FGF21;Fibroblast growth factor 21,0.544389346806542,1.72355556624575,1.47904074819823,2.00849354120605,3.08167038557907e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,CD302;CD302 antigen,1.57775156385507,4.84405201594681,4.16250473980827,5.63719236372068,1.91584489549739e-92
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,CD302;CD302 antigen,1.61716842671628,5.03880235926885,3.50429530517195,7.24525960420664,2.60697895225233e-18
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63006753411363,CD302;CD302 antigen,0.228185528692088,1.25631838691905,1.18903240069303,1.32741201029588,4.48071706734739e-16
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67773750816944,CD302;CD302 antigen,0.192108450991082,1.21180193095919,1.15637165347828,1.26988923972615,8.85490656163274e-16
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.998158160537104,CD302;CD302 antigen,0.336671123453178,1.40027846925576,1.28310809780768,1.52814855958859,4.3142826519261e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354504584793931,CD302;CD302 antigen,0.508864710563478,1.66340168021953,1.43943977996291,1.92220972927985,5.31731840074099e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.538688531083516,CD302;CD302 antigen,0.334261789422603,1.39690879165701,1.2406304933791,1.57287297275255,3.35170184386672e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.306973243815974,CD302;CD302 antigen,0.446753947872508,1.56322961598951,1.3375614923358,1.82697157948176,1.9503155098146e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,CD302;CD302 antigen,0.392380507585741,1.48050094607863,1.39412980054652,1.57222308172488,1.76995413170573e-37
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25760006337512,CD302;CD302 antigen,0.201355543160326,1.22305954498432,1.13101908135539,1.32259010943001,4.55143218240267e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,CD302;CD302 antigen,0.648044480764512,1.91179861225736,1.74602453749768,2.09331189529976,1.48729824936642e-44
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70914780266571,CD302;CD302 antigen,0.225721060208008,1.25322604190707,1.1716853383129,1.34044138025617,4.83960654855092e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,CD302;CD302 antigen,0.355256047632836,1.42654587121647,1.32968493532847,1.53046264465803,4.05740902111951e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.346582694630938,CD302;CD302 antigen,0.567397945465018,1.76367190513681,1.52461587047714,2.04021134057554,2.25818784312323e-14
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.126750242607886,CD302;CD302 antigen,0.598630437509793,1.81962500292432,1.43272457242182,2.31100604749908,9.19620414442148e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172301111045095,CD302;CD302 antigen,0.721550279182052,2.05762062573451,1.68067870761332,2.51910291971295,2.77141035746524e-12
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.106945517200404,CD302;CD302 antigen,0.653921077921315,1.92306655870995,1.48505210737546,2.4902728805687,7.09939631567877e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,CD302;CD302 antigen,0.397074839467716,1.48746724714282,1.38155696997198,1.60149661534949,5.8749655132074e-26
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239637177430534,CD302;CD302 antigen,0.62748501671264,1.87289435313816,1.57426548249838,2.22817135801644,1.43683051498088e-12
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.53896579723922,CD302;CD302 antigen,0.227076601980872,1.2549259940755,1.1872316106369,1.32648022213757,1.00685384743852e-15
sensitivity,Circulatory system disorders,I95 (hypotension),0.514922860594537,CD302;CD302 antigen,0.347742252192307,1.41586726602136,1.25414508715764,1.59844354175493,1.91659750364739e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0217851979482304,CD302;CD302 antigen,1.30450316877625,3.68585738968134,2.21130907322609,6.14366614850834,5.60711735316756e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288562956476745,DKK4;Dickkopf-related protein 4,0.899832967533465,2.45919231189196,2.09810123251276,2.88242851829683,1.17254670671533e-28
sensitivity,Circulatory system disorders,I50 (heart failure),0.901510477820454,DKK4;Dickkopf-related protein 4,0.311905583592539,1.3660257117004,1.2456183416611,1.49807222855929,3.46951243582179e-11
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.54788703454259,CD80;T-lymphocyte activation antigen CD80,0.210039141241513,1.23372634859267,1.16215921615876,1.30970066927892,5.62775917381719e-12
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53873199242026,CD80;T-lymphocyte activation antigen CD80,0.185461966119205,1.20377441469185,1.14388545708569,1.26679890236437,1.05550045820184e-12
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999977169471016,CD80;T-lymphocyte activation antigen CD80,0.254725215577493,1.29010707083627,1.17417928275816,1.41748051482573,1.14286336105522e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15291888313052,CD80;T-lymphocyte activation antigen CD80,0.225287127790729,1.25268234447381,1.17428470359808,1.33631397168696,8.35885626225627e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.915504212232597,CD80;T-lymphocyte activation antigen CD80,0.325316869100517,1.38446927201648,1.25531669412744,1.52690964290103,7.46839113335887e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54562681217323,CD80;T-lymphocyte activation antigen CD80,0.191533261653895,1.21110511582924,1.12247555587957,1.30673277819257,7.82565478661615e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38581310928974,CD80;T-lymphocyte activation antigen CD80,0.3146742781935,1.36981306029958,1.26435513095544,1.48406707437441,1.37571545500247e-14
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5296226113559,CD80;T-lymphocyte activation antigen CD80,0.188834770099375,1.20784136448577,1.1376897727757,1.28231860448524,6.19094279498309e-10
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.05251021666172,CD80;T-lymphocyte activation antigen CD80,1.25680016496502,3.51415874923894,2.41058458758905,5.12295307056774,6.35647226069302e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0182644231866852,CD80;T-lymphocyte activation antigen CD80,1.51642449419724,4.55590636883982,2.50450016924655,8.28759490476678,6.78760813336865e-07
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.11883541295306,THOP1;Thimet oligopeptidase,0.750082300716917,2.1171742544016,1.66327386662393,2.69494213397297,1.1102283780093e-09
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0277282630223806,THOP1;Thimet oligopeptidase,1.14698587744182,3.14868806078327,1.98283076934085,5.00004168657061,1.16754526886098e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.306991483462071,THOP1;Thimet oligopeptidase,-0.427039848582594,0.652437552998169,0.55663912272653,0.76472303721161,1.35883232134895e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.3025509195175,CD4;T-cell surface glycoprotein CD4,1.11060375354143,3.03619095221325,2.60611745762482,3.53723715380931,4.41319216915303e-46
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0395491398062092,CD4;T-cell surface glycoprotein CD4,1.15590289329956,3.17689051615123,2.10355857234666,4.79788558506961,3.90221658439972e-08
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00652560806802,CD4;T-cell surface glycoprotein CD4,0.286094519752652,1.33121827572808,1.22035054034598,1.45215824391738,1.12990193011521e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.357919715246193,CD4;T-cell surface glycoprotein CD4,0.372625797048967,1.4515410672411,1.25610924965542,1.67737915349754,4.40706993040627e-07
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.527981016412893,CD4;T-cell surface glycoprotein CD4,0.398272823955145,1.48925027763864,1.32159374142247,1.67817561473893,6.32675674806998e-11
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.379671742139608,CD4;T-cell surface glycoprotein CD4,0.34690254821349,1.41467885567089,1.22860277463101,1.62893679389855,1.4266236802761e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.306505833498121,CD4;T-cell surface glycoprotein CD4,0.414102746101853,1.51301257504255,1.29341085285871,1.76989936892616,2.2726384039408e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16333794739964,CD4;T-cell surface glycoprotein CD4,0.286586571233366,1.33187346483197,1.25406216022664,1.4145127590828,1.05097381186186e-20
sensitivity,Circulatory system disorders,I50 (heart failure),0.895788016610638,CD4;T-cell surface glycoprotein CD4,0.575633284556538,1.77825631266542,1.6212226459607,1.95050045804201,2.98776239575637e-34
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70654538263792,CD4;T-cell surface glycoprotein CD4,0.204000661973168,1.22629896523295,1.14654515021198,1.31160046497372,2.7525951086017e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56416847933557,CD4;T-cell surface glycoprotein CD4,0.188555727700176,1.20750437255328,1.12551070633639,1.29547129274443,1.47602275240583e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175993672137631,CD4;T-cell surface glycoprotein CD4,0.547539058985228,1.72899282861403,1.40679380185817,2.12498533719026,1.95260294027571e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38619735020763,CD4;T-cell surface glycoprotein CD4,0.230013164994361,1.25861657950058,1.16845131411088,1.35573958030005,1.32151772914502e-09
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173500136973792,SHISA5;Protein shisa-5,0.623219941994415,1.86492332937197,1.49894193934548,2.32026266871584,2.25312273897323e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200894895443338,SHISA5;Protein shisa-5,1.56764476052564,4.79534070735609,3.97371588556724,5.78684867308874,4.48188824926122e-60
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.56825860651995,SHISA5;Protein shisa-5,0.302547640534674,1.35330214692331,1.27382884603298,1.43773373210283,1.14775898320543e-22
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55446991142361,SHISA5;Protein shisa-5,0.278223572870259,1.32078145510294,1.25433618568451,1.3907464936857,4.35319486265598e-26
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00447447721669,SHISA5;Protein shisa-5,0.376970357203406,1.45786109365085,1.32795831272986,1.60047115034189,2.43877543168258e-15
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.404072687425805,SHISA5;Protein shisa-5,0.5977677204507,1.81805585835437,1.57437874474763,2.09944850635447,3.90756356057136e-16
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554743859008309,SHISA5;Protein shisa-5,0.416947822983187,1.51732334146413,1.33871259925161,1.71976428984006,6.79453478409123e-11
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303625239704136,SHISA5;Protein shisa-5,0.432980140612655,1.54184560028758,1.30132064830535,1.82682712229456,5.62481461933784e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383526618573646,SHISA5;Protein shisa-5,0.484366076809798,1.62314573291658,1.39611402075629,1.88709663474199,2.964036380464e-10
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0867500684868961,SHISA5;Protein shisa-5,0.833108168305199,2.30045784991616,1.69752448485832,3.11754343836906,7.77097214529718e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14592274678111,SHISA5;Protein shisa-5,0.372130019075571,1.45082160351435,1.35915832488898,1.54866676433439,5.37538091886851e-29
sensitivity,Circulatory system disorders,I50 (heart failure),0.90859282257328,SHISA5;Protein shisa-5,0.7104080772218,2.03482145352903,1.84462224132264,2.24463212845853,1.07847070392155e-45
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66879737010318,SHISA5;Protein shisa-5,0.282615906107154,1.32659552670947,1.2329404667166,1.42736469358669,3.85696654951732e-14
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54780385352935,SHISA5;Protein shisa-5,0.388212649637258,1.47434326951715,1.36646128764597,1.59074252305763,1.33416552962523e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351566067025842,SHISA5;Protein shisa-5,0.524494928359609,1.68960526113502,1.44532057450531,1.97517837136737,4.61744887754828e-11
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.0981645511825404,SHISA5;Protein shisa-5,0.765862747861873,2.15084921497183,1.61449235988678,2.86539128984752,1.66723057017887e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39941557848598,SHISA5;Protein shisa-5,0.425486226218819,1.53033432746855,1.41383061141906,1.65643828540255,6.16995794499909e-26
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.143822481965117,SHISA5;Protein shisa-5,0.673122901907215,1.96034975138489,1.54019516990888,2.49511959447461,4.51539356966247e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.232855446991142,SHISA5;Protein shisa-5,0.596743890262906,1.81619543042714,1.50094933824434,2.19765301696509,8.52076214817374e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54542964112866,SHISA5;Protein shisa-5,0.219812866592004,1.24584356981892,1.17395543807,1.32213383074478,4.20512916509839e-13
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0525066203999634,SHISA5;Protein shisa-5,1.00999240529707,2.74558016307203,1.89572960137612,3.97641648175068,9.06578926252507e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.506803031686604,SHISA5;Protein shisa-5,0.380496156471642,1.46301029141263,1.28324517191614,1.66795804856466,1.28310840246498e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0182631723130307,SHISA5;Protein shisa-5,1.60072764195526,4.95663777013421,2.84463490114032,8.63669990636496,1.60509080895638e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.196791146713587,SERPINF1;Pigment epithelium-derived factor,1.20348274628768,3.33170020673526,2.7456976292888,4.04277082412567,3.37072535740731e-34
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0185215196906906,SERPINF1;Pigment epithelium-derived factor,1.50030515920216,4.48305690769259,2.53084501327247,7.94114184480349,2.70325243686089e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,NRCAM;Neuronal cell adhesion molecule,0.223444618677869,1.25037639086123,1.17754810355302,1.32770891830726,2.92481330561183e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3917088844645,NRCAM;Neuronal cell adhesion molecule,0.18747453407844,1.20619953204719,1.11965858461831,1.29942942527148,7.999106031299e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01128506715409,CDCP1;CUB domain-containing protein 1,0.260963533544545,1.29818032453554,1.19165536527856,1.41422780790085,2.31763449036481e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,CDCP1;CUB domain-containing protein 1,0.277800120016809,1.32022228482647,1.2081808777283,1.44265392167909,8.277586894606e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39275212588412,CDCP1;CUB domain-containing protein 1,0.216008672118614,1.24111314203438,1.1531832941746,1.33574761194661,8.33699616774901e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.296753875968992,PXN;Paxillin,0.504268549400403,1.65577396056051,1.41040442607431,1.94383068982639,7.17969875064508e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15802648578811,PXN;Paxillin,0.18602421096892,1.20445142096054,1.13316769209035,1.28021936698333,2.28188373702911e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.896317829457364,PXN;Paxillin,0.278169864113754,1.32071051947832,1.20226011063236,1.45083103135081,6.54936547780632e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39019792648444,CD163;Scavenger receptor cysteine-rich type 1 protein M130,0.19547138927512,1.21588400610173,1.12899500310115,1.30946010587573,2.37585222006481e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,IFNLR1;Interferon lambda receptor 1,0.41481762051362,1.51409457571835,1.29126091140428,1.77538277816107,3.27300476287619e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.310806665985073,CD59;CD59 glycoprotein,1.66645762930047,5.29338341988216,4.54228190164377,6.16868539571344,4.4553947053843e-101
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0388508332481341,CD59;CD59 glycoprotein,1.8933710128315,6.64172031045163,4.54173171793997,9.71269362036956,1.60658540917883e-22
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999897760965136,CD59;CD59 glycoprotein,0.340825311047742,1.40610758794506,1.2834573880168,1.54047852880551,2.49491763471153e-13
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.349657499233207,CD59;CD59 glycoprotein,0.470986838642832,1.60157390864945,1.37684883478952,1.86297792470354,1.02350676678029e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.545956446171148,CD59;CD59 glycoprotein,0.359970320617626,1.43328687485985,1.26664911755913,1.62184715338075,1.14059962011956e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.312851446682343,CD59;CD59 glycoprotein,0.480913533004004,1.61755141404303,1.37420532623813,1.90398954735183,7.41198520083027e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.390553113178611,CD59;CD59 glycoprotein,0.380834817877603,1.46350584044178,1.26288460146684,1.69599767272438,4.13411076666598e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17973622329005,CD59;CD59 glycoprotein,0.247014676953345,1.28019790204526,1.20101765871572,1.36459831086382,3.37656066198858e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.926285655863408,CD59;CD59 glycoprotein,0.560534057089775,1.75160770906196,1.59127350937505,1.92809692888702,2.51712365355037e-30
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.73806359267968,CD59;CD59 glycoprotein,0.22339130975586,1.25030973642038,1.16535250197508,1.34146057466569,4.90361696836865e-10
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.366015744811368,CD59;CD59 glycoprotein,0.41663137525958,1.51684326391048,1.30325073269679,1.76544192882177,7.43178852854307e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5785706982926,CD59;CD59 glycoprotein,0.322905189943583,1.38113439926764,1.28266969783158,1.48715778665791,1.15933831414274e-17
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.359881402719558,CD59;CD59 glycoprotein,0.456656269007171,1.578786113253,1.35795350828538,1.83553087509437,2.84957077459213e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39454043553828,CD59;CD59 glycoprotein,0.224778902089533,1.25204586086327,1.15807345517559,1.3536437008369,1.63595249559267e-08
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5743788978632,CD59;CD59 glycoprotein,0.225393894775185,1.25281609673024,1.18262735436767,1.32717052960915,1.82848372582677e-14
sensitivity,Circulatory system disorders,I95 (hypotension),0.523463858501175,CD59;CD59 glycoprotein,0.33409348521824,1.39667370581778,1.23158417644878,1.5838929062466,1.93475600130492e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.296109126083265,FOLR1;Folate receptor alpha,1.51303853119666,4.54050632514301,3.89921353195054,5.28727075850873,1.75148650247137e-84
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394812168111021,FOLR1;Folate receptor alpha,1.59159057569824,4.91155491856579,3.40102067960739,7.09298001706729,2.10258128758994e-17
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00479696784254,FOLR1;Folate receptor alpha,0.269053953540753,1.30872574952972,1.19822546093915,1.42941636888577,2.25845238020977e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.896223621612018,FOLR1;Folate receptor alpha,0.323868873723203,1.38246601761214,1.26222760765908,1.51415820590146,3.03235104767043e-12
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.363227194662139,FOLR1;Folate receptor alpha,0.355733397320631,1.4272269949969,1.23711026227149,1.64656050262467,1.07588258882336e-06
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54963775983575,FOLR1;Folate receptor alpha,0.309093793029561,1.36219012845091,1.26953638867472,1.46160595521498,7.96033962420669e-18
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351382829618808,FOLR1;Folate receptor alpha,0.463255516695935,1.58923936773304,1.37406316861404,1.83811183185999,4.3473366122477e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173717353968849,FOLR1;Folate receptor alpha,0.560944739177337,1.75232721070562,1.43467923093198,2.14030466683804,3.86169474072224e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39566101427246,FOLR1;Folate receptor alpha,0.320749264839591,1.37815998440421,1.27866717962439,1.4853943018784,4.86917789933899e-17
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240835422547722,FOLR1;Folate receptor alpha,0.500926138843947,1.65024892281155,1.38845608262378,1.96140269852423,1.31675647409326e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,NT5C1A;Cytosolic 5'-nucleotidase 1A,1.03975690894877,2.82852934060045,2.36376383830123,3.3846774796197,7.16466507882559e-30
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0206001510677745,NT5C1A;Cytosolic 5'-nucleotidase 1A,1.41858487191586,4.13127002544843,2.45856975514442,6.94200031846001,8.45565265733293e-08
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00254068529835,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.258669449482385,1.29520560317826,1.18191808752845,1.41935179113161,3.04326587478838e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.400558492984504,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.406856760175778,1.50208893129706,1.30416822230552,1.73004610826699,1.66304749276365e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.556204078829911,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.337788413568566,1.4018438608837,1.24138577564413,1.58304231356094,5.14274920924473e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309002266016617,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.459412196298631,1.58314313404847,1.34837065340384,1.85879318610041,2.0275845527473e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14699352239694,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.329521828197026,1.3903031657218,1.30500698550393,1.48117436464881,1.96542637092739e-24
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24287578108906,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.2197469559472,1.24576145817196,1.14656671419242,1.3535379943066,2.0953108433705e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.908695552656275,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.49691000492862,1.64363459305134,1.49551681419319,1.80642213436597,6.16516602633728e-25
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65945661379294,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.199344827335942,1.22060279054828,1.13564525010989,1.31191599854804,6.10526451686445e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54730023575728,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.202206170415117,1.2241003553756,1.13582445074138,1.31923703443135,1.19017666177068e-07
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.123600906406646,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.67299909912539,1.96010706965497,1.53885038578314,2.49668178271672,4.9958134591634e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39852136693446,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.220996415253883,1.24731895923425,1.1536839646482,1.34855353263026,2.84741198409149e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.50813705967177,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.317463556861658,1.37363918423035,1.2094324656887,1.56014053035905,1.02213910259041e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,CALB1;Calbindin,1.33515617013596,3.80058943864456,3.25798677869861,4.4335600670873,1.01748878478218e-64
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,CALB1;Calbindin,1.42481051955318,4.15707008462889,2.79226693026618,6.18896119894564,2.26214839113457e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,CALB1;Calbindin,0.301761545628642,1.35223874102303,1.23449116610267,1.48121725204104,8.46844039502116e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,CALB1;Calbindin,0.299535141747909,1.34923146039519,1.25747837187879,1.44767939905023,7.68370019748415e-17
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,CALB1;Calbindin,0.221565024662087,1.24802839820723,1.15817344504164,1.34485459790152,6.18210819623373e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.900225056264065,PSPN;Persephin,0.321789671240905,1.37959457702428,1.22200728818874,1.55750396527982,1.99616162412817e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14921286789869,SHBG;Sex hormone-binding globulin,0.210092692575653,1.23379241805363,1.14931657515799,1.32447731438779,6.40780995326006e-09
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.124229318119076,APCS;Serum amyloid P-component,-0.815564204028767,0.442389658908159,0.33259373566019,0.588431438494777,2.1019492395097e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.174841262537958,APCS;Serum amyloid P-component,-0.613686001109729,0.541351763783699,0.426119012539385,0.687746201243801,5.02712945183322e-07
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.4032391644428,APCS;Serum amyloid P-component,-0.259287977991629,0.771600787000714,0.734515983052997,0.810557956854103,5.87199588907227e-25
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.55820373608171,APCS;Serum amyloid P-component,-0.363005536363964,0.695582582490091,0.652431957134408,0.741587109234609,1.12921472010142e-28
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53133339468114,APCS;Serum amyloid P-component,-0.326330063839537,0.721566984953328,0.683017330095296,0.762292391178411,2.31818529174996e-31
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.397993926566669,APCS;Serum amyloid P-component,-0.42576076328892,0.653272610218104,0.556350978078705,0.767078912550778,2.03463593950317e-07
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.559031931535842,APCS;Serum amyloid P-component,-0.435817111790407,0.646735995508352,0.564938340347323,0.740377166876351,2.66802387162789e-10
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.345081439219655,APCS;Serum amyloid P-component,-0.768186630919764,0.463853443618062,0.392366115987053,0.548365438272031,2.35007992869145e-19
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.381890126069752,APCS;Serum amyloid P-component,-0.409588879771793,0.663923146271322,0.564503746448827,0.78085211467196,7.47003575513041e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14410600901812,APCS;Serum amyloid P-component,-0.709863512567662,0.491711305294684,0.458208565956167,0.527663657378528,1.57090616163925e-86
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.23999263826262,APCS;Serum amyloid P-component,-0.346232327980334,0.707348131252281,0.645661950611578,0.774927774994585,1.02998890107718e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.899512284899236,APCS;Serum amyloid P-component,-0.560032738585051,0.571190363578407,0.513883545027018,0.634887874114903,2.99493339357063e-25
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65639090825434,APCS;Serum amyloid P-component,-0.299654035524962,0.741074561808439,0.684705080613819,0.802084754018818,1.13896632348415e-13
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.361185239716573,APCS;Serum amyloid P-component,-0.466448546868446,0.627225880736159,0.530834784781762,0.741120056077317,4.27462922169879e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55516701941658,APCS;Serum amyloid P-component,-0.247101169597508,0.781061669839279,0.720088340809309,0.847197902699658,2.54539398350046e-09
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0529124873470139,APCS;Serum amyloid P-component,-1.22432811485516,0.29395513807888,0.198271806669943,0.435813969995324,1.10310794357083e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17109144542772,LDLR;Low-density lipoprotein receptor,-0.257084837596243,0.77330260584823,0.727801334056953,0.821648562909706,9.65124705716645e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.910521140609636,LDLR;Low-density lipoprotein receptor,-0.251877490382428,0.777339963857485,0.708340233290218,0.853060988224824,1.09050608923595e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173470795797275,REN;Renin,0.664956056313983,1.94440507513332,1.55066503364683,2.43812236309527,8.41970917407942e-09
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0727000335114,REN;Renin,0.356996503757822,1.42903087360712,1.39888826634691,1.45982298004057,2.95453496027991e-236
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,REN;Renin,1.14617846770881,3.14614680545198,2.64389904382251,3.74380396429395,3.63765400413422e-38
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394251808630172,REN;Renin,1.58248363118745,4.86702871702069,3.00356881014565,7.88660757572436,1.31195541486628e-10
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.5851485343689,REN;Renin,0.317951108652609,1.37430906776293,1.31330604141999,1.43814568285489,7.17042695043273e-43
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.66119970825366,REN;Renin,0.532826627950485,1.70374135165385,1.60237865716785,1.81151601111923,5.28358408904082e-65
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70399574208046,REN;Renin,0.42918132920069,1.53599953071399,1.45897555885583,1.61708984364606,4.31583410621679e-60
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360740404896607,REN;Renin,0.787199533456297,2.19723452041438,1.87895797648405,2.56942390310112,6.21740800547002e-23
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540124977823335,REN;Renin,0.50706395337601,1.6604089930484,1.46011386714447,1.88818015240671,1.06635438136825e-14
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309487669774685,REN;Renin,1.05559753322914,2.87369176730477,2.41701705961951,3.4166512563942,6.13016865162805e-33
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.394251808630172,REN;Renin,0.599263213378051,1.82077678208605,1.5623191048015,2.12199164690165,1.69219989838739e-14
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0808216207691852,REN;Renin,0.99723335681332,2.71077170626346,1.93168443413942,3.80408058045582,8.00680293919981e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,REN;Renin,0.358912667470848,1.43177175586285,1.34114671246713,1.52852058751687,5.4197822009119e-27
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,REN;Renin,1.0127556913548,2.75317747840054,2.4791412959301,3.05750472553367,6.13895048518168e-80
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71696662658439,REN;Renin,0.318976106877057,1.37571845430318,1.28029955224178,1.47824879122735,3.39786911175133e-18
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.36665418202606,REN;Renin,0.426170194060893,1.53138138497217,1.30893303123285,1.79163401815178,1.02818061126583e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56912219834808,REN;Renin,0.370906715385472,1.44904789320747,1.34311808622395,1.56333223291798,1.00592256389785e-21
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175442054840426,REN;Renin,0.853061208659026,2.34681997273633,1.86241622728427,2.95721434540179,4.75502457972983e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3917088844645,REN;Renin,0.41995362955564,1.52189098322125,1.40544158192957,1.6479889271742,4.64023164208638e-25
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151786946322616,REN;Renin,0.699551103457805,2.01284894370664,1.57300238530347,2.57568641219785,2.68562510743107e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,NECTIN4;Nectin-4,1.99167409626912,7.32779092706197,6.08999038476827,8.8171764614001,8.39512688329796e-99
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,NECTIN4;Nectin-4,2.35404538163146,10.5280737704651,6.50829127301571,17.0306356410192,8.57088547726854e-22
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00023581197924,NECTIN4;Nectin-4,0.28668485290065,1.33200437000939,1.21866937242384,1.45587940574505,2.63774732992843e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.898050620971545,NECTIN4;Nectin-4,0.326699103372773,1.38638425606654,1.26186231971295,1.52319415156671,1.01820931030548e-11
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.363543468008174,NECTIN4;Nectin-4,0.37641399473367,1.45705022004299,1.25747183567128,1.68830448802377,5.49490244508305e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55242886338626,NECTIN4;Nectin-4,0.337394538492902,1.40129181825198,1.30420513409147,1.50560575830569,3.26294333895651e-20
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351752869045747,NECTIN4;Nectin-4,0.439877821418445,1.55251752253443,1.33640175080629,1.80358238555303,8.84144776866457e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172928784782266,NECTIN4;Nectin-4,0.580852305824138,1.78756133060275,1.44236086070457,2.21537868762286,1.12241455245709e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39522087722056,NECTIN4;Nectin-4,0.242804744997425,1.27481968489508,1.18224012374725,1.37464902125368,2.75368537290732e-10
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239742178902688,NECTIN4;Nectin-4,0.466120255193255,1.59379865038945,1.32938796790903,1.91079970580646,4.74806888550607e-07
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0569878949850652,NECTIN4;Nectin-4,0.929610553683413,2.53352231453184,1.74716329584721,3.67380389313771,9.44295435732233e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.512891054865587,NECTIN4;Nectin-4,0.329433488143772,1.39018035169088,1.22802023064919,1.57375372326375,1.93150527260073e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,MSR1;Macrophage scavenger receptor types I and II,0.586339381264357,1.79739677370983,1.54274472356138,2.09408278168322,5.38878353987226e-14
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64212151413886,MSR1;Macrophage scavenger receptor types I and II,0.232887461532488,1.26223942084383,1.19632570031216,1.33178477660092,1.728652140268e-17
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.54718492896367,MSR1;Macrophage scavenger receptor types I and II,0.288977153843617,1.33506122716251,1.18845575946634,1.49975164500278,1.12109816384091e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16138046940649,MSR1;Macrophage scavenger receptor types I and II,0.262146198998151,1.29971654579676,1.22519751160347,1.3787679810148,3.26326418260682e-18
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,MSR1;Macrophage scavenger receptor types I and II,0.455698614983284,1.57727490610109,1.4424774091217,1.72466904069642,1.56104890768982e-23
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70213597545484,MSR1;Macrophage scavenger receptor types I and II,0.191209947963306,1.2107136122572,1.13262855827739,1.29418196300316,1.89543013181012e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173926638134881,MSR1;Macrophage scavenger receptor types I and II,0.650951979153768,1.91736525221995,1.57268823895822,2.33758313908148,1.20846952998968e-10
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.170018174356569,MSR1;Macrophage scavenger receptor types I and II,0.706157862997558,2.02619137926701,1.66194021029071,2.47027629513686,2.86791649529503e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39923003263567,MSR1;Macrophage scavenger receptor types I and II,0.297544570619023,1.34654839051061,1.25130619327649,1.4490398734773,1.86684185333381e-15
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0508100291180551,MSR1;Macrophage scavenger receptor types I and II,0.942083626261121,2.56532102377973,1.78740366865981,3.68180510672253,3.21653232448052e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0195423188915596,MSR1;Macrophage scavenger receptor types I and II,1.35044130269582,3.85912819865097,2.25602645634579,6.60137225418265,8.206226911563e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.198353890700166,B2M;Beta-2-microglobulin,1.253665302002,3.50315959256196,2.90683261735446,4.2218210493757,1.34356275699046e-39
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.5512414217642,B2M;Beta-2-microglobulin,0.209857129245709,1.23350181603211,1.1615485625887,1.30991228361864,7.73063342972722e-12
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.996329313057157,B2M;Beta-2-microglobulin,0.296574445513477,1.3452427035534,1.2258829139965,1.47622412450788,3.94683050445562e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.396707781400332,B2M;Beta-2-microglobulin,0.504959706487809,1.65691875603967,1.435090143308,1.91303645761773,5.74840543695976e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554022936093568,B2M;Beta-2-microglobulin,0.343077392966592,1.4092778258977,1.24481153114218,1.59547364470879,6.00469096540655e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307790520051982,B2M;Beta-2-microglobulin,0.496386630208217,1.64277458132959,1.39381246758945,1.93620618829011,3.22128739259986e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.37846834317503,B2M;Beta-2-microglobulin,0.439608092242804,1.55209881973363,1.33637747833575,1.80264243095339,8.52607796506334e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13857413191673,B2M;Beta-2-microglobulin,0.26534931539371,1.30388636381524,1.22216425662048,1.39107295973823,9.35634558664755e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.898292332596156,B2M;Beta-2-microglobulin,0.620743997593096,1.86031159445129,1.68863212435201,2.04944533420974,3.27702006822628e-36
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65750894872437,B2M;Beta-2-microglobulin,0.237741474984992,1.26838124215534,1.17932829449626,1.3641587189585,1.54436030255985e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54807231937256,B2M;Beta-2-microglobulin,0.302694356713787,1.35350071280955,1.25542702540805,1.45923589543606,3.08843470409504e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34654932628075,B2M;Beta-2-microglobulin,0.422563813950963,1.52586858819995,1.30611130795399,1.78260071272373,1.00520169950101e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39303709445749,B2M;Beta-2-microglobulin,0.323284493187018,1.38165836739003,1.27716940380031,1.49469587863487,7.78857816996854e-16
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5512414217642,B2M;Beta-2-microglobulin,0.202118321726185,1.22399282448755,1.15400880454882,1.29822097413091,1.7154229563646e-11
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0524383848977451,B2M;Beta-2-microglobulin,0.941435805931107,2.56365969484694,1.7735914624731,3.7056735838242,5.49313962131593e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.908430232558139,BAIAP2;Brain-specific angiogenesis inhibitor 1-associated protein 2,0.251665016967064,1.28616512162085,1.17051726460321,1.41323906113827,1.64828064969848e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300329967793562,RETN;Resistin,1.336653595699,3.80628480155139,3.25930359712204,4.44506120979765,5.64334300718998e-64
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0375412459741953,RETN;Resistin,1.6134395389706,5.02004821867175,3.31507456610483,7.60190566313569,2.52293723732347e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.353678054177945,RETN;Resistin,0.377973123841591,1.45932372133323,1.26118856305766,1.68858629552011,3.83644639179692e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.389243445100867,RETN;Resistin,0.384354760927469,1.46866637471842,1.27939418558462,1.68593928636849,4.75828902807365e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15763371599059,RETN;Resistin,0.221569975760158,1.24803457733352,1.17573949949001,1.3247750091714,3.40005829841293e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.910869178637055,RETN;Resistin,0.437784589836425,1.54927114272237,1.41533379444749,1.69588339025654,2.31920298423828e-21
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.69923534409515,RETN;Resistin,0.189966907644711,1.20920958140205,1.13062438496834,1.29325692174546,3.00994299973116e-08
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.363557329434312,RETN;Resistin,0.381790039525399,1.46490448080168,1.26987991193874,1.68988037191374,1.62611216764761e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56685305565983,RETN;Resistin,0.2922343483304,1.33941687096977,1.24919343975887,1.43615672091966,2.15087501375546e-16
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30079134366925,CFC1;Cryptic protein,0.873205307174738,2.39457391067372,2.04470170218126,2.80431331746937,2.3454458114539e-27
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0403746770025839,CFC1;Cryptic protein,1.18690655989913,3.27692853000728,2.15548286248003,4.9818352897599,2.80087835608413e-08
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6485788113695,CFC1;Cryptic protein,0.230614320342782,1.25937343105884,1.19200887474669,1.33054499212009,2.00227861474613e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.908430232558139,CFC1;Cryptic protein,0.379461847058807,1.46149786838866,1.33240799688648,1.60309456585061,8.79519236111342e-16
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304711305570747,VEGFD;Vascular endothelial growth factor D,0.69791158540826,2.00955154534312,1.73361681719774,2.32940599867882,2.02320985333217e-20
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15446519259317,VEGFD;Vascular endothelial growth factor D,0.441378937051119,1.55484978091432,1.4671786934823,1.64775964369501,3.02997635710561e-50
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25791077427924,VEGFD;Vascular endothelial growth factor D,0.231459340756069,1.2604380770765,1.16679713609356,1.36159414263157,4.18875310030362e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.900460973513555,VEGFD;Vascular endothelial growth factor D,0.423115618270117,1.52671080142446,1.39819194595749,1.66704283909312,4.07523638800029e-21
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.30870227814466,PLAT;Tissue-type plasminogen activator,0.416612897344091,1.51681523606779,1.2981037334079,1.77237642967662,1.57068668323119e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.910476339338048,PLAT;Tissue-type plasminogen activator,0.254886776470899,1.29031551852527,1.17740959793451,1.41404838237079,4.88090398452413e-08
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64729141953341,CA6;Carbonic anhydrase 6,-0.22673331383098,0.797133338382205,0.752765042357971,0.844116720896013,8.51269179098175e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.901542111506524,CA6;Carbonic anhydrase 6,-0.253487478467604,0.776089462693645,0.704673679049761,0.854742942742406,2.65107559922279e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,CD300LG;CMRF35-like molecule 9,1.53209229184716,4.62784951152956,3.95832132636895,5.41062469049491,2.7471080774916e-82
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,CD300LG;CMRF35-like molecule 9,1.85399454458214,6.38527491271657,4.21155843255659,9.68091417081859,2.51072270300126e-18
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,CD300LG;CMRF35-like molecule 9,0.242935894757463,1.27498688815493,1.16529751885364,1.39500130967942,1.20397750087951e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,CD300LG;CMRF35-like molecule 9,0.277387226619185,1.31967728628256,1.20126700581469,1.4497594052781,7.33480580757542e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,CD300LG;CMRF35-like molecule 9,0.2206411604403,1.24687592187015,1.15992398064983,1.34034608342914,2.19858084105372e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,CD300LG;CMRF35-like molecule 9,0.248926055391467,1.28264718471913,1.18859058540291,1.3841467538717,1.49142459626892e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56415310024045,CD300LG;CMRF35-like molecule 9,0.185620973225561,1.20396583859671,1.13750085413423,1.27431441940424,1.4885924326042e-10
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0492727344396704,CD300LG;CMRF35-like molecule 9,0.953611092664759,2.59506377562539,1.76120399860709,3.82372286509072,1.42178448863068e-06
sensitivity,Circulatory system disorders,I95 (hypotension),0.516378256927746,CD300LG;CMRF35-like molecule 9,0.306640021242699,1.35885172226387,1.1996902117993,1.53912900592074,1.40449185339947e-06
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173553557847935,PGF;Placenta growth factor,0.512494188696169,1.66944992959868,1.35788736865161,2.05249944272227,1.15764425361878e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,PGF;Placenta growth factor,1.52645744255828,4.60184560983922,3.99139289556184,5.30566235169278,4.1206656397364e-98
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.03900079951639,PGF;Placenta growth factor,1.72300905292403,5.60135791363438,3.92890319577476,7.98574281758232,1.69553929658689e-21
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6403541272596,PGF;Placenta growth factor,0.212102587798032,1.23627470527306,1.16680792286382,1.30987724453117,6.55364385945327e-13
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68752559427468,PGF;Placenta growth factor,0.190624712198814,1.21000526664556,1.15212423957139,1.2707941513796,2.49473456502913e-14
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0003705075954,PGF;Placenta growth factor,0.260667335775677,1.2977958633609,1.18656291026563,1.41945621962818,1.18703123873161e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356857315574969,PGF;Placenta growth factor,0.583753267506093,1.79275450648713,1.55655003970437,2.06480269734235,5.57449721444425e-16
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304206236227842,PGF;Placenta growth factor,0.490648742267635,1.63337551604933,1.39188697036403,1.9167616575444,1.84640719465575e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15479417328055,PGF;Placenta growth factor,0.306465399008852,1.35861445725714,1.27612438530893,1.44643677741592,8.85601062461536e-22
sensitivity,Circulatory system disorders,I50 (heart failure),0.898968428852791,PGF;Placenta growth factor,0.656468517444469,1.92797169958949,1.75589503304176,2.11691177688388,4.2836972308182e-43
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7004348589146,PGF;Placenta growth factor,0.225873004069972,1.2534164763791,1.16911415769753,1.34379765475823,2.04081102029966e-10
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.366607515454066,PGF;Placenta growth factor,0.404288001879949,1.49823537943435,1.29256945912886,1.73662563070432,8.02962446739124e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55223182075232,PGF;Placenta growth factor,0.297383236536913,1.34633116388551,1.25173189669006,1.44807974266884,1.24150173353893e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354907275599149,PGF;Placenta growth factor,0.391553424484235,1.47927695500531,1.27510311754995,1.71614380005158,2.37925443796736e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173553557847935,PGF;Placenta growth factor,0.760143122234283,2.13858227726825,1.74445454214367,2.62175599659115,2.59470357512897e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39817866266258,PGF;Placenta growth factor,0.378863659988945,1.46062388069129,1.35502367225008,1.5744537638247,4.38107775205241e-23
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239854917025799,PGF;Placenta growth factor,0.490269801860837,1.63275668132497,1.36426631452084,1.95408649472347,8.85853391032215e-08
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55260232834773,PGF;Placenta growth factor,0.228406982453294,1.25659663415941,1.18741034346842,1.32981417053216,2.6824931324049e-15
sensitivity,Circulatory system disorders,I95 (hypotension),0.522610713519627,PGF;Placenta growth factor,0.376696569476927,1.45746200381194,1.28995820758081,1.64671652156795,1.47169777361985e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0214504397340145,PGF;Placenta growth factor,1.37696254940481,3.96284637806136,2.60258454700314,6.03406004012331,1.37429681268435e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,FGFR2;Fibroblast growth factor receptor 2,1.1072472324365,3.02601699730259,2.57474370030072,3.5563846090369,3.6315834660719e-41
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,FGFR2;Fibroblast growth factor receptor 2,1.24702848778298,3.47998675513337,2.2868143429097,5.2957109760361,5.84341602176274e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.898050620971545,FGFR2;Fibroblast growth factor receptor 2,0.41195943145616,1.50977318578665,1.37293211396557,1.66025329973274,1.92460696516163e-17
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0569878949850652,FGFR2;Fibroblast growth factor receptor 2,1.02455102175752,2.78584439621571,1.94217822436056,3.99599218165556,2.59828351047608e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216160980977833,FGFR2;Fibroblast growth factor receptor 2,1.83287579633127,6.25183984939408,3.69923535831839,10.5658325887757,7.60098443958528e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,CLEC7A;C-type lectin domain family 7 member A,1.59482292795613,4.92745648007559,4.18637478719168,5.79972615861429,5.64063444963841e-82
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.03900079951639,CLEC7A;C-type lectin domain family 7 member A,1.91832216669064,6.80952363352596,4.44112391093481,10.4409633789723,1.40887876609554e-18
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0003705075954,CLEC7A;C-type lectin domain family 7 member A,0.231849672833241,1.26093016252139,1.15459329634301,1.37706054572818,2.49762126360135e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.898968428852791,CLEC7A;C-type lectin domain family 7 member A,0.417361783349955,1.51795158321569,1.3827028489732,1.6664296386589,1.85888328959562e-18
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55223182075232,CLEC7A;C-type lectin domain family 7 member A,0.277632661815716,1.32000122128758,1.22947791177046,1.41718953022232,1.86743906430061e-14
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354907275599149,CLEC7A;C-type lectin domain family 7 member A,0.372949168821988,1.45201053055113,1.2525059797533,1.68329302607133,7.59275936213474e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173553557847935,CLEC7A;C-type lectin domain family 7 member A,0.682771145389105,1.97935522035951,1.60380787521893,2.44284065996972,2.00982475982357e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39817866266258,CLEC7A;C-type lectin domain family 7 member A,0.248773403802846,1.28245140153243,1.19010631083798,1.38196191576737,6.81919520918908e-11
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239854917025799,CLEC7A;C-type lectin domain family 7 member A,0.491692073531354,1.63508055709727,1.36636058327114,1.95664926296178,7.98098447457451e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0526510793471266,CLEC7A;C-type lectin domain family 7 member A,1.05630539198451,2.87572665530418,1.96819708610493,4.20171529284853,4.7643857553839e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.522610713519627,CLEC7A;C-type lectin domain family 7 member A,0.342622787744549,1.40863730644151,1.24673972865927,1.59155837861415,3.79287188402542e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301511551286915,PIGR;Polymeric immunoglobulin receptor,0.779038086346423,2.17937488645161,1.85035594161054,2.56689796210878,1.06248843922524e-20
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0379385395659032,PIGR;Polymeric immunoglobulin receptor,1.10377088827927,3.01551578428517,1.94064646933824,4.68572488031464,9.18488044575875e-07
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.59655358319522,PIGR;Polymeric immunoglobulin receptor,0.198447394756839,1.21950787321863,1.1687716961486,1.27244649895521,5.53511552081868e-20
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64571394341167,PIGR;Polymeric immunoglobulin receptor,0.32126796778012,1.37887502547156,1.30394688908391,1.45810872496881,1.84811476386143e-29
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70200275553603,PIGR;Polymeric immunoglobulin receptor,0.256297580611898,1.29213718570765,1.23238527701164,1.35478615156542,2.68200494820987e-26
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.299514786046604,PIGR;Polymeric immunoglobulin receptor,0.405818572149293,1.50053028977535,1.27376532314223,1.76766560497886,1.2060725878928e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13853557237275,PIGR;Polymeric immunoglobulin receptor,0.257171254670098,1.29326658573836,1.21598687140284,1.37545766415865,2.82565732973456e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.904534653860745,PIGR;Polymeric immunoglobulin receptor,0.547652161116734,1.72918839244744,1.57197707614824,1.90212220136281,2.04378165144533e-29
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70723428046564,PIGR;Polymeric immunoglobulin receptor,0.209291489916282,1.23280429618297,1.1508506616456,1.32059396004867,2.47464986708554e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55348335696172,PIGR;Polymeric immunoglobulin receptor,0.247814972681175,1.28122284903269,1.19207804792237,1.37703398845772,1.63915872992666e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39973243345779,PIGR;Polymeric immunoglobulin receptor,0.29342330869558,1.34101033163488,1.24213511318086,1.44775611804934,5.97401013690196e-14
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.243605359317904,PIGR;Polymeric immunoglobulin receptor,0.548449880703989,1.73056835023465,1.44202330053946,2.07685050145411,3.7870552447828e-09
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0499191310077674,PIGR;Polymeric immunoglobulin receptor,1.06454190741138,2.89951043554262,1.95824377484946,4.2932146006525,1.06123051085731e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0199676524031069,PIGR;Polymeric immunoglobulin receptor,1.57285142182401,4.82037353440354,2.78781273434185,8.33485001519073,1.80634915868147e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.310918734377857,LCN2;Neutrophil gelatinase-associated lipocalin,1.41838254115731,4.13043422700711,3.52545534298364,4.83922933177571,5.60536573221799e-69
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.040642971814099,LCN2;Neutrophil gelatinase-associated lipocalin,1.74421923448345,5.72143263378391,3.82162786574369,8.56566691810986,2.42281897296669e-17
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351561706191956,LCN2;Neutrophil gelatinase-associated lipocalin,0.504245607826249,1.65573597493514,1.42670223503601,1.92153734070881,3.17416693287792e-11
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.380011786461826,LCN2;Neutrophil gelatinase-associated lipocalin,0.439367762839034,1.55172584956934,1.34233005600933,1.79378618652113,2.84090777185041e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15814180332865,LCN2;Neutrophil gelatinase-associated lipocalin,0.289409835920846,1.33563900921646,1.25554128924949,1.42084659279273,4.63738253671523e-20
sensitivity,Circulatory system disorders,I50 (heart failure),0.918531162998638,LCN2;Neutrophil gelatinase-associated lipocalin,0.577062732649021,1.78080005540047,1.62098098184158,1.9563763380564,2.52743917094718e-33
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70497266760145,LCN2;Neutrophil gelatinase-associated lipocalin,0.21536045744831,1.24030889497874,1.15771750850719,1.32879233807823,9.04801097809934e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5627222662521,LCN2;Neutrophil gelatinase-associated lipocalin,0.341523083610881,1.40708907362782,1.30925704882403,1.51223143148333,1.56203051958648e-20
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39202178463289,LCN2;Neutrophil gelatinase-associated lipocalin,0.199102938868953,1.22030757651635,1.13098232061023,1.31668776263428,2.84312832129361e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,XCL1;Lymphotactin,0.785921605209642,2.19442840574471,1.8782618219069,2.56381510382314,4.11292735170195e-23
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,XCL1;Lymphotactin,0.194228595547208,1.21437385168467,1.14413698748673,1.28892245227985,1.6628950357491e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,XCL1;Lymphotactin,0.371047187926503,1.44925145894447,1.32281815689805,1.58776909758924,1.62725761212361e-15
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,XCL1;Lymphotactin,0.191234473189878,1.21074330564697,1.12909274199825,1.29829844586072,7.94966143832259e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0566849100860046,XCL1;Lymphotactin,0.929952400587073,2.53438853934012,1.77380268426536,3.62110471774303,3.25576142149183e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,SPINK5;Serine protease inhibitor Kazal-type 5,1.24659651687192,3.47848382671834,2.94873296696311,4.10340640142898,1.75126579756984e-49
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,SPINK5;Serine protease inhibitor Kazal-type 5,1.76561326479958,5.84515588750137,3.6645408780468,9.32336368625864,1.24811457570584e-13
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.58875487691363,ADGRG1;Adhesion G-protein coupled receptor G1,0.19577904272129,1.21625813455436,1.16638405749939,1.26826480554019,4.98158248546353e-20
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63006753411363,ADGRG1;Adhesion G-protein coupled receptor G1,0.29825244026195,1.34750190868246,1.2758753466589,1.42314952527122,9.91858688594367e-27
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67773750816944,ADGRG1;Adhesion G-protein coupled receptor G1,0.262729685694121,1.30047513440142,1.24130431997458,1.36246651846909,2.0037637199655e-28
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,ADGRG1;Adhesion G-protein coupled receptor G1,0.285649238700121,1.33062564140733,1.25239761701569,1.41373999240728,2.45894259225252e-20
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,ADGRG1;Adhesion G-protein coupled receptor G1,0.446835941889515,1.56335779672018,1.42331716808909,1.71717706732025,1.03748504906047e-20
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0574337036816984,ADGRG1;Adhesion G-protein coupled receptor G1,1.36988670666274,3.93490487171182,2.63292564900569,5.88071157849393,2.35060370638182e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302293877067156,AGER;Advanced glycosylation end product-specific receptor,1.11653808265939,3.05426227614689,2.63159020837539,3.54482169062825,7.25097886950256e-49
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0395155394859028,AGER;Advanced glycosylation end product-specific receptor,1.18358582364852,3.26606476248352,2.20986981056292,4.82706220146935,2.88102797108036e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16347578685318,AGER;Advanced glycosylation end product-specific receptor,0.273665870852762,1.31477542404703,1.23871670515581,1.39550424119017,2.2345974690671e-19
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.303352637592089,MMP12;Macrophage metalloelastase,0.7186053811229,2.0515700562752,1.7583440901737,2.39369513585322,6.73014466360072e-20
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.57786707638971,MMP12;Macrophage metalloelastase,0.237540342560014,1.2681261552143,1.21598001106129,1.32250853707293,1.44016924009501e-28
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65138084544774,MMP12;Macrophage metalloelastase,0.343900521151246,1.41043831974828,1.33538763775918,1.48970695666504,6.47304961583375e-35
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67568845290154,MMP12;Macrophage metalloelastase,0.352966719289567,1.4232837747502,1.35811280439687,1.49158206660661,2.65986459762264e-49
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360477484930859,MMP12;Macrophage metalloelastase,0.376412936422686,1.45704867803155,1.25962396641833,1.68541636770384,4.04103352830251e-07
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.547610605523381,MMP12;Macrophage metalloelastase,0.351633918420392,1.42138808446758,1.26301204313642,1.59962377052978,5.41335971657429e-09
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.380175708151124,MMP12;Macrophage metalloelastase,0.578391824636514,1.78316847606124,1.55069001704738,2.05049995747887,4.8498300815743e-16
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1589252649411,MMP12;Macrophage metalloelastase,0.197681482126459,1.21857419433955,1.14755786545712,1.29398535081173,1.09951124829529e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.906118268132214,MMP12;Macrophage metalloelastase,0.482680764636052,1.62041252945059,1.47870391606902,1.77570150255685,4.7666504274785e-25
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55418981207895,MMP12;Macrophage metalloelastase,0.242598312209633,1.27455654747462,1.18768464316464,1.36778260294911,1.63245554012731e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175314186660363,MMP12;Macrophage metalloelastase,0.857345619039546,2.35689628269869,1.93248228883787,2.87452056843403,2.59236709014564e-17
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.169404719694283,MMP12;Macrophage metalloelastase,1.47798431023695,4.38409978356757,3.6022144750118,5.33569865026269,3.22586237131821e-49
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40448331560493,MMP12;Macrophage metalloelastase,0.303688397898344,1.35484681719216,1.25768438113754,1.45951553949925,1.25934916411061e-15
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.149706496474018,MMP12;Macrophage metalloelastase,0.665783535999653,1.94601469670644,1.56222562506824,2.42408851770821,2.84549304477091e-09
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236378678643186,MMP12;Macrophage metalloelastase,0.453700829459053,1.57412699459894,1.31725801118748,1.8810861456757,5.98965815209387e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,KYNU;Kynureninase,-0.511240966998853,0.599750845806118,0.511987946736979,0.702557705386649,2.39952240869348e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.199352690088653,AHNAK;Neuroblast differentiation-associated protein AHNAK,0.899314855600744,2.45791850502607,2.02261309102289,2.9869100542083,1.52990245852112e-19
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1647356817862,AHNAK;Neuroblast differentiation-associated protein AHNAK,0.20621575313529,1.2290183399525,1.15197455878322,1.31121479065913,4.28646840780987e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.928749003236549,AHNAK;Neuroblast differentiation-associated protein AHNAK,0.282068446428165,1.32586946791036,1.20270180477578,1.46165062607903,1.42534372966675e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288568699251711,EPHB6;Ephrin type-B receptor 6,1.8329593513998,6.25236224412518,5.23858699154496,7.46232403792402,1.10581301944206e-91
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0398025792071326,EPHB6;Ephrin type-B receptor 6,2.03117036950874,7.62300287007991,4.89534194559902,11.8705033076368,2.49919046982967e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.899538290081197,EPHB6;Ephrin type-B receptor 6,0.28472117124949,1.32939130392338,1.21279104642506,1.45720175306084,1.20849076859058e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55628084699888,EPHB6;Ephrin type-B receptor 6,0.26349447531718,1.30147010471225,1.21266214500119,1.39678181630552,2.72967481234561e-13
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.358223212864193,EPHB6;Ephrin type-B receptor 6,0.373563765874478,1.45290320623321,1.25532227540208,1.68158230603102,5.47158706162652e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39508040120999,EPHB6;Ephrin type-B receptor 6,0.228201670537941,1.25633866638046,1.16541759176613,1.35435302830008,2.61890973992632e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.3042952444115,CXCL16;C-X-C motif chemokine 16,1.16641371310705,3.2104583435675,2.75186164430327,3.7454800088221,9.11336337302236e-50
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390122108219872,CXCL16;C-X-C motif chemokine 16,1.58907923366775,4.89923579949902,3.28052679427574,7.31666373247594,8.13422049150931e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00456442866617,CXCL16;C-X-C motif chemokine 16,0.228947836765089,1.25727645369228,1.15157845970824,1.37267597156126,3.22185292636145e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.908984512152303,CXCL16;C-X-C motif chemokine 16,0.244972419840043,1.27758607669062,1.16498103412797,1.40107532701208,1.95312057034511e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39663714742714,CXCL16;C-X-C motif chemokine 16,0.259838883553256,1.29672114673081,1.20342788026821,1.3972467814225,9.05267510477461e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,CXCL17;C-X-C motif chemokine 17,0.389521129648213,1.47627368089152,1.26011643966119,1.72950999788479,1.41933360388792e-06
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6403541272596,CXCL17;C-X-C motif chemokine 17,0.30629191007737,1.35837877313154,1.28547753818164,1.43541433940919,1.38996483643246e-27
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68752559427468,CXCL17;C-X-C motif chemokine 17,0.184863275015889,1.20305394135139,1.14819516419345,1.26053377590889,8.27934888172224e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0003705075954,CXCL17;C-X-C motif chemokine 17,0.23534893245529,1.265350213468,1.15842847923344,1.38214071168468,1.74279144637036e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304206236227842,CXCL17;C-X-C motif chemokine 17,0.406953992419252,1.50223498987443,1.28242281292009,1.75972381500645,4.61357813174613e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15479417328055,CXCL17;C-X-C motif chemokine 17,0.235421121788896,1.26544156155383,1.19118268883212,1.34432976630797,2.34848558824327e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.898968428852791,CXCL17;C-X-C motif chemokine 17,0.471115804665816,1.60178047058641,1.4603516560907,1.75690606111975,1.70263869316254e-23
sensitivity,Circulatory system disorders,I60 (subarachnoid haemorrhage),0.191103917630311,CXCL17;C-X-C motif chemokine 17,0.495793725624456,1.64180086144025,1.34641362893938,2.00199256059915,9.62640708138557e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39817866266258,CXCL17;C-X-C motif chemokine 17,0.214283297266303,1.23897360291451,1.14968949514696,1.33519145403928,1.9604826810688e-08
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152103118113921,CXCL17;C-X-C motif chemokine 17,0.599202324783987,1.82066592092281,1.46495248888694,2.26275215118292,6.56811179736872e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309945907529513,NECTIN2;Nectin-2,1.70703602093322,5.51259801400478,4.67244158623723,6.50382381526611,4.94459546006431e-91
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394835550993011,NECTIN2;Nectin-2,1.94025046110206,6.96049408535649,4.56077980201352,10.6228496036781,2.35606205726023e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00683065503217,NECTIN2;Nectin-2,0.249039244998323,1.28279237526658,1.17527999538424,1.40013978328975,2.45710327120175e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.908121767283926,NECTIN2;Nectin-2,0.411803630353854,1.50953797978323,1.37738628927067,1.65436880718088,1.25340661850148e-18
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57144549295218,NECTIN2;Nectin-2,0.274241818036865,1.31553288335758,1.22645590033675,1.41107949068525,1.77120560012625e-14
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357326173648675,NECTIN2;Nectin-2,0.403404233845879,1.4969118718215,1.29355262515664,1.73224120025949,6.12799739440064e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17570182019189,NECTIN2;Nectin-2,0.556728841039173,1.74495512857337,1.41960994256552,2.1448626904034,1.23637555479027e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39179531725036,NECTIN2;Nectin-2,0.274470462059256,1.31583370647701,1.22114860159383,1.41786048056822,5.86566223055589e-13
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242823863860702,NECTIN2;Nectin-2,0.526742385750481,1.69340684731813,1.41954124143792,2.02010809325918,4.84823628897243e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54866348165988,NECTIN2;Nectin-2,0.202563826864792,1.2245382410644,1.15832924059717,1.29453168518482,9.16397605963574e-13
sensitivity,Circulatory system disorders,I95 (hypotension),0.525131282820705,NECTIN2;Nectin-2,0.379878713572743,1.46210724491569,1.29539868775335,1.65027000246738,7.73685271962291e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,1.52968124062498,4.61670496973808,3.95104802144672,5.39450916868378,1.26447340135519e-82
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,1.60970473353453,5.00133428350174,3.32622859706168,7.52003173727328,1.0315888571169e-14
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00023581197924,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.292819545921714,1.34020092388699,1.2285781117377,1.46196525823424,4.12236426395956e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361578368181103,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.464506543562728,1.59122879303262,1.37972065052218,1.83516066880478,1.73353247738359e-10
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540402452444584,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.291277245441787,1.33813552450153,1.18951333519006,1.5053271190498,1.24055296271316e-06
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0589529948121364,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.840679134159724,2.31794063502353,1.64349710736413,3.26915621781066,1.65226761803769e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.302625373368967,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.562771696354846,1.75553156369712,1.5046521580017,2.0482415518746,8.51085271335342e-13
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16160980977833,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.253530376136693,1.28856652056357,1.21416164598105,1.36753099013904,6.55828597551864e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.898050620971545,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.572066509171432,1.77192496977221,1.61920038576063,1.93905468780341,1.59344625327126e-35
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55242886338626,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.265181289892557,1.30366729606051,1.21565011131017,1.39805722304918,1.04316043166157e-13
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172928784782266,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.549862960867868,1.73301551065232,1.41521062055673,2.12218783305911,1.03875508998215e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39522087722056,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.252295493863584,1.28697627469491,1.19521090435629,1.38578716575518,2.31315513671753e-11
sensitivity,Circulatory system disorders,I95 (hypotension),0.512891054865587,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.319242191066481,1.37608455993827,1.21940565302702,1.5528948151092,2.26337524148551e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305433186490455,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,1.03827288173282,2.82433483922479,2.42601672747239,3.28805122970848,7.29524838180611e-41
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0391581008321096,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,1.19409732868849,3.30057708916648,2.18892075752247,4.97679465284108,1.20731345124019e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16348507097405,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,0.194905287584617,1.21519588690152,1.1446627150372,1.29007525460841,1.67424004486942e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.906510034263338,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,0.288996274077496,1.33508675408945,1.21826954371873,1.46310531206766,6.17003658242966e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,TGFBR2;TGF-beta receptor type-2,1.73547554646253,5.67162428346832,4.84992891771188,6.63253473578817,9.99754228494554e-105
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393019965414243,TGFBR2;TGF-beta receptor type-2,1.9080546495168,6.73996444384783,4.6144652961999,9.84450370484812,5.56006288824806e-23
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00023581197924,TGFBR2;TGF-beta receptor type-2,0.259890573766148,1.29678817625532,1.18812599299862,1.41538825342199,5.86518688637511e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.898050620971545,TGFBR2;TGF-beta receptor type-2,0.298240986797427,1.34748647520554,1.22984276938821,1.47638368583089,1.56811458910357e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55242886338626,TGFBR2;TGF-beta receptor type-2,0.362584451496815,1.43703857592046,1.33970785088062,1.54144044712889,3.94593183105392e-24
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.351752869045747,TGFBR2;TGF-beta receptor type-2,0.538596433271825,1.71360002152363,1.48204333897829,1.98133546876581,3.55661600515315e-13
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.123801289105486,TGFBR2;TGF-beta receptor type-2,0.651077824452068,1.9176065588054,1.50562188691649,2.44232296722547,1.32113058118537e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172928784782266,TGFBR2;TGF-beta receptor type-2,0.529054019625571,1.69732591192678,1.38360134120432,2.08218593427384,3.89713395721011e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39522087722056,TGFBR2;TGF-beta receptor type-2,0.31747197946281,1.37365075389404,1.27527823680998,1.47961153825824,5.5810657137322e-17
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239742178902688,TGFBR2;TGF-beta receptor type-2,0.510029310414252,1.66534000603599,1.39818034049065,1.98354765504049,1.08502318945278e-08
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55659487501965,TGFBR2;TGF-beta receptor type-2,0.201652732298164,1.22342307901253,1.15751961413977,1.29307876253383,9.49774202904368e-13
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0569878949850652,TGFBR2;TGF-beta receptor type-2,1.03395421137821,2.81216376842126,1.99864449452654,3.95681427191215,2.94899107817806e-09
sensitivity,Circulatory system disorders,I95 (hypotension),0.512891054865587,TGFBR2;TGF-beta receptor type-2,0.412556771107922,1.51067530258393,1.33783882882866,1.70584065932304,2.83213852087953e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216160980977833,TGFBR2;TGF-beta receptor type-2,1.45643588113065,4.29063989345651,2.58060099766521,7.13383847870185,1.96965764488515e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.289040385918749,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,0.827593573964225,2.28780667319012,1.96056223989884,2.66967264153945,7.92784962350418e-26
sensitivity,Circulatory system disorders,I50 (heart failure),0.899015269305904,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,0.370554346988669,1.44853738447331,1.32069148939348,1.58875904862564,3.83540357765059e-15
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39536738029741,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,0.253964209512309,1.28912566500589,1.19742620204264,1.3878475160657,1.52334610444715e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359041498056018,OSM;Oncostatin-M,0.400091973311787,1.49196191200925,1.28952913629266,1.72617297604131,7.53933144725134e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.898595572482742,OSM;Oncostatin-M,0.353627474098986,1.42422452711863,1.29602811724921,1.5651014639648,2.01028976907457e-13
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242005871617868,OSM;Oncostatin-M,0.468915566025992,1.59826004561025,1.33605535928087,1.91192315172405,2.91533129723295e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,CCL27;C-C motif chemokine 27,0.592356734498498,1.80824495092323,1.55202729541929,2.10676050104906,2.99777680831035e-14
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.62822148507272,PON3;Serum paraoxonase/lactonase 3,-0.252010922488649,0.777236248668479,0.734634284427318,0.822308731092194,1.91671956634933e-18
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15910652246452,PON3;Serum paraoxonase/lactonase 3,-0.283396979403451,0.753220715390576,0.708561285516447,0.80069495425505,1.01281043798389e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.900936267101105,PON3;Serum paraoxonase/lactonase 3,-0.269367671577339,0.763862353535107,0.695181728053167,0.839328295900735,2.09795882966264e-08
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.123901521235344,"GSR;Glutathione reductase, mitochondrial",0.78918787068403,2.20160770985629,1.70074386040023,2.8499744264595,2.06724066068718e-09
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0321226166165706,"GSR;Glutathione reductase, mitochondrial",1.3435739783414,3.83271710415758,2.38330990541017,6.16357963651982,2.97449321625991e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.555262372943578,"GSR;Glutathione reductase, mitochondrial",0.379350728855416,1.46133547839368,1.28989801279809,1.65555831486218,2.54975710229464e-09
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.3441708923204,"GSR;Glutathione reductase, mitochondrial",0.588423561375165,1.8011467788024,1.54086887394225,2.10538987038547,1.47685812897046e-13
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14074295023288,"GSR;Glutathione reductase, mitochondrial",0.315601201319011,1.3710833603471,1.28557934054818,1.46227426167186,7.51954329731688e-22
sensitivity,Circulatory system disorders,I50 (heart failure),0.897138792648509,"GSR;Glutathione reductase, mitochondrial",0.31609902637672,1.37176608992593,1.24327835378926,1.51353250841657,2.98531326214462e-10
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65202028313792,"GSR;Glutathione reductase, mitochondrial",0.224816225143295,1.25209259191032,1.16369782611696,1.34720184530028,1.76097158820014e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.296753875968992,MUC13;Mucin-13,0.609690626267439,1.83986210571697,1.55694736251703,2.1741856208811,8.24127105590731e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.896317829457364,MUC13;Mucin-13,0.255171532899652,1.29068299648266,1.17433146912849,1.41856251084352,1.19741891027538e-07
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.541686292981629,ACP5;Tartrate-resistant acid phosphatase type 5,-0.432001509953174,0.649208396410128,0.576311524291568,0.731325896159207,1.16979105860171e-12
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.376825247291568,ACP5;Tartrate-resistant acid phosphatase type 5,-0.355948980021598,0.700508359244901,0.607815136130519,0.807337514652827,8.86735792262345e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386638404773119,ACP5;Tartrate-resistant acid phosphatase type 5,-0.3800436610013,0.683831551790285,0.594627910021929,0.786417158264005,9.87284994673771e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17263306641545,ACP5;Tartrate-resistant acid phosphatase type 5,-0.553744645799775,0.574793377754409,0.54115066556522,0.610527618524206,2.1392819897695e-72
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25804678913487,ACP5;Tartrate-resistant acid phosphatase type 5,-0.235635029901611,0.790068972870118,0.730416099016832,0.854593679865836,4.03327702925205e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.914586277280577,ACP5;Tartrate-resistant acid phosphatase type 5,-0.42167242649349,0.655948875677479,0.598866648272379,0.718472015003335,1.10965731528785e-19
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.202272032363525,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,1.57151750652044,4.81394785098861,3.85575160926663,6.01026628798986,8.67973051219298e-44
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0188160030105604,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,1.83373175843253,6.25719347829313,3.09083973220881,12.6672599089485,3.47175983137862e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294065404882669,VSIG4;V-set and immunoglobulin domain-containing protein 4,1.58079335879071,4.85880906141165,4.18019077439255,5.64759523414013,3.01838849295973e-94
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374982731058438,VSIG4;V-set and immunoglobulin domain-containing protein 4,1.98643095545662,7.28947083399531,4.89185620260939,10.862213204739,1.65232330265166e-22
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64066786397994,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.275816654344172,1.31760626449518,1.2471918737256,1.39199613532672,7.35904458826421e-23
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69061951094357,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.256781165240877,1.29276219449933,1.23372833069286,1.35462082692725,4.89629491884486e-27
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00061181392962,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.313218370516222,1.36782019001825,1.25306642571985,1.49308291549409,2.45263926176747e-12
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.357220391166196,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.470159762099146,1.60024983206844,1.38457737061004,1.84951710131359,1.94691719637204e-10
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.550632536659496,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.296994119046602,1.34580738479431,1.19621862170377,1.51410242584856,7.80407764561962e-07
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0828909194971284,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.73905926074737,2.09396471283548,1.56533500505854,2.80111810215105,6.40924080020643e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14529594031853,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.248406221263584,1.28198059421174,1.20680708366636,1.3618367559979,7.82123108047654e-16
sensitivity,Circulatory system disorders,I50 (heart failure),0.897984961218891,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.57999287104385,1.7860256982058,1.62933958881862,1.95777959152419,3.32755354985027e-35
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70518462965521,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.240995849208354,1.2725157533495,1.18944959649105,1.36138290121724,2.612391552112e-12
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.365114764451637,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.422063923218938,1.52510601125288,1.32110621491297,1.7606066183807,8.36784892728681e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55519153723183,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.38859341343196,1.47490475294464,1.37447909952089,1.58266795836835,3.42701648404345e-27
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.349326017880755,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.466624992599516,1.59460330323846,1.37727161553957,1.84622965144231,4.32256795013383e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173676212279697,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.716747899130603,2.04776283885329,1.67170549405272,2.50841590166853,4.40658872774371e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39927766484438,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.413632439449893,1.51230116246815,1.40431027993446,1.62859649942124,7.20005254229819e-28
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.148019499102015,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.548131878223056,1.73001811269894,1.3843416523002,2.16201157083827,1.43861756012473e-06
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.238804791884584,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.632017028611633,1.88140159553308,1.58075117584209,2.23923411715242,1.12430796408786e-12
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56172413112554,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.222443987048405,1.24912585046528,1.18176245515324,1.32032912663339,3.70709715264068e-15
sensitivity,Circulatory system disorders,I87 (other disorders of veins),0.122362785924332,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.617972253945772,1.85516242699,1.45598555837158,2.36377868635225,5.76289753720757e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.517081450196372,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.352460755357399,1.42256382664418,1.25996936439739,1.60614051266589,1.25843265050398e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,KIAA0319;Dyslexia-associated protein KIAA0319,1.24440372144611,3.47086458007194,2.8558694659421,4.2182953656896,6.93393221683053e-36
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,RBP5;Retinol-binding protein 5,0.879448298946422,2.4095699773493,2.07890232448598,2.79283322133889,1.66223430073381e-31
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.538688531083516,RBP5;Retinol-binding protein 5,0.332857938371067,1.3949491156494,1.23983522759965,1.56946906486784,3.12332556229463e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.306973243815974,RBP5;Retinol-binding protein 5,0.49649436851263,1.64295158061214,1.40831611155609,1.91667898569548,2.70479651645928e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,RBP5;Retinol-binding protein 5,0.276463960069306,1.31845943467484,1.2412043247125,1.40052306157227,2.86241434532269e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,RBP5;Retinol-binding protein 5,0.446542846907614,1.56289965153836,1.42608616542919,1.71283852265938,1.25118541635415e-21
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70914780266571,RBP5;Retinol-binding protein 5,0.199540235120862,1.22084132914124,1.14132540467933,1.30589711297816,6.36576806034419e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,RBP5;Retinol-binding protein 5,0.205766950309647,1.22846687680712,1.14087644010915,1.32278204225855,4.97670401160918e-08
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.66097628132006,PROC;Vitamin K-dependent protein C,-0.29392460902267,0.745332680684413,0.705480029130596,0.787436613309683,1.03059322236374e-25
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68957243440978,PROC;Vitamin K-dependent protein C,-0.236628540595414,0.789284420691753,0.753118686187967,0.827186880596443,4.69549618863606e-23
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15946190457459,PROC;Vitamin K-dependent protein C,-0.42682625005767,0.652576927581667,0.614145554368326,0.69341322001417,3.24328019825635e-43
sensitivity,Circulatory system disorders,I50 (heart failure),0.914526216418204,PROC;Vitamin K-dependent protein C,-0.382913700861391,0.681871741690878,0.621861486173056,0.747673046899648,3.74364891854498e-16
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.051134799197577,PROC;Vitamin K-dependent protein C,-0.960835669757914,0.382573047628012,0.260923436977411,0.56093901899681,8.61340949061399e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309945907529513,FAM3C;Protein FAM3C,1.73864309945485,5.68961793681919,4.80148503702903,6.742029188329,1.13804800686072e-89
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394835550993011,FAM3C;Protein FAM3C,1.91430663289949,6.78223458798468,4.38226449984103,10.4965608552665,8.63362719216688e-18
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00683065503217,FAM3C;Protein FAM3C,0.250557371389612,1.2847412952051,1.17643707863372,1.40301612859924,2.45754971802865e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361274529158605,FAM3C;Protein FAM3C,0.395935406915105,1.48577334376807,1.28313246231857,1.72041663185954,1.2077194372669e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.908121767283926,FAM3C;Protein FAM3C,0.510021173002458,1.66532645453372,1.51657213123624,1.82867147763633,1.21831487027987e-26
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57144549295218,FAM3C;Protein FAM3C,0.209936091900398,1.23359922045567,1.1492912020969,1.32409178277216,6.15658083292712e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17570182019189,FAM3C;Protein FAM3C,0.523146389640939,1.68732829865221,1.36670429626968,2.08316955994318,1.14243665084704e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39179531725036,FAM3C;Protein FAM3C,0.219425784093575,1.24536141889938,1.15532487615211,1.342414671143,9.99319724396133e-09
sensitivity,Circulatory system disorders,I95 (hypotension),0.525131282820705,FAM3C;Protein FAM3C,0.334525385398529,1.39727705972808,1.23703034292048,1.57828237020688,7.34386278135486e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301798958497711,PRELP;Prolargin,1.42969343166632,4.17741833142072,3.5486631838746,4.91757684837146,3.86837191497171e-66
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394508442480669,PRELP;Prolargin,1.3988611596053,4.05058437002678,2.64071103229934,6.21318786418634,1.46782196302424e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16190626479406,PRELP;Prolargin,0.259099228862023,1.29576237547495,1.21910102971265,1.37724445536088,8.29296417500235e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.901451791068328,PRELP;Prolargin,0.492041339500272,1.63565173483297,1.48832998521939,1.79755606903782,1.65780488363714e-24
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.28705844828961,SFRP1;Secreted frizzled-related protein 1,0.806510134645801,2.24007676337991,1.91330033997941,2.62266399110588,1.18479451838557e-23
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0398692289291125,SFRP1;Secreted frizzled-related protein 1,1.00764183508407,2.73913406309659,1.82379535990383,4.11386912181399,1.19930951537133e-06
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63734949366079,SFRP1;Secreted frizzled-related protein 1,0.264584063825635,1.30288894441779,1.23281918150801,1.37694126352711,6.54748780778737e-21
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68192329160354,SFRP1;Secreted frizzled-related protein 1,0.229571138908226,1.25806036108058,1.20022631148057,1.31868119952294,1.16603327815458e-21
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.30499960130771,SFRP1;Secreted frizzled-related protein 1,0.56383753731386,1.75740367865372,1.504469268978,2.05286193173202,1.14825744027601e-12
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384738059165935,SFRP1;Secreted frizzled-related protein 1,0.432384484077266,1.54092746335348,1.33990695220628,1.77210622230689,1.33928638099674e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16290566940435,SFRP1;Secreted frizzled-related protein 1,0.373833130454454,1.45329461960919,1.36835663989513,1.54350495317279,4.68689862244041e-34
sensitivity,Circulatory system disorders,I50 (heart failure),0.901044573797942,SFRP1;Secreted frizzled-related protein 1,0.60746280060099,1.83576777611483,1.67539938173993,2.01148655332662,8.85305965035995e-39
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71038992105892,SFRP1;Secreted frizzled-related protein 1,0.183059576820209,1.20088595091605,1.12243354053595,1.28482178679277,1.09232250498938e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55888685112829,SFRP1;Secreted frizzled-related protein 1,0.187472688829128,1.20619730631038,1.12371822451576,1.29473021795779,2.12960513370199e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39342955107248,SFRP1;Secreted frizzled-related protein 1,0.199170757671589,1.22039033912144,1.1326968305942,1.31487308836173,1.65023897069294e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,1.99375048818915,7.34302210040489,6.14450873417419,8.77531075302171,1.35504289838058e-106
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,2.19429976643084,8.97371515968329,5.76282220988029,13.9736332016396,2.70583251480947e-22
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0027365129007,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.30095820133599,1.35115286397309,1.23590993181997,1.47714167094225,3.67760326844186e-11
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.383111806098514,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.391526285869586,1.47923681002281,1.28003863450744,1.70943398202075,1.12317778376939e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.206529521540313,1.2294040275819,1.15620769691387,1.3072342167146,4.27020222333093e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.577486942305229,1.7815556482333,1.61967138362926,1.95962005616226,1.48094315226357e-32
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.367474589523064,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.396496714374679,1.48660755353134,1.28261389522404,1.7230454359224,1.40069914923193e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.358791606420927,1.43159843456228,1.33198989315152,1.53865587747971,1.82667632158306e-22
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34401876465989,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.451302775333183,1.57035667538649,1.34879555394863,1.82831273480371,6.03262615021934e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173964034401876,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.664363185438973,1.94325263565271,1.56716422080735,2.40959483111848,1.41536822919526e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3975762314308,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.284116404301255,1.32858757506032,1.23178639037707,1.43299597916836,1.82693819196931e-13
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236512900703674,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.531022592450467,1.70067051255684,1.41494711843177,2.04409066219093,1.5263017983142e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.521892103205629,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.342048024620347,1.40782790629136,1.24437775137701,1.59274738843528,5.56612755500873e-08
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.110435114350541,NPPB;Natriuretic peptides B,1.40412773014808,4.07197333215158,3.05628771855068,5.42519826164028,8.68658106379913e-22
sensitivity,Circulatory system disorders,I07 (rheumatic tricuspid valve diseases),0.0501977792502459,NPPB;Natriuretic peptides B,1.3237922289774,3.75764423941244,2.46649330539725,5.72468216276603,7.13857952366507e-10
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.178704094130875,NPPB;Natriuretic peptides B,1.17380288777446,3.23426884266146,2.60553461413642,4.0147211592803,1.88283992131627e-26
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0261028452101279,NPPB;Natriuretic peptides B,1.58878456541866,4.89779236294199,2.69767381777524,8.89224259524304,1.7766369878618e-07
sensitivity,Circulatory system disorders,I11 (hypertensive heart disease),0.0341344898901672,NPPB;Natriuretic peptides B,1.20865036077689,3.34896171098407,2.09269972333518,5.35936638045848,4.70072598770467e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.295162941991446,NPPB;Natriuretic peptides B,0.853153500875435,2.34703657594837,1.99440629619914,2.76201529213855,9.54644329856538e-25
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.58004537879244,NPPB;Natriuretic peptides B,0.553453994206618,1.73925001458361,1.66496813038949,1.81684595519643,2.44698796873799e-136
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.62835572154287,NPPB;Natriuretic peptides B,0.84293620846231,2.32317830795068,2.19240025942515,2.4617573489741,7.68455104609487e-179
sensitivity,Circulatory system disorders,I22 (subsequent myocardial infarction),0.11244302552055,NPPB;Natriuretic peptides B,1.00052467145824,2.71970840755983,2.10385895627409,3.51583161033347,2.2112272822787e-14
sensitivity,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.160632893600787,NPPB;Natriuretic peptides B,0.691298835744782,1.99630672464432,1.60502023261958,2.48298461157448,5.2781189591006e-10
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.6945565528181,NPPB;Natriuretic peptides B,0.738186289145502,2.09213753875744,1.99170016936024,2.19763975944431,4.30367773726989e-190
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00395558500491,NPPB;Natriuretic peptides B,0.224356369392037,1.25151694229886,1.14443417897869,1.36861925799776,8.82610370804248e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361424010601771,NPPB;Natriuretic peptides B,1.04321484961089,2.83832715759321,2.43512158419958,3.30829520209734,1.27035470332687e-40
sensitivity,Circulatory system disorders,I31 (other diseases of pericardium),0.196775294660964,NPPB;Natriuretic peptides B,0.582579912526986,1.79065220267615,1.4691964641376,2.18244148363853,7.88950399064729e-09
sensitivity,Circulatory system disorders,I33 (acute and subacute endocarditis),0.0461819569102262,NPPB;Natriuretic peptides B,1.21815822254786,3.38095502901667,2.2518259685015,5.07626125114806,4.23801683882476e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540128104732646,NPPB;Natriuretic peptides B,0.951307006296642,2.58909140762361,2.28681881646792,2.93131850619633,5.52072940033401e-51
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.379495211131859,NPPB;Natriuretic peptides B,0.746040624488752,2.10863459044982,1.82388166999929,2.43784446610684,6.8342846211373e-24
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0562215127602754,NPPB;Natriuretic peptides B,1.09936169378365,3.00224905796914,2.04075892887987,4.41673892909237,2.38355567463997e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301186675501475,NPPB;Natriuretic peptides B,1.12791521158526,3.08920943403669,2.62260542471356,3.63882985881628,1.55222174643286e-41
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387526855811898,NPPB;Natriuretic peptides B,0.777320604788697,2.17563506273518,1.88700112002247,2.50841818586008,9.74671063198588e-27
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0783085356303837,NPPB;Natriuretic peptides B,1.04883294778639,2.85431803531923,2.08758640789827,3.90265591686379,4.98650324259054e-11
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.714816376523502,NPPB;Natriuretic peptides B,0.604046697044588,1.82950730258725,1.64319605270543,2.0369431661604,2.96008391516545e-28
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15649659659056,NPPB;Natriuretic peptides B,1.18111230160544,3.25799606246694,3.04602431332796,3.48471885027507,1.78458485335148e-259
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25896030359616,NPPB;Natriuretic peptides B,0.482367283230086,1.61990463986374,1.49468045311887,1.7556200971094,6.98122444202435e-32
sensitivity,Circulatory system disorders,I50 (heart failure),0.907575848844447,NPPB;Natriuretic peptides B,1.2913335844311,3.6376344151415,3.29378750794328,4.01737638093249,2.59359631942018e-143
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.72479569503845,NPPB;Natriuretic peptides B,0.685141043119178,1.98405165263725,1.85003220195358,2.12777969819975,3.65816420250799e-82
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.57621026845772,NPPB;Natriuretic peptides B,0.262327936011893,1.29995277386555,1.21062885794466,1.39586728268622,5.10508520331724e-13
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.176696182960865,NPPB;Natriuretic peptides B,0.772195400207767,2.1645130136795,1.75825593308271,2.66463857634969,3.31926599666091e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39750617432684,NPPB;Natriuretic peptides B,0.276227997034531,1.31814836368747,1.22144169497446,1.42251170550412,1.20054118035951e-12
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.23693351806116,NPPB;Natriuretic peptides B,0.510625576103781,1.66633328724331,1.38902042422506,1.9990106522186,3.83831745294792e-08
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5520550970825,NPPB;Natriuretic peptides B,0.201440209616449,1.22316310148544,1.15568872304821,1.29457694186834,3.45458110589499e-12
sensitivity,Circulatory system disorders,I95 (hypotension),0.516033170692528,NPPB;Natriuretic peptides B,0.347850314991584,1.41602027686878,1.24980137876284,1.60434566529951,4.75973242193797e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200894895443338,PRAP1;Proline-rich acidic protein 1,0.978799902692876,2.66126055312084,2.16254075372958,3.27499387902063,2.36023888343575e-20
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303625239704136,PRAP1;Proline-rich acidic protein 1,0.443153098175016,1.55761078345658,1.30638990960125,1.8571418340798,7.88330703289304e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.90859282257328,PRAP1;Proline-rich acidic protein 1,0.327270757728444,1.38717701523568,1.25140538847919,1.53767922794123,4.74393990197051e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39941557848598,PRAP1;Proline-rich acidic protein 1,0.235252145582575,1.26522775010447,1.16548708643523,1.37350407247379,1.96272015962971e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.310295076783208,ANG;Angiogenin,0.97337667284179,2.64686699052471,2.26472557339061,3.09348953703055,2.01080553571928e-34
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0395280352590074,ANG;Angiogenin,1.46846210047573,4.34255159503682,2.84001340132078,6.64002301777408,1.22183752604226e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.351799513805166,ANG;Angiogenin,0.383274997045493,1.46708141765601,1.26508553740889,1.7013299278086,3.95572251499424e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.917050418008972,ANG;Angiogenin,0.400943456638743,1.49323283370931,1.35736357784932,1.64270231797471,1.76093585605024e-16
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.296753875968992,GPKOW;G-patch domain and KOW motifs-containing protein,0.484491596567544,1.6233494825628,1.37984401162685,1.90982714011992,5.13162752394636e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.30379746835443,CCL16;C-C motif chemokine 16,1.07959408928464,2.94348451663751,2.52361504690696,3.43321027123524,5.17710084938532e-43
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0389483933787731,CCL16;C-C motif chemokine 16,1.18286324615545,3.26370563002589,2.15108271030282,4.95182002460667,2.68110597848634e-08
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00681596884128,CCL16;C-C motif chemokine 16,0.23911088581044,1.27011936699101,1.16159981690368,1.38877708392356,1.54360329594743e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356377799415774,CCL16;C-C motif chemokine 16,0.442490193661359,1.5565785784022,1.34150572259486,1.80613234064627,5.46328233247624e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543330087633885,CCL16;C-C motif chemokine 16,0.308401578329275,1.36124752669844,1.20569526099815,1.53686830236738,6.31608162725706e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.909444985394352,CCL16;C-C motif chemokine 16,0.477097240592745,1.61139012896733,1.46591472807926,1.77130231247186,4.94082191600941e-23
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.299051353652981,AREG;Amphiregulin,1.00980484643362,2.74506525346657,2.32050533623923,3.24730270088576,4.98188012582897e-32
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0396094508149644,AREG;Amphiregulin,1.31861742116206,3.73824937825524,2.35688199605204,5.92923550582254,2.10929635321197e-08
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.58875487691363,AREG;Amphiregulin,0.251370191313211,1.28578598304054,1.23099154014598,1.34301946054599,1.1336307036339e-29
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63006753411363,AREG;Amphiregulin,0.378334351916034,1.45985096525299,1.37556275302291,1.54930397473085,1.10842763189151e-35
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67773750816944,AREG;Amphiregulin,0.34455552697608,1.41136246769138,1.34279862931542,1.48342720324598,6.84886591205116e-42
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.998158160537104,AREG;Amphiregulin,0.263932824145163,1.30204072766412,1.19291722391317,1.42114643205077,3.42339943096203e-09
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,AREG;Amphiregulin,0.241757456549207,1.27348527984099,1.19586635340861,1.35614214192842,4.89184193478599e-14
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,AREG;Amphiregulin,0.479373210635342,1.61506178132825,1.46389431922874,1.78183938775131,1.17012245460261e-21
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70914780266571,AREG;Amphiregulin,0.201105885924145,1.22275423743134,1.14224484042128,1.30893821731326,7.16207803973955e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5566514170281,AREG;Amphiregulin,0.304800682975585,1.35635463149309,1.26153819111139,1.45829741765647,1.67229114477771e-16
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.172301111045095,AREG;Amphiregulin,0.592369936673708,1.80826882384749,1.44726793944191,2.25931636443191,1.8523316855286e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40217455884974,AREG;Amphiregulin,0.300724615196467,1.35083729024995,1.25469531406952,1.45434621797648,1.42665994700281e-15
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239637177430534,AREG;Amphiregulin,0.681908901390722,1.97764926877904,1.64405440699491,2.37893381974576,4.67434527200709e-13
sensitivity,Circulatory system disorders,I95 (hypotension),0.514922860594537,AREG;Amphiregulin,0.305110005103096,1.35677424688818,1.20098692532746,1.53276968982578,9.43697410757346e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,SEMA3F;Semaphorin-3F,1.29762802216921,3.6606034913556,3.14603597932866,4.25933397105785,2.92898040240204e-63
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394251808630172,SEMA3F;Semaphorin-3F,1.47227406138118,4.35913682298385,2.91377112675604,6.52147097862458,7.86987258981144e-13
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00928463009324,SEMA3F;Semaphorin-3F,0.220922875038327,1.24722723450189,1.14338670444159,1.36049839344856,6.32136887776195e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,SEMA3F;Semaphorin-3F,0.293122450660673,1.34060693858678,1.22353396554538,1.46888195538235,3.23451186634051e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175442054840426,SEMA3F;Semaphorin-3F,0.540157140299923,1.7162765372057,1.39937385936542,2.10494510273226,2.14527437887625e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3917088844645,SEMA3F;Semaphorin-3F,0.267330567678367,1.30647225245549,1.21310671515552,1.40702357435825,1.58800359045857e-12
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54883794279406,SEMA3F;Semaphorin-3F,0.189272902945849,1.20837067540667,1.14337914948242,1.2770564251095,1.94463552120851e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0177413313883577,SEMA3F;Semaphorin-3F,1.43805910090097,4.21251181701631,2.3521683461409,7.5442116367291,1.31904280668574e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.92137346604309,CCL18;C-C motif chemokine 18,0.236905380237536,1.26732119847124,1.15635136193995,1.38894031084125,4.0395202950056e-07
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.118275542589051,COL4A1;Collagen alpha-1(IV) chain,0.65391343380287,1.92305185861758,1.50624234189254,2.45520149585356,1.55184745814524e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173470795797275,COL4A1;Collagen alpha-1(IV) chain,0.500776837691577,1.65000255713747,1.34595584586887,2.02273235553482,1.4425393195152e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,COL4A1;Collagen alpha-1(IV) chain,0.398452741584128,1.48951824412278,1.27746689357922,1.73676876537939,3.67232806211592e-07
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.5851485343689,COL4A1;Collagen alpha-1(IV) chain,0.185506437381864,1.20382794925039,1.15464458684739,1.25510633133722,2.8771872007703e-18
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.66119970825366,COL4A1;Collagen alpha-1(IV) chain,0.252463806416963,1.28719290718831,1.21920193361266,1.35897551885141,7.6385722496281e-20
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70399574208046,COL4A1;Collagen alpha-1(IV) chain,0.264426760303933,1.3026840115172,1.24377259800412,1.36438577002396,4.11930699499893e-29
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360740404896607,COL4A1;Collagen alpha-1(IV) chain,0.435792007475309,1.54618716593005,1.34125759099679,1.78242775148814,1.88698033266626e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540124977823335,COL4A1;Collagen alpha-1(IV) chain,0.435509352037516,1.54575018947955,1.37608794612923,1.73633062842895,2.10869302608114e-13
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.380452995328116,COL4A1;Collagen alpha-1(IV) chain,0.342565910107548,1.4085571887586,1.22564907372052,1.61876135391749,1.38587166530866e-06
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0591377712945258,COL4A1;Collagen alpha-1(IV) chain,0.906974970690447,2.4768187402262,1.77078224721175,3.46436219450202,1.17316152127762e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309487669774685,COL4A1;Collagen alpha-1(IV) chain,0.504868352980438,1.65676739761355,1.42285395437576,1.92913559494545,7.96216853554876e-11
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.394251808630172,COL4A1;Collagen alpha-1(IV) chain,0.348151569567207,1.41644692371779,1.23540083525852,1.62402503742014,6.04898944221173e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,COL4A1;Collagen alpha-1(IV) chain,0.587844810435118,1.80010466500227,1.696970788429,1.9095065319084,6.3436818596103e-85
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24977823335764,COL4A1;Collagen alpha-1(IV) chain,0.221429439765493,1.24785919587681,1.15451051574856,1.34875564275366,2.38180536906377e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,COL4A1;Collagen alpha-1(IV) chain,0.517667546353129,1.67810897001914,1.53408891932174,1.83564960269952,1.20813010936238e-29
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71696662658439,COL4A1;Collagen alpha-1(IV) chain,0.260498132734121,1.29757629093019,1.2141665499311,1.3867160406286,1.53473084980412e-14
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.36665418202606,COL4A1;Collagen alpha-1(IV) chain,0.440402714890064,1.55333264275351,1.34953512488409,1.78790626086953,8.3905608484472e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56912219834808,COL4A1;Collagen alpha-1(IV) chain,0.224125644816225,1.25122821989218,1.16706281815662,1.34146340188216,2.82200921406739e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3917088844645,COL4A1;Collagen alpha-1(IV) chain,0.212771131745833,1.23710148558379,1.14916036002501,1.33177243043808,1.55521221192715e-08
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0512527351219223,COL4A1;Collagen alpha-1(IV) chain,0.95743703320365,2.60501135261036,1.82227408831878,3.72396457301857,1.51074157614325e-07
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.56825860651995,ADAMTSL2;ADAMTS-like protein 2,0.222142591377537,1.24874942607077,1.17722408822714,1.32462047345671,1.56404994382667e-13
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.55446991142361,ADAMTSL2;ADAMTS-like protein 2,0.218737850984278,1.24450498816358,1.18300474130556,1.30920241609073,2.69041747604084e-17
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.404072687425805,ADAMTSL2;ADAMTS-like protein 2,0.488272759340267,1.62949925050315,1.39925293070996,1.89763247881359,3.33778764400998e-10
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554743859008309,ADAMTSL2;ADAMTS-like protein 2,0.402750104859355,1.49593301855892,1.31516509512467,1.70154728429944,8.82836640599117e-10
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303625239704136,ADAMTSL2;ADAMTS-like protein 2,0.603383636444228,1.82829463045881,1.5389039139525,2.17210524026759,6.73618893474107e-12
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14592274678111,ADAMTSL2;ADAMTS-like protein 2,0.50707827809194,1.66043277810591,1.55458644975049,1.77348581100202,1.92995549377932e-51
sensitivity,Circulatory system disorders,I50 (heart failure),0.90859282257328,ADAMTSL2;ADAMTS-like protein 2,0.579407527781626,1.78498056600758,1.61616787756381,1.97142615272587,2.94365219571746e-30
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66879737010318,ADAMTSL2;ADAMTS-like protein 2,0.293593294500098,1.34123830373043,1.24513491155978,1.44475925515588,9.97553202785473e-15
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.11407442372748,F7;Coagulation factor VII,-1.47027371242273,0.229862560337174,0.179026557222155,0.295133847539701,9.40574887774589e-31
sensitivity,Circulatory system disorders,I06 (rheumatic aortic valve diseases),0.0177012036818503,F7;Coagulation factor VII,-1.56849327304836,0.208358885913888,0.112585006406881,0.385605745603291,5.90835059972195e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173078436000314,F7;Coagulation factor VII,-0.814567177196473,0.442830953223,0.361083620847176,0.543085428999249,5.15470543462418e-15
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.0275352057273227,F7;Coagulation factor VII,-1.78046988347781,0.168558925603398,0.101664715586134,0.279468754097876,5.12965369287599e-12
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.65518055227755,F7;Coagulation factor VII,-0.295610661355058,0.744077069590199,0.704545754941755,0.785826444353082,2.58863861049817e-26
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69168436787034,F7;Coagulation factor VII,-0.264391232334469,0.767673142342378,0.73265962098038,0.804359946417196,1.24903093032691e-28
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00700180945637,F7;Coagulation factor VII,-0.288923550022738,0.749069469557635,0.686301417348523,0.817578189465418,9.75673059123961e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354024073637007,F7;Coagulation factor VII,-0.966487631545707,0.380416858471033,0.329807982625051,0.43879164190363,3.48985376869736e-40
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544803713319172,F7;Coagulation factor VII,-0.646236295104049,0.524014305163153,0.466373576800395,0.588779051119239,1.61760603650242e-27
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.377625678546141,F7;Coagulation factor VII,-0.828622143865303,0.436650513612961,0.380331027933691,0.501309798662295,6.21035966788537e-32
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.306820863818739,F7;Coagulation factor VII,-0.667653043017137,0.512910946207942,0.439694071629184,0.598319731182988,1.96278257341183e-17
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.387459680591613,F7;Coagulation factor VII,-0.567437268780917,0.566976587053861,0.493976411502587,0.65076477900921,7.08578641203434e-16
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.715915348910392,F7;Coagulation factor VII,-0.357612814742358,0.699343798201815,0.630687658906621,0.775473788295189,1.17633139996958e-11
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16151364959483,F7;Coagulation factor VII,-1.06122369571193,0.346032113131674,0.325160275813002,0.368243700799516,4.59389615508995e-245
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24891825977499,F7;Coagulation factor VII,-0.337108100000565,0.713831670527802,0.659938195929985,0.772126324845384,3.87218914795265e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.914562190228935,F7;Coagulation factor VII,-0.706055204944076,0.493587463433387,0.451077471149132,0.540103639931195,2.78358797226382e-53
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70521595468491,F7;Coagulation factor VII,-0.422456449259814,0.655434798375891,0.612795060240185,0.701041510931346,8.1106488494693e-35
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.365824876091574,F7;Coagulation factor VII,-0.381976843324294,0.682510857704997,0.591344444736952,0.787732217713521,1.77457030727434e-07
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17111163559122,F7;Coagulation factor VII,-0.561561685575725,0.570317711080616,0.46428960644584,0.700559062827471,8.74230127940782e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.198353890700166,ADIPOQ;Adiponectin,0.623501239436702,1.86544800132556,1.49689186904684,2.32474791106013,2.82513522775116e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13857413191673,ADIPOQ;Adiponectin,0.366922937462396,1.44328669149455,1.34440176612236,1.54944491024694,3.95604383121628e-24
sensitivity,Circulatory system disorders,I50 (heart failure),0.898292332596156,ADIPOQ;Adiponectin,0.362872828259084,1.43745304421088,1.29006990252016,1.60167387075279,4.87812210224133e-11
sensitivity,Circulatory system disorders,I83 (varicose veins of lower extremities),3.12350379608308,ADIPOQ;Adiponectin,0.212456606743573,1.23671244742056,1.16505312186002,1.31277934791776,3.03326609674818e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,SNRPB2;U2 small nuclear ribonucleoprotein B'',0.647914830397116,1.91155076293211,1.55733091342971,2.34633903928555,5.77859037401674e-10
sensitivity,Circulatory system disorders,I50 (heart failure),0.908695552656275,SNRPB2;U2 small nuclear ribonucleoprotein B'',0.297992575472733,1.34715178587725,1.22010401969082,1.48742886254251,3.72012989112765e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39852136693446,SNRPB2;U2 small nuclear ribonucleoprotein B'',0.213243843746599,1.23768641654324,1.14295332236761,1.34027141416624,1.53121918705705e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,1.36944684719095,3.9331744471331,3.35949836301079,4.60481285001034,5.36677806169177e-65
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039736151951045,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,1.53865450441801,4.65831830578367,3.12289223689929,6.94866418430917,4.65489986850328e-14
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68155447826432,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.219812347308371,1.24584292287291,1.18869170414694,1.30574192034629,4.53813935386621e-20
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01128506715409,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.25679736232396,1.29278313364558,1.18497502681702,1.41039953823142,7.4617793164522e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.408645505558551,1.5047781904203,1.37234823969376,1.64998747174398,3.49224081804321e-18
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.365572597949614,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.351763985630685,1.42157297247414,1.23099672786097,1.64165319885172,1.66936614849152e-06
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55567034888341,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.324621658006326,1.38350710811127,1.28928979976545,1.48460952575799,1.86514775727262e-19
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357625367559405,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.464483197561801,1.59119164463738,1.37642180847011,1.83947307023419,3.41654726579113e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.164905030596837,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.574106779413769,1.77554386606753,1.43797899672116,2.19235192413687,9.49293052983916e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39275212588412,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.365585153428307,1.44135717652698,1.33816977787954,1.55250144239384,5.10665547860584e-22
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55304776285464,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.205555849537267,1.22820757387107,1.16212354586774,1.29804946288038,3.22903111454671e-13
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0516569975363585,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.978419818535856,2.66024924235067,1.83313606600457,3.86055686900094,2.61043636710345e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.287471053261997,HNMT;Histamine N-methyltransferase,1.06397216591574,2.89785893463942,2.47646272452413,3.39096014727343,3.43043033683803e-40
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0399265351752774,HNMT;Histamine N-methyltransferase,1.10882089279605,3.03078266908946,2.02018777942863,4.54692562780031,8.42847260684294e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.900343368202507,HNMT;Histamine N-methyltransferase,0.283413347585459,1.32765383091915,1.20945105176454,1.45740887337495,2.56759256427845e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,1.26781304331586,3.55307364122525,3.04445606560335,4.14666266417865,3.29032718083041e-58
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039736151951045,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,1.45033722114586,4.26455236995445,2.90273108082566,6.26527446383738,1.47446474270862e-13
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.5855519351506,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.223979353590553,1.25104518957049,1.19956204975584,1.30473789719009,1.52030528954455e-25
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63450687435428,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.338523104029641,1.40287416062557,1.32833411269963,1.48159705584246,5.56746407514983e-34
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68155447826432,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.301041254219981,1.35126508577526,1.28968251474743,1.41578823559751,1.12840395078207e-36
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01128506715409,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.324434390406686,1.38324804631374,1.26656173292124,1.51068448374618,5.37862365064859e-13
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.363585790352062,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.410789911372992,1.50800850783913,1.30279844794834,1.74554219288216,3.70778157962512e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.552332512119526,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.311364631721883,1.36528695736957,1.21291904259336,1.53679545831682,2.50811247064981e-07
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0596042279265675,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.878963937549346,2.40840315727283,1.69921553495989,3.41357858883901,7.84918069986206e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303981562425494,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.415759123146518,1.51552077102581,1.29453569283575,1.77422933961705,2.33740096974741e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15965985853929,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.277450343613099,1.3197605829745,1.24271809850025,1.40157932718225,1.55660581768247e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.592184826377722,1.80793412564928,1.65030293559282,1.98062169810846,4.41041521887836e-37
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71064134149248,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.200170102466564,1.22161053945355,1.14155227238326,1.30728337738612,7.11728487508086e-09
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.365572597949614,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.388541272696599,1.47482785233108,1.27700923549392,1.7032901043744,1.23911400889643e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55567034888341,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.349531132368059,1.41840234970948,1.3214608072821,1.52245546335896,3.77565503439698e-22
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357625367559405,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.416571014530302,1.51675170890806,1.31025267651115,1.7557954948058,2.42172528367366e-08
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.121195263450687,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.722222912431166,2.05900511535612,1.60924951126332,2.63445912855025,9.27022522371358e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.164905030596837,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.525882125948098,1.69195070389893,1.37018268443426,2.08928139068263,1.02740093841155e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39275212588412,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.353482684385303,1.42401832898517,1.32067448141341,1.53544891631094,3.72179103299428e-20
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.236430104108718,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.525020718800719,1.69049387302192,1.41535441286224,2.01911938716852,6.9258834480786e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0198680759755225,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,1.4074432359743,4.08549638895756,2.33104441543521,7.16043016326178,8.82993841069212e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.306320812142871,SORD;Sorbitol dehydrogenase,-0.42031073441064,0.656842684476318,0.564094413666007,0.76484060415728,6.24081531387417e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.288087101645076,CRIP2;Cysteine-rich protein 2,0.736237862020468,2.08806512991191,1.78903354140615,2.4370789512013,1.00005833540542e-20
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.039736151951045,CRIP2;Cysteine-rich protein 2,1.05114220279515,2.86091699995243,1.93479602643547,4.230340546903,1.38545918912123e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01128506715409,CRIP2;Cysteine-rich protein 2,0.276522164904849,1.31853617762279,1.20932585039903,1.43760893817532,3.64419209388753e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.363585790352062,CRIP2;Cysteine-rich protein 2,0.357592796654693,1.42988324867381,1.24060354930639,1.64804147624845,7.97910265441792e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303981562425494,CRIP2;Cysteine-rich protein 2,0.442308297489676,1.55629546846695,1.33143094966927,1.81913721156356,2.77324835503461e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15965985853929,CRIP2;Cysteine-rich protein 2,0.261817917549458,1.29928994299294,1.22271787367095,1.38065729823208,2.96034528064613e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.902010649288722,CRIP2;Cysteine-rich protein 2,0.372281849501595,1.45104189909986,1.32233131817135,1.59228066673567,3.98289610941532e-15
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53873199242026,HEPH;Hephaestin,0.203453180107178,1.22562777253688,1.16367875052415,1.29087468181155,1.49261243611833e-14
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15291888313052,HEPH;Hephaestin,0.297210855570883,1.34609910202099,1.26035724713409,1.4376739583812,8.68768928934013e-19
sensitivity,Circulatory system disorders,I50 (heart failure),0.915504212232597,HEPH;Hephaestin,0.278298797897522,1.32088081466102,1.1947456017213,1.46033274700981,5.48913843897752e-08
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.66434556288669,HEPH;Hephaestin,0.202403854124141,1.22434236399386,1.13726079698179,1.31809188204531,7.58383792306182e-08
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.40710426118875,CFP;Properdin,-0.258887145552253,0.771910131619929,0.737322452318768,0.808120313471607,1.78436442640156e-28
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.5512414217642,CFP;Properdin,-0.326776254784061,0.721245100115165,0.679392891710695,0.765675503507694,8.76106082040816e-27
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53389115615239,CFP;Properdin,-0.319494246936505,0.72651638205884,0.69030456676641,0.76462778722783,1.73027799634338e-34
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13857413191673,CFP;Properdin,-0.385173808520131,0.680332378363893,0.637727776769468,0.725783260366889,1.74046137582196e-31
sensitivity,Circulatory system disorders,I50 (heart failure),0.898292332596156,CFP;Properdin,-0.396568104467424,0.672624466410248,0.609459767499904,0.74233558462699,3.22658682834662e-15
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.114312743900035,THBS2;Thrombospondin-2,0.732165165072557,2.07957836716737,1.59076020059359,2.71860345989093,8.533025295643e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,THBS2;Thrombospondin-2,0.459481911374023,1.5832535068387,1.3514901374746,1.85476134631737,1.27094648434143e-08
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.64693129409909,THBS2;Thrombospondin-2,0.232915655506263,1.26227500889064,1.19627158926485,1.33192011945132,1.89415349353754e-17
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.69348417359769,THBS2;Thrombospondin-2,0.226911489964308,1.25471880781892,1.1983025099521,1.31379119514441,4.16132821812846e-22
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356734597343214,THBS2;Thrombospondin-2,0.484039552451334,1.62261582281643,1.39892009105722,1.88208184676544,1.60035816955892e-10
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549883716346722,THBS2;Thrombospondin-2,0.432434573313707,1.54100464916661,1.36866125641341,1.73504971929725,8.91792315027949e-13
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0591272813276045,THBS2;Thrombospondin-2,0.914189226522904,2.49475175316277,1.73191045437092,3.59359590110529,9.13259707711674e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301549134770783,THBS2;Thrombospondin-2,0.507196413559715,1.66062894569581,1.41817328917128,1.94453563350797,3.00359336117749e-10
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386298238007016,THBS2;Thrombospondin-2,0.348104302555201,1.4163799740863,1.23228671039241,1.62797522206003,9.57265503651613e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1522330403248,THBS2;Thrombospondin-2,0.503493200419438,1.65449065547641,1.55784894638449,1.75712756709287,2.04306217416905e-60
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,THBS2;Thrombospondin-2,0.584846987677524,1.79471635091214,1.6384737418236,1.96585804093905,2.54836596986045e-36
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70286570223501,THBS2;Thrombospondin-2,0.268280087390373,1.30771336274848,1.22196806455073,1.39947539442422,8.94207688694086e-15
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,THBS2;Thrombospondin-2,0.189567773682204,1.20872704109584,1.12128978450809,1.30298258314844,7.4929636975548e-07
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0492727344396704,THBS2;Thrombospondin-2,1.20926147201913,3.35100892460942,2.23710371021224,5.01955307728967,4.4790791724402e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197090937758681,THBS2;Thrombospondin-2,1.58869097552201,4.89733400051033,2.61196915816144,9.18229843473217,7.28465434286217e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.294764974060682,DCXR;L-xylulose reductase,-0.445295280014822,0.64063508136467,0.542871698390737,0.756004243160449,1.35889403648863e-07
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.168998585128124,DCXR;L-xylulose reductase,-0.550352968110695,0.576746201431797,0.465025806792062,0.71530692707286,5.44670113514425e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200789148046975,PENK;Proenkephalin-A,1.77852318559945,5.92110558450835,4.72335678509269,7.42257952089213,1.13168365163676e-53
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.54488571361864,PENK;Proenkephalin-A,0.196896273396767,1.21761773480371,1.14558147324556,1.29418376844745,2.48271934823558e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.40391305362938,PENK;Proenkephalin-A,0.469187286058362,1.59869438388811,1.37561839681103,1.85794529863829,9.41529266538321e-10
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303518479605892,PENK;Proenkephalin-A,0.461766402496906,1.58687456998883,1.33418877725012,1.88741724096001,1.80751855734932e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1549812052018398,PENK;Proenkephalin-A,0.199983107975384,1.22138212636897,1.14364102918186,1.30440781726829,2.52378054240076e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.905885923746818,PENK;Proenkephalin-A,0.489980431230856,1.63228427784863,1.47478005591496,1.8066097063259,2.95906209081475e-21
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40785879386425,PENK;Proenkephalin-A,0.268713566907353,1.30828035258568,1.20679322146351,1.41830220001236,6.91627948370413e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,ITGA5;Integrin alpha-5,0.238802098540214,1.26972723084525,1.15790121211427,1.3923530124009,3.83889937207211e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,ITGA5;Integrin alpha-5,0.192925504485574,1.21279244255689,1.12589898235746,1.30639207581779,3.65304897778604e-07
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0492727344396704,ITGA5;Integrin alpha-5,1.03897266493626,2.82631195300098,1.92770383157971,4.14381043644563,1.0274700075191e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197090937758681,ITGA5;Integrin alpha-5,1.59628286089789,4.93465548986704,2.81675692692931,8.64498621477467,2.40593732924173e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305660599173148,PRCP;Lysosomal Pro-X carboxypeptidase,-0.396470560393816,0.672690080140774,0.576505628345707,0.784921988044231,4.75116866490961e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.17097399925544,PRCP;Lysosomal Pro-X carboxypeptidase,-0.303600736388275,0.738155526264637,0.695669929264319,0.78323578184734,1.03728896988512e-23
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,CCDC80;Coiled-coil domain-containing protein 80,1.09349701969712,2.9846933752145,2.56031795395416,3.47940947345667,2.22918632038804e-44
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394251808630172,CCDC80;Coiled-coil domain-containing protein 80,1.2933389305041,3.64493645013749,2.42138851636678,5.48675342091548,5.72478434659465e-10
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00928463009324,CCDC80;Coiled-coil domain-containing protein 80,0.237038417343025,1.26748981043078,1.16168552968999,1.38293055950743,9.82765592917891e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,CCDC80;Coiled-coil domain-containing protein 80,0.422613393240257,1.52594424155551,1.39153642155444,1.67333444692402,2.62697576051443e-19
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56912219834808,CCDC80;Coiled-coil domain-containing protein 80,0.27153088855223,1.3119713961276,1.22290019943676,1.40753018525125,3.74161978642484e-14
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356797886810305,CCDC80;Coiled-coil domain-containing protein 80,0.402098958902057,1.49495926488379,1.29233813361718,1.72934864763799,6.26505821977568e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.524354905478128,CCDC80;Coiled-coil domain-containing protein 80,0.32142270277751,1.37908840220302,1.22243910480495,1.55581150309679,1.74352132977319e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.307764687432615,RARRES2;Retinoic acid receptor responder protein 2,0.878008448943535,2.40610305453383,2.08846134311032,2.77205605367588,5.41970538042406e-34
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392056926665751,RARRES2;Retinoic acid receptor responder protein 2,1.05341902947018,2.86743823313466,1.98673648428301,4.13854685102325,1.83450457341516e-08
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00366573226432,RARRES2;Retinoic acid receptor responder protein 2,0.214524085135674,1.23927196864854,1.13615417398959,1.35174877445119,1.29957985355431e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.913492639131202,RARRES2;Retinoic acid receptor responder protein 2,0.373304631535252,1.45252675789836,1.32918589250954,1.58731295171008,1.64865902610214e-16
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.170544763099602,RARRES2;Retinoic acid receptor responder protein 2,0.513614543406539,1.67132135382475,1.36920396995234,2.04010149623495,4.4446626005075e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301984469370146,CD300E;CMRF35-like molecule 2,1.48405806651128,4.41080876695404,3.79606021198959,5.12511206149749,1.15743724957746e-83
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392187622558632,CD300E;CMRF35-like molecule 2,1.58377984243753,4.87334150486759,3.2843957293015,7.23099753515876,3.64310118365854e-15
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63942269981959,CD300E;CMRF35-like molecule 2,0.221755054708387,1.24826558363698,1.18286788885567,1.31727894718656,6.65506171569117e-16
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67479802337438,CD300E;CMRF35-like molecule 2,0.220796259270895,1.2470693258655,1.19089436897343,1.30589407762104,6.0596502738906e-21
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00400031375009,CD300E;CMRF35-like molecule 2,0.284638338797714,1.3292811917428,1.21772385704493,1.4510584452284,1.95909517807741e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.354929798415562,CD300E;CMRF35-like molecule 2,0.407435309850061,1.50295821579689,1.29900924185545,1.7389278887692,4.35477218649566e-08
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0588281433837948,CD300E;CMRF35-like molecule 2,0.884623022572782,2.42207115320938,1.71908733469302,3.41252509562383,4.24989125236224e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16683661463644,CD300E;CMRF35-like molecule 2,0.237506405929957,1.26808312001634,1.19494993918344,1.34569218888719,4.63319284146926e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.90595340811044,CD300E;CMRF35-like molecule 2,0.578520037247827,1.78339711540488,1.63132672384895,1.94964333308435,4.45506545611475e-37
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70601615813004,CD300E;CMRF35-like molecule 2,0.206643651294025,1.22954434716795,1.14945984850725,1.31520844648547,1.81630294655482e-09
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.36669542709232,CD300E;CMRF35-like molecule 2,0.38217412112901,1.46546723172802,1.27189136609446,1.68850443089578,1.24131748035074e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56286767589614,CD300E;CMRF35-like molecule 2,0.357937438087088,1.43037613061368,1.33409179554283,1.53360951762459,7.72022592614757e-24
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.345125107851596,CD300E;CMRF35-like molecule 2,0.580282211064379,1.78654254168613,1.54466704517772,2.06629270898124,5.36169386593853e-15
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174523492038591,CD300E;CMRF35-like molecule 2,0.747908326779884,2.11257657218381,1.73456863398294,2.57296234112797,1.04302149469851e-13
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39814887442152,CD300E;CMRF35-like molecule 2,0.392878154149459,1.48123789564203,1.37521144456619,1.59543880481459,3.47249496100224e-25
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.237273511647972,CD300E;CMRF35-like molecule 2,0.524673183391791,1.6899064686203,1.41998373762664,2.01113843561186,3.44064865350598e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55510236096948,CD300E;CMRF35-like molecule 2,0.24723184850963,1.28047595480748,1.21096788594575,1.35397370142448,3.88466579849824e-18
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0568672052710016,CD300E;CMRF35-like molecule 2,1.14395634065092,3.13916342935556,2.23731858767539,4.40453455779052,3.58745659266425e-11
sensitivity,Circulatory system disorders,I95 (hypotension),0.52160953800298,CD300E;CMRF35-like molecule 2,0.38166439497684,1.46472043510192,1.29838600190381,1.65236374226105,5.44589812456235e-10
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0215703192407247,CD300E;CMRF35-like molecule 2,1.4689945063708,4.34486421067612,2.55181926616479,7.39779860569294,6.2998672260988e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,CTSO;Cathepsin O,0.396647866017325,1.48683227368801,1.26999135865093,1.74069704885911,8.15346752601057e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39817866266258,CTSO;Cathepsin O,0.207821439309282,1.23099334290167,1.14308090841344,1.32566697520255,3.85529344880886e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16069554195631,IGSF3;Immunoglobulin superfamily member 3,0.21798467236285,1.2435680065138,1.17094150218634,1.3206990989193,1.24927391463855e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.907056423662685,IGSF3;Immunoglobulin superfamily member 3,0.246903517788644,1.28005560422482,1.16759227178683,1.40335148621686,1.42246964764094e-07
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0574337036816984,IGSF3;Immunoglobulin superfamily member 3,1.04170615624178,2.83404822084456,2.04019857128426,3.93678803187101,5.22367153461318e-10
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0217851979482304,IGSF3;Immunoglobulin superfamily member 3,1.29622403409685,3.65546765388701,2.24205568805753,5.95990716902805,2.02311286954604e-07
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173144665353155,ACVRL1;Serine/threonine-protein kinase receptor R3,0.520253588950909,1.68245424741392,1.36219530151209,2.0780076773859,1.37200892432282e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.286584273687981,ACVRL1;Serine/threonine-protein kinase receptor R3,1.75388891523801,5.77702540983735,4.90024431741273,6.81068543201279,7.51195151930565e-97
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0398033713455529,ACVRL1;Serine/threonine-protein kinase receptor R3,2.03240728844727,7.63243774058044,5.09076899019609,11.4430857059166,7.86310894349609e-23
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63299301450832,ACVRL1;Serine/threonine-protein kinase receptor R3,0.203039403920878,1.22512074185718,1.15851275524279,1.29555831417165,1.08977895104826e-12
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.01299580074432,ACVRL1;Serine/threonine-protein kinase receptor R3,0.278795714952952,1.32153734597331,1.21002794986129,1.4433228232475,5.69307411533152e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.364200847811809,ACVRL1;Serine/threonine-protein kinase receptor R3,0.507583548794584,1.66127195813108,1.43618867930413,1.92163088223887,8.30603836136101e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.553266861703186,ACVRL1;Serine/threonine-protein kinase receptor R3,0.327061689027662,1.3868870302538,1.23124304113663,1.56220629918083,7.24020798697759e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.30449579079348,ACVRL1;Serine/threonine-protein kinase receptor R3,0.553803340766413,1.73985772173685,1.48340262287432,2.04064954801136,9.98393917479943e-12
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384102533484586,ACVRL1;Serine/threonine-protein kinase receptor R3,0.375487467517857,1.45570084857054,1.26172418227182,1.67949936309652,2.65888470088369e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16132306406352,ACVRL1;Serine/threonine-protein kinase receptor R3,0.317475934547079,1.37365618680928,1.29209494678998,1.46036583785673,2.82642683458908e-24
sensitivity,Circulatory system disorders,I50 (heart failure),0.901546360976774,ACVRL1;Serine/threonine-protein kinase receptor R3,0.681544710125261,1.97692915732631,1.80028146677019,2.17090991893537,3.31105583998628e-46
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71154496785877,ACVRL1;Serine/threonine-protein kinase receptor R3,0.23104640680626,1.2599177068495,1.17687490987716,1.34882018021659,3.10521886658119e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55631181961112,ACVRL1;Serine/threonine-protein kinase receptor R3,0.24603241181807,1.27894102567381,1.1905905269414,1.37384777565266,1.62311596970975e-11
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.358230342109976,ACVRL1;Serine/threonine-protein kinase receptor R3,0.513334760541444,1.67085381215601,1.4423455583336,1.9355642241667,7.84481655331988e-12
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.165183991084044,ACVRL1;Serine/threonine-protein kinase receptor R3,0.566562020490685,1.76219822377412,1.41961036405226,2.18746119252644,2.79663129309923e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39311799709435,ACVRL1;Serine/threonine-protein kinase receptor R3,0.380595236619389,1.46315525386979,1.35696852607566,1.57765140147945,4.12608227741204e-23
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.23683005950604,ACVRL1;Serine/threonine-protein kinase receptor R3,0.544112470697195,1.72307842094444,1.43835862671593,2.06415784601872,3.53361827783411e-09
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.55736660895177,ACVRL1;Serine/threonine-protein kinase receptor R3,0.18738442699547,1.20609084982247,1.14048413051467,1.27547161692555,5.15610296510387e-11
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0517443827492188,ACVRL1;Serine/threonine-protein kinase receptor R3,1.04966454413069,2.85669266299184,1.97685124161889,4.12812699255431,2.295889381911e-08
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0199016856727764,ACVRL1;Serine/threonine-protein kinase receptor R3,1.47786352047295,4.38357026117044,2.51465663127498,7.64147597553911,1.8661840402835e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.201197828935055,GM2A;Ganglioside GM2 activator,1.47620597292614,4.37631030356245,3.62320379307745,5.28595490810071,5.54455942624787e-53
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00832865431405,GM2A;Ganglioside GM2 activator,0.285958072745258,1.33103664736978,1.21099802006738,1.46297394981933,3.02856767188994e-09
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.549784765113232,GM2A;Ganglioside GM2 activator,0.361635558863883,1.43567562735073,1.26401410467116,1.63064992657271,2.60642071027108e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14065131948343,GM2A;Ganglioside GM2 activator,0.201053785664755,1.22269053327792,1.14499871664668,1.30565398758325,1.94440228821119e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.898371701291409,GM2A;Ganglioside GM2 activator,0.498034871186208,1.64548450240011,1.48887767194175,1.81856394159485,1.66980572402191e-22
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.53003930376193,GM2A;Ganglioside GM2 activator,0.336683807504573,1.40029623057248,1.29647429527903,1.51243224836437,1.07097361046903e-17
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.166105184353359,GM2A;Ganglioside GM2 activator,0.581823942870363,1.78929903548647,1.4231609050465,2.24963391492841,6.32763587668864e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40370578326782,GM2A;Ganglioside GM2 activator,0.309727691461539,1.36305389237776,1.25793771969745,1.4769538145124,3.90352521203581e-14
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.145049597604342,GM2A;Ganglioside GM2 activator,0.641220420800795,1.89879679692793,1.48935974632049,2.4207914071339,2.28436798795968e-07
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.233950963877971,GM2A;Ganglioside GM2 activator,0.506949346981802,1.6602187104648,1.36844443572609,2.0142039344951,2.73451511687891e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304363193653536,SCG2;Secretogranin-2,1.58568393579239,4.8826296419768,4.13554403777606,5.76467618357917,3.74634132418246e-78
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0392726701488434,SCG2;Secretogranin-2,1.49652167525792,4.46612738035379,2.90335969527217,6.8700732499753,9.70003185172598e-12
sensitivity,Circulatory system disorders,I50 (heart failure),0.90523504693084,SCG2;Secretogranin-2,0.386267575878474,1.47147835025505,1.34322505404294,1.61197747819862,1.0258943346509e-16
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174763382162353,SCG2;Secretogranin-2,0.513863639635142,1.67173772552693,1.36050799608082,2.05416434964043,1.01365939961031e-06
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173274663140375,CFD;Complement factor D,0.600761058942583,1.82350606802725,1.45781760939487,2.28092620002887,1.43447419493786e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.198353890700166,CFD;Complement factor D,1.36480083146043,3.9149432408106,3.22843963458024,4.74742671803477,9.08766730500647e-44
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.5512414217642,CFD;Complement factor D,0.203167112325741,1.22527721006383,1.15298676148188,1.30210015557529,5.8264696162656e-11
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.396707781400332,CFD;Complement factor D,0.556395946759424,1.74437433966867,1.50321586935567,2.02422147006655,2.31413866990414e-13
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.554022936093568,CFD;Complement factor D,0.406673696988425,1.50181397927717,1.32234729800093,1.70563756719738,3.77577257993571e-10
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.307790520051982,CFD;Complement factor D,0.485923461369818,1.62567556446866,1.37117603814123,1.92741192042204,2.21988062563714e-08
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.37846834317503,CFD;Complement factor D,0.402165215745249,1.49505831944686,1.28132143469963,1.74444859659376,3.23346036477218e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.13857413191673,CFD;Complement factor D,0.372485910483096,1.45133803034738,1.35854930472204,1.55046421282707,2.19126175687326e-28
sensitivity,Circulatory system disorders,I50 (heart failure),0.898292332596156,CFD;Complement factor D,0.652879387624275,1.9210643619507,1.73726688808539,2.1243070411733,4.34181192115928e-37
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65750894872437,CFD;Complement factor D,0.234064807448326,1.26372638843662,1.17329592573805,1.36112667725022,6.46175408367592e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54807231937256,CFD;Complement factor D,0.336067803574664,1.39943390821566,1.29578475954245,1.51137389835891,1.1315205105451e-17
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6403541272596,HGF;Hepatocyte growth factor,0.200094509045885,1.22151819722441,1.15632438816889,1.29038764676858,8.66207430959727e-13
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68752559427468,HGF;Hepatocyte growth factor,0.192989600248653,1.21287017990524,1.15761514676347,1.27076263421071,4.97105823842724e-16
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356857315574969,HGF;Hepatocyte growth factor,0.477943441644088,1.61275426607431,1.39813745666102,1.86031517169454,5.38895293822666e-11
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304206236227842,HGF;Hepatocyte growth factor,0.435833887936751,1.54625192231804,1.32314934850158,1.80697289386103,4.20265200945301e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.15479417328055,HGF;Hepatocyte growth factor,0.323977659223873,1.38261641805057,1.30211832420776,1.4680909744712,3.47251340009251e-26
sensitivity,Circulatory system disorders,I50 (heart failure),0.898968428852791,HGF;Hepatocyte growth factor,0.54035470917897,1.7166156535356,1.56690779163278,1.88062712924084,3.83118049012422e-31
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7004348589146,HGF;Hepatocyte growth factor,0.202830371521023,1.22486467869208,1.14539820802457,1.30984444588486,3.0939292496266e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55223182075232,HGF;Hepatocyte growth factor,0.204809889797495,1.22729172210562,1.14398251167313,1.31666782995313,1.12602378818213e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39817866266258,HGF;Hepatocyte growth factor,0.242870828789344,1.27490393259754,1.18438840975267,1.37233700023466,1.02141856595212e-10
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239854917025799,HGF;Hepatocyte growth factor,0.440857296091478,1.55403891909026,1.30413222679566,1.85183443244949,8.28570987074943e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,TGFA;Protransforming growth factor alpha,0.948356431187353,2.58146335806127,2.20759410871349,3.01864959808961,1.49438218753831e-32
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394835550993011,TGFA;Protransforming growth factor alpha,1.23210967530296,3.42845483858925,2.26132187780834,5.1979785344129,6.52197637638967e-09
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63355312512338,TGFA;Protransforming growth factor alpha,0.213959955258874,1.23857305546299,1.17191080168837,1.30902728391001,3.45793554351758e-14
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.66802226872507,TGFA;Protransforming growth factor alpha,0.224049400777368,1.25113282483587,1.19350418519391,1.31154407734855,1.25081707220051e-20
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361274529158605,TGFA;Protransforming growth factor alpha,0.459893027779925,1.58390454214654,1.36927071767317,1.83218231884461,6.01158651747707e-10
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.388913017728116,TGFA;Protransforming growth factor alpha,0.356442550613169,1.42823947667953,1.24087193150226,1.64389889960381,6.77128922310376e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16567299719666,TGFA;Protransforming growth factor alpha,0.223970341266975,1.25103391479724,1.177598159003,1.32904917013284,3.97080120578215e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.900225056264065,TGFA;Protransforming growth factor alpha,0.457959594547933,1.58084512700895,1.44073971490113,1.73457515590138,3.96783225785562e-22
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.7056895802898,TGFA;Protransforming growth factor alpha,0.199801901392869,1.22116082393924,1.14116993125357,1.30675871934852,7.45591091499742e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56157460417736,TGFA;Protransforming growth factor alpha,0.233419613771102,1.26291130313328,1.17655536163009,1.35560553425385,1.05279996120364e-10
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17570182019189,TGFA;Protransforming growth factor alpha,0.534443399297098,1.70649813980078,1.38651100564313,2.10033377974719,4.54881968233842e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38784696174043,TGFA;Protransforming growth factor alpha,0.26259289686814,1.30029725610073,1.20641361184072,1.40148696734559,6.52389529758714e-12
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242823863860702,TGFA;Protransforming growth factor alpha,0.626388262823265,1.87084137498365,1.56840715319315,2.2315936542529,3.34061179603278e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.310817231548938,IGFBP6;Insulin-like growth factor-binding protein 6,1.83236574743343,6.24865191843883,5.29424584345031,7.37511100775837,4.11032356264194e-104
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0395945517896737,IGFBP6;Insulin-like growth factor-binding protein 6,2.09440658617913,8.12062065160359,5.31996851273628,12.3956522692523,2.84845028251202e-22
sensitivity,Circulatory system disorders,I50 (heart failure),0.91859360152043,IGFBP6;Insulin-like growth factor-binding protein 6,0.441320947483983,1.55475961846283,1.40192930577735,1.72425061751764,6.29719536339364e-17
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56398479569211,IGFBP6;Insulin-like growth factor-binding protein 6,0.289625110070497,1.33592656871936,1.23455532025352,1.44562156732174,6.32392432335826e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.298997479040863,STC1;Stanniocalcin-1,0.676592383050394,1.96716296019672,1.68206236779341,2.30058658113039,2.46282084572088e-17
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.54718492896367,STC1;Stanniocalcin-1,0.319815412909483,1.37687358778824,1.22368734574405,1.54923631705625,1.06955736739042e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.300951710930019,STC1;Stanniocalcin-1,0.388341912749987,1.4745338600353,1.25918930800032,1.72670629473773,1.42719982226364e-06
sensitivity,Circulatory system disorders,I50 (heart failure),0.904809364679212,STC1;Stanniocalcin-1,0.370815787246146,1.44891613996888,1.32198041001915,1.58804015910637,2.24509831824559e-15
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70213597545484,STC1;Stanniocalcin-1,0.18483233094323,1.20301671453879,1.1244771995975,1.28704185018401,8.06079089598477e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39923003263567,STC1;Stanniocalcin-1,0.19608090804584,1.2166253361308,1.1292881477139,1.3107170313545,2.48274016510946e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302287904532342,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.408271469665832,0.664798381729233,0.567593273067056,0.778650680550956,4.14840849088938e-07
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17386493855455,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.525191563891359,0.591442054572641,0.481119363000212,0.727062202892369,6.1634070533611e-07
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.56558019455073,TTR;Transthyretin,-0.224954349299186,0.798552672416435,0.750699566385143,0.849456159531426,9.68757391145324e-13
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0530173804803835,TTR;Transthyretin,-1.43472256247266,0.238181435317405,0.159170273540788,0.356413260264467,3.02255310971654e-12
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0184408279931768,TTR;Transthyretin,-2.07172920027613,0.125967769763948,0.0656824272771293,0.241584845096435,4.50380088029724e-10
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304699402320403,LAMP3;Lysosome-associated membrane glycoprotein 3,0.777360529984077,2.17572192712416,1.8499702283052,2.55883355944901,5.78433195558883e-21
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00003906402593,LAMP3;Lysosome-associated membrane glycoprotein 3,0.242116661893231,1.27394280472682,1.16532401951772,1.39268584748377,1.01019565216676e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.900425797882729,LAMP3;Lysosome-associated membrane glycoprotein 3,0.251812120295751,1.28635433470808,1.17052389867913,1.4136468945995,1.69158129570888e-07
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.35548263604047,LAMP3;Lysosome-associated membrane glycoprotein 3,0.401707727722977,1.4943745046036,1.28590348025084,1.73664290851256,1.6032887102015e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40044532989569,LAMP3;Lysosome-associated membrane glycoprotein 3,0.295245382862594,1.34345597931696,1.24549199985846,1.44912530033722,2.12599875019541e-14
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240243759521856,LAMP3;Lysosome-associated membrane glycoprotein 3,0.515338949286538,1.67420587652383,1.39438398300309,2.01018180870822,3.33621163175344e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304818092428711,CES1;Liver carboxylesterase 1,-0.514482281331907,0.597810011918913,0.514950628646617,0.694002085772264,1.39522865937761e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,RSPO3;R-spondin-3,1.61421654507844,5.02395034259003,4.31008253574293,5.85605422529568,1.1176633729723e-94
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,RSPO3;R-spondin-3,1.63085125328401,5.10822125839276,3.50713192521763,7.44024604180708,1.8975551603174e-17
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6446442533229,RSPO3;R-spondin-3,0.202079336538358,1.22394510782752,1.15860380565774,1.29297143653389,5.23195369816813e-13
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67865519937451,RSPO3;R-spondin-3,0.18838080198697,1.20729316746285,1.15215644965278,1.26506846586828,2.82245193737061e-15
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0027365129007,RSPO3;R-spondin-3,0.229742242774824,1.25827563848965,1.15348921625477,1.37258117380339,2.2351389107471e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304925723221266,RSPO3;R-spondin-3,0.383042205896086,1.46673993383527,1.25425637391623,1.71522033154185,1.60948727239234e-06
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,RSPO3;R-spondin-3,0.305833619929332,1.35775638415077,1.27874252365854,1.44165253332456,1.56069609833063e-23
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,RSPO3;R-spondin-3,0.609762491170127,1.83999433197931,1.68043920975748,2.01469896801838,1.21446540165065e-39
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.367474589523064,RSPO3;R-spondin-3,0.389985021178244,1.47695867061628,1.28079512981309,1.70316615353383,8.15082713727612e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56176700547302,RSPO3;R-spondin-3,0.28130747490405,1.32486090279392,1.23519509441234,1.42103576972755,3.61404176785241e-15
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.34401876465989,RSPO3;R-spondin-3,0.448189849685824,1.56547587254572,1.35214568856308,1.81246350023655,2.01903962675373e-09
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173964034401876,RSPO3;R-spondin-3,0.587959849715397,1.80031175965914,1.46783185387559,2.20810198621135,1.66025501214855e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3975762314308,RSPO3;R-spondin-3,0.261978087258949,1.29949806655276,1.20709258818312,1.39897737879091,3.37855410047272e-12
sensitivity,Circulatory system disorders,I95 (hypotension),0.521892103205629,RSPO3;R-spondin-3,0.303057139247648,1.3539918283064,1.20086143022248,1.52664897462887,7.45571605857223e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.305894348797992,DPY30;Protein dpy-30 homolog,0.653110501232283,1.92150839737594,1.65192381923196,2.23508764641633,2.50124743563842e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.905917879132515,DPY30;Protein dpy-30 homolog,0.298896782809666,1.34837044128155,1.23138526693464,1.47646954673067,1.08294477976104e-10
sensitivity,Circulatory system disorders,I00 (rheumatic fever without mention of heart involvement),0.360740404896607,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.366983771406036,1.44337449498649,1.24504185843348,1.67330111728032,1.13844341543051e-06
sensitivity,Circulatory system disorders,I05 (rheumatic mitral valve diseases),0.118275542589051,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.54225616066977,4.67512621702242,3.58566199187915,6.09561224526794,4.52038835494613e-30
sensitivity,Circulatory system disorders,I07 (rheumatic tricuspid valve diseases),0.0492814760787715,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.49900855297708,4.47724791500055,2.98898271903875,6.70654559649761,3.57031026049521e-13
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173470795797275,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.29277495312636,3.6428813680007,2.95996822152329,4.48335376198641,2.90961700186908e-34
sensitivity,Circulatory system disorders,I09 (other rheumatic heart diseases),0.027597626604112,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.78160463131762,5.93937929021511,3.45285234222197,10.2165464539776,1.21228475083887e-10
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0727000335114,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.191797409353134,1.21142506871467,1.18749144476438,1.23584106949212,3.63147316096914e-79
sensitivity,Circulatory system disorders,I11 (hypertensive heart disease),0.0295688856472629,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.24308520017657,3.46629118702001,2.15131079558608,5.58504824959021,3.26143220342891e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.22216680964209,3.39453508194004,2.91619934565381,3.95133084426992,4.91887513084621e-56
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394251808630172,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.22688141650415,3.41057676573319,2.27229074203546,5.11907814426044,3.19190598950326e-09
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.5851485343689,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.67592589216198,1.96585230082751,1.88392890735221,2.05133816546205,1.18123983655747e-212
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.66119970825366,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.942530207318062,2.56646690339894,2.42811292726505,2.7127042948786,1.17403008518343e-243
sensitivity,Circulatory system disorders,I22 (subsequent myocardial infarction),0.112361765459599,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.11753150674803,3.05729796147685,2.41114959852661,3.87660343885847,2.83009960191752e-20
sensitivity,Circulatory system disorders,I24 (other acute ischaemic heart diseases),0.16164324153837,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.804009011026906,2.23448105517491,1.82364306267712,2.73787436155734,8.75811958505572e-15
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70399574208046,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.845633424731768,2.32945288041526,2.22115425503816,2.443031909993,1.44952397047715e-265
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00928463009324,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.256794562266159,1.29277951378315,1.18348687613744,1.4121651071552,1.21167991599947e-08
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360740404896607,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.22745242690419,3.4125247966566,2.94424494060314,3.95528419772392,9.99907061082855e-60
sensitivity,Circulatory system disorders,I31 (other diseases of pericardium),0.199097163358236,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.568602602306258,1.76579780479573,1.46606013269023,2.12681718702751,2.08755026716449e-09
sensitivity,Circulatory system disorders,I33 (acute and subacute endocarditis),0.0473102170356206,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.34774375854884,3.84873205829419,2.64282959825687,5.60487837214759,2.10519569931139e-12
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540124977823335,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.12678503997854,3.08572006940894,2.7395187367621,3.47567191966243,7.0222670019026e-77
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.380452995328116,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.951199040950802,2.58881189056372,2.25646416183258,2.97011010326934,6.1543511030276e-42
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0591377712945258,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.59659924243801,4.93621697076973,3.45608434290355,7.05024402328223,1.65394015146271e-18
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.309487669774685,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.258410323918,3.51982166128202,3.01897615316129,4.10375700194152,4.22292362047037e-58
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.394251808630172,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.00973055140038,2.74486131632816,2.40153100656128,3.13727519040571,1.25363209038905e-49
sensitivity,Circulatory system disorders,I45 (other conduction disorders),0.264148711782215,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.588943468234972,1.80208345083823,1.5313855648216,2.12063169353653,1.3254438039919e-12
sensitivity,Circulatory system disorders,I46 (cardiac arrest),0.0808216207691852,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.26616478621317,3.54722208611811,2.65758587178174,4.73466715105923,8.36171325442309e-18
sensitivity,Circulatory system disorders,I47 (paroxysmal tachycardia),0.71162451457746,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.629370877496266,1.87642970369232,1.69104415539875,2.08213867252249,1.95156061750924e-32
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.35956677026197,3.89450572057337,3.64184337227405,4.16469717589969,0.0
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.24977823335764,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.661381890901848,1.9374678545386,1.79159280290049,2.09522034320144,1.3500981720694e-61
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.4430501170715,4.23358908635634,3.84096461100455,4.66634774524203,1.14497447657371e-185
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71696662658439,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.765116400567355,2.1492445333787,2.00863922652667,2.29969225098018,7.6235691652926e-109
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.36665418202606,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.503031191774685,1.65372644304089,1.43703417448309,1.90309402307457,2.22259767056312e-12
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56912219834808,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.355861032307419,1.4274091707213,1.3314706475589,1.53026050134473,1.18948713235905e-23
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175442054840426,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.922543155260144,2.51568002646574,2.06911499984928,3.058624579117,2.19221583340787e-20
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.173470795797275,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.773736713276932,2.16785177825562,1.78813064540083,2.6282091549483,3.4019038897543e-15
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3917088844645,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.360621010930579,1.43421980423614,1.33004032940617,1.54655945491634,7.07668537099884e-21
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151786946322616,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.534176678960944,1.7060430427378,1.37417888608537,2.11805238251436,1.29909215070178e-06
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242464862307555,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.639601778028279,1.89572580930257,1.59767733756615,2.2493755525947,2.32234266745864e-13
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54883794279406,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.285981229726063,1.33106747051675,1.25774531975084,1.40866404608752,4.48798163989401e-23
sensitivity,Circulatory system disorders,I95 (hypotension),0.524354905478128,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.457654507046963,1.5803629044835,1.39973587839731,1.78429870121441,1.46328734360732e-13
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304206236227842,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,1.77402626841168,5.89453864247418,5.0078442700585,6.93823208827847,6.14341858380957e-101
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.03900079951639,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,1.924436314028,6.85128560363958,4.54354475629717,10.3311658496555,4.18269037841564e-20
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.6403541272596,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.188883097328889,1.2078997375231,1.14396629047709,1.27540626682268,9.92986326674106e-12
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.356857315574969,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.391687200832323,1.4794748605114,1.27739496066898,1.71352317042094,1.72075405356849e-07
sensitivity,Circulatory system disorders,I50 (heart failure),0.898968428852791,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.531229329375115,1.70102214029441,1.55060318536348,1.86603274718123,2.43053055014782e-29
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.366607515454066,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.455402245738976,1.57680751959201,1.36503241882296,1.8214380256154,6.06290284704439e-10
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55223182075232,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.367591546645905,1.444252008905,1.34554996789173,1.55019428114912,2.49391628881787e-24
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.354907275599149,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.425647133517884,1.53058058924398,1.32151327600474,1.77272297048194,1.34515020647758e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173553557847935,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.738340075413303,2.09245930552227,1.70094908252421,2.57408407473857,2.83376986656052e-12
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39817866266258,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.275092550820589,1.31665252650055,1.22209866655685,1.41852202525061,4.65624051802287e-13
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.239854917025799,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.521789329421447,1.6850400455407,1.41060898058667,2.01286110761531,8.77025552432649e-09
sensitivity,Circulatory system disorders,I95 (hypotension),0.522610713519627,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.350002062132825,1.41907047490204,1.2568015700301,1.60229033823572,1.61213572076633e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,SMOC1;SPARC-related modular calcium-binding protein 1,1.02519558531576,2.78764062882327,2.39394440113312,3.24608218628135,9.08157137787538e-40
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0390930414386239,SMOC1;SPARC-related modular calcium-binding protein 1,1.06571406573367,2.90291111350732,1.91538567482314,4.39958022224552,5.07289006484012e-07
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0027365129007,SMOC1;SPARC-related modular calcium-binding protein 1,0.325216201750577,1.3843299081786,1.26920525733991,1.50989706636911,2.11499513881753e-13
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361610633307271,SMOC1;SPARC-related modular calcium-binding protein 1,0.352159748052259,1.42213568897985,1.23166949006514,1.64205570908737,1.58487696571756e-06
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304925723221266,SMOC1;SPARC-related modular calcium-binding protein 1,0.397285505128306,1.48778063842227,1.27163090371825,1.74067115040373,7.04505894157685e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16379984362783,SMOC1;SPARC-related modular calcium-binding protein 1,0.204578071803243,1.22700724677477,1.15527698469202,1.30319118582558,2.80685321591749e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,SMOC1;SPARC-related modular calcium-binding protein 1,0.410156299174095,1.50705331789448,1.37460030719269,1.65226916587499,2.36040591999582e-18
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0566849100860046,SMOC1;SPARC-related modular calcium-binding protein 1,1.06420333520603,2.89852890806835,2.06290161589625,4.07264688057254,8.61900983799229e-10
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.302055159615422,GGT1;Glutathione hydrolase 1 proenzyme,0.447960015178671,1.5651161135142,1.32944621478408,1.8425630322921,7.45296265704041e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1538704518982,GGT1;Glutathione hydrolase 1 proenzyme,0.194242427783653,1.2143906493071,1.13940811665064,1.29430765638182,2.32303418865116e-09
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197421672951256,GGT1;Glutathione hydrolase 1 proenzyme,1.50080205613229,4.48528507844738,2.65137836099137,7.58766931605361,2.20377443825364e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.173500136973792,CKB;Creatine kinase B-type,0.528329180413529,1.69609606932311,1.36976277003317,2.10017525611654,1.26104486992471e-06
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.200894895443338,CKB;Creatine kinase B-type,1.19666860788977,3.30907471459003,2.7718106466155,3.95047745419028,5.26244418228834e-40
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00447447721669,CKB;Creatine kinase B-type,0.250412428709345,1.28455509485284,1.17124605170094,1.40882591605416,1.06722814507367e-07
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.404072687425805,CKB;Creatine kinase B-type,0.411003763481424,1.5083310331232,1.30796791923187,1.73938708437021,1.58731156703483e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14592274678111,CKB;Creatine kinase B-type,0.333287528788391,1.39554850115805,1.30910085374927,1.48770479639264,1.6952440330281e-24
sensitivity,Circulatory system disorders,I50 (heart failure),0.90859282257328,CKB;Creatine kinase B-type,0.51988942493697,1.68184166966807,1.52924555727322,1.84966461951049,8.84632519844647e-27
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54780385352935,CKB;Creatine kinase B-type,0.274482852972535,1.31585001095937,1.22083533307055,1.41825945271992,7.07168857295439e-13
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.164368550817276,CKB;Creatine kinase B-type,0.609916047818317,1.84027689703594,1.48173625987912,2.2855748013081,3.46002077098348e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39941557848598,CKB;Creatine kinase B-type,0.293903245071954,1.34165408574228,1.24080641916856,1.45069823784045,1.68428273383772e-13
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.232855446991142,CKB;Creatine kinase B-type,0.503065572534393,1.65378330038974,1.37387123060318,1.99072456262675,1.05359004959185e-07
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.54542964112866,CKB;Creatine kinase B-type,0.227891216046907,1.25594869093717,1.18446147385841,1.33175046135385,2.50220266877316e-14
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0525066203999634,CKB;Creatine kinase B-type,1.01784785920897,2.76723287610347,1.94789589300844,3.93120485446534,1.33115909422509e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301793005503284,LGALS9;Galectin-9,1.15873302128337,3.18589425776334,2.77320400842034,3.65999839565752,3.10627929873364e-60
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394500660788606,LGALS9;Galectin-9,1.29809469211377,3.66231218365064,2.57152751141781,5.21578340926282,6.23241391286988e-13
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63131940746,LGALS9;Galectin-9,0.214415699732148,1.23913765693499,1.17302860907128,1.30897245042471,1.78829124597036e-14
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.68266366846164,LGALS9;Galectin-9,0.215379679831683,1.24033273690097,1.1838603646721,1.29949894779554,1.31773734436334e-19
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00597668501094,LGALS9;Galectin-9,0.379538351424667,1.46160968363341,1.34217091137285,1.59167722172271,2.64104057153727e-18
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.357023098013689,LGALS9;Galectin-9,0.458736690928134,1.58207407347789,1.37412426926548,1.82149346311221,1.76781152150783e-10
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.540465905280391,LGALS9;Galectin-9,0.352296390095767,1.42233002578352,1.26630628634382,1.59757771406663,2.80467359853709e-09
sensitivity,Circulatory system disorders,I35 (nonrheumatic aortic valve disorders),0.380693137661005,LGALS9;Galectin-9,0.398123918401583,1.48902853651131,1.29769725461549,1.70856952548765,1.3980504230533e-08
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.303765508807227,LGALS9;Galectin-9,0.47369043219897,1.60590977211376,1.37871483017471,1.87054359591073,1.15454329909517e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.386610647572834,LGALS9;Galectin-9,0.350860271902622,1.4202888577869,1.23781953380831,1.62965633071518,5.70518220346793e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16580862772945,LGALS9;Galectin-9,0.288288369406906,1.33414197438703,1.25708222199331,1.41592552712976,2.15657819859514e-21
sensitivity,Circulatory system disorders,I50 (heart failure),0.901434009901966,LGALS9;Galectin-9,0.596969911960677,1.81660597639621,1.66308302186947,1.98430098202123,4.43971862757532e-40
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70227035130283,LGALS9;Galectin-9,0.226047148246931,1.25363477056654,1.17259599057042,1.34027418702746,3.36339224104924e-11
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55827761011499,LGALS9;Galectin-9,0.30223467390444,1.35287867478048,1.26205162663001,1.4502423435427,1.54420313521358e-17
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357023098013689,LGALS9;Galectin-9,0.466491874495004,1.59439104679718,1.38499753457625,1.8354421193138,8.36096705700802e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.173580290746987,LGALS9;Galectin-9,0.673710900490187,1.96150277321522,1.61454557121744,2.38301922096247,1.17336874764177e-11
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39653233919166,LGALS9;Galectin-9,0.442076041634199,1.55593405170375,1.44757253484342,1.67240723002051,3.43765750587034e-33
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.238672899777107,LGALS9;Galectin-9,0.48547467587291,1.62494614854053,1.36908329341897,1.92862625550181,2.79879790018067e-08
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56030928851805,LGALS9;Galectin-9,0.235404110221516,1.26542003459254,1.19812404876683,1.33649588754713,3.09373999220573e-17
sensitivity,Circulatory system disorders,I95 (hypotension),0.524685878848847,LGALS9;Galectin-9,0.313657661075156,1.36842119251174,1.21555537130441,1.540511114772,2.10599372034511e-07
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0216975363433733,LGALS9;Galectin-9,1.23891859701162,3.45187857386026,2.11601050597015,5.63109949362589,6.98430466197112e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,DSG2;Desmoglein-2,1.03337858227661,2.81054547093193,2.41630174763409,3.26911398872696,5.99091617634323e-41
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,DSG2;Desmoglein-2,1.50210616581795,4.49113819788647,3.04124750361585,6.63225281353577,4.28501184953968e-14
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1522330403248,DSG2;Desmoglein-2,0.183175548039267,1.20102522719959,1.13005058102727,1.27645755029705,3.77131625502995e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,DSG2;Desmoglein-2,0.238744064297987,1.26965354532574,1.15703696184117,1.39323131267391,4.70635441875127e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,DSG2;Desmoglein-2,0.248546854946208,1.28216089654175,1.19400106803964,1.37683006207006,8.011269604698e-12
sensitivity,Circulatory system disorders,I10 (essential (primary) hypertension),28.0727000335114,LEP;Leptin,0.410796480680916,1.50801841444392,1.46591024610318,1.55133613694782,8.56266548120779e-178
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.309487669774685,LEP;Leptin,1.28489970386743,3.61430543818076,2.9577687546794,4.41657373646811,3.38972882157925e-36
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.5851485343689,LEP;Leptin,0.473461285780092,1.60554182579884,1.51367523216895,1.7029839027595,6.92994026352572e-56
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.66119970825366,LEP;Leptin,0.487210164000929,1.62776867180937,1.50866562524646,1.75627442196888,3.19811764160963e-36
sensitivity,Circulatory system disorders,I22 (subsequent myocardial infarction),0.112361765459599,LEP;Leptin,0.932969709559112,2.54204712096161,1.81681674452898,3.55677235177868,5.20661052108652e-08
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.70399574208046,LEP;Leptin,0.51500569609171,1.67364803502307,1.56808199847862,1.78632096271385,3.8817766583571e-54
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16838494746594,LEP;Leptin,0.242956536105509,1.27501320587466,1.17245565379613,1.38654171685836,1.3579596538137e-08
sensitivity,Circulatory system disorders,I50 (heart failure),0.906779159849395,LEP;Leptin,0.675981297827676,1.96596122320032,1.7324133364321,2.23099386840746,1.1095910213055e-25
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.71696662658439,LEP;Leptin,0.276011713983825,1.31786330136628,1.19895670632358,1.4485624642891,1.05928148898208e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56912219834808,LEP;Leptin,0.428769682761677,1.53536737209869,1.3917158033258,1.69384651785361,1.17912862276049e-17
sensitivity,Circulatory system disorders,"I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",0.134045614934258,LEP;Leptin,0.79028507178146,2.20402464193946,1.60414560795063,3.02823172547429,1.08508600604372e-06
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.356797886810305,LEP;Leptin,0.538938853861229,1.71418689392587,1.39912215611599,2.10020025375368,1.98168404502305e-07
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175442054840426,LEP;Leptin,1.09869719478584,3.00025472916709,2.30152022611651,3.91112289075046,4.57953344424438e-16
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.173470795797275,LEP;Leptin,0.769521669295742,2.15873341830986,1.63210560283793,2.85528703732445,6.91827547040224e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.3917088844645,LEP;Leptin,0.369215238465333,1.4465989339029,1.30242601181815,1.60673117442404,5.47147414019659e-12
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151786946322616,LEP;Leptin,0.816400360302956,2.2623415484449,1.6788488791231,3.04863013310253,8.12825108624901e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242464862307555,LEP;Leptin,0.787625709621031,2.19817112896126,1.73179698119197,2.79014016346943,9.57382657727404e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302049196509653,CCL3;C-C motif chemokine 3,0.820075732323726,2.27067179427238,1.96701313306692,2.62120791703363,4.25672444516075e-29
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.00880483278714,CCL3;C-C motif chemokine 3,0.283626765387376,1.32793720611903,1.21983055279111,1.44562473809196,5.88850963763705e-11
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.529079638330635,CCL3;C-C motif chemokine 3,0.296946782576436,1.34574368053097,1.19721988143953,1.51269293282323,6.46591268927006e-07
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16567299719666,CCL3;C-C motif chemokine 3,0.24085261054621,1.27233349294912,1.19900181266951,1.3501501834062,1.83372165205548e-15
sensitivity,Circulatory system disorders,I50 (heart failure),0.900225056264065,CCL3;C-C motif chemokine 3,0.437800578369693,1.5492959134936,1.41671898981944,1.69427941943086,8.63723487509615e-22
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17570182019189,CCL3;C-C motif chemokine 3,0.523573361003418,1.68804889334054,1.3853893007693,2.05682912718173,2.0643331235855e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38784696174043,CCL3;C-C motif chemokine 3,0.258550548562112,1.29505161119517,1.20418212207153,1.39277825581236,3.26920232144281e-12
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.242823863860702,CCL3;C-C motif chemokine 3,0.497332482620737,1.64432913870559,1.39012438249992,1.94501898566363,6.46723733221515e-09
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.300808053005131,ANGPTL4;Angiopoietin-related protein 4,1.19972800325913,3.31921398455795,2.83346453523004,3.88823694043187,5.90373125557502e-50
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0393213141183178,ANGPTL4;Angiopoietin-related protein 4,1.59637180974414,4.93509444130133,3.22048289085413,7.56257926838539,2.29789210165964e-13
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.359790024182608,ANGPTL4;Angiopoietin-related protein 4,0.595547152570426,1.81402322094037,1.57208443908753,2.09319560978598,3.51090953194745e-16
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.542634134832786,ANGPTL4;Angiopoietin-related protein 4,0.515529377126413,1.67452472228999,1.48947619215683,1.88256318585396,6.22562525053663e-18
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.302774118711047,ANGPTL4;Angiopoietin-related protein 4,0.463704642943887,1.58995329715759,1.35857600355818,1.86073615353241,7.51594445096749e-09
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.385348878359514,ANGPTL4;Angiopoietin-related protein 4,0.396835828052221,1.48711176797406,1.29293876711713,1.71044558852382,2.71554890688539e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16267227650748,ANGPTL4;Angiopoietin-related protein 4,0.432293414596032,1.54078713827854,1.45091355075308,1.63622774372212,3.91661424844536e-45
sensitivity,Circulatory system disorders,I49 (other cardiac arrhythmias),1.25238385466842,ANGPTL4;Angiopoietin-related protein 4,0.233810916159849,1.26340558004253,1.16865299316594,1.36584056089945,4.14697507790463e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.900458093309478,ANGPTL4;Angiopoietin-related protein 4,0.620249210937806,1.85939136477713,1.69563356687657,2.03896426382755,1.0545463187214e-39
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70261290132316,ANGPTL4;Angiopoietin-related protein 4,0.201616840412442,1.2233791688392,1.14401734006132,1.30824642104592,3.82216048451777e-09
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55515797337947,ANGPTL4;Angiopoietin-related protein 4,0.201102227156442,1.22274976366581,1.13974367382542,1.31180108201576,2.06074496498766e-08
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.174979847826514,ANGPTL4;Angiopoietin-related protein 4,0.60423067725191,1.82984392668521,1.48870566331453,2.24915433489509,9.47502721087675e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39590665120028,ANGPTL4;Angiopoietin-related protein 4,0.193325648826778,1.21327783169621,1.12696511424333,1.30620112218276,2.82921203541469e-07
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151387059355523,ANGPTL4;Angiopoietin-related protein 4,0.560035330298188,1.7507343531702,1.40323299682138,2.18429211849585,7.01381817432357e-07
sensitivity,Circulatory system disorders,I95 (hypotension),0.522973477773627,ANGPTL4;Angiopoietin-related protein 4,0.341884374861304,1.40759753444438,1.24882034343149,1.58656193374431,2.15958038360372e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.171115674195756,RNASE1;Ribonuclease pancreatic,0.647176521998593,1.91013996981393,1.52187471643209,2.39746062201143,2.37619029714631e-08
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.193931097421857,RNASE1;Ribonuclease pancreatic,1.43395933075118,4.19527684067468,3.4355564670579,5.12299766825655,5.9744661930144e-45
sensitivity,Circulatory system disorders,I20 (angina pectoris),4.4125028519279,RNASE1;Ribonuclease pancreatic,0.186445504221391,1.20495895511997,1.15044511203102,1.26205593673265,2.94622457113556e-15
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.5576089436459,RNASE1;Ribonuclease pancreatic,0.295718807909422,1.3440921556059,1.26473724154435,1.4284261294902,1.6609363782718e-21
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.53410905772302,RNASE1;Ribonuclease pancreatic,0.262050084961976,1.2995916307968,1.23384705548059,1.3688393543876,4.43674212684653e-23
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999315537303217,RNASE1;Ribonuclease pancreatic,0.374612229294232,1.45442732094703,1.32239829788414,1.59963819924887,1.20717556719723e-14
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.399269906456764,RNASE1;Ribonuclease pancreatic,0.590305862161956,1.80454027158639,1.55428402090059,2.09509043906291,9.20183228602481e-15
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.55441478439425,RNASE1;Ribonuclease pancreatic,0.418001290695035,1.51892263486687,1.33706194858969,1.72551913031737,1.32491669111453e-10
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.305726671229751,RNASE1;Ribonuclease pancreatic,0.586115803568152,1.79699496079988,1.51469782464807,2.13190435517423,1.79411621264637e-11
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.378736025553274,RNASE1;Ribonuclease pancreatic,0.527661032254238,1.69496320435938,1.45286472114925,1.97740383004117,1.94397618455023e-11
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.14921286789869,RNASE1;Ribonuclease pancreatic,0.376226538390454,1.45677711233554,1.36385292703436,1.55603255523989,4.70215184118572e-29
sensitivity,Circulatory system disorders,I50 (heart failure),0.894364590463153,RNASE1;Ribonuclease pancreatic,0.687888508636518,1.98951026137341,1.79759599150342,2.20191361063266,2.6036828512036e-40
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.65639972621492,RNASE1;Ribonuclease pancreatic,0.301564521025937,1.35197234296666,1.25522032991808,1.45618197266296,1.72067013910992e-15
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55144877937485,RNASE1;Ribonuclease pancreatic,0.316290415222406,1.37202865577972,1.27059943246198,1.48155475611471,6.93401778174399e-16
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39630390143737,RNASE1;Ribonuclease pancreatic,0.341154720233267,1.4065708489974,1.29751752104306,1.52478985536846,1.17668623406569e-16
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.5347935204198,RNASE1;Ribonuclease pancreatic,0.192482502960364,1.21225529264297,1.14162969606702,1.28725005980803,3.27951187835771e-10
sensitivity,Circulatory system disorders,I95 (hypotension),0.504220853296828,RNASE1;Ribonuclease pancreatic,0.350100807873869,1.41921060898639,1.241700794389,1.62209669331058,2.8155356402409e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.302275960170697,FSTL3;Follistatin-related protein 3,1.60038825807579,4.95495585260265,4.29404711916038,5.71758688713269,2.05447314540557e-106
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0395131974079342,FSTL3;Follistatin-related protein 3,1.70185276380343,5.48409872442349,3.91852646191332,7.67516542545903,3.29859200329518e-23
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63355460723881,FSTL3;Follistatin-related protein 3,0.223635548082149,1.25061514727275,1.18472898332906,1.32016542905292,5.5517689791794e-16
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67867867867867,FSTL3;Follistatin-related protein 3,0.221533365241883,1.24798888697719,1.19163803183067,1.3070044933241,5.59834274659211e-21
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999683894420736,FSTL3;Follistatin-related protein 3,0.311534337974963,1.36551867476488,1.25170199930623,1.48968464711659,2.28445070470495e-12
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.361545756282598,FSTL3;Follistatin-related protein 3,0.394772736226483,1.48404688249878,1.28606532347567,1.71250644057662,6.5255038216832e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.543306464359095,FSTL3;Follistatin-related protein 3,0.356629821867827,1.4285069699244,1.27100774140736,1.60552300087726,2.18499865808522e-09
sensitivity,Circulatory system disorders,"I38 (endocarditis, valve unspecified)",0.0572941362415046,FSTL3;Follistatin-related protein 3,0.832976102393347,2.30015405791326,1.64932264193824,3.20780698427648,9.18037508699804e-07
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.304251620041093,FSTL3;Follistatin-related protein 3,0.415055744835654,1.51445516139309,1.29815733667411,1.76679233793519,1.3012995689452e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.385253674727358,FSTL3;Follistatin-related protein 3,0.444978758101652,1.56045704841061,1.36152406053461,1.78845623850247,1.60314299402124e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.1633475580844,FSTL3;Follistatin-related protein 3,0.326385319794886,1.385949299699,1.30620750909856,1.4705591936627,3.62149235134889e-27
sensitivity,Circulatory system disorders,I50 (heart failure),0.902876560771297,FSTL3;Follistatin-related protein 3,0.653076872595651,1.92144378075475,1.75998972739039,2.09770894974217,3.55947035873636e-48
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70499446815236,FSTL3;Follistatin-related protein 3,0.277112213139543,1.31931440714067,1.23392029501255,1.4106182643436,4.79394899038863e-16
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.365497076023391,FSTL3;Follistatin-related protein 3,0.373987652324247,1.45351920276223,1.26200975374909,1.67409013006613,2.12318499655266e-07
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.5568199778726,FSTL3;Follistatin-related protein 3,0.37471561465825,1.45457769521816,1.35700324784718,1.55916817058676,3.81216090681467e-26
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.353643116801011,FSTL3;Follistatin-related protein 3,0.491605436939582,1.63493890542672,1.4174369771801,1.88581592516074,1.48333158110125e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175833728465307,FSTL3;Follistatin-related protein 3,0.670314290366831,1.95485161512868,1.61085373563812,2.37231025550397,1.13802116020484e-11
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.17385806859491,FSTL3;Follistatin-related protein 3,0.507110216876908,1.66048581115826,1.36139313307929,2.02528796573365,5.59842934098701e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39481586850007,FSTL3;Follistatin-related protein 3,0.368207103967439,1.44514130248073,1.34245611062085,1.55568094004195,1.22828801608645e-22
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.152125810020546,FSTL3;Follistatin-related protein 3,0.593137017904002,1.80965644506264,1.46415045442782,2.23669394033453,4.08366549183713e-08
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.241030504188398,FSTL3;Follistatin-related protein 3,0.564296273724967,1.75821004865163,1.48392889284596,2.08318780642577,6.97882815989144e-11
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56243085190453,FSTL3;Follistatin-related protein 3,0.225298387042011,1.2526964488185,1.18535851101387,1.3238597253925,1.32887749506567e-15
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0533428165007112,FSTL3;Follistatin-related protein 3,1.02102540676122,2.77603987507424,2.0031323267921,3.84717339185652,8.64140985904115e-10
sensitivity,Circulatory system disorders,I95 (hypotension),0.525525525525525,FSTL3;Follistatin-related protein 3,0.459772952045107,1.58371436506282,1.40718911685231,1.78238387439828,2.43629820400489e-14
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0217322585743638,FSTL3;Follistatin-related protein 3,1.52243124762806,4.58335493089235,2.96451803691546,7.08619146888133,7.47432743039388e-12
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.297607316015609,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.74819047269152,5.74419898103793,4.92455356022178,6.70026663945376,9.97214621391156e-110
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0374472781741495,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.99558840698099,7.35653038847783,4.93192286529263,10.9731114688442,1.35004638251632e-22
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),0.999251054436517,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.270341851035847,1.31041233998899,1.20067568529941,1.43017845852955,1.37399238288656e-09
sensitivity,Circulatory system disorders,I50 (heart failure),0.902676494934763,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.49453130656772,1.6397295284656,1.49678164997814,1.79632942891923,2.24976731262764e-26
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70286570223501,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.190417515671133,1.20975458372704,1.13096964765572,1.29402778923569,2.99004696659611e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.55307658953841,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.388331394302263,1.47451835030954,1.37450554700382,1.58180836020557,2.31551757848583e-27
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.348850959832866,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.520735677921456,1.68326553559087,1.45542197826874,1.94677757077601,2.25880068390999e-12
sensitivity,Circulatory system disorders,I69 (sequelae of cerebrovascular disease),0.116283653277622,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.615854296281812,1.85123742946637,1.44355520317327,2.37405539651253,1.21876457577996e-06
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.17344002522764,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.697480342741677,2.0086851278076,1.64185450138013,2.45747472707466,1.20909857141508e-11
sensitivity,Circulatory system disorders,I72 (other aneurysm),0.104458197012101,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.645582980646929,1.90709850677674,1.46847416047465,2.47673729129458,1.28988595029211e-06
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.40131656746422,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.387787315330733,1.47371631408731,1.36879960285971,1.58667475492369,7.70831850492294e-25
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240450944065591,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.639112663640962,1.89479880925784,1.59426007078453,2.25199300500462,4.07232764192268e-13
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56415310024045,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.204517442755921,1.22693285674946,1.161029039635,1.29657759072473,3.86213323359705e-13
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0492727344396704,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.99426168188547,2.70272813131314,1.88170290442309,3.88198335381269,7.36873804249246e-08
sensitivity,Circulatory system disorders,I95 (hypotension),0.516378256927746,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.412429783420979,1.5104834776015,1.338916810723,1.70403442382287,2.02169594731605e-11
sensitivity,Circulatory system disorders,I98 (other disorders of circulatory system in diseases classified elsewhere),0.0197090937758681,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.49731768434435,4.46968387364243,2.64047002053106,7.56610519148448,2.46915823254896e-08
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16138046940649,NTRK3;NT-3 growth factor receptor,0.202317027422204,1.22423606299931,1.15312769904141,1.29972937012435,3.43323593743785e-11
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.304925723221266,ANGPTL7;Angiopoietin-related protein 7,0.585811578745927,1.79644835347736,1.53283438322868,2.1053981578322,4.64976050017189e-13
sensitivity,Circulatory system disorders,I50 (heart failure),0.906958561376075,ANGPTL7;Angiopoietin-related protein 7,0.244911037122811,1.27750765739255,1.16408602077284,1.40198042547844,2.4319119372111e-07
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39772527063798,VWA1;von Willebrand factor A domain-containing protein 1,0.248748524814536,1.28241949583589,1.19149683957398,1.38028042431738,3.36301254166005e-11
sensitivity,Circulatory system disorders,I50 (heart failure),0.914616039435392,ICAM1;Intercellular adhesion molecule 1,0.251561286714372,1.28603171430709,1.17336802740104,1.40951306971172,7.54100436557525e-08
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39172094312355,ICAM1;Intercellular adhesion molecule 1,0.230246023740358,1.25890969350473,1.16781534384243,1.35710977318174,1.87740482319114e-09
sensitivity,Circulatory system disorders,I85 (oesophageal varices),0.0514718983232039,ICAM1;Intercellular adhesion molecule 1,0.992376577899408,2.69763800695378,1.84115916960239,3.95253758431605,3.54433481242371e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.20142369932935,PRND;Prion-like protein doppel,0.782912459762255,2.18783497676661,1.76573048051498,2.71084513655069,8.13700682098402e-13
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.54730023575728,PRND;Prion-like protein doppel,0.249792485039328,1.28375898984863,1.18822971791343,1.38696846171392,2.43144291856296e-10
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.39852136693446,PRND;Prion-like protein doppel,0.250035156901401,1.28407055983625,1.18508567139922,1.39132321184123,1.00293489087505e-09
sensitivity,Circulatory system disorders,I95 (hypotension),0.50813705967177,PRND;Prion-like protein doppel,0.367800665221113,1.44455406040853,1.26444513347548,1.65031789691588,6.18693344803868e-08
sensitivity,Circulatory system disorders,I08 (multiple valve diseases),0.169638630266687,COLEC12;Collectin-12,0.555867778172477,1.74345325920287,1.41391443751309,2.14979717752332,1.99027360543256e-07
sensitivity,Circulatory system disorders,I12 (hypertensive renal disease),0.301798958497711,COLEC12;Collectin-12,1.65120806222219,5.21327398390177,4.49079207949784,6.05198930391497,2.33077321105521e-104
sensitivity,Circulatory system disorders,I15 (secondary hypertension),0.0394508442480669,COLEC12;Collectin-12,1.72075479183754,5.58874521196059,3.90083224051623,8.00702801822591,6.61487688976894e-21
sensitivity,Circulatory system disorders,I21 (acute myocardial infarction),2.63531639577086,COLEC12;Collectin-12,0.235088854051703,1.26502116599543,1.19822022584917,1.33554626761731,2.011362542666e-17
sensitivity,Circulatory system disorders,I25 (chronic ischaemic heart disease),3.67879122613223,COLEC12;Collectin-12,0.221444346457065,1.24787779746761,1.19132216826714,1.30711829166888,8.13700842538536e-21
sensitivity,Circulatory system disorders,I26 (pulmonary embolism),1.0040239861133,COLEC12;Collectin-12,0.284438140841318,1.32901509900123,1.21688999077403,1.45147149435405,2.53144159669891e-10
sensitivity,Circulatory system disorders,I27 (other pulmonary heart diseases),0.360975224869812,COLEC12;Collectin-12,0.407763206401862,1.50345111141832,1.29958947802073,1.73929173993277,4.14182024287478e-08
sensitivity,Circulatory system disorders,I34 (nonrheumatic mitral valve disorders),0.544421650623323,COLEC12;Collectin-12,0.347629906836554,1.4157082088445,1.257606624692,1.59368573068749,8.73466531479229e-09
sensitivity,Circulatory system disorders,I42 (cardiomyopathy),0.301798958497711,COLEC12;Collectin-12,0.419870280529938,1.52176414037676,1.30100209650775,1.77998644671886,1.51733962647164e-07
sensitivity,Circulatory system disorders,I44 (atrioventricular and left bundle-branch block),0.384645731418652,COLEC12;Collectin-12,0.447322497689137,1.56411864260504,1.3619543376391,1.79629159402326,2.37781254418433e-10
sensitivity,Circulatory system disorders,I48 (atrial fibrillation and flutter),2.16190626479406,COLEC12;Collectin-12,0.258135799219609,1.29451460076098,1.21931677026775,1.37435003966638,2.81239101809398e-17
sensitivity,Circulatory system disorders,I50 (heart failure),0.901451791068328,COLEC12;Collectin-12,0.61642200306055,1.85228868787916,1.69336840209313,2.02612342299771,2.39352407354285e-41
sensitivity,Circulatory system disorders,I51 (complications and ill-defined descriptions of heart disease),1.70230392930408,COLEC12;Collectin-12,0.201329636417887,1.22302785990613,1.14290031678847,1.30877306107478,5.76494304718203e-09
sensitivity,Circulatory system disorders,I63 (cerebral infarction),0.362947767082215,COLEC12;Collectin-12,0.397119505233458,1.48753368749022,1.28884446411623,1.71685298965501,5.6747234425749e-08
sensitivity,Circulatory system disorders,"I64 (stroke, not specified as haemorrhage or infarction)",1.56028089001104,COLEC12;Collectin-12,0.356871299821953,1.42885196451757,1.33183928076288,1.53293116218667,2.57041795272957e-23
sensitivity,Circulatory system disorders,I67 (other cerebrovascular diseases),0.357030140445005,COLEC12;Collectin-12,0.488713197314542,1.63021710192503,1.41050449940186,1.88415407433004,3.67499942536737e-11
sensitivity,Circulatory system disorders,I70 (atherosclerosis),0.175556256903897,COLEC12;Collectin-12,0.719212776498228,2.05281654895817,1.6862270798756,2.4991033734243,7.73898577046289e-13
sensitivity,Circulatory system disorders,I71 (aortic aneurysm and dissection),0.173583714691494,COLEC12;Collectin-12,0.588647583319809,1.80155032040578,1.47651166101939,2.19814285429577,6.68546209023427e-09
sensitivity,Circulatory system disorders,I73 (other peripheral vascular diseases),1.38866971753195,COLEC12;Collectin-12,0.28268699999614,1.32668984289718,1.23063482055416,1.43024226996436,1.68086270433226e-13
sensitivity,Circulatory system disorders,I74 (arterial embolism and thrombosis),0.151885750355057,COLEC12;Collectin-12,0.67695433316412,1.96787510392636,1.58803976993791,2.43856136222871,6.13568404268085e-10
sensitivity,Circulatory system disorders,I77 (other disorders of arteries and arterioles),0.240650149913208,COLEC12;Collectin-12,0.551622441307104,1.73606740162811,1.46014280736775,2.06413373252791,4.20300260234074e-10
sensitivity,Circulatory system disorders,I80 (phlebitis and thrombophlebitis),2.56035979169954,COLEC12;Collectin-12,0.212342820476977,1.23657173453406,1.16928728712238,1.30772793947989,1.01669714379245e-13
sensitivity,Circulatory system disorders,I95 (hypotension),0.524696228499289,COLEC12;Collectin-12,0.402243724496873,1.49517569921674,1.32473588800016,1.68754420543636,7.32166321365846e-11
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0330129138751335,CDH3;Cadherin-3,1.31711951259649,3.73265401420939,2.32135858556393,6.00196198744916,5.47565252158225e-08
primary,Nervous system disorders,G35 (multiple sclerosis),0.666000666000666,CHRDL2;Chordin-like protein 2,-0.277164059048298,0.757930141612255,0.682390659972583,0.841831714970209,2.28913472336187e-07
primary,Nervous system disorders,G40 (epilepsy),1.21565200504903,OXT;Oxytocin-neurophysin 1,-0.406616420337126,0.665899566851124,0.615070226079389,0.720929439161766,1.04926340163914e-23
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0336767036450079,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,0.995002912311546,2.70473221829085,1.74031671020901,4.20358911096241,9.74309232923839e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349623183901794,KLK4;Kallikrein-4,1.31750321772898,3.73408652752625,2.46066138400138,5.66652619726941,5.96387134729883e-10
primary,Nervous system disorders,G62 (other polyneuropathies),0.337969077771734,KLK4;Kallikrein-4,0.373138361536191,1.45228526635264,1.25672819412917,1.67827260080407,4.26512092257786e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,KLK4;Kallikrein-4,0.880891485895342,2.41304994781309,1.74717880400851,3.33269270281991,8.93819466881748e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,CCN5;CCN family member 5,1.36308278401176,3.90822295710021,2.54804975793955,5.99446954864665,4.22116050300748e-10
primary,Nervous system disorders,G62 (other polyneuropathies),0.330970193098586,CCN5;CCN family member 5,0.358850916258755,1.43168334495125,1.22381505221076,1.67485862876755,7.34877563199953e-06
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0522003585937677,SRPX;Sushi repeat-containing protein SRPX,0.913425126316093,2.4928462409261,1.69575771667778,3.66460510235742,3.37592824916375e-06
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936213192448139,ANGPT2;Angiopoietin-2,0.25409656006905,1.28929629279645,1.17873857094162,1.41022358273284,2.77524786889496e-08
primary,Nervous system disorders,G47 (sleep disorders),2.03364151969543,ANGPT2;Angiopoietin-2,0.227507469804088,1.25546681781027,1.18075427643349,1.33490681514497,3.65490013268896e-13
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349623183901794,ANGPT2;Angiopoietin-2,1.11154459300702,3.03904886469379,1.93611034591066,4.77029525796604,1.35146550176394e-06
primary,Nervous system disorders,G62 (other polyneuropathies),0.337969077771734,ANGPT2;Angiopoietin-2,0.383072046964008,1.46678370357432,1.2654560925443,1.70014151083308,3.66828573349904e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,ANGPT2;Angiopoietin-2,1.06564088494682,2.90269868396087,2.07476868060171,4.06101158584321,4.97188974986414e-10
primary,Nervous system disorders,G40 (epilepsy),1.20943553224838,GDF15;Growth/differentiation factor 15,0.394666644073892,1.48388944512205,1.37926507447376,1.59645011397446,3.70750318940232e-26
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.948197457282737,GDF15;Growth/differentiation factor 15,0.326527946071305,1.38614698658426,1.27464625011214,1.50740134233131,2.31799768485538e-14
primary,Nervous system disorders,G46 (vascular syndromes of brain in cerebrovascular diseases),0.0174158716643768,GDF15;Growth/differentiation factor 15,0.988724786079883,2.68780475996109,1.76060104680092,4.10331144627926,4.6389192365618e-06
primary,Nervous system disorders,G47 (sleep disorders),2.04539737213847,GDF15;Growth/differentiation factor 15,0.19379573023315,1.21384830511963,1.14391774307043,1.28805389790258,1.54053398960486e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.036766840180351,GDF15;Growth/differentiation factor 15,1.22078250084686,3.38983924816227,2.57169196127229,4.46826847905082,4.62302960210913e-18
primary,Nervous system disorders,G62 (other polyneuropathies),0.334771755326354,GDF15;Growth/differentiation factor 15,0.550882568237076,1.73478340716493,1.52240460520796,1.9767895206568,1.36405035477763e-16
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.05998800239952,GDF15;Growth/differentiation factor 15,1.06478925113712,2.90022769995832,2.2964068424351,3.66281817149012,3.89730918960522e-19
primary,Nervous system disorders,G72 (other myopathies),0.036766840180351,GDF15;Growth/differentiation factor 15,0.821199255927539,2.27322438130714,1.62337243920892,3.18321844264364,1.74969321582778e-06
primary,Nervous system disorders,G81 (hemiplegia),0.234146719043288,GDF15;Growth/differentiation factor 15,0.595452249986873,1.81385107361882,1.55903172403693,2.11031992905759,1.26675030208259e-14
primary,Nervous system disorders,G20 (parkinson's disease),0.297876210832689,VGF;Neurosecretory protein VGF,-0.590729002461297,0.553923326040902,0.465727978919777,0.658820309322811,2.45307982470221e-11
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0279739841946989,PRRT3;Proline-rich transmembrane protein 3,1.18539422452245,3.27197646060321,1.93715150786142,5.52658370565995,9.32114193792336e-06
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0534150816321791,C7;Complement component C7,1.0768909295429,2.93553855223571,1.99594194962671,4.31745351776078,4.46892859348492e-08
primary,Nervous system disorders,G35 (multiple sclerosis),0.682640586797066,KLK6;Kallikrein-6,-0.30750071488821,0.735282341902935,0.660946984475377,0.81797804515803,1.56057943290648e-08
primary,Nervous system disorders,G40 (epilepsy),1.21070103495411,PLA2G15;Phospholipase A2 group XV,0.25659137708314,1.29251686682493,1.1942154124201,1.39890997357121,2.04741530846395e-10
primary,Nervous system disorders,G35 (multiple sclerosis),0.681133212778782,GFAP;Glial fibrillary acidic protein,0.337124227656178,1.40091308507824,1.25627121997081,1.56220841546386,1.33389413875417e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0368245600434142,SPP1;Osteopontin,1.21069720599867,3.35582353741278,2.19205328143546,5.13744429007628,2.51698395004088e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351493848857645,SEZ6L;Seizure 6-like protein,1.18026864421854,3.2552485891484,2.1237447174226,4.98960317133258,6.08061900961735e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0624877953524702,SEZ6L;Seizure 6-like protein,0.863238571603511,2.37082636503569,1.69147721231549,3.32302298382956,5.41305483413281e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.950529271980989,TFPI;Tissue factor pathway inhibitor,-0.332598844418927,0.717057788200552,0.654951735616394,0.785053071330768,6.22008680410153e-13
primary,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.132079869474011,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.752316220088717,2.12190913768665,1.73037496768841,2.60203624802373,4.87352985354088e-13
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936213192448139,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.311712424607152,1.36576187704175,1.25245271084465,1.48932210264661,1.73732826560677e-12
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349623183901794,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.48847227568078,4.43032203559769,3.21509830185713,6.10486880844822,9.09525379629985e-20
primary,Nervous system disorders,G62 (other polyneuropathies),0.337969077771734,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.657686222207457,1.93032082989429,1.69143889220885,2.2029400668787,1.71188829159247e-22
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.16251489462824,3.19796571831606,2.47139087345604,4.13814943049585,9.53186498841088e-19
primary,Nervous system disorders,G71 (primary disorders of muscles),0.0330199673685028,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.06364439779345,2.89690926450203,2.0110081989868,4.17307263639496,1.12056266054663e-08
primary,Nervous system disorders,G81 (hemiplegia),0.236966824644549,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.466697150467982,1.59471837056532,1.34963457568239,1.88430759498933,4.21041694110169e-08
primary,Nervous system disorders,G20 (parkinson's disease),0.298191234747126,ITGA11;Integrin alpha-11,-0.402544680554391,0.668616464104461,0.569921788510654,0.784402325167806,7.81264269098027e-07
primary,Nervous system disorders,G35 (multiple sclerosis),0.674853847059285,ITGA11;Integrin alpha-11,-0.348503593536718,0.705743378904625,0.63494920903296,0.784430801364874,1.03470638675293e-10
primary,Nervous system disorders,G81 (hemiplegia),0.237375917134225,ITGA11;Integrin alpha-11,-0.646013653737639,0.524130985412516,0.438513143521521,0.626465349848773,1.25439826285352e-12
primary,Nervous system disorders,G40 (epilepsy),1.21164784106384,CHI3L1;Chitinase-3-like protein 1,0.203052160597267,1.22513637042571,1.13084496963038,1.3272899172293,6.72021296671328e-07
primary,Nervous system disorders,G40 (epilepsy),1.21107601681942,FLT3LG;Fms-related tyrosine kinase 3 ligand,0.22447561729264,1.25166619196547,1.15670838432108,1.35441938291896,2.45519683345596e-08
primary,Nervous system disorders,G40 (epilepsy),1.20453564562325,COL9A1;Collagen alpha-1(IX) chain,0.23499772287735,1.26490588838376,1.1675766627959,1.37034848113233,8.79356073410432e-09
primary,Nervous system disorders,G55 (nerve root and plexus compressions in diseases classified elsewhere),0.45121042099894,COL9A1;Collagen alpha-1(IX) chain,0.332662181532141,1.39467607154605,1.22453604975563,1.58845576243451,5.39879199000784e-07
primary,Nervous system disorders,G95 (other diseases of spinal cord),0.184407737277827,COL9A1;Collagen alpha-1(IX) chain,0.543413719620368,1.72187483859355,1.40716063105154,2.10697548976054,1.31448013445519e-07
primary,Nervous system disorders,G40 (epilepsy),1.21421017586463,TIMP4;Metalloproteinase inhibitor 4,0.237183604898748,1.26767384753789,1.16880702999689,1.37490359185791,1.03424187949984e-08
primary,Nervous system disorders,G56 (mononeuropathies of upper limb),2.8859827027531,FSHB;Follitropin subunit beta,0.206677992423318,1.22958657183436,1.13844552983561,1.32802413291894,1.44192107903264e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.950475237618809,OCLN;Occludin,0.316633290998593,1.37249917182969,1.24726095823378,1.51031262883488,8.82218232902152e-11
primary,Nervous system disorders,G81 (hemiplegia),0.247851198326435,OCLN;Occludin,0.482794686328286,1.62059714010344,1.34861236739198,1.94743512221411,2.596567116452e-07
primary,Nervous system disorders,G35 (multiple sclerosis),0.680928108948497,OMG;Oligodendrocyte-myelin glycoprotein,-0.425953709497451,0.653146575904138,0.586317143874094,0.72759334103133,1.03913200996631e-14
primary,Nervous system disorders,G81 (hemiplegia),0.238128038100486,OMG;Oligodendrocyte-myelin glycoprotein,-0.515100464438821,0.59744057007152,0.49906652232844,0.715205726687635,2.00689863431721e-08
primary,Nervous system disorders,G91 (hydrocephalus),0.0472320075571212,OMG;Oligodendrocyte-myelin glycoprotein,-1.07151787810017,0.342488267240005,0.229990777234039,0.51001268228116,1.33410308851704e-07
primary,Nervous system disorders,G40 (epilepsy),1.20745794247616,IGFBP2;Insulin-like growth factor-binding protein 2,0.358217854348792,1.4307772875839,1.3251667289289,1.54480459098197,5.37529683827901e-20
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0368245600434142,IGFBP2;Insulin-like growth factor-binding protein 2,1.39060910768458,4.0172962739443,2.83915144886149,5.68432844930426,4.08664425453913e-15
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0600821769129389,IGFBP2;Insulin-like growth factor-binding protein 2,0.912129604703957,2.4896187958091,1.84106666337291,3.36663623960829,3.14394567584269e-09
primary,Nervous system disorders,G91 (hydrocephalus),0.047011811717694,APLP1;Amyloid-like protein 1,-0.909053143731283,0.402905537114324,0.270072145030806,0.601072249857036,8.4232599298245e-06
primary,Nervous system disorders,G40 (epilepsy),1.20638419302147,DPP6;Dipeptidyl aminopeptidase-like protein 6,-0.244353664248172,0.783210591690652,0.722069656047633,0.849528609599898,3.80907583609452e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0570720091315214,DPP6;Dipeptidyl aminopeptidase-like protein 6,0.924291812834846,2.5200829378698,1.76578977632572,3.59658782652902,3.52283008285624e-07
primary,Nervous system disorders,G35 (multiple sclerosis),0.686950265729072,CHAD;Chondroadherin,-0.253656269164413,0.775958477067339,0.693984380968468,0.867615431477588,8.47435080781299e-06
primary,Nervous system disorders,G40 (epilepsy),1.20554069697816,DPP4;Dipeptidyl peptidase 4,0.233105109955947,1.26251417516264,1.16430006015531,1.36901310670205,1.68566758578396e-08
primary,Nervous system disorders,G40 (epilepsy),1.21565200504903,NCAN;Neurocan core protein,-0.225285540398404,0.79828824266988,0.734947799256763,0.867087593199704,9.23756303438653e-08
primary,Nervous system disorders,G81 (hemiplegia),0.231090397125934,NCAN;Neurocan core protein,-0.452011082848334,0.636347117147418,0.527346334685919,0.767878008942653,2.41459801203601e-06
primary,Nervous system disorders,G91 (hydrocephalus),0.0466064666472473,NCAN;Neurocan core protein,-1.19907425419066,0.30147317029403,0.200258677028712,0.453843367766292,9.18827046016999e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94395049155928,OGN;Mimecan,0.314228304594974,1.36920229604226,1.25051158109982,1.49915838911192,1.10524674725974e-11
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,OGN;Mimecan,1.56911507033049,4.80239652966695,3.11098714934836,7.41340652371002,1.40720846896831e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.330970193098586,OGN;Mimecan,0.468071143681271,1.59691100877365,1.37395158014717,1.85605141170209,1.05700977265043e-09
primary,Nervous system disorders,G35 (multiple sclerosis),0.673274364239456,BCAN;Brevican core protein,-0.29157791780366,0.747083800206207,0.670121851237227,0.83288465150044,1.46770574237673e-07
primary,Nervous system disorders,G81 (hemiplegia),0.236929395040278,BCAN;Brevican core protein,-0.574704130805414,0.562871380474901,0.469187198713718,0.675261797053069,6.1191332093846e-10
primary,Nervous system disorders,G91 (hydrocephalus),0.0473858790080556,BCAN;Brevican core protein,-1.05131606341003,0.349477511760958,0.233875644923994,0.522219965513391,2.89440366941992e-07
primary,Nervous system disorders,G35 (multiple sclerosis),0.693468703258849,TF;Serotransferrin,-0.333698399930946,0.716269776667705,0.640328871329704,0.801217024467792,5.35625503021331e-09
primary,Nervous system disorders,G40 (epilepsy),1.20337216153741,TF;Serotransferrin,-0.278260786464436,0.757099354503204,0.694872720825541,0.824898453213391,2.03126860828832e-10
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.951253207025853,PTGDS;Prostaglandin-H2 D-isomerase,0.266457672529303,1.30533233674976,1.18860616737156,1.43352151127779,2.47501831268956e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374975330570357,PTGDS;Prostaglandin-H2 D-isomerase,1.61333341906563,5.0195155198973,3.27867344128839,7.6846738492471,1.13163468580544e-13
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0611801855141109,PTGDS;Prostaglandin-H2 D-isomerase,0.912517309253773,2.49058421948103,1.74416151763662,3.55644227418407,5.15513141122533e-07
primary,Nervous system disorders,G81 (hemiplegia),0.247851198326435,LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,-0.460386049674155,0.6310399856967,0.520687297987213,0.764780445168206,2.67495469314193e-06
primary,Nervous system disorders,G91 (hydrocephalus),0.0454772840965937,LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,-1.07244404024019,0.342171214417311,0.222418017178488,0.526401329627271,1.06237446719865e-06
primary,Nervous system disorders,G81 (hemiplegia),0.247339399577934,BGLAP;Osteocalcin,0.42827455518228,1.53460735753587,1.27108955565431,1.85275674033129,8.37268164490606e-06
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0536168030398396,DMP1;Dentin matrix acidic phosphoprotein 1,-0.92810824822999,0.395300814496529,0.264934389506134,0.589816724936727,5.47338095479973e-06
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.954480152716824,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.271497653594012,1.31192779353764,1.17892619722694,1.459934081968,6.42163380205283e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0354240056678409,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1.32405175341073,3.75861956645944,2.36964985952541,5.96173353990835,1.84978632583755e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94785803627267,CST3;Cystatin-C,0.246406420120434,1.27941944969735,1.16860367509172,1.40074360808029,9.78157821753278e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0371325828642901,CST3;Cystatin-C,1.46974304299659,4.34811771820477,2.9871575839208,6.32913636466108,1.67879830129599e-14
primary,Nervous system disorders,G62 (other polyneuropathies),0.330284552845528,CST3;Cystatin-C,0.398865577734785,1.49013329805053,1.28079146403065,1.73369147774537,2.41746114886859e-07
primary,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.131326198596573,MEGF10;Multiple epidermal growth factor-like domains protein 10,0.613509712268445,1.84690213200481,1.45871461645058,2.33839261411108,3.46633328708063e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0330129138751335,SCARA5;Scavenger receptor class A member 5,1.67934418324227,5.36203830320048,3.36884102075492,8.53452406565218,1.42277071115144e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.332071074861637,SCARA5;Scavenger receptor class A member 5,0.374396389799599,1.45411343196514,1.25232300835915,1.68841892938777,9.02459326125106e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0543742110884551,SCARA5;Scavenger receptor class A member 5,1.08729165263961,2.96622960375479,2.06123448682067,4.26856726803678,4.77712073950668e-09
primary,Nervous system disorders,G40 (epilepsy),1.21130825356177,EPHA2;Ephrin type-A receptor 2,0.226433246656889,1.25411889041106,1.15677892484744,1.35964976323657,3.95158506943952e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0345507387760908,EPHA2;Ephrin type-A receptor 2,1.61237648932775,5.01471449371529,3.26138236674928,7.71064494303481,2.05064100140195e-13
primary,Nervous system disorders,G62 (other polyneuropathies),0.337377802166534,EPHA2;Ephrin type-A receptor 2,0.477758860173808,1.61245660899252,1.38628217568087,1.87553180838284,5.79948399611997e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0569070991606202,EPHA2;Ephrin type-A receptor 2,1.415721758023,4.11945864557486,2.9346626425005,5.78258614357869,2.79115714296333e-16
primary,Nervous system disorders,G40 (epilepsy),1.20337216153741,AFM;Afamin,-0.267719727369006,0.765122193864751,0.703435680368025,0.83221819404744,4.31220389504772e-10
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.951666403411783,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.301023464101558,1.35124104682319,1.23768183326413,1.47521949304575,1.80433180818673e-11
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.033564997630706,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,1.22666636293602,3.40984338789094,2.30097494441971,5.05308932552319,9.81272803577567e-10
primary,Nervous system disorders,G62 (other polyneuropathies),0.331701153056389,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.453746229297594,1.57419846133262,1.3615709356149,1.82003062113164,8.85677592859987e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0513347022587269,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.934209223867362,2.54519997834254,1.81741193238682,3.564432924817,5.43135071262802e-08
primary,Nervous system disorders,G81 (hemiplegia),0.236929395040278,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,0.451109238690555,1.57005278323589,1.32201808990442,1.8646233065729,2.71897136416112e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.033564997630706,GGT5;Glutathione hydrolase 5 proenzyme,1.25014086259043,3.49083465084211,2.21919864805079,5.49113824047403,6.33911230116694e-08
primary,Nervous system disorders,G62 (other polyneuropathies),0.331701153056389,GGT5;Glutathione hydrolase 5 proenzyme,0.426403811715552,1.53173918449224,1.31970809772524,1.77783627557722,2.03238438600651e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0513347022587269,GGT5;Glutathione hydrolase 5 proenzyme,1.07702063930542,2.93591934493992,2.02005230739976,4.26702930830922,1.64484788795899e-08
primary,Nervous system disorders,G72 (other myopathies),0.0355394092560416,GGT5;Glutathione hydrolase 5 proenzyme,1.10531861379537,3.02018658863784,1.92579570614943,4.73649775054596,1.47636309323101e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.036766840180351,DPT;Dermatopontin,1.45430906559767,4.28152419102956,2.80833624767,6.52751229970429,1.38926324340892e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.05998800239952,DPT;Dermatopontin,0.841915816861768,2.32080896535291,1.6405147288926,3.28320993332275,1.96788817359061e-06
primary,Nervous system disorders,G20 (parkinson's disease),0.299380352294089,GHR;Growth hormone receptor,-0.431136413485986,0.649770267301551,0.545081026138094,0.774566312205787,1.5106001830569e-06
primary,Nervous system disorders,G40 (epilepsy),1.19287985332683,GHR;Growth hormone receptor,-0.269255153574805,0.763948306636882,0.69947379638126,0.834365802168305,2.16054994764009e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.954480152716824,TAFA5;Chemokine-like protein TAFA-5,0.244998327383955,1.27761917623676,1.16802841198807,1.39749234071249,8.58443769837441e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0354240056678409,TAFA5;Chemokine-like protein TAFA-5,1.50175725704548,4.48957147370863,2.88891932540956,6.9770906512527,2.45133606670287e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0570720091315214,TAFA5;Chemokine-like protein TAFA-5,1.02441754206053,2.78547256736618,1.94471400174038,3.98971643984973,2.29558157561543e-08
primary,Nervous system disorders,G20 (parkinson's disease),0.294622648872239,AOC3;Membrane primary amine oxidase,-0.401085397662655,0.669592876929654,0.569328356657942,0.787515000072808,1.25854367661608e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370717240302817,AOC3;Membrane primary amine oxidase,1.41150683249816,4.10213197514537,2.70293598083498,6.22563274188677,3.32015732708574e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.33169437290252,AOC3;Membrane primary amine oxidase,0.430553307291676,1.53810833470354,1.32187179063097,1.7897176307509,2.54849165392472e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604854444704596,AOC3;Membrane primary amine oxidase,1.34861267262252,3.85207772908518,2.76947176965956,5.35788195910661,1.13907924729364e-15
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352243596015733,SPON1;Spondin-1,1.37624398568619,3.95999984326242,2.5616549091966,6.12166717005476,5.92220484610733e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0606641748693763,SPON1;Spondin-1,0.961165370929138,2.61474184271674,1.86529015423652,3.66531442227663,2.43768022004024e-08
primary,Nervous system disorders,G35 (multiple sclerosis),0.675649210763385,ITGAM;Integrin alpha-M,-0.482943235944478,0.616964843806235,0.554306388624587,0.686706172442567,9.70369302038345e-19
primary,Nervous system disorders,G81 (hemiplegia),0.231091614116172,ITGAM;Integrin alpha-M,-0.619245888769829,0.538350260534858,0.448579131301836,0.64608668302703,2.86848316886766e-11
primary,Nervous system disorders,G40 (epilepsy),1.2137716397588,AMBP;Protein AMBP,0.348484998327741,1.41691928660523,1.30982423780301,1.53277073885987,3.60285461296184e-18
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0350126434545808,AMBP;Protein AMBP,1.39558814455599,4.03734841897464,2.69642967381103,6.04509823286395,1.23326298412525e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.338455553394281,AMBP;Protein AMBP,0.421744489281728,1.52461891843617,1.31594686665139,1.76638047124834,1.95459216975682e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0622446994748103,AMBP;Protein AMBP,1.06757814550136,2.90832741802487,2.1126036987628,4.00376482129075,5.91726946577242e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0570720091315214,IL12A_IL12B;Interleukin-12,1.04124427155751,2.83273951963465,1.97096788282438,4.07130590814146,1.84020958737105e-08
primary,Nervous system disorders,G40 (epilepsy),1.21447180270709,CDHR5;Cadherin-related family member 5,-0.399875006362466,0.670403837013065,0.619583879579166,0.72539218577977,2.73595722445991e-23
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370717240302817,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,1.23550911758454,3.44012950536305,2.24680765242598,5.26724706536013,1.31261542299131e-08
primary,Nervous system disorders,G81 (hemiplegia),0.234137204401779,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.569350892349939,1.76711962820418,1.46961143932686,2.12485538477762,1.42079881888236e-09
primary,Nervous system disorders,G40 (epilepsy),1.20520283791158,BPIFB2;BPI fold-containing family B member 2,-0.256766550641367,0.773548777154323,0.708877640916514,0.84411988204805,8.20175584681964e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.951823678564462,AGRN;Agrin,0.216167524702208,1.24131031172357,1.1357326952513,1.35670241460321,1.87573117676659e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351082504388531,AGRN;Agrin,1.3220794757291,3.75121383045933,2.45276891582334,5.73702851134911,1.06741441134585e-09
primary,Nervous system disorders,G62 (other polyneuropathies),0.329627462453676,AGRN;Agrin,0.477059809573088,1.61132981412057,1.38807978718401,1.87048597194913,3.6226489604387e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604642090891359,AGRN;Agrin,0.989999906510303,2.69123422074657,1.92633659521779,3.75985258697667,6.51877136118444e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.954871429137446,VWC2;Brorin,0.253022050974504,1.28791167622904,1.17618897928693,1.41024658024998,4.62727163035315e-08
primary,Nervous system disorders,G62 (other polyneuropathies),0.337969077771734,NPY;Pro-neuropeptide Y,0.391932793740933,1.47983825366718,1.27399426471648,1.7189412210612,2.91549919091639e-07
primary,Nervous system disorders,G40 (epilepsy),1.21421017586463,PAMR1;Inactive serine protease PAMR1,-0.267083897416916,0.765608836167101,0.707401939990531,0.828605149181509,3.58714237105455e-11
primary,Nervous system disorders,G40 (epilepsy),1.1898532590149,PALM2;Paralemmin-2,0.219308011941224,1.24521475864103,1.14382976530818,1.35558615640649,4.16403231990182e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0546012967807985,PALM2;Paralemmin-2,0.978839927922251,2.66136707281662,1.90069356119227,3.72646850649064,1.2032865272038e-08
primary,Nervous system disorders,G81 (hemiplegia),0.24343078148106,PALM2;Paralemmin-2,0.44075179776551,1.55387497923365,1.29641318413138,1.86246752242507,1.85390258732543e-06
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.953904375475489,COL18A1;Collagen alpha-1(XVIII) chain,0.232744007663726,1.26205836070281,1.1543614227465,1.37980295809802,3.15071088428787e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370637691902541,COL18A1;Collagen alpha-1(XVIII) chain,1.4903777667097,4.43877202262222,2.93972341598862,6.70222816257285,1.3513820138953e-12
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0585217408267171,COL18A1;Collagen alpha-1(XVIII) chain,0.914239419372312,2.49487697500442,1.76386658763312,3.52884462127012,2.36721716138644e-07
primary,Nervous system disorders,G40 (epilepsy),1.21432668156557,LAYN;Layilin,0.196639550387839,1.21730518443626,1.12407683459329,1.31826567940219,1.31758159050177e-06
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.953266222336491,LAYN;Layilin,0.230635908148453,1.2594006184612,1.15169908520593,1.37717389737862,4.27042004083679e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0336214227795028,LAYN;Layilin,1.56713653090574,4.79290419237806,3.10767256785905,7.39200481894433,1.34783874238341e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.332258766291557,LAYN;Layilin,0.52258014625765,1.68637313062198,1.45418399499572,1.9556358380166,4.70474003020287e-12
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0514209995451219,LAYN;Layilin,1.21882618119131,3.3832141215576,2.36047274482929,4.84908703876372,3.21506108934768e-11
primary,Nervous system disorders,G35 (multiple sclerosis),0.683561510826293,RGMB;RGM domain family member B,-0.26193274824035,0.7695627764182,0.690834543871107,0.85726296130175,1.96554810327278e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0330129138751335,RGMB;RGM domain family member B,1.35503407071161,3.87689304288784,2.36837021279266,6.34626275267546,7.08938590795558e-08
primary,Nervous system disorders,G40 (epilepsy),1.21421017586463,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.221522234084357,1.24797499549362,1.15316904347864,1.35057526750729,3.90024785449525e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94395049155928,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.23454255972091,1.26433028083461,1.15620722163525,1.3825644997914,2.71622341355704e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.37363818359339,3.94969430031744,2.55959613023436,6.09474474573914,5.42000210578056e-10
primary,Nervous system disorders,G62 (other polyneuropathies),0.330970193098586,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.409236908991776,1.50566838461437,1.29683583881039,1.74812972974809,7.78723602871243e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0548352982648544,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.894553423700426,2.44624311130188,1.71659892195995,3.48602418598718,7.42558996089065e-07
primary,Nervous system disorders,G81 (hemiplegia),0.231091614116172,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,0.458348279148878,1.58145969659543,1.32296843620653,1.89045687221918,4.8137804405894e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.036766840180351,CCL15;C-C motif chemokine 15,1.52994446227482,4.61792034638672,2.97380058031912,7.17102164371898,9.52678887412651e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.334771755326354,CCL15;C-C motif chemokine 15,0.398193782538511,1.48913256983893,1.28292497695147,1.72848440118802,1.64013315946932e-07
primary,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.128795959026785,NEFL;Neurofilament light polypeptide,0.610213703797501,1.84082474798921,1.4793686448228,2.29059590026353,4.46976897255972e-08
primary,Nervous system disorders,G35 (multiple sclerosis),0.692278279768972,NEFL;Neurofilament light polypeptide,0.393426867139389,1.4820508931473,1.33755166600591,1.64216075214324,5.62012085036453e-14
primary,Nervous system disorders,G40 (epilepsy),1.21349942645549,NEFL;Neurofilament light polypeptide,0.241863784511808,1.27362069413523,1.17779118821165,1.37724724786956,1.35980101548903e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0342114266164899,NEFL;Neurofilament light polypeptide,1.23887593810443,3.45173132363336,2.45024876741764,4.86254672953414,1.38403487449701e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.332052081865931,NEFL;Neurofilament light polypeptide,0.565100165977396,1.75962402835541,1.53227058172967,2.02071145794011,1.1884861629422e-15
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0563482320742186,NEFL;Neurofilament light polypeptide,0.863426526250408,2.37127201474764,1.74848636191502,3.21588494506004,2.78607493431371e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351082504388531,IL10RB;Interleukin-10 receptor subunit beta,1.14403863064134,3.139421761713,2.03292778592403,4.84816483210067,2.471424603308e-07
primary,Nervous system disorders,G35 (multiple sclerosis),0.68015210317927,MEPE;Matrix extracellular phosphoglycoprotein,-0.287691457779474,0.749992961037261,0.671031812820152,0.838245565797333,4.00809921540159e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.942292051022634,IGFBP4;Insulin-like growth factor-binding protein 4,0.276517327956216,1.31852979994645,1.20479454879318,1.44300190857293,1.87919707294361e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0337241365629153,IGFBP4;Insulin-like growth factor-binding protein 4,1.50397079801818,4.49952033115508,3.01167346440173,6.72240315883641,2.10034660368546e-13
primary,Nervous system disorders,G62 (other polyneuropathies),0.333273820151163,IGFBP4;Insulin-like growth factor-binding protein 4,0.400254055486061,1.49220375203833,1.28432431616108,1.73373034332397,1.70293274884345e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0535618639528655,IGFBP4;Insulin-like growth factor-binding protein 4,0.893683303707569,2.44411551203091,1.71553046122947,3.48213032129371,7.4775372664689e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0570720091315214,VMO1;Vitelline membrane outer layer protein 1 homolog,0.946067850878462,2.57556222703367,1.78539442248719,3.71543716154419,4.1847272077426e-07
primary,Nervous system disorders,G40 (epilepsy),1.21366526911272,"NOS3;Nitric oxide synthase, endothelial",0.285795390446727,1.33082012888089,1.22782957742838,1.44244954511032,3.54372145395081e-12
primary,Nervous system disorders,G81 (hemiplegia),0.228690645750165,"NOS3;Nitric oxide synthase, endothelial",0.539702655200462,1.71549669232035,1.43355074994407,2.05289481483433,3.82844096533338e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936213192448139,CLMP;CXADR-like membrane protein,0.249886146537678,1.28387923427018,1.1698444015358,1.40903002657977,1.39846977105656e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349623183901794,CLMP;CXADR-like membrane protein,1.20945477828979,3.3516567582607,2.31928463866903,4.84356376009169,1.20966968067641e-10
primary,Nervous system disorders,G62 (other polyneuropathies),0.337969077771734,CLMP;CXADR-like membrane protein,0.411136403174827,1.50853111095782,1.29894596546117,1.75193285420436,7.16234503825339e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,CLMP;CXADR-like membrane protein,0.989337059957699,2.6894509365083,1.98665360645032,3.64086940793332,1.53379846874192e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352229810382952,SCGB1A1;Uteroglobin,1.22670279302544,3.40996761105317,2.15031214317725,5.40753078353107,1.84441733573345e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0368874737904791,FAS;Tumor necrosis factor receptor superfamily member 6,1.01215431644893,2.7515222842996,1.85495091071687,4.08144217577779,4.87396460565988e-07
primary,Nervous system disorders,G40 (epilepsy),1.20775774603917,IL18BP;Interleukin-18-binding protein,0.264121428751892,1.30228632170286,1.20316562665419,1.40957290178787,6.18978556817369e-11
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370717240302817,IL18BP;Interleukin-18-binding protein,1.53245955552522,4.6295494647091,3.03993357215934,7.05039361467497,9.28302945380652e-13
primary,Nervous system disorders,G62 (other polyneuropathies),0.33169437290252,IL18BP;Interleukin-18-binding protein,0.405553065976118,1.50013194260454,1.29164742042669,1.74226790502864,1.0838705227235e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604854444704596,IL18BP;Interleukin-18-binding protein,0.972866932946403,2.64551812063746,1.88440733112944,3.71404102022167,1.90374944852456e-08
primary,Nervous system disorders,G40 (epilepsy),1.21318509849814,CSF1;Macrophage colony-stimulating factor 1,0.278866757077883,1.32163123412951,1.2212260680335,1.43029138072639,4.5938628621398e-12
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351082504388531,CSF1;Macrophage colony-stimulating factor 1,1.28546537729686,3.61635053310637,2.36355213558029,5.53319344279574,3.1424778822065e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604642090891359,CSF1;Macrophage colony-stimulating factor 1,0.896391368119372,2.45074330446131,1.74778554183189,3.43643004282252,2.02235353439894e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353121199042649,CD83;CD83 antigen,1.19838128957498,3.3147469622395,2.15887152076012,5.08948648310823,4.31058826679529e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.056891748734649,CD83;CD83 antigen,0.890385467602136,2.43606849581289,1.72079894905306,3.44864791994309,5.15264856526271e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.9512344338971,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.255179955768824,1.29069386778247,1.17966417431649,1.41217364789136,2.69419907503414e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374967930374375,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,1.3178304295665,3.73530856476196,2.56933452578383,5.43040617481584,5.10005488951626e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.333524106490892,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.378895076667524,1.46066976936311,1.2567799381015199,1.69763704086032,7.83091151658122e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351082504388531,BTN2A1;Butyrophilin subfamily 2 member A1,1.60190590865583,4.9624814533982,3.16555945215741,7.77942178863129,2.87627596429501e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.329627462453676,BTN2A1;Butyrophilin subfamily 2 member A1,0.44934092789708,1.56727889522384,1.348096980956,1.8220967557335,5.03336721524278e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604642090891359,BTN2A1;Butyrophilin subfamily 2 member A1,1.03371635331609,2.81149495214178,1.98528351971773,3.98154912757375,5.78930207214943e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0361083249749247,CD28;T-cell-specific surface glycoprotein CD28,1.11497908509158,3.04950439841051,1.97015945730318,4.72016467573364,5.66563652552527e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0561685055165496,CD28;T-cell-specific surface glycoprotein CD28,1.06004698458187,2.88650660738799,2.02587025259476,4.11276111282195,4.40314182492056e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94395049155928,RELT;Tumor necrosis factor receptor superfamily member 19L,0.261355103357316,1.29868875229814,1.17867538454476,1.43092194633141,1.27181577324686e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,RELT;Tumor necrosis factor receptor superfamily member 19L,1.35673455835408,3.88349126010188,2.44854852283914,6.15936512044302,8.15454100638574e-09
primary,Nervous system disorders,G35 (multiple sclerosis),0.69436565386099,COL15A1;Collagen alpha-1(XV) chain,-0.297084600010991,0.742981153489294,0.662689059191924,0.833001521276677,3.55458374398366e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94624339104586,COL15A1;Collagen alpha-1(XV) chain,0.264864022867688,1.30325375102164,1.18064088008242,1.43860031293631,1.48879982659418e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0330129138751335,CD74;HLA class II histocompatibility antigen gamma chain,1.24539774094803,3.47431640245824,2.27844971764946,5.29784544766831,7.22786796661326e-09
primary,Nervous system disorders,G62 (other polyneuropathies),0.332071074861637,CD74;HLA class II histocompatibility antigen gamma chain,0.452435643563557,1.57213669064539,1.35715213735974,1.82117664338047,1.63524087538654e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.947149816586767,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.255135991766253,1.29063712496127,1.1807010821538,1.41080940257097,1.94435695464714e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349358538904955,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.44082216044011,4.22416733300306,2.7315117875225,6.53249593822711,9.32778567811585e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.333831492731401,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.388017893611895,1.474056160241,1.26997940366802,1.71092661602914,3.33525983141703e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.06016730392252,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.0357155343239,2.81712126158523,2.0021285763691,3.96386740399459,2.77843443283428e-09
primary,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.132079869474011,HSPB6;Heat shock protein beta-6,0.674379579562381,1.96281482769251,1.57369339636719,2.44815289731994,2.20344343751767e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349623183901794,HSPB6;Heat shock protein beta-6,1.22863470918571,3.41656175019803,2.37084988363512,4.92350623862305,4.38332341636878e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.337969077771734,HSPB6;Heat shock protein beta-6,0.558612148467271,1.7482445120166,1.51634106168131,2.01561439641244,1.43297504726447e-14
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,HSPB6;Heat shock protein beta-6,1.0068569314351,2.73698495030902,2.04347926591538,3.66584909529895,1.44286453585504e-11
primary,Nervous system disorders,G71 (primary disorders of muscles),0.0330199673685028,HSPB6;Heat shock protein beta-6,1.02719082780985,2.79320820034477,1.89399234751374,4.1193471878147,2.19428463779659e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374384236453202,REG1A;Lithostathine-1-alpha,1.73164250216679,5.64992630757828,3.64526037095071,8.7570335264528,9.56092586349451e-15
primary,Nervous system disorders,G62 (other polyneuropathies),0.334975369458128,REG1A;Lithostathine-1-alpha,0.395539856517234,1.48518576174761,1.2787498583621,1.72494779371715,2.21719202179868e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0610837438423645,REG1A;Lithostathine-1-alpha,1.35020642527206,3.85822188300239,2.73958574072137,5.43362300263647,1.08522456950989e-14
primary,Nervous system disorders,G40 (epilepsy),1.19386944535302,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.240228465738887,1.2715396203778,1.16763128587547,1.38469483110695,3.33345441779021e-08
primary,Nervous system disorders,G81 (hemiplegia),0.233633942339143,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,0.504315423137404,1.65585157469269,1.37716653115492,1.99093165233465,8.15871812732543e-08
primary,Nervous system disorders,G40 (epilepsy),1.21565200504903,CXCL13;C-X-C motif chemokine 13,0.542654905383097,1.72056875105281,1.59073273307686,1.86100201846817,7.32875210350295e-42
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94395049155928,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.256697824590054,1.29265445934611,1.18228142614032,1.4133314744886,1.72972124141459e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.4392276036935,4.21743702583778,2.76906408245352,6.42338874698324,2.01673319055243e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.330970193098586,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.419508184490575,1.52121321535859,1.31028654772686,1.76609433302676,3.61775168850898e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0548352982648544,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,0.924545976757722,2.52072353343996,1.76831546274956,3.59327691573656,3.19825702448918e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0330129138751335,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.3854911825581,3.99678857559912,2.5447488042071,6.27736572333982,1.79922380742595e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0275065328015403,PALM;Paralemmin-1,1.36409846349352,3.91219447552136,2.38873283182752,6.40727393636165,5.9798161175697e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0513347022587269,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,0.944579491466879,2.5717317160486,1.7486991864258,3.78212792152568,1.58775076698053e-06
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94572288571706,THY1;Thy-1 membrane glycoprotein,0.221702747734292,1.24820029234905,1.1398097641658,1.36689824811293,1.7236619449487e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0330129138751335,THY1;Thy-1 membrane glycoprotein,1.41195131963415,4.10395572532518,2.66166409930106,6.32779042248496,1.64625067823788e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0543742110884551,THY1;Thy-1 membrane glycoprotein,0.922385843906955,2.51528431256255,1.74893738915203,3.61742805217901,6.52103527608518e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351658656663931,CHRDL1;Chordin-like protein 1,1.47573168457521,4.37423516271186,2.96076407627534,6.46249845167518,1.25389612989584e-13
primary,Nervous system disorders,G62 (other polyneuropathies),0.330168405423357,CHRDL1;Chordin-like protein 1,0.478145515115007,1.61308019385617,1.3912657354829,1.8702593224636,2.3732647951825e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0605634353143437,CHRDL1;Chordin-like protein 1,0.93191893584514,2.53937740754521,1.83701418342621,3.51028188901845,1.68764780191149e-08
primary,Nervous system disorders,G40 (epilepsy),1.21421017586463,HAVCR2;Hepatitis A virus cellular receptor 2,0.245317461644339,1.27802697335518,1.18065582533003,1.38342852301332,1.30122591549714e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,HAVCR2;Hepatitis A virus cellular receptor 2,1.41953564571303,4.13519979660335,2.73242564268653,6.25813090416459,1.88359332034745e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.330970193098586,HAVCR2;Hepatitis A virus cellular receptor 2,0.471209010259604,1.60192977244406,1.38087848141367,1.85836699635986,4.98216884191335e-10
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.953150242326332,NPC2;NPC intracellular cholesterol transporter 2,0.305439998143379,1.35722204682826,1.23249798789445,1.49456770111534,5.28937272419842e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0230786983614124,NPC2;NPC intracellular cholesterol transporter 2,1.29305291993764,3.64389410886607,2.17009436872533,6.11861146132004,1.0089838802211e-06
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.9469365533065,XG;Glycoprotein Xg,0.32514297567021,1.38422854283683,1.24057746886146,1.54451350834435,6.01651898316636e-09
primary,Nervous system disorders,G56 (mononeuropathies of upper limb),2.9127535048319,XG;Glycoprotein Xg,0.253499987513886,1.28852736339659,1.20428593035004,1.37866159886064,2.00546503656272e-13
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0369441365766396,XG;Glycoprotein Xg,1.40541626886894,4.07722360932663,2.82222913769747,5.89029152112469,7.02055357042084e-14
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0602772754671488,XG;Glycoprotein Xg,1.11583378437726,3.05211192180695,2.23528711008999,4.16742312036198,2.19252627185849e-12
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351493848857645,DLL1;Delta-like protein 1,1.64055232057231,5.15801760486775,3.27730722184724,8.11798949905276,1.34338010843053e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.328060925600468,DLL1;Delta-like protein 1,0.388782565509537,1.4751837606295,1.26627958556529,1.71855185255436,6.03185306207196e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0624877953524702,DLL1;Delta-like protein 1,1.20921493917342,3.35085299625608,2.37645690908501,4.72477146949047,5.29176382979215e-12
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0273547916476702,ATRAID;All-trans retinoic acid-induced differentiation factor,1.29519715830123,3.65171586926967,2.15266537225473,6.19465940305839,1.56009873136454e-06
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.953748131833556,PRSS8;Prostasin,0.339615205173829,1.40440707799959,1.28074716475394,1.54000672030711,5.13493967973245e-13
primary,Nervous system disorders,G81 (hemiplegia),0.235978919216549,PRSS8;Prostasin,0.468326829135429,1.5973193678937,1.3326494070061,1.91455393266583,4.04404068657146e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351082504388531,SMOC2;SPARC-related modular calcium-binding protein 2,1.25123648512986,3.49466138391173,2.22063094893163,5.4996343242354,6.36170021338401e-08
primary,Nervous system disorders,G35 (multiple sclerosis),0.686950265729072,MXRA8;Matrix remodeling-associated protein 8,-0.408368588990216,0.66473382009469,0.591034965167389,0.747622522556743,9.68262253468519e-12
primary,Nervous system disorders,G40 (epilepsy),1.20513178634849,GPR37;Prosaposin receptor GPR37,0.269084102717449,1.30876520712839,1.20576685945597,1.42056182250908,1.24180620675999e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.037909774736128,GPR37;Prosaposin receptor GPR37,1.20331938975874,3.3311559962054,2.11700288823274,5.24165570710134,1.96448939491233e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0558670364532412,GPR37;Prosaposin receptor GPR37,1.08451230582569,2.95799686906836,2.03169769312314,4.30661781377919,1.5260003636639e-08
primary,Nervous system disorders,G40 (epilepsy),1.20878124007801,VNN1;Pantetheinase,0.484538324234831,1.62342533966961,1.48694999414962,1.7724266746365,2.92343272384884e-27
primary,Nervous system disorders,G40 (epilepsy),1.21189649115959,CPM;Carboxypeptidase M,0.914001789367835,2.49428418781248,2.30918419453017,2.69422145895,2.13110389615116e-119
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.954086026379005,PROS1;Vitamin K-dependent protein S,-0.321116335766976,0.725338863228607,0.65982673649403,0.797355483509613,2.95704587345174e-11
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.935364186682288,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.253191301592689,1.28812967452407,1.17653989824935,1.41030326371288,4.33787867538983e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351493848857645,NBL1;Neuroblastoma suppressor of tumorigenicity 1,1.67967483264866,5.36381155112798,3.43283718877878,8.38096092936146,1.6233922843298e-13
primary,Nervous system disorders,G62 (other polyneuropathies),0.328060925600468,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.408641139221862,1.50477162006643,1.29170707040045,1.75298074961791,1.55541462150831e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0624877953524702,NBL1;Neuroblastoma suppressor of tumorigenicity 1,0.975580847499054,2.65270758214374,1.87448725595844,3.75401726205114,3.6606825603242e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.951666403411783,ASGR1;Asialoglycoprotein receptor 1,0.248551575630779,1.28216694923319,1.17290314819118,1.40160940674531,4.51704864333656e-08
primary,Nervous system disorders,G55 (nerve root and plexus compressions in diseases classified elsewhere),0.446217027325856,ASGR1;Asialoglycoprotein receptor 1,0.328028166898563,1.38822807381806,1.22041349662079,1.57911821712294,6.03317403848582e-07
primary,Nervous system disorders,G72 (other myopathies),0.0355394092560416,ASGR1;Asialoglycoprotein receptor 1,1.01009149649068,2.74585223936752,1.82419596825517,4.13316587233294,1.29178644245445e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0350126434545808,CD5;T-cell surface glycoprotein CD5,1.12092646702987,3.06769500541527,1.99269530947735,4.72262498009193,3.53909513955334e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0622446994748103,CD5;T-cell surface glycoprotein CD5,0.9318167675493,2.53911797693601,1.81683808344433,3.54853861747396,4.86162284456252e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349358538904955,BSG;Basigin,1.22753809579148,3.41281715638168,2.20780098769834,5.2755302709759,3.31361396143462e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.943081779503166,TFF3;Trefoil factor 3,0.264257259751438,1.30246322456981,1.18937565662447,1.42630332301513,1.1818675604546e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372527106248652,TFF3;Trefoil factor 3,1.45928903027336,4.30289920950235,2.8061231825751,6.59805019327247,2.22179976312488e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.331353057663274,TFF3;Trefoil factor 3,0.416255750051853,1.51627360633996,1.30154681635943,1.76642562555988,9.15606065401338e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0588200694076819,TFF3;Trefoil factor 3,1.10316018034801,3.01367474710409,2.12983450650832,4.26429164030328,4.69686998448262e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372176842765078,NPDC1;Neural proliferation differentiation and control protein 1,1.57048820143996,4.80899537924785,3.19632756590977,7.23531492963384,4.86865071348726e-14
primary,Nervous system disorders,G62 (other polyneuropathies),0.333288119828705,NFASC;Neurofascin,0.368063575487974,1.44493389843152,1.24387002531609,1.67849849931544,1.47541274468943e-06
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0600693704342434,NFASC;Neurofascin,1.18877642195005,3.28306166658181,2.31679856208495,4.65232242585607,2.3258598908756e-11
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.036766840180351,REG1B;Lithostathine-1-beta,1.51102577376559,4.53137657836131,2.92749689351816,7.01396942226816,1.21087211810619e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.05998800239952,REG1B;Lithostathine-1-beta,1.09170833730653,2.97935947847862,2.11851043894736,4.19001140556615,3.49867306153359e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352243596015733,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,1.52083496178022,4.57604442266332,2.91596569457287,7.18121704832174,3.72453390792067e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.330717598481438,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.458775700203972,1.58213579024557,1.36122891857558,1.83889250707026,2.24371935032001e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0606641748693763,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,1.12185832436654,3.07055499185547,2.17596447790552,4.33293284598276,1.71738448448865e-10
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.952604962954251,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.297484567225685,1.3464675954619,1.23343513414708,1.46985839420136,2.93614169320507e-11
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352816652946019,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,1.29274849625582,3.64278499003488,2.54865499653048,5.20662172859326,1.30590542434281e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.331255635265984,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.456893956992001,1.57916141634349,1.36607073183078,1.82549169729001,6.50290261254939e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0607628680073699,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.808574234315019,2.24470528030303,1.6406494917615,3.07116286612229,4.29494822978767e-07
primary,Nervous system disorders,G81 (hemiplegia),0.235211101964012,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.457507586453816,1.58013073368394,1.32917009845852,1.87847525190959,2.16430790185337e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372176842765078,LGALS1;Galectin-1,1.09377570327119,2.98552527614498,2.02059496792674,4.4112557518869,3.98714075334385e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.948197457282737,"FABP4;Fatty acid-binding protein, adipocyte",0.290490928204804,1.3370837390459,1.21405627649407,1.47257829792185,3.66690913299355e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.036766840180351,"FABP4;Fatty acid-binding protein, adipocyte",1.28086556039358,3.59975418214641,2.48819276163674,5.20788838054355,1.06304166220548e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.334771755326354,"FABP4;Fatty acid-binding protein, adipocyte",0.403847990915634,1.49757628445542,1.27844481747571,1.75426791763416,5.638069842489e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.05998800239952,"FABP4;Fatty acid-binding protein, adipocyte",0.924038393428243,2.51944438086188,1.81685052786715,3.49373814240412,3.03168048313579e-08
primary,Nervous system disorders,G81 (hemiplegia),0.234146719043288,"FABP4;Fatty acid-binding protein, adipocyte",0.55145792115787,1.73578180705379,1.4385620925172,2.09440975636086,8.67266576045886e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0274122807017543,RNASE6;Ribonuclease K6,1.32938670102979,3.77872518850008,2.30643706917267,6.19083184234757,1.30756796662847e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0336214227795028,EFNA4;Ephrin-A4,1.45378396534856,4.27927655177991,2.80887276203148,6.51941520959791,1.30507531384739e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.332258766291557,EFNA4;Ephrin-A4,0.461596868643231,1.58660556383115,1.36483598105876,1.84441006107354,1.8680476311075e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0514209995451219,EFNA4;Ephrin-A4,1.10616638111172,3.02274808974202,2.10316812079097,4.34440115543531,2.27055164628871e-09
primary,Nervous system disorders,G81 (hemiplegia),0.237327690208255,EFNA4;Ephrin-A4,0.473337487225452,1.60534307434421,1.3421840188708,1.92009914446241,2.19896996486145e-07
primary,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.148529787184664,MYOM3;Myomesin-3,0.711107969275296,2.03624610738844,1.58294289020931,2.61936058179985,3.11865254420253e-08
primary,Nervous system disorders,G40 (epilepsy),1.19287985332683,INHBB;Inhibin beta B chain,-0.444833604296819,0.640930915310257,0.586295660495314,0.700657476900645,1.30030294076489e-22
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0278493350971245,INHBB;Inhibin beta B chain,1.5816290028627,4.86287099332903,2.8162449675164,8.396824342527,1.38523508802987e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.948846539618856,SORCS2;VPS10 domain-containing receptor SorCS2,0.226293494375686,1.25394363668157,1.14528914944396,1.37290626104122,9.90689488969472e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0361083249749247,SORCS2;VPS10 domain-containing receptor SorCS2,1.27372030378614,3.5741246884878,2.32061949069316,5.50472291562214,7.45526422843333e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0561685055165496,SORCS2;VPS10 domain-containing receptor SorCS2,1.02915655040024,2.79870427291109,1.9593992153431,3.99752411140944,1.53329232232705e-08
primary,Nervous system disorders,G81 (hemiplegia),0.238128038100486,IL6;Interleukin-6,0.472406817270067,1.60384972479241,1.36067170751619,1.89048829743972,1.79140034797776e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.95215089478028,SCARB2;Lysosome membrane protein 2,0.250032844249112,1.28406759023096,1.17324786082634,1.40535485410582,5.64945013937358e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0342210680999255,SCARB2;Lysosome membrane protein 2,1.13818713564439,3.12110509319167,2.0655140257249,4.71616114992403,6.51786343382475e-08
primary,Nervous system disorders,G62 (other polyneuropathies),0.336171668981621,SCARB2;Lysosome membrane protein 2,0.445502552999707,1.56127462195293,1.34501847045457,1.81230109377639,4.72814818837093e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0273006483903992,YAP1;Transcriptional coactivator YAP1,1.46491486365247,4.32717482475852,2.80186888816919,6.68284017253175,3.94680857650013e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.313957456489591,YAP1;Transcriptional coactivator YAP1,0.427922647338842,1.53406741218123,1.30448940172791,1.80404901871889,2.29506435936394e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0546012967807985,YAP1;Transcriptional coactivator YAP1,0.928735037131873,2.53130514453791,1.77775406037651,3.60427006050941,2.59081491699405e-07
primary,Nervous system disorders,G81 (hemiplegia),0.24343078148106,YAP1;Transcriptional coactivator YAP1,0.467027730183989,1.59524563925874,1.32638661643293,1.91860247837681,7.07024209789153e-07
primary,Nervous system disorders,G93 (other disorders of brain),0.734317085110846,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,0.312081745676609,1.3662663748339,1.22023900997892,1.52976899749665,6.25604825640056e-08
primary,Nervous system disorders,G40 (epilepsy),1.20513178634849,ACE2;Angiotensin-converting enzyme 2,0.838252577370067,2.3123228391445,2.12591361508622,2.51507722349878,4.37369478668126e-85
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.916295195641406,WFDC2;WAP four-disulfide core domain protein 2,0.289365559178606,1.33557987278152,1.21844289482736,1.46397800352542,6.46677666954578e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0371471025260029,WFDC2;WAP four-disulfide core domain protein 2,1.49017299221716,4.43786316839204,2.93225309699407,6.71655169247161,1.81567825987722e-12
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0619118375433382,WFDC2;WAP four-disulfide core domain protein 2,0.944663429263933,2.57194759060335,1.85358930601299,3.56870553112913,1.57880227294338e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0350146867158169,GFRA1;GDNF family receptor alpha-1,1.73721100325688,5.68147568823717,3.79143259283478,8.51371221976428,3.82422658776786e-17
primary,Nervous system disorders,G62 (other polyneuropathies),0.338475304919563,GFRA1;GDNF family receptor alpha-1,0.480848980617999,1.61744700060988,1.39839081561125,1.8708180650045,9.41218432274781e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.06224833193923,GFRA1;GDNF family receptor alpha-1,1.36317131469006,3.9085689700457,2.86129172177634,5.33916597085736,1.07001222888645e-17
primary,Nervous system disorders,G81 (hemiplegia),0.237321765518314,GFRA1;GDNF family receptor alpha-1,0.468943622968533,1.59830488852959,1.3414059459282,1.90440375223619,1.56013231992225e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.036766840180351,MFAP5;Microfibrillar-associated protein 5,1.23070345264796,3.42363705595505,2.22520508389,5.2675102963624,2.16225228564752e-08
primary,Nervous system disorders,G40 (epilepsy),1.2137716397588,HAVCR1;Hepatitis A virus cellular receptor 1,0.247255628941338,1.28050640544054,1.18445476786993,1.38434721093066,5.12848965266398e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0350126434545808,HAVCR1;Hepatitis A virus cellular receptor 1,1.0590699737539,2.88368783638666,1.91268638778483,4.34763147311102,4.2846166889355e-07
primary,Nervous system disorders,G62 (other polyneuropathies),0.338455553394281,HAVCR1;Hepatitis A virus cellular receptor 1,0.451917097631793,1.57132167688957,1.36141928373012,1.81358663107677,6.52583787790673e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0622446994748103,HAVCR1;Hepatitis A virus cellular receptor 1,1.3634505224256,3.90966042510127,2.89433569904041,5.28115817549111,6.27090718133644e-19
primary,Nervous system disorders,G72 (other myopathies),0.0350126434545808,HAVCR1;Hepatitis A virus cellular receptor 1,1.1538842313378,3.17048391666454,2.10340687203125,4.77889865222384,3.55490734668442e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372176842765078,IGSF8;Immunoglobulin superfamily member 8,1.21424833964685,3.36776169975328,2.18239811733911,5.19695227750361,4.1154204656202e-08
primary,Nervous system disorders,G40 (epilepsy),1.20967741935483,CTSZ;Cathepsin Z,0.201837612576583,1.22364928672203,1.12975465227164,1.32534756452174,7.23233215695392e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0371907297212652,CTSZ;Cathepsin Z,1.24768217442694,3.48226231966841,2.25256805750507,5.38325615627048,1.97989598829206e-08
primary,Nervous system disorders,G62 (other polyneuropathies),0.332759160663952,CTSZ;Cathepsin Z,0.376937142421455,1.45781267191667,1.25330488145135,1.69569098297916,1.02048768297188e-06
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0606796116504854,CTSZ;Cathepsin Z,1.1222405465937,3.07172885054622,2.17722045372859,4.33374494306228,1.65359149296503e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.033564997630706,SNCG;Gamma-synuclein,1.26104258228516,3.52909894604939,2.21710334997783,5.61748254592257,1.05444381655122e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936213192448139,RTN4R;Reticulon-4 receptor,0.232313480452604,1.2615151271833,1.15172394004754,1.38177245499177,5.71407443517527e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,RTN4R;Reticulon-4 receptor,0.874332426003087,2.39727440161551,1.73271360572055,3.31671924181096,1.30183604915621e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.948197457282737,COL6A3;Collagen alpha-3(VI) chain,0.34903473897516,1.41769843887741,1.29738299008706,1.54917158537786,1.22205405453483e-14
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.036766840180351,COL6A3;Collagen alpha-3(VI) chain,1.60326415813091,4.9692263207967,3.4664813004746,7.12342230835572,2.64506446662921e-18
primary,Nervous system disorders,G62 (other polyneuropathies),0.334771755326354,COL6A3;Collagen alpha-3(VI) chain,0.486972590794583,1.62738200351965,1.40474955622665,1.88529846736064,8.70775302235572e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.05998800239952,COL6A3;Collagen alpha-3(VI) chain,0.940809650561166,2.56205494802516,1.85434181786714,3.53986815885447,1.17102756237635e-08
primary,Nervous system disorders,G81 (hemiplegia),0.234146719043288,COL6A3;Collagen alpha-3(VI) chain,0.456818495737944,1.57904225533873,1.3239184579491,1.8833293162237,3.75895018562855e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0377148755409107,PI3;Elafin,1.41640117920393,4.12225844404613,2.65841629630421,6.3921571287137,2.47671661922676e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0615347969351701,PI3;Elafin,0.936769197468277,2.55172397015666,1.7846212830344,3.64855853831401,2.82362144689479e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0350487762135638,CKAP4;Cytoskeleton-associated protein 4,1.69963708685198,5.47196118467933,3.53574798312224,8.46846532885432,2.3847991903721e-14
primary,Nervous system disorders,G62 (other polyneuropathies),0.334910528262943,CKAP4;Cytoskeleton-associated protein 4,0.523998320927089,1.68876639891417,1.45677495196045,1.95770248950501,3.6539764227572e-12
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0603617812566933,CKAP4;Cytoskeleton-associated protein 4,1.11393576522071,3.04632444901598,2.17386391581618,4.26893909096802,9.78020037330627e-11
primary,Nervous system disorders,G40 (epilepsy),1.20943199890051,IL1R2;Interleukin-1 receptor type 2,0.284225429706622,1.32873243275569,1.22544371678199,1.44072702293757,5.81869275124136e-12
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0333483727955744,EFNA1;Ephrin-A1,1.47707216042948,4.38010265106303,2.81360571757802,6.81875897322395,6.1176455684099e-11
primary,Nervous system disorders,G62 (other polyneuropathies),0.331522058967769,EFNA1;Ephrin-A1,0.420895185536952,1.52332460359041,1.31229366573687,1.76829158632025,3.16420587607876e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0549267316632991,EFNA1;Ephrin-A1,0.907177371848524,2.47732010194396,1.72671076941337,3.5542228589798,8.39887282415461e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.952604962954251,"FABP1;Fatty acid-binding protein, liver",0.353173082358696,1.42357751826606,1.30227672882192,1.55617689056447,7.69841496289994e-15
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352816652946019,"FABP1;Fatty acid-binding protein, liver",1.36093902722837,3.89985365170778,2.57552831724578,5.90514124923407,1.28242556214572e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0607628680073699,"FABP1;Fatty acid-binding protein, liver",0.846956270858885,2.33253642721573,1.66621631313697,3.26531803907567,8.03152767975614e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936213192448139,ADM;Pro-adrenomedullin,0.307113687973489,1.35949551757696,1.24474127374528,1.48482909765718,8.74931660655618e-12
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349623183901794,ADM;Pro-adrenomedullin,0.97824623959592,2.65978751918108,1.83133107914978,3.86302057980464,2.78432929440383e-07
primary,Nervous system disorders,G62 (other polyneuropathies),0.337969077771734,ADM;Pro-adrenomedullin,0.368593862065577,1.44570033067979,1.25080741489801,1.67096023035495,6.06913275371513e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,ADM;Pro-adrenomedullin,0.804289044048401,2.23510687127677,1.65438729016404,3.01966943032624,1.60924156460227e-07
primary,Nervous system disorders,G81 (hemiplegia),0.236966824644549,ADM;Pro-adrenomedullin,0.444202838565364,1.5592467289172,1.31434732159602,1.84977769702966,3.47918356566412e-07
primary,Nervous system disorders,G40 (epilepsy),1.21421017586463,INHBC;Inhibin beta C chain,-0.318542608306213,0.727208092190386,0.671834419650078,0.78714575180983,3.19857089503974e-15
primary,Nervous system disorders,G40 (epilepsy),1.20748165101412,PLAUR;Urokinase plasminogen activator surface receptor,0.207133135530655,1.23014633706439,1.13696016667054,1.3309701209888,2.55552141344281e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.954936469102675,PLAUR;Urokinase plasminogen activator surface receptor,0.282356183435212,1.32625102451414,1.215409809797,1.44720057864152,2.28312670031854e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0355141662062978,PLAUR;Urokinase plasminogen activator surface receptor,1.14862379270418,3.15384957091862,2.0904614722775,4.7581681116308,4.39148663956754e-08
primary,Nervous system disorders,G62 (other polyneuropathies),0.333438560492463,PLAUR;Urokinase plasminogen activator surface receptor,0.446761612750367,1.5632415979995,1.3538488310671,1.80502005662619,1.13731520340981e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0611632862441796,PLAUR;Urokinase plasminogen activator surface receptor,0.941551713267538,2.56395685903511,1.85966905131285,3.53497025202,9.12762188612172e-09
primary,Nervous system disorders,G81 (hemiplegia),0.236761108041985,PLAUR;Urokinase plasminogen activator surface receptor,0.46668910839238,1.59470554577119,1.34081286191962,1.89667465903669,1.33007090630881e-07
primary,Nervous system disorders,G40 (epilepsy),1.207435892327,GGH;Gamma-glutamyl hydrolase,0.339396290097571,1.40409966576682,1.29680268988128,1.52027435383173,5.8639901411042e-17
primary,Nervous system disorders,G40 (epilepsy),1.20638419302147,CD302;CD302 antigen,0.219273422969653,1.24517168868802,1.15005657335692,1.348153273699,6.3571625077453e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0354240056678409,CD302;CD302 antigen,1.42582681393946,4.16129703917057,2.79081346457516,6.20478339667383,2.64734698795257e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.332592053214728,CD302;CD302 antigen,0.492632620001011,1.63661914978839,1.41084361235366,1.89852526389199,7.80113748522505e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0570720091315214,CD302;CD302 antigen,1.26499915315695,3.54308973566681,2.56755111483918,4.88928333400434,1.37414856170374e-14
primary,Nervous system disorders,G81 (hemiplegia),0.238128038100486,CD302;CD302 antigen,0.43980661676499,1.55240697999788,1.3017797733232,1.85128658543674,9.79606227767344e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0514189656877286,DKK4;Dickkopf-related protein 4,0.999872946305204,2.71793648264843,1.87212820030753,3.94587225516814,1.46593758154636e-07
primary,Nervous system disorders,G40 (epilepsy),1.20287782846508,CD80;T-lymphocyte activation antigen CD80,0.27357092272998,1.3146505945149,1.20688242022479,1.43204189297617,3.63399322967341e-10
primary,Nervous system disorders,G40 (epilepsy),1.21234163787355,LAMP2;Lysosome-associated membrane glycoprotein 2,0.550964977838735,1.7349263758654,1.59820256553482,1.88334670121505,1.58301118938305e-39
primary,Nervous system disorders,G62 (other polyneuropathies),0.336018864216938,CD4;T-cell surface glycoprotein CD4,0.389258601789277,1.47588616879146,1.27132974108586,1.71335564081862,3.15984081351785e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0249608568381401,SHISA5;Protein shisa-5,1.25689149248525,3.51447970329895,2.13985525978751,5.77215095666182,6.86576207985132e-07
primary,Nervous system disorders,G40 (epilepsy),1.20453564562325,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,0.374595093532187,1.45440239844008,1.34403403074354,1.5738339120908,1.36464602734913e-20
primary,Nervous system disorders,G40 (epilepsy),1.20775774603917,CD163;Scavenger receptor cysteine-rich type 1 protein M130,0.198525838234792,1.21960353940974,1.12683651370018,1.32000762777602,8.72509744457128e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370717240302817,CD163;Scavenger receptor cysteine-rich type 1 protein M130,1.13334601655552,3.10603196658546,2.02746331560647,4.75837688563303,1.91394504481068e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.957103086708256,CD59;CD59 glycoprotein,0.24307766998173,1.2751676625213,1.16018224212997,1.40154926398009,4.61926356368517e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0386092540285708,CD59;CD59 glycoprotein,1.38824451646243,4.00780823252872,2.75696504196408,5.82616267679693,3.51745805831394e-13
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.927833029286569,FOLR1;Folate receptor alpha,0.260843481661514,1.29802448489767,1.18552471969614,1.4211998580896,1.70784952593926e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353086565056199,FOLR1;Folate receptor alpha,1.40732093730357,4.08499676873199,2.71678264105811,6.14226487918504,1.35493381656663e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0627709448988799,FOLR1;Folate receptor alpha,1.02545335393659,2.78835928772343,2.02344434017942,3.84243211589606,3.65686927397631e-10
primary,Nervous system disorders,G81 (hemiplegia),0.24343078148106,NT5C1A;Cytosolic 5'-nucleotidase 1A,0.443296805369268,1.55783463941648,1.30187036320859,1.86412474878424,1.29509119345889e-06
primary,Nervous system disorders,G40 (epilepsy),1.20878124007801,SHBG;Sex hormone-binding globulin,0.667035506741388,1.94845257592799,1.77731666129638,2.13606698418686,6.76859400830287e-46
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.960504951174331,APCS;Serum amyloid P-component,-0.307584967831307,0.735220394811271,0.66287242918164,0.815464643195048,5.89335744636464e-09
primary,Nervous system disorders,G20 (parkinson's disease),0.291152102548069,LDLR;Low-density lipoprotein receptor,-0.490653297243506,0.612226297754973,0.520012566654672,0.720792272529196,3.84393738148811e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.953948012771542,REN;Renin,0.484137616632498,1.62277495111071,1.47446897270488,1.78599793600366,4.1285104995182e-23
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372176842765078,REN;Renin,1.80026765833577,6.05126691970596,3.78878197431306,9.66480298464964,4.85156460483929e-14
primary,Nervous system disorders,G62 (other polyneuropathies),0.336917983976807,REN;Renin,0.57359178249942,1.77462970187129,1.51002559098032,2.08560079880451,3.34023686776397e-12
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0607235901353548,REN;Renin,1.49160072766404,4.44420378823274,3.06950335931476,6.43457426146992,2.80038810222169e-15
primary,Nervous system disorders,G81 (hemiplegia),0.23505905858847,REN;Renin,0.703280098964515,2.02036886052747,1.66892317361553,2.44582278988081,5.47563204558333e-13
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.935364186682288,NECTIN4;Nectin-4,0.225373297711861,1.25279029266351,1.14348732042278,1.37254125110162,1.30723767002457e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351493848857645,NECTIN4;Nectin-4,1.6437955072171,5.17477317471097,3.22250025268142,8.30978287353934,1.03033763834805e-11
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0624877953524702,NECTIN4;Nectin-4,0.888488577311895,2.43145192108898,1.70395255223045,3.46955579064021,9.68440328621452e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0330129138751335,MSR1;Macrophage scavenger receptor types I and II,1.15813424231328,3.18398718229619,2.08458050436004,4.86322037255101,8.36751387676976e-08
primary,Nervous system disorders,G40 (epilepsy),1.197592778335,BAIAP2;Brain-specific angiogenesis inhibitor 1-associated protein 2,0.249417913356195,1.28327822013004,1.18257133139948,1.39256123206646,2.21066068929376e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0373031766599913,RETN;Resistin,1.13478581096429,3.11050723500452,2.02925158111106,4.76789341897076,1.91599058402079e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.948846539618856,CFC1;Cryptic protein,0.243944981672589,1.27627411009091,1.16623413577832,1.39669690169141,1.14068774431534e-07
primary,Nervous system disorders,G35 (multiple sclerosis),0.67777297552159,CA6;Carbonic anhydrase 6,-0.408281169885662,0.664791933070065,0.594555161433091,0.743326007312391,7.69362817335785e-13
primary,Nervous system disorders,G40 (epilepsy),1.21421017586463,CD300LG;CMRF35-like molecule 9,0.363442956015359,1.43827280975307,1.32466267576661,1.56162675458325,4.84710458403309e-18
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,CD300LG;CMRF35-like molecule 9,1.18797732394217,3.28043922647719,2.07263859906527,5.19206846937206,3.95646711587009e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.947545875559517,PGF;Placenta growth factor,0.262792464425301,1.30055677914304,1.18518622966303,1.42715793808695,2.94413957328737e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0348789892843994,PGF;Placenta growth factor,1.30069609949051,3.67185175235353,2.56211465988622,5.26225289693335,1.39919888954971e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.333288119828705,PGF;Placenta growth factor,0.465887130489346,1.59342713985681,1.36779108539747,1.85628498177733,2.2281875384123e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0600693704342434,PGF;Placenta growth factor,0.941389608987671,2.56354126434061,1.88053259450227,3.49461840395084,2.59944466535782e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0624877953524702,FGFR2;Fibroblast growth factor receptor 2,1.04694131255677,2.84892381032859,2.01919581198925,4.01960366045984,2.50963221354711e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0348789892843994,CLEC7A;C-type lectin domain family 7 member A,1.21493223975421,3.37006570010452,2.15490732857243,5.27045533347594,1.00995443713142e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0600693704342434,CLEC7A;C-type lectin domain family 7 member A,1.00871490994766,2.74207493661425,1.93530428318828,3.88516422111205,1.39647010308181e-08
primary,Nervous system disorders,G40 (epilepsy),1.2102934465586,PIGR;Polymeric immunoglobulin receptor,0.451028238076959,1.56992561314757,1.45032025041796,1.69939461998582,6.73667986884887e-29
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.055554453284657,PIGR;Polymeric immunoglobulin receptor,0.970007461296383,2.63796414191303,1.84047511891737,3.78100999165497,1.28274848620729e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.949168972272148,LCN2;Neutrophil gelatinase-associated lipocalin,0.251191435017728,1.28555616124309,1.17302004563299,1.40888866295397,7.69378564338201e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0383706605812145,LCN2;Neutrophil gelatinase-associated lipocalin,1.26209450656566,3.53281324415671,2.31897810404853,5.38201261853218,4.19982248084452e-09
primary,Nervous system disorders,G81 (hemiplegia),0.234262980390572,LCN2;Neutrophil gelatinase-associated lipocalin,0.468716448067222,1.59794183501416,1.33211258445305,1.9168185466372,4.44128655842828e-07
primary,Nervous system disorders,G62 (other polyneuropathies),0.332592053214728,ADGRG1;Adhesion G-protein coupled receptor G1,0.451625398771144,1.5708633909907,1.34603870292139,1.83323985246426,9.99828483795949e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.941549543906354,MMP12;Macrophage metalloelastase,0.273645076295759,1.31474808415879,1.20282578950635,1.43708468830605,1.65833620550501e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0626394706964726,MMP12;Macrophage metalloelastase,0.88638181596061,2.42633482429766,1.74721960561799,3.36941084032612,1.21762114618801e-07
primary,Nervous system disorders,G20 (parkinson's disease),0.296057999393897,AHNAK;Neuroblast differentiation-associated protein AHNAK,-0.482110121494615,0.617479060303523,0.517858469336149,0.736263694599977,7.84799399210028e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0336214227795028,EPHB6;Ephrin type-B receptor 6,1.25371652301814,3.50333903255149,2.22102598156847,5.52599766002354,6.98056243446328e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0514209995451219,EPHB6;Ephrin type-B receptor 6,0.97901651980698,2.66183709014337,1.82409222517344,3.8843302968353,3.83089494148472e-07
primary,Nervous system disorders,G62 (other polyneuropathies),0.335316806543523,CXCL16;C-X-C motif chemokine 16,0.374100970720533,1.45368392255997,1.25172154014182,1.68823246939564,9.49378543567365e-07
primary,Nervous system disorders,G40 (epilepsy),1.21235899950956,NECTIN2;Nectin-2,0.193758968268572,1.21380368249144,1.12130420955707,1.31393369174255,1.66005802438614e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372731731240804,NECTIN2;Nectin-2,1.62511699996022,5.07901324676598,3.30800320870969,7.79817126322752,1.0976618455011e-13
primary,Nervous system disorders,G62 (other polyneuropathies),0.337420304070622,NECTIN2;Nectin-2,0.403712249927569,1.49737301576712,1.29067386674466,1.73717466985105,1.00042962275129e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.060814124570868,NECTIN2;Nectin-2,1.11267958362499,3.04250011484054,2.15801935108303,4.28949209568442,2.16711495060824e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351493848857645,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,1.50334179021216,4.49669098767629,2.94019983981113,6.87716173739674,4.05800210264003e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.328060925600468,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.440567125526397,1.55358804815685,1.33873565433033,1.80292189542317,6.57460430950672e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0624877953524702,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.993234932040562,2.69995452976463,1.94781793703945,3.74252353065218,2.49349069691926e-09
primary,Nervous system disorders,G40 (epilepsy),1.20287782846508,TCTN3;Tectonic-3,0.255950881377992,1.29168928038397,1.18321423628593,1.41010912976851,1.0711352306336e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0350201365785326,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,1.12493189545417,3.0800070792917,1.99417176827612,4.75708449964048,3.93599499417397e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.062258020584058,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,0.887416986797564,2.42884779580147,1.74183872135203,3.38682424661598,1.68252987531874e-07
primary,Nervous system disorders,G40 (epilepsy),1.21070103495411,TGFBR2;TGF-beta receptor type-2,0.244888025939355,1.27747826076771,1.18031041813028,1.38264534622954,1.30239879674357e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351493848857645,TGFBR2;TGF-beta receptor type-2,1.40750778085611,4.08576009534949,2.72927956857595,6.11642564908087,8.06739042772354e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.328060925600468,TGFBR2;TGF-beta receptor type-2,0.438003100387476,1.5496097118026,1.33479815741905,1.79899128985617,8.77071867649666e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0624877953524702,TGFBR2;TGF-beta receptor type-2,1.10609810152428,3.02254170479553,2.19932240832486,4.15389681960575,9.20389716430128e-12
primary,Nervous system disorders,G35 (multiple sclerosis),0.695818268640425,CDA;Cytidine deaminase,-0.333805829241438,0.716192832432579,0.638274069233569,0.803623706417718,1.34589195045906e-08
primary,Nervous system disorders,G20 (parkinson's disease),0.285988521282638,CCL27;C-C motif chemokine 27,-0.471803497801962,0.623876093897395,0.530104372811238,0.734235370428207,1.36781582022349e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.951823678564462,PON3;Serum paraoxonase/lactonase 3,-0.233458543284592,0.791790420089956,0.72305687519658,0.867057752788509,4.68386987333503e-07
primary,Nervous system disorders,G62 (other polyneuropathies),0.330999618848923,MUC13;Mucin-13,0.372269632781516,1.45102417223544,1.24505944490812,1.69106074173584,1.87764077602702e-06
primary,Nervous system disorders,G40 (epilepsy),1.21506445887699,ACP5;Tartrate-resistant acid phosphatase type 5,0.201994582231909,1.22384137760463,1.1297780651723,1.3257362341415,7.4051925689468e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94524631314716,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.287108745252551,1.33256911616187,1.2185056576722,1.45730997485949,3.20415207593081e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0333385629118293,VSIG4;V-set and immunoglobulin domain-containing protein 4,1.44789078037028,4.25413214657385,2.83435090059841,6.38510930904571,2.78138854518474e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.329463445246313,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.429898732095895,1.53710185658296,1.32351707872338,1.78515423449598,1.78100199214942e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0529494822717288,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.878040797392029,2.40618088949347,1.69088667393992,3.42406535115274,1.07121189524045e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372731731240804,FAM3C;Protein FAM3C,1.78305782588526,5.94801663828849,3.8989427815251,9.07397310291328,1.29061761338157e-16
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.060814124570868,FAM3C;Protein FAM3C,1.30412428389813,3.68446113857939,2.61731094018927,5.18671804455913,7.76175422907122e-14
primary,Nervous system disorders,G56 (mononeuropathies of upper limb),2.90093692422282,PRELP;Prolargin,0.221398899661217,1.24782108670878,1.1837625202217,1.31534614235249,1.8123060320195e-16
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352816652946019,PRELP;Prolargin,1.59620241120404,4.93425851431211,3.14264729919556,7.74726043622325,4.0708198325295e-12
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0607628680073699,PRELP;Prolargin,1.01128533133547,2.7491322909799,1.92347295936788,3.9292095667371,2.86200908131786e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936213192448139,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.287723512800418,1.3333885882764,1.21622311190218,1.46184126082346,8.70921732907803e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349623183901794,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,1.29949377829077,3.66743966005692,2.32317362471021,5.78954302730438,2.42469098054606e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.929729062661122,2.53382257746292,1.78360703198189,3.59959157983741,2.10064220342613e-07
primary,Nervous system disorders,G40 (epilepsy),1.20513178634849,NPPB;Natriuretic peptides B,0.236111101389617,1.26631499170705,1.16765157181612,1.37331520543232,1.16349787739875e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0249608568381401,PRAP1;Proline-rich acidic protein 1,1.40167373940196,4.06199299810821,2.45416779056268,6.72316993977707,4.9782298981596e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0521908824797476,PRAP1;Proline-rich acidic protein 1,0.950432722212313,2.58682879544009,1.754315122648,3.81441346000452,1.61310462025235e-06
primary,Nervous system disorders,G40 (epilepsy),1.20780062452129,ANG;Angiogenin,-0.248879684613728,0.779673774493072,0.717105534702528,0.8477011614259,5.50289120660225e-09
primary,Nervous system disorders,G40 (epilepsy),1.20943553224838,CCL16;C-C motif chemokine 16,0.230641559868288,1.25940773626077,1.16088154378073,1.36629603136585,2.8696320289439e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.954480152716824,AREG;Amphiregulin,0.260695244811977,1.2978320840982,1.1846314412592,1.42184991875979,2.16018152552774e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0354240056678409,AREG;Amphiregulin,1.48218451634975,4.40255263203274,2.73507183622758,7.08664007324655,1.04319700254094e-09
primary,Nervous system disorders,G62 (other polyneuropathies),0.332592053214728,AREG;Amphiregulin,0.443421920156422,1.55802955975926,1.33399951933987,1.81968289635133,2.16391271745248e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0570720091315214,AREG;Amphiregulin,1.15812620046435,3.18396157725521,2.19814246289825,4.61189913599641,8.9933039739774e-10
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372176842765078,SEMA3F;Semaphorin-3F,1.19269209615991,3.29594226814104,2.1724387408691,5.00047952126502,2.04719980618468e-08
primary,Nervous system disorders,G40 (epilepsy),1.21447180270709,COL4A1;Collagen alpha-1(IV) chain,0.320181544058378,1.37737779639443,1.27398693805738,1.48915937622817,8.81520513899284e-16
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372176842765078,COL4A1;Collagen alpha-1(IV) chain,1.02686469972144,2.79229740521986,1.85516164732202,4.20282772148327,8.56137496061805e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0607235901353548,COL4A1;Collagen alpha-1(IV) chain,1.00853512256558,2.74158199045398,1.98880354125979,3.77929325569307,7.37232463012699e-10
primary,Nervous system disorders,G47 (sleep disorders),2.06494361115523,ADAMTSL2;ADAMTS-like protein 2,0.20447841745795,1.22688497626342,1.14846887040976,1.31065524174271,1.29679729127869e-09
primary,Nervous system disorders,G62 (other polyneuropathies),0.322221970092355,ADAMTSL2;ADAMTS-like protein 2,0.436650170140301,1.54751461553132,1.31325083561423,1.82356745591786,1.85000377505385e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0521908824797476,ADAMTSL2;ADAMTS-like protein 2,1.14739500336254,3.14997653424116,2.09636956894117,4.73311209687207,3.33474454539481e-08
primary,Nervous system disorders,G40 (epilepsy),1.18765387070301,MEP1A;Meprin A subunit alpha,-0.23321237098347,0.791985360953211,0.725380116684033,0.864706376060494,1.95863525996989e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.033564997630706,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,1.25994700507449,3.5252346628667,2.27320132703935,5.46686264892442,1.82019087736349e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0513347022587269,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.992017220093845,2.69666876384237,1.86500220608976,3.89920312058503,1.34463766366785e-07
primary,Nervous system disorders,G81 (hemiplegia),0.236929395040278,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,0.465425394745813,1.59269156742473,1.33421198759719,1.90124691767624,2.58676279404755e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0337254746364592,HNMT;Histamine N-methyltransferase,1.11116699047031,3.03790152876539,1.95814050029566,4.71306614468249,7.08612339675823e-07
primary,Nervous system disorders,G40 (epilepsy),1.21426314958142,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.377698469325415,1.45892296651968,1.34791220387875,1.57907630490602,8.45460014424889e-21
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.951666403411783,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.344966078698628,1.4119420239444,1.29187468122809,1.54316847287777,2.78723939901517e-14
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.033564997630706,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,1.25834684605274,3.51959823760815,2.31393201302552,5.35347265366598,4.08787246957372e-09
primary,Nervous system disorders,G62 (other polyneuropathies),0.331701153056389,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.475266880015218,1.60844340160973,1.38703205308673,1.8651985514138,3.1811548836989e-10
primary,Nervous system disorders,G81 (hemiplegia),0.236929395040278,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.530093745692053,1.69909158366913,1.42363677664298,2.02784323716529,4.25734720529856e-09
primary,Nervous system disorders,G40 (epilepsy),1.21421017586463,THBS2;Thrombospondin-2,0.193425899312798,1.21339946948554,1.12070461656281,1.31376122734591,1.83719600898429e-06
primary,Nervous system disorders,G47 (sleep disorders),2.04457326387528,THBS2;Thrombospondin-2,0.24387993174539,1.27619109125318,1.20007191420114,1.35713841989055,7.69599722167885e-15
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0548352982648544,THBS2;Thrombospondin-2,1.03297594234211,2.80941406087835,1.9428901242221,4.06240541709539,4.02629354227973e-08
primary,Nervous system disorders,G40 (epilepsy),1.21447180270709,CCDC80;Coiled-coil domain-containing protein 80,0.215211872134119,1.24012461698272,1.14570311341987,1.34232773537287,1.00233710573684e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372176842765078,CCDC80;Coiled-coil domain-containing protein 80,1.33033682894567,3.78231716693739,2.52396543791927,5.66803448905502,1.14898117901013e-10
primary,Nervous system disorders,G81 (hemiplegia),0.23505905858847,CCDC80;Coiled-coil domain-containing protein 80,0.465886594566258,1.59342628590264,1.33408757958172,1.90317889729665,2.74273792807587e-07
primary,Nervous system disorders,G62 (other polyneuropathies),0.331145177941835,RARRES2;Retinoic acid receptor responder protein 2,0.374137925413224,1.45373764399522,1.25627037667626,1.68224386788464,5.08959378685037e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0350740452065471,CD300E;CMRF35-like molecule 2,1.44492649247108,4.24154034621121,2.81231346241245,6.39710499878089,5.50606678215143e-12
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0623538581449727,CD300E;CMRF35-like molecule 2,0.835443579350852,2.30583664299056,1.66026068809618,3.20243842565162,6.19407236830613e-07
primary,Nervous system disorders,G81 (hemiplegia),0.235775526110678,CD300E;CMRF35-like molecule 2,0.485353258811444,1.62474886433121,1.36098479452244,1.93963142187188,7.87173513956209e-08
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0600693704342434,CTSO;Cathepsin O,0.852754012630896,2.34609914968462,1.65328215938001,3.32924491377505,1.79305377439e-06
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0570720091315214,IGSF3;Immunoglobulin superfamily member 3,0.912117119756707,2.4895877132438,1.76588842741375,3.50987462498516,1.94024711503128e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0336214227795028,ACVRL1;Serine/threonine-protein kinase receptor R3,1.34897096410616,3.85345814301033,2.45569215836698,6.04682456200343,4.40877267615319e-09
primary,Nervous system disorders,G62 (other polyneuropathies),0.332258766291557,ACVRL1;Serine/threonine-protein kinase receptor R3,0.469958940377718,1.59992849940882,1.37571170872654,1.8606886798907,1.05728818947435e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0232558139534883,GM2A;Ganglioside GM2 activator,1.33698073034112,3.8075301728587,2.27509895719346,6.37215624023366,3.60631744377687e-07
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351219512195121,SCG2;Secretogranin-2,1.47833159978279,4.38562260000411,2.79675052732412,6.87715454122725,1.18963455339707e-10
primary,Nervous system disorders,G62 (other polyneuropathies),0.339512195121951,SCG2;Secretogranin-2,0.382369827494375,1.46575406105975,1.26536180752589,1.69788194549186,3.43689238972179e-07
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0624390243902439,SCG2;Secretogranin-2,1.31076462156071,3.70900861621454,2.64322015210221,5.20453996395747,3.3624658765241e-14
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353121199042649,TGFA;Protransforming growth factor alpha,1.23872274402414,3.45120257932909,2.24068959467777,5.31568463202535,1.90052706838563e-08
primary,Nervous system disorders,G62 (other polyneuropathies),0.335465139090516,TGFA;Protransforming growth factor alpha,0.373270841771674,1.45247767819182,1.25084465159742,1.68661344392467,9.82025665413275e-07
primary,Nervous system disorders,G70 (myasthenia gravis and other myoneural disorders),0.0490446109781457,TGFA;Protransforming growth factor alpha,0.946153420340874,2.57578262593842,1.76164827558954,3.76616389776552,1.0538380610846e-06
primary,Nervous system disorders,G40 (epilepsy),1.20785301176378,IGFBP6;Insulin-like growth factor-binding protein 6,-0.273467173279417,0.760737308457047,0.695637145876899,0.831929772451921,2.08104812862238e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.946217098792146,IGFBP6;Insulin-like growth factor-binding protein 6,0.281552922338749,1.32518612641486,1.19775508301265,1.46617475855361,4.81297064729344e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0373765589959475,IGFBP6;Insulin-like growth factor-binding protein 6,1.41170071298835,4.10292737560739,2.69913393512212,6.23682020016059,3.91738744971387e-11
primary,Nervous system disorders,G35 (multiple sclerosis),0.685173551122977,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.272878078314842,0.761185587001175,0.683803853027111,0.847324119765309,6.07511938797834e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.952175278781215,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.238852213145882,0.787531260540408,0.71993293590114,0.861476750681024,1.82478937981815e-07
primary,Nervous system disorders,G40 (epilepsy),1.20916872076548,LAMP3;Lysosome-associated membrane glycoprotein 3,0.22804306792536,1.25613942358632,1.16172148642736,1.35823109921144,1.06566607911306e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0349623183901794,RSPO3;R-spondin-3,1.44640436886231,4.24781345284766,2.8413292628532,6.35052028854771,1.79342849407207e-12
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0621552326936524,RSPO3;R-spondin-3,0.884764013514498,2.42241266737681,1.74449686850397,3.36376822281138,1.27703701044325e-07
primary,Nervous system disorders,G40 (epilepsy),1.21447180270709,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.22849877014066,1.25671197955198,1.16040571743444,1.36101104624097,1.94143930508406e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.953948012771542,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.249032805762802,1.28278411509094,1.17377092993807,1.40192182644742,3.88779029977562e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0372176842765078,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.3741002066207,3.95151957166124,2.5918921031566,6.02436610158477,1.69928447702984e-10
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.947545875559517,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.277684787919909,1.32007002960211,1.20726659321087,1.44341348700712,1.10900304240263e-09
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0348789892843994,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,1.67200444099947,5.32282640281434,3.48634565197614,8.12669876793139,9.59932466169763e-15
primary,Nervous system disorders,G62 (other polyneuropathies),0.333288119828705,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.484708916131941,1.6237023065016,1.39777379898646,1.88614866157191,2.28752708671433e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0600693704342434,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,1.395669939874,4.03767866867874,2.90137073521562,5.61901615454591,1.26237558488946e-16
primary,Nervous system disorders,G81 (hemiplegia),0.23446431685624,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.538203432578946,1.71292670784289,1.43221138983809,2.04866259775604,3.77862579881148e-09
primary,Nervous system disorders,G40 (epilepsy),1.21034976558055,GGT1;Glutathione hydrolase 1 proenzyme,0.771503494393245,2.16301589253286,1.99754816121075,2.34219021208176,1.68824393370634e-80
primary,Nervous system disorders,G40 (epilepsy),1.20719780344459,CKB;Creatine kinase B-type,0.386029993683859,1.471128794725,1.35368448584051,1.59876245410707,9.56165468043451e-20
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.954546345479135,LGALS9;Galectin-9,0.216861019385293,1.24217145238853,1.13693700121008,1.35714636385901,1.57520829177966e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352809737548756,LGALS9;Galectin-9,1.11202297107137,3.04050302679902,2.07624513887037,4.45258533440986,1.10603856269971e-08
primary,Nervous system disorders,G40 (epilepsy),1.21421017586463,DSG2;Desmoglein-2,0.220240659197411,1.24637664650059,1.14962932400868,1.35126576236352,9.17741885476278e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,DSG2;Desmoglein-2,1.18648965065133,3.27556263294608,2.13360541513383,5.0287229711027,5.802466010834e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.953948012771542,LEP;Leptin,0.35579825343433,1.42731956239491,1.25312240836095,1.62573194733614,8.43091150826488e-08
primary,Nervous system disorders,G62 (other polyneuropathies),0.336917983976807,LEP;Leptin,0.530799810754855,1.70029167649681,1.37041182370753,2.1095788398432,1.41142929949885e-06
primary,Nervous system disorders,G40 (epilepsy),1.21506445887699,GUSB;Beta-glucuronidase,0.555863673481682,1.74344610288101,1.60500497140768,1.89382859729406,1.34224695196032e-39
primary,Nervous system disorders,G40 (epilepsy),1.20520871813816,CFB;Complement factor B,-0.402377470997795,0.668728272514413,0.612649143489847,0.729940631129801,2.17042065374025e-19
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351658656663931,ANGPTL4;Angiopoietin-related protein 4,1.39535662320204,4.03641379479923,2.57793715604192,6.32002850987287,1.06350855054837e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0605634353143437,ANGPTL4;Angiopoietin-related protein 4,0.989626415002287,2.69022925530375,1.91186121356701,3.78549101510842,1.35544128920644e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.954778427904023,RNASE1;Ribonuclease pancreatic,0.252956499966744,1.28782725508774,1.16906193571605,1.41865797549125,2.98893943290783e-07
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.946248380383996,FSTL3;Follistatin-related protein 3,0.217279945575659,1.2426919395581,1.13709424749008,1.3580960945422,1.6225097936731e-06
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353370764458753,FSTL3;Follistatin-related protein 3,1.30910255740347,3.70284912608648,2.59156429134287,5.2906623603209,6.46480389242602e-13
primary,Nervous system disorders,G62 (other polyneuropathies),0.329812713494836,FSTL3;Follistatin-related protein 3,0.447160922962428,1.56386594097847,1.35144614006799,1.80967380707412,1.93155880458177e-09
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.060858298323452,FSTL3;Follistatin-related protein 3,0.897645158873614,2.45381795083629,1.8007128069594,3.34379947350603,1.30670560460811e-08
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332928596608045,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.51730333138012,4.55991202866205,3.02707558483467,6.86893905567029,3.91360660828863e-13
primary,Nervous system disorders,G62 (other polyneuropathies),0.330970193098586,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.545369843843906,1.72524633613417,1.48940721383473,1.99842923593805,3.54524885170067e-13
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0548352982648544,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.00480180370397,2.73136587257689,1.94563854529936,3.83440158908336,6.40810861693161e-09
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94572288571706,NTRK3;NT-3 growth factor receptor,-0.240296723603757,0.786394484638661,0.718875655878463,0.86025487219261,1.55073790658873e-07
primary,Nervous system disorders,G35 (multiple sclerosis),0.674853847059285,CLEC4A;C-type lectin domain family 4 member A,-0.35738590461177,0.699502504399732,0.629130069408866,0.777746570150826,3.9433050596745e-11
primary,Nervous system disorders,G40 (epilepsy),1.20638419302147,CES2;Cocaine esterase,0.258097752385374,1.29446534951548,1.1949346370677,1.40228635869839,2.56893037826925e-10
primary,Nervous system disorders,G40 (epilepsy),1.20287782846508,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,0.237588681192484,1.26818745618003,1.1622042161126,1.38383547548287,9.5073576100612e-08
primary,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.952604962954251,COLEC12;Collectin-12,0.301720639378177,1.35218342713775,1.23699894432264,1.47809343655277,3.09257128056516e-11
primary,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352816652946019,COLEC12;Collectin-12,1.40883881029263,4.09120198315995,2.77701451094061,6.02731228125365,1.02909444367084e-12
primary,Nervous system disorders,G62 (other polyneuropathies),0.331255635265984,COLEC12;Collectin-12,0.471994495848658,1.60318855950982,1.38287028183614,1.85860784710083,3.9076198147929e-10
primary,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0607628680073699,COLEC12;Collectin-12,0.960435568796338,2.61283429469417,1.89571679171549,3.60122518372173,4.43255934142984e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332219421156514,CDH3;Cadherin-3,1.32151357956492,3.74909163346983,2.3451489761424,5.99351607046902,3.37644721301838e-08
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.660371779455538,CHRDL2;Chordin-like protein 2,-0.270158033105505,0.763258864636678,0.686714983278934,0.848334620084795,5.42865538957365e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.21553223505501,OXT;Oxytocin-neurophysin 1,-0.386490535371851,0.679437155964236,0.627775104405161,0.7353506783965,9.83036471177801e-22
sensitivity,Nervous system disorders,G20 (parkinson's disease),0.295026412837635,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,-0.389578036731054,0.677342627914672,0.57606176832605,0.796430280251958,2.42397450967733e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351837372947615,KLK4;Kallikrein-4,1.26243034538252,3.53399989922806,2.33298114276618,5.35330314454909,2.55120547822638e-09
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.340109460516028,KLK4;Kallikrein-4,0.330008397900337,1.39097980972454,1.20277185011008,1.60863827240738,8.62417322295263e-06
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0625488663017982,KLK4;Kallikrein-4,0.776828555137394,2.17456480559262,1.57031399977092,3.01132900452513,2.91342892297178e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0378154605525037,ACAN;Aggrecan core protein,1.07064243489713,2.91725304325651,1.88974168150937,4.5034543089466,1.34613901752588e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,CCN5;CCN family member 5,1.26007498729172,3.52568585908705,2.27872983913557,5.45499539413669,1.52679583270274e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351837372947615,ANGPT2;Angiopoietin-2,0.99910901122744,2.71586094851781,1.74164959136948,4.23500842433194,1.04494734726675e-05
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0625488663017982,ANGPT2;Angiopoietin-2,0.80512011071839,2.23696516617787,1.59267248999799,3.14189714842095,3.39742867802267e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.2093476144109,GDF15;Growth/differentiation factor 15,0.353226305086152,1.42365328696062,1.32073679069857,1.53458940172459,2.8010274054393e-20
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.946445959104186,GDF15;Growth/differentiation factor 15,0.227067128358582,1.25491410543694,1.15001124928275,1.36938609340281,3.43023657479479e-07
sensitivity,Nervous system disorders,G46 (vascular syndromes of brain in cerebrovascular diseases),0.0175267770204479,GDF15;Growth/differentiation factor 15,0.911065275655851,2.48697043182138,1.66829917240863,3.7073817640418,7.73448553250608e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370009737098344,GDF15;Growth/differentiation factor 15,1.08241893269794,2.95181115467374,2.28388494392763,3.81507357278345,1.34362931680794e-16
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.336903602726387,GDF15;Growth/differentiation factor 15,0.408167211475339,1.50405863600831,1.30929126446402,1.72779918567412,7.99449779695333e-09
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0603700097370983,GDF15;Growth/differentiation factor 15,0.723928652419881,2.06252023981024,1.57512405628863,2.70073314075993,1.41730400800865e-07
sensitivity,Nervous system disorders,G72 (other myopathies),0.0370009737098344,GDF15;Growth/differentiation factor 15,0.789647449523031,2.20261975471091,1.59773845459364,3.03650060489823,1.43156170813002e-06
sensitivity,Nervous system disorders,G81 (hemiplegia),0.233690360272638,GDF15;Growth/differentiation factor 15,0.420841963706845,1.52324353162458,1.29292587345391,1.79458923692026,4.86654143649996e-07
sensitivity,Nervous system disorders,G20 (parkinson's disease),0.299675161275563,VGF;Neurosecretory protein VGF,-0.603730886404705,0.546767897071899,0.459748608831648,0.650257831183343,8.7171653716874e-12
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0281439091889863,PRRT3;Proline-rich transmembrane protein 3,1.1990765310825,3.31705231320954,1.98633030577974,5.53927814349566,4.58176916531937e-06
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0539424926122238,PRRT3;Proline-rich transmembrane protein 3,0.87472805148235,2.39822301208444,1.63025982384124,3.52794906160396,8.9262010056117e-06
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.677125366612207,KLK6;Kallikrein-6,-0.308773598636138,0.734347008371502,0.659640780399906,0.817513932927624,1.69218213440447e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.21050149347586,PLA2G15;Phospholipase A2 group XV,0.221690256925041,1.24818470141466,1.1526349436461,1.35165522911992,4.87295828015618e-08
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.675347783888709,GFAP;Glial fibrillary acidic protein,0.345645908837929,1.41290223103911,1.26620152336135,1.57659952041108,6.41956067632026e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370587087965671,SPP1;Osteopontin,1.25334918131623,3.50205234637015,2.29431976410154,5.34553675935377,6.30080053538758e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353717968872818,SEZ6L;Seizure 6-like protein,1.13937110840182,3.12480258502795,2.04721987876997,4.76958596223876,1.28725143506264e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0628831944662789,SEZ6L;Seizure 6-like protein,0.876987664042722,2.4036481940214,1.72285784096716,3.35345407104453,2.44711227882492e-07
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.948672846216178,TFPI;Tissue factor pathway inhibitor,-0.281357494514652,0.754758465233307,0.689231568820007,0.826515160668887,1.2642550774117e-09
sensitivity,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.132916340891321,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.757063684795853,2.13200677655625,1.73515203500496,2.61962802312523,5.84309185397489e-13
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936278342455043,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.254768780099224,1.29016327495804,1.18151559632884,1.40880178071486,1.37738105908031e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351837372947615,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.45632873760336,4.29018020379082,3.10503240307778,5.92768248175271,1.05920801967982e-18
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.340109460516028,EDA2R;Tumor necrosis factor receptor superfamily member 27,0.612758421379827,1.84551509236123,1.61236183995871,2.11238313368932,5.98361015600443e-19
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0625488663017982,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.07218616634229,2.92175997636503,2.23460316508852,3.82022253116715,4.59112449999994e-15
sensitivity,Nervous system disorders,G71 (primary disorders of muscles),0.0332290852228303,EDA2R;Tumor necrosis factor receptor superfamily member 27,1.06949834963081,2.91391736554533,2.01432086152048,4.21527402879467,1.36779300398532e-08
sensitivity,Nervous system disorders,G20 (parkinson's disease),0.298100840999723,ITGA11;Integrin alpha-11,-0.428969541138492,0.651179763073191,0.554546909938568,0.764651423056404,1.65853977347639e-07
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.669246258933154,ITGA11;Integrin alpha-11,-0.329127289214916,0.71955141978223,0.646822636529689,0.800457832596058,1.41387958182135e-09
sensitivity,Nervous system disorders,G81 (hemiplegia),0.236901330595806,ITGA11;Integrin alpha-11,-0.528407760573699,0.589542916237179,0.492595376661822,0.705570670274574,8.1863899510228e-09
sensitivity,Nervous system disorders,G40 (epilepsy),1.2111563419451,CHI3L1;Chitinase-3-like protein 1,0.189394695717697,1.20851785518318,1.11493757661115,1.30995262598987,4.10970200653936e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.21097482498391,FLT3LG;Fms-related tyrosine kinase 3 ligand,0.208209135227134,1.23147068652172,1.13762262435739,1.33306073498576,2.63130980393486e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.20424843052868,COL9A1;Collagen alpha-1(IX) chain,0.229583695964796,1.25807615871488,1.16104783525761,1.36321310204728,2.06553426429051e-08
sensitivity,Nervous system disorders,G55 (nerve root and plexus compressions in diseases classified elsewhere),0.452086705886998,COL9A1;Collagen alpha-1(IX) chain,0.324953098135316,1.38396573388493,1.21504401783346,1.57637182230067,9.94621791313764e-07
sensitivity,Nervous system disorders,G95 (other diseases of spinal cord),0.18359853121175,COL9A1;Collagen alpha-1(IX) chain,0.55226902287656,1.73719027378844,1.41884959567753,2.12695556776339,8.92445569117258e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.21408017659348,TIMP4;Metalloproteinase inhibitor 4,0.220348384347835,1.24651091984449,1.14912861720308,1.35214583470509,1.10100584313581e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,TIMP4;Metalloproteinase inhibitor 4,1.07470339479078,2.92912397824626,1.87056792842546,4.58671783556085,2.64133793970058e-06
sensitivity,Nervous system disorders,G56 (mononeuropathies of upper limb),2.8800600403396,FSHB;Follitropin subunit beta,0.198480604884543,1.21954837390335,1.13119110674692,1.31480722171471,2.31081922145432e-07
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94706501349682,OCLN;Occludin,0.222278209925341,1.24891879113877,1.13378692708474,1.37574186965637,6.65133950514554e-06
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.675341136395143,OMG;Oligodendrocyte-myelin glycoprotein,-0.399639732887583,0.670561583809465,0.601320535313511,0.747775622608036,6.62886443251384e-13
sensitivity,Nervous system disorders,G81 (hemiplegia),0.237656704889786,OMG;Oligodendrocyte-myelin glycoprotein,-0.473688279315207,0.622701331202336,0.519425996060141,0.746510476607461,3.06093717061945e-07
sensitivity,Nervous system disorders,G91 (hydrocephalus),0.0475313409779573,OMG;Oligodendrocyte-myelin glycoprotein,-1.07667331468837,0.340727134301334,0.228651001727661,0.50773877731564,1.22084258195657e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.207333723425,IGFBP2;Insulin-like growth factor-binding protein 2,0.316103624884546,1.37177239801753,1.26999882662636,1.48170177208865,9.20813260335127e-16
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370587087965671,IGFBP2;Insulin-like growth factor-binding protein 2,1.40127701722772,4.06038183502747,2.88934284155965,5.70603820670919,6.92038742795583e-16
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604642090891359,IGFBP2;Insulin-like growth factor-binding protein 2,0.898287372811334,2.45539433305808,1.82031032114797,3.31205139078242,4.03348409074213e-09
sensitivity,Nervous system disorders,G91 (hydrocephalus),0.0473102170356206,APLP1;Amyloid-like protein 1,-0.922953526328774,0.397343741098256,0.265654440712745,0.594313605924912,7.0186085497035e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.20610777731566,DPP6;Dipeptidyl aminopeptidase-like protein 6,-0.237399621719651,0.788676052953886,0.726778624466442,0.855845088949284,1.24964496138319e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0574337036816984,DPP6;Dipeptidyl aminopeptidase-like protein 6,0.835615050480786,2.30623206130562,1.62410692512844,3.27484985027902,3.00333920910973e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.20501285347043,DPP4;Dipeptidyl peptidase 4,0.236885859154085,1.26729645922983,1.16848717282297,1.37446122895505,1.06823727847158e-08
sensitivity,Nervous system disorders,G56 (mononeuropathies of upper limb),2.92215616966581,DPP4;Dipeptidyl peptidase 4,0.191136492558355,1.21062468206477,1.14919867014974,1.27533398610133,6.27650750998371e-13
sensitivity,Nervous system disorders,G91 (hydrocephalus),0.0469015653397432,NCAN;Neurocan core protein,-1.21435080913718,0.296902698261798,0.196232054191326,0.449219229745152,9.05643353244153e-09
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.942094682486499,OGN;Mimecan,0.260566328324936,1.29766478292932,1.18452767148543,1.42160789434603,2.16310033166783e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,OGN;Mimecan,1.53911206667088,4.66045026411689,3.01256987581965,7.20972377724442,4.71955696337392e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.333083684812172,OGN;Mimecan,0.429324905130848,1.53622007910768,1.32081304377217,1.78675713613006,2.55125319145498e-08
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.667567352777557,BCAN;Brevican core protein,-0.261875231726345,0.769607040259346,0.68987415780449,0.858555128810329,2.69364257208684e-06
sensitivity,Nervous system disorders,G81 (hemiplegia),0.236430104108718,BCAN;Brevican core protein,-0.510255190656917,0.600342357502187,0.499220351271373,0.721947623516188,5.89710816542621e-08
sensitivity,Nervous system disorders,G91 (hydrocephalus),0.047683382341254,BCAN;Brevican core protein,-1.07936237025713,0.339812130902271,0.225143098885555,0.512883960822798,2.76177550233998e-07
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.688538793005175,TF;Serotransferrin,-0.335502697806296,0.714978577835432,0.638737992555806,0.800319337069831,5.48626190531192e-09
sensitivity,Nervous system disorders,G40 (epilepsy),1.20152299309181,TF;Serotransferrin,-0.286180757821847,0.751126831625201,0.689182091489807,0.81863925971683,7.17702190727679e-11
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0377365985421756,PTGDS;Prostaglandin-H2 D-isomerase,1.52477241755918,4.59409791430816,2.98984539939592,7.05913946270095,3.46937909512491e-12
sensitivity,Nervous system disorders,G91 (hydrocephalus),0.04575193301917,LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,-1.06302522000938,0.345409289056971,0.224336111077771,0.531825110071031,1.38231453175568e-06
sensitivity,Nervous system disorders,G81 (hemiplegia),0.246552826225915,BGLAP;Osteocalcin,0.456735000683798,1.57891041862405,1.30854213940535,1.90514163431717,1.87782428601003e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0373692077727952,CST3;Cystatin-C,1.44881849952286,4.25808061769678,2.920352832643,6.20858217683091,5.07782295761825e-14
sensitivity,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.132160328231024,MEGF10;Multiple epidermal growth factor-like domains protein 10,0.626884896263825,1.87177072812727,1.47883139878671,2.36911771115255,1.84461344118686e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332219421156514,SCARA5;Scavenger receptor class A member 5,1.56517044540867,4.78349019035547,2.99809362166701,7.63210936305057,5.16231530429753e-11
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.054718492896367,SCARA5;Scavenger receptor class A member 5,0.947071477263241,2.57814842681245,1.78543976809013,3.7228079207542,4.36664507721229e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0347655371275486,EPHA2;Ephrin type-A receptor 2,1.52530602847896,4.59655002930127,3.01446540444064,7.00896156935329,1.3785909941188e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.339475244892533,EPHA2;Ephrin type-A receptor 2,0.403305854226068,1.49676461344439,1.28565702062996,1.74253651799109,2.00151249145056e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0572608846806683,EPHA2;Ephrin type-A receptor 2,1.20620026754731,3.34076648620188,2.37131456645654,4.70655427719451,5.29789404935162e-12
sensitivity,Nervous system disorders,G40 (epilepsy),1.20152299309181,AFM;Afamin,-0.247588610277437,0.780681041382299,0.717570821987329,0.849341792752706,8.57523298430098e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0337757291583883,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,1.16656671869319,3.21094959920961,2.20660415678501,4.67242722124032,1.09216401662903e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370009737098344,DPT;Dermatopontin,1.38828240170989,4.00796007221161,2.62972854987173,6.10851790814151,1.06811865055273e-10
sensitivity,Nervous system disorders,G40 (epilepsy),1.19072634306927,GHR;Growth hormone receptor,-0.251494833428094,0.777637475319321,0.711714034776017,0.849667160506844,2.63011528656508e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035648505733468,TAFA5;Chemokine-like protein TAFA-5,1.47235545469168,4.35949164200056,2.80369236338719,6.77862080193143,6.25630828122347e-11
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0574337036816984,TAFA5;Chemokine-like protein TAFA-5,0.943818820917755,2.56977621931063,1.78490577793673,3.69977502396125,3.86095270082467e-07
sensitivity,Nervous system disorders,G20 (parkinson's disease),0.294533459000942,AOC3;Membrane primary amine oxidase,-0.41284450499018,0.661765176010495,0.56289272093294,0.778004639062253,5.72352162290665e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0373075714734527,AOC3;Membrane primary amine oxidase,1.32682236541219,3.7690476824,2.47767335475442,5.73349202990999,5.67984119934354e-10
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0608702481935281,AOC3;Membrane primary amine oxidase,1.10265833590196,3.01216273060031,2.14434840253329,4.23118011275535,2.02145044371056e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0354477244530219,SPON1;Spondin-1,1.31317342936729,3.7179536742616,2.41236967785006,5.73012488545072,2.68076426608388e-09
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.670109188379518,ITGAM;Integrin alpha-M,-0.450867347766763,0.637075346040437,0.571965202945376,0.709597357396065,2.47087954380461e-16
sensitivity,Nervous system disorders,G81 (hemiplegia),0.230596397177657,ITGAM;Integrin alpha-M,-0.578687276881227,0.560633840726706,0.466817436762582,0.6733045482357,5.88587558482324e-10
sensitivity,Nervous system disorders,G40 (epilepsy),1.21363974474415,AMBP;Protein AMBP,0.312862730158824,1.36733382444775,1.26321338293496,1.48003639981638,9.78388590222667e-15
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352347022667658,AMBP;Protein AMBP,1.317695235349,3.7348036067779,2.48314307525397,5.61737989252777,2.49406951079625e-10
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0626394706964726,AMBP;Protein AMBP,0.87485926481249,2.3985377115582,1.72207753004369,3.34072250139685,2.27649193125289e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0574337036816984,IL12A_IL12B;Interleukin-12,1.01037091887849,2.74661959916056,1.92428515739032,3.92037489533194,2.61424443690578e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.21429557058093,CDHR5;Cadherin-related family member 5,-0.424374327720346,0.654178958752626,0.604537023825734,0.707897272141322,5.67866285022415e-26
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0373075714734527,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,1.16457742679953,3.20456843230709,2.09898363623126,4.8924911371761,6.87269149783919e-08
sensitivity,Nervous system disorders,G81 (hemiplegia),0.233663210807414,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,0.467674652890085,1.59627797376889,1.3262487852295,1.92128611005574,7.56868789277124e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.20322078872723,BPIFB2;BPI fold-containing family B member 2,-0.295035463588484,0.744505184172258,0.682333115598094,0.812342178018886,3.32812011111654e-11
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370009737098344,NOTCH3;Neurogenic locus notch homolog protein 3,1.00531301714083,2.73276254047921,1.80819583851751,4.13007869145923,1.83240164695313e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353308340039649,AGRN;Agrin,1.23957741037325,3.45415346687013,2.25526984124717,5.29035415384837,1.20513823726352e-08
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.331717274815003,AGRN;Agrin,0.40577336875615,1.50046246224777,1.29088493750326,1.74406528049596,1.24807266770216e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.19072634306927,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,-0.226315076518274,0.797466799015498,0.729972468271553,0.871201755098861,5.27969912684981e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.21408017659348,PAMR1;Inactive serine protease PAMR1,-0.280442068945461,0.755449706772762,0.697892900117181,0.817753353512018,4.03526962113702e-12
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0549337361807319,PALM2;Paralemmin-2,0.847695026486284,2.33426023828661,1.6470294853608,3.30824123579807,1.89410545205949e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0373002473595351,COL18A1;Collagen alpha-1(XVIII) chain,1.38984248008878,4.01421768397697,2.63859963886943,6.10700591972257,8.46559861437401e-11
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0338321923260627,LAYN;Layilin,1.50837277660057,4.51937078185909,2.93894902602542,6.94966536780791,6.41466231999416e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.334341665339914,LAYN;Layilin,0.456778095879167,1.57897846354321,1.35979549205993,1.83349114105122,2.08976220453168e-09
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0517433529692724,LAYN;Layilin,1.06254085085222,2.8937141524465,2.0091878981575,4.1676448498162,1.13934822011517e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332219421156514,RGMB;RGM domain family member B,1.33837054404787,3.81282560946461,2.32964829103224,6.24027205486356,1.01201819551529e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,1.28422497279558,3.61186757654146,2.34735869859894,5.55756024771924,5.19261302064177e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370009737098344,CCL15;C-C motif chemokine 15,1.37637383516901,3.96051408058004,2.54647323110881,6.15976307579041,1.00949609870806e-09
sensitivity,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.129604503756505,NEFL;Neurofilament light polypeptide,0.604715324552774,1.83073097053962,1.46974137929165,2.28038478994737,6.79653904112363e-08
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.68649885583524,NEFL;Neurofilament light polypeptide,0.389927269354028,1.47687337602174,1.33160776137427,1.63798607373002,1.56955937004603e-13
sensitivity,Nervous system disorders,G40 (epilepsy),1.21301715234604,NEFL;Neurofilament light polypeptide,0.222200063374957,1.24882119625693,1.15421193186518,1.35118546010903,3.24001047409074e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0344261963103217,NEFL;Neurofilament light polypeptide,1.20393812219214,3.33321772822541,2.3499179108611,4.72796959093984,1.47377407625518e-11
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.33413661124724,NEFL;Neurofilament light polypeptide,0.528890421137082,1.69704825468588,1.47537640741315,1.9520257774638,1.30625686482899e-13
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0567019703934711,NEFL;Neurofilament light polypeptide,0.787319680512938,2.19749852753428,1.60355793129996,3.01142832713291,9.71555561449578e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353308340039649,IL10RB;Interleukin-10 receptor subunit beta,1.0920737029474,2.98044823294849,1.929004607586,4.60500282599232,8.66634131530425e-07
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.674609436641944,MEPE;Matrix extracellular phosphoglycoprotein,-0.282472238137225,0.753917571824966,0.673873817366057,0.843469044884548,8.11437315642573e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0339402651333652,IGFBP4;Insulin-like growth factor-binding protein 4,1.50778285727623,4.5167055039278,2.99537780891944,6.81070299327985,6.23229808671534e-13
sensitivity,Nervous system disorders,G40 (epilepsy),1.21325904392764,"NOS3;Nitric oxide synthase, endothelial",0.248638135605678,1.28227793837568,1.183014397272,1.38987041496413,1.46428854560382e-09
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936278342455043,CLMP;CXADR-like membrane protein,0.229973338938692,1.25856645476476,1.1472056757395,1.38073717255459,1.14298093202843e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351837372947615,CLMP;CXADR-like membrane protein,1.20430662954699,3.334446269823,2.31702491225156,4.79862424764874,8.92004660645473e-11
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.340109460516028,CLMP;CXADR-like membrane protein,0.395233972117029,1.4847315360655,1.27975919417179,1.7225332267403899,1.84530754426264e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0625488663017982,CLMP;CXADR-like membrane protein,1.00212628164482,2.72406781035001,2.02614822620426,3.66239021381302,3.2272607771941e-11
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0354463283511549,SCGB1A1;Uteroglobin,1.1212497109541,3.06868677947099,1.96030761374437,4.80375553534327,9.40222144322334e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0371224258528388,FAS;Tumor necrosis factor receptor superfamily member 6,0.967637274189423,2.63171907722477,1.77610089582886,3.89952244137382,1.41325744874759e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.20758718190386,IL18BP;Interleukin-18-binding protein,0.21633256369107,1.24151519322853,1.14657004384598,1.34432255865245,9.84729893800946e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0373075714734527,IL18BP;Interleukin-18-binding protein,1.42715809634091,4.16684058988299,2.76945844374345,6.2692980790958,7.52397254891895e-12
sensitivity,Nervous system disorders,G40 (epilepsy),1.21302530080279,CSF1;Macrophage colony-stimulating factor 1,0.217889083734785,1.24344914123533,1.14860439332813,1.34612559016842,7.34614352978459e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353308340039649,CSF1;Macrophage colony-stimulating factor 1,1.25367677186082,3.50319977353834,2.29767387566404,5.34123174890183,5.68733982336624e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035535199589371,CD83;CD83 antigen,1.28516184434123,3.61525301811489,2.3346324926979,5.59833482394698,8.41360951572277e-09
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.94929795642762,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.224235434295764,1.25136559912849,1.14311747889292,1.36986433292819,1.18844793891238e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0377336007785037,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,1.29141642767523,3.63793578106032,2.49926328965085,5.29539116663768,1.56091668337128e-11
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.335630449029849,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,0.368755046744509,1.44593337420444,1.24357526891574,1.68121976602278,1.63588722253325e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353308340039649,BTN2A1;Butyrophilin subfamily 2 member A1,1.5506758184909,4.71465535743828,3.03388917594155,7.32656133773349,5.40864122227406e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.331717274815003,BTN2A1;Butyrophilin subfamily 2 member A1,0.391975176129459,1.47990097407611,1.27252013006065,1.72107838715843,3.60699841124181e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0608475474512728,BTN2A1;Butyrophilin subfamily 2 member A1,0.860887254715653,2.36525834961507,1.66894187365317,3.35209221407935,1.30567280268964e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0363372093023255,CD28;T-cell-specific surface glycoprotein CD28,1.08765465058227,2.9673065344484,1.91034379089765,4.60906990214721,1.29296891029206e-06
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0565245478036175,CD28;T-cell-specific surface glycoprotein CD28,0.983047938573963,2.67258972977688,1.87382331039716,3.81185132241467,5.74995253952749e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,RELT;Tumor necrosis factor receptor superfamily member 19L,1.29741752823192,3.65983303760462,2.29886126953167,5.8265272640271,4.53753885909357e-08
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.689434754816911,COL15A1;Collagen alpha-1(XV) chain,-0.298675690179198,0.741799943435859,0.661062532347304,0.832398039755107,3.77101385368477e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374539218198663,LPL;Lipoprotein lipase,1.1400004952711,3.12676991378455,1.98675003066674,4.92094624026116,8.35359290160527e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332219421156514,CD74;HLA class II histocompatibility antigen gamma chain,1.17775497650695,3.24707625145046,2.1272777776792,4.95633635313778,4.80858520995295e-08
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.33417365304567,CD74;HLA class II histocompatibility antigen gamma chain,0.379688261452246,1.46182881000561,1.26090378322898,1.69477124122034,4.82890269697827e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351576233446619,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,1.37748512828794,3.96491781909417,2.55409061919817,6.15505698740861,8.30933969095262e-10
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0605492402046955,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,0.855978111568882,2.35367541220869,1.6643995492089,3.32840029226686,1.28787323455349e-06
sensitivity,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.132916340891321,HSPB6;Heat shock protein beta-6,0.671643149418815,1.95745106416089,1.56997474058887,2.44055816283224,2.4049082672021e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351837372947615,HSPB6;Heat shock protein beta-6,1.18786409471164,3.28006780589599,2.25719280702285,4.76647133457148,4.68374111932488e-10
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.340109460516028,HSPB6;Heat shock protein beta-6,0.533291420847202,1.70453342259215,1.47802422921731,1.96575545332725,2.29162089843997e-13
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0625488663017982,HSPB6;Heat shock protein beta-6,0.921459731662801,2.51295595528966,1.8612988487574,3.39276394945478,1.78361474574927e-09
sensitivity,Nervous system disorders,G71 (primary disorders of muscles),0.0332290852228303,HSPB6;Heat shock protein beta-6,1.02972026204116,2.80028237984606,1.89098797782861,4.14681716585034,2.74204329817648e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0376759865159627,REG1A;Lithostathine-1-alpha,1.57564796724465,4.8338727947866,3.16838626474626,7.37483508755498,2.65816897387371e-13
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0614713464207812,REG1A;Lithostathine-1-alpha,1.02879408589129,2.79769002576652,1.99728945317325,3.91884584772527,2.18626739778162e-09
sensitivity,Nervous system disorders,G40 (epilepsy),1.21553223505501,CXCL13;C-X-C motif chemokine 13,0.514561378198169,1.67290456843361,1.54626959275164,1.80991057976236,1.40200751683326e-37
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,1.38510747638452,3.99525527733498,2.62397006499208,6.08317333495234,1.06605775697584e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332219421156514,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,1.41125343280436,4.10109262784967,2.61203065159427,6.43903651434463,8.71393224635424e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,CD99L2;CD99 antigen-like protein 2,1.10485762279311,3.01879463066002,1.94172099869896,4.69332155763262,9.23670841364975e-07
sensitivity,Nervous system disorders,G20 (parkinson's disease),0.302107836354411,PALM;Paralemmin-1,-0.415453378771808,0.660040964296521,0.556718411012784,0.782539369870915,1.72675020775192e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.02767400027674,PALM;Paralemmin-1,1.37957719629528,3.97322137959332,2.47643381432882,6.37468606668013,1.06858930350432e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0516569975363585,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,0.934009664396763,2.54469211025892,1.73433902626372,3.73367481095322,1.79776907018766e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332219421156514,THY1;Thy-1 membrane glycoprotein,1.3876638803592,4.00548182983616,2.58529815382695,6.20581601599733,5.23033924306461e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035389182706486,CHRDL1;Chordin-like protein 1,1.45570861607655,4.287520595418,2.91032441904713,6.31642051168722,1.78485134032931e-13
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.332265104299785,CHRDL1;Chordin-like protein 1,0.452000269392064,1.57145237191439,1.35506663757247,1.82239196857452,2.23420562366487e-09
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0609480368833926,CHRDL1;Chordin-like protein 1,0.878427053290504,2.40711047057136,1.73742035412038,3.3349331978258,1.28600739955338e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,HAVCR2;Hepatitis A virus cellular receptor 2,1.35006849019176,3.8576897355589,2.57309790997759,5.78360039784344,6.39402334678581e-11
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.333083684812172,HAVCR2;Hepatitis A virus cellular receptor 2,0.399666375561298,1.49132707147861,1.28365201086894,1.73260074793904,1.75381974009584e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0232174781175268,NPC2;NPC intracellular cholesterol transporter 2,1.27804650990345,3.58962058362884,2.13860888490951,6.02512035993763,1.31958623324079e-06
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.945168486556299,XG;Glycoprotein Xg,0.312242108973224,1.36648549138248,1.22800694269037,1.52057983814644,1.01909873828002e-08
sensitivity,Nervous system disorders,G56 (mononeuropathies of upper limb),2.90790967085437,XG;Glycoprotein Xg,0.231330113116587,1.26027520416315,1.18002156978983,1.345986913198,5.54676473121673e-12
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0371805408790262,XG;Glycoprotein Xg,1.34473274410932,3.83716089969784,2.70581159327948,5.44154803931654,4.53017866724495e-14
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0606629877499902,XG;Glycoprotein Xg,1.14441857950998,3.14061480809352,2.3441271765348,4.20773304091672,1.74292562555169e-14
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353717968872818,DLL1;Delta-like protein 1,1.51634269748786,4.55553372593126,2.92203476089622,7.10220419203089,2.19089794865697e-11
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0628831944662789,DLL1;Delta-like protein 1,0.989096333606848,2.68880359271804,1.89814540993553,3.80880449009385,2.58915378831615e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0275229357798165,ATRAID;All-trans retinoic acid-induced differentiation factor,1.28080843998122,3.59954856857554,2.12561682246905,6.0955247251403,1.88158270866808e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353308340039649,SMOC2;SPARC-related modular calcium-binding protein 2,1.23390012762982,3.43459882214603,2.17644727602396,5.42005735633405,1.15100445541573e-07
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.681749200345544,MXRA8;Matrix remodeling-associated protein 8,-0.378723482254732,0.684734927848922,0.608507387723856,0.770511469334931,3.18832019618611e-10
sensitivity,Nervous system disorders,G40 (epilepsy),1.2047467020059,GPR37;Prosaposin receptor GPR37,0.237658083612935,1.26827547451338,1.16812600002119,1.37701128065206,1.48980909250852e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.20693588866073,VNN1;Pantetheinase,0.484224629353405,1.62291615931799,1.48565781469616,1.77285565634379,6.60326993030478e-27
sensitivity,Nervous system disorders,G40 (epilepsy),1.2116808389466,CPM;Carboxypeptidase M,0.911612626069958,2.4883320487239,2.30289306492643,2.68870338749502,9.16038295225915e-118
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.950730717493901,PROS1;Vitamin K-dependent protein S,-0.322607618009243,0.724257984410258,0.658536305324925,0.796538662698626,2.99480795757571e-11
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353717968872818,NBL1;Neuroblastoma suppressor of tumorigenicity 1,1.61534944561073,5.02964520385394,3.23339743328432,7.82376166203461,7.7255097233753e-13
sensitivity,Nervous system disorders,G72 (other myopathies),0.0357625367559405,ASGR1;Asialoglycoprotein receptor 1,1.06175403168808,2.89143821818758,1.92239191622941,4.3489649009729,3.42912387095666e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352347022667658,CD5;T-cell surface glycoprotein CD5,1.12154685641628,3.0695987613113,1.99667955791655,4.7190529487244,3.19873646770174e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351576233446619,BSG;Basigin,1.31353610003215,3.71930231153336,2.40624025799463,5.74888963752358,3.3806769326082e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.037490134175217,TFF3;Trefoil factor 3,1.31946278821206,3.74141090724222,2.48211977055103,5.63959714712859,2.93483674168603e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374539218198663,NPDC1;Neural proliferation differentiation and control protein 1,1.54490786600173,4.687539725349,3.10011991348673,7.08779959805222,2.41857286971085e-13
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370009737098344,REG1B;Lithostathine-1-beta,1.35730787131874,3.88571835433944,2.54784565778932,5.92610744810624,2.91795184344821e-10
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0603700097370983,REG1B;Lithostathine-1-beta,0.848196205007417,2.33543041258939,1.65929863151653,3.28707268748997,1.15185085366867e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0354477244530219,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,1.39915939656644,4.05179258415822,2.59268841904727,6.3320463131749,8.13513102240994e-10
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.332814746253372,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.389883237169739,1.47680834749276,1.26995105577154,1.71735980320856,4.10909482598146e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0610488587802044,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,0.910405659390592,2.48533052658687,1.75523860947235,3.5191043502862698,2.89105869599446e-07
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.950765346378412,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.245329820062458,1.27804276784448,1.16986989859958,1.39621791995406,5.41708877408079e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0355057598232602,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,1.22748374505807,3.41263167230685,2.3883597204058,4.87617289444704,1.5694687451393e-11
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.333359633896165,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,0.398378976721995,1.48940837406718,1.28691014393231,1.72377016002302,9.13867869803146e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374539218198663,LGALS1;Galectin-1,1.06987777699072,2.91502319529609,1.97202444781982,4.30895278124394,8.07337095777197e-08
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.946445959104186,"FABP4;Fatty acid-binding protein, adipocyte",0.242612974053778,1.27457523496107,1.15657805147148,1.40461080642954,9.84255124720736e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370009737098344,"FABP4;Fatty acid-binding protein, adipocyte",1.21633755566051,3.37480503639053,2.32520288313754,4.89820011674791,1.55967688787931e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0275766976904515,RNASE6;Ribonuclease K6,1.28501002724164,3.61470420254822,2.23236669317584,5.85301980712298,1.73382237484908e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.03383286564372,EFNA4;Ephrin-A4,1.39730680965616,4.04429323499656,2.63060585051177,6.2176961126491,1.91970457671144e-10
sensitivity,Nervous system disorders,G12 (spinal muscular atrophy and related syndromes),0.149424482267516,MYOM3;Myomesin-3,0.713419396687754,2.04095818617567,1.58937419720049,2.62084934124047,2.25327199881275e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.19072634306927,INHBB;Inhibin beta B chain,-0.496255821398808,0.608805875578979,0.557017629519424,0.66540909029983,7.37460575266474e-28
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0280170904251593,INHBB;Inhibin beta B chain,1.58737359896683,4.89088661526472,2.81889157363184,8.48587867200448,1.64084343939651e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0363372093023255,SORCS2;VPS10 domain-containing receptor SorCS2,1.22293036797828,3.39712799729442,2.19965614647415,5.24649211582453,3.49150681875656e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0565245478036175,SORCS2;VPS10 domain-containing receptor SorCS2,0.890974138988123,2.4375029618038,1.69853391878233,3.49796999818623,1.33454788912904e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0344373544008913,SCARB2;Lysosome membrane protein 2,1.05196930811971,2.86328425848735,1.87637742378187,4.36926848564263,1.06844917166358e-06
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.33829636382052,SCARB2;Lysosome membrane protein 2,0.393712152539807,1.48247376094592,1.27557161095892,1.72293615898286,2.84348132520345e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0274668680903659,YAP1;Transcriptional coactivator YAP1,1.48614740296859,4.42003406453641,2.86072995881284,6.82927134435634,2.15678920269268e-11
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.315868983039208,YAP1;Transcriptional coactivator YAP1,0.402517951386512,1.49558577282223,1.27049591383683,1.76055411080648,1.31998451048371e-06
sensitivity,Nervous system disorders,G93 (other disorders of brain),0.729396313147896,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,0.27530500508969,1.31693228466759,1.17620082787151,1.47450214393936,1.80186949389325e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.2047467020059,ACE2;Angiotensin-converting enzyme 2,0.828230741905215,2.2892648547614,2.10621138051363,2.48822773617703,1.68481510753094e-84
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0373839539761988,WFDC2;WAP four-disulfide core domain protein 2,1.49953079632117,4.47958673858837,3.09846234156212,6.47634056395211,1.54934127548203e-15
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352367715286886,GFRA1;GDNF family receptor alpha-1,1.7310977704204,5.64684945146048,3.74370732601125,8.51746836776196,1.52187992189122e-16
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.340622124777323,GFRA1;GDNF family receptor alpha-1,0.408537118249482,1.5046151004001,1.29852570534894,1.74341300370613,5.45852996553757e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0626431493843353,GFRA1;GDNF family receptor alpha-1,1.1755619661615,3.23996318200674,2.35321558579483,4.46085836084311,5.79776831868245e-13
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370009737098344,MFAP5;Microfibrillar-associated protein 5,1.22041921950793,3.38860800647853,2.19907074673178,5.22159836769042,3.16484813690265e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.21363974474415,HAVCR1;Hepatitis A virus cellular receptor 1,0.231494444818824,1.26048232435048,1.16491540753603,1.36388932597308,8.68879815237472e-09
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.340602121912069,HAVCR1;Hepatitis A virus cellular receptor 1,0.369327251656714,1.44676098114168,1.25006947850936,1.67440080134583,7.28327424553125e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0626394706964726,HAVCR1;Hepatitis A virus cellular receptor 1,1.12830536436845,3.0904149328443,2.27075365799442,4.20594476354711,7.20522085020886e-13
sensitivity,Nervous system disorders,G72 (other myopathies),0.0352347022667658,HAVCR1;Hepatitis A virus cellular receptor 1,1.17596219757312,3.24126017657632,2.15407062418304,4.87716949217671,1.69269818426528e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374539218198663,IGSF8;Immunoglobulin superfamily member 8,1.11152502698318,3.03898940317294,1.96890587912706,4.69065418032684,5.18994484813148e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374273613710233,CTSZ;Cathepsin Z,1.21343344798431,3.36501845669745,2.18037224411744,5.19331010769579,4.23630956188892e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0610656948685117,CTSZ;Cathepsin Z,0.892297383695904,2.44073050964506,1.72515311228535,3.45312272765207,4.64946194481169e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0337757291583883,SNCG;Gamma-synuclein,1.1549109238021,3.1737407001814,1.97411854960874,5.10234303506456,1.86472207519366e-06
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.946445959104186,COL6A3;Collagen alpha-3(VI) chain,0.277395917452841,1.31968875542817,1.20639775826635,1.44361873956587,1.38419687761746e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0370009737098344,COL6A3;Collagen alpha-3(VI) chain,1.59178343737232,4.91250226061977,3.37247662357497,7.15577338383822,1.09097368730979e-16
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.336903602726387,COL6A3;Collagen alpha-3(VI) chain,0.429901110067857,1.53710551177243,1.32435041621232,1.78403942445879,1.55151513700102e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0379521802528813,PI3;Elafin,1.36516714279036,3.9163775915692,2.5341133886007,6.05261528893733,7.92529822819967e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035271295044383,CKAP4;Cytoskeleton-associated protein 4,1.66649829023103,5.29359865815366,3.44681481898507,8.12987880847557,2.68113778866125e-14
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.337036819312993,CKAP4;Cytoskeleton-associated protein 4,0.463607425659661,1.58979873372923,1.37079542747983,1.84379081159742,8.75508178201586e-10
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.060745008131993,CKAP4;Cytoskeleton-associated protein 4,0.988780095914997,2.68795342611049,1.91176582235251,3.77927753308631,1.29041076176376e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.20919939935193,IL1R2;Interleukin-1 receptor type 2,0.30308048292882,1.35402343582886,1.24851732889666,1.46844534900768,2.43437900569268e-13
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335616844017136,EFNA1;Ephrin-A1,1.42007291007269,4.1374220889999,2.65530645338037,6.44681201326187,3.48376384347639e-10
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.950765346378412,"FABP1;Fatty acid-binding protein, liver",0.230032581051555,1.25864101710931,1.15061895123834,1.37680437841303,5.049128413762e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0355057598232602,"FABP1;Fatty acid-binding protein, liver",1.19335219612738,3.29811863775673,2.16657899082295,5.02062772453389,2.60373450985579e-08
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936278342455043,ADM;Pro-adrenomedullin,0.267369607373599,1.30652325772966,1.19472407722727,1.42878431558036,4.68120422638722e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351837372947615,ADM;Pro-adrenomedullin,0.952562241498109,2.59234336685814,1.76876498701236,3.79939911805052,1.04053344689397e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.21408017659348,INHBC;Inhibin beta C chain,-0.342560683741086,0.709950035654175,0.655878713526803,0.768479053718773,2.34366256624266e-17
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.953042787650154,PLAUR;Urokinase plasminogen activator surface receptor,0.231894420157043,1.26098658703407,1.15183934210743,1.38047652528571,5.1605004181243e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0357391045368807,PLAUR;Urokinase plasminogen activator surface receptor,1.29899921858397,3.66562634060826,2.3596378232896,5.69444019600799,7.47477488806401e-09
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.335550481485158,PLAUR;Urokinase plasminogen activator surface receptor,0.38063205615301,1.46320912755565,1.25761871047444,1.70240863397656,8.34509237752487e-07
sensitivity,Nervous system disorders,G72 (other myopathies),0.0337535987292762,PLAUR;Urokinase plasminogen activator surface receptor,1.20601501452779,3.34014765644461,2.10744643434972,5.29388846378671,2.85804576282498e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.20706594750666,GGH;Gamma-glutamyl hydrolase,0.285551432131157,1.33049550384302,1.22807318692689,1.44145992648554,2.81405110306304e-12
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035648505733468,CD302;CD302 antigen,1.37810978266949,3.9673952960852,2.68355541360359,5.86543708231548,4.89376964403572e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.334699859386449,CD302;CD302 antigen,0.436846593450271,1.54781861332948,1.33314178938496,1.79706500752216,9.7816739666454e-09
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0574337036816984,CD302;CD302 antigen,1.14432923067089,3.1403342103421,2.26663633269659,4.35080776319887,6.01860449926526e-12
sensitivity,Nervous system disorders,G40 (epilepsy),1.20088582452455,CD80;T-lymphocyte activation antigen CD80,0.230328552082529,1.25901359352196,1.15522998930058,1.37212091389073,1.54196998806002e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.21182546460087,LAMP2;Lysosome-associated membrane glycoprotein 2,0.564021099580278,1.75772630126575,1.61821120440316,1.90926977996109,9.40614689707786e-41
sensitivity,Nervous system disorders,G40 (epilepsy),1.20424843052868,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,0.387415554843974,1.47316854641854,1.36133227096669,1.59419240433918,6.7431185075585e-22
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0388508332481341,CD59;CD59 glycoprotein,1.38258065347969,3.98517271857441,2.72411455429102,5.83000504580581,1.05695494441473e-12
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0355330951299919,FOLR1;Folate receptor alpha,1.37893393464428,3.97066638050344,2.65991127455204,5.92733737252776,1.52145167037186e-11
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0631699468977633,FOLR1;Folate receptor alpha,0.935152475412725,2.54760187477354,1.8480311866225,3.51199447245879,1.13443215548207e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.20693588866073,SHBG;Sex hormone-binding globulin,0.620176786713884,1.85925670467696,1.69812609266147,2.0356765665548,5.37237908999039e-41
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.957025858102512,APCS;Serum amyloid P-component,-0.267152540808785,0.765556283983442,0.690443752698609,0.848840215666878,3.97018076240314e-07
sensitivity,Nervous system disorders,G20 (parkinson's disease),0.291052114060963,LDLR;Low-density lipoprotein receptor,-0.465360122654112,0.627908940234425,0.53314524044066,0.739516378126987,2.47425744740665e-08
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.952118117841865,REN;Renin,0.275798438154085,1.31758226294761,1.19659659246165,1.45080057102853,1.99719192182421e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374539218198663,REN;Renin,1.41786299233939,4.12828882215652,2.5549924875892,6.67037914276742,6.96573368523177e-09
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.339056555421948,REN;Renin,0.410307676358786,1.5072814686509,1.28077618218411,1.77384421832717,7.87355342560901e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0611090303376766,REN;Renin,1.00714673396216,2.73777825040878,1.86361587412256,4.02198213295454,2.86442573167957e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353717968872818,NECTIN4;Nectin-4,1.58980520863949,4.90279381342837,3.06614234177256,7.83961881009585,3.17126780546801e-11
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0332219421156514,MSR1;Macrophage scavenger receptor types I and II,1.05185719841293,2.86296327452172,1.86423549018435,4.39673997969515,1.54341585221334e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.19710917312661,BAIAP2;Brain-specific angiogenesis inhibitor 1-associated protein 2,0.2293003157407,1.25771969532082,1.1590208912887,1.36482339868702,3.81524937538974e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0375412459741953,RETN;Resistin,1.1191370810191,3.06221062318908,2.00411145046215,4.67894831827324,2.29071063136514e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.20736138787949,PLTP;Phospholipid transfer protein,0.210265368236169,1.23400548236934,1.13950606401359,1.3363417524555,2.30718676278039e-07
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.672202451561882,CA6;Carbonic anhydrase 6,-0.382359434937271,0.682249784720424,0.609809115795447,0.763295852250263,2.45095117159922e-11
sensitivity,Nervous system disorders,G40 (epilepsy),1.21408017659348,CD300LG;CMRF35-like molecule 9,0.353161131825186,1.42356050585688,1.31229290879681,1.54426233674731,1.81559703912256e-17
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,CD300LG;CMRF35-like molecule 9,1.26801666480931,3.55379719704966,2.28929233766667,5.51675917922761,1.59296519045238e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035100719564751,PGF;Placenta growth factor,1.24454557260289,3.47135696114926,2.40597892448054,5.00848907241408,2.85321590709148e-11
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.335406875840954,PGF;Placenta growth factor,0.406092154045101,1.500940863857,1.28656346679809,1.75103952112247,2.41196860924412e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604512392504046,PGF;Placenta growth factor,0.81734434799215,2.26447817933335,1.62953766121807,3.14681982915562,1.12456796192593e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035100719564751,CLEC7A;C-type lectin domain family 7 member A,1.1950445074311,3.30370480664363,2.10239045776231,5.19145499787756,2.19159377476238e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604512392504046,CLEC7A;C-type lectin domain family 7 member A,0.879056747427914,2.40862669125032,1.68972683788209,3.43338485709031,1.17220578770677e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.21003973562828,PIGR;Polymeric immunoglobulin receptor,0.420627715963655,1.52291721509313,1.40196526089904,1.65430407493816,2.2263286087212e-23
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.038610823223394,LCN2;Neutrophil gelatinase-associated lipocalin,1.23985384428204,3.4551084440025,2.27132760674532,5.25585755413044,6.91723525545405e-09
sensitivity,Nervous system disorders,G20 (parkinson's disease),0.297856372250105,AHNAK;Neuroblast differentiation-associated protein AHNAK,-0.470227829753459,0.624859890389582,0.524249675312793,0.744778492012836,1.52368619014916e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0338321923260627,EPHB6;Ephrin type-B receptor 6,1.24225215408359,3.46340480909938,2.20669999048319,5.43579685658409,6.60680352661354e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0517433529692724,EPHB6;Ephrin type-B receptor 6,0.939260626320225,2.55808933501234,1.75550796540025,3.7275940496299,1.01080625248817e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.037509377344336,NECTIN2;Nectin-2,1.56473237586505,4.78139514791152,3.10670697456175,7.35883356482208,1.13712382462436e-12
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0611995104039167,NECTIN2;Nectin-2,0.924507528625152,2.52062661819049,1.78063394140009,3.56814413148539,1.84989651538757e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353717968872818,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,1.36879060729473,3.93059418786925,2.56880618443628,6.01429985777692,2.84055418507252e-10
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.330136770947964,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,0.372999586088556,1.45208373879857,1.25083436772228,1.6857125442778,9.57032949143379e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.20088582452455,TCTN3;Tectonic-3,0.272481430776748,1.31321907322792,1.20265177674842,1.43395151250865,1.26271275910359e-09
sensitivity,Nervous system disorders,G40 (epilepsy),1.21050149347586,TGFBR2;TGF-beta receptor type-2,0.198516141106232,1.21959171281477,1.12639607346779,1.32049816312592,9.85157220368857e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0353717968872818,TGFBR2;TGF-beta receptor type-2,1.37638435667187,3.96055575135948,2.64925407205328,5.92091261653486,1.96186480839314e-11
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.330136770947964,TGFBR2;TGF-beta receptor type-2,0.394075952549081,1.48301318302883,1.27656621639766,1.72284686276878,2.57000157952523e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0628831944662789,TGFBR2;TGF-beta receptor type-2,1.00904214191165,2.74297237800889,1.98179545405997,3.79650556322856,1.16884596261816e-09
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.690790978544306,CDA;Cytidine deaminase,-0.316362883857501,0.728794934259178,0.649294396241847,0.818029632284092,7.95276448858645e-08
sensitivity,Nervous system disorders,G20 (parkinson's disease),0.285832561256874,CCL27;C-C motif chemokine 27,-0.460091530030497,0.631225866739886,0.536230154229247,0.743050519816867,3.22271454583209e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.21486889621604,ACP5;Tartrate-resistant acid phosphatase type 5,0.195029978662087,1.21534742043324,1.12190086192046,1.31657742897647,1.77209265489241e-06
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.943377607610176,VSIG4;V-set and immunoglobulin domain-containing protein 4,0.226412153133482,1.25409243690389,1.14583559756138,1.37257722106621,8.85654486174414e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335510864631234,VSIG4;V-set and immunoglobulin domain-containing protein 4,1.35458592136359,3.87515600505358,2.56373752569086,5.85739917328557,1.30522428145289e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.037509377344336,FAM3C;Protein FAM3C,1.75203431023231,5.76632123866704,3.74156749971008,8.88677289132937,2.03547847515297e-15
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0611995104039167,FAM3C;Protein FAM3C,1.06560031959072,2.90258093734332,2.03681832555896,4.13634146556333,3.71731871256615e-09
sensitivity,Nervous system disorders,G56 (mononeuropathies of upper limb),2.89569196780811,PRELP;Prolargin,0.222178077113866,1.24879373964989,1.18440403882537,1.31668396346856,1.93869365565304e-16
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0355057598232602,PRELP;Prolargin,1.56470810579343,4.78127910451703,3.04198246598082,7.51504327554375,1.18595879157531e-11
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0611488085845037,PRELP;Prolargin,1.0076843537208,2.73925052981875,1.91663113839043,3.91493872494094,3.19325719532055e-08
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.936278342455043,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.24005169883364,1.27131487411864,1.15908221639825,1.3944148967945,3.5686823668177e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351837372947615,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,1.28371436591863,3.61002380288004,2.27798586904818,5.72096255487565,4.63906257689758e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0625488663017982,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,0.868114209411824,2.38241388100879,1.67176017589615,3.39516156818413,1.56148119111657e-06
sensitivity,Nervous system disorders,G40 (epilepsy),1.2047467020059,NPPB;Natriuretic peptides B,0.220144372104195,1.24625664229376,1.14878386691176,1.35199985236267,1.17052063801564e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.20758147716267,ANG;Angiogenin,-0.261618541260616,0.769804616405811,0.708245434273576,0.836714391314794,7.64074624954351e-10
sensitivity,Nervous system disorders,G40 (epilepsy),1.2093476144109,CCL16;C-C motif chemokine 16,0.205038669884205,1.2275725341331,1.13145840496953,1.33185128144286,8.26469069872735e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035648505733468,AREG;Amphiregulin,1.29504721493792,3.65116835975912,2.2696037066719,5.87372603953597,9.36112560102503e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374539218198663,SEMA3F;Semaphorin-3F,1.19831027147324,3.31451156356136,2.18018060933586,5.03902605955597,2.06266005221918e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.21429557058093,COL4A1;Collagen alpha-1(IV) chain,0.296533802477852,1.34518802991733,1.2434749631152,1.45522096504426,1.44535327029552e-13
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0611090303376766,COL4A1;Collagen alpha-1(IV) chain,0.83983979707647,2.31599591774261,1.66380952705338,3.22382881200339,6.45643124568197e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.18577981651376,MEP1A;Meprin A subunit alpha,-0.236845165922396,0.789113460213892,0.722793420770005,0.861518706724487,1.23721399762691e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0337757291583883,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,1.21495873483828,3.37015499146145,2.16694416759869,5.24145699566358,6.97231944389508e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.21393944210442,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.328558744215722,1.38896483158126,1.28187096489107,1.50500585176568,1.00980933099919e-15
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.949694031629977,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.221582923577138,1.24805073676142,1.14036293391903,1.36590781338157,1.48788523727498e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0337757291583883,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,1.14791487666617,3.15161454869147,2.03262004493276,4.88663598899633,2.90061897838743e-07
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.333783676388778,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,0.368910256361225,1.44615781438644,1.24389197054978,1.68131354942873,1.59412399546188e-06
sensitivity,Nervous system disorders,G47 (sleep disorders),2.03594938704718,THBS2;Thrombospondin-2,0.213935556460893,1.23854283613788,1.16392231823015,1.3179473689284,1.50136011611332e-11
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374539218198663,CCDC80;Coiled-coil domain-containing protein 80,1.35704091208111,3.88468116437983,2.5726754069287,5.8657799224283,1.08773354562533e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0352968860302768,CD300E;CMRF35-like molecule 2,1.42543855666542,4.15968169892973,2.74938785284189,6.29338338660579,1.50573074695848e-11
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.03383286564372,ACVRL1;Serine/threonine-protein kinase receptor R3,1.4054981281056,4.07755738139998,2.64549430851512,6.28482705296071,1.9245483498685e-10
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.334348319302644,ACVRL1;Serine/threonine-protein kinase receptor R3,0.418832343442035,1.52018546436134,1.3048176211792,1.77110104013388,7.72460012081831e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0233950963877971,GM2A;Ganglioside GM2 activator,1.34240755387827,3.82824913544761,2.279589360669,6.42900501990161,3.86991657077755e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035345403133959,SCG2;Secretogranin-2,1.34437522052259,3.83578926937982,2.43531549188467,6.04163171799266,6.63207053106358e-09
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0628362722381494,SCG2;Secretogranin-2,1.10751931603267,3.02684043890667,2.15069288878065,4.25991227775671,2.12396825032535e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035535199589371,TGFA;Protransforming growth factor alpha,1.19990285679142,3.31979441159095,2.14193143211197,5.14537242882869,8.00830071734331e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.20763382958504,IGFBP6;Insulin-like growth factor-binding protein 6,-0.287890502592036,0.749843693684847,0.686050499964181,0.819568770794993,2.2082841701058e-10
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.03761482420019,IGFBP6;Insulin-like growth factor-binding protein 6,1.30955983486557,3.70454274273423,2.41501859471569,5.68262164224061,1.98533854993668e-09
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.679653850713241,DNER;Delta and Notch-like epidermal growth factor-related receptor,-0.268120601618157,0.764815537549194,0.686718158811331,0.851794581184754,1.06694706254492e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351576233446619,LAMP3;Lysosome-associated membrane glycoprotein 3,1.12328600874143,3.07494190605884,1.97472374894136,4.78814706649762,6.64878939201592e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0351837372947615,RSPO3;R-spondin-3,1.45956016851317,4.30406604820028,2.8859861226534,6.41894443007173,8.23431390240375e-13
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0625488663017982,RSPO3;R-spondin-3,0.900520578187178,2.46088386022182,1.77388655519017,3.41394400661153,6.97614684924505e-08
sensitivity,Nervous system disorders,G40 (epilepsy),1.21429557058093,NTproBNP;N-terminal prohormone of brain natriuretic peptide,0.199875673344401,1.2212509146794,1.12722735069899,1.32311711180572,1.0091207990215e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0374539218198663,NTproBNP;N-terminal prohormone of brain natriuretic peptide,1.31562374223354,3.72707499446617,2.4267708085491,5.72410380306167,1.85760832560722e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035100719564751,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,1.51721050074303,4.55948874877033,2.96535256673888,7.01061245915378,4.77594908037745e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.335406875840954,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,0.385627988938773,1.47053751282592,1.26505783116073,1.70939266440024,5.12158837054821e-07
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0604512392504046,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,1.1398306797094,3.12623898467662,2.21974640460836,4.40292195947325,6.85055621517162e-11
sensitivity,Nervous system disorders,G40 (epilepsy),1.21188428459734,SMOC1;SPARC-related modular calcium-binding protein 1,-0.247828577789381,0.780493725770906,0.720536419148048,0.845440202298205,1.22490159498464e-09
sensitivity,Nervous system disorders,G40 (epilepsy),1.2101948551912,GGT1;Glutathione hydrolase 1 proenzyme,0.787707808340122,2.19835160340355,2.03217239577976,2.37811997752907,6.8194029093889e-86
sensitivity,Nervous system disorders,G40 (epilepsy),1.20536937266003,CKB;Creatine kinase B-type,0.339791188468317,1.40465425193258,1.29162920401484,1.52756964718615,2.0379735102114e-15
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0355050594709746,LGALS9;Galectin-9,1.06853334242067,2.91110677061812,1.96781314981107,4.30657892023553,8.89892442226492e-08
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,DSG2;Desmoglein-2,1.19059409117722,3.28903461352047,2.12969901038581,5.07947303172013,7.90916150798675e-08
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.952118117841865,LEP;Leptin,0.337845264059783,1.40192355866121,1.23614749885715,1.58993135216175,1.42711749399275e-07
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.339056555421948,LEP;Leptin,0.539385454742957,1.71495262227889,1.3935774620408,2.11044062979768,3.49576168504559e-07
sensitivity,Nervous system disorders,G40 (epilepsy),1.21486889621604,GUSB;Beta-glucuronidase,0.544399011372329,1.7235722237424,1.58684158554444,1.87208429468849,3.98598564093327e-38
sensitivity,Nervous system disorders,G40 (epilepsy),1.20549090655703,CFB;Complement factor B,-0.431071433830701,0.649812490521345,0.595230478457303,0.70939961598059,5.97630508519061e-22
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.035389182706486,ANGPTL4;Angiopoietin-related protein 4,1.33912271135123,3.81569457105575,2.43738909260618,5.97341027895408,4.7414393214077e-09
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0355618776671408,FSTL3;Follistatin-related protein 3,1.31018736917645,3.70686819998721,2.5756928627435,5.33482545641731,1.74607674244474e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.331910858226647,FSTL3;Follistatin-related protein 3,0.404272868207979,1.49821270580316,1.29246618858945,1.73671182398956,8.14403573233428e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.061245455982298,FSTL3;Follistatin-related protein 3,0.793054972213411,2.2101380335816,1.60309517376942,3.04704936263911,1.29545374796891e-06
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0335054594189759,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,1.45731975935466,4.2944339731306,2.84056226546541,6.49243404159517,4.82438328408288e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.333083684812172,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,0.469542871002879,1.59926295662387,1.37768270396053,1.85648117456703,6.80199780393581e-10
sensitivity,Nervous system disorders,G35 (multiple sclerosis),0.669246258933154,CLEC4A;C-type lectin domain family 4 member A,-0.346964730361278,0.706830257465943,0.635330047304609,0.78637712003228,1.81062889341373e-10
sensitivity,Nervous system disorders,G40 (epilepsy),1.20610777731566,CES2;Cocaine esterase,0.251110104942349,1.28545161111518,1.18672511901024,1.39239139548741,7.32919241596252e-10
sensitivity,Nervous system disorders,G45 (transient cerebral ischaemic attacks and related syndromes),0.950765346378412,COLEC12;Collectin-12,0.236582230060159,1.26691172956469,1.15799530742692,1.38607239616115,2.49154062246507e-07
sensitivity,Nervous system disorders,G59 (mononeuropathy in diseases classified elsewhere),0.0355057598232602,COLEC12;Collectin-12,1.40247013929232,4.0652292573938,2.7491059610458,6.01144122829075,2.11532026615384e-12
sensitivity,Nervous system disorders,G62 (other polyneuropathies),0.333359633896165,COLEC12;Collectin-12,0.416713281250413,1.51696750754903,1.30655803815956,1.76126153737573,4.50397261191695e-08
sensitivity,Nervous system disorders,G63 (polyneuropathy in diseases classified elsewhere),0.0611488085845037,COLEC12;Collectin-12,0.849110921966927,2.33756764772914,1.68138989120623,3.24982476479022,4.39698274392809e-07
